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Message From Donna E. Shalala 
Secretary of Health and Human Services 
This nation is faced with many challenges in its efforts to improve the health 
status of all people living in the United States. One of the biggest challenges is to 
remedy the fact that approximately one-fourth of our adults continue to smoke 
and that tobacco use rates among our youth have increased since the early 1990s. 
Tobacco use, particularly cigarette smoking, remains the leading cause of prevent­
able illness and death in this country.  Our overall success in improving the health 
status of the U.S. population thus depends greatly on achieving dramatic reduc­
tions in the rate of tobacco use among both adults and young people. 
Reducing tobacco use is a key component of Healthy People 2010, the national 
action plan for improving the health of all Americans for the first decade of the 
21st century.  No fewer than 21 specific national health objectives related to to­
bacco are listed, including a goal to more than halve the current  rates of tobacco 
use among young people and adults. Attaining all of the Healthy People 2010 to­
bacco use objectives will require significant commitment and progress in numer­
ous areas. 
This Surgeon General’s report provides a major resource in our national ef­
forts to achieve the Healthy People 2010 tobacco use objectives. The research find­
ings reviewed indicate that many strategies and approaches have been shown to 
be effective in preventing tobacco use among young people and in helping to­
bacco users end their addiction. The challenge to public health professionals, health 
care systems, and other partners in our national prevention effort is to implement 
these proven approaches. 
The Secretary’s Initiative to Prevent Tobacco Use Among Teens and Preteens 
coordinates federal and nonfederal efforts to reduce young people’s demand for 
tobacco products.  This Surgeon General’s report highlights additional strategies 
and approaches that this initiative can expand upon.  Only by a coordinated na­
tional effort will the tobacco use rates among our young people be reduced.  Each 
day that we delay in developing a comprehensive national response to this prob­
lem, 3,000 additional teens and preteens become regular smokers.  That statistic 
poses an urgent public health challenge and—given that we have at hand numer­
ous strategies proven to be effective—a moral imperative. 

Foreword
 
For more than three decades, the Surgeon General of the U.S. Public Health 
Service has released reports focused on tobacco use and the health of the Ameri­
can people. The tone and content of these reports have changed over the years. 
Early on, there was a need for critical review of the epidemiologic and biologic 
aspects of tobacco use. Today, the deleterious effects are well documented, and 
the reports have begun to investigate the social, economic, and cultural conse­
quences of these effects and what can be done to address them.  The present 
report—the 25th in the series—assesses past and current efforts to reduce the use 
of tobacco in this country and thereby ameliorate its disastrous health effects. 
Tobacco use is an extraordinary phenomenon.  Although substantial progress 
has been made since the initial report of the Surgeon General’s Ad Hoc Committee 
in 1964, approximately a quarter of the U.S. adult population smokes, and the 
percentage of high school youth who smoke has steadily increased throughout the 
1990s. 
Results from community-based interventions and statewide programs show 
that a comprehensive approach to tobacco control is needed to curtail the epidemic. 
This report summarizes several effective approaches to reducing tobacco use and 
presents the considerable evidence—as well as the attendant controversies— 
supporting their application. Multifaceted school-based education programs that 
are performed in conjunction with community-based campaigns have met with 
substantial success. The management of nicotine addiction in persons who al­
ready smoke has the benefit of clinical tools, that is, systems for weaning persons 
from nicotine, the efficacy of which is clearly demonstrated.  Product regulation, 
enforcement of clean indoor air standards, and protecting young people from the 
supposed attractiveness of cigarettes all promise substantial impact.  By analyzing 
the economics of tobacco and by examining models that assess the effect of eco­
nomic policies, we find that various approaches can mitigate the adverse outcomes 
associated with tobacco use—and can do so without the dire economic conse­
quences claimed by those who profit from tobacco use. 
But if the evidence is clear that tobacco use is harmful and if the tools are 
available to reduce its use, why has the reduction in prevalence been less than 
would be expected? The answer is very complex. As described in Chapter 1 of 
this report, numerous forces influence a person’s decision to smoke, or if that per­
son is a smoker, the forces that drive continued use.  The most important force for 
smoking is the totality of industry activity, including advertising, promotion, 
organizational activity, support for ancillary issues, and political action, which 
maintains marketability and profitability of the product.  Efforts to reduce tobacco 
use face a more than $5 billion annual budget that the tobacco industry dedicates 
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to advertising and promotion aimed at sustaining or increasing tobacco use.  None­
theless, there is cause for optimism based on considerable public support for ef­
forts to prevent children from becoming addicted to tobacco.  If the recent pattern 
of increases in youth tobacco use can be reversed, we can make progress toward 
tobacco-free generations in the future. 
Jeffrey P. Koplan, M.D., M.P.H. 
Director 
Centers for Disease Control and Prevention 
and 
Administrator 
Agency for Toxic Substances and Disease Registry 
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Preface 
from the Surgeon General, 
U.S. Department of Health and Human Services 
Almost 50 years ago, evidence began to accumulate that cigarette smoking 
poses an enormous threat to human health.  More than 30 years ago, an initial 
report from the Surgeon General’s office made an unqualified announcement of 
tobacco’s harm. Beginning in 1969, the series of Surgeon General’s reports began 
meticulous documentation of the biologic, epidemiologic, behavioral, pharmaco­
logic, and cultural aspects of tobacco use. The present report, an examination of 
the methods and tools available to reduce tobacco use, is being issued at a time of 
considerable foment. The past several years have witnessed major initiatives in 
the legislative, regulatory, and legal arenas, with a complex set of results still not 
entirely resolved. 
This report shows that a variety of efforts aimed at reducing tobacco use, 
particularly by children, would have a heightened impact in the absence of 
countervailing pressures to smoke.  Besides providing extensive background and 
detail on historical, social, economic, clinical, educational, and regulatory efforts 
to reduce tobacco use, the report indicates some clear avenues for future research 
and implementation. It is of special concern to derive a greater understanding of 
cultural differences in response to tobacco control measures.  Since racial and eth­
nic groups are differentially affected by tobacco, elimination of disparities among 
these groups is a major priority. 
Perhaps the most pressing need for future research is to evaluate multifocal, 
multichannel programs that bring a variety of modalities together.  For example, 
as Chapter 3 demonstrates, school-based education programs are more effective 
when coupled with community-based initiatives that involve mass media and other 
techniques. As pointed out in Chapter 4, a combination of behavioral and phar­
macologic methods improves the success rate when managing nicotine addiction. 
Synergy among economic, regulatory, and social approaches has not been fully 
explored, but may offer some of the most fruitful efforts for the future.  Chapter 7 
provides the preliminary data on new statewide, comprehensive tobacco control 
programs, which offer great promise as new models for tobacco control and com­
bine multiple intervention modalities. Although all aspects—social, economic, 
educational, and regulatory—have not been combined into a fully comprehensive 
effort, it is exciting to contemplate the potential impact of such an undertaking to 
eventually ensure that children are protected from the social and cultural influ­
ences that lead to tobacco addiction, that all smokers are encouraged to quit as 
soon as possible, and that nonsmokers are protected from environmental tobacco 
smoke. 
David Satcher, M.D., Ph.D. 
Surgeon General and 
Assistant Secretary for Health 
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Introduction 
What works? 
It would be a boon if the answer were as easy to 
state as the question. Programs to reduce the use of 
tobacco have a long history in the United States and in 
other countries, and the accumulated experience has 
provided considerable empirical understanding of the 
prospects and pitfalls of such efforts.  Rigorous answers 
to formal evaluation questions are difficult to obtain, 
however, in part because of the wide variety of influ­
ences that are brought to bear on the use of tobacco. 
Researchers have little control over many of these 
influences and are only beginning to learn how to 
measure some of them. 
Nonetheless, a substantial body of literature 
exists on attempts to reduce the use of tobacco.  This 
report provides an overview of the major modalities 
that have been studied and used intensively, and it at­
tempts, where possible, to differentiate their techniques 
and outcomes. The report also attempts a more diffi­
cult task: to provide some qualitative observations 
about how these efforts interact.  The report is thus a 
prologue to the development of a coherent, long-term 
policy that would permit these modalities to be used 
as effectively as possible. 
Development of the Report 
This report of the Surgeon General was prepared 
by the Office on Smoking and Health, National Cen­
ter for Chronic Disease Prevention and Health Promo­
tion, Centers for Disease Control and Prevention 
(CDC), U.S. Department of Health and Human Ser­
vices, to report current information on the health ef­
fects of cigarette smoking and smokeless tobacco use. 
Previous reports have dealt with some of the issues 
included in this report, but a composite assessment of 
efforts to reduce tobacco use is a new topic for this 
series. However, the current report must acknowledge 
the considerable contributions of three prior mono­
graphs: Growing Up Tobacco Free, a report of the Insti­
tute of Medicine (Lynch and Bonnie 1994), Healthy 
People 2000: National Health Promotion and Disease Pre­
vention Objectives, and Healthy People 2010, an ongoing 
work of the Office of Health Promotion and Disease 
Prevention (U.S. Department of Health and Human 
Services [USDHHS] 1991, 2000). 
The current report is the result of the work of 
16 experts in the field of reducing tobacco use who 
contributed initial drafts in major chapter areas.  The 
chapters were reviewed separately by some 60 re­
searchers and public health workers whose expertise 
was specific to particular subject areas.  After revision, 
a preliminary draft volume was reviewed by an addi­
tional 40 experts, including representatives of the in­
stitutes and agencies within the Department of Health 
and Human Services that have special interests in re­
ducing tobacco use. 
Several concerns guided preparation of the re­
port. First, it was clear that the primary countervailing 
influence against reducing tobacco use is the effort of 
the tobacco industry to promote the use of tobacco 
products.  Although this report was not conceived as 
a documentation of such industry efforts, repeated 
reference to them is necessary to underscore the diffi­
culties both in achieving desired outcomes and in 
evaluating the effectiveness of efforts to reduce the use 
of the industry’s products.  Second, the report has at­
tempted to present the wide variety of techniques and 
methods used for tobacco control, but the disparate 
methods make comparisons difficult.  The result is 
more a menu than a cookbook—a set of activities, as 
outlined in Chapter 7, whose combination depends on 
specific circumstances and the context in which they 
are undertaken. Third, a result of this methodological 
diversity is that rigorous evaluation of the ways in 
which tobacco reduction efforts interact remains part 
of the unfinished research agenda.  Although interac­
tion of interventive efforts is noted several places in 
the report (see, for example, the discussion of the in­
teraction of school education with community-based 
programs in Chapter 3), such demonstration of syn­
ergy has been elusive. 
Finally, during the report’s preparation, a cascade 
of legal and legislative events substantially changed 
the landscape where the diverse efforts to reduce to­
bacco use take place. Several legal rulings, still under 
adjudication, and the Master Settlement Agreement 
between states and the tobacco industry to recover 
costs of government programs have altered prospects 
for reducing tobacco use through large-scale social 
maneuvers. Many of these issues are still unresolved, 
and they are likely to influence activities in the com­
ing years. 
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Major Conclusions 
1.	 	 Efforts to prevent the onset or continuance of to­
bacco use face the pervasive, countervailing in­
fluence of tobacco promotion by the tobacco 
industry, a promotion that takes place despite 
overwhelming evidence of adverse health effects 
from tobacco use. 
2.	 	 The available approaches to reducing tobacco 
use—educational, clinical, regulatory, economic, 
and social—differ substantially in their tech­
niques and in the metric by which success can be 
measured.  A hierarchy of effectiveness is diffi­
cult to construct. 
3.	 	 Approaches with the largest span of impact (eco­
nomic, regulatory, and social) are likely to have 
the greatest long-term, population impact.  Those 
with a smaller span of impact (educational and 
clinical) are of greater importance in helping in­
dividuals resist or abandon the use of tobacco. 
4.	 	 Each of the modalities reviewed provides evi­
dence of effectiveness: 
• Educational strategies, conducted in conjunc­
tion with community- and media-based 
activities, can postpone or prevent smoking 
onset in 20 to 40 percent of adolescents. 
• Pharmacologic treatment of nicotine addic­
tion, combined with behavioral support, will 
enable 20 to 25 percent of users to remain ab­
stinent at one year posttreatment.  Even less 
intense measures, such as physicians advising 
their patients to quit smoking, can produce 
cessation proportions of 5 to 10 percent. 
• Regulation of advertising and promotion, par­
ticularly that directed at young people, is very 
likely to reduce both prevalence and uptake 
of smoking. 
• Clean air regulations and restriction of minors’ 
access to tobacco products contribute to a 
changing social norm with regard to smoking 
and may influence prevalence directly. 
• An optimal level of excise taxation on tobacco 
products will reduce the prevalence of smok­
ing, the consumption of tobacco, and the long-
term health consequences of tobacco use. 
5.	 	 The impact of these various efforts, as measured 
with a variety of techniques, is likely to be un­
derestimated because of the synergistic effect of 
these modalities. The potential for combined 
effects underscores the need for comprehensive 
approaches. 
6.	 	 State tobacco control programs, funded by excise 
taxes on tobacco products and settlements with 
the tobacco industry, have produced early, en­
couraging evidence of the efficacy of the com­
prehensive approach to reducing tobacco use. 
Issues in Reducing Tobacco Use 
Two themes have permeated the history of to­
bacco use in the United States. First, and most obvi­
ously, tobacco is an extraordinary economic fuel, and 
its powerful economic impact comes into direct con­
flict with its vast social costs. Second, antitobacco ac­
tivity has a continuous history characterized by waxing 
and waning and by a changing mix of motivations and 
strategies. These two themes are inextricably linked, 
and their interaction provides a backdrop for current 
efforts to reduce tobacco use. 
Such efforts take place in a complicated context. 
Chronic diseases have largely replaced infectious pro­
cesses as the leading causes of death during the 20th 
century (Rothenberg and Koplan 1990).  But this re­
placement has occurred during a period of remark­
able gains in life expectancy.  Mortality is now less than 
half of what it was in 1900. The single most important 
risk associated with the leading chronic diseases is 
cigarette smoking; the evidence for that statement fills 
25 volumes of Surgeon General’s reports on smoking 
and health, and these volumes are merely summaries 
of a massive literature.  Since the first of these reports 
in 1964, the prevalence of smoking has declined by 
nearly half, and it is clear that the declining use of to­
bacco has contributed to the observed decline in mor­
tality.  But paradoxically, as life expectancy increases, 
an increasing proportion of deaths are caused by the 
chronic diseases associated with smoking—primarily 
cancer, cardiovascular disease, and emphysema.  This 
interplay raises key questions. 
First, does the current smoking prevalence of 
about 25 percent represent a remarkable public health 
success, or is it evidence of continuing failure?  The 
answer is yes to both questions. Health advocates can 
be both pleased with overall trends and loathe to de­
clare success for a job unfinished, because goals and 
standards change with evolving efforts to reduce to­
bacco use. If the worldwide public health response to 
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smallpox can be used as an analogy, the control pro­
gram reached a point at which a single case was 
deemed unacceptable. 
Second, why has the decline in smoking preva­
lence been slow? In the face of voluminous evidence 
about adverse health effects, prevalence has declined 
sluggishly (an average of about 0.5 percent per year 
since the mid-1960s). Currently, the decline exhibits 
epidemiologic signs of pausing in its downward tra­
jectory, and it has even reversed in some population 
subgroups.  There is no single, facile explanation for 
the persisting practice of tobacco use. If rationality 
were the only force at work, tobacco use would have 
been abandoned long ago. But as is shown in Figure 
1.1, the forces that can be brought to bear on current 
or potential smokers are more complex and subtle than 
the mere awareness that smoking is harmful to one’s 
health. A young person on the threshold of deciding to 
smoke may be subject to various influences, including 
the existence or nonexistence of targeted health educa­
tion programs that discourage smoking, as well as of 
restrictions on access to cigarettes and a variety of regu­
lations that determine the content and packaging of the 
product.  Widespread and local norms, affecting this 
young person in the form of peer pressure, perceived 
smoking prevalence, and the commercial presentation 
of tobacco products, can affect the decision either way. 
The cost of cigarettes is likely to have significant influ­
ence on a young person, and other economic policies— 
largely unseen by the potential smoker—can affect the 
outcome. Personal psychosocial factors undoubtedly 
play a role and are likely to interact with these other 
Figure 1.1. Influences on the decision to use tobacco 
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influences. Arrayed among and against such factors 
are the variety of conduits—also largely unseen by 
the current or potential smoker—through which the 
influences of the tobacco industry are manifested:  use 
of advertising and promotion to alter perceived social 
norms, alteration or prevention of legislation that 
would inhibit smoking, legal mechanisms to influence 
regulation, political mechanisms to influence economic 
policy, and countereducation that can serve to encour­
age the uptake of smoking. 
Whatever the precise interplay of these influences, 
the net result has been a slower decline than would be 
warranted by awareness of the well-publicized public 
health threat that smoking poses.  The forces that have 
tried to accelerate the decline may be thought of col­
lectively as “interventions,” although the term, in a 
more narrow sense, is often reserved for circumscribed, 
planned, and measurable activities. Many of the ma­
neuvers described in this report do not meet the nar­
rower definition, but all share the common 
characteristic of being directed toward a reduction in 
tobacco use. With a broader definition in mind, 
Ramström (1995) has classified tobacco interventions 
by the point they affect on the spectrum of tobacco 
use. These classifications, depicted in Figure 1.2, are 
creating a nonsmoking norm, reducing stimuli to 
smoke, strengthening motivation to quit, and reduc­
ing impediments to quitting. Although the conceptu­
alization is useful, a line could legitimately be drawn 
from each box to any other box in Figure 1.2, as these 
activities are all intimately tied to each other in both 
process and outcome.  To borrow from the language 
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of statistics, the main effects of these efforts may be 
much less important than their interactions, both with 
each other and with the counterinfluences of the to­
bacco industry. 
The result is a considerable challenge for evalua­
tion. Suppose the young person in Figure 1.1 “decides” 
not to smoke, or the current smoker quits.  Attribution 
of cause to this outcome in individual cases is highly 
unlikely.  The totality of such decisions—which leads 
to a decline in prevalence—poses similar problems of 
attribution. Although the epidemiologic methods ex­
ist, data are rarely available to make attributive judg­
ments. The challenge of evaluating these separate 
efforts and strategies results from their disparate 
nature and the type of metric that may be appropriate 
to their evaluation (Table 1.1). 
Management of nicotine addiction (Chapter 4), 
for example, is usually studied by using standard 
epidemiologic study design—often a prospective 
comparison of a study group and a control group— 
and the effect is measured by some form of the rela­
tive or attributable risk statistic. Educational strategies 
(Chapter 3), like other behavioral studies, may use 
similar statistics but usually invoke a different set of 
confounding factors to be considered; sorting out 
the relative influence of such factors often requires 
Figure 1.2. Overview of relationships among interventions
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environment 
Reduce morbidity 
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Protect nonsmokers’ 
health and rights 
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addiction 
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uptake 
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to smoke 
Chapter Chapter Chapter Chapter 
Health education  3,4 Pharmacologic Rx 4 Health education 3 Advertising restrictions 5 
Economic policy 6 Behavioral Rx 4 Economic policy 6 Promotion restrictions 5 
Smoke-free policy 5 Knowledge Rx 4 Product regulation 5 Sales restrictions 4 
Comprehensive 7 Attitude Rx 4 Smoke-free policy 5 Comprehensive  7
  programs Comprehensive 7   programs 
  programs 
Personal litigation 5 
Source:  Adapted from Ramström 1995. 
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Table 1.1.  Characteristics of interventions 
Type of 
intervention Targets Tools Study approaches 
Outcome 
measurements 
Educational Children and adoles­
cents, usually in school 
Administrative groups 
(e.g., members of 
health maintenance 
organizations) 
General population 
Health care providers 
School curricula 
Interactive training 
Targeted services 
Mass media 
Epidemiologic and 
behavioral: 
• Usually a comparison 
of “treatment” and “no 
treatment” groups 
• Control of confounding 
by behavioral and 
social variables 
Relative risk 
Attributable 
risk 
Effect size 
(absolute or 
relative) 
Clinical Persons who smoke, 
usually in a health care 
setting 
General population 
of smokers in a 
commercial or quasi-
commercial setting 
Pharmacologic 
methods 
Behavioral 
modification 
Reinforcing 
environment 
Epidemiologic and 
behavioral: 
• Usually a comparison 
of “treatment” and “no 
treatment” groups 
• Control of confounding 
by behavioral and 
demographic variables 
Relative risk 
Attributable 
risk 
Effect size 
(absolute or 
relative) 
Regulatory Product manufacture Local ordinance Observational Linear trend 
Product sale 
Vendors and buyers 
Public venues 
Public transportation 
Worksites 
State regulation 
Federal regulation 
Federal law 
Nongovernment 
action (e.g., joint 
commission 
Knowledge/attitude/ 
practice studies 
Surveillance 
Case study 
Cross-sectional 
comparison of 
proportions 
Case analysis 
results 
Health care sites accreditation of 
hospital organization) 
Economic Taxes Local ordinance Econometric analysis Linear trend 
Tariffs and trade 
Price supports 
State regulation 
Federal regulation 
Trend analysis 
Multivariate models 
Parameter 
estimates (e.g., 
elasticities) 
Federal law 
International 
agreements 
Social/Com­
prehensive 
Legislators 
Media 
Communication 
networks 
Media advocacy 
Direct advocacy 
Community 
interventions 
Observational 
Case study 
General epidemiologic 
methods 
Linear trends 
Case study 
analysis 
Cross-sectional 
Case-by-case strategy Countermarketing Trend analysis 
comparisons 
State/local programs Regulation 
Policy formation 
Knowledge/attitude/ 
practice studies 
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complex multivariate procedures.  Regulatory efforts 
(Chapter 5) are frequently evaluated after the effect 
(with a pre- and post-type of study design) or are 
evaluated according to ecological correlations with 
changes in epidemiologic trends.  Economic measures 
(Chapter 6) depend for their evaluation on economet­
ric information—that is, on administrative data sets 
and survey results that are subjected to correlation and 
trend analysis.  Finally, comprehensive program strat­
egies are often evaluated using surveillance data sys­
tems, trend analyses, and case studies. 
In each instance, some form of evaluation is pos­
sible, but the ability to connect the intervention to the 
outcome differs greatly among these efforts, as does 
the ability to estimate impact. Theoretically, it might 
be possible to associate each effort with some pre­
sumed number of persons who start smoking or some 
number who quit, but to do so would usually require 
numerous assertions and assumptions.  For example, 
to estimate the number of persons who would benefit, 
through prevention or cessation of smoking, from an 
educational strategy, assumptions would be needed 
about its generalizability to the U.S. population, the 
variability of its impact, the use-effectiveness to which 
it is put, the proportion of the population reached, and 
the permanence of its effect.  It is even more difficult 
to create a set of assumptions for the impact of a regu­
lation that is promulgated in an environment of de­
clining prevalence and whose existence may depend 
on the prior emergence of the very changes it wishes 
to create. For example, a ban on smoking during 
airline flights, a measure intended not only to protect 
nonsmokers from environmental tobacco smoke (ETS) 
but also to promote a norm of nonsmoking, was pos­
sible only in an era when the dangers of ETS were 
widely known and when the danger and discomfort 
experienced by nonsmokers had begun to outweigh 
the inconvenience, discomfort, and even social ostra­
cism experienced by smokers being subjected to such 
restrictions. It is virtually impossible to link a social 
strategy to a direct effect on prevalence, however suc­
cessful by other criteria. (Many would argue, quite 
justly, that the impact measure of reducing prevalence 
by reducing uptake and increasing cessation is not the 
only outcome of interest.  Unfortunately, proximal 
process measures are even more variable among the dif­
ferent strategies, and the ultimate outcome measures— 
morbidity and mortality—are too distal to easily 
consider.) 
Without a common metric, the various types of 
efforts to reduce tobacco use are difficult to compare 
quantitatively, although several attempts have been 
made (USDHHS 1998a; U.S. Department of the Treasury, 
Office of Economic Policy, unpublished report, 1998).  Per­
haps a more qualitative approach could be used.  One 
approach, illustrated in Table 1.2, would be to consider 
the potential span of impact (the proportion of the 
population, or population sectors) that the particular 
effort can exercise in the context of a qualitative esti­
mate of its potential impact. Several examples of each 
type of effort are presented, and a qualitative assess­
ment is made based on the data provided in the re­
port. The assessments in Table 1.2 are by no means 
meant to be definitive but are meant to provide a 
framework for approaching the difficult issue of rela­
tive effectiveness.  Although some observers would 
urge a more quantitative approach (e.g., using only 
randomized controlled trials as a measure of effective­
ness), a number of effective modalities would likely 
be falsely discredited.  For example, advocacy activity 
played a critical role in the formulation of the Food 
and Drug Administration’s (FDA’s) policy regarding 
regulation of tobacco products (see “Product Regula­
tion” in Chapter 5), yet linking that policy, or anteced­
ent advocacy work, directly to changing prevalence 
would be difficult. 
In a qualitative assessment of relative impact, the 
examples provide a basis for a hierarchy of activities, 
but that hierarchy requires still another framework: 
consideration of the entity conducting the activity (in­
dividual, nongovernment citizens group, nongovern­
ment agency, or government agency) and the 
organizational level at which the activity is conducted 
(local, state, national, or international). Thus, no single 
set of rules is available for invoking these efforts to 
reduce tobacco use, and relative efficacy depends on 
the context in which an effort takes place. For example, 
local efforts to reduce tobacco use might include regu­
latory ordinances (with potentially large impact on 
many people), education programs in schools (smaller 
impact on fewer people), and promotion of treatment 
for nicotine addiction (targeting a still smaller group). 
Specific local circumstances would dictate the specific 
activities. The federal government would more likely 
act to put in place economic measures and a variety of 
regulatory efforts (both types of interventions having 
very large span and size of impact), depending on the 
specific political context. 
In summary, then, these efforts to reduce tobacco 
use line up side by side and not in relative order.  Their 
use is predicated on the particular context in which 
they are to operate.  Because they all face the same 
counterinfluence of the industry’s tobacco promotion 
(the right-hand side of Figure 1.1), a reasonable case 
can be made that the large-scale strategies (economic 
and regulatory) have the greatest direct impact on that 
10 Chapter 1
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Table 1.2.  Examples of a qualitative assessment of intervention impact 
Type of intervention Specific modality Span of impact Size of impact 
Educational School curriculum Large Moderate 
Mass media Large Small 
Clinical Pharmacologic Small Moderate 
Behavioral (alone) Small Very small 
Regulatory Product manufacture Very large Very large 
Product sale Large Large 
Public venues Large Moderate 
Worksites Large Small 
Economic Taxation Very large Very large 
Tariffs and trade Very large Very large 
Comprehensive programs Statewide programs Large Large 
Case-by-case strategy Unpredictable Unpredictable 
Note:  Examples use a five-point ordinal scale (very small, small, moderate, large, very large), with the additional 
use of “unpredictable.”  (See text for the context for such assessment.) 
barrier.  But the context necessary for those large-scale 
efforts to work depends on public attitudes and social 
norms that must be influenced by other means. 
In the 1990s, it became increasingly apparent that 
a public health success in reducing tobacco use requires 
activity on all fronts.  A comprehensive approach—one 
that optimizes synergy from a mix of strategies—has 
emerged as the guiding principle for future efforts to 
reduce tobacco use. Such an approach makes moot the 
issue of a hierarchy of interventions, since a compre­
hensive approach presupposes an interdependence of 
the available strategies. A coordinated, cohesive in­
frastructure makes intuitive sense, since it permits a 
modular approach to the interventions themselves, but 
has been challenged on analytic grounds.  In such a 
framework, attribution of success to particular pro­
gram elements is difficult, and there is no experimen­
tal evidence (nor is there likely to be) that an approach 
that is comprehensive is superior to one that is not. 
Nonetheless, the 20th century’s difficult experience 
with tobacco control (as described in Chapter 2) and 
the previous decade’s success in changing social norms 
and generating assets (as discussed in Chapter 7) lend 
empirical credibility to the comprehensive approach. 
Eliminating Disparities Related to Tobacco 
Use and Its Effects 
The elimination of health disparities related to 
tobacco use poses a great challenge to this nation.  This 
was not a main focus of the current report, because two 
other recent, important publications have emphasized 
the issue. The 1998 Surgeon General’s report Tobacco 
Use Among U.S. Racial/Ethnic Minority Groups (USDHHS 
1998b) was the first to address the diverse tobacco con­
trol needs of the four major U.S. racial/ethnic minor­
ity groups—African Americans, American Indians and 
Alaska Natives, Asian Americans and Pacific Island­
ers, and Hispanics. Healthy People 2010 (USDHHS 
2000) presents two overarching goals:  increase qual­
ity and years of healthy life and eliminate health dis­
parities among different segments of the U.S. 
population. Evidence reviewed in these two publica­
tions highlights the significant disparities that exist in 
the United States. These publications also discuss the 
critical need for a greater focus on this issue, both in 
research and in public health action. 
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Summary and Implications 
In fact, each of the approaches described in this 
report shows evidence of effectiveness.  In some in­
stances, the synergism that might be expected through 
interaction among these various efforts has been docu­
mented. The remainder of this chapter describes the 
major findings and implications for each type of activ­
ity and presents the conclusions of the other chapters. 
Historical Review (Chapter 2) 
The forces that have shaped the movement to 
reduce tobacco use over the past 100 years are com­
plex and intertwined. In the early years (1880–1920), 
antitobacco activity—some of it quite successful—was 
motivated by moral and hygienic principles. After 
important medical and epidemiologic observations of 
the midcentury linked smoking to lung cancer and 
other diseases, and after the subsequent appearance 
of the 1964 report of the advisory committee to the 
Surgeon General on smoking and health (USDHEW 
1964), the movement to reduce tobacco use was fu­
eled by knowledge of the health risks that tobacco use 
poses and by reaction against the continued promo­
tion of tobacco in the face of such known risks. De­
spite overwhelming evidence of adverse health 
consequences of smoking, the stubborn norm of smok­
ing in the United States has receded slowly, in part 
because of such continued promotion that works syn­
ergistically with tobacco addiction.  Although strate­
gies have varied, health advocates have focused in 
recent years on the prevention of harm to nonsmokers 
and on the concept of smoking as a pediatric disease, 
with the consequent need for protecting young per­
sons from forces influencing them to smoke. 
Educational Strategies (Chapter 3) 
The design of educational programs for tobacco 
use prevention and the methods used to evaluate them 
have become increasingly refined over the past two 
decades. Early studies tended to be confined to the 
school context, to have short duration, and to be of 
low intensity.  Studies tended to focus on a single mo­
dality and to ignore the larger context in which pre­
vention takes place. The reported size, scope, and 
duration of program effects have become larger in re­
cent reports.  In particular, several large programs have 
attempted a multifaceted approach that incorporates 
other than school-based modalities. Improvements in 
evaluation designs have increased confidence in the 
validity of these reports.  The pattern of consistency 
across this group of large studies also provides assur­
ance that these effects can be achieved in a variety of 
circumstances when programs include the critical 
multiple elements that have been defined by this re­
search literature. 
To summarize the major findings, school-based 
social influences programs have significant and sub­
stantial short-term impacts on smoking behavior. 
Those programs with more frequent educational con­
tacts during the critical years for smoking adoption 
are more likely to be effective, as are programs that 
address a broad range of educational needs.  These 
effects have been demonstrated in a range of imple­
mentation models and student populations. The smok­
ing prevention effects of strong school programs can 
be extended through the end of high school or longer 
when combined with relatively intensive efforts di­
rected through other powerful channels, such as strat­
egies that vigorously engage the influences of parents, 
the mass media, and other community resources. 
These conclusions have been codified in national 
guidelines for school programs to prevent tobacco use. 
Thus, an extensive body of research findings 
document the most effective educational programs for 
preventing tobacco use.  This research has produced a 
wide array of curricula, protocols, and recommenda­
tions that have been codified into national guidelines 
for schools. Implementing guidelines could postpone 
or prevent smoking onset in 20 to 40 percent of U.S. 
adolescents. Unfortunately, existing data suggest that 
evidence-based curricula and national guidelines have 
not been widely adopted. By one set of criteria, less 
than 5 percent of schools nationwide are implement­
ing the major components of CDC’s Guidelines for 
School Health Programs to Prevent Tobacco Use and Ad­
diction (CDC 1994). Almost two-thirds of schools (62.8 
percent) had smoke-free building policies in 1994, but 
significantly fewer (36.5 percent) reported such poli­
cies that included the entire school environment. 
Schools, however, should not bear the sole respon­
sibility for implementing educational strategies to 
prevent tobacco use.  Research findings, as noted, indi­
cate that school-based programs are more effective 
when combined with mass media programs and with 
community-based efforts involving parents and other 
community resources.  In addition, CDC’s school health 
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guidelines and numerous Healthy People 2010 objectives 
recognize the critical role of implementing tobacco-free 
policies involving faculty, staff, and students and relat­
ing to all school facilities, property, vehicles, and events. 
Although significant progress is still required, the cur­
rent evaluation base provides clear direction for the 
amalgamation of school-based programs with other 
modalities for reducing tobacco use. 
Management of Nicotine Addiction 
(Chapter 4) 
The management of nicotine addiction is a com­
plex field that continues to broaden its understanding 
of the determinants of smoking cessation. Current lit­
erature suggests that several modalities are effective 
in helping smokers quit. Although the overall effect 
of such intervention is modest if measured by each 
attempt to quit, the process of overcoming addiction 
is a cyclic one, and many who wish to quit are eventu­
ally able to do so. The available approaches to man­
agement of addiction differ in their results. 
Self-help manuals and minimal clinical interventions. 
Although self-help manuals have had only modest and 
inconsistent success at helping smokers quit, manuals can 
be easily distributed to the vast population of smokers 
who try to quit on their own each year.  Adjuvant be­
havioral interventions, particularly proactive telephone 
counseling, may significantly increase the effect of self-
help materials. Process measures are not routinely in­
corporated into self-help investigations, but the available 
process data suggest that persons who not only have a 
self-help manual but also perform the exercises recom­
mended in the manual are more likely to quit smoking 
than are persons who try to quit smoking without them. 
Substantial evidence suggests that minimal clini­
cal interventions (e.g., a health care provider’s repeated 
advice to quit) foster smoking cessation and that the 
more multifactorial or intensive interventions produce 
the best outcomes. These findings highlight the impor­
tance of cessation assistance from clinicians, who have 
access to more than 70 percent of smokers each year. 
Moreover, minimal clinical interventions have been 
found to be effective in increasing smokers’ motivation 
to quit and are cost-effective (see “Cost-Effectiveness” 
in Chapter 4). However, research has not fully clarified 
the specific elements of minimal interventions that are 
most important to clinical success nor the specific 
changes they produce in smokers that lead to abstinence. 
Intensive clinical interventions.  Intensive pro-
grams—more formally systematic services to help 
people quit smoking—serve an important function in 
Reducing Tobacco Use 
the nation’s efforts to reduce smoking, despite the re­
sources the programs demand and the relatively small 
population of smokers who use them. Such programs 
may be particularly useful in treating those smokers 
who find it most difficult to quit. Because intensive 
smoking cessation programs differ in structure and 
content, evaluation is often hampered by variation in 
methodology and by a lack of research addressing spe­
cific treatment techniques.  Because few studies have 
chosen to isolate single treatments, assessment of the 
effectiveness of specific approaches is difficult.  None­
theless, skills training, rapid smoking, and both intra-
treatment and extra-treatment social support have all 
been associated with successful smoking cessation. 
When such treatments are shown to be effective, they 
are usually part of a multifactorial intervention. Little 
clear evidence has implicated particular psychologi­
cal, behavioral, or cognitive mechanisms as the agents 
of change. The specific impact of intensive interven­
tions may be masked by the efficacy of several multi­
component programs, some of which have achieved 
cessation proportions of 30 to 50 percent.  Thus, in their 
positive effect on smoking cessation and long-term 
abstinence rates, intensive interventions seem little 
different from other forms of counseling or psycho­
therapy.  With intensive interventions, as with coun­
seling, it is difficult to attribute the efficacy to specific 
characteristics of the interventions or to specific change 
mechanisms. 
Pharmacologic interventions. Abundant evidence 
confirms that nicotine gum and the nicotine patch are 
effective aids to smoking cessation.  The efficacy of 
nicotine gum may depend on the amount of behav­
ioral counseling with which it is paired.  The 4-mg dose 
(rather than the 2-mg dose) may be the better phar­
macologic treatment for heavy smokers or for those 
highly dependent on nicotine. The nicotine patch ap­
pears to exert an effect independent of behavioral sup­
port, but absolute abstinence rates increase as more 
counseling is added to patch therapy.  Nicotine inhal­
ers and nicotine nasal spray are effective aids for smok­
ing cessation, although their mechanisms of action are 
not entirely clear.  All nicotine replacement therapies 
produce side effects, but these are rarely so severe that 
patients must discontinue use. Nicotine nasal spray 
appears to have greater potential for inappropriate use 
than other nicotine replacement therapies.  Nicotine 
replacement therapies, especially the gum and the 
patch, have been shown to delay but not prevent 
weight gain following smoking cessation. All nico­
tine replacement therapies are thought to work in part 
by reducing withdrawal severity.  The available evi­
dence suggests that they do ameliorate some elements 
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of withdrawal, but the relationship between withdrawal 
suppression and clinical outcome is inconsistent. 
Bupropion is the first nonnicotine pharmaco­
therapy for smoking cessation to be studied in large-
scale clinical trials. Results suggest that it is an effective 
aid to smoking cessation. In addition, bupropion has 
been demonstrated to be safe when used in conjunc­
tion with nicotine replacement therapy.  In the only 
direct comparison with a nicotine replacement prod­
uct, bupropion achieved quit rates about double those 
achieved with the nicotine patch. Bupropion appears 
to delay but not prevent postcessation weight gain, and 
available literature contains inconsistent evidence 
about bupropion-mediated withdrawal relief. 
Bupropion does not appear to work by reducing 
postcessation symptoms of depression, but its mecha­
nism of action in smoking cessation remains unknown. 
Evidence suggests that clonidine is also capable 
of improving smoking cessation rates. Clonidine is 
hypothesized to work by alleviating withdrawal symp­
toms. Although clonidine may reduce the craving for 
cigarettes after cessation, it does not consistently ame­
liorate other withdrawal symptoms, and its effect on 
weight gain is unknown. Unpleasant side effects are 
common with clonidine use. 
Antidepressants and anxiolytics are potentially 
useful agents for smoking cessation. At present, only 
nortriptylene appears to have consistent empirical 
evidence of smoking cessation efficacy.  However, tri­
cyclic antidepressants produce a number of side ef­
fects, including sedation and various anticholinergic 
effects, such as dry mouth. 
In summary, research on methods to treat nico­
tine addiction has documented the efficacy of a wide 
array of strategies. The broad implementation of these 
effective treatment methods could produce a more 
rapid and probably larger short-term impact on 
tobacco-related health statistics than any other com­
ponent of a comprehensive tobacco control effort.  It 
has been estimated that smoking cessation is more cost-
effective than other commonly provided clinical pre­
ventive services, including Pap tests, mammography, 
colon cancer screening, treatment of mild to moderate 
hypertension, and treatment of high levels of serum 
cholesterol. 
Contemporaneously with the appearance of this 
report, research advances in managing nicotine addic­
tion have been summarized in evidence-based clinical 
practice guidelines by the Agency for Healthcare 
Research and Quality (AHRQ). That document con­
firms that less intensive interventions, such as brief 
physician advice to quit smoking, could produce ces­
sation rates of 5 to 10 percent per year.  More intensive 
interventions, combining behavioral counseling and 
pharmacologic treatment of nicotine addiction, can 
produce 20 to 25 percent quit rates at one year.  Thus, 
the universal provision of even less intensive interven­
tions to smokers at all clinical encounters could each 
year help millions of U.S. smokers quit (Fiore et al. 
2000). 
Progress has been made in recent years in dissemi­
nating clinical practice guidelines on smoking cessation. 
Healthy People 2010 Objective 27-8 calls for universal 
insurance coverage of evidence-based treatment for 
nicotine dependency by both public and private pay­
ers. Similarly, CDC’s Best Practices for Comprehensive 
Tobacco Control Programs advises states that tobacco-
use treatment initiatives should include 
•	 	 Establishing population-based counseling and 
treatment programs, such as cessation help lines. 
•	 	 Making the system changes recommended by the 
AHRQ-sponsored cessation guidelines. 
•	 	 Covering treatment for tobacco use under both 
public and private insurance. 
•	 	 Eliminating cost barriers to treatment for under-
served populations, particularly the uninsured 
(CDC 1999, p. 24). 
Regulatory Efforts (Chapter 5) 
Advertising and Promotion 
Attempts to regulate advertising and promotion 
of tobacco products were initiated in the United States 
almost immediately after the appearance of the 1964 
report to the Surgeon General on the health conse­
quences of smoking. Underlying these attempts is the 
hypothesis that advertising and promotion recruit new 
smokers and retain current ones, thereby perpetuat­
ing a great risk to public health.  The tobacco industry 
asserts that the purpose of marketing is to maintain 
brand loyalty.  Considerable evidence has accumulated 
showing that advertising and promotion are perhaps 
the main motivators for adopting and maintaining to­
bacco use. Attempts to regulate tobacco marketing 
continue to take place in a markedly adversarial and 
litigious atmosphere. 
The initial regulatory action, promulgated in 1965, 
provided for a general health warning on cigarette pack­
ages but effectively preempted any further federal, state, 
or local requirements for health messages.  In 1969, a 
successful court action invoked the Fairness Doctrine 
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(not previously applied to advertising) to require 
broadcast media to air antitobacco advertising to 
counter the paid tobacco advertising then running on 
television and radio. Indirect evidence suggests that 
such counteradvertising had considerable impact on 
the public’s perception of smoking.  Not surprisingly, 
the tobacco industry supported new legislation 
(adopted in 1971) prohibiting the advertising of to­
bacco products on broadcast media, because such leg­
islation also removed the no-cost broadcasting of 
antitobacco advertising. A decade later, a Federal Trade 
Commission (FTC) staff report asserted that the domi­
nant themes of remaining (nonbroadcast) cigarette 
advertising associated smoking with “youthful vigor, 
good health, good looks and personal, social and pro­
fessional acceptance and success” (Myers et al. 1981, 
p. 2-13). A nonpublic version of the report detailed 
some of the alleged marketing strategy employed by 
the industry; the industry denied the allegation that 
the source material for the report represented indus­
try policy.  Nonetheless, some of these concerns led to 
the enactment of the Comprehensive Smoking Educa­
tion Act of 1984 (Public Law 98-474), which required a 
set of four rotating warnings on cigarette packages. 
The law did not, however, adopt other FTC recommen­
dations that product packages should bear informa­
tion about associated risks of addiction and 
miscarriage, as well as information on toxic compo­
nents of cigarettes.  In fact, many FTC-recommended 
requirements for packaging information that have been 
enacted in other industrialized nations have not been 
enacted in the United States. 
The role of advertising is perhaps best epitomized 
by R.J. Reynolds Tobacco Company’s Camel brand 
campaign (initiated in 1988) using the cartoon charac­
ter “Joe Camel.” Considerable research has demon­
strated the appeal of this character to young people 
and the influence that the advertising campaign has 
had on minors’ understanding of tobacco use and on 
their decision to smoke. In 1997, the FTC brought a 
complaint asserting that by inducing minors to smoke, 
R.J. Reynolds’ advertising practices violated the Fed­
eral Trade Commission Act (Public Law 96-252).  The 
tobacco company subsequently agreed to cease using 
the Joe Camel campaign. Although the FTC’s act 
grants no private right of enforcement, a private law­
suit in California resulted in a settlement whereby the 
tobacco company agreed to cease its Joe Camel cam­
paign; notably, the Supreme Court of California re­
jected R.J. Reynolds’ argument that the Comprehensive 
Smoking Education Act of 1984 preempted the suit’s 
attempt to further regulate tobacco advertising. 
Product Regulation 
Current tobacco product regulation requires that 
cigarette advertising disclose levels of “tar” (an all-
purpose term for particulate-phase constituents of to­
bacco smoke, many of which are carcinogenic or 
otherwise toxic) and nicotine (the psychoactive drug 
in tobacco products that causes addiction) in the smoke 
of manufactured cigarettes and that warning labels 
appear on packages and on some (but not all) adver­
tising for manufactured cigarettes and smokeless to­
bacco. The current federal laws preempt, in part, states 
and localities from imposing other labeling regulations 
on cigarettes and smokeless tobacco.  Federal law (the 
Comprehensive Smokeless Tobacco Health Education 
Act of 1986 and the Comprehensive Smoking Educa­
tion Act of 1984) requires cigarette and smokeless to­
bacco product manufacturers to submit a list of 
additives to the Secretary of Health and Human Ser­
vices; attorneys for the manufacturers released such 
lists in 1994 to the general public. Smokeless tobacco 
manufacturers are required to report the total nicotine 
content of their products, but these data may not be 
released to the public. Tobacco products are explic­
itly protected from regulation in various federal con­
sumer safety laws. No federal public health laws or 
regulations apply to cigars, pipe tobaccos, or fine-cut 
cigarette tobaccos (for “roll-your-own” cigarettes). 
Although much effort has been devoted to con­
sidering the need for regulating nicotine delivery, tar 
content, and the use of additives, until recently no regu­
lation had directly broached the issue of whether to­
bacco should be subject to federal regulation as an 
addictive product.  Responding in part to several pe­
titions filed by the Coalition on Smoking OR Health 
in 1988 and 1992, the FDA began serious consideration 
of the need for product regulation.  Motivated by the 
notion that the cigarette is a nicotine delivery system, 
by allegations of product manipulation of nicotine lev­
els, and by the concept that smoking is a pediatric dis­
ease and that young people are especially susceptible 
to cigarette advertising and promotion, in August 1995 
the FDA issued in the Federal Register (1) a proposed 
rule of regulations restricting the sale and distribution 
of cigarettes and smokeless tobacco products to pro­
tect children and adolescents and (2) an analysis of the 
FDA’s jurisdiction over cigarettes and smokeless to­
bacco. The final regulations published by the FDA on 
August 28, 1996, differed only slightly from the pro­
posed regulation. The announcement prompted 
immediate legal action on the part of the tobacco in­
dustry, advertising interests, and the convenience store 
industry, which challenged the FDA’s jurisdiction over 
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tobacco products.  In April 1997, a federal district court 
upheld the FDA’s jurisdiction over tobacco products, 
but held that it lacked authority under the statutory 
provision relied on to regulate tobacco product 
advertising. 
Although many of the FDA’s regulations on to­
bacco sales and distribution were incorporated, to 
some extent, in the June 20, 1997, proposed settlement 
of lawsuits between 41 state attorneys general and the 
tobacco industry, the settlement presupposed congres­
sional legislation that would uphold the FDA’s as­
serted jurisdiction. After considerable congressional 
negotiation, no such legislation emerged.  In August 
1998, a three-judge panel of the United States Court of 
Appeals for the Fourth Circuit held that the FDA lacked 
jurisdiction to regulate tobacco products.  In Novem­
ber 1998, the full Court of Appeals rejected the 
government’s request for rehearing by the entire court. 
On March 21, 2000, in a 5 to 4 decision, the United 
States Supreme Court affirmed the decision of the 
United States Court of Appeals for the Fourth Circuit 
and held that the FDA lacks jurisdiction under the Fed­
eral Food, Drug, and Cosmetic Act to regulate tobacco 
products as customarily marketed.  As a result of 
this decision, the FDA’s August 1996 assertion of ju­
risdiction over cigarettes and smokeless tobacco and 
regulations restricting the sale and distribution of ciga­
rettes and smokeless tobacco to protect children and 
adolescents (principally codified at 21 Code of Fed­
eral Regulations Part 897) are invalid. 
Clean Indoor Air Regulation 
Unlike the regulation of tobacco products per se 
and of their advertising and promotion, regulation of 
exposure to ETS has encountered less resistance.  This 
course is probably the result of (1) long-standing 
grassroots efforts to diminish exposure to ambient to­
bacco smoke and (2) consistent epidemiologic evidence 
of adverse health effects of ETS. Since 1971, a series of 
rules, regulations, and laws have created smoke-free 
environments in an increasing number of settings: 
government offices, public places, eating establish­
ments, worksites, military establishments, and domes­
tic airline flights. As of December 31, 1999, smoking 
was restricted in public places in 45 states and the Dis­
trict of Columbia. Currently, some 820 local ordi­
nances, encompassing a variety of enforcement 
mechanisms, are in place. 
The effectiveness of clean indoor air restrictions 
is under intensive study.  Most studies have concluded 
that even among smokers, support for smoking restric­
tions and smoke-free environments is high.  Research 
has also verified that the institution of smoke-free 
workplaces effectively reduces nonsmokers’ exposure 
to ETS. Although most studies indicate that smoke-
free environments have not reduced smoking preva­
lence, such environments have been shown to decrease 
daily tobacco consumption and to increase smoking 
cessation among smokers. 
Minors’ Access to Tobacco 
There is widespread approval for restricting the 
access of minors to tobacco products.  Recent research, 
however, has demonstrated that a substantial propor­
tion of teenagers who smoke purchase their own 
tobacco, and the proportion varies with age, social 
class, amount smoked, and factors related to local 
availability.  In addition, research has shown that most 
minors can easily purchase tobacco from a variety of 
retail outlets. It has been suggested that a reduction 
in commercial availability may result in a reduced 
prevalence of tobacco use among minors. 
Several approaches have been taken to limiting 
minors’ access to tobacco. All states prohibit sale or 
distribution of tobacco to minors. More than two-thirds 
of states regulate the means of sale through restrictions 
on minors’ use of vending machines, but many of these 
restrictions are weak, and only two states have total 
bans on vending machines. Restrictions on vending 
machines are a subclass of the larger category of regu­
lation of self-service cigarette sales; in general, such 
regulation requires that cigarettes be obtained from a 
salesperson and not be directly accessible to custom­
ers. Such policies can reduce shoplifting as well, an 
important source of cigarettes for some minors. 
Regulations directed at the seller include the 
specification of a minimum age for sale (18, in all but 
two states and Puerto Rico), a minimum age for the 
seller, and the prominent in-store announcement of 
such policy.  Providing merchant education and train­
ing is an important component of comprehensive mi­
nors’ access programs.  Penalties for sales to minors 
vary considerably; in general, civil penalties have been 
found to be more effective than criminal ones.  Requir­
ing licensure of tobacco retailers has been found to 
provide a funding source for compliance checks and 
to serve as an incentive to obey the law when revoca­
tion of the license is a provision of the law.  Applying 
penalties to business owners, instead of to clerks only, 
is considered essential to preventing sales to minors. 
Tobacco retail outlets and the tobacco industry have 
vigorously opposed this policy.  An increasing num­
ber of states and local jurisdictions are imposing sanc­
tions against minors who purchase, possess, or use 
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tobacco products.  Sanctions against both buyers and 
sellers are enforced by a variety of agencies and mecha­
nisms. Because regulations in general may be more 
effective if generated and enforced at the local level, 
considerable energy is devoted to the issue of oppos­
ing or repealing preemption of local authority by states. 
Public health analyses have resulted in strong recom­
mendations that state laws not preempt local action to 
curb minors’ access to tobacco. 
Litigation Approaches 
Private litigation shifts enforcement of public 
health remedies from the enterprise or the government 
to the private individual—typically, victims or their 
surrogates.  In the tort system, the coalescence of in­
stances in which injurers are forced to compensate the 
injured can create a force that generates preventive 
effects.  Although relatively inefficient as a system for 
compensating specific classes of injuries, the tort sys­
tem is justified by its generation of preventive actions 
and by its flexibility.  Tobacco represents an atypical 
pattern of litigation and product modification, because 
private law remedies have not yet succeeded in insti­
tutionalizing recovery for tobacco injuries or have not 
yet generated significant preventive effects.  In the case 
of tobacco, regulation has been the predominant 
control, and such regulation has been distinctive in re­
lying primarily on notification requirements rather 
than safety requirements. 
Private litigation against tobacco has occurred in 
several distinct waves. The first wave was launched 
in 1954 and typically used one or both of two legal 
theories: negligence and implied warranty.  Courts 
proved unreceptive to both these arguments, and this 
approach had receded by the mid-1970s.  In many of 
these and subsequent cases, legal devices and exhaus­
tion of plaintiff resources figured prominently in the 
defendants’ strategy.  A second wave began in 1983 
and ended in 1992. In these cases, the legal theory 
shifted from warranty to strict liability.  The tobacco 
industry based its defense on smokers’ awareness of 
risks and so-called freedom of choice.  For example, 
plaintiffs argued that the addictive nature of nicotine 
limited free choice; defense counsel rebutted by point­
ing to the large number of former smokers who suc­
cessfully quit. Taking freedom-of-choice defense even 
further, counsel argued that the claimant’s lifestyle was 
overly risky by choice or was in some way immoral. 
The case that symbolized the second-wave litigation 
was that filed by Rose Cipollone, a dying smoker, in 
1983. The Supreme Court accepted the tobacco 
industry’s defense that federal law requiring warning 
Reducing Tobacco Use
 
labels on product packages had preempted claims 
under state law that imposed liability for failure to 
warn. The Supreme Court left open several other ap­
proaches, but the likelihood of recovery seemed small, 
and counsel for the Cipollone estate withdrew. 
In the third wave, begun soon after the Cipollone 
decision and still ongoing, diverse legal arguments 
have been invoked. This third wave of litigation dif­
fers from its predecessors by enlarging the field of 
plaintiffs, focusing on a range of legal issues, using 
the class action device, and making greater attempts 
to use private law for public policy purposes. These 
new claims have been based on theories of intentional 
misrepresentation, concealment, and failure to dis­
close, and such arguments have been joined to a new 
emphasis on addiction. For example, in one case that 
ended as a mistrial, plaintiffs were barred from pre­
senting evidence that the tobacco companies may have 
manipulated nicotine levels. The class action device 
has figured prominently in these new cases, which 
have included claims of smokers as well as claims of 
those who asserted that they have been injured by ETS. 
Arguably the most notable series of third-wave claims 
brought against tobacco companies is the proposed 
1997 settlement of suits brought by 41 state attorneys 
general attempting to recover the states’ Medicaid ex­
penditures for treating tobacco-related illnesses.  In the 
absence of congressional legislation needed to give that 
settlement the force of law, four states made indepen­
dent settlements with the tobacco industry.  Notably, 
each state obtained a concession guaranteeing that it 
would benefit from any more favorable agreement that 
another state might later obtain from the tobacco in­
dustry.  Subsequently, a multistate Master Settlement 
Agreement was negotiated in November 1998 cover­
ing the remaining 46 states, the District of Columbia, 
and five commonwealths and territories. Another 
notable recent development is the filing of large claims 
by other third-party payers, such as large health care 
plans. 
Perhaps in partial response, the level of litiga­
tion initiated by the tobacco industry itself has in­
creased in recent years and has included a number of 
well-publicized cases, including a threatened suit 
against the media to prevent airing of a program that 
accused a tobacco company of manipulating nicotine 
levels. The company was successful in making the 
network withdraw the program, even though similar 
information was later made public in other contexts. 
Although the industry continues aggressive legal pur­
suit of its interests on a number of fronts, litigation 
against the industry has had undoubted impact on 
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tobacco regulation and is likely to continue to play a 
key role in efforts to reduce tobacco use. 
Overview and Implications 
Tobacco products are far less regulated in the 
United States than they are in many other developed 
countries. This level of regulation applies to the manu­
factured tobacco product; to the advertising, promo­
tion, and sales of these products; and to the protection 
of nonsmokers from the involuntary exposure to ETS 
from the use of these products.  As with all other con­
sumer products, adult users of tobacco should be fully 
informed of the products’ ingredients and additives 
and of any known toxicity when used as intended. 
Additionally, as with other consumer products, the 
manufactured tobacco product should be no more 
harmful than necessary given available technology. 
The sale, distribution, and promotion of tobacco prod­
ucts need to be sufficiently regulated to protect un­
derage youth from influences to take up smoking. 
Finally, involuntary exposure to ETS remains a com­
mon public health hazard that is entirely preventable 
by appropriate regulatory policies. 
Such are the basic, reasonable regulatory issues 
related to tobacco products.  Yet these issues remain 
unresolved as the new millennium begins.  When con­
sumers purchase a tobacco product, they receive little 
information regarding the ingredients, additives, or 
chemical composition in the product. Although public 
knowledge about the potential toxicity of most of these 
constituents is negligible, findings in this report con­
clude that the warning labels on cigarette packages in 
this country are weaker and less conspicuous than in 
other countries.  Further, the popularity of “low tar and 
nicotine” brands of cigarettes has shown that consum­
ers may be misled by another, carefully crafted kind of 
information—that is, by the implied promise of reduced 
toxicity underlying the marketing of these products. 
Current regulation of the advertising and pro­
motion of tobacco products in this country is consid­
erably less restrictive than in several other countries, 
notably Canada and New Zealand. The review of cur­
rent case law in this report supports the contention 
that greater restrictions of tobacco product advertis­
ing and promotion could be legally justified.  In fact, 
the report concludes that regulation of the sale and 
promotion of tobacco products is needed to protect 
young people from smoking initiation. 
ETS contains more than 4,000 chemicals; of 
these, at least 43 are known carcinogens (Environmen­
tal Protection Agency 1992).  Exposure to ETS has 
serious health effects (USDHHS 2000b).  Despite this 
documented risk, research has demonstrated that 
more than 88 percent of nonsmokers in this country 
aged 4 years and older had detectable levels of se­
rum cotinine, a marker for exposure to ETS (Pirkle et 
al. 1996). The research reviewed in this report indi­
cates that smoking bans are the most effective method 
for reducing ETS exposure.  Four Healthy People 2010 
objectives address this issue and seek optimal pro­
tection of nonsmokers through policies, regulations, 
and laws requiring smoke-free environments in all 
schools, worksites, and public places. 
Despite the widespread support among the gen­
eral public, policymakers, and the tobacco industry for 
restricting the access of minors to tobacco products, a 
high proportion of underage youth smokers across 
this country continue to be able to purchase their own 
tobacco. National efforts by the Substance Abuse and 
Mental Health Services Administration to increase the 
enforcement of state laws to comply with the Synar 
Amendment and by the FDA to implement the access 
restrictions defined in their 1996 rule have reduced the 
percentage of retailers in many states who sell to mi­
nors. Unfortunately, nine states failed to attain their 
Synar Amendment targets in 1999.  Additionally, the 
March 2000 Supreme Court ruling that the FDA lacks 
jurisdiction to regulate tobacco products has suspended 
all enforcement of the agency’s 1996 regulations. 
Although several states have increased emphasis on 
this issue as part of their state-funded program efforts, 
the loss of the FDA’s program removes a major 
infrastructure in support of these state efforts.  The 
current regulatory environment poses considerable 
challenges for the interweaving of regulation into a 
comprehensive, multicomponent approach to tobacco 
use control and prevention. 
Economic Approaches (Chapter 6) 
The argument for using economic policy for re­
ducing tobacco use requires considerable technical and 
analytic understanding of economic theory and data. 
Because experiments and controlled trials—in the 
usual sense—are not available to the economist, judg­
ment and forecasting depend on the results of com­
plex analysis of administrative and survey data. Such 
analyses have led to a number of conclusions regard­
ing the importance of the tobacco industry in the U.S. 
economy and regarding the role of policies that might 
affect the supply of tobacco, affect the demand for to­
bacco, and use different forms of taxation as a pos­
sible mechanism for reducing tobacco use. 
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Supply.  The tobacco support program has success­
fully limited the supply of tobacco and raised the price 
of tobacco and tobacco products. However, the princi­
pal beneficiaries of this program are not only the 
farmers whose income is supported but also the own­
ers of the tobacco allotments. If policies were initiated 
to ameliorate some short-run effects, the tobacco sup­
port program could be removed without imposing 
substantial losses for many tobacco farmers. Elimi­
nating the tobacco support program would lead to a 
small reduction in the prices of cigarettes and other 
tobacco products, which would lead to slight increases 
in the use of these products. However, because the 
support program has created a strong political con­
stituency that has successfully impeded stronger leg­
islation to reduce tobacco use, removing the support 
program could make it easier to enact stronger policies 
that would more than offset the impact that the result­
ing small reductions in price would have on demand. 
Throughout the 1980s and 1990s, competition 
within the tobacco industry appeared to have de­
creased as a result of the favorable deregulatory busi­
ness climate and an apparent increase in collusive 
behavior.  This reduction in competition, coupled with 
the addictive nature of cigarette smoking, has magni­
fied the impact that higher cigarette taxes and stronger 
smoking reduction policies would have on demand. 
The recent expansion of U.S. trade in tobacco and 
tobacco products through multinational agreements, 
together with the U.S. threat of retaliatory trade sanc­
tions were other countries to impede this expansion, 
is nearly certain to have increased the use of tobacco 
products worldwide.  Such an increase would result 
in a consequent global rise in morbidity and mortality 
related to cigarette smoking and other tobacco use. 
These international trade policy efforts conflict with 
current domestic policies (and the support of compa­
rable international efforts) that aim to reduce the use 
of tobacco products because of their harmful effects 
on health. 
Industry importance. Although employment in the 
tobacco industry is substantial, the industry greatly 
overstates the importance of tobacco to the U.S. 
economy.  Indeed, most regions would likely benefit— 
for example, through redistribution of spending and 
changes in types of job—from the elimination of rev­
enues derived from tobacco products.  Moreover, as 
the economies of tobacco-growing regions have be­
come more diversified, the economic importance of 
tobacco in these areas has fallen.  Higher tobacco taxes 
and stronger prevention policies could be joined to 
other efforts to further ease the transition from tobacco 
in major tobacco-producing regions.  Finally, trading 
lives for jobs is an ill-considered strategy, particularly 
with the availability of stronger policies for reducing 
tobacco use. 
Demand. Increases in the price of cigarettes will 
lead to reductions in both smoking prevalence and ciga­
rette consumption among smokers; relatively large re­
ductions are likely to occur among adolescents and 
young adults. Limited research indicates that increases 
in smokeless tobacco prices will similarly reduce the 
use of these products.  More research is needed to clarify 
the impact of cigarette and other tobacco prices on the 
use of these products in specific sociodemographic 
groups, particularly adolescents and young adults. 
Additional research also is needed to address the po­
tential substitution among cigarettes and other tobacco 
products as their relative prices change. 
Taxation. After the effects of inflation are ac­
counted for, federal and average state excise taxes on 
cigarettes are well below their past levels.  Similarly, 
average cigarette excise taxes in the United States are 
well below those imposed in most other industrialized 
countries. Moreover, U.S. taxes on smokeless tobacco 
products are well below cigarette taxes.  Studies of the 
economic costs of smoking report a wide range of es­
timates for the optimal tax on cigarettes.  However, 
when recent estimates of the costs of ETS (including 
the long-term costs of fetal and perinatal exposure to 
ETS) are considered, and when the premature death 
of smokers is not considered an economic benefit, a 
tax that would generate sufficient revenues to cover 
the external costs of smoking is almost certainly well 
above current cigarette taxes.  The health benefits of 
higher cigarette taxes are substantial.  By reducing 
smoking, particularly among youth and young adults, 
past tax increases have significantly reduced smoking-
related morbidity and mortality.  Further increases in 
taxes, indexed to account for the effects of inflation, 
would lead to substantial long-run improvements in 
health. 
The revenue potential of higher cigarette and 
other tobacco taxes—obviously not in itself a goal—is 
considerable; significant increases in these taxes would 
lead to sizable increases in revenues for many years. 
However, because of the greater price responsiveness 
of adolescents and young adults and the addictive 
nature of tobacco use, the long-run increase in revenues 
is likely to be less than the short-run gain.  Neverthe­
less, current federal and most state tobacco taxes are 
well below their long-run revenue-maximizing levels. 
In short, the research reviewed in this report sup­
ports the position that raising tobacco prices is good 
public health policy.  Further, raising tobacco excise 
taxes is widely regarded as one of the most effective 
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tobacco prevention and control strategies.  Research 
indicates that increasing the price of tobacco products 
would decrease the prevalence of tobacco use, particu­
larly among minors and young adults. As noted, how­
ever, this report finds that both the average price of 
cigarettes and the average cigarette excise tax in this 
country are well below those in most other industrial­
ized countries and that the taxes on smokeless tobacco 
products are well below those on cigarettes.  Making 
optimal use of economic strategies in a comprehen­
sive program poses special problems because of the 
complexity of government and private controls over 
tobacco economics and the need for a concerted, mul­
tilevel, political approach. 
Comprehensive Programs (Chapter 7) 
Community-based interventions were originally 
developed as research projects that tested the efficacy 
of a communitywide approach to risk reduction.  A 
number of national and international efforts to con­
trol cardiovascular disease (in the United States, nota­
bly the Minnesota, Stanford, and Pawtucket studies) 
used controlled designs.  The results from these and 
other studies were largely disappointing, particularly 
regarding prevention and control of tobacco use.  Other 
large-scale research efforts, such as the Community In­
tervention Trial (COMMIT) for Smoking Cessation, 
also failed to meet their primary goals for smoking re­
duction and cessation. Similarly, the results to date 
from numerous worksite-based cessation projects sug­
gest either no impact or a small net effect (summarized 
in Chapter 4). 
As these studies were under way in the 1970s and 
1980s, health promotion—an organized approach to 
changing social, economic, and regulatory environ­
ments—emerged as a more effective mechanism for 
population behavior change than traditional health 
education. Although the aforementioned community-
based research projects used a health promotion per­
spective, they lacked the reach and penetration required 
for effective social change. In any event, the results 
made clear the distinction between a specific program 
(even one using multiple modalities) and a comprehen­
sive multimessage, multichannel approach that used 
some or all of the modalities described in Chapters 3 
through 6.  The legal and economic events of the 1990s— 
most notably large excise tax increases and the settle­
ments with the tobacco industry for reimbursement of 
Medicaid costs incurred by caring for smokers—have 
provided those states with the resources necessary to 
mount such a comprehensive approach.  The early 
results are encouraging, as exemplified by results from 
California, Massachusetts, Oregon, and Florida.  The 
well-funded, coherent, and organized approach to to­
bacco prevention and control provides a credible coun­
terweight to the advertising and promotional efforts of 
the tobacco industry and fosters a powerful nonsmok­
ing norm. 
On a broader scale, other social initiatives can also 
serve some of these same purposes through means that 
are not directly related to changing population behav­
ior.  For example, direct advocacy—the presentation 
of information to decision makers to encourage their 
support for nonsmoking policies—has been pursued 
vigorously by health advocates since the organization 
of grassroots movements for nonsmokers’ rights in the 
early 1970s. Much of the clean air legislation now in 
place may be attributed in part to such direct advo­
cacy.  An interesting observation that supports the logic 
behind comprehensive programs is that initial short­
comings in direct advocacy activity may have been 
related to a failure of coordination among grassroots 
groups and professional organizations.  In recent years, 
in part as the result of electronic networking and me­
diating by the Advocacy Institute, a more unified ap­
proach to reducing tobacco use has been achieved 
among the participating organizations. 
Media advocacy—the use of mass media to ad­
vance public policy initiatives—has also been effective 
in placing smoking issues in the public eye and main­
taining a continued impetus for reducing tobacco use. 
Case analysis of several instances of such activity— 
advocacy opposing the promotion of the “X” cigarette, 
the marketing of “Dakota” cigarettes, the Philip 
Morris-sponsored Bill of Rights tour, and the attempted 
marketing of “Uptown” cigarettes—highlights several 
successes but also indicates that such activities do not 
always achieve their immediate aims. Nonetheless, 
considerable experience has been gained in seizing 
such opportunities. 
Countermarketing activities can promote smok­
ing cessation and decrease the likelihood of initiation. 
Countermarketing campaigns also can have a power­
ful influence on public support for tobacco control ac­
tivities and provide an educational climate that can 
enhance the efficacy of school- and community-based 
efforts.  For youth, the CDC has estimated that the 
average 14-year-old has been exposed to more than 
$20 billion in imagery advertising and promotions 
since age 6, creating a “friendly familiarity” for tobacco 
products.  The recent increase in movie depictions of 
tobacco use further enhances the image of tobacco use 
as glamorous, socially acceptable, and normal.  In light 
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of the ubiquitous and sustained protobacco messages, 
countermarketing campaigns need to be of comparable 
intensity and duration to alter the general social and 
environmental atmosphere supporting tobacco use. 
In sum, the comprehensive approach that has 
been developed within the statewide tobacco control 
programs has produced results that led the Institute 
of Medicine (2000) to conclude that “multifaceted state 
tobacco control programs are effective in reducing to­
bacco use” (p. 4). Although these initial results are 
encouraging, they need to be considered from the per­
spective of the less favorable results from the commu­
nity trials. Nevertheless, although our knowledge 
about the mechanisms by which these new compre­
hensive tobacco control efforts function is imperfect, 
the results are sufficiently favorable to support the con­
tinued application of this model. But, accountability 
and program evaluation must be emphasized in these 
new statewide tobacco control programs to improve 
our understanding of how the various components of 
the comprehensive programs work. 
Perhaps the most important aspect of comprehen­
sive programs has been the emergence of statewide to­
bacco control efforts as a laboratory for their development 
and evaluation.  The number of states with such pro­
grams grew slowly in the early and mid-1990s, but in 
recent years there has been a surge in funding for such 
efforts fueled by the state settlements with the tobacco 
industry.  Although the data on the impact of these pro­
grams on per capita consumption, adult prevalence, 
and youth prevalence are generally favorable, the uni­
form data systems needed to conduct more controlled 
evaluations of these efforts are still emerging.  The chal­
lenge for the new millennium will be to ensure that these 
ever increasing comprehensive statewide tobacco con­
trol programs are as efficient and effective as possible. 
The review of statewide tobacco control programs 
indicates that reducing the broad cultural acceptability 
of tobacco use necessitates changing many facets of the 
social environment.  In addition, this report stresses— 
as does the Best Practices (CDC 1999) document—that 
these individual components must work together to 
produce the synergistic effects of a comprehensive 
Reducing Tobacco Use 
program.  However, both of these findings highlight 
the complexity involved in evaluating these types of 
programs. 
Within the current statewide tobacco control pro­
grams, each of these various modalities discussed in 
this report is represented with varying degrees of in­
tensity.  As noted above, some of the recommendations 
for actions within these modalities could most effec­
tively be done at the national rather than the state level. 
Thus, the overall efficacy of these emerging statewide 
programs will depend in some ways on public health 
advances at the national level. Again, this synergy 
between the statewide and national efforts adds greater 
complexity to the evaluation issue. 
Finally, this report concludes that the span of 
impact of these educational, clinical, regulatory, eco­
nomic, and social approaches indicates the importance 
of their sustained and long-term implementation. Pro­
gram evaluation and research efforts are needed to 
improve our understanding of how these various ele­
ments work. Although knowledge about the efficacy 
of comprehensive programs is imperfect, evidence 
points to early optimism for their continuance. With 
the expansion of tobacco control surveillance and 
evaluation systems and increases in the number and 
diversity of statewide tobacco control programs, criti­
cal questions can be answered about how to make these 
efforts more efficient and effective. 
A Vision for the Future—Reducing 
Tobacco Use in the New Millennium 
(Chapter 8) 
Chapter 8 outlines broad strategies and courses 
of action for tobacco control in the future.  Six future 
challenges are outlined: continuing to build the scien­
tific base, responding to the changing tobacco indus­
try, using a comprehensive approach in reducing 
tobacco use, eliminating health disparities, improving 
dissemination of state-of-the-art interventions, and 
influencing tobacco use in developing nations. 
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Chapter Conclusions 
Following are the specific conclusions for each 
chapter of the report.  Note that Chapters 1 and 8 have 
no conclusions. 
Chapter 2. Historical Review 
1.	 	 In the years preceding the development of the 
modern cigarette, and for some time thereafter, 
antismoking activity was largely motivated by 
moralistic and hygienic concerns. Health con­
cerns played a lesser role. 
2.	 	 In contrast, in the second half of the 20th cen­
tury, the impetus for reducing tobacco use was 
largely medical and social. The resulting plat­
form has been a more secure one for efforts to 
reduce smoking. 
3.	 	 Despite the growing scientific evidence for ad­
verse health effects, smoking norms and habits 
have yielded slowly and incompletely.  The rea­
sons are complex but attributable in part to the 
industry’s continuing stimulus to consumption. 
Chapter 3. Educational Strategies 
1.	 	 Educational strategies, conducted in conjunction 
with community- and media-based activities, can 
postpone or prevent smoking onset in 20 to 40 
percent of adolescents. 
2.	 	 Although most U.S. schools have tobacco use pre­
vention policies and programs in place, current 
practice is not optimal. 
3.	 	 More consistent implementation of effective edu­
cational strategies to prevent tobacco use will re­
quire continuing efforts to build strong, multiyear 
prevention units into school health education cur­
ricula and expanded efforts to make use of the 
influence of parents, the mass media, and other 
community resources. 
Chapter 4. Management of Nicotine 
Addiction 
1.	 	 Tobacco dependence is best viewed as a chronic 
disease with remission and relapse.  Even though 
both minimal and intensive interventions in­
crease smoking cessation, most people who quit 
smoking with the aid of such interventions will 
eventually relapse and may require repeated at­
tempts before achieving long-term abstinence. 
Moreover, there is little understanding of how 
such treatments produce their therapeutic effects. 
2.	 	 There is mixed evidence that self-help manuals 
are an efficacious aid to smoking cessation.  Be­
cause these materials can be widely distributed, 
such strategies may have a significant public 
health impact and warrant further investigation. 
3.	 	 Programs using advice and counseling—whether 
minimal or more intensive—have helped a sub­
stantial proportion of people quit smoking. 
4.	 	 The success of counseling and advice increases 
with the intensity of the program and may be im­
proved by increasing the frequency and duration 
of contact. 
5.	 	 The evidence is strong and consistent that phar­
macologic treatments for smoking cessation 
(nicotine replacement therapies and bupropion, 
in particular) can help people quit smoking. 
Clonidine and nortriptylene may have some util­
ity as second-line treatments for smoking cessa­
tion, although they have not been approved by 
the FDA for this indication. 
Chapter 5. Regulatory Efforts 
Advertising and Promotion 
1.	 	 Since 1964, numerous attempts to regulate ad­
vertising and promotion of tobacco products 
have had only modest success in restricting such 
activity. 
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2.	 	 Current regulation in the United States is con­
siderably less restrictive than that in several other 
countries, notably Canada and New Zealand. 
3.	 	 Current case law supports the contention that ad­
vertising does not receive the protections of free 
speech under the First Amendment to the Con­
stitution that noncommercial speech does. 
Product Regulation 
1.	 	 Warning labels on cigarette packages in the 
United States are weaker and less conspicuous 
than those of other countries. 
2.	 	 Smokers receive very little information regard­
ing chemical constituents when they purchase a 
tobacco product.  Without information about 
toxic constituents in tobacco smoke, the use of 
terms such as “light” and “ultra light” on pack­
aging and in advertising may be misleading to 
smokers. 
3.	 	 Because cigarettes with low tar and nicotine con­
tents are not substantially less hazardous than 
higher-yield brands, consumers may be misled 
by the implied promise of reduced toxicity un­
derlying the marketing of such brands. 
4.	 	 Additives to tobacco products are of uncertain 
safety when used in tobacco. Knowledge about the 
impact of additives is negligible and will remain 
so as long as brand-specific information on the 
identity and quantity of additives is unavailable. 
5.	 	 Regulation of tobacco product sale and promo­
tion is required to protect young people from in­
fluences to take up smoking. 
Clean Indoor Air Regulation 
1.	 	 Although population-based data show declining 
ETS exposure in the workplace over time, ETS 
exposure remains a common public health haz­
ard that is entirely preventable. 
2.	 	 Most state and local laws for clean indoor air re­
duce but do not eliminate nonsmokers’ exposure 
to ETS; smoking bans are the most effective 
method for reducing ETS exposure. 
Reducing Tobacco Use 
3.	 	 Beyond eliminating ETS exposure among non­
smokers, smoking bans have additional benefits, 
including reduced smoking intensity and poten­
tial cost savings to employers. Optimal protec­
tion of nonsmokers and smokers requires a 
smoke-free environment. 
Minors’ Access to Tobacco 
1.	 	 Measures that have had some success in reduc­
ing minors’ access include restricting distribu­
tion, regulating the mechanisms of sale, enforcing 
minimum age laws, having civil rather than 
criminal penalties, and providing merchant edu­
cation and training. Requiring licensure of to­
bacco retailers provides both a funding source 
for enforcement and an incentive to obey the law 
when revocation of the license is a provision of 
the law. 
2.	 	 The effect of reducing minors’ access to tobacco 
products on smoking prevalence requires further 
evaluation. 
Litigation Approaches 
1.	 	 Two historic waves of tobacco litigation were ini­
tiated by private citizens, were based largely on 
theories of negligence and implied warranty, and 
were unsuccessful. 
2.	 	 A third wave has brought in new types of claim­
ants, making statutory as well as common-law 
claims and using more efficient judicial proce­
dures.  Although several cases have been settled 
for substantial money and have yielded public 
health provisions, many other cases remain 
unresolved. 
3.	 	 Private law initiative is a diffuse, uncentralized 
activity, and the sum of such efforts is unlikely 
to produce optimal results for a larger policy to 
reduce tobacco use. On the other hand, the liti­
gation actions of individuals are likely to be a 
valuable component in some larger context of 
strategies to make tobacco use less prevalent. 
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Chapter 6. Economic Approaches 
1.	 	 The price of tobacco has an important influence 
on the demand for tobacco products, particularly 
among young people. 
2.	 	 Substantial increases in the excise taxes on ciga­
rettes would have considerable impact on the 
prevalence of smoking and, in the long term, re­
duce the adverse health effects caused by tobacco. 
3.	 	 Policies that influence the supply of tobacco, par­
ticularly those that regulate international com­
merce, can have important effects on tobacco use. 
4.	 	 Although employment in the tobacco sector is 
substantial, the importance of tobacco to the U.S. 
economy has been overstated. Judicious policies 
can be joined to higher tobacco taxes and stron­
ger prevention policies to ease economic diver­
sification in tobacco-producing areas. 
Chapter 7. Comprehensive Programs 
1.	 	 The large-scale interventions conducted in com­
munity trials have not demonstrated a conclu­
sive impact on preventing and reducing tobacco 
use. 
2.	 	 Statewide programs have emerged as the new 
laboratory for developing and evaluating com­
prehensive plans to reduce tobacco use. 
3.	 	 Initial results from the statewide tobacco control 
programs are favorable, especially regarding 
declines in per capita consumption of tobacco 
products. 
4.	 	 Results of statewide tobacco control programs 
suggest that youth behaviors regarding tobacco 
use are more difficult to change than adult ones, 
but initial results of these programs are gener­
ally favorable. 
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Reducing Tobacco Use 
Introduction 
Like many other social phenomena, the use of 
tobacco has created a tapestry of themes, motivations, 
and social forces, woven together with a complexity 
that has begun to capture the interest of social histori­
ans (Brandt 1990; Burnham 1993; Klein 1993; Tate 
1999). Tobacco has economic, social, and political 
reverberations and is intimately tied to collective im­
ages and attitudes. Nonetheless, some simplification 
is possible: the history of tobacco use can be thought 
of as the conflict between tobacco as an agent of eco­
nomic gain and tobacco as an agent of human harm. 
An exhaustive history would not be content with such 
a simple contrast, but it serves the purpose of this chap­
ter.  The chief barrier to reducing tobacco use—the path 
of most resistance—is a powerful industry whose 
efforts to promote tobacco have continued to shape 
public opinion and social norms. Against this back­
ground, the chapter considers the underlying forces 
Early Events 
that have motivated the movement to reduce smok­
ing. Many recent events that are of critical historical 
importance for nonsmoking are considered in other 
segments of the report (e.g., social advocacy actions 
[Chapter 7]; taxation-based initiatives in states [Chap­
ter 7]; Food and Drug Administration regulations re­
garding minors as the target of tobacco advertising 
[Chapter 5]; and proposed national legislation, settle­
ment and attempted settlement of various lawsuits 
against the tobacco companies, and criminal proceed­
ings against tobacco companies [Chapter 5]). As noted 
in Chapter 1, some of the most dynamic changes in the 
history of smoking control efforts are currently taking 
place, and we are not sufficiently distanced from these 
events to evaluate them fully.  This chapter will con­
sider, rather, the changing thematic content—religious, 
hygienic, medical, and social—of the movement to 
reduce smoking that has presaged the current events. 
In North America, the history of tobacco use pre­
cedes written records.  After American Indians intro­
duced tobacco to the European colonists, tobacco was 
transported from the colonies to Europe, where it 
quickly became a widely used consumer item. Just as 
quickly, however, the use of tobacco became contro­
versial. Critics of the day attacked tobacco use as 
morally irresponsible, extravagant, and a habit of 
people of base condition (Best 1979). In England, King 
James I published an antitobacco tract in 1604 that, 
among other things, offered an early critique of sec­
ondhand smoke: the royal author expressed his con­
cerns that a husband who smoked might “reduce 
thereby his delicate, wholesome, and cleane complex­
ioned wife to that extremitie, that either shee must also 
corrupt her sweete breath therewith, or else resolve to 
live in a perpetuall stinking torment” (quoted in 
Apperson 1916, p. 206). In many countries of north­
ern Europe, tobacco use was criminalized (Best 1979). 
Part of the objection in England and elsewhere was 
that trading gold to Spain for tobacco—the best tobacco 
came from Spain’s colonies—was dangerous to the 
state economy.  But with the English colonization of 
Virginia and the growing need in England, and else­
where in Europe, for more state revenue, governments 
turned their policies around, despite continued moral 
objections to tobacco use. King James I himself set 
aside his previous objections and sought ways for the 
crown to profit from the tobacco trade (Morgan 1975; 
Best 1979). 
Of all the novel consumer goods the New World 
made available to the Old World, “tobacco enjoyed the 
most rapid diffusion” (Shammas 1990, p. 80) among 
people of different income levels, who bought it on 
a fairly regular basis.  Closer to the source, mass 
consumption was even more pronounced:  in the 
American colonies during the 18th century, yearly con­
sumption averaged between 2 and 5 pounds per capita 
(Shammas 1990). When used medicinally, tobacco was 
favorably regarded; but in its widespread use for plea­
sure, “it was considered harmful and faintly immoral” 
(Morgan 1975, p. 91; see also Stewart 1967). 
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Although that reputation for immorality never 
entirely vanished, by 1776, tobacco was not only a val­
ued consumer good but also the economic foundation 
of the colonies’ independence movement. “King 
Tobacco Diplomacy” was a central element in gaining 
French support for the struggling colonies; tobacco, 
The Rise of the Cigarette 
one historian reports, “helped to buy American inde­
pendence” (Morgan 1975, p. 6).  Thomas Jefferson 
thought well enough of tobacco to propose that its 
leaves be carved into the pillars in one of the Capitol 
rotundas in Washington (U.S. House of Representa­
tives 1969). 
Before the 20th century, tobacco was used pre­
dominantly for chewing, pipe smoking, inhaling (as 
snuff), and cigar smoking.  The cigarette was an inno­
vation that appeared sometime early in the 19th cen­
tury.  The term “cigarette” first made its appearance 
in English in the 1840s (Apperson 1916). For reasons 
including cost and ease of use (discussed later in this 
chapter), the product quickly caught on among tobacco 
users. In the United States, cigarette smoking increased 
enough during the Civil War for cigarettes to become 
subject to federal tax in 1864 (Tennant 1950).  But it 
was not until its manufacture was mechanized that the 
cigarette became a major tobacco product. 
James Albert Bonsack patented a cigarette roll­
ing machine in 1881 that, by the late 1880s, produced 
cigarettes at 40 times the rate of a skilled hand worker 
(Tennant 1950; Chandler 1977).  The mechanization of 
cigarette manufacture, like that of a number of other 
products in the late 19th century (such as prepared 
cereals, photographic film, matches, flour, and canned 
food products such as soup), precipitated a marketing 
revolution.  Industries that developed “continuous 
process” production (Chandler 1977, p. 249) could 
increase unit production without increasing produc­
tion costs—the main production problem of the day. 
The cigarette industry, like these others, could now pro­
duce almost unlimited quantities of product at mini­
mal cost per additional unit. When James Buchanan 
Duke installed two Bonsack machines in 1884 and 
arranged the next year an advantageous leasing ar­
rangement with Bonsack, his cigarette output soared. 
Within a decade, his unit cost of producing cigarettes 
dropped to one-sixth of what it had been (Chandler 
1977). In 1890, following a series of price wars made 
feasible by these cost savings, Duke merged with 
several competitors to form The American Tobacco 
Company.  With the production problem solved and 
competition reduced, the focus of business thinking 
shifted to marketing. At a time when national adver­
tising of many products was in its infancy, The Ameri­
can Tobacco Company was innovative and expansive 
in its promotional efforts (U.S. Department of Health 
and Human Services [USDHHS] 1994). 
Popularity and Protest 
The growing popularity of cigarette smoking 
coincided with the years of populist health reform in 
the 19th century.  Antitobaccoism was a standard fea­
ture of various writings on personal health, which held 
that any “stimulant” was unhealthy (Nissenbaum 
1980).  Some of these health beliefs were tied to a reli­
gious orientation. Ellen Gould Harmon White, the 
prophetess who founded the Seventh-day Adventists, 
spoke out strongly against tobacco. In 1848, her first 
vision concerning healthful living taught her the reli­
gious duty of abstaining from tobacco, tea, and coffee. 
She attacked these products for the money squandered 
on them and for their dangers to health. White may 
have picked up these views from Captain Joseph Bates, 
a Millerite (follower of William Miller, whose 
millenarian group believed that the Second Coming 
of Christ would occur in 1843). Not until 1855, how­
ever, did tobacco abstention become a larger theme 
among the Adventists.  In that year, the group’s 
Review and Herald printed two lead articles attacking 
“the filthy, health-destroying, God-dishonoring 
practice of using tobacco” (quoted in Numbers 1976, 
p. 40). 
This protest was an integral part of the complex 
antitobacco crusading at the time.  In addition to the 
religious motif, there was the considerable influence 
of the hygiene movement, which branded “tobacco­
ism” a disease, tobacco a poison (Burnham 1989, p. 6), 
and dubbed cigarettes “coffin nails” (Tate 1999, p. 24). 
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Spearheaded by the American Anti-Tobacco Society, 
which was founded in 1849, antitobacco critics found 
tobacco a cause of ailments ranging from insanity to 
cancer.  During this time, cigarettes were often con­
sidered narcotics because they seemed to have addict­
ing qualities (Tate 1999).  This litany of physiological 
ills ascribed to tobacco use did not prove to have the 
social power of the announcement, a century later, that 
numerous medical studies had found a direct link be­
tween smoking and specific diseases that, as was un­
derstood only in that later century, often took decades 
to manifest themselves. Between 1857 and 1872, George 
Trask published the Anti-Tobacco Journal in Fitchburg, 
Massachusetts, attacking the filth (especially of chew­
ing tobacco), the dangers to health, and the costliness 
of tobacco (Tennant 1971).  Early 19th century popular 
health movements tended to ally themselves with 
“nature” and “natural” remedies in opposition to pro­
fessional medicine; by the late 19th century, health 
movements were more likely to take medical profes­
sionals as their spokesmen (Burnham 1987). 
One such professional was Dr. John Harvey 
Kellogg, Seventh-day Adventist and director of the 
famous Adventist-founded Battle Creek (Michigan) 
Sanitarium, whose main concern was improving diet. 
Kellogg argued that tobacco was a principal cause of 
heart disease and other illnesses and that it adversely 
affected both judgment and morals (Schwarz 1970). 
Along with Ellen Gould Harmon White and her hus­
band, a Millerite preacher, Kellogg organized the 
American Health and Temperance Association in 1878, 
which opposed the use of alcohol, tea, coffee, and 
tobacco. Later, Kellogg served as president of the 
Michigan Anti-Cigarette Society and, after World War I, 
as a member of the Committee of Fifty to Study the 
Tobacco Problem. 
Other organizational efforts directed specifically 
at cigarettes began in the last two decades of the 19th 
century.  These efforts were generally directed at sav­
ing boys and young men from the dangers of cigarette 
smoking. In New York City, the president of the board 
of education, a smoker himself, set up the Consolidated 
Anti-Cigarette League and won the pledges of 25,000 
schoolboys not to smoke until they turned 21 (Troyer 
and Markle 1983). 
The first to call for cigarette prohibition was the 
National Woman’s Christian Temperance Union 
(WCTU) (Tate 1999).  Led by Frances Willard, a friend 
of Harvey Kellogg, who was further inspired by her 
brother’s death from smoking-related illnesses, the 
WCTU as early as 1875 made plans to instruct mem­
bers of its youth affiliate, the Juvenile Work, about the 
dangers of tobacco, as well as the hazards of alcohol. 
Reducing Tobacco Use 
In 1883, the WCTU established the Department for 
Overthrow of Tobacco Habit, which was renamed the 
Department of Narcotics in 1885 (Lander 1885; Tate 
1999). 
The campaign against tobacco became a perma­
nent part of the WCTU. Reports from their annual 
meetings documented the accomplishments of state 
and local chapters in combating smoking. In 1884, the 
superintendent of the Department for Overthrow of 
Tobacco Habit acknowledged the difficulty of the task 
before her:  “With a spittoon in the pulpit and the vis­
ible trail of the vice in countless churches, with its 
entrenchments bearing the seal of respectability, its for­
tifications so long impregnable will yield slowly and 
unwillingly to the mightiest opposing forces” (WCTU 
1884, p. v). She noted that tobacco was a habit costing 
people “more than the support of all [their] ministers 
of the gospel” or than the price of educating their chil­
dren; that it caused disease, “especially the loss of sight, 
paralysis, prostration, and scores of ailments hitherto 
credited to other sources”; and that it “lower[ed] the 
standard of morality” (WCTU 1884, p. v). 
The WCTU was one group that pressed with 
some success for legislation to prohibit the sale of 
tobacco to minors.1  By 1890, such laws had been passed 
in 23 states. Connecticut and New York enacted pen­
alties for both the underaged smoker and the merchant 
who sold to the minor (WCTU 1890). In New York, 
the strengthened law arose out of WCTU lobbying. 
“We found so many evasions of the law as it stood,” 
the WCTU reported at its annual meeting in 1890, “that 
we decided our only way to save the boys was to 
amend the law, so as to punish the boy who was found 
using tobacco in any public place, street or resort” 
(WCTU 1890, p. 185). The Department of Narcotics 
organized a letter-writing campaign that mobilized 
women, educators, and ministers (p. 185). By 1897, 
the Department of Narcotics report could proudly 
claim, “everything points to the death of the little cof­
fin nail, if our women will only continue faithful” 
(WCTU 1897, p. 343). 
1The laws prohibiting sales to minors began in New Jersey 
and Washington as early as 1883, Nebraska in 1885, and 
Maryland in 1886. By 1940, all states except Texas had 
laws of this sort on the books (Gottsegen 1940). By 1964, 
Texas had joined the list, but Louisiana and Wisconsin had 
repealed their laws as unenforceable (USDHHS 1989). 
The legality of the laws was confirmed by the United 
States Supreme Court (Austin v. Tennessee, 179 U.S. 343, 21 
S. Ct. 132 [1900]), and a Federal Court of Appeals ruled in 
1937 to uphold the authority of local jurisdictions to ban 
vending machine sales of cigarettes in the effort to protect 
minors (USDHHS 1989). 
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Announcements of tobacco’s death were prema­
ture, but cigarette sales declined in the last years of 
the 19th century.  Most likely, the decline was precipi­
tated by the “Plug War,” in which The American 
Tobacco Company bought several plug tobacco pro­
ducers and sharply cut prices, attracting cigarette us­
ers back to other tobacco products. Moreover, as the 
country came out of the depression of the 1890s, cigar 
smokers who had shifted to the cheaper cigarettes 
moved back to their preferred smoke (Sobel 1978).  But 
the campaign against the cigarette certainly had a leg­
islative impact. Cigarettes were prohibited for both 
adults and minors by law—if only temporarily—in 
North Dakota in 1895, Iowa in 1896, Tennessee in 1897, 
and Oklahoma in 1901. Eleven states had some gen­
eral anticigarette legislation by 1901, and almost all 
state legislatures had considered curbs on cigarette 
sales (Outlook 1901). 
In 1899, Lucy Page Gaston, a WCTU activist, set 
up the Chicago Anti-Cigarette League (changed to the 
National Anti-Cigarette League in 1901 and to the Anti-
Cigarette League of America in 1911).  The league 
focused on the dangers of cigarettes to boys.  Gaston 
sponsored frequent rallies, at which a chorus of young 
nonsmoking men provided the music (Duis 1983; Tate 
1999). One of the innovations of Gaston’s crusade was 
the establishment of a smoking cessation clinic in Chi­
cago (Troyer and Markle 1983).  Gaston, whose long 
career against tobacco would culminate with her bid 
for the Republican presidential nomination in 1920 on 
an antitobacco platform (New York Times 1920), worked 
tirelessly lobbying for antitobacco legislation. 
Such legislation continued to pass, particularly 
in midwestern and some western states—Indiana, 
Nebraska, and Wisconsin in 1905; Arkansas in 1907; 
and Kansas, Minnesota, South Dakota, and Washing­
ton in 1909. But evasion of the laws was apparently 
easy.  Cigarette “makings” (e.g., cigarette papers and 
cigarette tobacco) were sold even if cigarettes were not, 
and some retailers sold matches for a higher-than­
usual price and gave away cigarettes with them 
(Warfield 1930; Sobel 1978).  Other retailers and smok­
ers evaded the law through a product wrapped in a 
tobacco leaf rather than paper (New York Times 1905). 
The WCTU was not alone in its efforts.  Several 
businesses and prominent individuals were outspo­
ken in the crusade against tobacco use, some going so 
far as to support Gaston’s proposed (and defeated) 
20th amendment to the Constitution that would have 
outlawed the manufacture and shipment of tobacco 
products (Junod 1997).  Henry Ford attacked the habit 
of cigarette smoking and enlisted Thomas Edison to 
investigate its dangers (Brandt 1990). According to 
Harper’s Weekly (1910), many railroads and other firms 
would not hire smokers.  Sears, Roebuck and Com­
pany and Montgomery Ward Holding Corporation 
refused to employ smokers (Porter 1947–48).  The Non-
Smokers’ Protective League of America was estab­
lished in 1911 with a distinguished board of directors, 
including Harvey W. Wiley, chief chemist of the U.S. 
Department of Agriculture and father of the (1906) 
Pure Food and Drug Act; James Roscoe Day, chancel­
lor of Syracuse University; and David Starr Jordan, 
president of Stanford University (New York Times 
1911).  Dr. Charles G. Pease, a physician and dentist, 
was the leader of this group.  “Almost single-handed,” 
according to a New York Times report (1928, p. 7), Pease 
won a 1909 prohibition against smoking in the sub­
ways. In 1917, he opposed sending tobacco to Ameri­
can soldiers in Europe. 
But the New York Times reported in 1928 that “little 
has been heard from Dr. Pease since” (p. 7).  Indeed, 
the anticigarette movement by then was waning. 
Cigarette prohibition was repealed in Indiana in 
1909; Washington in 1911; Minnesota in 1913; Okla­
homa and Wisconsin in 1915; South Dakota in 1917; 
Nebraska in 1919; Arkansas, Idaho, Iowa, and Tennes­
see in 1921; Utah in 1923; North Dakota in 1925; and 
Kansas in 1927 (Gottsegen 1940). Legislatures in other 
states—including Lucy Page Gaston’s home state of 
Illinois—considered but did not enact anticigarette bills 
(Duis 1983). Even the WCTU, at the time judged “the 
most powerful and the most formidable organization 
which is actively opposing the use of tobacco” (Brown 
1920, p. 447), in 1919 voted against supporting tobacco 
prohibition.  The organization pledged to keep to an 
educational rather than a legislative campaign (New 
York Times 1919). 
A major weapon against the tobacco prohibition 
movement was the American soldier.  Cigarettes had 
been popular among the armed forces since the Civil 
War.  By 1918, during World War I, cigarettes were part 
of the army’s daily ration (Dillow 1981); soldiers used 
cigarettes for relief during the extremes of tedium and 
tension characteristic of the profession.  General John 
Joseph Pershing himself is supposed to have said, “You 
ask me what we need to win this war.  I answer 
tobacco, as much as bullets” (quoted in Sobel 1978, 
p. 84). “The soldiers, we are told, must have their 
tobacco,” a newspaper editorialized in 1915: “The ciga­
rette is the handiest form in which this can be sent” 
(Lynn [Mass.] Evening News 1915, p. 4). Even the Young 
Men’s Christian Association altered its antitobacco 
stance and, along with the International Red Cross and 
other charitable and patriotic organizations, sent ciga­
rettes off to the soldiers in the field (Schudson 1984). 
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This outspoken, soldier-directed sentiment in favor 
of the cigarette was thus a large-scale factor in the 
reversal of anticigarette laws.  A representative ques­
tion that fueled the repeal effort in Kansas in 1927 was, 
“If cigaret[te]s were good enough for us while we were 
fighting in France, why aren’t they good enough for 
us in our own homes?” (Literary Digest 1927, p. 12; see 
also Smith 1973). 
Weakened but not vanquished by these legisla­
tive setbacks, the war on tobacco persevered.  In 1921, 
the Loyal Temperance Legion reported holding anti­
cigarette essay contests, distributing antitobacco blot­
ters in schools, and stubbing out 125,000 cigars and 
cigarettes (WCTU 1921).  The Department of Narcot­
ics held up its own end; in 1929, for instance, it held 
poster contests, cooperated in antitobacco work with 
Reducing Tobacco Use 
other civic organizations, sponsored 214 debates on 
tobacco, and ran essay contests producing more than 
50,000 essays against tobacco use (WCTU 1929). Reli­
gious denominations, including the Presbyterians, 
Methodists, and Baptists, also took a stand against 
tobacco (Troyer and Markle 1983).  The antitobacco 
position was especially strong among the Mormons 
(Latter-day Saints). A motto of the Mormon youth or­
ganization in 1920, “We stand for the non-use and non-
sale of tobacco” (quoted in Smith 1973, p. 360), seems 
to have presaged the current low prevalence of tobacco 
use in Utah. 
Such dedicated opponents did not prevent the 
popularity of the cigarette—an inexpensive, easy-to­
use form of tobacco product—from increasing in the 
1920s (Figure 2.1; the demographic and epidemiologic 
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details of cigarette consumption have been docu­
mented in detail in prior reports [USDHHS 1989, 1994] 
and will not be repeated here).  Men in substantial 
numbers either switched from other tobacco forms or 
took up smoking, and women in smaller but visible 
numbers began taking up tobacco use—in the form of 
cigarette smoking—for the first time, even as the fre­
quently women-led antitobacco efforts continued.  By 
the 1930s, cigarettes accounted for more than one-half 
of all tobacco consumption (Schudson 1984). 
In response to these trends, the WCTU cam­
paigned for strict enforcement of laws forbidding the 
sale of tobacco to minors, attacked advertising that 
claimed or suggested health benefits, and criticized 
smoking among women. In 1927, the Department of 
Narcotics reported that chapters across the country had 
sponsored thousands of antismoking events and strat­
egies. For example, the Portland, Oregon, chapter suc­
cessfully protested a leading department store’s use 
of a female mannequin holding a cigarette.  Members 
stubbed out 219,560 cigarettes and 39,713 cigars.  The 
WCTU also lobbied for laws prohibiting smoking in 
places where food was displayed for sale and reported 
that 21 states had enacted such laws (Schudson 1993). 
As the cigarette’s popularity increased, so did 
concerns about its health consequences. Serious re­
search of the day sought to link tobacco with a variety 
of conditions (Burnham 1989), but uncovered little new 
ground (Tate 1999), while sobering results were often 
lost amid a welter of overblown charges.  For example, 
the common observation at the time that cigarette 
smokers seemed more dependent on their habits than 
other tobacco users, now explained by increased blood 
nicotine levels (Tate 1999), led one writer in 1912 to 
warn that users would naturally progress from tobacco 
to alcohol to morphine (Sinclair 1962). Similar unsub­
stantiated charges have often made better headlines 
than the results of serious scientific studies over the 
years. In 1930, one doctor claimed that 60 percent of 
all babies born to mothers who smoked died before 
reaching the age of two (Sinclair 1962). Smoking was 
said to depress intelligence and academic achievement 
(Troyer and Markle 1983).  One historian writing in 
1931 recalled a widely distributed antismoking poster 
that wordlessly voiced these concerns by showing a 
woman who had a cigarette in her mouth and was 
holding a baby; the poster bore “no words—the mere 
presentment, it was hoped, would have a deterrent 
effect” (Corti 1931, p. 266). 
That image of mother and child projected an anti­
smoking message that, typical of its time, contained 
both a moral and a medical objection to smoking. His­
torian Allan M. Brandt has observed that antitobacco 
crusaders early in the century “saw no tension in see­
ing the cigarette as ungodly and unhealthy; they 
equated moral dangers and health risks” (Brandt 1990, 
p. 159). A 1925 WCTU pamphlet held that because the 
brain’s higher functions develop last, youthful smok­
ers would have “impaired morals, weak will, lack of 
religious and spiritual development, and a shocking 
incapacity for unselfishness and consideration of the 
rights of others” (p. 9). One of the moral dangers that 
remained a theme in anticigarette propaganda was the 
danger smoking posed to thrift, as cigarettes were a 
needless expense, especially among the poor (Brown 
1920). 
Although anticigarette crusaders had medical 
objections to smoking, they did not have any medical 
consensus behind them. Medical opinion was gener­
ally noncommittal. Most physicians counseled that 
tobacco in moderation was not harmful (Hygeia 1928; 
Tobey 1930; Johnson 1932).  Media reports even located 
medical research that suggested that smoking had 
health benefits. During World War I, army surgeons 
praised cigarettes for providing the wounded relax­
ation and relief from pain (New York Times 1918); a Paris 
physician claimed that tobacco use might prevent the 
development of microbial infections (New York Times 
1923); and a famous mountain climber said that smok­
ing helped breathing at high altitudes (New York Times 
1922). 
Without a strong medical component, the objec­
tion against tobacco use was scarcely distinguished 
from any number of other protest targets of the reform 
movement early in the century.  Lacking as strong an 
opponent as, for example, the alcohol temperance 
movement, tobacco use continued unabated. In the 
instance of cigarettes, use proliferated. 
The Attraction of Cigarettes 
Throughout its boom period, from the 1920s un­
til the mid-1960s, cigarette smoking was generally 
regarded as a consumer activity rather than as a medi­
cal problem.  In its commercial essence, the cigarette 
is simply a “package,” as a Philip Morris Companies 
Inc. memorandum has suggested, for a “product” 
(Cipollone v. Liggett Group, Inc., 505 U.S. 504, 112 S. Ct. 
2608 [1992], cited in Lynch and Bonnie 1994, p. 60).  In 
fact, the cigarette is by far the most commercially suc­
cessful package for the product—tobacco, itself a 
delivery device for nicotine—yet devised. Such think­
ing fits well with the notion that consumption is an 
act of imagination—that is, that one buys not the prod­
uct but rather the attributes for which the product is 
merely the vehicle (Fox and Lears 1983). 
34 Chapter 2
 

   Historical Review 35
 
Reducing Tobacco Use
 

Each vehicle for nicotine delivery has different 
social propensities.  The unique qualities of the cigarette 
as a tobacco form were critical in its role as the agent 
through which tobacco use was made both available 
and acceptable to all social classes. Put simply, ciga­
rettes not only made tobacco cheaper (through auto­
mated production) but also easier to use. This utility 
stemmed from several distinctive features that sepa­
rated cigarettes from other modes of tobacco use and 
fueled the spread of the smoking habit. 
The first distinctive feature of the cigarette is its 
mildness. This attribute, along with its inexpensive 
unit cost, made the cigarette especially appealing to 
boys. Before the cigarette became popular, adolescent 
males were likely to first try smoking by using cigars, 
a practice that required a degree of skill to draw in but 
not inhale the strong smoke.  The unpleasant side 
effects resulting from failing this tobacco rite of pas­
sage were largely avoided when new smokers tried 
cigarettes, which used a milder form of tobacco that 
was meant to be inhaled. Many of the legislative ef­
forts during the 1890s and after were directed not at 
tobacco use generally but at cigarettes exclusively be­
cause they were so accessible to boys and young men 
and because they were inhaled (Outlook 1901). A 1907 
Wisconsin court decision used this issue of adolescent 
accessibility to justify a regulatory distinction between 
cigarettes and other forms of tobacco.  The cigarette, 
the decision stated, was able “. . . to remove the pro­
tection which nature placed in the way of acquiring 
habits of use of the more vigorous tobacco commonly 
used in cigars. Before the day of the cigarette, mas­
tery of the tobacco habit was obstructed by agonies of 
nausea usually sufficient to postpone it to a period of 
at least reasonable maturity” (State v. Goodrich, 113 
N.W. 388, p. 390 [Wis. 1907]). 
Mildness was especially characteristic of ciga­
rettes smoked after the 1870s, when cigarette tobacco 
was made milder by being flue-cured rather than fire-
cured.  Moreover, the stronger Turkish tobaccos that 
were popular in the early 20th century became unavail­
able with the interruption of trade during World War I; 
thus, blended American tobaccos came into wider use, 
making the cigarette an even milder product than be­
fore (Tennant 1950). 
The inhalability of the milder tobaccos used in 
cigarettes is the source of a second important distinc­
tion between cigarettes and other forms of tobacco. 
Because the smoke of pipes, cigars, and dark tobacco 
is relatively alkaline, its nicotine dose is absorbed 
through the linings of the mouth and nose.  Flue-cured 
“blond” or light-colored tobacco, from which Ameri­
can cigarettes are normally blended, produces slightly 
acidic tobacco smoke; the nicotine dose thus must be 
inhaled to be absorbed. Drawn into the lungs through 
cigarette smoking, nicotine is absorbed into the sys­
temic circulation more quickly than in other forms of 
smoking—hence the greater potential for nicotine 
addiction (Lynch and Bonnie 1994). 
A third distinctive feature of the cigarette is its 
relative convenience and disposability.  This mild and 
quickly consumed tobacco product seemed to contem­
poraries “peculiarly adaptable to the temperament of 
the American people in an age when things are done 
hurriedly and yet with greater efficiency than at any 
previous time” (Young 1916, p. 119).  The New York 
Times editorialized in 1925 that the cigarette was “short, 
snappy, easily attempted, easily completed or just as 
easily discarded before completion—the cigarette is the 
symbol of a machine age in which the ultimate cogs 
and wheels and levers are human nerves” (New York 
Times 1925, p. 24). Facility of use was further aug­
mented by the introduction of the safety match just 
before World War I (Burnham 1989). 
In short, cigarettes had a “natural adaptability” 
to the rhythms of urban life (Tennant 1950, p. 142). 
Cigarettes fit more easily than other forms of tobacco 
into brief moments of relaxation, they were more 
readily used while working, and they were more eas­
ily managed without the use of one’s hands. Ciga­
rettes helped combat the tedium of industrial work. 
Particularly before workplace smoking restrictions 
were widespread, cigarettes could, in the words of one 
commentator, “not only help pace out a day—on the 
production line, in the typing pool, behind a lunch 
counter or waiting on a welfare line—but they could 
give you a steady flow of small rewards to keep on 
trucking” (Blair 1979, p. 33).  Cigarettes organized and 
controlled the passage of time; a cigarette, writes Ri­
chard Klein, is “a clock” (Klein 1993, p. 24). 
After World War I, cigarettes, which were less 
costly to use than cigars or pipe tobacco, became part 
of a more general “throwaway ethic” reflected in other 
consumer developments of the day (Busch 1983). The 
disposable razor blade came into widespread use dur­
ing and after World War I (Schudson 1984); in 1927, 
U.S. wristwatch production surpassed pocket watch 
production, as the more conveniently consulted wrist­
watch had won favor among soldiers (Busch 1983). 
Changing attitudes about hygiene also stimu­
lated this predilection for convenience and disposa­
bility.  Between 1909 and 1936, 45 states banned the 
common drinking cup used in public facilities such 
as railroads; the railroads became the first principal 
customers for the paper cup and paper cup dispens­
ers (Busch 1983). Disposable sanitary napkins and 
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Kleenex tissues also became mass-market items for the 
first time in the 1920s (Busch 1983). From a strictly 
hygienic perspective, the cigarette appeared to give a 
cleaner smoke than the cigar.  A Lucky Strike adver­
tisement directly contrasted the neatness of cigarettes 
to the messiness of cigars, which require more oral 
manipulation: “Spit Is an Ugly Word, but It’s Worse 
on the End of Your Cigar” (Tennant 1950, p. 286).  This 
advertisement also played on an earlier scandal in 
which cigar makers were purported to have used spit 
to seal the cigar’s leaf wrapper (John C. Burnham, tele­
phone conversation with Richard B. Rothenberg, May 
25, 1995). For a generation working in offices and 
riding to work in subways, streetcars, and automobiles, 
milder smoke was less irritating to others. Both the 
strong fumes of cigar and pipe smokers and the 
unsightly by-products of snuff and chewing tobacco 
users were generally more objectionable than the 
smoke and ashes of cigarette smokers.  Historian 
Cassandra Tate has concluded that one of the lessons 
of the first antismoking campaign is that “any success­
ful social reform movement carries within it the seeds 
of a backlash” while “incessant warnings can fade into 
the ozone of the commonplace” (Tate 1999, p. 155). 
An important part of the cigarette’s convenience 
was its readiness of use.  Some smokers still rolled their 
own cigarettes in the 1920s and 1930s, but these con­
sumers were a small segment of the market (Tennant 
1950). By far, most smokers during these key decades 
of rising cigarette popularity used cigarettes prerolled 
by the manufacturer.  (Cigars were also prerolled, but 
by hand rather than by machine, and thus at consider­
able expense to the buyer.)  The cigarette’s ready-made 
convenience was immediately apparent when com­
pared with, for example, the care required to load a 
pipe so that it burned neither too quickly (thereby over­
heating the bowl) nor too slowly (thereby requiring 
frequent relighting).  The cigarette was far more easily 
lit and drawn than other smoked tobacco products. 
One final distinctive feature of the cigarette is 
its cultural connotation as a minor moral transgres­
sion. Smoking cigarettes is—and has always been— 
considered slightly illicit.  A practice that “looked so 
strange, felt so pleasant, accomplished so little, and 
cost so much [although less than cigar or pipe smok­
ing] could not be unopposed” (Tennant 1950, p. 115). 
The pleasure it offers is culturally mediated—that is, 
part of the pleasure of smoking is the guilt connected 
with it. None of the marketing efforts of the tobacco 
giants ever fully legitimized the image of smoking— 
and there is some suspicion that they never meant to 
(Burnham 1993). As one sympathetic cultural observer 
has put it, part of the seductive quality of the cigarette 
is “beauty [that] has never been understood or repre­
sented as unequivocally positive; the smoking of ciga­
rettes, from its inception in the nineteenth century, has 
always been associated with distaste, transgression, 
and death” (Klein 1993, p. xi). A modern parallel is 
the recent cachet of smoking as a sexual fetish, with 
images available on the Internet (Hwang 1996, p. 5). 
Culturally, in fact, interviews have shown that ciga­
rettes became a generational marker for the transform­
ing generation that had come of age during World War I, 
as well as for the reform-minded generation of the Viet­
nam War era (Tate 1999). 
Women and Cigarettes 
Several features of the cigarette helped make it a 
particularly suitable product for, and symbol of, the 
liberation of women, who came to smoking in grow­
ing numbers beginning in the 1920s. Just as the ciga­
rette “fairly leaped” into its rightful position as “the 
smoke of manly men” with the aid of stories and pic­
tures from the World War I front ([New York] Tobacco 
Leaf 1914, p. 6, quoted in Young 1916, p. 228), so for 
young women after the war smoking was “perhaps 
the one most potent symbol” of the new sense of free­
dom and equality (Fass 1977, p. 292). For the growing 
number of women who attended college in the 1920s, 
smoking was “a welcome form of notoriety” (p. 293). 
Objections to women’s smoking betrayed a traditional 
double standard, for such opposition arose from the 
twin cultural perceptions that cigarettes were not moral 
and were not feminine. Smoking “implied a promis­
cuous equality between men and women and was 
an indication that women could enjoy the same vul­
gar habits and ultimately also the same vices as men” 
(p. 294). But while they were tokens of equality with 
men, cigarettes were also amorphic, making men ap­
pear more manly and women more womanly (Tate 
1999). 
Aware of (and perhaps sharing) these objections, 
cigarette manufacturers were initially cautious about 
targeting this potential new market.  As late as 1924, 
the editor of a tobacco trade journal wrote that “all 
responsible tobacco opinion [found the idea of women 
smoking so] novel . . . that it would not be in good taste 
for tobacco men as parties in interest to stir a particle 
toward or against a condition with whose beginnings 
they had nothing to do and whose end, if any, no one 
can foresee” (Wessel 1924, p. 6).  Even advertisements 
with women in mind did not dare picture them actu­
ally smoking. 
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This initial caution was dictated by canny atten­
tion to the political environment. Cigarette manufac­
turers feared a backlash in legislation or public 
opinion if they too aggressively sought female 
consumers (Tennant 1950).  In light of anticigarette leg­
islation arising during the 1920s, and particularly in 
light of the ongoing experiment in alcohol prohibition, 
this anxiety was reasonable. 
The cigarette industry’s caution was short-lived. 
As the 1920s advanced, appeals to women through 
tobacco marketing were increasingly direct.  In 1926, 
the Chesterfield brand ran a then-controversial 
advertisement wherein a woman urged a male com­
panion to “Blow Some My Way” (Ernster 1985, p. 336). 
In 1927, Lucky Strike advertisements showed a famous 
female opera star recommending Luckies as soothing 
to the throat and a famous actress assuring readers that 
Luckies did not irritate the throat (Schudson 1984). 
And in 1928, Luckies were advertised with the diet-
conscious slogan, “Reach for a Lucky Instead of a 
Sweet” (Ernster 1985, p. 336). 
Winds of Change 
The industry’s direct appeal to the new market 
of female smokers likely reflected less boldness than 
it did a recognition of a prevailing wind of cultural 
change, of which the women’s movement was only a 
single component. In the 1920s, on the heels of the 
19th Amendment, women’s growing assertion of their 
equality with men was part of a larger shift in Ameri­
can culture, the move to a more modern culture from 
the somewhat puritanical milieu that supported the 
populist reform movement.  In the language of one 
observer, the change was from a culture of middle-class 
respectability to one of “lower-order parochialism” 
sponsored and encouraged by industries that catered 
to the minor vices (Burnham 1993, p. 16). The 1920s 
saw the triumph of “a new behavioral ethic” (Brandt 
1990, p. 157), one of consumerism and self-indulgence 
rather than the self-denial that had been, for example, 
the traditional lot of women. Through the marketing 
of cigarettes, the tobacco companies strategically ex­
ploited this development among the less puritanical 
and self-recriminating members of both sexes. 
Even at the time, opinion was divided on whether 
the massive marketing efforts of the cigarette giants 
motivated the change toward a society of smokers 
or only took advantage of a cultural and behavioral 
shift already under way.  In 1940, by which time the 
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cigarette had clearly triumphed over other forms of 
tobacco, one study of the tobacco industry concluded, 
“how much of increased cigarette consumption is due 
to advertising and how much to fashion is impossible 
to determine. The latter influence is still imponder­
able” (Gottsegen 1940, p. 204). 
Fashion and advertising were not the only two 
factors. Three other matters were potentially impor­
tant: (1) the physical product itself was not a constant, 
(2) the price was variable, and (3) society changed in 
ways that influenced consumption. For example, 
before the explosion of cigarette marketing in 1914 
(Burnham 1989), men smoked more than women, the 
rich smoked more than the poor, and urban dwellers 
smoked more than rural inhabitants.  (For a more com­
prehensive account of the demographic dynamics, see 
USDHHS 1989.) With growth in the movement for 
women’s equality, a rising per capita income in real 
dollars, and the long-term trend toward urbanization, 
there would likely have been an increase in cigarette 
sales even if tobacco companies had not marketed the 
product aggressively. 
Regardless of what directed the impetus, per 
capita consumption of all forms of tobacco was remark­
ably steady from 1913 to 1945 (Figure 2.1), rising when 
real income per capita rose, falling when real income 
fell (Tennant 1950).  The spectacular growth in ciga­
rette consumption reflected not only the introduction 
into the tobacco market of new consumer groups (such 
as women) but also, as was previously noted, a major 
shift among existing male smokers from other forms 
of tobacco use to the cigarette. Annual per capita con­
sumption of tobacco hovered at 7 pounds from 1915 
through the late 1930s, except for a transient decline 
in the early 1930s that was coincident with a drop in 
per capita income in the early years of the Great De­
pression (Tennant 1950).  It is possible, however, that 
actual consumption of tobacco per unit of weight in­
creased because of less work in both the manufactur­
ing and the use of the increasingly popular cigarette. 
World War II, like World War I, served to increase and 
promote cigarette smoking, to which numerous war 
novels, movies, and other public images testify (Klein 
1993). A 1943 treatise observed that the cigarette 
achieved a heroic standing from its association with 
soldiers during World War II (Gehman 1943).  In short, 
between about 1920 and 1950, “cigarettes became an 
acceptable and noncontroversial part of U.S. life” 
(Troyer and Markle 1983, p. 124). 
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Medical Warnings 
Medical opinion at first took little heed of the 
growing popularity of cigarettes.  Physicians tended 
to take an ambivalent or qualified position on the ciga­
rette phenomenon. For instance, although Dr. James 
J. Walsh wrote in 1937, “We physicians of the older 
generation who have seen the smoking of cigarettes 
grow from what seemed scarcely more than a toy into 
what is now one of the most significant of social insti­
tutions are under an obligation to the rising genera­
tion to warn them of the serious dangers associated 
with the abuse of cigarettes in our day” (Walsh 1937, 
p. 665), even Walsh admitted to smoking an occasional 
cigarette himself.  He further attested that many doc­
tors he knew smoked 20 or 30 cigarettes a day and yet 
were “as healthy as the proverbial trout” (p. 665).  He 
held that “not the cigarette smoke so much as the ex­
cess of it” (p. 665) brought about serious conditions 
like Buerger’s disease. 
The Puritan temperament that had fueled anticiga­
rette activity early in the century was on the defensive. 
Antipathy to Puritan moralism was strong enough to 
weaken faith in any research tainted by it.  For example, 
Alton Ochsner’s suggestions in the 1930s and 1940s of 
a connection between cigarette smoking and lung can­
cer were discounted by his colleagues because he was 
known to be “an anti-smoking enthusiast” (Burnham 
1989, p. 18). During these crucial times when cigarette 
smoking became widespread, “physicians tended to 
absorb the common sense of the general population” 
(p. 11).  By the 1930s, common sense, in some measure 
influenced by the advertising claims of the era, held that 
smoking in moderation was not a health hazard 
(Burnham 1993). 
In 1938, Raymond Pearl published one of the first 
significant epidemiologic studies that indicated smok­
ing to be “statistically associated with an impairment 
of life duration” (Pearl 1938, p. 217, quoted in Breslow 
1982, p. 134; see also Brandt 1990). But only in the late 
1940s and early 1950s did definitive evidence begin to 
accumulate from various sources and studies show­
ing the association between cigarette smoking and 
overall mortality.  First retrospective and then large-
scale prospective studies confirmed that smoking was 
associated with higher death rates; excess mortality 
was especially pronounced for coronary artery disease 
and lung cancer. 
In the late 1940s and early 1950s, research linked 
lung cancer to smoking. The initial report by Wynder 
and Graham (1950) just preceded an article by Doll 
and Hill (1950). Subsequent articles by Doll and Hill 
(1952), Levin (1953), and others confirmed the asso­
ciation. Levin’s contribution was of particular inter­
est, because he derived the formula for attributable risk 
in a footnote to the article—an overt demonstration of 
the link between the smoking etiology and the emerg­
ing methodology of epidemiologic analysis. 
Public Dissemination 
The findings from these and other studies of the 
era were publicized in a 1952 Christian Herald article. 
In December 1952, that article was reprinted in the 
widely circulated magazine Reader’s Digest as “Can­
cer by the Carton” (Norr 1952). Popular concerns 
aroused by this publicity apparently led to an almost 
immediate decline in cigarette consumption (Tennant 
1971). The decline was temporary but severe enough 
to lead the tobacco companies to step up their market 
promotion of the relatively new filter-tip cigarette. 
Originally intended to attract new smokers by offer­
ing a milder smoking experience, the filtered cigarette 
assumed a marketing prominence that was seen as a 
tacit acknowledgment that there might be a health risk 
in smoking (Fortune 1953). Whether for smoking com­
fort or for supposed health advantage, the market 
share of filter brands increased from less than 1 per­
cent in 1952 to 73 percent in 1968 (Tennant 1971). 
The nonprofit consumer advocacy organization 
Consumers Union paid attention to smoking through­
out the 1950s. Early mentions in the organization’s 
monthly magazine Consumer Reports, like so much 
commentary elsewhere, warned only against excessive 
smoking. In 1953, Consumer Reports found the evidence 
connecting smoking to lung cancer “suggestive” and 
recommended that until further research results were 
available, “those who can” should reduce smoking to 
a “moderate” level, which was defined as not more 
than one pack a day (p. 74). In the same issue, how­
ever, the magazine reminded readers that smoking had 
health benefits; specifically, smoking reduced “the 
inner nervous tensions and strains resulting from 
man’s exposure to the stresses and responsibilities 
imposed by society” (p. 74). Smoking, the magazine 
further observed, relieved such pressure in a way less 
harmful than alcohol or overeating (Consumer Reports 
1953). 
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In 1954, medical advisers for Consumers Union 
spoke more strongly about the research link between 
smoking and lung cancer, but the organization 
remained vague in its advice to smokers (Consumer 
Reports 1954). In the absence of further scientific sup­
port, this tentativeness was not surprising. It was hard 
to imagine that a habit so widespread, so apparently 
normal, so integrated into American culture, and so 
ennobled by its wartime use could turn out to be fun­
damentally destructive.  In 1954, the American Can­
cer Society’s (ACS) Tobacco and Cancer Committee 
adopted a resolution recognizing an association be­
tween cigarette smoking and lung cancer (Breslow 
1982), but the board of directors did not consider the 
possibility of a causal association. Efforts of the phy­
sician members of the board were blocked by lay mem­
bers in meetings that were themselves “filled with 
smoke” (Breslow 1977, p. 849). 
By 1958, Consumers Union agreed that the medi­
cal research provided nearly definitive evidence on 
the risk of lung cancer posed by smoking. The organi­
zation further argued that smokers should not try to 
allay their concerns by switching to filter cigarettes, as 
no evidence indicated that filters reduced the risk of 
cancer.  Smokers were thus advised “to cut out or cut 
down” on cigarettes (Consumer Reports 1958, p. 636). 
Toward a Medical Consensus 
With growing sentiment, in and beyond the 
medical community, that there were serious risks to 
tobacco use, government agencies became more con­
cerned about tobacco advertising that stated or implied 
health benefits to the cigarette.  Several times during 
the 1950s, the Federal Trade Commission (FTC) issued 
orders against cigarette advertising that made health 
claims. Congress also took an interest in tobacco 
advertising; in 1957, Representative John A. Blatnik 
(D-MN) held hearings on deceptive filter-tip cigarette 
advertising (Neuberger 1963).  The Surgeon General 
first brought the Public Health Service into the scene 
by establishing a scientific study group in 1956 to ap­
praise the effects of smoking on health.  The study 
group determined that there was a causal relationship 
between excessive smoking of cigarettes and lung 
cancer.  Surgeon General Leroy E. Burney issued a 
statement in 1957 that “the weight of the evidence is 
increasingly pointing in one direction:  that excessive 
smoking is one of the causative factors in lung can­
cer” (Burney 1958, p. 44). In an article he subsequently 
published in the Journal of the American Medical Asso­
ciation, Burney reiterated this view and went even 
further: “The weight of evidence at present implicates 
smoking as the principal etiological factor in the 
increased incidence of lung cancer” (Burney 1959, 
p. 1835). 
Much of the medical profession, however, 
remained ambivalent on the issue. In an editorial sev­
eral weeks after Burney’s article, the journal itself ar­
gued against taking the Surgeon General too seriously: 
“Neither the proponents nor the opponents of the 
smoking theory [that cigarette smoking causes cancer] 
have sufficient evidence to warrant the assumption of 
an all-or-none authoritative position” (Talbott 1959, 
p. 2104). 
In June 1961, the presidents of the ACS, the 
American Public Health Association, the American 
Heart Association (AHA), and the National Tubercu­
losis Association (later the American Lung Association 
[ALA]) urged President John F. Kennedy to establish 
a commission to study the health consequences of 
smoking (U.S. Department of Health, Education, and 
Welfare [USDHEW] 1964).  Early in 1962, representa­
tives of these organizations met with Surgeon General 
Luther L. Terry, who then proposed establishing an 
advisory committee to assess available knowledge and 
make recommendations concerning smoking and 
health. In April, Terry provided the Secretary of 
Health, Education, and Welfare a fuller proposal ask­
ing to reevaluate the Public Health Service’s position 
on smoking. Among the factors prompting his call for 
action, Terry cited new studies on the adverse conse­
quences of smoking, the 1962 Royal College of Physi­
cians report (which had been summarized that year in 
Reader’s Digest [Miller 1962]), and other evidence of a 
shift in medical opinion against smoking as well as 
similar views among the national voluntary organiza­
tions. Terry also pointed to efforts to reduce tobacco 
use in Britain, Denmark, and Italy; to Senator Maurine 
(Brown) Neuberger’s (D-OR) proposal that Congress 
create a commission on smoking; and to a request from 
the FTC for guidance on the labeling and advertising 
of tobacco products. 
In the summer, Terry announced the appoint­
ment of a committee to review all of the data on the 
medical effects of smoking.  The committee was es­
tablished after consultation with representatives of 
relevant government agencies, the voluntary health or­
ganizations, the American Medical Association (AMA), 
the American College of Chest Physicians, and the 
Tobacco Institute.  Each organization was empowered 
to veto any names proposed for the committee; people 
who had taken public positions on the questions at 
issue were eliminated from consideration. 
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While the committee reviewed the data, actions 
were being urged or taken in response to the evidence 
that had emerged.  Leroy Collins, former governor of 
Florida and president of the National Association of 
Broadcasters, urged broadcasters in 1962 to “make 
corrective moves” on their own to limit or regulate 
tobacco advertising to which children might be ex­
posed. “We cannot ignore the mounting evidence that 
tobacco provides a serious hazard to health,” he as­
serted (New York Times 1962, p. 71). Also in 1962—a 
busy year for efforts to reduce smoking—Air Force 
Surgeon General Major General Oliver K. Niess 
ordered an end to the distribution of free cigarettes in 
Air Force hospitals and flight lunches (Neuberger 
1963). Smoking education was a growing phenom­
enon in public schools, where materials were provided 
by the ACS and other voluntary organizations.  Church 
groups (particularly the Seventh-day Adventists) and 
temperance organizations continued their campaign 
against smoking. And although the AMA remained 
silent on the issue, at least eight state medical societies 
had adopted resolutions on smoking and health. 
Turning Point:  The Surgeon General’s Report
 

Social movements may be precipitated or 
strengthened by events that “dramatize a glaring con­
tradiction between a highly resonant cultural value 
[such as health] and conventional social practices [such 
as smoking]” (McAdam 1994, p. 40). Rarely in social 
history, however, can a single such event be identified 
as a key source of social change.  The publication of 
the 1964 Surgeon General’s report on smoking and 
health might qualify as such a rarity.  The Surgeon 
General’s report consolidated and legitimized 15 years 
of growing evidence of the dangers of smoking to 
health (USDHEW 1964). Its publication “marked the 
beginning of a revolution in attitudes and behaviors 
relating to cigarettes” (Brandt 1990, p. 156).  “Begin­
ning” should be stressed, because abandonment of 
cigarettes was not precipitous.  Smoking prevalence 
did begin a persistent but hardly precipitate decline 
in 1965 of 0.5 percent per year (USDHHS 1989). 
Cigarette sales kept increasing and would not peak 
until the late 1970s. Although per capita cigarette con­
sumption reached its highest level in 1963, the year 
before the report’s publication, it did not begin a steady 
year-to-year decline until 1973 (USDHHS 1994). 
Thus, the Surgeon General’s report was certainly 
a pivotal event, but it did not change smoking pat­
terns overnight. Why this was so—why people did 
not, upon learning of the report’s findings, immedi­
ately cease either beginning or continuing to smoke— 
is a complex phenomenon, even if one disregards the 
major role of nicotine addiction.  On the one hand, 
a change in behavioral norms can be precipitated by 
a change in what people generally believe. On the 
other hand, people do not always act in their own 
best interests, even in response to clearly stated facts 
(Schudson 1984; USDHHS 1989). The outcome in a 
conflict between cultural mores (in this instance, be­
liefs instilled through the social, behavioral, and physi­
ological habit of smoking, reinforced by marketing) 
and scientific fact (as represented in the widely publi­
cized findings of the Surgeon General’s report) often 
depends on how the latter is diffused—that is, on 
whether new information can become so broadly and 
effectively transmitted and received that it becomes 
accepted knowledge that then supplants habit. As one 
sociologist has observed, “The diffusion of new knowl­
edge is a major cause of collective searches for new 
norms in the modern world” (Davis 1975, p. 53). 
A Stubborn Norm 
In the case represented by the Surgeon General’s 
report, the diffusion of new knowledge was impeded 
by the entrenched norm of smoking, a widespread 
practice fueled by the persistent and pervasive mar­
keting of cigarettes (see “Advertising and Promotion” 
in Chapter 5). During the decade preceding the 
report, many social norms were established or 
strengthened through the dominant new mass 
medium, television. Whatever effect television adver­
tising had on cigarette sales, the constant presence of 
cigarettes both in advertisements and in the real and 
imaginary lives of the medium’s “stars” was a strong 
force in reinforcing smoking as a norm.  Furthermore, 
TV-related marketing coincided with, and helped bring 
to the public’s attention, the availability of the filter-
tipped cigarette—thereby not only reinforcing the 
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smoking norm but also helping screen the imputed 
health hazards of smoking (USDHHS 1994). 
The smoking norm could be found in the most 
unlikely settings and thus gave rise to considerable 
cognitive dissonance. The first significant government 
response to the report was the FTC’s 1964 ruling that 
warning labels be required on cigarette packs and that 
tobacco advertising be strictly regulated (see “Attempts 
to Regulate Tobacco Advertising and Packaging” in 
Chapter 5). The resulting legislation that was passed, 
however (the Federal Cigarette Labeling and Adver­
tising Act of 1965 [Public Law 89-92]), undermined 
much of the original proposal’s strength by requiring 
a more weakly worded warning label than the FTC had 
proposed (USDHHS 1994). Furthermore, the act not 
only preempted the FTC’s ruling but also prohibited 
the FTC or any other federal, state, or city authority 
from further restricting cigarette advertising until 
after the expiration of the law on June 30, 1969. In 1969, 
former Surgeon General Terry would refer to the 1965 
act as a “hoax on the American people” (U.S. House of 
Representatives 1969, p. 267, citing Dr. Terry). 
This dissonance between legislative intent and 
legislative action was detectable, in more than one 
sense, in the smoke-filled congressional hearings at the 
time. In 1967, for example, when Dr. Paul Kotin, 
director of the Division of Environmental Health Sci­
ences, National Institutes of Health, came to testify 
about the health hazards of cigarette smoking, Sena­
tor Norris Cotton (R-NH) asked, “Is it going to preju­
dice anybody if I smoke my pipe?” Dr. Kotin replied, 
“I trust it won’t prejudice anybody any more than my 
smoking my pipe will” (U.S. Senate 1968, p. 14). Dr. 
Kotin’s smoking was a topic of conversation again in 
congressional hearings in 1969. Dr. Kotin along with 
Surgeon General William H. Stewart, Dr. Kenneth Milo 
Endicott (director of the National Cancer Institute), and 
Dr. Daniel Horn (director of the National Clearing­
house on Smoking and Health) came together to tes­
tify in favor of stronger health warnings on cigarette 
packages and legislation requiring similar warnings 
in all cigarette advertising.  At one point, Representa­
tive Dan H. Kuykendall (R-TN) asked Surgeon 
General Stewart, “Isn’t [Dr. Kotin] one of the most 
knowledgeable men in this field?” When the Surgeon 
General replied affirmatively, Kuykendall returned, 
“Why doesn’t he quit smoking?” Kuykendall then 
directly asked Kotin whether he was sure that smok­
ing a pipe did not cause lip cancer; Kotin responded, 
“A risk I am willing to take, sir” (U.S. House of Repre­
sentatives 1969, p. 167). The next day, Representative 
Tim Lee Carter (R-KY) observed that, in fact, all four 
of the men in the delegation, including the Surgeon 
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General, were smokers (U.S. House of Representatives 
1969). Actions undermine words, and scenes such as 
these were symbolic of a strong wish not to believe in 
the health consequences of smoking. Given that the 
nation’s chief health policymakers did not, or were not 
able to, apply to their own behaviors the very evidence 
they had gathered, the strength with which the smok­
ing norm persisted among the general population is 
more easily comprehended. 
Economic and Social Impedance 
General economic conditions also supported the 
continuation of smoking. The 1960s and early 1970s 
was a time of general prosperity.  Real cigarette prices 
rose in the 1960s but declined in the 1970s (USDHHS 
1994). The affordability of cigarettes increased from 
1965 to 1980 and served as an economic counterweight 
to the growing awareness of tobacco’s ill effects (Lynch 
and Bonnie 1994) (see also “Effect of Price on Demand 
for Tobacco Products” and “Taxation of Tobacco Prod­
ucts” in Chapter 6). 
Another compelling social condition may have 
further limited the initial impact of the Surgeon 
General’s report.  From the early 1960s to 1973, Ameri­
can military personnel were engaged in Vietnam. 
During this period, 8.7 million Americans served in 
the military, including 2.7 million in Vietnam (Moss 
1990). Whether the Vietnam War encouraged smok­
ing has not been a topic of speculation, probably 
because of that war’s more publicized role in suppos­
edly encouraging the use of marijuana and other drugs 
(Klein 1993). But the norm of smoking would only 
have been strengthened by the mobilization of a large 
military force bringing several million young men and 
women into a setting where smoking was tradition­
ally held to offer relief from both stress and boredom, 
and where it was part of a lingering cultural image of 
the heroic soldier.  Moreover, the prevalence of ciga­
rette smoking was and has remained higher in the 
military than in the population at large (in 1992, 35 vs. 
26 percent) (Lynch and Bonnie 1994). 
Delayed Effects and Delayed Actions 
A significant biologic explanation for the delayed 
effect of the 1964 report can be found in the delayed 
progression of smoking-related diseases, which 
generally take substantial time to fully manifest 
themselves in chronic illness and death.  The cigarette’s 
tremendous growth in popularity during the decades 
preceding the Surgeon General’s report would thus 
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have only begun to show its vast health consequences. 
In 1965, an estimated 180,000 persons died from 
smoking-related diseases (USDHHS 1989); over the 
next two decades, that yearly estimate increased to 
337,000, even though smoking prevalence had been 
steadily declining since the early 1970s (USDHHS 
1989). First-time or long-time smokers in the mid-1960s 
to mid-1970s thus had far less opportunity than the 
next generation to personally witness the tragic but 
convincing demonstration of the health consequences 
of smoking. It might be hypothesized that this som­
ber proof of the Surgeon General’s report at last evoked 
a meaningful response among the surviving relatives 
and friends of the deceased. 
From Disease Treatment to Risk 
Management 
Another possible reason for the delayed response 
to the Surgeon General’s report was its less-than­
traditional medical perspective. The report’s medical 
researchers were reporting not the kind of traditional 
clinical data that physicians were used to encounter­
ing in their literature but rather data from epidemio­
logic studies that indicated the risks of smoking. 
Eventually, such data would be persuasive enough to 
mark a perceptual shift to “a new kind of numeracy 
among medical researchers and clinicians alike” 
(Burnham 1989, p. 19). But in 1964, most physicians 
were not prepared to understand—much less be per­
suaded by—the epidemiologic data represented in the 
report, nor to incorporate a public health model into 
their medical practice. 
Accordingly, the medical profession did not 
quickly jump on the smoking reduction bandwagon 
that began rolling with the Surgeon General’s report. 
The American Medical Association Alliance House of 
Delegates, in fact, refused to endorse the report when 
it appeared in 1964 (Burnham 1989).  Medical person­
nel increasingly warned people against smoking, but 
this precept did not carry over into practice.  In 1964, 
smoking remained as acceptable in medical settings 
as it was elsewhere. Moreover, although 95 percent of 
physicians in that year saw smoking as hazardous, 25 
percent continued to smoke (Burnham 1989); even by 
the mid-1970s, nearly one in five physicians was a 
smoker (Nelson et al. 1994). The AMA was criticized 
by other health organizations for not taking a more 
aggressive stance to reduce tobacco use.  As late as 
1982, for example, the association was faulted for help­
ing prepare for Newsweek a 16-page “personal health 
care” supplement, in which the only advice provided 
on smoking was that a smoker should discuss the risks 
with a personal physician and should refrain from 
smoking in bed (Iglehart 1984). Soon thereafter, the 
AMA had become an active advocate (see “Toward a 
National Policy to Reduce Smoking,” later in this chap­
ter). By 1990–1991, only 3.3 percent of physicians 
smoked, although smoking rates among nurses were 
significantly higher (Nelson et al. 1994). 
Some social critics of the time tacitly welcomed 
what they saw as a rare reluctance by the establish­
ment to embrace a social movement. Sociologists and 
other outside observers of American medicine had 
noted a previous tendency of the establishment to 
“medicalize” social problems, such as tobacco use and 
alcohol abuse. From this perspective, medicine was 
viewed askance as an “institution of social control,” 
as a “new repository of truth, the place where abso­
lute and often final judgments are made by suppos­
edly morally neutral and objective experts” (Zola 1972, 
p. 487). Implicit in this criticism was the fear that the 
medical establishment was using its considerable 
clout—its professional domination of the world of 
facts—to translate all social ills into clinical terms that 
could be treated in a clinical setting. One such critic, 
medical sociologist Eliot Freidson, wrote that the phy­
sician who calls alcoholism a disease “is as much a 
moral entrepreneur as a fundamentalist who claims it 
is a sin” (Freidson 1974, p. 253). 
But the medical establishment’s initial hesitancy 
to join the movement to reduce smoking likely had 
little to do with scruples about overstepping its pur­
view.  There is no dispute that cancer is a disease and 
little dispute that the medical profession is the expert 
social authority for defining and treating it.  The “moral 
entrepreneurship” of the Surgeon General’s 1964 re­
port was not to declare cancer a medical problem but 
rather to declare smoking a health risk—hence the cen­
tral position of epidemiologic data in the report. 
Thus, while organized medicine followed slowly 
and sometimes reluctantly in the wake, and while so­
cial skeptics worried about the Orwellian implications, 
a battery of public health officials, politicians, and con­
sumer advocates, armed with the findings of the Sur­
geon General’s report, moved against the persisting 
social and medical problem of smoking.  Ultimately, 
the broad cultural current that distrusted medical moral 
entrepreneurship embraced these efforts.  The “de­
medicalizing” movement, which sought to make health 
care both a personal matter and a political matter rather 
than one wholly under the guardianship of physicians 
(Starr 1982), supported a practice of medicine that took 
a preventive stance instead of an exclusively therapeu­
tic one. Preventive action—to prevent smoking, and 
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thereby to prevent unnecessary illness and death from called for in the epidemiologically based recommen­
smoking-related illnesses—was precisely the solution dations of the 1964 Surgeon General’s report. 
The Diverse Momentum of the Movement to Reduce Smoking 
Another reason for the languid pace of change 
in smoking prevalence after 1964 is that it took time to 
assemble an active dissemination and lobbying force 
around the Surgeon General’s report.  In the present 
period, so many different groups are active in anti­
smoking activity, and so many different strategies are 
operating, that sorting them becomes difficult. Since 
1964, the campaign to reduce smoking refers to “the 
entirety of changes in the social environment spawned 
by scientific and social interest in the hazards of smok­
ing” (Warner 1989, p. 144); this movement covers not 
only specific activities but also “the changing social 
norms that have accompanied them” (p. 144). The span 
of activities involves persons, private organizations, 
and government agencies, all with different motiva­
tions: those ideologically committed to a movement 
to reduce smoking, those who operate profit-making 
businesses, those seeking public office, and those in 
public office who mandate laws and regulations. 
Important actors have included national health orga­
nizations, medical researchers, organized medicine, 
government regulatory agencies and health depart­
ments, school officials, voluntary organizations in 
health, lobbying groups for reducing smoking, private 
firms dealing with the health or insurance needs of 
employees, smoking cessation clinics, and individual 
medical practitioners. 
The industry-funded Tobacco Institute began 
distributing smoking education materials in 1984 
(USDHHS 1994), although with a different agenda.  For 
example, the institute’s “It’s the Law” program pur­
ports to discourage minors from purchasing cigarettes 
(Tobacco Institute 1990), but the program focuses on 
the legal responsibilities of the purchaser rather than 
the vendor, characterizes smoking as an “adult behav­
ior” (which may make it more attractive to adoles­
cents), does not address the dangers of smoking, and, 
in one assessment, was ineffective in preventing ille­
gal sales (DiFranza et al. 1996). 
The work of the Tobacco Institute highlights what 
may be the foremost obstacle to changing the social 
norm of smoking: the multifaceted actions of the 
industry in preventing prevention.  In an analysis of 
tobacco industry tactics, the Advocacy Institute (1995) 
has defined nine areas of activity:  intimidation, alli­
ances, front groups, campaign funding, lobbying, 
legislative action, buying expertise, philanthropy, and 
advertising and public relations (see the text box).  In 
its discussion of well over 100 instances in these areas, 
documented largely from media reports, the Advocacy 
Institute does not accuse the tobacco industry of ille­
gal activity but rather of a far-ranging and systematic 
effort to ensure the continued use of tobacco.  Taken 
together, and backed by the enormous resources of the 
industry, these efforts have considerable impact in pro­
moting tobacco use and retarding efforts to reduce or 
prevent it.  Because of the considerable litigation now 
directed at the industry, however (see Chapter 5), the 
public is more aware of these efforts and may prove 
more resistant than previously to this powerful com­
mercial subterfuge. 
Support From Business 
The supportive role of businesses in the move­
ment to reduce smoking probably did not arise from a 
spontaneous realization that preventive measures 
could improve employee health.  Already shoulder­
ing new costs from complying with health-related (but 
non-tobacco-related) new federal legislation, such as 
the Occupational Safety and Health Act of 1970 (Pub­
lic Law 91-596) and the Toxic Substances Control Act 
(1976) (Public Law 94-469), many companies in the 
1970s sought ways to control the rapidly rising costs 
of health care (Iglehart 1982).  Supporting or enacting 
policies to curb a proven health risk (such as smok­
ing) that had expensive consequences simply made 
good business sense. 
A special case is insurance. Beginning with State 
Mutual Life Assurance Company of America in 1964, 
life insurance companies began offering discounted 
policies for nonsmokers (Cowell 1985). By 1987, 
approximately 80 percent of life insurance companies 
offered discounts to nonsmokers (Schauffler 1993). 
   
Surgeon General's Report
 

Framework of Tobacco Industry Tactics 
The Advocacy Institute has developed an overview of tobacco industry strategy, with extensive docu­mentation taken from current media reporting.  The documentation provides examples of each of the 
strategies listed below. 
I. Intimidation 
A.	 	Legal (harassing suits, subpoenas, in­
junctions, outspending plaintiffs) 
B.	 	Economic (withdrawal of advertising, 
withdrawal of business operations) 
C.	 Political (retribution directed at elected 
and other officials) 
D.	 Personal (harassing researchers, advo­
cates, and reporters) 
II. Alliances 
A.	 Strong allies (subsidiaries, trade asso­
ciations, advertising industry, tobacco 
farmers) 
B.	 	 Weak allies (labor unions, lawyers’ asso­
ciations, doctors’ associations) 
III. Front Groups 
A.	 Political groups (Michigan Citizens for 
Fair Taxes, Californians for Statewide 
Smoking Restrictions) 
B.	 	Scientific groups (Council for Tobacco 
Research U.S.A. Inc., Healthy Buildings 
International) 
C.	 Smokers’ rights groups (National Smok­
ers Alliance) 
IV.	 Campaign Funding 
A.	 Candidate funding 
B.	 	 Continued contributions after election 
C.	 	Direct funding of interest groups and 
caucuses 
D.	 Political party funding 
E.	 	 Funding state ballot initiatives, or fund­
ing opposition to initiatives 
V. Lobbying 
A.	 	Support of lobbyists at state and national 
levels 
B.	 	Seeking alliances with other lobbying 
groups on specific issues 
C.	 	 Gifts and contributions to specific causes 
D.	 Generating grassroots activity 
Source:  Advocacy Institute 1995 
VI. Legislative Action 
A.	 Preemption 
B.	 	Weakening or diluting legislation, or 
making it unenforceable 
C.	 Adding unrelated clauses to, or chang­
ing, the contents of legislative bills 
D.	 	Shifting debate (stressing personal free­
dom rather than health; promoting smok­
ers’ rights) 
VII. Buying Expertise 
A.	 Enlisting outside experts (economists, 
epidemiologists, medical researchers, 
statisticians, legal counsel) 
B.	 	Creating the Council for Tobacco Re­
search U.S.A. Inc. 
VIII. Philanthropy 
A.	 Buying innocence by association (finan­
cial support to wide range of organiza­
tions) 
B.	 	 Funding (women’s groups, racial and eth­
nic minority groups, homeless shelters, 
acquired immunodeficiency syndrome 
[AIDS] groups, arts groups, educational 
initiatives, community-based nonprofit 
organizations, sporting events) 
IX. Advertising and Public Relations 
A.	 Issue framing (choice, civil rights, per­
sonal freedom) 
B.	 	 Advertising to promote corporate char­
acter 
C.	 	 Disinformation (health effects, economic 
importance of tobacco) 
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Health insurance rates, in contrast, have not typically 
distinguished between smokers and nonsmokers. 
Acceptable actuarial data on additional medical ex­
penses incurred by smokers did not exist until the early 
1980s; at present, discounts for nonsmokers or sur­
charges for smokers have not been widely adopted by 
health insurance companies (Schauffler 1993).  None­
theless, both the health insurance and the life insur­
ance industries have become active in smoking-related 
public policy.  In 1977, the trade associations of the 
two industries formed the Center for Corporate Pub­
lic Involvement to take up public policy issues that 
affected them.  By 1980, the organization was urging 
its members to adopt workplace nonsmoking policies, 
and by 1984, it had become an active lobbyist support­
ing legislation to reduce tobacco use (Schauffler 1993). 
The Attack on Advertising 
In the 1970s and 1980s, the movement to reduce 
smoking was in part the work of grassroots activity, in 
part the work of professional consumer advocates, and 
in part the work of the public health bureaucracy.  In 
1966, a complaint filed with the Federal Communica­
tions Commission (FCC) by John F. Banzhaf III called 
for the application of the Fairness Doctrine to man­
date reply time to cigarette advertising on television 
and radio broadcasts (see also “Attempts to Regulate 
Tobacco Advertising and Packaging” in Chapter 5). 
The FCC agreed with Banzhaf’s complaint and on June 
2, 1967, ordered broadcasters to provide “significant” 
air time for antismoking messages. Banzhaf, antici­
pating and forestalling an almost certain appeal from 
the tobacco industry, appealed his own victory 
(Whiteside 1971). Under the guise of seeking equal 
rather than significant broadcast time, Banzhaf 
succeeded in having his original ruling upheld and 
in having its application specified: television and 
radio stations were required to run one counter-
advertisement, free of charge, for every three cigarette 
commercials.  This policy lasted until 1971, when a ban 
on cigarette broadcast advertising went into effect. 
The campaign to ban or regulate cigarette adver­
tising has been one of the most visible and emotion­
ally compelling of all the subthemes in the campaign 
to reduce smoking.  (Highlighted in this section, this 
theme is discussed in greater detail in “Attempts to 
Regulate Tobacco Advertising and Packaging” in 
Chapter 5.) All along, opponents have apparently “re­
sented most of all the ubiquity and presumed power 
of cigarette advertising” (Patterson 1987, p. 224).  These 
critics have argued that advertising is a powerful force 
blinding Americans to the health consequences of 
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smoking, but the tobacco industry has maintained a 
vigorous defense of its right to advertise (Patterson 
1987). 
In 1969, congressional hearings considered ban­
ning cigarette advertising on television and radio; 
strengthening health warnings on packages; extend­
ing the warnings to all cigarette advertising; and 
ending the preemptive ban on FTC, state, and local 
regulatory activity.  This time, the tobacco industry did 
not benefit, as they had during hearings in previous 
years, from the hesitancy of those conducting the hear­
ings. Since 1964, public concern about the health haz­
ards of smoking had been growing, and although the 
tobacco industry had powerful supporters in the U.S. 
House of Representatives, in the Senate, Warren Grant 
Magnuson (D-WA) and Frank E. Moss (D-UT) were 
canny and committed antagonists. Recognizing it 
would have to make some concessions, the industry 
agreed to a television and radio advertising ban. 
This concession may not have been unwilling. 
There is some indication that since the Fairness Doc­
trine was invoked in 1966, the resulting counter-
advertisements were hurting cigarette sales more than 
the cigarette commercials were helping (Hamilton 
1972). With the passage in 1969 of the Public Health 
Cigarette Smoking Act (Public Law 91-222), which con­
tained the ban on cigarette advertising on television 
and radio, the counteradvertisements vanished. The 
tobacco industry shifted its advertising to print and, 
perhaps even more notable, shifted its marketing bud­
get from advertising toward promotion.  The latter 
move exposed vast audiences to cigarette brands 
through techniques such as sponsoring sports events 
and, later, merchandising brand-touting items such as 
T-shirts and caps.  Nonetheless, the elimination of ciga­
rette advertising from the nation’s most powerful 
medium was at the very least a stunning symbolic 
defeat for the tobacco industry.  At the same time, the 
presence of cigarettes was gradually fading in televi­
sion programming; by 1982, fictional television char­
acters smoked nine times fewer cigarettes than they 
had before 1964 (Signorielli 1993). 
Toward a National Policy 
to Reduce Smoking 
Victories through federal administrative agencies 
or through direct assault on Congress were rare.  The 
first chairman of the new (1973) Consumer Product 
Safety Commission claimed authority to set standards 
for cigarettes or even to ban them, but Congress in 
1976 passed legislation to deny the commission that 
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authority (Walsh and Gordon 1986).  In 1972, the Civil 
Aeronautics Board required a nonsmoking section on 
commercial air flights, in part because of some volun­
tary action already taken; in 1983, responding to a 
Court of Appeals ruling that nonsmokers were inad­
equately protected, the board banned smoking alto­
gether on flight segments up to two hours—but almost 
at once Congress passed legislation to reverse this 
move (Walsh and Gordon 1986). 
In the executive branch, several voices spoke out 
against smoking. During his tenure as Surgeon Gen­
eral and thereafter, Dr. Jesse L. Steinfeld was an active 
participant in the national and international movement 
to reduce smoking (Steinfeld et al. 1976).  Joseph A. 
Califano, President Jimmy Carter’s Secretary of 
Health, Education, and Welfare, declared in 1978 that 
smoking was “Public Health Enemy Number One.” 
When Califano was designated Secretary, he had no 
notion that reducing smoking should be a significant 
effort of the Secretary’s department, but experts he 
consulted invariably urged that his public health efforts 
include a major campaign on that topic (Califano 1981). 
Over the years, the main voluntary organizations 
increased their aggressive posture against smoking.  In 
1982, the ACS, the ALA, and the AHA established the 
jointly sponsored Coalition on Smoking OR Health as 
a Washington-based lobbying organization.  The coa­
lition represented some 5 million volunteers across the 
country, at least some of whom were physicians and 
other civic leaders who could influence particular leg­
islators (Pertschuk 1986). In 1985, the AMA called for 
a complete ban on tobacco advertising and promotion 
(Troyer 1989).  Also that year, a rotating series of four 
more specific, more severe, and larger print warning 
labels replaced the traditional warning that “The Sur­
geon General has determined that cigarette smoking 
is dangerous to your health” (Waxman 1985; see 
“Attempts to Regulate Tobacco Advertising and Pack­
aging” in Chapter 5 for discussion of this regulatory 
process). 
From Antismoking to Nonsmokers’ Rights
 

The rhetoric of the smoking controversy in the 
1950s and 1960s focused on the scientific evidence link­
ing smoking and disease. In the wake of the 1964 Sur­
geon General’s report and subsequent research and 
reports, the battle over the credibility of the scientific 
evidence was essentially over.  In what has been called 
“a remarkable demonstration of creative lobbying” 
(Jacobson et al. 1992, p. 39), the tobacco industry 
sought to shift the debate from the medical conse­
quences of smoking to the legal implications of 
impeding the personal freedom of smokers to smoke 
and of tobacco companies to advertise their wares 
under the protection of the First Amendment.  The 
tactic appeared to work.  By the late 1970s, the effort 
to reduce smoking was foundering “on a traditional 
American libertarian ethic: ‘It’s my body and I’ll do 
with it as I please’” (Brandt 1990, p. 167). Serious dis­
cussion on the ethics of legislation to reduce smoking 
emerged (Goodin 1989).  To bring a public health per­
spective back into the center of the debate, a 
countershift to nonsmokers’ rights seemed strategi­
cally sound (Jacobson et al. 1992). During the 1980s, 
this strategy acquired a conceptual foundation that 
was framed in a persuasive vocabulary when the 
terms (and the concerns they aroused) “passive smok­
ing,” “ambient smoke,” “secondhand smoke,” and 
most commonly, “environmental tobacco smoke” 
(ETS) increasingly appeared in research reports and 
public debate. 
Regulations, Legislation, and Lobbying 
for Nonsmokers 
Evidence mounted in the 1970s and 1980s that 
smoking was not only an annoyance but also a health 
hazard to nonsmokers. The 1972 Surgeon General’s 
report on smoking and health became the first of the 
series to include a review of the effects of ETS.  A year 
earlier, Surgeon General Steinfeld had called for a na­
tional “Bill of Rights for the Non-Smoker.”  The call 
was answered when the National Interagency Coun­
cil on Smoking and Health developed a Non-Smoker’s 
Bill of Rights and promoted the nonsmokers’ rights 
theme among its 34 member agencies (Schmidt 1975). 
At the same time, the first successful efforts were 
made to segregate smokers and nonsmokers in public 
places. In 1971, United Air Lines became the first 
46 Chapter 2
 

   Historical Review 47
 
major carrier to institute separated “smoking” and 
“nonsmoking” sections on its airplanes. 
Analogous to private citizens who were active 
in the antismoking movement early on, some private 
businesses took the initiative to introduce worksite 
regulations for reducing smoking.  Typically, the pri­
vate firms would begin with a mild antismoking policy 
that was made stricter over time. A life insurance com­
pany in Connecticut, for instance, in 1976 restricted 
smoking in parts of the employee cafeteria. In 1983, 
smoking was prohibited throughout the cafeteria and 
was also banned from all conference rooms.  In 1986, 
all smoking at the workplace was prohibited except in 
designated restrooms and lounges.  Moreover, the com­
pany instituted an educational campaign about smok­
ing hazards and provided subsidies for employees who 
attended smoking cessation clinics (Petersen et al. 
1988). Other firms have also turned to carrots as well 
as sticks, paying employees bonuses if they stop smok­
ing for a given length of time (Fielding 1984). 
States began advancing legislation against ETS 
in the early 1970s. In 1973, Arizona passed the first 
statewide ban on smoking in public places. This im­
portant step for nonsmokers’ rights, which was initi­
ated by a private citizen, Betty Carnes, was defeated 
in a vote in 1972 but passed on its second try and a 
year later was further strengthened (Schmidt 1975). 
Two years later, Minnesota passed the first statewide 
act to keep indoor air smoke free; the legislation re­
quired no-smoking areas in all buildings open to the 
public unless a posted sign explicitly permitted smok­
ing. By 1975, legislation had passed in 10 states to regu­
late smoking in public places (Schmidt 1975); more 
than 30 states and hundreds of local jurisdictions had 
done so by 1985 (Koop 1985). By 1990, smoking was 
restricted to some extent in public places or worksites 
in 44 states, and hundreds of cities and towns had 
passed their own, often more rigorous ordinances 
(Rigotti and Pashos 1991). In cities with populations 
of 25,000 or more, local smoking restrictions reached 
more than two-thirds of citizens in various public and 
private settings, and one-half of these restrictions could 
be judged comprehensive. 
The courts supported these public and private 
efforts to protect nonsmokers’ rights.  In 1976, a Supe­
rior Court of New Jersey ruled that an office worker 
with an allergy to tobacco smoke had the right to a 
smoke-free office.  New Jersey was also the site of a 
comprehensive ruling in 1978 that restricted smoking 
in restaurants and other public places; this was the first 
such regulation to be enacted by administrative rule 
(through the State of New Jersey Department of 
Health) rather than by new legislation, though the rule 
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was never actually implemented (Regina Carlson, 
memorandum to John Slade, September 30, 1996). 
At the federal level, government acted not only 
legislatively to regulate public behavior in the states 
but also administratively to regulate domains the 
government itself directly controlled.  For instance, ciga­
rettes were removed from military C rations and K ra­
tions in 1975, and smoking was restricted in all federal 
government buildings in 1979. Smoking was banned in 
the White House in 1993 (Stephanopoulos 1993). 
Behind many of these reforms in industry and 
government were the unified efforts of private citizens. 
How these grassroot activists could band together to 
form powerful lobbying groups for nonsmokers’ rights 
was shown in the transformation of a segment of the 
Group Against Smokers’ Pollution (GASP), Inc., a na­
tional organization founded in 1971.  In 1976, local 
California chapters of GASP banded together and tried 
but failed to effect statewide ordinances to protect 
nonsmokers. In 1981, the chapters became Californians 
for Nonsmokers’ Rights and began focusing on local 
legislative activity.  Five years later, the group became 
a national organization that took its successful local-
level approach to sites throughout the country.  By 
1986, more than 75 ordinances had been enacted in 
California alone; nationwide, more than 400 had been 
enacted by 1990 (Samuels and Glantz 1991). In 1985, 
Los Angeles banned smoking in most public places 
and in businesses employing four or more persons if 
nonsmokers requested it (Fritschler 1989).  California 
has now banned smoking in practically all public 
places (Tobacco Education and Research Oversight 
Committee 1995). 
By the 1980s, the movement to reduce smoking 
proceeded along many avenues and through a wide 
set of loosely coordinated organizations.  This lack of 
systematic action has concerned activists in the move­
ment, who bemoan duplication of effort, lack of com­
munication, organizational rivalries, and the lack of a 
federal effort and policy.  At the same time, the move­
ment has clearly benefited from its multiple locations; 
the movement is represented by active legislative ef­
forts in hundreds of small communities as well as by a 
strong presence in Washington, DC, and in state capi­
tals (see also “Direct Advocacy” in Chapter 7 for a dis­
cussion of the influences of these advocacy activities). 
ETS: From Annoyance to Carcinogen 
The powerful call for nonsmokers’ rights added 
considerable momentum to the campaign to reduce 
smoking. The Surgeon General’s report in 1979 
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reviewed further research on ETS.  Considerable pub­
lic interest was aroused by a Japanese study, published 
early in 1981, that found a high incidence of lung can­
cer among nonsmoking women married to smoking 
men (Hirayama 1981; Newsweek 1981). While local-
level smoking restrictions began to gather force, often 
proving more comprehensive than statewide legisla­
tion, the evidence on passive smoking accumulated. 
On releasing his 1982 report on smoking and health, 
Surgeon General C. Everett Koop observed that ETS 
might be a serious public health problem (Troyer 1989); 
two years later, he spoke of solid evidence on this point 
(quoted in Molotsky 1984, p. 1). 
within the same air space “may reduce, but does not 
eliminate” exposure of nonsmokers to tobacco smoke 
(p. 13). 
The growing urgency of a public health focus 
on ETS set the stage for two authoritative messages 
that ETS posed a definite danger to all. In 1986, the 
National Research Council report Environmental To­
bacco Smoke: Measuring Exposures and Assessing Health 
Effects found that ETS exposure increased the risk for 
lung cancer by 30 percent in nonsmokers and had del­
eterious effects on the respiratory health of children 
(National Research Council 1986). The same year, the 
Surgeon General released The Health Consequences of 
Involuntary Smoking, which concluded that “involun­
tary smoking is a cause of disease, including lung can­
cer, in healthy nonsmokers” (USDHHS 1986, p. 13). 
That report also found that children of smoking par­
ents have an increased incidence of respiratory infec­
tions and that separating smokers and nonsmokers 
Critics charged that the evidence on passive 
smoking was weak, but the evidence and the authori­
tative conclusions of the Surgeon General and the 
National Academy of Sciences added support for 
stronger acts to limit or prohibit smoking indoors.  In 
1987, Congress banned smoking on domestic air trips 
shorter than two hours; in 1990, the ban was effectively 
extended to all domestic commercial air travel. 
Two further developments raised public (and 
public policy) awareness of ETS to a level that posi­
tioned it in the front ranks of the campaign to reduce 
smoking. In 1991, the National Institute for Occupa­
tional Safety and Health, Centers for Disease Control, 
issued the report Environmental Tobacco Smoke in the 
Workplace, which concluded that ETS can cause lung 
cancer and other health problems (National Institute 
for Occupational Safety and Health 1991). More 
important, in December 1992, the Environmental Pro­
tection Agency (EPA) classified ETS as a “Class A” 
carcinogen, the most dangerous class of carcinogens. 
The agency’s final report, Respiratory Health Effects of 
Passive Smoking: Lung Cancer and Other Disorders, con­
cluded that ETS is a human lung carcinogen respon­
sible for some 3,000 deaths annually from lung cancer 
among nonsmokers (EPA 1992). 
The Impact of the Movement to Reduce Smoking
 

The campaign against tobacco promotion is, in a 
sense, a public health hybrid. It is in part a public 
health movement, like those oriented to ensure that 
food and drugs are pure and that water supplies and 
air quality are clean—movements that look to improve 
upon the collective provision of healthful environ­
ments. But because the campaign to reduce smoking 
necessarily seeks to alter personal behavior, it is per­
ceived or cast by some as a moral reform movement. 
“We are in the midst of one of those periodic moments 
of repression,” writes one observer, “when the culture, 
descended from Puritans, imposes its hysterical visions 
and enforces its guilty constraints on society, legislat­
ing moral judgments under the guise of public health, 
all the while enlarging the power of surveillance and 
the reach of censorship to achieve a general restriction 
of freedom” (Klein 1993, p. 3).  Such critics worry about 
possible erosions of civil liberties and express irrita­
tion with the puritanical cast of the movement to re­
duce smoking (Berger 1986; Hitchens 1994; Leonard 
1994; Laqueur 1995). One recent historian refers to 
health reform movements of this and the past century 
as “hygienic ideologies,” because the movements have 
sometimes reached levels of  “devotion, asceticism, and 
zeal” that virtually mark them as “hygienic religion” 
(Whorton 1982, p. 4). In sum, the arguments have pit­
ted this moralism against the freedom to choose 
(Sullum 1996). In doing so, issues of addiction and 
corporate responsibility are sidestepped (Hilts and 
Collins 1995). 
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It would be hard to deny that moral zealotry has 
entered into the contemporary movement to reduce 
smoking. But it would be equally hard to argue that 
zealotry is the dominant element in the movement. 
The contemporary campaign to reduce smoking, like 
some elements of the early 20th-century efforts, has 
been fueled by medical research and, more recently, 
by revelations about the additional but secret medical 
research carried on by tobacco companies themselves 
on nicotine and other addictive substances (Kluger 
1996). But leadership has been both medical and non­
medical and has been oriented to conventional public 
policy mechanisms rather than to moral reformation. 
Where the broad contemporary health movement has 
“an ambivalent orientation toward science and technol­
ogy” and “draws upon Americans’ significant and 
growing distrust of physicians” (Goldstein 1992, pp. 
30–1), the movement to reduce smoking firmly em­
braces establishment medical research.  Its sometimes 
inventive and ingenious strategies notwithstanding, the 
movement has typically avoided ideological ends and 
has instead worked toward concrete, public policy ob­
jectives. In this respect, it is self-consciously political, 
adopting a style found now in many health movements 
(e.g., AIDS, breast cancer, and even advocates of spe­
cific health care reforms). 
Whether or not the movement to reduce smok­
ing has avoided the finger-pointing associated with 
many ideological movements is debatable. On the one 
hand, the movement has tended to demonize the to­
bacco companies rather than the smokers who use their 
products.  This distinction may arise partly because, 
some cultural icons aside, smoking has rarely been 
perceived as a feature of personal behavior that is cen­
tral to someone’s identity.  Placing the burden else­
where than on the smoker has been amply reinforced 
by the research-steered perceptual transition of smok­
ing as “habit” to smoking as “addiction.” As codified 
by the 1988 Surgeon General’s report (USDHHS 1988) 
and reiterated more recently (Lynch and Bonnie 1994), 
smoking is now medically viewed as nicotine addic­
tion, and as the title for Chapter 4 states, smoking ces­
sation is now the management of such addiction. This 
transition has had considerable impact on overall strat­
egy for reducing smoking, especially in litigation ap­
proaches (see “Litigation Approaches” in Chapter 5). 
On the other hand, as regulations against smok­
ing become more widespread, the tendency to stigma­
tize smokers may increase (Troyer 1989).  Moreover, 
some critics have complained of an ideology that 
smacks of political conservatism, in that the focus for 
the problem is turned away from the product source 
(the manufacturer) and to the user-victim (the smoker); 
this blame-the-victim perspective also characterizes 
sociopolitical movements that divert public attention 
to personal behaviors and away from larger, corporate 
sources of environmental health risks, such as indus­
trial pollution and workplace hazards (Crawford 1979). 
In at least one sense—that of social values— 
efforts to reduce smoking have been moralistic.  The 
contemporary reform movement can fairly be charac­
terized as middle-class—that is, its values are those 
connected with traditional values such as deferred 
gratification, self-control, and personal responsibility 
(Goldstein 1992). Nonsmokers may feel morally su­
perior to smokers, and former smokers may pride 
themselves on their personal accomplishment and self-
denial. As one cultural observer has pointed out, 
former smokers especially may be “tediously zealous 
about the addiction they have left behind” (Styron 
1987, p. 284). 
The net result, whatever the role of moral issues, 
is the main emphasis the movement places on chang­
ing the social conditions that enable, and the cultural 
conditions that legitimatize or romanticize, smoking. 
In this sense, the movement to reduce smoking is an 
old-fashioned populist movement that seeks to defend 
the “public interest” against the moneyed corpora­
tions, the purveyors of death and disease. It is now 
less an “anti-smoking” political movement and more 
a campaign against tobacco promotion. 
A reflection of this broadly populist attitude has 
been the movement’s lack of any real links to partisan 
politics. Senators Wallace F. Bennett (R-UT) and Rich­
ard L. Neuberger (D-OR) were among the first to seek 
curbs on the tobacco industry (Fritschler 1989). In the 
early 1980s, Republican Senators Robert W. Packwood 
(R-OR) and Orrin G. Hatch (R-UT) introduced legisla­
tion to require more explicit warning labels on ciga­
rette packages (Troyer 1989).  House Democrats have 
been both key defenders and key critics of the tobacco 
industry.  In the White House, Democratic President 
Lyndon B. Johnson remained silent on the preemptive 
Federal Cigarette Labeling and Advertising Act of 
1965, but White House pressure helped support the 
Tobacco Institute’s efforts to pass the bill (Pertschuk 
1986); the President signed the act into law privately 
in his office, without guests or comment (Fritschler 
1989). Similarly, Democratic President Jimmy Carter 
refused to take a position on tobacco (Fritschler 1989), 
but he regarded USDHEW Secretary Joseph Califano’s 
crusade against tobacco as “an enormous political 
liability” (Califano 1985, p. 360). The absence of po­
litical affiliation for the antitobacco movement may be 
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altered, however, by recent changes in the party com­
position of elected officials from tobacco-producing 
states. 
The efficacy of efforts to reduce smoking, inde­
pendent of other social changes beginning early in the 
20th century, is hard to determine.  Students of 19th­
century temperance, for example, have concluded that 
although the temperance efforts likely accelerated the 
antebellum decline in alcohol consumption, the decline 
may have been more deeply tied to independent 
changes in styles of liquor consumption (Aaron and 
Musto 1981). The antismoking movement of the early 
20th century, despite temporary gains, had little long-
term effect on stopping the rapid growth of smoking; 
though noteworthy, the emergence of antismoking 
legislation in some midwestern and western states 
was brief and showed little convincing evidence of 
enforcement. 
But neither the temperance movement of the 19th 
century nor the antismoking movement early in the 20th 
century commanded the significant allies and the range 
of weapons of the contemporary effort to reduce 
smoking. The critical factor has been definitive medi­
cal research linking smoking to cancer, heart disease, 
chronic obstructive pulmonary disease, and adverse 
outcomes of pregnancy (USDHHS 1989). Beginning in 
1964, the imprimatur of the Surgeon General of the 
United States provided a symbolic centerpiece that has 
given inestimable momentum to the campaign. The 
all-but-unanimous and compelling character of the 
epidemiologic research in that first report and its suc­
cessors is the chief factor that leads to the conclusion, 
“As a target of opportunity for public health action, 
smoking stands alone” (Walsh and Gordon 1986, p. 127). 
Measuring the overall impact of the rich and 
multifaceted effort to reduce smoking is difficult, in 
part because current prevalence should not be judged 
against an arbitrary historical benchmark (for instance, 
against prevalence at the time of the 1964 Surgeon 
General’s report) but against an estimate of what 
prevalence would have been in the absence of such 
efforts.  The events of the past decades that coincided 
with these efforts are clear:  cigarette consumption rose 
steadily from the 1930s until 1963, fluctuated, then 
fell from 1973 to the present.  But such broad-brush 
observations provide little insight into cause and ef­
fect, especially given the multiplier effect of certain 
social actions, the differential changes in demographic 
and social subgroups, and the influence of forces ex­
traneous to smoking (Warner 1989). 
It is problematic, for example, to try to assess the 
relative impact of, on the one hand, government edu­
cational actions and government regulatory actions 
and, on the other hand, changing social norms—two 
factors that are clearly interrelated.  The impact of gov­
ernment curbs on smoking in public places (see “Clean 
Indoor Air Regulation” in Chapter 5) may actually be 
bound up with “voluntary adjustments to new infor­
mation” (Zimring 1993, p. 97). Similarly, doubts have 
been raised as to the influence of curbs on tobacco 
advertising (Schudson 1993; see “Advertising and Pro­
motion” in Chapter 5), because such restrictions have 
occurred in conjunction with a growing stigmatization 
of smoking. Once nonsmoking is established as a 
norm, the minority status of smokers makes them 
“more vulnerable to negative social evaluations. . . . 
As smokers, the group most interested in defending 
the moral position of the cigarette smoker, become both 
less numerous and less influential, smoking behavior 
and the people who engage in it become more vulner­
able to social reinterpretation” (Zimring 1993, p. 106). 
Such a reinforcing chain of events may permit curbs 
on advertising, rather than the reverse. 
It is equally difficult to gauge or predict the in­
fluence of government restrictions.  On the one hand, 
a regulation may be an educative force—for example, 
by reminding people to take their Surgeon General 
seriously.  In some instances (such as indoor prohibi­
tions and access restrictions), government actions in­
terpose a physical barrier.  On the other hand, legal or 
otherwise formal barriers could have an unintended 
effect on individual predisposition, as the abiding aura 
of antisocial behavior can be at least as great a stimu­
lus for some as it is a deterrent for others. Finally, the 
psychological and social pathways by which economic 
actions of government affect smoking are complex. 
Sorting through this complexity is critical to 
understanding appropriate policy and action for re­
ducing smoking. The ensuing chapters assess the 
available evidence to judge the efficacy of educational 
efforts (Chapter 3), the management of nicotine 
addiction (Chapter 4), regulatory efforts (Chapter 5), 
economic approaches (Chapter 6), and comprehensive 
programs (Chapter 7).  This brief history of the anti­
smoking movement provides a backdrop to such as­
sessment and may furnish some perspective on future 
directions. 
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Reducing Tobacco Use 
Conclusions 
1.	 	 In the years preceding the development of the 
modern cigarette, and for some time thereafter, 
antismoking activity was largely motivated by 
moralistic and hygienic concerns. Health con-
cerns played a lesser role. 
3. Despite the growing scientific evidence for ad-
verse health effects, smoking norms and habits 
have yielded slowly and incompletely.  The rea-
sons are complex but attributable in part to the 
industry’s continuing stimulus to consumption. 
2.	 	 In contrast, in the second half of the 20th cen­
tury, the impetus for reducing tobacco use was 
largely medical and social. The resulting plat­
form has been a more secure one for efforts to 
reduce smoking. 
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Introduction 
Trends in Tobacco Use Among 
Young People 
Smoking prevalence among youth underwent a 
sustained and substantial decline for about a decade 
from the mid-1970s to the mid-1980s.  The Monitoring 
the Future study, funded by the National Institute on 
Drug Abuse, has assessed the substance use behaviors 
of large representative samples of high school seniors 
annually since 1975 (Giovino et al. 1994; Johnston et al. 
1994). The data from this multiyear study have shown 
that daily cigarette smoking reached a peak of about 29 
percent among high school seniors in 1977.  Daily smok­
ing then declined steadily until 1986, falling below 19 
percent, but has shown little change since.  Detailed 
analyses of trends in smoking by adolescents in 1974– 
1991, based on Monitoring the Future data and two 
other national health behavior survey series, also have 
shown consistent evidence that smoking prevalence 
among adolescents has generally been stable since about 
1985 (Nelson et al. 1995). In 1997, daily cigarette smok­
ing in the month before the survey was reported by 24.6 
percent of high school seniors, the highest level since 
1979, when 25.4 percent reported daily smoking.  Long-
term trends show that daily smoking among seniors 
was at a 25-year high of 28.8 percent in 1976 and 1977, 
declined to 21.3 percent in 1980, varied in the range of 
18–21 percent from 1980 to 1991, and decreased to 17.2 
percent in 1992.  After that, seniors’ daily cigarette use 
increased steadily to reach 24.6 percent in 1997, then 
decreased to 22.4 percent in 1998 and remained statisti­
cally unchanged at 23.1 percent in 1999 (Johnston et al. 
1999). A recent report with more current prevalence 
estimates and trend data from 1991 through 1997 shows 
that current cigarette use increased overall and for 
white, black (the racial/ethnic terms “black” and “Af­
rican American” are both used in this report, according 
to the usage in the study cited), and Hispanic high 
school students (Centers for Disease Control and Pre­
vention [CDC] 1998). Even so, the prevalence of smok­
ing among African American high school seniors was 
lower than that for Asian Americans/Pacific Islanders 
and for American Indians/Alaska Natives (US Depart­
ment of Health and Human Services [USDHHS] 1998). 
Although the decade-long decline in smoking 
prevalence among young people stalled in the mid­
1980s, it has persisted among all major adult popula­
tion groups in the United States (Giovino et al. 1994). 
Changes in prevalence among young people thus do 
not seem to be closely linked to changes among adults 
(Reid et al. 1992) and may be more heavily influenced 
by other social forces.  Downward trends in smoking 
by adults may, for instance, be partly the result of the 
continued accumulation of scientific knowledge about 
the long-term health consequences of smoking and 
of secondary exposure to cigarette smoke (USDHHS 
1989; Environmental Protection Agency 1992).  That 
no such downward trend was observed among most 
groups of adolescents in the past decade may reflect 
other factors: prices of tobacco products decreased (see 
Chapter 6); during the 1980s, public education efforts 
to prevent tobacco use among young people dimin­
ished; and youth-oriented marketing by cigarette 
manufacturers intensified (Nelson et al. 1995).  More­
over, because of the highly addictive nature of ciga­
rette smoking, the recent increases in prevalence of 
smoking among young people could carry over into 
their adulthood and eventually arrest or reverse the 
long-term declines that have persisted for decades 
(CDC 1994a; Giovino et al. 1994). 
In a similar vein, a major portion of tobacco con­
sumption at the beginning of the 20th century was 
in the form of spitting tobacco. The emergence of 
machine-made cigarettes as the dominant form of to­
bacco use in the 1930s (see Chapter 2) was accompa­
nied by a 38.4-percent decline in total smokeless 
tobacco production from 150.2 million to 92.5 million 
pounds between 1944 and 1968. 
In the early 1970s, however, the market for 
smokeless tobacco reemerged.  Between 1970 and 1981, 
the production of fine-cut tobacco, used in the manu­
facture of moist snuff, increased threefold from 4.8 
million to 15.2 million pounds (USDHHS 1986). Sales 
of moist snuff have increased every year since the Fed­
eral Trade Commission (FTC) began monitoring it, 
from 36.1 million pounds in 1986 to 55.3 million 
pounds in 1997 (FTC 1999). Loose leaf chewing to­
bacco has seen a slight decline in sales over this pe­
riod, from 65.7 million pounds in 1986 to 51.8 million 
pounds in 1997. 
The growth in the sales of moist snuff has been 
attributed to a smokeless tobacco advertising and 
marketing campaign that encourages young non­
users to experiment with low nicotine starter products 
with the intent of graduating new users to higher nico­
tine brands as dependence progresses (Connolly 1995). 
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The basis and success of this “graduation” strategy is 
supported by laboratory and epidemiologic data 
as well as tobacco industry documents. Smokeless 
tobacco manufacturers appear to be able to manipu­
late the nicotine-dosing characteristics of their prod­
ucts and have developed moist snuff products with a 
wide range of bioavailable nicotine (Henningfield 
et al. 1995; Djordjevic et al. 1995; Food and Drug 
Administration 1996; Tomar and Henningfield 1997). 
A national longitudinal study found that young males 
were twice as likely to switch from a brand with low 
or medium nicotine delivery to a high nicotine deliv­
ery product than to switch in the opposite direction 
(Tomar et al. 1995).  Advertising and promotional 
expenditures have increased for nearly every year 
between 1986 and 1997, from $76.7 million to $150.4 
million (FTC 1999). In 1997, $103.6 million was spent 
for advertising and promotion of moist snuff. 
Smokeless tobacco use is primarily a male behav­
ior.  Use of snuff and chewing tobacco by young males 
increased sharply through the 1970s and early 1980s. 
Data from the National Health Interview Survey indi­
cate that the prevalence of smokeless tobacco use 
among males aged 18–24 years increased from 2.2 per­
cent in 1970 to 8.9 percent in 1987 and declined slightly 
to 8.4 percent in 1991 (Giovino et al. 1994). Based on 
CDC’s Youth Risk Behavior Survey, the prevalence of 
past-month smokeless tobacco use remained at about 
20 percent among high school males during most of 
the 1990s (CDC 1992; Kann et al. 1995). Recent data 
indicate that smokeless tobacco use may be starting to 
decline among high school males (CDC 1998). 
More vigorous steps are clearly required to pre­
vent young people from beginning to use tobacco 
products.  This chapter considers the effect of educa­
tional programs in such prevention.  Throughout the 
discussion, the term “education” is used to encompass 
the range of activities that impart knowledge, alter per­
ceptions, and modify behavior. 
Reasons Young People Smoke 
The public health importance of smoking among 
young people has generated a substantial amount of 
research on why they take up the habit.  The results of 
these efforts have provided several consistent insights 
that have been reviewed in detail and summarized in 
recent reports (Lynch and Bonnie 1994; USDHHS 1994). 
Development of tobacco addiction is a staged 
process that requires several years to progress from ini­
tiation to acquisition of an established habit (Leventhal 
and Cleary 1980; McCarthy 1985; see also Flay 1993). 
The initial stages are consistently associated with a 
well-defined group of risk factors.  Early adolescence 
(aged 11–15 years, or 6th–10th grades) is the period 
when people are most likely to try smoking for the 
first time. Especially at risk are adolescents whose 
parents or guardians smoke or have lower levels of 
income and education (USDHHS 1994). 
Young people’s perceptions of smoking behav­
iors in proximal and wider social environments are 
among the most powerful psychosocial forces influ­
encing whether they begin to smoke (USDHHS 1994). 
Cigarette smoking among friends, peers, siblings, and 
others from the young person’s immediate environ­
ment is consistently associated with smoking initia­
tion. The influence of friends and peers seems to be 
especially powerful in the early stages of developing 
a smoking habit. Perceptions of the larger social envi­
ronment also seem to have considerable influence on 
smoking decisions. Adolescents tend to overestimate 
the prevalence of smoking among people their own 
age and among adults. Such perceptions—and in gen­
eral, susceptibility to becoming a smoker—are likely 
to be strongly influenced by the effects of advertising 
(Evans et al. 1995). Young people who perceive high 
levels of smoking among their peers and who report 
that peers are more likely to approve of cigarette smok­
ing are more likely to become smokers themselves. 
These external influences are likely supported or 
opposed by internal, personal factors. The personal 
factors most often associated with smoking initiation 
include the young person’s belief that cigarette smok­
ing is linked with positive functions, such as having 
a positive social image and bonding with a peer group. 
Among young women, smoking may be viewed as a 
means of weight control (French et al. 1994).  Adop­
tion of such perceptions may reflect, in part, the influ­
ence of a larger social environment in which smoking 
is presented through local and mass media as an 
adventurous and glamorous adult behavior.  Thus, 
smoking provides some young people a perceived tran­
sition from childhood to adulthood (USDHHS 1994). 
These findings, summarized in the 1994 Surgeon 
General’s report Preventing Tobacco Use Among Young 
People, strongly suggest that tobacco use is socially 
learned by children and adolescents and that it tends 
to have socially relevant meanings for them (USDHHS 
1994). Smoking prevention programs should thus 
address the most salient psychosocial dimensions 
that can influence a young person to not begin smok­
ing. These dimensions include enabling the young to 
cope with direct social pressure to smoke from their 
friends and peers and correcting or preventing 
misperceptions about the social effects and short-term 
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health consequences of smoking, about peers’ and 
adults’ attitudes toward smoking, and about smoking 
prevalence. 
Educational Models for 
Smoking Prevention 
During the past two decades, several different 
theoretical orientations and program objectives have 
emerged for educational approaches to smoking pre­
vention. Several changes have influenced these events: 
research and evaluation results that highlighted the 
ineffectiveness of the models used in earlier programs, 
the accumulation of consistent research characterizing 
the process of smoking initiation, advances in theo­
ries of human behavior, and promising results obtained 
from initial tests of newer educational models. 
Another important change is the expansion from 
relatively simple strategies and educational techniques 
to more complex plans that use multiple educational 
channels. Complex sociobehavioral problems are thus 
being addressed with more intensive educational 
strategies. 
The earliest group (mostly from the 1960s and 
1970s) of evaluated programs designed to prevent ado­
lescents from beginning to smoke was based on an 
information deficit model (USDHHS 1994). This 
approach assumed that adolescents, as rational crea­
tures, would refrain from cigarette smoking if they 
were supplied with adequate information demonstrat­
ing that this habit causes serious harm to the body. 
The educational techniques associated with these pro­
grams included lectures, demonstrations, films, post­
ers, and books intended to raise levels of awareness 
and comprehension of health effects.  Many programs 
based solely on this objective did increase knowledge 
among children and adolescents, as intended, but the 
programs were consistently found to be ineffective in 
dissuading young people from smoking (Goodstadt 
1978; Thompson 1978; Kinder et al. 1980; Schaps et al. 
1980, 1981). Although this approach alone was clearly 
inadequate, information about the health and social 
consequences of smoking was retained as an impor­
tant component of later developments in smoking 
prevention education. 
The limitations of this approach led to efforts in 
the 1970s to identify a more complex set of personal 
factors related to cigarette smoking by young people. 
Once these factors were identified, educational pro­
grams could be developed to try to modify them. Stud­
ies conducted during these years often observed that 
the use of cigarettes was associated with negative or 
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antisocial patterns of adolescent behavior (USDHHS 
1994). Educators interpreted these patterns as reflect­
ing reduced levels of perceived self-worth and poor 
attitudes toward family, school, and community; 
these factors were hypothesized to be the root causes 
of smoking initiation. Various educational strategies 
to address these broad educational targets included 
programs focused on clarifying values, building self-
esteem, and developing general skills for decision mak­
ing, communication, and assertiveness. 
Such efforts to prevent smoking initiation by 
helping young people develop stronger intrapersonal 
resources and general social competence have been 
collectively referred to as the affective education 
model. Evaluations of these programs, however, dem­
onstrated that they were not much more effective in 
reducing cigarette smoking among young people than 
programs based on the information deficit model 
(Schaps et al. 1981; Durell and Bukoski 1984; Hansen 
1992). The affective education strategy did mark the 
beginning of promising trends in designing education 
programs to prevent smoking:  many programs began 
more directly incorporating results from research 
about factors found to influence smoking initiation and 
began including more powerful theoretical models of 
behavior change. 
By the mid-1970s, results of analytic and theo­
retical research began to highlight a complex set 
of psychosocial factors associated with smoking 
initiation. Numerous studies had consistently found 
that smoking experimentation by the young was as­
sociated with peer smoking, smoking by others in the 
immediate social environment, and other social and 
psychological factors (USDHHS 1994). Although the 
resulting psychosocial intervention programs were 
developed through several different conceptual per­
spectives, they tended to share a core set of compo­
nents that compose what is generally called the social 
influences model (USDHHS 1991). This model focuses 
on the development of social skills to resist social 
influences that encourage smoking. 
The initial efforts to design programs based on 
these findings used a public health model: the prob­
lem was conceptualized as a social contagion in which 
the habit spread through a population by passing from 
one person to another.  This concept directed program 
efforts toward strengthening the resistance of non­
smoking adolescents to the behavior of their smoking 
peers. For example, Evans and colleagues (1978) at 
the University of Houston used methods derived from 
communications and social learning theories to try 
“inoculating” young people against peer influences to 
smoke cigarettes; the study group of adolescents was 
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shown videotaped models of credible peers who suc­
cessfully resisted such influences (McGuire 1964). 
This approach was developed further in small-
scale studies that added other objectives and used 
other educational technologies (Botvin et al. 1980; 
McAlister et al. 1980; Perry et al. 1980). The appeal of 
the overall conceptual approach and the generally 
positive results of this initial group of studies stimu­
lated a sustained evolution of the approach through 
several stages of development; the result was a gener­
ally recognized social influences model for school-
based programs to prevent smoking (Flay 1985). 
The main goal of this approach was to equip 
younger adolescents with specific skills and other 
resources that would help them resist direct and indi­
rect social influences to try smoking cigarettes.  The 
specific objectives usually included having the young 
person learn the short-term negative social and health 
consequences of smoking and the advantages of re­
maining a nonsmoker; learn that a relatively small 
proportion of young people and adults are regular 
smokers; recognize the social influences in the imme­
diate environment and from the wider community and 
culture that promote smoking; and develop specific 
skills for managing direct social pressures from friends 
and peers, as well as indirect pressures from adult 
modeling, the mass media, and tobacco industry mar­
keting. Although representing a significant departure 
from previous approaches, this model retained 
the provision of information on the negative short-
term consequences of smoking (from the information 
deficit model) and continued to emphasize the devel­
opment of social competencies (from the affective 
education model). 
Social influences strategies have typically been 
applied through school-based programs for students 
in sixth through eighth grades (primarily during early 
adolescence). These programs have taken various 
formats, used different delivery methods, and been 
offered to diverse student populations. 
By the mid-1980s, detailed analyses of research 
results indicated that social influences programs were 
consistently more effective than programs based on 
the information deficit or affective education models 
in preventing cigarette smoking (Tobler 1986, 1992; 
Rundall and Bruvold 1988; Hansen 1992; Bruvold 
1993). Some reviewers, however, wondered whether 
this evidence was strong enough to justify developing 
public policies that would make these school-based 
programs a large-scale, key component of policies to 
prevent tobacco use (Flay 1985; Cleary et al. 1988; 
Kozlowski et al. 1989). 
Concern focused on the quality of the effects 
achieved, the quality of the evaluation research that 
provided the evidence, and the generalizability of the 
programs.  The programs’ effects reported up to the 
mid-1980s were not consistently achieved, were of 
short duration, and tended to be small. For example, 
Drug Abuse Resistance Education (D.A.R.E.), a drug 
resistance program that included but was not pri­
marily focused on tobacco use, has been in wide use 
since the mid-1980s. A recent meta-analysis of pub­
lished and unpublished results concluded that the 
program’s effect on tobacco use was small at best 
(Ennett et al. 1994). Limitations in evaluation 
methods—such as outcome measurement, attrition ef­
fects, consistency between assignment and analysis 
units, and completeness of reported effects on total 
populations—precluded drawing clear conclusions 
about program effectiveness.  These reviewers also 
were concerned that the programs might be too com­
plex to be carried out in most schools by most class­
room teachers.  Since 1990, many of these questions 
have been addressed by research on these educational 
strategies (Graham et al. 1991). 
Recent Research on Educational Strategies for Smoking Prevention
 

Most early research programs on smoking pre­
vention were located exclusively in school settings. 
Schools provide direct access to target populations and 
have a mission consistent with smoking prevention 
education. Schools, however, have some inherent 
limitations that reduce their usefulness as exclusive 
channels for such education; the obvious one is that 
school programs cannot reach individuals who leave 
school. This section reviews shorter-term and longer-
term studies of the effects of school-based smoking pre­
vention programs (Table 3.1).  The section also reviews 
studies of prevention programs that have tried to 
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enhance such programs by combining them with edu­
cational activities directed toward young people 
through parents, community programs, and the mass 
media or by combining them with programs that tar­
geted multiple substances. 
Shorter-Term Follow-Up of 
School-Based Programs 
The group of studies summarized in this subsec­
tion evaluated programs that were based, with few 
exceptions, exclusively on educational experiences 
provided in school classrooms.  These studies gener­
ally have addressed methodological problems com­
monly found in earlier evaluations of smoking 
prevention efforts.  Improvements include use of bio­
chemical measures to enhance the accuracy of self-
reported smoking behavior, attention to validity issues 
related to attrition, and improved consistency between 
units of assignment to treatment and units of analysis. 
Most of this initial group of studies also improved 
on earlier reports by using more diverse study popu­
lations to test these programs and by following 
participants into the first year of high school to assess 
smoking prevention effects at an intermediate stage 
of adolescent development. The studies described 
and analyzed in this subsection thus represent the cur­
rent state of the art in the evaluation of school-based 
smoking prevention. 
Project Towards No Tobacco Use 
Project Towards No Tobacco Use (Project TNT) 
was designed to assess the relative effectiveness of three 
main components of most smoking prevention pro­
grams based on the social influences model (Sussman 
et al. 1993b, 1995). The investigators developed sepa­
rate classroom curricula to address each of these com­
ponents (Sussman 1991; Sussman et al. 1993a). The first 
curriculum provided social skills to help students more 
easily refuse direct offers of cigarettes from peers; the 
second provided methods to counteract the impact of 
indirect pressures to smoke cigarettes, such as smoking 
(real or perceived) by peers or adults, tobacco industry 
advertising, and exaggerated notions of the actual 
prevalence of smoking among peers and adults; and 
the third improved knowledge of the short-term and 
long-term negative effects of smoking.  A fourth cur­
riculum addressed all three of these areas and was 
similar to the social influences model used with many 
other school-based smoking prevention programs. 
Each curriculum included 10 lessons designed for 
Reducing Tobacco Use
 
seventh-grade students. The curricula were delivered 
on 10 consecutive school days by trained health educa­
tors employed by the project. A control group received 
the standard curriculum. 
The study included seventh graders from 48 
junior high schools in 27 southern California school 
districts. Students from 8 schools were assigned to 
receive one each of the four curricula; students from 
the remaining 16 schools were assigned to receive the 
standard education program provided by their schools. 
These populations were relatively diverse:  about 40 
percent were from minority ethnic groups.  Student 
reports of smoking behavior were measured immedi­
ately after the curricula were completed in the seventh 
grade (n = 6,716) and one year later in the eighth grade 
(n = 7,052). 
Analyses of these data indicated that the curricu­
lum that combined all three main objectives drawn 
from the social influences model achieved the lowest 
increase in weekly smoking prevalence (defined as 
smoking one or more cigarettes per week); this increase 
was 64 percent lower than the increase in the control 
group.  The curricula that focused on indirect pressures 
to smoke cigarettes and on negative consequences of 
smoking also were significantly more effective than the 
control condition. The curriculum that focused on 
refusal skills did not yield results significantly differ­
ent from the comparison condition.  Changes in 
psychosocial mediators of program effects were con­
sistent with these results (Sussman et al. 1993a).  Simi­
lar effects were obtained for smokeless tobacco use. 
A two-year follow-up survey, completed when the 
participating students were in ninth grade, showed 
that the combined curriculum continued to have a sig­
nificant impact on weekly smoking rates after these 
students entered high school (Dent et al. 1995). 
Know Your Body 
The Know Your Body (KYB) program, a school-
based effort to reduce risk factors for chronic disease 
among young people, addressed cigarette smoking 
status, dietary behaviors, and physical fitness through 
curricula for fourth- through ninth-grade students 
(Walter 1989; Walter and Wynder 1989).  Program 
components included parent education and periodic 
student health examinations. Designed to meet the 
rapidly changing educational needs of young people 
in this age group, the six-year curriculum progressed 
from a focus on knowledge and beliefs to a focus on 
decision-making skills (Walter and Wynder 1989).  In 
the fourth and fifth grades, the curriculum’s compo­
nent on smoking prevention concentrated on students’ 
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Table 3.1.  School-based and multifaceted educational strategies 
Project name  Educational methods
 

School-based educational strategies with shorter-term follow-up
 

Project TNT (Towards No Tobacco Use) 
Know Your Body 
SHOUT (Students Helping Others 
Understand Tobacco) 
2 years; 10 class sessions delivered by project staff in grade 7 
6 years; multiple risk factor curriculum delivered weekly by 
classroom teachers in grades 4–9, plus parent education 
3 years; 18 class sessions in grades 7–8 delivered by project staff, 
plus telephone and mail contact in grade 9 
School-based educational strategies with longer-term follow-up
 

Life Skills Training Program 
Minnesota Smoking Prevention Program 
Waterloo Smoking Projects 
Project ALERT 
Multifaceted educational strategies 
Class of 1989 Study (Minnesota Heart 
Health Program) 
Midwestern Prevention 
Project 
University of Vermont School and 
Mass Media Project 
3 years; 30 class sessions delivered by teachers in grades 7–9 
1 year; 5 class sessions in grade 7 delivered by teachers and peers 
3 years; 11 class sessions delivered by project staff in grades 6–8 
2 years; 11 class sessions delivered by teachers and peers in 
grades 7–8 
5 years; 17 class sessions delivered by teachers and peers in grades 
7–9, plus related school courses and activities and very intensive 
community education directed toward adults 
3 years; 15 class sessions delivered by teachers and peers in grades 
6–7 or 7–8, plus parent education and participation in school 
curriculum, informational media, and community organization 
4 years; 15 class sessions in grades 5–8 or 6–9 or 7–10 delivered by 
teachers, plus 540 television and 350 radio spot broadcasts each year 
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Design Results* Comment 

5 conditions tested in 48 schools 64% less weekly smoking for full Very large short-term effect 
(n = 6,716) intervention group by end of achieved by moderately intensive 
grade 8 and 55% by end of grade 9 school program 
2 conditions in 15 schools 73% less smoking by end of Very large short-term effect 
(n = 911) grade 9 achieved by very intensive school 
program with parent education 
2 conditions in 22 schools 33% less monthly smoking by end Large short-term effect achieved 
(n = 3,655) of grade 9 by intensive school program 
supplemented with other contacts 
3 conditions tested in 56 schools 18% less weekly smoking Large sustained effects achieved 
(n = 5,954) observed at grade 12 by very intensive school program 
4 conditions tested in 18 schools Program effects at grades 8 No long-term effects of 
(n = 7,030) and 9 but not at grade 12 less-intensive school program 
2 conditions tested in 22 schools Program effects at grades 8 No long-term effects of moder­
(n = 654) and 9 but not at grade 12 ately intensive school program 
3 conditions tested in 30 schools Program effects less at grades 8 No long-term effects of moder­
(n = 6,527) and not at grade 12 ately intensive school program 
2 conditions tested in 13 schools 39% less weekly smoking by end Large sustained effects achieved 
(n = 2,401) of grade 12 by intensive school programs 
supported by intensive commu­
nity programs 
2 conditions tested in 42 schools 32% less monthly smoking after Large short-term effects achieved 
(n = 5,065) 1 year; 19% less monthly smoking by intensive school program sup-
by end of grades 9–10 ported by parent education, mass 
media, and community programs 
2 conditions tested in 50 schools 40% less weekly smoking by end Large sustained effects achieved 
(n = 5,458) of grades 8–10; 31% less weekly by intensive school program 
smoking at end of grades 10–12 combined with intensive mass 
media intervention 
*Results are reported relative to a comparison group. 
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health beliefs about smoking. Social influences, both 
direct and indirect, on decisions about smoking were 
addressed in the sixth through eighth grades.  Psycho­
logical influences, such as stress and self-image, were 
addressed in the ninth grade. 
The classroom program was delivered by the stu­
dents’ usual classroom teachers, who had been trained 
by project staff.  The overall curriculum required about 
two hours per week throughout the school year.  If the 
curriculum gave equal attention to each of the three 
targeted behavioral areas, the smoking component 
would include about 24 hours of class time per year 
over six years. The parent education component 
of the program included participation in students’ 
homework from the curriculum, attendance at school 
meetings about the program, receipt of program news­
letters, and self-assessment of risk factors for chronic 
disease. 
The program was initially tested with students 
attending the fourth grade in 15 elementary schools 
from suburban communities near New York City 
(Walter et al. 1989).  Students in eight schools received 
the KYB educational program, and students in the 
remaining schools received only measurement acti­
vities from the study.  The follow-up survey in the ninth 
grade included 593 students (65 percent) from the origi­
nal study cohort. 
Analyses of these data showed that students who 
had received the program were significantly less likely 
than students not receiving the program to smoke ciga­
rettes (verified through salivary cotinine measures). 
Smoking prevalence in the ninth grade was 73 percent 
lower among students who had received the program. 
This smoking prevention effect was stronger among 
boys than among girls. Favorable changes in health 
knowledge, dietary behavior, blood cholesterol, and 
obesity were also observed (Walter et al. 1988; Walter 
and Wynder 1989). 
Project SHOUT 
The Students Helping Others Understand 
Tobacco (SHOUT) project was designed to assess the 
effectiveness of a prevention program delivered to sev­
enth through ninth graders by trained college under­
graduates through classroom activities and telephone 
and mail support (Elder et al. 1993b). The program 
began with 10 class sessions distributed throughout 
the seventh-grade school year.  Components focused 
on pressures to smoke, refusal skills, negative social 
and health consequences of smoking, decision mak­
ing, and commitment to nonsmoking. In the eighth 
grade, eight classroom sessions reviewed refusal skills 
and engaged students in community action projects, 
such as encouraging others to quit, writing letters 
about tobacco issues to mass media organizations and 
tobacco firms, and debating issues about tobacco 
use. Throughout the ninth grade, when students had 
transferred into secondary school, the college under­
graduates trained by the program staff made four sup­
portive telephone calls to each participant; 69 percent 
of participants were reached at least once (Elder et al. 
1994a). Also during the ninth grade, five newsletters 
were mailed to students and two to their parents. 
This program was initially tested in 22 southern 
California schools. Students from 12 schools received 
the SHOUT program, and students from the remain­
ing schools did not. About 45 percent of the students 
were from minority ethnic groups.  The effectiveness 
of the program was assessed through classroom and 
mail surveys conducted at the end of each of the three 
years. The ninth-grade survey included 2,668 mem­
bers (73 percent) of the original study cohort. 
By the end of the ninth grade, the prevalence of 
monthly smoking (defined as smoking one or more 
cigarettes per month) was about 33 percent lower 
among students who had received the program than 
among those who had not. The relative difference in 
the two groups’ reported smoking increased each year 
and was statistically significant at the end of the ninth 
grade. The results at the end of the ninth grade were 
particularly encouraging, because program contact (via 
telephone calls and newsletters) was less costly.  It was 
not possible to assess whether program effects had 
accumulated during the seventh and eighth grades. 
Results for ethnic subgroups were consistent with these 
overall results but were not always statistically signifi­
cant. Similar effects for ninth graders were obtained 
for weekly cigarette smoking and for smokeless to­
bacco use. Assessments of cigarette refusal skills 
among students receiving and not receiving the pro­
gram indicated that the program had positive effects 
on this mediator of smoking initiation at the end of 
the seventh grade but not subsequently (Elder et al. 
1993a, 1994b). As was found with Project TNT, the 
results of the SHOUT program did not in general sup­
port a strong link between refusal skills and smoking 
behavior.  In an extension of this program, newslet­
ters and supportive telephone calls were offered again 
in 11th grade to a subset of the original intervention 
group.  Results of an additional follow-up survey 
suggested positive effects of providing continued 
smoking avoidance support to students throughout the 
secondary school years (Eckhardt et al. 1997). 
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Longer-Term Follow-Up of 
School-Based Programs 
The preceding group of studies did not address 
whether the observed prevention effects were perma­
nent or whether they simply represented delays in 
smoking initiation from middle school to later high 
school years. Because few people begin smoking 
after high school, programs that prevent young people 
from smoking throughout the high school years are 
likely to prevent young people from ever becoming 
regular smokers. 
Several studies of school-based programs to pre­
vent smoking have followed participating students 
into the later years of high school to assess the dura­
bility of effects several years after the programs were 
implemented. 
Life Skills Training Program 
The Life Skills Training (LST) Program was 
designed to help adolescents develop a wide spectrum 
of personal and social skills, including those related 
to preventing cigarette smoking and the use of alco­
hol and other drugs (Botvin et al. 1990a).  The core 
program consists of 12 curriculum units designed to 
be taught in 15 class periods to seventh graders. The 
problem-specific components of the LST Program are 
similar to those included in smoking prevention pro­
grams focused more directly on the social influences 
model. These components include offering practice 
in assertively resisting peer pressure to smoke and 
providing information about the negative short-term 
social consequences of cigarette use, the decreasing 
social acceptability of use, and the actual prevalence 
of use among adolescents and adults. Other program 
components address the development of generic per­
sonal and social competencies, such as communica­
tion skills and ways to develop personal relationships. 
One of the notable strengths of this program is 
the relatively large number of separate trials reported 
by the investigators. The largest trial was conducted 
among students attending 56 suburban and rural 
schools in three geographic regions of New York 
(Botvin et al. 1990a). Students in 34 schools received 
the smoking prevention program, and students from 
the remaining schools did not.  The smoking preven­
tion program included the full 15-session LST Program 
in the seventh grade, followed by a 10-session booster 
program in the eighth grade and a 5-session booster 
in the ninth grade. These programs were delivered 
by the students’ usual classroom teachers, who had 
been trained either through group workshops followed 
Reducing Tobacco Use 
by monitoring, feedback, and reinforcement of imple­
mentation procedures or through use of a training 
videotape. This study thus tested whether program 
effectiveness could be maintained while using low-cost 
methods for disseminating the program to large num­
bers of schools, teachers, and students. 
Analyses of reports from the 4,466 students sur­
veyed at the end of the ninth grade (75 percent of the 
original cohort) showed that the prevalence of ciga­
rette smoking was significantly lower among students 
who had received the LST Program than among those 
who had not. The relative difference in the smoking 
scores was about 10 percent.  Results were similar for 
both teacher training conditions. The analyses indi­
cated that most of the knowledge, attitude, and skill 
variables that were targeted as mediators of effects 
showed significant changes consistent with program 
objectives. Program recipients also had significantly 
lower levels of marijuana use and alcohol intoxication. 
In a long-term follow-up of the LST Program, data 
were collected from school, telephone, and mailed 
surveys administered six years after the initial 56 pub­
lic schools had been randomized to treatment and 
control conditions (Botvin et al. 1995).  The 3,597 pre­
dominantly white, 12th-grade students sampled repre­
sented 60.4 percent of the initial 7th-grade sample. 
Among all students included in the 12th-grade 
follow-up, weekly cigarette smoking was reported by 
about 22 percent of those receiving the intervention and 
by 27 percent of those in the comparison condition, rep­
resenting an 18-percent relative reduction in smoking 
prevalence.  For the subset of students receiving a rea­
sonably complete version of the program, the relative 
reduction in smoking prevalence was 26 percent.  The 
study is unique in demonstrating effects of a preven­
tion program that lasted through high school.  The 
generalizability of these results to other populations and 
school settings is an important area for exploration. 
Similar support for the effectiveness of the 
LST Program has been obtained from shorter-term 
studies of variations in implementation procedures 
and study populations. These studies have provided 
evidence for the effectiveness of booster sessions after 
the initial program delivery (Botvin et al. 1983) and 
have compared the use of peers and teachers as pro­
gram facilitators (Botvin et al. 1990b). Other studies 
have replicated the short-term effectiveness of the pro­
gram with African American and Hispanic adolescents 
(Botvin et al. 1989a,b, 1992). Components of the pro­
gram also appear to have had positive effects when 
implemented outside the context of a research project 
(Bruvold 1990). These multiple tests of one approach 
to school-based smoking prevention provide a 
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well-rounded picture of the potential effectiveness of 
various approaches.  The results also demonstrate that 
relatively intensive programs that address the core 
objectives of the social influences model in the context 
of a larger curriculum can reduce smoking prevalence 
in diverse target populations and school settings when 
the curriculum maintains a reasonable level of integ­
rity to the program design. 
Minnesota Smoking Prevention Program 
Two replications of a smoking prevention pro­
gram based on the social influences model were com­
bined into a single study of long-term effects, the 
Minnesota Smoking Prevention Program (Arkin et al. 
1981; Murray et al. 1984). The core program contained 
units that identified social pressures to smoke, offered 
practice in skills to resist direct social pressures, pro­
vided information about actual levels of smoking 
among peers and adults, and provided information 
about the negative short-term social and physiologi­
cal consequences of smoking. These objectives were 
addressed in five class periods delivered throughout 
the seventh grade; no additional educational compo­
nents were offered in later grades.  Both replications 
of the program compared the relative effectiveness of 
same-age peer leaders and adult leaders. 
The two studies included 7,030 seventh-grade 
students participating in baseline surveys in 18 sub­
urban Minnesota schools. In the first study, students 
received a social influences program led by adults 
or by peers or received an adult-led program of simi­
lar length on the long-term health consequences of 
smoking. In the second study, conducted a year later, 
seventh-grade students from the same 18 schools 
received the adult-led or peer-led social influences pro­
gram, the adult-led health consequences program, or 
no specific smoking prevention program. 
Results from the first study indicated that among 
students who were nonsmokers at the start of seventh 
grade, those who received the peer-led smoking pre­
vention program were significantly less likely than 
those who received the adult-led programs to have 
tried smoking by the end of the eighth grade; similar 
results were seen for students who at the start had al­
ready tried smoking (Murray et al. 1984). Results from 
the second study indicated that at the end of the eighth 
grade, students who were initially nonsmokers and 
who received any of the test programs were signifi­
cantly less likely than similar students from the schools 
receiving no program to have tried smoking (Murray 
et al. 1987). In the first study, differences among treat­
ment groups had diminished by the ninth grade and 
were not statistically significant.  In the second study, 
students who had initially tried smoking and who 
received the peer-led programs had a significantly 
lower smoking prevalence than students receiving the 
adult-led health consequences program (Murray et al. 
1987). Modest effects of a peer-led program were 
detected in an 11th-grade follow-up conducted for the 
second study (Murray et al. 1988). 
The investigators surveyed members of the origi­
nal study cohorts when the first study participants 
were one year beyond high school and the second 
study participants were in the 12th grade (Murray et 
al. 1989). Those still attending school in their original 
districts participated in a classroom survey, and oth­
ers were interviewed by telephone; participation ex­
ceeded 90 percent in both studies.  Responses indicated 
that the programs had no lasting differential effects 
on smoking behavior. 
Waterloo Smoking Projects 
The Waterloo Smoking Projects (WSP) in Canada 
tested a social influences program designed to follow 
students from the sixth through eighth grades.  The 
program included three main components common 
to social influences curricula (Best et al. 1984). The 
first component provided information on negative 
consequences of smoking, on smoking prevalences in 
the general population, and on social influences to 
smoke. The second component provided practice in 
skills to resist direct social pressures to smoke.  The 
third component focused on decision making and 
public commitment to not smoke. These topics were 
delivered in six sessions during the first three months 
of the sixth grade. Information about social influences 
was reviewed in two booster sessions later in the sixth 
grade. Two additional booster sessions in the seventh 
grade and one in the eighth grade featured student 
presentations and discussions about smoking pres­
sures and decisions. All sessions were presented by 
graduate students who were members of the project 
staff. 
The evaluation design for this study provided 
methodologically stronger evidence for potential 
longer-term effects than previous follow-up studies of 
school-based programs.  The WSP was tested with stu­
dents from 22 schools in two school districts in south­
western Ontario (Flay et al. 1985). Students from half 
the schools received the program, and students from 
the other half did not. The schools were located in 
urban, suburban, and rural areas.  The study sample 
included 654 students tested at the sixth-grade baseline 
classroom survey. 
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At the end of the seventh grade, 18 months after 
the baseline survey, results were reported for the 498 
students (76 percent) who had been present for all 
cross-sectional analyses at each time point. The analy­
ses showed reduced experimentation with smoking 
in the entire target population receiving the program 
and reduced consumption among students who were 
regular smokers before involvement in the program 
(Flay et al. 1985). Longitudinal analyses showed 
significantly less smoking among program recipients 
who had already tried smoking before starting the 
program. Psychosocial mediators, such as knowledge 
and perceived control, showed changes throughout the 
target population that were consistent with program 
objectives (Flay et al. 1983). 
Results at the end of the eighth grade were re­
ported for the 439 students (67 percent) who had par­
ticipated in all six school surveys administered through 
that time (Best et al. 1984). These analyses indicated 
that the program significantly reduced the amount of 
experimental smoking among the subgroup that at the 
baseline survey had reported never smoking.  Effects 
that had been detected at the end of the seventh grade 
among students with more smoking experience were 
still apparent but no longer statistically significant. 
The project surveyed original cohort members at 
the 12th grade by classroom survey, mailed question­
naire, and telephone interview.  This effort yielded 
long-term follow-up data for 560 members (86 percent) 
of the original study cohort (Flay et al. 1989). There 
were no program effects at the 12th grade for any 
smoking level in the overall study sample or for any 
subgroups defined by initial level of risk. 
Project ALERT 
The Adolescent Learning Experiences in Resis­
tance Training (ALERT) school program was based on 
a social influences model that included many features 
common to this type of program (Ellickson et al. 1993a). 
The overall goal was to provide young people with 
the motivation and skills needed to avoid substance 
use, including alcohol and marijuana as well as 
cigarettes.  The motivational component focused on 
reducing barriers to resisting social pressures, such as 
normative beliefs that most young people and adults 
smoke, that this behavior is widely acceptable and 
approved, and that smoking has positive physical and 
social consequences. The skill component focused on 
practicing skills to resist direct social pressures to 
smoke. Eight sessions covering these objectives were 
delivered one week apart during the seventh grade; 
three booster sessions reviewed the main points dur­
ing the eighth grade. 
This program was tested with students from 30 
schools in eight school districts located in urban, sub­
urban, and rural communities of California and Oregon 
(Ellickson and Bell 1990). In the initial school survey, 
about 33 percent of these students were from minority 
ethnic groups.  Students in 20 schools received the 
ALERT curriculum, and students in the other 10 schools 
did not. In 10 of the program schools, the curriculum 
was delivered by classroom teachers alone; in the other 
10 program schools, teachers were assisted by older 
peer leaders recruited from nearby high schools. 
The initial assessment of this program was re­
ported for follow-up school surveys completed 15 
months after the baseline survey.  After substantial 
follow-up effort, about 60 percent of the baseline co­
hort of 6,527 students were included in these reports 
(Ellickson and Bell 1990). Among students in the treat­
ment group who had experimented with smoking be­
fore the program, smoking was reduced by about 20 
percent.  Among students who had never smoked, 
however, the program did not achieve a statistically 
significant reduction.  Psychosocial risk factors tar­
geted by the program, including beliefs about the con­
sequences of use and perceived norms for cigarette 
smoking, showed changes consistent with program 
objectives (Ellickson et al. 1993a). These findings were 
generally consistent across school districts in various 
geographic regions with differing ethnic and socioeco­
nomic profiles; the results were not affected by whether 
an older peer assisted in delivering the program. 
An additional follow-up of these students was 
reported at the ninth grade, two years after the baseline 
survey (Bell et al. 1993). These analyses included about 
75 percent of the baseline sample.  Earlier effects on 
psychosocial risk factors persisted, but program effects 
on cigarette smoking and other substance use behav­
iors had disappeared at this time (one year after the 
end of the program). 
A final follow-up survey was completed in the 
12th grade, five years after the baseline survey and 
four years after completion of the program; 57 percent 
of the baseline sample were included in these analy­
ses (Ellickson et al. 1993b). By the end of high school, 
the program had no detectable effect on cigarette smok­
ing or other substance use behaviors; most program 
effects on cognitive risk factors had also disappeared 
by this time. Similar to the other longer-term follow-
up studies, these outcomes indicated that program 
effects eroded rapidly when the program ended and 
that no effects on smoking behavior or related beliefs 
were detectable at a later time. 
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Summary of Recent School-Based 
Research Studies 
These reports reflect a high level of consistency 
in approaches taken to prevent smoking initiation and 
in the results obtained.  All studies used some form of 
multiple-session school curriculum that was based on 
the social influences model and was delivered through 
classroom activities beginning in the sixth or seventh 
grade; all included a similar set of core curriculum 
components; and all reported achieving significant 
differences in smoking behaviors for one year or more 
after the program was initiated.  For most programs, 
significant differences were reported through the ninth 
grade (the first year of high school and more than two 
years after program initiation). 
Some specific features of these results strengthen 
the case for the effectiveness of school-based social 
influences curricula. The magnitude and scope of the 
effects achieved across studies were generally more 
impressive than those reported by earlier studies.  The 
size of the reduction in smoking achieved at the eighth 
and ninth grades and the duration of these effects were 
larger than those of the short-term follow-up studies. 
Most of these studies also reported substantial effects 
on theory-based psychosocial mediators of cigarette 
smoking that were targeted for change by the pro­
grams, such as relevant knowledge, attitudes, skills, 
and perceived norms. These results thus indicated 
important and persistent effects (at least for several 
years) across a wide range of outcomes anticipated by 
the theoretical approach.  As discussed later in this 
section, however, the effects did not persist in the 
longer term. 
Programs that were successful in achieving pre­
vention effects through the ninth grade tended to in­
clude a larger number of educational contacts with 
students over a longer time period than most earlier 
programs.  For example, Project ALERT included 11 
class sessions over two years; SHOUT included 18 class 
sessions, four telephone contacts, and five newsletters 
over three years; the LST Program included 30 class 
sessions over three grades; and the KYB program in­
cluded an even larger number of class sessions over 
six school years. These relatively intensive programs 
successfully deterred young people from smoking 
cigarettes and using other substances during the peri­
ods that these curricula were provided.  Comparable 
programs with smaller numbers of contacts over a 
more limited time have reported achieving a less sus­
tained effect on smoking initiation (Biglan et al. 1987; 
Ary et al. 1990). These observations suggest a dose-
response relationship between how much the students 
are exposed to the social influences program and how 
effective the program is in preventing students from 
smoking. These results suggest that larger numbers 
of educational contacts over a longer period of time 
may yield larger and more enduring smoking preven­
tion effects.  This conclusion is strongly supported by 
the long-term reductions in cigarette smoking preva­
lence achieved by the relatively intensive LST Program. 
The results were also obtained within a wide 
range of curriculum formats. Some of the recent so­
cial influences programs have tried to reduce the 
prevalence of several substance use behaviors often 
linked in the behavioral development of young people. 
These programs have included efforts within the same 
curriculum to prevent the use of smokeless tobacco, 
marijuana, and alcohol, as well as cigarettes.  Includ­
ing several substances in the program objectives, as 
might often be the case in ordinary school programs 
to prevent substance abuse, does not appear to have 
reduced the potential effectiveness of these programs 
in reducing cigarette smoking.  In several cases, the 
positive effects on smoking behavior were also ob­
served for other substance use behaviors. Similarly, 
social influences programs have been successful in 
diminishing smoking behavior when they have been 
incorporated in a larger health education program that 
successfully addressed other health behaviors, such as 
diet and physical activity.  The success of programs 
under this broad diversity of curriculum formats in­
creases confidence in the theoretical relevance and 
generalizability of this approach. 
These studies also tested the social influences 
model under various implementation conditions. 
Successful programs were reported from a diverse 
group of geographic areas and with urban, suburban, 
and rural populations.  A much wider mix of ethnic 
student populations has been involved in these than 
in earlier studies. Some studies reviewed here have 
reported favorable program effects for African Ameri­
can and Hispanic adolescents; similar programs have 
demonstrated positive effects for American Indian 
adolescents (Schinke et al. 1988, 1994; Moncher and 
Schinke 1994). Successful programs also used various 
personnel to deliver the programs.  These included 
programs delivered by students’ usual classroom 
teachers with or without intensive training, programs 
delivered with and without the assistance of peer lead­
ers, programs delivered by college undergraduate or 
graduate students, and programs delivered by profes­
sional staff members of the research team.  These 
diverse characteristics of successful programs further 
support the generalizability of the social influences 
model. 
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The more recent studies can be interpreted with 
much greater confidence than was possible with the 
pioneering studies reviewed a decade ago because 
of improvements in study design, measurement, and 
data analysis methods. Internal validity has been im­
proved by including larger numbers of schools and 
students in study samples to enable investigators to 
account for school-level effects on smoking behavior 
(Murray and Hannan 1990). This approach also has 
improved external validity by providing for tests of 
programs with more diverse populations and placing 
program activities farther from the direct control of 
the chief investigators. In general, these reports have 
thus provided stronger demonstrations than were pre­
viously available of the benefits of social influences 
programs over other school health education programs 
for preventing smoking. The reports also provide 
greater assurances that the results obtained could be 
achieved in many types of classrooms if this curricu­
lum approach was implemented with a reasonable 
level of fidelity. 
The primary limitation of this promising record 
of success is its generally short-lived nature.  Three of 
the studies that followed participants through the 12th 
grade consistently found that effects had faded over 
the high school years. The fourth, the LST Program, 
demonstrated a statistically significant impact through 
the 12th grade (Botvin et al. 1995). Thus, although the 
majority of programs based on the social influences 
model did not permanently protect young people from 
pressures or desire to begin smoking, the evidence 
shows that all of these programs successfully delayed 
this initiation for several years and that the most in­
tensive of these programs reduced smoking prevalence 
through the end of high school. These results demon­
strate that larger-scale implementation of intensive in­
terventions based on this model can achieve long-term 
reductions in cigarette smoking among young people. 
Further suggestions for overcoming this duration 
limitation may be drawn from these recent school-
based studies. The studies provide evidence not only 
for the importance of overall program intensity, or the 
amount of exposure to the program (discussed earlier), 
but also for the effectiveness of programs that target a 
relatively broad array of educational modalities for 
smoking prevention.  The LST Program addresses a 
spectrum of developmental concerns in addition to 
using a core unit on resistance to social influences that 
promote smoking; this curriculum has been shown to 
be effective with a wide range of populations.  The 
KYB program achieved smoking prevention effects 
with a curriculum that was embedded in a larger 
program to change health behaviors.  The SHOUT 
program included classroom-based community action 
and advocacy components in addition to conventional 
units based directly on the social influences model. 
Such broader approaches within school settings thus 
seem to be effective in addressing the diversity of 
smoking prevention needs among adolescents. 
This perspective receives additional support from 
a series of studies that have tried to identify more pre­
cisely the strengths of the social influences model by 
testing main components separately.  The design of 
the Project TNT program evaluation provided a direct 
comparison between the effects of four curricula 
focused on skills training for resisting peer pressures, 
on social norms about the prevalence and acceptabil­
ity of smoking, on knowledge of the negative conse­
quences of smoking, or on a combination of the three 
elements. Contrary to theory-based expectations, the 
social skills curriculum did not perform as well as 
the social norms or negative consequences curriculum; 
the combined curriculum had the best results (Sussman 
et al. 1993b). A similar study found that a curriculum 
based on correcting erroneous normative perceptions 
was more effective than a curriculum on training in 
resistance skills; the results also suggested that a com­
bined curriculum addressing a variety of educational 
needs about social influences on smoking was more 
effective than curricula focused on individual compo­
nents of the model (Hansen and Graham 1991). 
These studies thus indicate that attempts to 
reduce the scope of smoking prevention programs 
to skills training alone are likely to be ineffective.  Al­
though school programs are well suited to provide 
skills training through direct modeling and practice, 
as well as to convey knowledge about the conse­
quences of smoking, they may not be as well equipped 
to influence young people’s perceptions of the preva­
lence and acceptability of cigarette smoking among 
their wider peer group and adult society.  As is 
discussed in the next section, more complex and 
intensive programs combining interventions within 
and outside of schools may be needed to overcome 
the powerful prosmoking cultural images fostered by 
the larger social environment. 
Research on Multifaceted Programs 
Another group of recent studies has expanded 
the traditional school-based scope of educational 
methods to prevent smoking.  To counteract the 
multiple sources of social influences that promote 
smoking initiation, these projects enlist the positive 
influences of parents, community organizations, 
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and the mass media in addition to offering strong 
school programs based on the social influences model. 
Relatively few examples of this new direction for 
smoking prevention efforts have been reported.  Edu­
cational objectives for these programs have generally 
been developed directly from programs that have 
school-based components only, but specific strategies 
reflect various approaches, as might be expected when 
new techniques are being developed.  Results provide 
good evidence that these multifaceted educational 
programs can achieve substantial smoking prevention 
effects that persist throughout the high school years 
more consistently than programs based only in schools. 
Minnesota Heart Health Program: 
Class of 1989 Study 
The Class of 1989 Study of the Minnesota Heart 
Health Program (MHHP) tested the efficacy of a school-
based smoking prevention program conducted in the 
context of a wide range of associated school and 
community programs designed to improve health 
behaviors. These programs focused collectively on the 
overall goal of reducing the risk of cardiovascular dis­
ease among the adults of the targeted communities 
(Perry et al. 1992). 
Smoking prevention programs were provided in 
the seventh through ninth grades. The main compo­
nent of this multifaceted effort was based on the Min­
nesota Smoking Prevention Program (discussed in the 
previous section), which was one of the early success­
ful designs for a social influences program (Perry and 
Jessor 1985). The Class of 1989 Study used a seven-
session program delivered in weekly sessions during 
the seventh grade by peer leaders assisted by teachers 
(Perry et al. 1986). This program was followed by a 
two-session unit in the eighth grade that addressed 
smoking and exercise and by an eight-session unit in 
the ninth grade to prevent smoking and drug abuse. 
Similar curriculum units on eating and exercise behav­
iors were added to the school curriculum after the 
smoking prevention unit in the seventh grade (Perry 
et al. 1988). 
These classroom components were supported in 
school by the development of health councils through 
which students participated in other projects related 
to the overall community program theme of cardio­
vascular risk reduction. Altogether, the students in 
the Class of 1989 Study participated in five years of 
educational programs that were provided through 
their schools and were focused on smoking and other 
health behaviors. 
The school-based educational components were 
complemented and supported over the entire program 
period by community education and organization 
activities intended to reduce three cardiovascular risk 
factors—cigarette smoking, high levels of serum cho­
lesterol, and elevated blood pressure—in adults of the 
targeted communities (Mittelmark et al. 1986; Perry et 
al. 1992; Luepker et al. 1994). The activities included 
individual risk factor screening and education, which 
was received by more than 60 percent of all adults; 
direct education sessions that were conducted in vari­
ous community settings, which engaged more than 30 
percent of all adults; food labeling education in gro­
cery stores and restaurants; intensive mass media edu­
cation; continued education of health professionals; 
and community organization to engage citizens, health 
professionals, and community leaders in developing 
and carrying out annual community education plans. 
Although the MHHP did not demonstrate a significant 
impact on adults (Luepker et al. 1994), a set curriculum 
and face-to-face training were found to increase the 
participation of teachers (Perry et al. 1990a). 
The effect of these interventions on the smoking 
behavior of the targeted students was assessed through 
an evaluation design in which students from one com­
munity received these direct and indirect interventions 
and students from a matching community did not 
(Perry et al. 1992). At baseline, the target population 
consisted of all sixth graders attending the 13 elemen­
tary schools in these two communities. Longitudinal 
analyses at each annual follow-up considered students 
who had been present since the baseline surveys.  The 
12th-grade survey included 45 percent of the original 
cohort of 2,401 students. Cross-sectional analyses in­
cluded all students participating in each survey. 
Cohort analyses comparing weekly smoking 
prevalence and amount of smoking showed that 
students in the two communities did not differ sig­
nificantly at the sixth-grade survey, which was admin­
istered before exposure to any substantial amount of 
program activities. Significant differences appeared at 
the seventh-grade survey, which was administered af­
ter completion of the core components of the smoking 
prevention program.  Weekly smoking prevalence was 
about 40 percent lower in the treatment community co­
hort. Similar effects were found in the cross-sectional 
analyses. These significant differences were maintained 
through the 12th-grade survey, three years after the 
end of direct smoking prevention education and one 
year after the end of general community education. 
This study was one of the first demonstrations 
in the United States that the effects of educational 
programs to prevent smoking could be maintained 
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through late adolescence—and thus, theoretically, 
through life.  Longer-term community programs sup­
porting these school-based components appeared to 
play a key role in maintaining positive effects. 
Midwestern Prevention Project 
The Midwestern Prevention Project (MPP), 
a three-year school-based program for preventing 
substance use, was supported by several community 
interventions explicitly designed for this purpose 
(Pentz et al. 1989a). The school program consisted 
of 10 classroom sessions in the sixth or seventh grade 
(depending on the year of transition into middle 
school) and is the same as that reported by Hansen 
and Graham (1991). These sessions emphasized the 
negative consequences of cigarette, alcohol, and mari­
juana use; corrected misperceptions on actual levels 
of use among peers and adults; discussed direct and 
indirect pressures to use substances; practiced skills 
to resist pressures for substance use; and obtained 
public commitments to avoid substance use. These 
activities were presented by classroom teachers with 
the assistance of peer leaders. Ten homework sessions 
that involved parents’ participation accompanied the 
school program.  These sessions emphasized clarify­
ing family rules on substance use, practicing tech­
niques for avoiding substance use, and learning ways 
to counteract media and community influences to use 
substances. The mass media component of this pro­
gram occurred throughout all three years of program 
effort and was equally available to program and con­
trol group students.  Media messages focused on news 
coverage of program activities through newspaper 
articles, brief television news segments, and radio and 
television talk show interviews with project staff. 
During the second year of the program (occur­
ring in either the seventh or the eighth grade) for the 
target cohort, a five-session classroom booster program 
was combined with homework designed to keep par­
ents actively engaged in prevention efforts (Pentz et 
al. 1989b). School administrators, parents, and stu­
dents also planned and presented a parent education 
evening featuring communication skills and school 
policies on substance use (Rohrbach et al. 1995). Dur­
ing the third year of the program, community leaders 
received training in organizing task forces to prevent 
substance use. This program component, like the 
media component, was equally capable of influencing 
students in the program or the control group (Johnson 
et al. 1990). 
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The overall program was tested in 42 schools 
from eight communities in the Kansas City metropoli­
tan area.  About 21 percent of the students from these 
sixth- and seventh-grade target groups were from mi­
nority ethnic groups.  Students from the target grades 
in these schools were assigned to the school and par­
ent components (24 schools) or to a delayed-treatment 
control condition (18 schools).  All students and par­
ents were exposed to the mass media components 
and were potentially exposed to the effects of the com­
munity organization component beginning with the 
third program year.  Effects were evaluated by using a 
one-third sample of the large sixth- and seventh-grade 
target group.  This study sample was obtained through 
baseline surveys of all targeted students in 16 schools 
and through a one-fourth sample from the remaining 
schools (total n = 5,065). 
Follow-up surveys combined sequential cross-
sectional surveys, including all students present at a 
survey point, and longitudinal surveys of a subset of 
baseline cohort members. The one-year follow-up 
sample included 5,008 members of the target popula­
tion, who were then in the seventh and eighth grades. 
Monthly cigarette use was about 32 percent lower 
among students who had received the combined 
school, parent, and mass media programs than among 
students who had received the mass media informa­
tion only.  Similar effects were observed among the 
subset of students tracked longitudinally (Dwyer et 
al. 1989). 
Additional classroom surveys were completed 
with 3,875 students two years after baseline, when the 
students were in the eighth and ninth grades (Pentz et 
al. 1989b). Significant program effects on monthly and 
weekly smoking prevalence were maintained from the 
one-year follow-up, although the magnitude of the dif­
ferences between program and control students was 
smaller.  Similar results were obtained from the panel 
of students measured longitudinally (Pentz et al. 1989c). 
The longitudinal panel from the original sample 
was followed up into the 9th and 10th grades (Johnson 
et al. 1990). The baseline sample included 1,607 sixth-
and seventh-grade students, of whom 1,105 (69 per­
cent) provided complete data at both baseline and the 
three-year follow-up.  Analyses indicated a significant 
treatment effect for monthly cigarette smoking.  Stu­
dents receiving the entire program reported about 
19 percent less monthly smoking than students who 
received only the mass media and community organi­
zation components. 
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University of Vermont School and 
Mass Media Project 
The University of Vermont School and Mass 
Media Project (VSMM) evaluated the effects of supple­
menting a school-based smoking prevention curricu­
lum with intensive mass media campaigns carefully 
targeted to the needs of adolescents.  Both the school 
and the mass media programs shared a set of objec­
tives consistent with the social influences model. These 
common objectives stated that adolescents exposed to 
the programs would perceive fewer advantages of 
smoking, perceive more disadvantages of smoking, 
acquire social skills to resist peer pressures to smoke, 
and perceive that most people their age do not smoke 
(Worden et al. 1988).  Other objectives concerned with 
smoking cessation and awareness of tobacco industry 
marketing to young people were introduced as the tar­
get group matured. 
The school program included grade-specific 
lesson plans and teaching materials, and classroom 
teachers received annual training.  Curriculum con­
tent covered key elements of the social influences 
model, such as short-term social and health conse­
quences, awareness of social pressures to smoke, skills 
for coping with peer pressures and other social pres­
sures, and decision-making skills related to smoking 
behavior (Flynn et al. 1995). The three-grade study 
cohort received this program for four years, in either 
the 5th–8th grades, 6th–9th grades, or 7th–10th grades. 
The program required four class sessions for the units 
in the 5th–8th grades and three class sessions for the 
units in the 9th and 10th grades. 
The mass media campaigns used the common 
objectives and data from high-risk young people in six 
predefined age and sex groups.  High-risk students 
were defined as those who had previous smoking 
experience or who knew at least two people in their 
immediate social environment who smoked, such as 
parents, siblings, or friends.  High-risk girls and boys 
from three age groups participated in diagnostic re­
search activities on two occasions during the study to 
provide information needed to tailor the mass media 
campaign to their needs (Worden et al. 1988).  These 
data were used to develop pilot mass media spots, which 
were assessed by small samples of high-risk students. 
Mass media advertisements that clearly ad­
dressed the common educational objectives and were 
attractive to their intended target groups were pro­
duced for broadcast as 30- and 60-second television 
and radio spots. Spots targeted to the six specific 
target groups were broadcast on programs that school 
survey data had indicated were popular among these 
groups; 36 television and 17 radio spots were pro­
duced. An average of 190 television broadcasts, 350 
cable television broadcasts, and 350 radio broadcasts 
of these spots was purchased per year for four years 
in each target community. 
The evaluation design included four geographi­
cally separate but demographically matched metro­
politan areas from three states (Flynn et al. 1992). 
Students in two communities received the mass me­
dia and school programs for four years.  Students in 
the other two communities received only the school 
programs during these four years.  The initial cohort 
included all students from the fourth through sixth 
grades from 50 elementary and middle schools; more 
than 99 percent of these students (n = 5,458) partici­
pated in the first school survey.  Interventions and 
annual follow-up surveys were conducted for the next 
four years, beginning at the 5th–7th grades in the 1985– 
1986 school year and ending at the 8th–10th grades. A 
classroom and telephone follow-up survey attempted 
to reach all original cohort members during the 10th– 
12th grades. 
Results after four years of the program concen­
trated on the 47 percent of the original cohort who were 
fully exposed to the program components (n = 2,540). 
These analyses indicated that significant hypothesized 
differences in mediators of program effects occurred 
in the media-school communities beginning at the end 
of the second program year and that the amount and 
prevalence of cigarette smoking were significantly 
reduced at the beginning of the third program year 
(Flynn et al. 1992; Worden et al. 1996).  By the end of 
the four-year program period, alternative measures of 
smoking prevalence and intensity indicated that stu­
dents in the media-school communities reported 
34–41 percent less smoking than students in the school-
only communities. Two years later, when the study 
cohort was in the 10th–12th grades, differences 
between smoking prevalences in the two groups con­
tinued to be statistically significant and of similar mag­
nitude (Flynn et al. 1994). Among students who were 
at high risk for smoking in grades 4–6, further analy­
ses showed that these interventions produced signifi­
cant differences in weekly smoking prevalence at 
grades 10–12 (Flynn et al. 1997). Cost-effectiveness 
analyses indicated that the cost per student smoker 
averted as a result of these interventions was about 
$754 in 1996 dollars, and the cost per life year gained 
was about $696 (Secker-Walker et al. 1997). 
These findings show that carefully targeted mass 
media campaigns can add to school programs a sub­
stantial and enduring effect on smoking prevention 
when the program efforts are sufficiently intensive 
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and the educational objectives for these two channels 
are closely coordinated. These interventions did not 
include a substantial program component directed to­
ward parents or other adults in the community.  The 
results provide powerful evidence of the influence of 
mass media messages on health behavior decisions 
made by young people. 
Observations on Research on 
Multifaceted Educational Programs 
These studies are notable because they all repre­
sent efforts to extend the impact of school programs 
by enlisting the influence, preferably throughout ado­
lescence, of other powerful forces in the lives of young 
people and because their effects more consistently ex­
ceed those achieved by programs involving only the 
school (Table 3.1).  This notion has added importance 
in view of the competition for curricular time within 
schools. The studies that were able to follow up study 
participants into the later high school years have pro­
vided the best evidence thus far that program effects 
can be extended when educational or other preven­
tion strategies include multiple components and take 
place over longer terms. Because few people begin 
smoking after high school, these results suggest that 
long-term multifaceted programs can prevent signifi­
cant proportions of young people from smoking not 
only during their junior and senior high school years 
but also for the rest of their lives. 
The interventions used in these three studies 
were based on a common core of approaches.  The main 
shared theme was that a strong school program was 
necessary to achieve substantial effects.  The school 
component of the MHHP included 17 class sessions 
explicitly directed toward smoking prevention objec­
tives over three school years; the MPP school program 
included 15 class sessions over two school years, as 
well as other school-based student activities; and the 
VSMM included 14–16 class sessions over four school 
years. The intensity of these school programs was simi­
lar to the intensity of successful school-only programs 
and approached that recommended by experts (Glynn 
1989; CDC 1994b). A related theme was use of the so­
cial influences model in designing programs.  The re­
search groups that developed the MHHP and the 
MPP included investigators who were key contribu­
tors to the development of this model for school-based 
programs.  The design of the VSMM program compo­
nents also closely followed this model. 
The third shared theme for these studies was their 
focus on entire communities.  The MHHP was pro­
vided to, and evaluated in, all schools in a single 
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moderate-sized community and was supported by 
communitywide mass media and organizational pro­
grams. Some components of the MPP were provided 
to students, parents, and community members in an 
entire large metropolitan area.  The VSMM was pro­
vided to adolescents in two entire moderate-size 
metropolitan areas, and the same large groups were 
the focus of targeted media campaigns. The educa­
tional messages of the school-only programs, in con­
trast, generally did not reach beyond the walls of the 
selected school. Directing messages to entire commu­
nities of adults and adolescents may have increased 
the capacity of multifaceted studies to influence ado­
lescents’ normative perceptions of the prevalence and 
acceptability of cigarette smoking. 
The importance of the school component was 
emphasized by results of a study conducted within 
the context of the Stanford Five-City Project.  This 
study shared with the MHHP the goal of reducing car­
diovascular risk factors in entire adult populations and 
shared many features of the programs for adults 
(Farquhar et al. 1990).  The adolescent smoking 
feature of this study assessed whether reductions in 
cigarette smoking among adults (Fortmann et al. 1993) 
were reflected among adolescents.  A seven-session 
smoking prevention program was provided to ado­
lescents in 7th and 8th grades during the fourth pro­
gram year (Telch et al. 1982; Winkleby et al. 1993), and 
a four-session cessation unit was provided to half of 
the 10th-grade classes (Killen et al. 1988). The effect of 
this combination of programs was assessed through 
cross-sectional population surveys conducted over a 
10-year period. No statistically significant differences 
in smoking prevalence were detected among partici­
pants aged 12–15, 16–19, or 20–24 years. 
The duration of the community programs in the 
MHHP was one year less than that of the Stanford study. 
The school programs in the MHHP, however, were 
much more intensive and of longer duration. Although 
differences in evaluation methods preclude direct com­
parisons, results suggested that the MHHP’s substan­
tial impact on the smoking behavior of adolescents in 
the Class of 1989 Study depended on the presence of a 
strong school-based program that was enhanced by the 
supportive community environment in which it was 
conducted. The Stanford study’s lack of effects on ado­
lescents suggested that intensive, communitywide pro­
grams to reduce health risks among adults would not 
be sufficient to change adolescent smoking unless these 
programs were combined with more intensive school 
programs.  These contrasting results affirm that a strong 
school program is important to the success of educa­
tional strategies for prevention. 
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The MHHP community activities were not spe­
cifically designed as smoking prevention programs; 
they were directed toward adults and addressed sev­
eral cardiovascular risk factors in addition to smok­
ing. These efforts to reduce adolescent smoking may 
have resulted because young people were directly 
exposed to community program messages and appeals 
intended for adults, school programs had heightened 
intensity from being conducted in communities 
focused on developing healthy behaviors, or parents 
stimulated by the community programs gave greater 
attention to adolescent health behaviors. The inten­
sity, pervasiveness, and duration of the community 
program may also have affected the general norms of 
the community on health behavior, which in turn may 
have influenced young people to decide against start­
ing to smoke. 
Similar results were obtained by another youth 
smoking prevention study conducted in the context 
of pervasive community cardiovascular risk reduction 
campaigns. The North Karelia Youth Project in Fin­
land included a school program with three sessions in 
grade seven, five sessions in grade eight, and two ses­
sions in grade nine (Vartiainen et al. 1998).  Intensive 
community programs on cardiovascular risk reduction 
were conducted for adults, including community 
organization and mass communication campaigns for 
cigarette smoking cessation, during the years the 
school program was delivered.  Significant differences 
in cigarette smoking prevalence between young 
people in the intervention and comparison areas were 
found at each follow-up survey through age 21.  At 
age 28, significant differences in smoking prevalence 
were found among those who were nonsmokers at the 
baseline survey, in seventh grade.  These results pro­
vide strong support for the findings of the MHHP Class 
of 1989 Study and emphasize the potential impact on 
youth smoking of combining school and community 
programs. 
The community component of the MPP was ex­
plicitly designed to complement the school program 
to prevent substance use.  Program activities that oc­
curred outside the classroom were more focused on 
parents’ behaviors than is usually found in research 
studies on smoking prevention.  These activities in­
cluded 10 homework exercises in the first program year 
and a wide range of family norm-setting activities; 
similar exercises accompanied the second year of the 
school curriculum. Parents helped plan and present a 
parent education evening in participating schools in 
the second year and participated in community orga­
nization activities in the third year. 
The only program components to directly reach 
or involve the wider community were the media mes­
sages and community organization activities.  The 
latter component was not introduced until the third 
program year and may not have had much effect on 
students’ smoking behaviors. Because parents, then, 
were the principal focus of educational efforts outside 
the classroom, the MPP effects were likely achieved 
mainly through strong and consistent parental sup­
port of the objectives of this school-based program. 
The media messages may also have influenced ado­
lescents’ perceptions of peer, family, and community 
smoking norms. 
Results of the MPP, the MHHP, and the North 
Karelia Youth Project thus offer the possible common 
interpretation that the programs’ effects depended on 
strong school programs supported by community pro­
grams that may have affected students in two ways: 
through substantially increased efforts by parents and 
through young people’s perceiving that smoking is not 
normative. Although parental components similar to 
the MPP homework assignments have been included 
in some school-only smoking prevention programs, the 
full scope of parent-oriented efforts used by the MPP 
in support of the school curriculum has not been tested 
previously.  Further exploration of combined school 
and parent programs may be a promising avenue for 
future educational research studies.  Similarly, these 
results highlight the importance of program compo­
nents designed to influence adolescents’ normative 
perceptions. 
The VSMM shared with the MPP and the MHHP 
the general strategy of supplementing a relatively 
strong school-based smoking prevention program with 
other forms of intervention but differed in several 
respects. The combined school and mass media pro­
gram in the VSMM was directed toward the target ado­
lescents, and no adult participation was anticipated 
outside of the classroom.  The project’s resources thus 
were applied to influencing adolescents’ smoking 
behaviors directly through changes in the students’ 
beliefs, skills, and perceived norms. 
The VSMM also differed in focusing on use of 
the mass media as a sole supplement to the school pro­
gram. This design provided a reasonably clear indi­
cation that the magnitude and duration of a relatively 
strong school curriculum to prevent smoking could 
be significantly increased by a mass media component 
that concentrated exclusively on the target audience 
of adolescents. 
Three other large-scale tests of mass media ap­
proaches to smoking prevention have been reported. 
One study conducted in North Carolina tested three 
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mass media campaigns that were not combined with 
school-based programs (Bauman et al. 1988).  The 
media campaigns included radio spots on the expected 
consequences of smoking, a similar radio campaign 
that featured a smoking prevention contest, and the 
radio and contest components with television spots 
added. The messages were broadcast during three 
four-week periods at levels intended to reach 75 
percent of the target audience four times during each 
period. Each campaign was conducted in two metro­
politan areas; four other communities served as 
control areas.  Adolescents aged 12–14 years were in­
terviewed through household surveys at baseline 
(n = 2,102); 78 percent of them were followed up 11–17 
months later.  Results indicated that the campaigns had 
effects on the recipients’ knowledge of the conse­
quences of smoking and other mediators but not on 
cigarette smoking behavior (Bauman et al. 1991). 
In the Television, School, and Family Smoking 
Prevention and Cessation Project (TVSFP), Flay and 
colleagues (1988, 1995) tested a mass media supple­
ment to a school program.  The study design was 
similar to that used in the MPP.  The main study was 
conducted in a single metropolitan area.  The mass 
media component was generally available to members 
of the community, and the school program was offered 
only to members of the main treatment group.  The 
main research question thus addressed whether 
a school program combined with a mass media cam­
paign had a stronger effect than the mass media 
campaign alone. The school curriculum included 10 
classroom sessions delivered by trained health educa­
tors during the seventh grade. The media component 
included segments that ran for two months in evening 
television news shows that were linked to the class­
room sessions. Students in the main intervention con­
ditions were asked to view these segments with their 
parents and to complete related homework activities 
together.  Seventh-grade students from 47 schools par­
ticipated in the study; they were surveyed during the 
seventh, eighth, and ninth grades. Program effects 
were observed in the follow-up surveys for mediating 
variables but not for smoking behavior. 
More promising results have been reported for a 
three-year mass media campaign on youth smoking 
in Norway (Hafstad et al. 1997). This campaign used 
the novel approach of creating messages intended to 
stimulate antismoking interactions among young 
people through use of provocative messages that pre­
sented starkly negative images of adolescent smokers. 
Unlike other mass media approaches, these messages 
were presented as movie and newspaper advertise­
ments and posters, as well as through broadcast 
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media channels. Messages were broadcast or placed 
at a relatively high level of intensity over one three-
week period each year for three years.  Message themes 
were varied each year.  The impact of these campaigns 
was evaluated over three years by comparing baseline 
and follow-up survey results among a cohort of 11,033 
young people aged 14 and 15 years for one interven­
tion county and one control county.  Results showed 
that young people from the intervention county were 
less likely to start smoking and more likely to stop 
smoking at the follow-up survey.  This study demon­
strates the potential impact of relatively intensive, 
highly targeted mass media smoking prevention cam­
paigns that are not combined with any other type of 
smoking prevention intervention. 
Results of these studies using mass media as a 
primary educational strategy suggested that better 
outcomes were associated with more intensive, multi­
faceted program efforts on social influences.  The 
TVSFP intervention included a substantial school 
curriculum for the seventh grade but did not include 
further sessions in later grades. The mass media 
campaign included a maximum of 10 exposures over 
a two-month period. The North Carolina study did 
not include a direct component for interpersonal edu­
cation; the media component for this study did not 
directly address social influences on adolescent smok­
ing and was delivered over a total period of three 
months. These program efforts contrast sharply with 
the three-year Norwegian media campaign and the 14­
to 16-session school program combined with a mass 
media campaign delivered over four years in the 
VSMM. 
Because only relatively brief individual messages 
about cigarette smoking can be delivered to adoles­
cents through the mass media, it is reasonable to 
hypothesize that behavioral effects can be achieved 
only when the media spots run frequently and over 
many months. Other evidence discussed here indi­
cates that these types of media campaigns are most 
likely to be effective when combined with some form 
of coordinated interpersonal education, such as school-
based smoking prevention programs.  The VSMM 
results thus align with those of the MHHP and MPP 
in supporting the importance of school programs. The 
VSMM also directly targeted normative perceptions 
in its school and media components and demonstrated 
positive changes in these mediators of adolescents’ 
smoking behaviors. 
Several guidelines for designing future educa­
tional efforts to prevent smoking can be drawn 
from this review of three successful multifaceted 
programs.  The central role of school programs in 
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smoking prevention education was affirmed by the 
results of all three studies.  The MHHP and the MPP 
results both suggested the power of influencing ado­
lescents’ perceptions of cigarette smoking norms 
through community programs that enhance the effect 
of school programs; the MPP results demonstrated the 
effectiveness of parents’ participation as a specific strat­
egy for enhancing school prevention programs; and 
the VSMM demonstrated that long-term mass media 
campaigns targeted to adolescents’ beliefs, skills, and 
perceived norms could enhance the effect of school 
programs. 
On a cautionary note, the theoretical and dem­
onstrated ability of these programs to alter the smok­
ing behavior of young people must be viewed in 
the larger context of their practicality.  As noted 
earlier, the ability to disseminate such programs has 
been a matter of active public health engagement. The 
following section examines the current status of such 
dissemination. 
Diffusing Programs to Prevent Tobacco Use
 

In the mid-1990s, several surveys were under­
taken to assess the extent to which national guidelines 
for tobacco prevention in schools (CDC 1994b) were 
being implemented. One of these, the School Health 
Policies and Programs Study (SHPPS), queried state 
and local education districts directly about their ad­
herence to guidelines (Collins et al. 1995).  A second 
survey used health department tobacco coordinators 
as the primary information source about tobacco pre­
vention programs in schools (J.K. Worden and B.S. 
Flynn, Tobacco use prevention education in the United 
States, 1994, unpublished data, September 1995). 
National Guidelines 
According to the CDC’s “Guidelines for School 
Health Programs to Prevent Tobacco Use and Addic­
tion” (CDC 1994b), all schools should, for developmen­
tally appropriate ages, provide instruction about the 
short-term and long-term negative physiological 
and social consequences of tobacco use, about social 
influences on tobacco use, about peer norms regard­
ing tobacco use, and about refusal skills.  Local school 
districts and schools are advised to “review these con­
cepts in accordance with student needs and educa­
tional policies to determine in which grades students 
should receive particular instruction” (CDC 1994b, 
p. 9). The guidelines recommend that students in kin­
dergarten through the 12th grade receive curricula for 
preventing tobacco use.  Because tobacco use often 
begins in the 6th–8th grades (USDHHS 1994), more 
intensive instructional programs should be provided 
in these grades, and students should receive annual 
prevention education thereafter through the 12th 
grade. The guidelines also recommend that programs 
include support from families, support from commu­
nity organizations, tobacco-related policies, and adver­
tising campaigns for preventing smoking, because 
school-based efforts appear to be enhanced by comple­
mentary programs in the community.  Finally, an on­
going assessment should monitor whether an adequate 
tobacco education program is being maintained. 
School Health Policies and Programs Study 
The SHPPS survey, in a follow-up to a similar 
survey conducted by the American School Health As­
sociation in 1989, examined state-, district-, school-, and 
classroom-level data (Collins et al. 1995).  SHPPS ex­
amined specific instruction provided in six critical ar­
eas: intentional and unintentional injury, alcohol and 
other drug use, tobacco use, sexual behaviors, dietary 
patterns, and physical activity.  The education agencies 
in all 50 states and the District of Columbia, a national 
sample of 413 school districts, a national sample of 
607 middle/junior and senior high schools, and 1,040 
randomly selected health education teachers were sur­
veyed. State and district data were collected with self-
administered questionnaires mailed to the person most 
knowledgeable about or responsible for each compo­
nent of the school health program.  School and class­
room data were collected through on-site personal 
interviews with lead health education and classroom 
teachers. The multiple levels of data collection were 
necessitated by the embedded tradition of local control 
in determining educational requirements and content 
of instruction.  The data from SHPPS are most clearly 
assessed by their relationship to the CDC guidelines. 
80 Chapter 3
 

   Effective Educational Strategies 81
 
Guideline: All schools should develop and enforce a school 
policy on tobacco use. Policies should prohibit tobacco use 
by all students, staff, and visitors during school-related 
activity. 
Almost two-thirds of schools had smoke-free 
building policies in place in 1994, though significantly 
fewer (37 percent) had prohibited the use of tobacco 
products by all persons on school property, in school 
vehicles, and at school-sponsored functions away from 
the school site. Most schools (83 percent) prohibited 
tobacco use by athletes and coaches during school-
sponsored events, and most (89 percent) provided writ­
ten copies of the policy to students, staff, and parents. 
Schools were significantly more likely to have used 
exclusively punitive consequences (58 percent) in 
response to the most recent violation of their school’s 
tobacco use policy than exclusively remedial conse­
quences (2 percent) or a combination of punitive and 
remedial consequences (30 percent); few (8 percent) 
invoked attendance at a tobacco use prevention pro­
gram as remediation for violations.  Only 30 percent 
of schools offered tobacco cessation services in or 
through the school. 
Guideline:  All schools should provide tobacco prevention 
education in kindergarten through 12th grade.  The instruc­
tion should be especially intensive in middle and junior high 
school and reinforced in high school. 
In 1994, tobacco use prevention education was 
required in 37 states (72 percent) and in 83 percent of 
school districts. At the school level, 91 percent of 
middle/junior high schools and 82 percent of senior 
high schools included tobacco use prevention educa­
tion in a required course.  However, only 55 percent of 
middle/junior high school teachers and 47 percent of 
senior high school teachers of health education re­
ported tobacco use prevention as a “major” topic in 
their courses. Of the middle/junior and senior high 
school teachers who included tobacco use prevention 
education as a major topic, only 21 percent spent six 
or more class periods on the topic. 
Guideline: Schools should provide instruction about the 
immediate and long-term consequences of tobacco use, about 
social norms regarding tobacco use and the reasons why 
adolescents say they smoke, and about social influences that 
promote tobacco use.  Schools should provide behavioral skills 
for resisting social influences that promote tobacco use. 
Of the approximately 50 percent of teachers who 
taught tobacco use prevention as a major topic, 74 
percent taught both short- and long-term effects of 
cigarette smoking. Fewer (61 percent) taught both 
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short- and long-term effects associated with using 
smokeless tobacco. Although 61 percent of teachers 
addressed group attitudes (i.e., social norms) about 
tobacco use, only 42 percent taught about the actual 
amount of smoking and tobacco use among adoles­
cents and adults. Less than half (48 percent) of this 
group of teachers provided instruction about “healthy 
alternatives” to tobacco use. Sixty-eight percent in­
cluded instruction on social influences.  Most teachers 
taught behavioral and social skills, though it is unclear 
if these skills were taught specifically within the 
context of tobacco use prevention education.  For ex­
ample, 89 percent of teachers taught decision-making 
skills, 87 percent taught skills for resisting social pres­
sures, 81 percent taught communication skills, and 78 
percent taught goal-setting skills. 
Guideline: Improve curriculum implementation and 
overall program effectiveness. 
In 1994, 82 percent of states had offered in-
service training on teaching tobacco use prevention 
during the past two years. However, only 24 percent 
of school districts had offered in-service training on 
tobacco use prevention. Consequently, it is not sur­
prising that only 9 percent of teachers of health edu­
cation received training on tobacco use prevention 
education during the same time period. Although 
state-level training is typically designed for district 
staff, district-level training is the most common source 
of training for teachers. Increased training opportu­
nities for teachers are needed to improve the effective­
ness of tobacco use prevention education. 
The 1994 SHPPS data were analyzed to examine 
the extent to which U.S. schools were implementing 
the CDC’s “Guidelines for School Health Programs to 
Prevent Tobacco Use and Addiction” (Crossett et al. 
1999). Although data do not exist in SHPPS that spe­
cifically assess adherence to each of the six recom­
mended program areas, three criteria were selected 
that reflect a “comprehensive” approach to tobacco use 
prevention (Crossett et al. 1999):  (1) a tobacco-free 
policy consistent with CDC guidelines, (2) at least one 
teacher who taught tobacco as a major topic and cov­
ered four essential content areas (short-term health 
effects, groups’ attitudes toward tobacco, social influ­
ences, and life/refusal skills), and (3) access to tobacco 
cessation services for students. Only 4 percent of 
middle schools, junior high schools, and high schools 
nationwide met all three criteria.  Twenty-six percent 
met two of the three criteria, and 41 percent met one 
of the three.  More than one-fourth of schools (29 per­
cent) met none of the three criteria.  This analysis is 
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limited, because not all of the CDC guideline recom­
mendations could be measured directly by SHPPS. 
Nevertheless, these findings indicated that very few 
schools were fully implementing the CDC recommen­
dations in 1994. 
Schools are faced with many competing demands 
for instruction and classroom content.  Currently, most 
of this nation’s schools are providing students with 
some basic tobacco use prevention education. How­
ever, the recent increases in tobacco use prevalence 
among youth and the overwhelming documentation 
of the health consequences of tobacco addiction em­
phasize the need for improvement in what schools are 
doing to reduce tobacco use and nicotine addiction 
among their students, faculty, and staff. 
A State-Based Assessment 
To estimate current program activity in smoking 
prevention education across the United States, tobacco 
control coordinators in all 50 states and the District of 
Columbia were asked to participate in a survey 
(Worden and Flynn, unpublished data; unless other­
wise noted, cited data in this section are derived from 
this survey). The position of tobacco control coordina­
tor was established to oversee tobacco control and edu­
cation efforts in each state health department, through 
either the American Stop Smoking Intervention 
Study (ASSIST) program of the National Cancer 
Institute (NCI) (Shopland 1993) or the Initiatives to 
Mobilize for the Prevention and Control of Tobacco 
Use (IMPACT) program of the CDC (USDHHS 1995). 
The survey was conducted between December 1994 
and March 1995.  The tobacco control coordinators 
were asked to describe any educational programs to 
prevent tobacco use—including school, community, 
and mass media activities—that were being imple­
mented in their state during 1994 and to send writ­
ten descriptions or examples of materials used in 
these programs.  This survey differed from SHPPS in 
its primary reliance on health department rather than 
education department personnel and in the absence 
of a multilevel sampling approach.  The state-based 
survey, on the other hand, focused more on the types 
of materials used. 
Basic Curriculum 
The state-based survey determined that school 
systems were generally left to create their own tobacco 
use prevention programs or to decide which of several 
available commercial programs would be imple­
mented. Examples such as Here’s Looking At You, 
2000 or the LST Program (Bosworth and Sailes 1993; 
Glynn 1994) were mentioned by a few of the states. A 
number of states had implemented some school-based 
educational programs on tobacco use that were supple­
mental to statewide school curricula. Among the 
supplementary programs, the most popular was Teens 
As Teachers (American Nonsmokers’ Rights Founda­
tion 1994). Reported in 10 states, this program trains 
older high school youth to discuss with younger 
students the physiological and social consequences of 
tobacco use. The older youth also may convey the 
accurate norm that most young people do not use to­
bacco. Six states reported using the Tar Wars program, 
in which medical professionals discuss the conse­
quences of tobacco use with junior high school students 
(Tar Wars 1995).  Save a Sweet Heart, a program that 
emphasizes social influences on tobacco use for junior 
high school and high school youth (American Heart 
Association 1989), was reported in three states.  Spo­
radic use was reported for several other programs, in­
cluding Growing Healthy®; Teenage Health Teaching 
Modules, a version of D.A.R.E. that includes tobacco 
use prevention; the Minnesota Smoking Prevention 
Program; and a curriculum developed at the Univer­
sity of Vermont (Bosworth and Sailes 1993; Gerstain and 
Green 1993; Glynn 1994).  In several states, either a vol­
untary health agency or a community or school group 
originated its own supplement to a school program. 
Supplemental Programs 
During 1994, two states—Massachusetts and Cali­
fornia (see Chapter 7)—were particularly active in 
developing and implementing supplemental programs 
(i.e., in addition to statewide curricula) using mass 
media in smoking prevention. Although smoking 
prevention was one of several aims of the generic me­
dia campaigns funded through tobacco tax revenues 
in each state, the topic was clearly emphasized in a set 
of media spots specifically targeting youth in 1994 in 
each state. The Massachusetts campaign was compre­
hensive; seven messages addressed various topics 
suggested in the CDC guidelines (Massachusetts De­
partment of Public Health 1994). The 1994 California 
campaign used seven television spots and six radio 
spots to describe the physiological consequences of 
smoking. Using humorous vignettes, the campaign 
identified toxic substances in cigarette smoke, such as 
arsenic, formaldehyde, ammonia, methane, and 
dichlorodiphenyltrichloroethane (DDT). 
On a smaller scale, supplemental efforts with 
comprehensive coverage also occurred in West Virginia 
and in Denver, Colorado.  In West Virginia, through a 
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contest sponsored by the American Cancer Society, 
four winning scripts for radio spots on smokeless to­
bacco use and on environmental tobacco smoke were 
selected from more than 300 entries from students in 
kindergarten through the 12th grade.  The spots were 
broadcast on 22 stations and included several topics, 
although the only one related to the CDC guidelines 
concerned the physiological consequences of tobacco 
use. In Denver, a three-month billboard campaign 
promoted the theme “Smoking Doesn’t Add Up,” 
which suggested the financial consequences of tobacco 
use (Colorado ASSIST Alliance 1994). 
Programs Including Families 
Only two states reported large-scale supplemental 
programs that included families:  New Jersey in its 
community grants programs and Oregon in a program 
entitled Parenting for a Positive Future.  Three other 
states reported using the Unpuffables program, which 
requires parents’ participation and includes the topics 
of social influences and refusal skills (Perry et al. 
1990b). It should be noted, however, that this estimate 
of parental involvement is likely to be low, since 
districts and schools, which vary considerably in the 
degree to which they involve parents in school activi­
ties, were not queried directly. 
Community Programs 
In general, virtually no states reported community 
organization programs dedicated to supplementing 
educational programs to prevent tobacco use.  Several 
programs—including the Kids Against Tobacco program, 
which involved 5,000 young people in northwestern 
Louisiana—combined tobacco education and advocacy, 
but the main emphasis was on inspiring young people 
to advocate against tobacco use. 
Combined Activities 
At the time of the Worden and Flynn survey, only 
Pennsylvania reported combining a mandated school 
curriculum with supplemental school, community, and 
mass media programs in an educational strategy to 
prevent tobacco use.  The statewide Youth Against To­
bacco program was sponsored by the state’s health and 
education departments along with the American Can­
cer Society and the Pennsylvania Medical Society. 
These sponsors asked community organizations 
throughout the state to participate in the program, 
which ran from 1992 through 1995.  More than 175,000 
young people in 47 counties participated with local 
Reducing Tobacco Use 
Boy Scouts and Girl Scouts, Boys’ & Girls’ Clubs, health 
organizations, Students Against Driving Drunk, 
D.A.R.E., and other groups.  Community events in­
cluded the 1994 Farm Show, in which 8,444 young 
people pledged not to smoke. The 1994 mass media 
program included a rap radio message aired by 223 
stations in January and 280 stations in June. Declar­
ing it “not cool” to smoke, the message described the 
social consequences of smoking (Pennsylvania Depart­
ment of Health 1992). 
Monitoring Program Objectives 
Only Vermont reported having a system in place 
to annually assess school program activity.  Act 51 
stipulates that schools in Vermont annually report the 
number of schools implementing a curriculum. In 
1994, 219 schools reported using the Here’s Looking 
At You, 2000 program, 25 used the LST Program, and 
19 used other programs (Glynn 1994).  Arkansas, In­
diana, Missouri, Pennsylvania, and Rhode Island were 
able to report the estimated number of students re­
ceiving specific programs run by voluntary agencies 
or local school districts. For example, Indiana reported 
that 15 percent of its students received the Growing 
Healthy program. 
Interpreting the Diffusion Process 
Because of the methodological differences, the 
results of SHPPS cannot be compared directly with 
those of the state-based survey conducted by Worden 
and Flynn. In particular, it is likely that the latter 
underestimated the type and amount of tobacco use 
prevention activity that may have been occurring on 
the local level. The two surveys concurred, however, 
in their overall assessment: considerable progress has 
been made, but comprehensive school health educa­
tion can be improved in some areas, including tobacco 
use prevention.  SHPPS, which focused on multiple 
activity levels, concluded that few schools met all the 
major criteria provided in the CDC guidelines (CDC 
1994a; Crossett et al. 1999).  As a result of its focus, the 
state-based survey concluded that optimal use had not 
yet been made of the available research on multichan­
nel methods for maximizing the impact of school 
health education programs for tobacco use prevention. 
Thus, the review of reported program activity in 
1994 indicated that we are far from attaining an ideal, 
national level of educational programs to prevent to­
bacco use. By one set of criteria, only 4 percent of the 
middle, junior, and high schools in this nation were 
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meeting three criteria of a comprehensive tobacco use 
prevention program in 1994 (Crossett et al. 1999).  Sev­
eral reasons have been offered for this shortcoming at 
the time. One reason is that the year 1994 fell between 
two periods that may have been more active.  The first 
period was the late 1980s and early 1990s, when the 
states of Minnesota and California were implement­
ing large-scale campaigns to reduce tobacco use that 
were financed by tax revenues from cigarette sales.  For 
a brief time, Michigan also developed mass media 
spots for preventing smoking among adolescents. 
Resources for these efforts apparently shrank (Begay 
et al. 1993), and the campaigns faded by 1994. A sec­
ond period, which follows the 1994 activities reported 
here, arguably began with the 1994 publication of the 
Surgeon General’s report Preventing Tobacco Use Among 
Young People (USDHHS 1994). That report seems to 
have stimulated development of a new set of guide­
lines. In addition, by this time all states had received 
support to coordinate their education and policy 
efforts to reduce tobacco use.  This support came 
through the ASSIST program, which began such 
activities as early as 1991, and through the IMPACT 
program, which supplemented ASSIST coverage. 
Therefore, 1994 may represent an interregnum in the 
enthusiasm for tobacco prevention education.  This 
view is supported by the events of the late 1990s. The 
major legal and legislative activities (see Chapter 5) 
were instrumental in mobilizing several states to 
intensify multichannel efforts at tobacco prevention 
(described in detail in Chapter 7). 
A second reason is that there has been little 
evidence that the community-based approaches to 
prevent tobacco use that have been shown to be effec­
tive in controlled research studies have been adapted 
effectively to statewide use.  Two states, California 
and Minnesota, have attempted some evaluation of 
community-based programs to prevent smoking on a 
statewide scale. In both cases, marketing research tech­
niques similar to those described as diagnostic and 
formative research in the VSMM (Worden et al. 1988, 
1996) were applied in developing mass media cam­
paigns. Several creative messages for preventing 
smoking were developed in each state, but the num­
ber of messages dedicated to young people was 
limited; exposure also was limited, because paid ad­
vertising slots were allocated to target groups of adults 
as well as youths (Kizer et al. 1990; Minnesota Depart­
ment of Health 1991). 
Although awareness of each of these campaigns 
appeared to be high among adolescents, there was no 
reduction in smoking behavior (Murray et al. 1994; 
Pierce et al. 1994; Popham et al. 1994).  Part of the 
difficulty may have been the absence of a sufficiently 
strong school-based program having similar educa­
tional objectives. It is also possible that, with funds 
divided to reach many targeted groups, the media 
could not be concentrated sufficiently on smoking pre­
vention among youth to have a measurable effect. 
A third reason is that programs implemented on 
a day-by-day basis over the years often lack the essen­
tial ingredients for success that were evident when they 
were created and evaluated by researchers.  To be ef­
fective, programs should be taught as designed 
(Rohrbach et al. 1993). For many curricula, teachers 
require training—if not to encourage adoption of the 
program, then at least to ensure that the curriculum is 
correctly and completely delivered (Perry et al. 1990a; 
Smith et al. 1993). Many teachers are resistant to train­
ing (Brink et al. 1991), and teachers who smoke may 
be particularly uncomfortable with a curriculum that 
discourages smoking. Such resistance may not affect 
the quality of a brief, single-pronged program format, 
such as the Smoke Free Class of 2000, but may jeopar­
dize the integrity of more long-term and comprehen­
sive curricula. It also has been found that a school 
system’s decision to use a curriculum is simply not 
enough to ensure successful implementation; teach­
ers should be brought in at the earliest stages of adop­
tion (Rohrbach et al. 1993). Teachers and school 
administrators with prior experience in tobacco use 
prevention education should be involved in orienting 
and inspiring other teachers, who will then be more 
likely to deliver the curriculum faithfully and effec­
tively (Smith et al. 1993). Successful implementation 
also depends on the size of the school organization; 
smaller organizations are more likely to adopt new 
programs quickly, whereas larger organizations are 
more likely to maintain a program once it is adopted 
(McCormick et al. 1995). 
A fourth reason is that there appears to be a short­
age of linking agents, who have been found to be 
essential for maintaining educational programs to pre­
vent tobacco use (Dijkstra et al. 1993) and have been 
recommended in several diffusion studies (Brink et al. 
1991; Goodman et al. 1992; Rohrbach et al. 1993). Link­
ing agents are persons or groups that have a strong 
incentive for maintaining a program and promoting 
its continuation by consistently and faithfully coordi­
nating all of the necessary resources for implementa­
tion. Potential candidates for local linking agents are 
school health teachers, principals, volunteers, and 
health professionals; each could ensure that school 
curricula include a strong component for preventing 
tobacco use, much as local voluntary agencies have 
supported the Smoke Free Class of 2000 effort (Brink 
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et al. 1991). These individuals, working through a 
coalition, could also coordinate community program 
efforts involving families, community organizations, 
and mass media. 
On a state level, the natural linking agents would 
be the tobacco control coordinators, who could work 
through coalitions or other state agencies to accom­
plish several long-term, comprehensive aims:  (1) es­
tablish legislation mandating school-based tobacco use 
prevention with guidelines specifying effective cur­
ricula; (2) establish a curriculum training program, 
through the state education department, that would 
involve school administrators and teachers in the on­
going implementation of school-based curricula to 
prevent tobacco use; (3) establish a monitoring and 
support system to determine the penetration and qual­
ity of programs throughout the school system and 
improve instruction with ongoing teacher training; 
(4) work with parents’ groups and volunteer organi­
zations to support the school program; and (5) work 
with interested citizens to place media messages that 
support each of the content areas recommended by the 
CDC guidelines. 
On a national level, linking agents could be agen­
cies, such as the NCI or the CDC, that could support 
local and state efforts to reduce tobacco use with 
funding and continued coordination, such as by regu­
larly convening state coordinators to share program 
ideas. These national linking agents might focus their 
diffusion efforts on using the mass media, because 
youth in different markets respond equally well to 
media-based messages for preventing tobacco use 
(Flynn et al. 1992). Considerable opportunity exists 
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for enhanced diffusion of programs that have demon­
strated effectiveness (Parcel et al. 1989a,b, 1995; O’Hara 
et al. 1991; Brink et al. 1995; Parcel 1995; McCormick 
and Tompkins 1998; Siegel and Biener 2000).  As an 
example of such diffusions, the CDC’s Division of 
Adolescent and School Health initiated the Research 
to Classroom project.  Through this project, CDC iden­
tified programs with credible evidence of effectiveness 
in reducing health risk behaviors among young people. 
So far, CDC has identified curricula for sexuality and 
tobacco use prevention. The CDC staff review elec­
tronic databases, literature reviews, meta-analyses, and 
reports to identify evaluation studies that meet the 
criteria for consideration in the Research to Classroom 
project.  Two external panels, one of evaluation experts 
and the other of program experts, review the curricula 
and their evaluations. If both panels recommend adop­
tion of the curriculum, based on attainment of identi­
fied criteria, CDC designates the curriculum as a 
Program that Works.  The Research to Classroom 
project identified Project Towards No Tobacco Use and 
Life Skills Training as appropriate tobacco use preven­
tion curricula. Research to Classroom also provides 
information and training on these curricula for inter­
ested educators from state and local education 
agencies, departments of health, and national nongov­
ernmental organizations.  The CDC identifies and 
disseminates information on Programs that Work to 
help inform local and state choices. The choice to 
adopt a curriculum ultimately rests with local deci­
sion makers and must address community standards 
and needs. 
1.	 Educational strategies, conducted in conjunction 
with community- and media-based activities, can 
postpone or prevent smoking onset in 20 to 40 
percent of adolescents. 
3.	 More consistent implementation of effective 
educational strategies to prevent tobacco use will 
require continuing efforts to build strong, 
multiyear prevention units into school health 
education curricula and expanded efforts to make 
use of the influence of parents, the mass media, 
and other community resources. 
2.	 Although most U.S. schools have tobacco use pre­
vention policies and programs in place, current 
practice is not optimal. 
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Introduction 
Preventing tobacco addiction among young 
people and promoting abstinence among current 
smokers are the final common denominators for pub­
lic health strategies to reduce smoking prevalence.  Al­
though prevention efforts are increasingly regarded as 
the most promising long-term approach for reducing 
tobacco use (Lynch and Bonnie 1994; U.S. Department 
of Health and Human Services [USDHHS] 1994), about 
1.2 million youths become regular smokers each year 
in the United States—adding to the millions of adult 
smokers who are candidates for addiction manage­
ment (Leventhal et al. 1991; Centers for Disease Con­
trol and Prevention [CDC] 1998; see “Trends in Tobacco 
Use Among Young People” in Chapter 3).  Effective 
treatments do exist for smoking cessation, and they 
are available for both the clinical and the public health 
context (Fiore et al. 1996). These treatments compose 
an important modality in the effort to eradicate tobacco 
use. Many of the adverse health effects of tobacco use 
are reversible by cessation (USDHHS 1989)—a fact im­
portant to the millions of adults who already smoke, 
as well as to the large numbers of young people who 
continue to take up smoking. 
not met. Unless smoking prevalence declines at a more 
rapid rate than that observed in the past, we will not 
achieve the Healthy People 2010 goal of an adult smok­
ing prevalence of 12 percent or less by the year 2010 
(USDHHS 2000). 
Since the 1964 release of the first Surgeon 
General’s report on the health consequences of smok­
ing, the prevalence of cigarette smoking among adults 
in the United States has decreased by 41 percent, fall­
ing from 42.2 percent in 1965 to 24.7 percent in 1997 
(Giovino et al. 1994; CDC 1999a). Although these data 
represent significant progress in the public health cam­
paign against tobacco use, the steady decline of 0.5 
percentage points per year observed from 1965 to 1985 
has lessened in recent years.  In 1997, approximately 
48 million adult Americans smoked; the prevalence 
was higher among men (27.6 percent) than among 
women (22.1 percent) and among American Indians 
and Alaska Natives (34.1 percent) than among blacks 
(26.7 percent), whites (25.3 percent), Hispanics (20.4 
percent), or Asian Americans and Pacific Islanders (16.9 
percent) (Table 4.1).  Smoking prevalence was also 
lower among college graduates (11.6 percent) than 
among high school dropouts (35.4 percent) and higher 
among those below the poverty level (33.3 percent) 
than above it (24.6 percent) (CDC 1999a).  Since smok­
ing prevalence did not decline at a more rapid rate 
than that observed in the past few years, the Healthy 
People 2000 goal of an adult smoking prevalence of 15 
percent or less by the year 2000 (USDHHS 1991) was 
Considered over the time frame of the last 30 
years, however, smoking cessation has increased dra­
matically.  Self-reported data from 1997 suggest that 
almost 50 percent (44 million) of people who have ever 
smoked have successfully quit smoking (Thomas and 
Larsen 1993). In 1991, the earliest year for which so­
cioeconomic data are available, the prevalence of 
smoking cessation was greater among male, white, 
older, more educated, and wealthier persons (Table 4.2) 
(Giovino et al. 1994). An encouraging finding from 
the 1993 National Health Interview Survey was that 
most (70 percent) current adult smokers were inter­
ested in quitting. Such interest was higher among 
women, African Americans, and younger persons 
(Thomas and Larsen 1993). 
Cessation represents a desired end result to what 
is usually a lengthy, demanding, and often frustrating 
undertaking. Data on cessation should be interpreted 
in light of the fact that for every successful attempt to 
quit using tobacco, many more attempts fail.  Although 
millions of Americans say they want to quit smoking, 
studies suggest that only about 6 percent of persons 
who try to quit smoking at any given time are suc­
cessful for more than one month (CDC 1993a). Re­
search into tobacco cessation seeks tools that will 
translate the desire to quit into prolonged abstinence 
from tobacco.  Such treatments hold a greater poten­
tial for immediate public health returns than do pre­
vention methods, and cessation treatments may also 
be cost-effective (see “Cost-Effectiveness” later in this 
chapter). 
In the course of this chapter, the terms “smoking 
cessation” and “management of tobacco addiction” are 
used interchangeably.  Though the former is the more 
familiar, the latter better conveys a more rigorous and 
systematized approach to a complex addiction behav­
ior.  Value judgments on the impact of a particular 
modality should be interpreted within a qualitative 
system for judging costs and benefits. A small impact 
may be viewed favorably if achieved with minimal 
intervention. More intense intervention may have a 
larger impact, but may not be justified by the resources 
it requires. 
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Table 4.1.	 Percentage of adults aged ≥18 years who were current cigarette smokers,* by sex, race/ethnicity, 
education, age, and poverty status—United States, National Health Interview Survey, 1997 
Men Women Total 
(n = 15,361) (n = 20,455) (n = 35,816) 
Characteristic % (95% CI†) % (95% CI) % (95% CI) 
Race/Ethnicity‡ 
White, non-Hispanic 27.4 (± 1.0) 23.3 (± 0.8) 25.3 (± 0.7) 
Black, non-Hispanic 32.1 (± 2.4) 22.4 (± 1.7) 26.7 (± 1.4) 
Hispanic 26.2 (± 2.1) 14.3 (± 1.4) 20.4 (± 1.4) 
American Indian/Alaska Native§ 37.9  (± 13.7) 31.3 (± 8.8) 34.1 (± 7.7) 
Asian American/Pacific Islander 21.6 (± 4.4) 12.4 (± 3.5) 16.9 (± 2.7) 
Education (years)Δ
<8 29.9 (± 3.0) 15.1 (± 2.2) 22.5 (± 1.9)
  9–11 41.3 (± 3.1) 30.5 (± 2.4) 35.4 (± 2.0)
 12 31.8 (± 1.7) 25.7 (± 1.3) 28.4 (± 1.0)
 13–15 27.4 (± 1.7) 23.1 (± 1.4) 25.1 (± 1.1) 
>16 13.0 (± 1.2) 10.1 (± 1.0) 11.6 (± 0.8) 
Age (years)
 18–24 31.7 (± 2.8) 25.7 (± 2.4) 28.7 (± 1.9)
 25–44 31.2 (± 1.3) 26.1 (± 1.1) 28.6 (± 0.8)
 45–64 27.6 (± 1.5) 21.5 (± 1.3) 24.4 (± 1.0) 
>65 12.8 (± 1.4) 11.5 (± 1.1) 12.0 (± 0.9) 
Poverty status¶ 
At or above 27.3 (± 1.0) 21.8 (± 0.8) 24.6 (± 0.7) 
Below 38.7 (± 2.8) 29.8 (± 1.9) 33.3 (± 1.7) 
Unknown 23.4 (± 2.0) 18.2 (± 1.5) 20.5 (± 1.2) 
Total 27.6 (± 0.9) 22.1 (± 0.7) 24.7 (± 0.6) 
*Persons who reported having smoked at least 100 cigarettes during their lifetime and who reported currently 
smoking every day or some days. Excludes 300 respondents with unknown smoking status. 
†95% confidence interval. 
‡Excludes 74 respondents of unknown, multiple, and other racial/ethnic categories.
 

§Wide variances on estimates reflect the small sample sizes.

ΔPersons aged >  25 years. Excludes 305 respondents with unknown years of education.
 

¶Published 1996 poverty thresholds from the Bureau of the Census are used in these calculations.
 

Source:  Centers for Disease Control and Prevention 1999a.
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Reducing Tobacco Use 
Table 4.2.  	Percentage of adults* who abstained from smoking cigarettes in the previous year, by sex, 
race/ethnicity, age, education, and poverty status—United States, National Health Interview 
Survey, 1991† 
Abstinence for 
> 1 day 
Maintenance 
among abstainers 
Maintenance‡ among 
all persons who 
were daily smokers 
1 year earlier* 
___________________________________________ ______________________________________________ ______________________________________________ 
Characteristic % (95% CI§) % (95% CI) % (95% CI) 
Sex 
Male 
Female 
42.6 (40.8–44.4) 13.8 (12.0–15.6) 5.8 (5.0–6.6) 
41.5 (40.0–43.0) 13.7 (12.0–15.4) 5.6 (4.9–6.3) 
Race/Ethnicity 
WhiteΔ 
BlackΔ 
Hispanic 
American Indian/ 
  Alaska Native 
Asian American/ 
Pacific Islander 
40.3 (39.0–41.6) 14.0 (12.6–15.4) 5.6 (5.0–6.2) 
48.7 (45.2–52.2) 7.9 (5.1–10.7) 3.8 (2.4–5.2) 
52.1 (46.4–57.8) 16.3 (10.3–22.2) 8.5 (5.2–11.8) 
53.3 (39.7–67.0) NA¶ NA¶ 
45.0 (33.7–56.3) NA¶ NA¶ 
Age (years) 
18–24 
25–44 
45–64 
56.7 (52.9–60.5) 14.0 (9.9–18.1) 7.9 (5.6–10.3) 
43.4 (41.8–45.0) 12.7 (11.0–14.4) 5.4 (4.7–6.1) 
36.1 (33.9–38.3) 14.1 (11.4–16.8) 5.0 (4.0–6.0) 
35.7 (32.2–39.2) 19.4 (14.6–24.2) 6.8 (5.1–8.5) 
Education (years)
 <12 
12 
13–15 
36.5 (34.1–38.9) 12.9 (10.2–15.6) 4.7 (3.7–5.7) 
42.5 (40.8–44.2) 12.8 (10.9–14.7) 5.3 (4.5–6.1) 
46.9 (44.2–49.6) 14.3 (11.4–17.2) 6.6 (5.2–8.0) 
45.9 (42.5–49.3) 18.8 (14.9–22.7) 8.5 (7.0–10.0) 
Poverty status** 
At or above 
Below 
Unknown 
42.7 (41.4–44.0) 14.8 (13.4–16.3) 6.2 (5.6–6.8) 
42.9 (39.5–46.3) 7.5 (4.7–10.3) 3.2 (2.0–4.4) 
35.2 (31.2–39.2) 12.6 (8.3–16.9) 4.4 (2.9–6.0)
      Total 42.1 (40.9–43.3) 13.8 (12.5–15.1) 5.7 (5.2–6.3) 
*Persons aged ≥18 years who reported having smoked at least 100 cigarettes in their lifetime and smoked 
cigarettes daily 1 year earlier and who provided information of their current smoking status. 
†Sample size = 9,703; race/ethnicity variable excludes 34 respondents of other, unknown, or multiple race; 
education variable excludes 24 respondents of unknown education level. 
‡Abstinence from smoking cigarettes for at least 1 month at the time of the survey.  Excludes 92 respondents who 
were abstinent from cigarettes for <1 month or for whom duration of abstinence was unknown. 
§Confidence interval. 
ΔExcludes persons of Hispanic origin. 
¶Sample sizes too small to derive reliable estimate. 
**Poverty statistics are based on definitions developed by the Social Security Administration, which includes a set 
of income thresholds that vary by family size and composition. 
Source:  National Center for Health Statistics, public use data tape, 1991. 
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Methods for Managing Nicotine Addiction 
Historically, the great majority of smokers (more 
than 90 percent) who successfully quit smoking did 
so “on their own”—that is, without the assistance of 
formal cessation programs (USDHHS 1989; Fiore et al. 
1990). With the advent of new treatments, including 
pharmaceuticals, more smokers (20 percent) are using 
some form of assistance when trying to quit (Zhu et 
al. 2000). The success rate among this large group of 
unassisted quitters is half that observed for those who 
use some form of assistance. Although more than 1 
million smokers quit each year, 75–80 percent relapse 
within six months (Carmody 1992). Those who quit 
may relapse at any time (even after a period of years), 
and a substantial portion of quitters go through cycles 
of quitting and relapse (Cohen et al. 1989a). Given 
this complex context in which the natural history of 
smoking occurs (an important leitmotif in the man­
agement of tobacco addiction), it is difficult to assign 
a single number to the proportion who quit on their 
own. Nonetheless, in the current environment of 
declining prevalence, the end result of this cyclic pro­
cess, and of all the interventional efforts brought to 
bear on it, is that each year about 3–5 percent of smok­
ers quit for a year, for longer, or for good. 
The success of smoking cessation methods 
should be evaluated in terms of both process and out­
come measures. Process measures are designed to as­
sess those variables that are affected by treatments and 
that influence outcomes. Ideally, process measures 
should target the specific change mechanisms that 
treatments are intended to influence.  For instance, if a 
treatment is intended to provide smokers with coping 
skills, process measures might assess a patient’s abil­
ity to anticipate and generate appropriate responses 
to stresses. If a treatment is intended to promote ces­
sation by reducing withdrawal symptoms, then a with­
drawal symptom scale might be used as a process 
measure.  Clinically significant outcome measures in­
clude attempts at quitting and abstinence success. 
Withdrawal symptom severity and concomitants of 
cessation attempts, such as weight gain, may be viewed 
as outcomes as well. 
Some of the efficacy evaluations reported here 
incorporate the results of published meta-analyses. 
Meta-analysis is a statistical technique that assesses the 
impact of a variable (or, in this context, a treatment) 
across a set of related investigations (Dickersin and 
Berlin 1992). Meta-analyses may present a more 
objective assessment of accumulated research findings 
than do traditional narrative reviews (e.g., Cooper and 
Rosenthal 1980) and can be useful for identifying study 
or treatment characteristics that are associated with 
differences in study outcomes (Dickersin and Berlin 
1992). Meta-analyses of smoking cessation treatments 
have used different techniques for estimating the size 
of treatment effects.  The precise methods used to cal­
culate and pool these estimates vary (for detailed de­
scriptions, see Fleiss 1981 and Cooper and Hedges 
1994). In both meta-analyses and individual studies, 
the most frequently encountered measures are the odds 
ratio (an estimate of the relative risk for the outcome 
in control versus treatment groups) and some form of 
effect size (difference in effect between treatment and 
control groups). 
Self-Help Manuals 
Because of the size of the population who try 
quitting on their own, the broad dissemination of ma­
terials that can help them in their efforts—without re­
quiring them to participate in a formal cessation 
program—may be a potent strategy at the national 
level for decreasing the prevalence of smoking (Glynn 
et al. 1990a; Curry 1993). A wide array of self-help 
strategies has been developed for smoking cessation 
(Curry 1993). This section discusses the efficacy of 
written manuals, the most extensively investigated 
self-help materials (Curry 1993). The discussion is lim­
ited to studies of such manuals distributed to relatively 
small populations of smokers. Self-help materials de­
livered to large populations are discussed later in the 
chapter in association with nonprint messages and pro­
grams (self-help or supervised) included in mass me­
dia and community-based efforts. 
Efficacy 
In a review of the research literature on self-help 
manuals, the median long-term prevalence of cessation 
associated with manual-based interventions was about 
5 percent (Curry 1993).  This proportion is lower than 
those of face-to-face cessation programs (Schwartz 1987; 
Lichtenstein and Glasgow 1992; Lando 1993). Further­
more, recent evidence suggests that self-help manuals, 
when used by themselves, may produce negligible 
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increases in long-term cessation (Gritz et al. 1992; 
Petersen et al. 1992; Gomel et al. 1993; Fiore et al. 2000). 
Because self-help manuals can be distributed, at 
low cost, to very large numbers of smokers, even rela­
tively small cessation success could translate into large 
numbers of successful quitters. Since 30–40 percent of 
smokers each year make a serious effort to quit, self-
help aids could have a vast influence on public health 
(Hatziandreu et al. 1990; CDC 1993b, 1999b).  The avail­
able evidence suggests that self-help manuals work 
better for smokers who are less dependent on nico­
tine, more motivated, and more confident of quitting 
(Curry 1993), but the relationship between motivation 
and success is complex. Less addicted smokers may 
be less likely to seek formal treatment (Fiore et al. 1990; 
Zhu et al. 2000) and are therefore an apt audience for 
self-help manuals. More addicted smokers are more 
likely to seek formal self-help programs (Wagner et al. 
1990) but may be less successful in quitting (Schoen­
bach et al. 1992). Thus, in view of both their uncertain 
effectiveness and their potential to be cost-effective, it 
is important to determine whether self-help manuals 
have a consistent, albeit small, benefit. 
Although many self-help manuals have been de­
veloped, there is little evidence that they differ in their 
effectiveness (Cummings et al. 1988; Glynn et al. 1990a; 
Curry 1993). Accordingly, an Expert Advisory Panel 
convened by the National Cancer Institute (NCI) has 
recommended that public health professionals try to 
increase the availability of existing manuals rather than 
refine them or develop new ones (Glynn et al. 1990a). 
The committee also concluded that if new materials are 
deemed necessary, they should, at a minimum, contain 
the following components:  (1) information about 
the social and health effects of smoking; (2) specific 
strategies and exercises for quitting; and (3) specific strat­
egies and exercises to avoid relapse and, in the event of 
relapse, to try quitting again (Glynn et al. 1990a). 
Manuals tailored to special populations of smok­
ers, such as pregnant women, older adults, African 
Americans, and Hispanics, have been developed and 
tested (Windsor et al. 1985; Glynn et al. 1990b; Davis 
et al. 1992; USDHHS 1998). Although manuals tar­
geted to specific populations have not had consistently 
greater success than generic manuals at helping mem­
bers of relevant populations quit (Curry 1993; Rimer 
et al. 1994), such manuals have the potential to reach 
smokers missed by traditional materials (Curry 1993). 
It appears that combining multiple types of 
self-help materials (manuals, videotapes, etc.) does not 
improve long-term cessation rates. A meta-analysis of 
21 studies using multiple types of self-help without 
person-to-person contact found no significant difference 
Reducing Tobacco Use 
between multiple types of self-help and no self-help at 
all (Fiore et al. 2000). 
Reading level has been increasingly recognized 
as an important attribute of self-help manuals. Since 
the early 1970s, trends in smoking prevalence have 
been different for those with differing levels of educa­
tional attainment (Pierce et al. 1989).  Smoking preva­
lence has dropped sharply among persons with a 
college education (10.1 percentage points between 1974 
and 1985) but has declined only marginally among 
high school dropouts (2.1 percentage points during the 
same period). Concerns about literacy have led to the 
recommendation that self-help materials for smoking 
cessation be written at no more than a seventh-grade 
reading level (Glynn et al. 1990a), although this level 
may be too high in some situations. 
Adjuncts to self-help manuals, such as telephone 
counseling (Orleans et al. 1991; Curry et al. 1992; Lando 
et al. 1992), hot lines (Ossip-Klein et al. 1991), and per­
sonalized feedback (Curry et al. 1991; Prochaska et al. 
1993), have also been evaluated. These adjunctive in­
terventions have met with varying success (Curry 
1993). For example, self-help treatments that include 
nicotine gum as well as smoking cessation manuals have 
not had greater long-term efficacy than the manuals 
alone (Harackiewicz et al. 1988; Killen et al. 1990b). 
Computer-generated personalized feedback (Curry et 
al. 1991) and telephone outreach, however, have im­
proved cessation success (Orleans et al. 1991; Lando et 
al. 1992; Prochaska et al. 1993; Strecher et al. 1994).  At 
present, research suggests that such adjuvants materi­
ally improve the effectiveness of self-help manuals. 
Adjunctive interventions that require financial 
and personnel resources, however, may undercut the 
potential population impact of self-help interventions. 
The addition of other components to self-help manu­
als may also mark the point at which the self-help 
modality merges with more formal assistance, which, 
as mentioned earlier, have not appealed to as large a 
population of smokers motivated to quit. But at least 
one such treatment, proactive telephone counseling (as 
opposed to reactive approaches, such as help lines 
smokers must call), appears to be effective when used 
as an adjuvant (Fisher et al. 1993). 
Relevant Process Measures 
Most studies of self-help manuals lack process 
measures, and the specific measures used across stud­
ies vary considerably (Curry 1993). Two distinct pro­
cess measures, manual reading and manual use, have 
been assessed in some studies of self-help manuals for 
smoking cessation. Reading measures simply ask 
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smokers whether they read most or all of the manual. 
Use measures assess the extent to which smokers 
performed the specific exercises recommended in the 
manual. In theory, persons who actually read a manual 
or practice manual-recommended exercises should be 
more successful than those who merely possess a 
manual. Curry (1993) concluded that although read­
ing has sometimes been related to program success, 
use has been more consistently related to improved 
outcomes. Further work is needed to determine with 
some certainty whether the information conveyed by 
the manuals, rather than nonspecific motivational ef­
fects, is responsible for their efficacy. 
Summary 
Although self-help manuals have had only mod­
est and inconsistent success at helping smokers quit, 
manuals can be easily distributed to the vast popula­
tion of smokers who try to quit on their own each year. 
Adjuvant behavioral interventions, particularly pro­
active telephone counseling, may increase the effect 
of self-help materials. Process measures are not rou­
tinely incorporated into self-help investigations, but 
the available process data suggest that persons who 
not only have a self-help manual but also perform the 
exercises recommended in the manual are more likely 
to quit smoking. 
Minimal Clinical Interventions 
Minimal clinical interventions are those that can 
be delivered briefly to smokers by health care profes­
sionals during the course of a regular health care en­
counter.  These strategies may be as simple as advising 
smokers to quit, or they may be as complex as using 
computers to tailor the intervention to the individual 
smokers. Minimal clinical interventions could have a 
great influence at a national level on smoking cessa­
tion, but they have been underused.  Findings from a 
1985 (Ockene et al. 1987), a 1991 (CDC 1993b), and a 
1992 national survey (Tomar et al. 1996) suggest that 
nearly 70 percent of American smokers (nearly 36 mil­
lion) make at least one outpatient health care visit each 
year; however, only 40–52 percent of the smokers in 
the surveys reported that during the preceding year 
they had been advised by a health care professional to 
quit smoking. In a separate study, 48.8 percent of 2,710 
current smokers had been advised by their physician 
to stop smoking or to smoke less (Frank et al. 1991). 
More than 50 percent of adult smokers in the United 
States saw a dentist in 1992, but fewer than 25 percent 
of those who saw a dentist in the preceding year re­
ported that the dentist had advised them to quit smok­
ing (Tomar et al. 1996).  Among adult users of 
smokeless tobacco, 18 percent reported that they had 
ever been advised by a dentist and 15 percent had ever 
been advised by a physician to quit (Tomar et al. 1996). 
Many clinicians may believe that they are not 
equipped to help smokers quit (Wells et al. 1984; Glynn 
1988) or that a physician can help a smoker quit 
(Ockene et al. 1988a). Training programs for clinicians 
have been developed to address this problem (Ockene 
et al. 1988b; Cummings et al. 1989a,b; Duncan et al. 
1991; Manley et al. 1991; Strecher et al. 1991); however, 
data suggest that simply training clinicians may not 
be effective (Dietrich et al. 1992; Carney et al. 1995; 
Klein et al. 1995). However, implementing reminder 
systems in the clinic has been shown to triple clinician 
intervention with smokers (Fiore et al. 1996, 2000). 
Some evidence suggests that the delivery of these mini­
mal clinical interventions is becoming more common 
(Gilpin et al. 1992). 
Surveys suggest that smokers who are white, fe­
male, older, better educated, or ill, or who smoke more 
cigarettes per day are more likely than others to re­
ceive clinical advice to quit (Ockene et al. 1987; Frank 
et al. 1991; Gilpin et al. 1992; CDC 1993b). At present, 
clinicians apparently do not ensure that all of their 
patients who smoke receive cessation advice and as­
sistance, in part because of structural and policy is­
sues (such as reimbursement) related to medical care 
delivery.  Nonetheless, such efforts might be more com­
mon if clinicians were trained to view smoking as a 
chronic disease, marked by periods of remission and 
relapse, rather than as an acute disorder (Fiore and 
Baker 1995). 
Researchers have shown that institutional changes 
can increase the systematic delivery of minimal clinical 
interventions for smoking cessation. For example, brief 
physician training, availability of nicotine gum, and 
patient chart stickers documenting smoking status can 
increase the amount of time physicians spend in cessa­
tion counseling and increase successful cessation by a 
factor of 2 to 6 (Cohen et al. 1989b; Ockene et al. 1991). 
One proposed change is to expand patient vital signs 
to include an assessment of tobacco use (Fiore 1991). 
This simple institutional change has been shown to 
increase markedly the proportion of patients who re­
port that their health care providers asked and coun­
seled them about smoking cessation (Fiore et al. 1995; 
Robinson et al. 1995). 
Finally, institutional changes are critical for 
prompting more clinicians to play a role in smoking 
cessation. Currently, clinicians are only sporadically 
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reimbursed for clinical and pharmacologic treatments 
to help patients quit smoking (Group Health Associa­
tion of America, Inc. 1993; Schauffler and Parkinson 
1993). Appropriate reimbursement may be essential 
to ensuring greater clinical attention to tobacco addic­
tion (Schauffler and Parkinson 1993; Fiore and Baker 
1995; Kaplan et al. 1995). 
Reducing Tobacco Use 
(4) assist patients who want to quit, and (5) arrange 
follow-up visits (Manley et al. 1991; Glynn and 
Manley 1993; Orleans et al. 1993; Houston et al. 1994; 
Fiore et al. 2000). These recommendations, based on 
a comprehensive review of the empirical literature, 
constitute a proscriptive algorithm for clinical inter­
ventions (see the text box). 
The Public Health Service-sponsored Clinical 
Practice Guideline Treating Tobacco Use and Dependence 
has recommended that health care professionals use 
the “five A’s” to help their patients quit smoking: 
(1) ask about smoking, (2) advise all smokers to quit, 
(3) address willingness to make a quit attempt, 
Additional follow-up visits, at increasing inter­
vals, with patients who continue not to smoke have 
been associated with greater long-term abstinence 
(Kottke et al. 1988; Wilson et al. 1988; Orleans et al. 
1991). Patients who have relapsed should be helped 
to quit again at follow-up visits and subsequent visits. 
The Five A’s 
To help their patients quit smoking, clinicians can use the “five A’s” approach:  (1) ask patients 
about smoking, (2) advise all smokers to quit, (3) as-
sess willingness to make a quit attempt, (4) assist 
those who want to quit, and (5) arrange follow-up 
visits with those trying to quit (Glynn and Manley 
1993). These brief clinician interventions, which are 
described in this text box, can be completed within 
two to three minutes at each visit and have been 
associated with a cessation prevalence of 5 percent 
(Glynn 1988) to 8 percent (Kottke et al. 1988). 
patient with practical advice about how to quit and 
self-help materials. 
Clinicians should assist patients who want to 
quit. The clinician should work together with the 
patient to set a date to quit (preferably within two 
weeks of the clinic visit) and should provide the 
Clinicians should determine whether the pa­
tient is likely to require adjunctive help and whether 
the patient is a candidate for pharmacotherapy. 
Pharmacotherapy should be considered for all pa­
tients motivated to make a quit attempt, except in 
the presence of specific contraindications (Fiore et 
al. 2000). The choice may take into account previ­
ous patient experience, preferences, and other fac­
tors (see “Pharmacologic Interventions,” later in this 
chapter). Clinicians should also present other treat-
ment options to their patients who want to quit. In 
particular, patients should be made aware of com­
munity cessation resources (such as those offered 
by the American Cancer Society and the American 
Lung Association) and of intensive clinical inter-
ventions (see “Intensive Clinical Interventions,” 
later in this chapter) available in the community. 
The primary care clinician, however, should con-
tinue to monitor and assist those patients who elect 
to undergo intensive treatments. 
All patients seen in a primary care setting 
should be routinely asked about their smoking sta-
tus. One means of institutionalizing the identifica-
tion of smokers is to expand the vital signs to include 
smoking status (Fiore 1991). Another means is to 
use stickers or other markers to clearly identify 
charts and prompt clinicians to help their patients 
who smoke quit (Cohen et al. 1989b; Ockene et al. 
1991). 
All patients who smoke should be advised to 
quit. This advice should be clearly stated and per-
sonalized. After giving this advice, clinicians should 
assess whether smokers desire to quit at the present 
time. Clinicians should provide motivational ma-
terials and messages to those not willing to quit. 
These patients should be asked about smoking and 
advised to quit at all subsequent visits. 
Clinicians should arrange for a follow-up visit 
to discuss smoking cessation within two weeks of 
the chosen date to quit. Researchers have docu­
mented that scheduling follow-up visits or making 
follow-up telephone calls improves cessation suc­
cess (Kottke et al. 1988; Wilson et al. 1988; Ockene 
et al. 1991, 1992; Orleans et al. 1991). Follow-up 
visits should be arranged whether the patient has 
been referred to another clinic or treated by the pri­
mary care clinician. 
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Modifications in treatment, including a discussion of 
more intensive efforts, should be considered for relaps­
ing patients at each iteration. 
An area of current active research in minimal in­
terventions is the use of computer-tailored messages 
for individual smokers who want to quit. Computer 
software that approximates deductive or inductive 
human reasoning has been proposed as an efficient and 
cost-effective mechanism for this modality (Velicer et 
al. 1993). In a large trial of one such system, interac­
tive computer reports plus individualized manuals 
produced higher current abstinence (20 percent) and 
prolonged abstinence (11 percent) than did standard 
manuals, individualized manuals alone, or personal­
ized counselor calls (Prochaska et al. 1993).  Similarly, 
analyses of two separate controlled trials found that 
computer-tailored letters generated significantly 
greater cessation proportions in groups receiving them 
than in control groups (Strecher et al. 1994).  Although 
these mechanisms have not been extensively evaluated, 
they are a promising avenue for further investigation. 
Efficacy 
Kottke and colleagues (1988) performed a meta­
analysis of 39 smoking cessation trials conducted in 
medical practice settings. Most of these trials involved 
relatively minimal interventions, but some more in­
tensive treatments were included.  Participants had a 
mean of 4.8 (standard deviation = ±4.4) contacts with 
these clinic-based programs.  The major conclusion of 
this analysis was that success increased with the num­
ber of intervention modalities employed, the number 
of health care professionals involved in the effort, and 
the number of follow-up assessments. Duration of 
follow-up (as opposed to number of follow-ups) was 
not predictive of success.  Using diverse techniques 
may be a key characteristic of successful clinic-based 
smoking cessation programs (Fiore et al. 2000).  A suc­
cessful program might be one in which face-to-face 
counseling or advice is given; dates for quitting are 
set; pamphlets are distributed; reminders by telephone 
are made; smokers are advised and counseled on quit­
ting by physicians, nurses, and other health profes­
sionals; and multiple clinic visits or telephone calls are 
made after the smoker’s quitting day.  In the meta­
analysis by Kottke and colleagues (1988), cessation 
assistance delivered by nonphysicians tended to be 
slightly more effective than that performed by physi­
cians, but a more recent meta-analysis (Fiore et al. 2000) 
found no difference in effectiveness between physi­
cians and nonphysicians. Both individual and group 
counseling was effective (Fiore et al. 2000). 
The meta-analysis by Kottke and colleagues (1988) 
also suggested, however, that complex interventions are 
not necessary for clinic-based success. Compared with 
smokers who received no assistance, smokers who 
received help consisting of advice only or brief coun­
seling had a 13.1-percentage point increase in cessation 
6 months after treatment and a 3.8-percentage point in­
crease after 12 months.  Comparable estimates for 
smokers whose only treatment was to receive written 
self-help materials from health care professionals were 
1.6 percent at 6 months and 2.0 percent at 12 months. 
The impact of brief intervention is illustrated in one 
study by Russell and colleagues (1979), who found that 
providing advice in a primary care setting produced 
a biochemically confirmed increase in abstinence of 
3.3 percentage points; when smokers were told they 
would be followed up and when self-help materials 
were distributed in conjunction with the advice, 
the resulting one-year increase in abstinence was 
5.1 percentage points. 
Trials postdating the meta-analysis of Kottke and 
colleagues (1988) have also indicated that brief clini­
cal interventions have a small but reliable impact on 
smoking cessation success (Cummings et al. 1989a; 
Risser and Belcher 1990; Taylor et al. 1990; Ockene et 
al. 1991, 1994; Weissfeld and Holloway 1991; Hollis et 
al. 1993; Strecher et al. 1994).  A meta-analysis of seven 
studies found that physician advice to quit increases 
cessation by 30 percent (Fiore et al. 2000).  The consis­
tency of these findings over a considerable time span 
and in multiple settings lends credence to the useful­
ness of minimal interventions. 
Smokeless tobacco use may be particularly ame­
nable to minimal clinical interventions, especially in 
dental office settings.  Oral lesions caused by smoke­
less tobacco are quite common among users of these 
products (Ernster et al. 1990; Tomar et al. 1997) and 
provide the opportunity for the dentist to point out 
the direct adverse health effects of smokeless tobacco. 
Several trials have examined the efficacy of minimal 
clinical interventions in smokeless tobacco cessation. 
In a randomized trial conducted in a dental 
health maintenance office clinic to test a minimal clini­
cal intervention, Stevens and colleagues (1995) re­
ported significantly higher smokeless tobacco quit 
rates in the intervention group than in the usual-care 
group at both 3 months (32.2 vs. 21.3 percent) and 12 
months (33.5 vs. 24.5 percent). In a randomized clini­
cal trial conducted in private dental offices, Severson 
and colleagues (1998) also found that a minimal inter­
vention significantly increased smokeless tobacco quit 
rates in the intervention group compared with rates 
in the usual-care group at 3 months (17.8 vs. 8.8 
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percent) and 12 months (10.2 vs. 3.3 percent).  A mini­
mal intervention trial for smokeless tobacco use among 
college athletes, which included dental examinations 
to demonstrate oral lesions, 15–20 minutes of counsel­
ing by dental hygienists, and follow-up telephone calls, 
found that three-month biochemically assayed quit 
rates were 24 percent in the intervention group and 16 
percent in the control group (Masouredis et al. 1997). 
Relevant Process Measures 
Although minimal clinical interventions provide 
smokers with some practical advice about quitting, their 
primary purpose is to increase smokers’ motivation to 
quit. Specific process measures—such as measures of 
this motivation—are seldom incorporated into minimal 
clinical interventions. The nonspecific measures some 
investigators use do not associate clinical success with 
changes (such as greater awareness of disease risk or 
enhanced belief in one’s ability to quit). Nonetheless, 
the available evidence suggests that minimal clinical 
interventions can enhance smokers’ desire and inten­
tion to quit (Russell et al. 1979), decrease the number of 
cigarettes smoked per day (Folsom and Grimm 1987), 
and increase the number of attempts to quit smoking 
(Folsom and Grimm 1987; Cummings et al. 1989b; 
Strecher et al. 1991).  In addition, patients have reported 
that physicians trained to perform more intensive in­
terventions are more helpful than physicians without 
such training (Ockene et al. 1991). 
Summary 
Substantial evidence suggests that minimal clini­
cal interventions (e.g., a health care provider’s repeated 
advice to quit) foster smoking cessation and that the 
more multifactorial or intensive interventions produce 
the best outcomes. These findings highlight the im­
portance of cessation assistance by clinicians, who have 
a unique access to more than 70 percent of smokers 
each year.  Moreover, minimal clinical interventions 
have been found to be effective in increasing smokers’ 
motivation to quit and are cost-effective (see “Cost-
Effectiveness,” later in this chapter).  However, re­
search has not clarified fully the specific elements of 
minimal interventions that are most important to clini­
cal success nor the specific types of changes they pro­
duce in smokers that lead to abstinence. 
Intensive Clinical Interventions 
Intensive clinical interventions (sometimes called 
“formal” or “organized” cessation treatments) are 
multisession counseling programs involving extensive 
contact between a health care provider and a smoker. 
The value of intensive interventions has been ques­
tioned because they are more expensive and reach 
fewer smokers than self-help and minimal clinical in­
terventions do (Chapman 1985). However, more in­
tensive interventions continue to attract interest 
because they are more successful at helping people quit 
smoking (Schwartz 1987). Despite their comparatively 
high cost, they are cost-effective (Elixhauser 1990), and 
they may be especially well-suited for treating the most 
addicted smokers (Lichtenstein and Glasgow 1992; 
Orleans 1993). 
Intensive clinical interventions may be charac­
terized by structure and content.  Structural variables 
include providers’ credentials and training; individual, 
telephone, or group format; session length; total num­
ber of sessions; and duration of follow-up. Relatively 
little research into intensive treatments has been de­
signed to assess the effects of different structural vari­
ables (Lichtenstein and Glasgow 1992). Increased 
patient contact results in better outcomes (Lando 1981; 
Decker and Evans 1989; Lichtenstein and Glasgow 
1992; Fiore et al. 2000).  In a meta-analysis of research 
on the nicotine patch (Fiore et al. 1994c), researchers 
found that the following counseling features were as­
sociated with significant increases in six-month absti­
nence rates: counseling being a main reason for 
clinician-patient contact, at least weekly clinician-
patient meetings during the first 4 weeks of treatment, 
and more than six clinician-patient meetings in the first 
12 weeks of treatment.  A more recent meta-analysis 
that was not restricted to nicotine patch studies (Fiore 
et al. 2000) found that quitting success increased with 
increasing contact time (up to 90 minutes of total con­
tact) and that there was a dose-response relationship 
between number of sessions and treatment efficacy 
(Fiore et al. 2000). Thirty to 90 minutes of total coun­
seling and four or more sessions were two to three 
times more effective in producing long-term smoking 
cessation than no contact controls. This research sup­
ports the notion that in general, as the intensity of 
clinician-patient counseling increases, so does the long-
term effectiveness of treatment. 
Because so little information is available on 
how structural variables affect intensive treatment 
outcomes, this section concentrates on a review of con­
tent variables. Content refers to the specific informa­
tion, materials, and techniques to which smokers are 
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exposed during the course of treatment.  The various 
contents of intensive smoking cessation interventions 
are not easy to evaluate, partly because the method­
ological quality of clinical trials tends to differ across 
content areas.  For example, trials of relatively unor­
thodox treatments, such as acupuncture and hypnosis, 
tend to use shorter follow-up periods than assessments 
of efforts involving pharmacologic and behavioral treat­
ments (Schwartz 1987; Ter Riet et al. 1990); inflated effi­
cacy estimates may thus result for unorthodox 
treatments.  These methodological concerns are handled 
here by limiting the review primarily to studies report­
ing outcomes with at least five months of follow-up. 
Another problem in evaluating the content of 
intensive interventions is that the evolution of treat­
ments over the past 40 years prevents a cumulative 
assessment of specific intensive interventions. More­
over, changing research interests and methodologies 
make it difficult to integrate findings from over the 
entire period. For instance, pharmacotherapies have 
changed greatly during this period and are now in­
corporated routinely into intensive treatments.  In ad­
dition, treatment response may be affected by changes 
in the nature of the smoking population; for instance, 
compared with 40 years ago, a higher proportion of 
today’s smokers are women.  Methodological and sta­
tistical changes have also altered the nature of the stud­
ies themselves: sample sizes are larger to increase 
statistical power, and biochemical confirmation of ab­
stinence is now routine, as is the application of the 
“intent to treat” principle in analyses. Because of these 
refinements, early cessation research is now often ne­
glected, perhaps because it is difficult to integrate with 
newer work. On the other hand, some apparently ef­
fective methods, such as rapid smoking, have often 
not been evaluated by newer methods. The older lit­
erature on such strategies is included selectively in this 
review. 
A related problem, complicating the interpreta­
tion of relatively recent research, arises from what 
Lichtenstein and Glasgow (1992) have referred to as a 
shift from a “clinical” to a “public health” (p. 518) ori­
entation among smoking cessation researchers.  This 
shift has resulted in a dearth of theory-driven research 
into intensive interventions. In fact, one observer has 
suggested that the long-term research trajectory favors 
modifying established models over applying innova­
tion in the basic approach to treatment (Shiffman 
1993b). Recent emphasis on public health has also 
produced a research climate that favors the evaluation 
of treatment packages and minimal interventions over 
treatment components (Lichtenstein and Glasgow 
1992). One reason for this shift is the high cost and 
large sample sizes required to evaluate individual com­
ponents. Thus clinical trials rarely allow assessment 
of a given treatment’s independent contribution. 
Smoking cessation trials now tend to combine specific 
treatment components into multicomponent interven­
tions. Moreover, within the same study, not only may 
groups receive different treatment packages but the 
packages may differ in their structural components. 
Finally, the question of selection bias remains a 
challenge to interpreting the literature on intensive 
interventions. Investigators typically recruit highly 
motivated volunteers to serve as subjects, because the 
efficacy of intensive interventions can be tested only 
if the patients under study actually receive the entire 
treatment.  Efficacy estimates derived from this atypi­
cal population may not be appropriate for making pre­
dictions about the larger population of smokers.  The 
principal types of intensive interventions must be 
evaluated in the context of these limitations stemming 
from the nature of the available evidence. 
Problem Solving/Skills Training 
Various strategies try to impart to smokers the 
knowledge and skills necessary to cope with cessation— 
that is, both to attain and to maintain abstinence when 
confronted with withdrawal symptoms or the temp­
tation to smoke (Marlatt and Gordon 1985; Curry and 
McBride 1994). This approach (hereafter referred to 
as problem solving/skills training) springs from the 
observation that most relapse efforts seem to be asso­
ciated with a finite number of factors, such as alcohol 
use, negative affect (e.g., depression), and the presence 
of others smoking (Shiffman 1982; Baer and Lichten­
stein 1988; Brandon et al. 1990). Problem solving/skills 
training tries to help people who have recently quit 
smoking anticipate these “high-risk” situations and 
learn to cope with them when they arise. Such inter­
ventions also train participants to cope with with­
drawal symptoms, replace positive reinforcements 
they had linked to smoking, and meet other challenges 
that might be encountered during or after an attempt 
to quit smoking. 
General problem solving/skills training targets 
challenges that occur early in the quitting process (e.g., 
withdrawal discomfort). Because newly abstinent 
smokers often return to regular smoking (Curry and 
McBride 1994), one specialized type of intervention 
teaches skills to help the former smoker maintain ab­
stinence (Marlatt and Gordon 1985).  These interven­
tions also train former smokers to prevent any relapse 
from becoming a long-term return to smoking.  Former 
smokers are encouraged to view relapses as a normal 
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part of the quitting process rather than as an indica­
tion of failure (Curry et al. 1988). 
Another type of problem solving/skills training 
focuses on coping with the immediate negative affects 
of quitting smoking. The growing body of research 
on dysphoria (feeling unhappy or unwell) after smok­
ing cessation (Glassman et al. 1988; Covey et al. 1990; 
Brandon 1994; Hall et al. 1994) suggests that strategies 
that help smokers who have just quit resist negative 
moods may be particularly successful (Shiffman 
1993b). However, a recent meta-analysis (Fiore et al. 
2000) did not find that interventions that targeted nega­
tive affect improved cessation rates.  These interven­
tions were used with the general population as well 
as smokers with a history of depression.  It is possible 
that the results might be more positive if the studies 
were restricted to high-risk populations. 
Efficacy 
Because nearly every state-of-the-art smoking 
cessation program contains elements of problem solv­
ing/skills training (Curry and McBride 1994), the tech­
nique is difficult to assess as an individual treatment. 
Some investigators have failed to uncover evidence that 
this technique increases cessation success relative to 
comparison groups (Curry et al. 1988; Emmons et al. 
1988; Omenn et al. 1988; Minneker-Hügel et al. 1992; 
Zelman et al. 1992). Other studies have found benefi­
cial effects, but these benefits have often been modest 
and have come only through protracted treatment (Hall 
et al. 1984b; Davis and Glaros 1986; Goldstein et al. 1989; 
Stevens and Hollis 1989). Even in studies that report 
success in long-term abstinence through skills train­
ing, the overall relapse curves for treatment subjects 
have paralleled those for comparison groups (Glasgow 
and Lichtenstein 1987; Goldstein et al. 1989; Stevens 
and Hollis 1989; Mermelstein et al. 1992; Minneker-
Hügel et al. 1992; Gruder et al. 1993).  A recent meta­
analysis (Fiore et al. 2000) of 104 studies, however, 
reported that problem solving/skills training increased 
quitting success by 50 percent.  Some evidence sug­
gests that problem solving/skills training may be par­
ticularly useful for female smokers (Curry et al. 1988), 
those who smoke fewer cigarettes (Hall et al. 1984b), 
those who smoke to cope with emotional stress 
(O’Connor and Stravynski 1982), and those who are 
less prone to negative affect (Zelman et al. 1992). 
Although multicomponent skills-training 
programs have sometimes included information about 
managing the dysphoria associated with smoking ces­
sation (Tiffany et al. 1986; Kristeller et al. 1993), 
relevant behavioral interventions have only recently 
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begun (Hall et al. 1994). Initial results suggest that 
such strategies are promising, but these findings re­
quire replication and extension. 
In sum, the evidence on problem solving/skills 
training suggests a beneficial impact (Fiore et al. 2000). 
Such training can offer practical strategies about quit­
ting and inculcate desired coping skills. 
Relevant Process Measures 
Skills training rests heavily on two assumptions: 
(1) coping skills will help former smokers remain ab­
stinent in the face of temptation, and (2) smokers can 
be taught these skills. Some cross-sectional research 
(Shiffman 1984) and skills-training intervention trials 
(Hall et al. 1984b; Davis and Glaros 1986; Zelman et al. 
1992) have suggested that coping strategies help avert 
relapse.  The available evidence also indicates that 
patients given skills training acquire coping skills (Hall 
et al. 1984b; Davis and Glaros 1986; Zelman et al. 1992), 
and there is evidence that the level of skill acquisition 
predicts long-term abstinence (Zelman et al. 1992). 
Although the results of one trial suggest that coping 
skills are not retained for very long (Davis and Glaros 
1986), consistent self-monitoring of smoking during 
treatment is associated with longer-term maintenance 
(Kamarck and Lichtenstein 1988); this finding suggests 
the importance of behavioral characteristics that fos­
ter maintenance. 
One of the goals of skills training is to encourage 
relapsed former smokers to renew their efforts to quit 
smoking. Curry and colleagues (1988) found evidence 
that smokers who had received skills training were 
more likely to try quitting again if they relapsed. 
Rapid Smoking 
Rapid-smoking strategies typically require that 
smokers inhale deeply from a cigarette about every 
six seconds until they become nauseated. In theory, 
this aversive conditioning transforms the subject’s 
perception of smoking from a pleasurable activity into 
an unpleasant one, thereby making it easier for smok­
ers to give up cigarettes. 
Medical complications produced by rapid smok­
ing can include elevations in heart rate, blood pres­
sure, and carboxyhemoglobin blood levels as well as 
electrocardiogram abnormalities (Horan et al. 1977). 
Because of these potential problems, candidates for 
rapid smoking should be selected carefully 
(Lichtenstein and Glasgow 1977). Older persons and 
persons with cardiovascular or pulmonary conditions 
are generally excluded from rapid-smoking strategies, 
   
Surgeon General's Report
 
but some evidence suggests that rapid smoking can 
be conducted with these persons if appropriate pre­
cautions are taken (Hall et al. 1984a). 
Efficacy 
The 1988 Surgeon General’s report on smoking 
and health (USDHHS 1988) reviewed the literature on 
rapid smoking and reached two conclusions: (1) al­
though its effectiveness is variable when used alone, 
rapid smoking yields moderately high long-term ab­
stinence success (40 percent of subjects were abstinent 
6–12 months after treatment) when incorporated in 
multicomponent behavioral interventions, and (2) aux­
iliary treatment factors, such as patient expectations, 
patient-therapist rapport, and admonitions not to 
smoke between sessions, can influence how success­
ful rapid-smoking strategies are. Few rapid-smoking 
trials have appeared since the 1988 report. 
The mid-1980s advent of pharmacologic treat­
ments for smoking cessation greatly reduced research 
interest in rapid smoking. Pharmacologic aids, such as 
nicotine gum, appear as efficacious as rapid smoking 
(Zelman et al. 1992) and are probably more acceptable 
to smokers and program administrators.  Nonetheless, 
the doubling of long-term success associated with rapid 
smoking (Fiore et al. 2000) suggests that it may remain 
an option for smokers who are unable to quit through 
other methods and for whom such aversive condition­
ing is acceptable. 
Relevant Process Measures 
Rapid smoking is intended to produce aversive 
conditioned responses to stimuli associated with smok­
ing (USDHHS 1988). The technique reliably produces 
tachycardiac responses to cigarettes, and the magnitude 
of these responses is directly related to treatment out­
come (Tiffany et al. 1986; Zelman et al. 1992).  More eas­
ily observable variables, such as the number of cigarettes 
smoked during a rapid-smoking session or the degree 
of nausea reported by patients, have not been shown to 
be consistently related to outcome (USDHHS 1988). 
Other Aversive-Smoking Strategies 
Three other techniques intended to produce aver­
sion to cigarettes have been investigated:  satiation 
therapy, rapid puffing, and focused smoking.  Con­
cern over the safety of rapid smoking (Horan et al. 
1977) was partly responsible for investigation of these 
alternative aversion techniques. Some evidence sug­
gests that they are less unpleasant and less risky than 
rapid smoking (Glasgow et al. 1981; Tiffany et al. 1986). 
Satiation therapy requires that patients smoke many 
more cigarettes per day than they normally do, usu­
ally about twice as many (Best et al. 1978). Rapid puff­
ing is similar to rapid smoking, but patients are 
instructed not to inhale cigarette smoke (Tiffany et al. 
1986). Focused smoking requires patients to smoke 
for an extended period of time at a normal rate while 
concentrating on the negative sensations smoking pro­
duces (Lowe et al. 1980). 
Efficacy 
Satiation therapy alone produces relatively little 
cessation success (15 percent at one year) (Lando 1982), 
but the technique may be more effective when incor­
porated into multicomponent programs (USDHHS 
1988). Focused smoking and rapid puffing produce 
long-term abstinence rates that are equivalent to, or 
slightly lower than, those produced by rapid smoking 
(USDHHS 1988; Fiore et al. 2000). Because these tech­
niques do not appear to result in significant tachycar­
diac responses (USDHHS 1988), their efficacy is 
probably accounted for by mechanisms other than 
aversive conditioning. 
Cue Exposure 
Cue exposure therapy is based on the premise 
that smokers become conditioned to certain cues or 
contextual signals correlated with smoking behavior. 
When persons who have recently quit smoking are 
exposed to these cues, they are motivated to begin 
smoking again (Rohsenow et al. 1990–91; Brandon et 
al. 1995). In cue exposure therapy, persons trying to 
quit smoking are repeatedly exposed to these signals 
in a therapeutic context in which smoking is prohib­
ited; the resulting reduced association between smok­
ing and previous cues is hypothesized to reduce some 
of the temptation for relapse that former smokers will 
face in the natural environment. 
Because cue exposure therapy has produced 
promising results with other addictive disorders (Monti 
et al. 1993), several researchers have suggested that 
such strategies be developed for smoking cessation 
(Hodgson 1989; Heather and Bradley 1990). These 
strategies may be particularly important for women, 
whose responsiveness to nicotine replacement therapy 
appears to be less than that of men (Perkins 1996). 
Women may be less controlled by nicotine and more 
influenced by nonnicotine factors (sensory stimuli, en­
vironmental factors) (Perkins et al. 1999) and may there­
fore respond better than men to behavioral approaches. 
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Efficacy 
Studies conducted to date that have evaluated 
cue exposure have failed to find significant differences 
in outcome between cue exposure and comparison 
interventions (Lowe et al. 1980; Raw and Russell 1980; 
Götestam and Melin 1983; Corty and McFall 1984). 
However, clinical research on cue exposure for smok­
ing cessation is sparse, and interpretation of most ex­
isting trials is hampered by methodological flaws 
(Brandon et al. 1995). 
Relevant Process Measures 
Environmental associations with cigarette smok­
ing can be strong enough to provoke the desire to 
smoke (Herman 1974; Rickard-Figueroa and Zeichner 
1985; Tiffany and Hakenewerth 1991).  These provoked 
responses may affect treatment outcome (Niaura et al. 
1989). However, because cue reactivity has not been 
assessed in existing clinical trials of cue exposure 
therapy, it is impossible to determine whether such 
interventions extinguish motivational responses to 
smoking-related cues. 
Nicotine Fading 
Nicotine fading is based on the assumption that 
withdrawal symptoms will be lessened through a 
gradual reduction of nicotine intake (Foxx and Brown 
1979; McGovern and Lando 1991). Nicotine fading can 
be accomplished either by progressively switching to 
brands of cigarettes yielding less nicotine or by using 
a series of graduated filters (McGovern and Lando 
1991). Once the lowest nicotine level is reached, ces­
sation is attempted. Nicotine fading should be distin­
guished from cigarette fading, in which the number 
of cigarettes smoked per day is gradually reduced. 
Cigarette fading has generally not been shown to be 
an effective smoking cessation technique; participants 
generally reach a level beyond which they find it diffi­
cult to reduce cigarette consumption (Lando 1993; 
Fiore et al. 2000). 
Efficacy 
Foxx and Brown (1979) reported that 4 of 10 sub­
jects who tried nicotine fading had quit smoking at 18 
months, but subsequent investigations have found 
more modest long-term results (usually around 20 
percent) (Beaver et al. 1981; Lando and McGovern 1985; 
Burling et al. 1989). Some evidence suggests that nico­
tine fading can increase abstinence success indepen­
dently within a larger smoking cessation program 
Reducing Tobacco Use 
(Burling et al. 1989). In a community setting where 
participants were allowed to select their treatment, 
about 25–30 percent of those who chose multicompo­
nent interventions containing nicotine fading achieved 
long-term abstinence (Lando et al. 1990; Lando 1993). 
Brand switching and graduated filters have produced 
equivalent outcomes (McGovern and Lando 1991). 
Cinciripini and colleagues (1995) found that 44 per­
cent of persons using a combined nicotine fading and 
skills-training package were abstinent from nicotine 
at one year, a proportion significantly higher than that 
produced by matched conditions. 
Relevant Process Measures 
Nicotine fading is presumed to exert its effects 
by gradually weaning smokers from nicotine, thereby 
reducing withdrawal symptoms. Reductions in nico­
tine intake and withdrawal indexes are thus the pro­
cess measures of primary importance to nicotine 
fading. One early study suggests that nicotine fading 
reduces the severity of withdrawal symptoms (West 
et al. 1984a,b). 
The process measure of reduced nicotine intake 
is problematic, because smokers’ nicotine consump­
tion seldom matches a given brand’s machine-rated 
nicotine yields (McMorrow and Foxx 1983).  Smokers 
are able to compensate for reduced nicotine yield by 
adjusting how they smoke—by inhaling more strongly, 
holding smoke in longer before exhaling, inhaling 
more frequently, or smoking the cigarette closer to its 
high-yield butt (Benowitz et al. 1983; Kozlowski et al. 
1988). Smokers can also compensate for nicotine fad­
ing by blocking the air inlet holes on the filters that 
are used to decrease nicotine intake (McGovern and 
Lando 1991). The best available evidence indicates that 
although nicotine consumption is indeed reduced by 
nicotine fading, the extent of these reductions is smaller 
than would be expected (i.e., based on machine rat­
ings); apparently, some compensatory smoking occurs 
(Lando 1993). For example, one study (McGovern and 
Lando 1991) compared two nicotine fading regimens, 
brand switching and graduated filter use, each of 
which was designed to reduce nicotine intake by 80 
percent by the final stage.  Each regimen significantly 
reduced nicotine consumption but by far less than 80 
percent:  brand switching reduced intake by 42.5 per­
cent and graduated filters by 55.2 percent. 
Lando and McGovern (1985) suggested that nico­
tine fading increases smokers’ self-efficacy by provid­
ing them with a series of concrete steps that are 
mastered before cessation.  Self-efficacy does increase 
during the fading process (McGovern and Lando 1991), 
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although no more than with comparison treatments 
(Burling et al. 1989). Moreover, increased self-efficacy 
has not been shown to predict treatment outcome for 
nicotine fading (McGovern and Lando 1991). 
Motivational Rewards 
Strategies that use motivational rewards are 
rooted in operant conditioning theory.  These efforts 
are designed to provide reasons for remaining absti­
nent to smokers who have just quit—reasons more tan­
gible and immediate than the important but delayed 
outcomes that typically motivate cessation attempts 
(e.g., improvements in health).  In a typical motiva­
tional rewards intervention, the provider collects a 
deposit from each participant at the outset of treatment 
and refunds a portion of this sum at each follow-up 
assessment at which the participant demonstrates ab­
stinence (Paxton 1983). Other variations of this tech­
nique have used nonmonetary rewards (Lando 1982), 
punished smokers for every cigarette smoked (Murray 
and Hobbs 1981), instructed participants to reward 
themselves for abstinence (Tiffany et al. 1986), and 
rewarded participants who had reduced their carbon 
monoxide levels (Stitzer and Bigelow 1985). Curry and 
colleagues (1991) used a theoretical framework that 
tested intrinsic motivation (personalized feedback) 
against extrinsic motivation (financial incentive). Ab­
stinence at 3 and 12 months was two times higher in 
the intrinsically motivated groups. 
Efficacy 
When used alone, motivational rewards foster 
relatively high abstinence success in the short term, but 
these gains do not appear to be durable (Antonuccio 
et al. 1992). Participants often return to smoking after 
the term of the contract expires (Paxton 1980, 1981).  At­
tempts to prolong abstinence by varying factors such 
as duration and frequency of reward have generally 
been unsuccessful (Paxton 1981, 1983). Multicompo­
nent treatments using motivational rewards have some­
times fared better than comparison treatments, but these 
comparisons are generally confounded by other factors 
(Jason et al. 1990; Lando et al. 1990) and may lead to 
type II errors.  A meta-analysis of 62 studies comparing 
components of behavioral controls found that motiva­
tional rewards (contingency contracting) did not sig­
nificantly alter long-term cessation rates (Fiore et 
al. 2000). In the final results of the Minnesota Heart 
Health Program, the failure of community education 
methods (which included motivational rewards for 
smoking cessation) to produce results that exceeded 
secular trends is an important demonstration of the 
difficulties in evaluating such modalities (Lando et al. 
1995). 
Relevant Process Measures 
The process measures most relevant to this strat­
egy are presumably motivational; making rewards 
contingent on abstinence should increase a smoker’s 
resolution to remain abstinent.  However, motivational 
measures have been neglected in research on this 
intervention. Many programs require participants to 
administer their own rewards or punishments.  Evalu­
ations of these strategies should routinely assess how 
well participants take on this responsibility; to date, 
evaluations have not made this assessment. 
Social Support 
Social support interventions try to ease the smok­
ing cessation process by enlisting the support of sig­
nificant persons in smokers’ lives (extratreatment 
social support) and by providing support from clini­
cians (intratreatment social support).  Both strategies 
may range from intense and pervasive to relatively 
minimal and limited. Intensive extratreatment social 
support may train participants to elicit aid and sup­
port of family and friends, whereas training clinicians 
to communicate caring, concern, and encouragement 
increases intratreatment social support. Increasing the 
cohesiveness of smoking cessation groups can enhance 
both forms of social support (Hajek et al. 1985; Lando 
and McGovern 1991). At the basic level, the simple 
use of a group rather than an individual format can be 
viewed as a social support intervention. 
Efficacy 
Strategies that add social support to pharmaco­
logic treatment appear to significantly increase long-
term quit rates compared to treatments without social 
support, although some intensive interventions have 
reported mixed results (Glasgow et al. 1986; McIntyre-
Kingsolver et al. 1986). A recent meta-analysis of 19 
studies (Fiore et al. 2000) reported that interventions 
to increase social support in the smoker’s environment 
increase long-term cessation by 50 percent.  A meta­
analysis of 50 studies (Fiore et al. 2000) reported that 
within-treatment social support increased cessation by 
30 percent. The importance of intratreatment social 
support may well be reflected in the finding that indi­
vidual and group counseling are both much more ef­
fective than no contact interventions (Kottke et al. 1988; 
Fiore et al. 1996). 
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Relevant Process Measures 
Studies of intensive social support interventions 
have regularly included measures of smokers’ per­
ceived support. These investigations have found that 
the amount of support a smoker perceives is directly 
related to outcome (Malott et al. 1984; Glasgow et al. 
1986; McIntyre-Kingsolver et al. 1986; Gruder et al. 
1993), but the trials have typically failed to find evi­
dence that the support itself has increased this per­
ception (Malott et al. 1984; Glasgow et al. 1986). In 
one study that found social support intervention to be 
effective, the strategy was itself associated with an in­
crease in received support (Gruder et al. 1993).  More­
over, this increase in support was statistically related 
to the differential outcome.  Because support measures 
have rarely been incorporated into the evaluation of 
group treatments for smoking cessation, little is known 
about whether group formats enhance perceived sup­
port and about what influence such support has on 
treatment outcome (Hajek et al. 1985). 
Weight Control 
Most people who quit smoking gain weight 
(Klesges et al. 1989), and this effect may be greater for 
women than for men (Williamson et al. 1991; Fant 
1996). This effect has been hypothesized to result from 
nicotine’s ability to modify various mechanisms in the 
central nervous system that regulate body weight 
(Schwid et al. 1992; Perkins 1993). Apprehension about 
weight gain may serve as a barrier to cessation at­
tempts, especially among young women (Gritz et al. 
1989). Cessation strategies that address this barrier 
have only recently begun to be assessed. 
Efficacy 
Two important trials have examined the contri­
bution of a weight control component to a multicom­
ponent smoking cessation program.  One study (Hall 
et al. 1992) compared a specialized weight control pro­
gram with both a nonspecific weight control program 
and a standard program.  Patients in the specialized 
group learned behavioral self-management, reduced 
their caloric intake under the direction of a dietitian, 
and received an individualized activity plan from an 
exercise counselor.  Patients in the nonspecific group 
attended several group sessions devoted to discuss­
ing weight-related issues.  Results showed that par­
ticipants in both of these weight control programs were 
less likely to be abstinent after one year (21 percent 
success for both groups combined) than participants 
treated with the standard protocol (35 percent success). 
Reducing Tobacco Use
 
Another study (Pirie et al. 1992) examined the ef­
fects of adding nicotine gum, weight control counsel­
ing, both, or neither to a standardized smoking cessation 
program in a sample of women who had indicated that 
they were concerned about postcessation weight gain. 
After 12 months, the group that added nicotine gum to 
the standard program had much greater success (44.4 
percent had quit smoking) than the groups that added 
weight control counseling to the standard package (27.8 
percent success for the group that added weight con­
trol only and 27.6 percent success for the group that 
added both weight control and nicotine gum).  How­
ever, the standard package alone was the least success­
ful program (19.4 percent had quit smoking) and was 
viewed by participants as less appealing than the weight 
control component (Pirie et al. 1992). 
A meta-analysis of six studies (Fiore et al. 2000) 
that looked at the effect of dieting and physical activ­
ity on smoking cessation did not find that these inter­
ventions increased cessation success. A recent single 
study (Marcus et al. 1999) found that vigorous physi­
cal activity increased quit rates. 
Relevant Process Measures 
Weight gain has not been a consistent predictor 
of smoking relapse (Gritz et al. 1989), and it has pre­
dicted abstinence as well (Hall et al. 1986; Gritz et al. 
1989; Hughes et al. 1991b). Nonetheless, actual con­
trol of weight is an important process measure for 
weight control interventions—the primary purpose of 
which is relapse prevention—because they explicitly 
assume that preventing weight gain will boost absti­
nence rates (Hall et al. 1992; Pirie et al. 1992). Neither 
published trial of weight control interventions found 
differences in weight gain among abstinent subjects 
across treatment conditions (Hall et al. 1992; Pirie et 
al. 1992). One of the studies (Hall et al. 1992) found 
evidence for lower caloric intake in specialized weight 
control interventions, especially among women, but 
failed to find differences in activity levels across treat­
ment conditions. In sum, despite the intuitive appeal 
of weight control interventions to promote smoking 
cessation, there is mixed evidence relating such inter­
ventions to cessation success (Fiore et al. 2000).  Hall 
and colleagues (1992) suggested that such interventions 
may interfere with cessation. However, Marcus and 
colleagues (1999) found that a vigorous exercise inter­
vention increased quit rates while contributing to weight 
management. Pharmacotherapies, including bupropion 
sustained release (SR) and nicotine gum, may help to 
delay weight gain after cessation (Emont and 
Cummings 1987; Doherty et al. 1996; Jorenby et al. 1999). 
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Hypnosis 
Some smokers try hypnosis therapy to help them 
quit (Schwartz 1987). Strategies for hypnosis interven­
tions include direct hypnotic suggestions to quit, sug­
gestions intended to produce aversion to smoking, and 
training in self-hypnosis to reinforce formal treatment 
(Simon and Salzberg 1982). 
Efficacy 
The methodological shortcomings of hypnosis 
research make it difficult to estimate the value of this 
therapy for smoking cessation (Schwartz 1987). Re­
viewers have noted that, in general, hypnosis is not 
very effective when used alone, but it may be useful 
as part of a multicomponent intervention in which 
subjects see a therapist many times (Holroyd 1980; 
Schwartz 1987). In methodologically sound studies, 
hypnosis often fails to outperform comparison tech­
niques, such as self-help strategies (Rabkin et al. 1984; 
Lambe et al. 1986). Hypnosis techniques may work 
best for the relatively small proportion of people highly 
susceptible to hypnosis (Barabasz et al. 1986; USDHHS 
1988). Since the late 1980s, there have been only two 
trials of hypnosis in smoking cessation, with incon­
clusive results. Johnson and Karkut (1994) conducted 
an uncontrolled clinical trial of hypnosis plus aversion 
treatment and reported about 90 percent abstinence at 
three months.  A similar uncontrolled study of 226 
smokers reported a 23-percent abstinence at two years 
(Spiegel et al. 1993). A recent review of hypnosis by 
the Cochrane group (Abbot et al. 2000) found insuffi­
cient evidence to support hypnosis as a treatment for 
smoking cessation. 
Relevant Process Measures 
Appropriate process measures for studies of 
hypnosis are those that assess the various means of hyp­
notic induction and the motivational changes that are 
presumed to accrue from them.  Because measures have 
rarely been collected, little is known about the mecha­
nisms of hypnotic treatments for smoking cessation 
(Holroyd 1980; Schwartz 1987; USDHHS 1988). 
Acupuncture 
The typical acupuncture treatment for smoking 
cessation involves the insertion of needles or staples 
into the outer ear, but a number of other techniques 
have been investigated (Schwartz 1988). The most 
commonly cited rationale for using acupuncture is that 
it relieves the discomfort of nicotine withdrawal. 
Efficacy 
The available evidence suggests that acupunc­
ture is no more effective in smoking cessation than 
placebo treatments (Schwartz 1987).  For example, 
Schwartz (1988) reviewed eight studies in which acu­
puncture at a theoretically appropriate site was con­
trasted with acupuncture at a placebo site. Only one 
of these studies found greater success among partici­
pants undergoing the procedure with theoretically 
appropriate sites (MacHovec and Man 1978).  A recent 
meta-analysis of five studies (Fiore et al. 2000) found 
that acupuncture was no more effective than placebo. 
Relevant Process Measures 
Acupuncture is commonly presumed to exert its 
effects by easing tobacco withdrawal. At present there 
is no evidence that acupuncture is capable of relieving 
withdrawal symptoms associated with smoking cessa­
tion (Clavel et al. 1987; Schwartz 1987; USDHHS 1988). 
Summary of Intensive Clinical Interventions 
Intensive programs serve an important function 
in the nation’s efforts to reduce smoking, despite the 
resources the programs demand and the relatively 
small population of smokers who use them. Such pro­
grams may be particularly useful in treating smokers 
who find it most difficult to quit. 
Because intensive smoking cessation programs 
differ in structure and content, evaluation is often ham­
pered by variation in methodology and by a lack of 
research addressing specific treatment techniques. 
Because few studies have chosen to isolate single treat­
ments, assessment of the effectiveness of specific ap­
proaches is difficult.  Nonetheless, skills training, rapid 
smoking, and both intratreatment and extratreatment 
social support have been associated with successful 
smoking cessation. When such treatments are shown 
to be effective, they are usually part of a multifactorial 
intervention. Little clear evidence has implicated par­
ticular psychological, behavioral, or cognitive mecha­
nisms as the agents of change. The specific impact of 
intensive interventions may be masked by the efficacy 
of several multicomponent programs, some of which 
have achieved cessation proportions of 30–50 percent 
(Lando 1993). 
Thus, in their positive effect on smoking cessa­
tion and long-term abstinence rates (Kottke et al. 1988; 
Fiore et al. 1994a), intensive interventions seem 
little different from other forms of counseling or psy­
chotherapy.  With intensive interventions, as with 
counseling, it is difficult to attribute the efficacy to 
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specific characteristics of the interventions or to spe­
cific change mechanisms (Luborsky et al. 1975; Elkin 
et al. 1989). 
Pharmacologic Interventions 
At first look, nicotine replacement therapy ap­
pears to be the treatment of a disease with its cause. 
The rationale, however, is well established.  Observa­
tions on the beneficial effects of nicotine replacement 
in abstinent smokers were first made in 1967 (Lucchesi 
et al. 1967), and the process has its medical precedent 
in the use of methadone for opiate dependence. Nico­
tine use, in the form of 10 or more cigarettes a day, 
provides continuous neuroexposure (Benowitz 1993). 
The resulting tolerance and physical dependence pro­
duce classic withdrawal symptoms (USDHHS 1988). 
As Benowitz (1993) has summarized, “Nicotine re­
placement therapy serves primarily to break the daily 
addiction cycle by relieving withdrawal symptoms, 
thereby facilitating behavioural modification that is 
necessary for permanent smoking cessation” (p. 158). 
However, as will be discussed later in this chapter, re­
cent data suggest that nicotine replacement may be 
effective without behavioral support or counseling.  A 
number of candidate delivery systems have now been 
extensively evaluated with clear and consistent results. 
In addition, nonnicotine pharmacotherapies for treat­
ment of tobacco use are now available. 
Nicotine Polacrilex 
Nicotine polacrilex (nicotine gum) was approved 
by the Food and Drug Administration (FDA) for use 
as an aid to smoking cessation in a 2-mg dose in 1984 
and in a 4-mg dose in 1994. The nicotine in the gum is 
bound to an ion-exchange resin.  Chewing the gum 
liberates the nicotine, which is absorbed through the 
buccal mucosa. Currently, both doses of nicotine 
polacrilex are approved for use as over-the-counter 
preparations by adults.  The package insert instructs 
patients to use the gum as needed with the constraint 
that they not exceed a daily dose of 20 pieces of 4-mg 
gum or 30 pieces of 2-mg gum. 
Efficacy 
With more than 50 studies on its efficacy, nico­
tine gum is the most extensively investigated pharma­
cologic treatment for smoking cessation. This body 
of research has been summarized by several major 
meta-analyses (Lam et al. 1987; Cepeda-Benito 1993; 
Silagy et al. 1994; Tang et al. 1994).  The most recent 
Reducing Tobacco Use 
meta-analysis (Fiore et al. 2000) is summarized in Table 
4.3. All meta-analyses found the gum to be effective 
in helping smokers quit. 
Lam and colleagues (1987) performed a meta­
analysis of nine randomized, controlled trials of the 
2-mg nicotine gum. These authors performed sepa­
rate analyses on the trials conducted in specialized 
smoking cessation clinics and on those conducted in 
general medical settings. In the specialized clinics, ces­
sation success was greater with nicotine gum than with 
placebo gum. In general medical practice settings, 
however, nicotine gum was no more successful than 
placebo gum; both types of gum were more successful 
than usual care.  The authors suggested that partici­
pants at the specialized cessation clinics had greater 
success because such participants may have been more 
motivated to quit and may have received more inten­
sive adjuvant behavioral support than those at the 
generalized settings. The authors also speculated that 
patients who seek treatment in specialized clinics may 
be more physically dependent on nicotine and thus 
more likely to benefit from nicotine replacement than 
the average patient seen in a general medical clinic. 
Cepeda-Benito (1993) performed a meta-analysis 
of 33 trials of the 2-mg gum. As in the review by Lam 
and colleagues (1987), the trials were categorized ac­
cording to whether the adjuvant behavioral support 
was intensive or brief and according to whether the 
control group used placebo gum or no gum.  Pooled 
estimates of efficacy were derived for short-term (0–8 
weeks after treatment) and long-term (12 ± 2 months) 
outcome measures within each category.  Effect sizes 
were not systematically related to the type of control 
treatment used but were related to the intensity of be­
havioral support provided.  When used in intensive 
interventions, the gum was associated with greater 
abstinence success than the control treatments at both 
long-term and short-term follow-up. When used in 
brief behavioral interventions, however, the gum out­
performed the control interventions only at short-term 
follow-up. The author concluded that nicotine gum is 
an effective aid to smoking cessation but questioned 
its long-term value in the absence of adjuvant psycho­
social support. 
In the context of a larger review of available nico­
tine replacement therapies, Tang and colleagues 
(1994) performed a meta-analysis of 28 randomized, 
controlled trials of the 2-mg gum and 6 randomized, 
controlled trials of the 4-mg gum.  The authors found 
that among participants recruited through advertise­
ments to attend specialized cessation clinics, the 2-mg 
gum was associated with an 11-percent increase in 
success over control treatments.  However, among 
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smokers who were directly invited to participate in a 
general smoking cessation trial conducted by a non­
specialist physician, the 2-mg gum increased absti­
nence success by only 3 percentage points over control 
conditions. Consistent with the analysis by Lam and 
colleagues (1987), the authors suggested that these 
findings reflect (1) the greater motivation of the smok­
ers who referred themselves (i.e., responded to adver­
tisements instead of being directly invited), (2) the 
greater degree of nicotine dependence in the self-
referred group, and (3) the more extensive encourage­
ment and more detailed instructions provided by 
therapists in the specialized settings in which the self-
referred smokers were treated. 
Six of the 28 trials of the 2-mg gum (Fagerström 
1982, 1984; Jarvik and Schneider 1984; Areechon and 
Punnotock 1988; Hughes et al. 1989b; Jensen et al. 
1990) reported abstinence success as a function of 
nicotine dependence as assessed by the Fagerström 
Tolerance Questionnaire (described later in this chap­
ter). The authors aggregated these data and found 
that the 2-mg gum improved cessation success by 
16 percentage points among smokers scoring high 
(indicating considerable nicotine dependence) on the 
Table 4.3. Meta-analyses of efficacy (estimated odds ratio and abstinence rates) for seven 
pharmacotherapies used in tobacco dependence treatment 
Pharmacotherapy 
Number of 
study groups 
Estimated 
odds ratio 
(95% CI*) 
Estimated 
abstinence rate 
(95% CI) 
Bupropion SR† (n = 2‡) 
Placebo 2 1.0 17.3 
Bupropion SR 4 2.1 (1.5, 3.0) 30.5 (23.2, 37.8) 
Nicotine gum, 2 mg (n = 13) 
Placebo 16 1.0 17.1 
Nicotine gum 18 1.5 (1.3, 1.8) 23.7 (20.6, 26.7) 
Nicotine inhaler (n = 4) 
Placebo 4 1.0 10.5 
Nicotine inhaler 4 2.5 (1.7, 3.6) 22.8 (16.4, 29.2) 
Nicotine nasal spray (n = 3) 
Placebo 3 1.0 13.9 
Nicotine spray 3 2.7 (1.8, 4.1) 30.5 (21.8, 39.2) 
Transdermal nicotine 
(the nicotine patch) (n = 27) 
Placebo 28 1.0 10.0 
Transdermal nicotine 32 1.9 (1.7, 2.2) 17.7 (16.0, 19.5) 
Clonidine (n = 5) 
Placebo 6 1.0 13.9 
Clonidine 8 2.1 (1.4, 3.2) 25.6 (17.7, 33.6) 
Nortriptyline (n = 2) 
Placebo 3 1.0 11.7 
Nortriptyline 3 3.2 (1.8, 5.7) 30.1 (18.1, 41.6) 
*Confidence interval. 
†SR = sustained release. 
‡Number of studies. 
Source:  Fiore et al. 2000. 
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questionnaire but produced only a 2-percentage point 
increase among smokers whose scores indicated low 
levels of nicotine dependence. 
When data from the 4-mg gum trials (Puska et 
al. 1979; Kornitzer et al. 1987; Tønnesen et al. 1988a,b; 
Blöndal 1989; Hughes et al. 1990a) were aggregated, 
the influence of nicotine dependence paralleled that 
seen in trials using the lower dose. Among smokers 
highly dependent on nicotine, those who used the 
4-mg gum had a 21-percent greater success at cessa­
tion than those using the 2-mg gum. In contrast, 
among smokers low in nicotine dependence, those who 
used the 4-mg gum had an 18-percent lower success 
than those using the 2-mg gum. Highly dependent 
participants using the 4-mg gum had a 35-percent 
greater success than those using the placebo gum, but 
this comparative improvement was only 5 percent 
greater among less dependent participants. 
Tang and colleagues (1994) concluded that nico­
tine gum is an effective aid to smoking cessation and 
suggested that its efficacy is a direct function of the 
dependence of the smoker.  On the basis of their re­
view of other nicotine replacement therapies (includ­
ing the nicotine patch), the authors concluded that the 
4-mg gum is the most effective form of nicotine re­
placement for highly dependent smokers. 
Silagy and colleagues (1994) examined 42 nico­
tine gum trials in their meta-analysis of nicotine re­
placement interventions. To compute effect sizes for 
each analysis, the authors combined data from the 
longest follow-up assessments (mainly 12 months) 
from available trials, regardless of gum dose or type 
of control treatment.  Across all 42 trials, 42 percent of 
participants using nicotine gum quit smoking, whereas 
only 18 percent of participants in the control groups, 
who used either placebo gum or no gum, succeeded 
in quitting. The pooled odds ratio (OR) for the gum­
to-control comparison across all trials was 1.61 (95 
percent confidence interval [CI], 1.46–1.78). Differ­
ences between gum and control conditions did not 
vary according to the intensity of adjuvant behavioral 
support. 
Fiore and colleagues (1990) conducted a meta­
analysis of 13 randomized controlled trials of 2-mg 
nicotine gum therapy with at least five months of fol­
low-up (Table 4.3).  Nicotine gum treatment was asso­
ciated with a 50-percent increase in quit rates (23.7 
percent quit rate vs. 17.1 percent) in the control group. 
There were too few studies done in the over-the­
counter setting to allow meta-analysis of the over-the­
counter effect of nicotine gum. 
Reducing Tobacco Use
 
Taken together, these meta-analyses suggest that 
nicotine chewing gum is an effective aid to smoking 
cessation. This conclusion continues to be borne out 
as evidence continues to accumulate. In an ongoing 
project, Silagy and colleagues (1999) have been regu­
larly searching medical databases for new nicotine re­
placement trials, recalculating effect sizes as new data 
sources are identified, and frequently publishing the 
updated meta-analyses. In the most recent edition of 
this meta-analysis, the pooled gum-to-control OR was 
estimated at 1.63. That in most settings nicotine-
containing gum is associated with greater cessation 
success than placebo gum suggests that the gum’s ef­
ficacy is due to its pharmacologic properties.  Some 
evidence indicates that the efficacy of the 2-mg gum 
depends on the presence of intensive adjuvant behav­
ioral support. The meta-analysis by Silagy and col­
leagues (1994) suggests that nicotine gum may be 
beneficial even without intensive adjuvant therapy.  In 
this analysis, however, because 2-mg and 4-mg gum 
studies are combined, definitive conclusions about the 
efficacy of either dose alone in the absence of behav­
ioral support cannot be drawn. This finding under­
scores the importance of selecting those smokers for 
whom nicotine gum is likely to be beneficial. The avail­
able evidence suggests that traditional measures of 
nicotine dependence may be a useful basis for select­
ing gum candidates. Both doses of the gum appear to 
be of greater value to smokers who are more depen­
dent on nicotine. The 4-mg gum may be particularly 
effective for the most dependent smokers. 
Relevant Process Measures 
Nicotine gum is presumed to exert its effects by 
replacing a portion of the nicotine that smokers usu­
ally obtain through smoking; in therapy, the gum ame­
liorates aversive tobacco withdrawal (Benowitz 1991; 
Hughes 1993). Some evidence suggests that nicotine 
gum reliably reduces some withdrawal symptoms. 
Patients receiving the 2-mg nicotine gum have 
consistently reported having less total withdrawal dis­
comfort than patients treated with placebo gum (Jarvis 
et al. 1982; Hughes et al. 1984, 1989a, 1991b; Gross and 
Stitzer 1989; Hatsukami et al. 1991). However, studies 
have found that withdrawal severity is not consistently 
related to smoking relapse (West 1992; Hughes 1993), 
and the withdrawal suppression produced by nicotine 
gum appears to be somewhat independent of its effi­
cacy.  Moreover, the suppression reported seems to 
accrue through the lessening of a relatively small sub­
set of withdrawal symptoms (Hughes et al. 1990b). The 
2-mg gum consistently alleviates symptoms such as 
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anxiety and irritability but does not appear to reliably 
ameliorate craving, hunger, sleep disturbance, or dif­
ficulty concentrating (West et al. 1984a,b; Gross and 
Stitzer 1989; Hughes et al. 1989a, 1990a; Hatsukami et 
al. 1991). One trial (Hughes et al. 1990a) has found 
that the 4-mg gum was no more effective than the 
2-mg gum either in suppressing total withdrawal se­
verity or in relieving any of the individual symptoms 
of withdrawal. Future research must explore whether 
these counterintuitive findings are a result of poor 
measurement of withdrawal severity or whether other 
mechanisms explain how nicotine gum produces clini­
cal success (Hughes 1993). 
Effect on Postcessation Change in Body Weight 
Evidence suggests that the 2-mg gum is capable 
of delaying, but not preventing, postcessation weight 
gain. Early in the cessation process, smokers given 
the 2-mg gum tend to gain less weight than smokers 
treated with placebo gum (Gross et al. 1989).  During 
this period, weight gain among the 2-mg gum users is 
inversely related to the amount of gum used (Emont 
and Cummings 1987; Fagerström 1987; Killen et al. 
1990a; Nides et al. 1994). However, differences in 
weight gain between smokers using the 2-mg gum, 
using placebo gum, and using no gum (Gross et al. 
1989; Nides et al. 1994) disappear when follow-up is 
conducted after gum therapy has ended. 
Relatively little is known about the weight-
related effects of the 4-mg gum.  Early trials did not 
show it to diminish weight gain any more than either 
the 2-mg gum (Kornitzer et al. 1987; Tønnesen et al. 
1988a) or the placebo gum (Puska et al. 1979; Tønnesen 
et al. 1988a). These trials, however, tended to use dif­
ferent weight measures and more distal end points 
than the typical trial with 2-mg gum, and one trial used 
a mixed-dose regimen (Tønnesen et al. 1988a).  A more 
recent study, however, reported that nicotine gum sup­
pressed weight gain with greater suppression occur­
ring with the 4-mg dose (Doherty et al. 1996). Analysis 
of salivary cotinine showed that smokers who replaced 
a greater percentage of their baseline cotinine levels 
gained less weight. 
Side Effects and Likelihood of Inappropriate Use 
Common side effects reported by the 2-mg gum 
users include mouth soreness, hiccups, indigestion, 
jaw ache, and unpleasant taste (American Medical As­
sociation [AMA] 1993; Tang et al. 1994).  Most of these 
symptoms are relatively mild and transient, and 
many can be resolved by correcting the user ’s chew­
ing technique. Symptoms observed less frequently (in 
less than 2 percent of patients) include irritability, 
lightheadedness, headache, excessive salivation, and 
anorexia (AMA 1993).  Moreover, absorption of nico­
tine from the gum is highly dependent on the pH of 
the mouth (Henningfield et al. 1990). Because nico­
tine is inactivated by an acidic environment, patients 
are urged to refrain from eating or drinking anything 
but water for 30 minutes before using the gum.  Ap­
proximately 10–25 percent of successful abstainers con­
tinue to use the gum for one year or longer (Hajek et 
al. 1988; Hughes 1988; Hughes et al. 1991a). Although 
discontinuance of use should be encouraged, contin­
ued use confers a substantial reduced health risk com­
pared to a return to smoking.  The 4-mg gum appears 
to have similar side effects, but it may produce slightly 
more dyspepsia and hiccuping than does the 2-mg 
gum (Tønnesen et al. 1988a,b). 
Transdermal Nicotine 
In 1991, the FDA approved the use of transdermal 
nicotine patches as an aid to smoking cessation. Nico­
tine patches contain a reservoir of nicotine that diffuses 
through the skin and into the wearer’s bloodstream at 
a constant rate. Patients are usually instructed to apply 
one patch each day.  Specific dosing regimen may vary. 
All currently marketed brands are designed to 
deliver approximately 0.9 mg per hour of nicotine over 
the weaning period. Most are intended for 24-hour 
wear and deliver 21–22 mg of nicotine; one is intended 
for waking hours wear (16 hours per day) and deliv­
ers 15 mg of nicotine. Full-strength patches typically 
produce serum nicotine levels similar to trough levels 
of serum nicotine in moderate to heavy smokers 
(Mulligan et al. 1990). On July 3, 1996, the FDA ap­
proved the transdermal nicotine patch for over-the­
counter sales at a dose of 15 mg for use as part of a 
comprehensive behavioral program of smoking ces­
sation, although the FDA’s proscription does not pro­
vide a clear statement of the constituents of such a 
program.  Since that time, all varieties of nicotine 
patches have become available over the counter, some 
as “house brands.” 
Efficacy 
Several meta-analyses of the efficacy of the nico­
tine patch have been published (Po 1993; Fiore et al. 
1994c; Gourlay 1994; Silagy et al. 1994; Tang et al. 1994; 
Fiore et al. 2000).  Each meta-analysis has concluded 
that the patch is an effective aid to smoking cessation. 
Po (1993) combined data from 11 nicotine patch 
trials and found that persons using the nicotine patch 
had greater cessation success than persons using a 
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 placebo patch. This finding held for both short-term 
follow-up (3–10 weeks; combined OR = 3.10 [95 per­
cent CI, 2.65–3.62]) and long-term follow-up (6–12 
months; combined OR = 2.26 [95 percent CI, 1.80– 
2.86]). Gourlay (1994) pooled the results of six trials 
and found that the nicotine patch produced greater 
cessation success than a placebo patch at all follow-up 
assessments (2–3 months, 6 months, and 12 months; 
all pooled ORs were between 2.2 and 2.4 [95 percent 
CI, 1.6–3.4]). Tang and colleagues (1994) conducted a 
meta-analysis of six patch trials. Overall, at long-term 
(12-month) follow-up, persons using nicotine patches 
had a 9-percent (6–13 percent) greater success at ces­
sation than did persons using placebo patches. Nico­
tine patches were found to be more effective among 
self-referred subjects than among invited subjects and 
slightly more effective among smokers who were more 
dependent on nicotine. Silagy and colleagues (1994) 
combined data from nine patch trials and found that 
at long-term (12-month) follow-up, nicotine patches 
were associated with a combined OR of 2.07 (95 per­
cent CI, 1.64–2.62) when compared with control con­
ditions (placebo patches or no patch). Secondary 
analyses indicated that the patch’s relative efficacy was 
not affected by the intensity of adjuvant support.  Fiore 
and colleagues (1994c) examined 17 nicotine patch tri­
als and found a combined OR of 2.6 (95 percent CI, 
2.2–3.0) at the end of the treatment and 3.0 (95 percent 
CI, 2.4–3.7) at 12-month follow-up. More intensive ad­
juvant support was found to produce higher absti­
nence rates at six months (26.5 vs. 19.5 percent for 
low-intensity interventions) but did not increase the 
relative advantage of nicotine patches over placebo 
patches. The 16- and 24-hour patches were found to 
be equally effective.  Neither weaning nor extending 
treatment beyond eight weeks was found to improve 
outcome. A recent meta-analysis (Fiore et al. 2000) of 
27 studies reported that transdermal nicotine increased 
long-term cessation by 90 percent (Table 4.3).  A meta­
analysis of three studies reported that over-the-counter 
nicotine patch use increased successful long-term 
cessation by 80 percent (Fiore et al. 2000). 
These meta-analyses strongly indicate that the 
nicotine patch is an effective aid to smoking cessation. 
This conclusion is buttressed by the findings of a con­
tinuing, regularly updated review of the existing re­
search literature on transdermal nicotine (Silagy et al. 
1999). In the most recent release of this evolving meta­
analysis, Silagy and colleagues (1999) found a pooled 
patch-to-control OR of 1.84 (95 percent CI, 1.60–2.10). 
The data continue to suggest that 16- and 24-hour 
patches are equivalent in efficacy, that there is no ad­
vantage associated with weaning or tapering of patch 
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dose, and that the relative efficacy of the patch is fairly 
independent of the intensity of adjuvant therapy.  Nico­
tine patches have been consistently found to outper­
form placebo patches regardless of dosing regimen and 
in a variety of investigational settings. For example, a 
study of “real-world” use of the patch—based on a 
follow-back of older persons who had filled patch 
prescriptions—produced a self-reported cessation pro­
portion of 29 percent at six months (Orleans et al. 1994). 
The patch is more effective than placebo treatment 
when paired with only brief support, and it is associ­
ated with the higher long-term success when paired 
with more intensive counseling or behavioral interven­
tions (Fiore et al. 1994b).  Though the nicotine patch 
does increase success rates when used with minimal 
formal counseling, many nicotine patch clinical trials 
involve frequent follow-up assessments.  Such contacts 
might boost success rates obtained with the patch. In 
support of this possibility, Jorenby and colleagues 
(1995b) found that the combination of nicotine patch 
treatment plus frequent assessments produced follow-
up outcomes equivalent to the nicotine patch plus in­
tensive behavioral therapy.  Further assessment of this 
issue is important, as frequent follow-up contact does 
not usually accompany nicotine patch use outside of 
clinical trials (Cummings et al. 1994; Swartz et al. 1995). 
A meta-analysis of three studies of over-the-counter 
nicotine patches, however, indicated that patch therapy 
was superior to placebo (Fiore et al. 2000). 
Effects on Discomfort of Nicotine Withdrawal 
Some evidence suggests that the nicotine patch 
reduces overall measures of nicotine withdrawal dis­
comfort (Daughton et al. 1991; Transdermal Nicotine 
Study Group 1991; Jorenby et al. 1996), but this find­
ing has not been consistent (Abelin et al. 1989; 
Tønnesen et al. 1991; Merz et al. 1993). Use of the nico­
tine patch has been repeatedly found to reduce the 
craving for cigarettes (Abelin et al. 1989; Rose et al. 
1990; Tønnesen et al. 1991; Transdermal Nicotine Study 
Group 1991; Merz et al. 1993; Sachs et al. 1993; Westman 
et al. 1993; Fiore et al. 1994b; Levin et al. 1994; Jorenby 
et al. 1996), but other symptoms of nicotine withdrawal 
are affected less reliably (Palmer et al. 1992).  In a study 
designed to clarify the impact the patch has on with­
drawal symptoms, the patch reliably reduced craving, 
anxiety, and irritability but did not alleviate depressed 
mood, restlessness, or sleep disruption (Jorenby et al. 
1996). The authors noted that with or without the 
patch, most withdrawal symptoms disappeared within 
three to four weeks. 
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Effect on Postcessation Change in Body Weight 
Nicotine patches can attenuate postcessation 
weight gain while they are in use (Abelin et al. 1989; 
Sachs et al. 1993; Jorenby et al. 1995a; Dale et al. 1998), 
but this short-term effect has not always been observed 
(Rose et al. 1990; Tønnesen et al. 1991; Transdermal 
Nicotine Study Group 1991; Fiore et al. 1994b).  More­
over, studies that follow up effects after treatment has 
ended have not found that persons who used the nico­
tine patch gained less weight than those who used a 
placebo patch (Tønnesen et al. 1991). 
Side Effects and Likelihood of Inappropriate Use 
Most side effects of nicotine patch use are rela­
tively mild; less than 5 percent of patients need to dis­
continue patch therapy because of side effects (Hughes 
and Glaser 1993). Minor skin irritation at the patch 
site is reported by 30–50 percent of patch users and 
can be relieved by moving the patch to another site. 
Insomnia is reported by 1–23 percent of patch users 
(AMA 1993).  Comparatively rare side effects include 
headache, dizziness, fatigue, gastrointestinal distress, 
sweating, limb pain, and palpitations (Palmer et al. 
1992). Studies have found little evidence that people 
will inappropriately use transdermal nicotine systems 
(Palmer et al. 1992; Hughes 1993; Jorenby et al. 1995b). 
The risks associated with using the nicotine patch 
during pregnancy are largely unknown.  Nicotine it­
self poses risks to the fetus, including neurotoxicity 
(Slotkin 1998), and pregnant women should first be 
encouraged to quit without pharmacotherapy.  Because 
exposure to nicotine through maternal use of the patch 
probably poses less danger to the fetus than does con­
tinued maternal smoking (Hackman et al. 1999), how­
ever, nicotine replacement therapy may be indicated 
for pregnant women who are unable to quit smoking 
(Benowitz 1991; Lewis and Fiore 1994). However, if a 
decision is made to use nicotine replacement therapy 
during pregnancy, the physician should consider moni­
toring blood nicotine levels, using doses at the low end 
of the effective range, and choosing intermittent de­
livery systems (such as nicotine gum) (Fiore et al. 2000). 
The issue is under active investigation. 
Continued smoking while using the patch may 
be a significant problem.  In an observational study of 
self-reported patch use, almost one-half the respon­
dents stated that they smoked while using the patch; 
20 percent of the respondents did so every day (Or­
leans et al. 1994). A small number of adverse cardio­
vascular events were reported in patients who 
continued to smoke while using the patch. When these 
events received much attention from the popular press, 
several analyses, including one by an FDA advisory 
committee, have documented no association between 
nicotine replacement therapy and cardiovascular 
events even in patients who continue to smoke inter­
mittently (Working Group for the Study of 
Transdermal Nicotine in Patients with Coronary Ar­
tery Disease 1994; Joseph et al. 1996; Benowitz and 
Gourlay 1997; Mahmarian et al. 1997). Caution should 
be used, however, for patients with acute cardiovas­
cular disease (immediately post-myocardial infarction 
or in the presence of serious arrhythmias or serious or 
accelerating angina pectoris). 
Relevant Process Measures 
Like nicotine gum, the nicotine patch is intended 
to reduce tobacco withdrawal symptoms (Palmer et 
al. 1992; Glover 1993b; Hughes and Glaser 1993). Al­
though the nicotine patch appears to reduce with­
drawal severity, particularly craving for cigarettes, 
withdrawal suppression may or may not be respon­
sible for the patch’s efficacy (Hughes 1993).  For ex­
ample, one trial failed to reveal reliable differences in 
withdrawal severity between persons using nicotine 
patches and those using placebo patches (Merz et al. 
1993); the trial nevertheless found that participants 
who used the nicotine patch were nearly twice as likely 
to quit smoking. Another trial employing two doses 
of transdermal nicotine found that the higher-dose 
patch produced significantly greater cessation success 
than the lower-dose patch, even though both doses 
provided about the same amount of relief from with­
drawal symptoms (Transdermal Nicotine Study Group 
1991; Hughes 1993). Clearly, other potential mecha­
nisms of the patch’s action, as well as the action of nico­
tine replacement therapy in general, need to be 
explored. 
Nicotine Nasal Spray 
Nicotine nasal spray was approved for prescrip­
tion use in the United States in March 1996.  The spray 
consists of a pocket-sized bottle and pump assembly, 
which is fitted to a nozzle designed for insertion into 
the nose. Each metered spray delivers 0.5 mg of nico­
tine to the nasal mucosa. The recommended dose is 1 
mg, or one 0.5-mg spray per nostril, as needed 
(Sutherland et al. 1992). 
Efficacy 
A number of clinical trials have assessed the effi­
cacy of the nicotine nasal spray as an aid to smoking 
cessation. Sutherland and colleagues (1992) found that 
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26 percent of participants given nicotine nasal spray 
were abstinent after one year, compared with only 10 
percent of participants given placebo.  Hjalmarson and 
colleagues (1994) found similar results in a placebo-
controlled trial; at one-year follow-up, abstinence rates 
were 27 percent and 15 percent, respectively, for par­
ticipants given active spray or placebo. Schneider and 
colleagues (1995) again replicated this effect, finding 
continuous abstinence rates of 18 percent and 8 per­
cent among participants given active or placebo spray. 
Another study (Blöndal et al. 1997) did not find a sig­
nificant difference in abstinence rates between active 
spray and placebo groups at one year (25 vs. 17 per­
cent); active spray was associated with higher absti­
nence rates at six months and earlier in this trial. 
Recently, Blöndal and colleagues (1999) provided 
all participants in a second trial with active nicotine 
patches, then studied the incremental efficacy of add­
ing nasal spray therapy to the patch regimen in a 
double-blind, placebo-controlled fashion.  Results 
showed that participants given the active spray were 
more likely to be abstinent after one year than partici­
pants given placebo (27 vs. 11 percent).  Participants 
given active spray had a higher rate of abstinence than 
participants given placebo a full six years after the start 
of treatment (16 vs. 9 percent), but this effect was only 
marginally significant. Taken together, the results of 
these studies suggest that nicotine nasal spray is an aid 
to smoking cessation. A meta-analysis by Silagy and 
colleagues (1999) reported a pooled spray-to-control 
OR of 2.27, and a recent meta-analysis (Fiore et al. 2000) 
reported an OR of 2.7 (30.5 percent long-term abstinence 
rate) (Table 4.3). 
Effect on Discomfort of Nicotine Withdrawal 
Evidence regarding the nicotine nasal spray’s 
effects on nicotine withdrawal discomfort is sparse. 
The results of two studies suggest that the spray may 
be useful for coping with craving, but may not be ef­
fective in alleviating other withdrawal symptoms. One 
study (Sutherland et al. 1992) found that, compared 
with participants using placebo spray, participants 
treated with nicotine spray reported having less total 
withdrawal discomfort during the 48 hours immedi­
ately after smoking cessation and reported less crav­
ing for cigarettes during this period.  After 48 hours, 
however, the two groups reported equivalent levels 
of withdrawal discomfort and craving. When craving 
did arise, the nicotine spray was consistently rated 
more effective than the placebo spray. 
The other study (Hjalmarson et al. 1994) found 
that during the first 48 hours of smoking cessation, 
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users of nicotine spray reported somewhat less severe 
withdrawal discomfort than placebo users, but this 
effect was not statistically significant.  The severity of 
craving was found to be similar across both groups, 
but the nicotine spray was more helpful in quelling 
craving than the placebo spray was. Other clinical tri­
als have not reported comparisons between active and 
placebo spray groups with regard to withdrawal mea­
sures (e.g., Schneider et al. 1995; Blöndal et al. 1999). 
Effect on Postcessation Change in Body Weight 
The limited evidence available suggests that the 
nicotine nasal spray may be capable of delaying, but 
not preventing, postcessation weight gain.  In one of 
the trials (Sutherland et al. 1992), participants were 
allowed to use the spray they were assigned for as long 
as one year.  Weight effects in that study differed as a 
function of duration of spray use: abstinent subjects 
who had continued to use the nicotine spray for the 
entire year of the study had gained significantly less 
weight than subjects still using the placebo spray. 
However, change in body weight was equivalent for 
abstinent patients who had stopped using either type 
of spray during the year. 
Another study (Hjalmarson et al. 1994) failed to 
find any statistically significant differences in weight 
gain between participants using nicotine spray and 
those using placebo spray.  The authors observed, how­
ever, that participants still using nicotine spray at the 
12-month follow-up tended to gain less weight than 
both participants continuing to use a placebo spray 
and participants who had stopped using the nicotine 
spray before that time. 
Side Effects and Likelihood of Inappropriate Use 
Unpleasant side effects are common with the 
nasal spray.  Between 75 and 100 percent of nasal spray 
users reported experiencing irritant effects, such as 
runny nose, sneezing, throat irritation, nasal irritation, 
watering eyes, and coughing (Sutherland et al. 1992; 
Hjalmarson et al. 1994; Schneider et al. 1995). Some 
authors have reported that these sensory irritation ef­
fects are actually viewed as desirable by many smok­
ers and have suggested that they may help bridge the 
gap between cigarette smoking and nicotine replace­
ment (Glover 1993a; Schneider 1993). Less common 
side effects, present in 15–25 percent of users, include 
nausea, sweating, headache, dizziness, and cold hands 
and feet. 
Because the spray rapidly delivers nicotine to the 
user, the potential for inappropriate use (e.g., using 
more often or at a higher dose than recommended) is 
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high. The results of both clinical trials lend some cre­
dence to these speculations. Sutherland and colleagues 
(1992) found that 43 percent of abstinent study par­
ticipants who had been given the nicotine spray chose 
to continue using it for the entire year of the study; 
moreover, mean plasma nicotine concentrations in­
creased over the follow-up period among participants 
who continued to use the spray.  Participants in the 
trial conducted by Hjalmarson and colleagues (1994) 
were explicitly encouraged to begin weaning them­
selves from the spray (whether nicotine or placebo) 
after three months.  Nonetheless, 30 percent of absti­
nent participants who had been given the nicotine 
spray continued to use it after one year.  Schneider 
and colleagues (1995) required that participants in their 
trial use the spray daily for six weeks, then allowed 
participants to use spray for up to six months 
postcessation as needed. Thirty-two percent of par­
ticipants given active spray continued using it daily 
for six months, compared with 13 percent of partici­
pants given placebo. The authors also reported that 
some continuous abstainers assigned to active spray 
reported being concerned that they were dependent 
upon the spray at six months postcessation. However, 
a substantial proportion of these individuals remained 
abstinent many months after drug weaning. 
Relevant Process Measures 
Nicotine nasal spray, like other nicotine replace­
ment products, is intended to aid smoking cessation 
by relieving withdrawal symptoms.  Although the 
spray has been found effective in promoting cessation, 
its circumscribed impact on total withdrawal severity 
suggests that withdrawal relief is not itself responsible 
for the spray’s usefulness. The spray’s documented 
ability to alleviate craving may be what makes it an 
effective smoking cessation treatment.  More research 
is needed to advance definitive conclusions about the 
spray’s mechanism of action. 
Nicotine Inhaler 
In May 1997, the FDA approved the nicotine in­
haler for prescription use.  The inhaler consists of a 
plastic tube, about the size of a cigarette, that contains 
a plug impregnated with nicotine. Menthol is added 
to the plug to reduce throat irritation.  Smokers are 
instructed to puff on the inhaler as they would on a 
cigarette.  An average puff delivers approximately 
13 μg of nicotine (about 1/80th the amount of nicotine 
contained in an average cigarette puff), which is ab­
sorbed primarily by the buccal route (Glover 1993a; 
Tønnesen et al. 1993). Each inhaler contains enough 
nicotine for approximately 300 puffs.  Smokers are in­
structed to use between 6 and 16 inhalers per day. 
Efficacy 
A handful of published trials have examined the 
efficacy of the nicotine inhaler as an aid to smoking ces­
sation. Tønnesen and colleagues (1993) found that 17 
percent of participants randomized to active inhalers 
had quit smoking at six months, compared with 8 per­
cent of participants given placebo. Corresponding rates 
at one year were 15 vs. 5 percent.  Schneider and col­
leagues (1996) found active-placebo abstinence rates of 
17 vs. 9 percent and 13 vs. 8 percent at six months and 
one year, respectively.  These differences were not sig­
nificant in the Schneider trial, although active inhalers 
were superior to placebo at all follow-ups through three 
months postcessation. Hjalmarson and colleagues 
(1997) found continuous abstinence rates of 35 percent 
and 28 percent for active inhaler users at 6 and 12 
months, compared with 19 percent and 18 percent, 
respectively, among placebo users.  Active-placebo 
comparisons were statistically significant at all follow-
ups in this trial.  The most recent edition of a regularly 
updated meta-analysis of nicotine replacement prod­
ucts (Silagy et al. 1999) found an inhaler-to-control 
pooled OR of 2.08, and another recent meta-analysis of 
four studies (Fiore et al. 2000) reported a pooled OR of 
2.5 (Table 4.3). 
Taken together, the results suggest that the nico­
tine inhaler is an effective aid to smoking cessation. 
However, the findings of Schneider and colleagues 
(1996) suggest that the inhaler may be most useful for 
producing initial abstinence and that additional inter­
ventions may be needed to prevent relapse among 
users of the inhaler. 
Effects on Discomfort of Nicotine Withdrawal 
Limited information is available regarding the 
effects of the nicotine inhaler on nicotine withdrawal 
symptoms. Two studies (Schneider et al. 1996; 
Hjalmarson et al. 1997) showed that active inhaler use 
was associated with decreased craving during the first 
several days of the quit attempt but not thereafter. 
Hjalmarson and colleagues (1997) assessed a wide ar­
ray of withdrawal symptoms across the cessation at­
tempt, but did not find any effects of active inhalers 
on these other than the fleeting effects on craving. 
However, this may have been influenced by a floor 
effect, as mean withdrawal scores were very low in 
both groups across all assessments. 
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Side Effects and Likelihood of Inappropriate Use 
The most common side effects associated with 
inhaler use are throat irritation and coughing.  These 
are reported by between 20 to 50 percent of active in­
haler users and are less common among placebo 
inhaler users (Tønnesen et al. 1993; Schneider et al. 
1996; Hjalmarson et al. 1997). Other less common side 
effects include nausea, bad taste in the mouth, dizzi­
ness, gastrointestinal disturbances, and oral burning 
or smarting. Few (0–9 percent) active inhaler users 
have withdrawn from clinical trials or stopped using 
the inhaler because of side effects.  The potential for 
inappropriate use appears to be fairly low, with between 
2 to 16 percent of active inhaler users continuing to use 
the device at six months postcessation in clinical trials 
allowing unrestricted inhaler use (Tønnesen et al. 1993; 
Schneider et al. 1996; Hjalmarson et al. 1997). 
Effect on Postcessation Change in Body Weight 
Two placebo-controlled inhaler trials have exam­
ined postcessation weight gain (Tønnesen et al. 1993; 
Hjalmarson et al. 1997). Neither study found evidence 
that active inhaler use prevented or reduced weight 
gain among successful quitters. 
Relevant Process Measures 
The nicotine inhaler is thought to act by reliev­
ing withdrawal symptoms (Glover 1993a; Leischow 
1994), but little published evidence to date supports 
this contention. It is often suggested that the inhaler 
may be effective because it more closely resembles 
smoking than other pharmacotherapies do, replacing 
some of the orosensory and behavioral aspects of 
smoking (Glover 1993a; Tønnesen et al. 1993; Leischow 
1994; Schneider et al. 1996; Hjalmarson et al. 1997). 
Schneider and colleagues (1996) asked partici­
pants to rate their assigned inhalers relative to their 
usual brand of cigarettes in terms of sensory effects, 
preference, and satisfaction.  Results showed that par­
ticipants given the active inhaler rated their devices 
more highly than did participants given placebo. How­
ever, the absolute magnitude of the ratings revealed 
that the inhalers did not compare very favorably to 
cigarettes in either group.  The mechanism of action 
of the nicotine inhaler would seem to require further 
scrutiny. 
Bupropion 
Bupropion is an atypical antidepressant that is 
believed to work by blocking neurotransmitter 
reuptake in noradrenergic and dopaminergic sites in 
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the central nervous system (Ascher et al. 1995). Anec­
dotal reports of spontaneous smoking cessation in 
patients prescribed bupropion for depression, coupled 
with a growing appreciation of the importance of nega­
tive affect and clinical depression in smoking mainte­
nance (Hall et al. 1994; Piasecki et al. 1997) have 
recently stimulated clinical investigations of a 
sustained-release bupropion preparation as an aid to 
smoking cessation. These investigations led to the 
approval of a smoking cessation indication for 
bupropion by the FDA in 1997.  The typical dosing regi­
men for smoking cessation consists of 150 mg 
sustained-release bupropion per day for three days, 
followed by 150 mg twice a day thereafter.  Therapy is 
initiated one to two weeks before the target quit date 
and is generally continued for three months. 
Efficacy 
Two large-scale clinical trials of bupropion’s ef­
ficacy as a smoking cessation aid have been published 
to date. Hurt and colleagues (1997) compared three 
doses of bupropion (100 mg, 150 mg, and 300 mg) with 
placebo. Abstinence rates in the 150-mg and 300-mg 
groups were significantly higher than those of the pla­
cebo group at 12 months.  All active treatment groups 
were found to have higher abstinence rates than the 
placebo group at earlier end points.  Jorenby and col­
leagues (1999) studied active and placebo patches and 
active and placebo bupropion in a 2 x 2 factorial de­
sign. Abstinence rates after one year showed no dif­
ference between patch-only and placebo groups (16 
percent and 15 percent, respectively).  Both placebo 
and patch treatments were associated with higher ab­
stinence rates when given with bupropion.  Thirty 
percent of the bupropion-only group (150 mg twice a 
day) were abstinent at 12 months, whereas 36 percent 
of participants given active patches and bupropion 
were counted as abstinent. 
A recent meta-analysis (Fiore et al. 2000) of two 
studies reported a pooled OR of 2.1 and an estimated 
abstinence rate of 30.5 percent (Table 4.3).  Thus, the 
available evidence suggests that bupropion is an ef­
fective aid to smoking cessation, and that it may im­
prove quit rates over those observed with conventional 
nicotine replacement therapies, although further stud­
ies will be needed to demonstrate such efficacy. 
Effect on Discomfort of Nicotine Withdrawal 
The evidence concerning bupropion’s ability to 
suppress withdrawal symptoms is somewhat mixed. 
Hurt and colleagues (1997) found that their groups 
using 150 mg and 300 mg reported withdrawal 
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symptoms that were equivalent to those reported by 
placebo participants. Individuals assigned to the 
100-mg group, however, reported withdrawal that was 
significantly worse than that among either the placebo 
group or the other bupropion groups.  The authors sug­
gested that this effect may have arisen because the 
100-mg dose produced side effects similar to with­
drawal symptoms but was not strong enough to re­
duce true withdrawal symptoms.  Jorenby and 
colleagues (1999) found that all three groups receiv­
ing active treatments compared with the placebo group 
reported reduced withdrawal.  The group given both 
active patches and active bupropion reported the most 
consistent withdrawal relief.  Further research is 
needed to characterize the reliability and magnitude 
of bupropion effects on withdrawal symptoms. 
Relevant Process Measures 
Although nicotine replacement therapies are 
strongly predicated on the assumption that nicotine 
will relieve withdrawal symptoms, withdrawal relief 
represents only one of several rationales for using 
bupropion as a smoking cessation aid.  One hypoth­
esis is that bupropion may selectively reduce depres­
sive symptoms after cessation. However, both trials 
mentioned previously excluded individuals with cur­
rent major depression.  Both clinical trials (Hurt et al. 
1997; Jorenby et al. 1999) also included multiple as­
sessments of postcessation depressive symptomatol­
ogy, and neither found any differences among 
treatment groups on these measures.  These findings 
suggest that bupropion does not work through its an­
tidepressant effects per se in relatively healthy clinical 
trial participants. 
Bupropion moderates dopaminergic activity in the 
central nervous system, and dopaminergic circuits are 
known to play a role in drug reinforcement (Nutt 1997). 
This raises the possibility that bupropion may exert its 
effects by replacing positive reinforcement associated 
with smoking (Hurt et al. 1997). To date, there is no 
evidence directly bearing on this hypothesis, and it is 
clear that this process is not easily studied in clinical 
trials. Laboratory-based pharmacokinetic and 
neuroimaging studies should be performed to explore 
this hypothesis. 
Effects of Postcessation Change in Body Weight 
Hurt and colleagues (1997) found evidence for a 
dose-response effect among continuous abstainers, 
suggesting that participants given the highest doses 
gained less weight after quitting. Moreover, the dis­
parities between treatment groups in terms of weight 
gain increased across time while medication was dis­
pensed. At six-month follow-up, 17 weeks after par­
ticipants went off the assigned medication, no 
differences in weight gain were observed.  These com­
parisons were limited to a small subsample of continu­
ous abstainers. In the Jorenby and colleagues (1999) 
trial, members of all active treatment groups tended 
to gain less weight than did placebo participants 
over the first seven weeks of cessation. Weight gain 
suppression was greatest for the combined patch­
bupropion group. However, none of the groups dif­
fered in weight gain after seven weeks after quitting. 
Together, the results of these trials suggest that 
bupropion treatment may delay, but not prevent, 
postcessation weight gain. 
Side Effects 
In both clinical trials, two side effects were re­
ported more commonly among participants given 
bupropion than among those given placebo. Dry 
mouth was reported by 10 to 15 percent of bupropion 
users, and insomnia was reported by about 30 to 40 
percent of bupropion users.  Bupropion may increase 
the risk of seizure and is thus contraindicated for in­
dividuals who are seizure prone, such as individuals 
with a history of alcoholism or alcohol abuse, eating 
disorder, seizure disorder, or using MAO inhibitors. 
No seizures were reported in either clinical trial, but 
participants with risk factors for seizure were excluded 
from each before enrollment. 
Clonidine 
Clonidine is a centrally acting α2-adrenergic 
agonist that dampens sympathetic nervous system 
activity.  Clonidine is most commonly used in the man­
agement of hypertension; it has not been approved by 
the FDA as an aid to smoking cessation. Clonidine is 
available for prescription in oral and transdermal 
forms; both of these preparations have been investi­
gated in smoking cessation trials. Smokers using 
clonidine as an aid to smoking cessation are generally 
started on the drug several days before quitting and 
are maintained on a fixed daily dose for several weeks. 
Efficacy 
Covey and Glassman (1991) conducted a meta­
analysis of nine early trials of clonidine for smoking 
cessation. They found that persons given clonidine 
were more successful at quitting than those given a pla­
cebo (OR = 2.36). Five of the nine trials assessed out­
come after the therapy was discontinued; only one 
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(Glassman et al. 1988) showed a significant overall ad­
vantage for clonidine. Clonidine trials using adjunc­
tive behavioral therapy were associated with greater 
relative success (OR = 4.2) than were trials in which 
treatment essentially consisted of dispensing the drug 
(OR = 1.7). Trials using transdermal clonidine produced 
somewhat greater relative success (OR = 3.2) than did 
trials using oral clonidine (OR = 2.2). The two trials 
that analyzed efficacy according to sex found clonidine 
to be much more effective, relative to placebo, among 
women (OR = 11.0) than among men (OR = 0.9).  There 
is no obvious explanation for this finding. 
Since the Covey and Glassman (1991) meta­
analysis, several large-scale clonidine trials have ap­
peared (Prochazka et al. 1992; Glassman et al. 1993; 
Hilleman et al. 1993; Niaura et al. 1996). These studies 
indicated a therapeutic effect for clonidine, with some 
evidence suggesting that clonidine was more effective 
among women (Glassman et al. 1993; Hilleman et al. 
1993) and among those most dependent on nicotine 
(Glassman et al. 1993). 
A recent meta-analysis (Fiore et al. 2000) of five 
clinical trials reported a pooled OR for long-term 
effectiveness of 2.1 (25.6 percent abstinence rate) 
(Table 4.3).  In these studies, the clonidine dose ranged 
from 0.1 mg to 0.75 mg per day and was delivered 
either orally or transdermally.  Because of the side 
effects, the lack of a specific dosing regimen, the prob­
lems with abrupt discontinuation of the drug, and 
the lack of FDA approval, clonidine has been recom­
mended as a second-line agent for smoking cessation 
(Fiore et al. 2000). 
Effect on Discomfort of Nicotine Withdrawal 
An early report (Glassman et al. 1984) that 
clonidine could reduce tobacco withdrawal symptoms, 
especially craving, spurred the initial investigations of 
clonidine’s usefulness in smoking cessation. Since that 
report, evidence for this effect has been mixed. 
Clonidine- and placebo-treated patients have had 
equivalent levels of withdrawal severity (Wei and Young 
1988; Franks et al. 1989; Gourlay et al. 1994). Studies 
have fairly consistently found that clonidine diminishes 
the specific symptom of craving (Glassman et al. 1984; 
Ornish et al. 1988; Prochazka et al. 1992; Gourlay et al. 
1994), and some studies have found some effects on 
withdrawal symptoms, such as anxiety and irritability 
(Ornish et al. 1988; Prochazka et al. 1992). 
Side Effects 
Unpleasant side effects are commonly associated 
with clonidine use (Gourlay et al. 1994), and as many 
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as 25 percent of patients may discontinue clonidine 
therapy because of them (Covey and Glassman 1991). 
The most frequently observed symptoms are dry 
mouth, fatigue, and dizziness. Local skin irritation is 
common with transdermal clonidine therapy.  The in­
cidence of side effects appears to be dose dependent 
(Gourlay et al. 1994). Care must also be taken to dis­
continue clonidine gradually to prevent rebound hy­
pertension. No published clinical trials have assessed 
the effect of clonidine on postcessation weight gain. 
Relevant Process Measures 
Clonidine is presumed to exert its effects by ame­
liorating withdrawal discomfort (Glassman et al. 1984; 
Franks et al. 1989). Although a few studies have found 
that clonidine reduces withdrawal discomfort, find­
ings from a well-designed, large-scale multicenter trial 
(Prochazka et al. 1992) have suggested that this effect 
does not necessarily lead to greater abstinence. 
Nortriptyline 
Nortriptyline is a tricyclic antidepressant that 
blocks reuptake of norepinephrine and serotonin.  As 
with clonidine, smoking cessation is not an FDA-
approved indication for nortriptyline; its primary 
indication is for the treatment of depressive symptoms. 
It is a prescription medication and is available in ge­
neric form. In smoking cessation studies conducted 
to date, treatment was initiated 2–4 weeks before the 
target quit date with gradual titration of dose. 
Efficacy 
Two studies have assessed the efficacy of nortrip­
tyline for smoking cessation. Hall and colleagues 
(1998) conducted a 2 (nortriptyline vs. placebo) x 2 (his­
tory vs. no history of major depression) x 2 (cognitive 
behavioral vs. health education therapy) trial that pro­
duced a 24-percent sustained abstinence rate in nortrip­
tyline users compared with 12 percent in the placebo 
group.  There was no difference in cessation rates as a 
function of previous history of major depression.  In a 
straight comparison of nortriptyline to placebo, 
Prochazka and colleagues (1998) found cessation rates 
at six months of 14 percent in participants given 
nortriptyline and 3 percent in participants given pla­
cebo. A meta-analysis (Fiore et al. 2000) of these two 
studies reported a pooled OR of 3.2 and a 30.1-percent 
abstinence rate (Table 4.3).  Both studies provide clear 
evidence of nortriptyline’s therapeutic effect. 
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Effect on Discomfort of Nicotine Withdrawal 
The Hall and colleagues (1998) study assessed 
both nicotine withdrawal symptoms and negative af­
fect in the first eight days following the target quit date. 
There were no significant differences between the drug 
therapy groups on nicotine withdrawal severity, sug­
gesting that as with many of the other smoking cessa­
tion pharmacotherapies, withdrawal relief may not be 
the primary mechanism of action. The negative affect 
measure, however, increased in the first three days in 
the placebo group and declined in the nortriptyline 
group.  This suggests that a negative affect assessment 
may be more sensitive to some of nortriptyline’s thera­
peutic effects than a conventional nicotine withdrawal 
symptom scale. 
Side Effects 
Tricyclic antidepressants are known to produce 
a number of side effects, including sedation and vari­
ous anticholinergic effects.  In the smoking cessation 
studies, commonly reported side effects included dry 
mouth (64–74 percent), lightheadedness (49 percent), 
shaky hands (23 percent), and blurry vision (16 per­
cent) (Hall et al. 1998; Prochazka et al. 1998). 
Other Antidepressants and Anxiolytics 
Investigators have begun to explore the poten­
tial use of other antidepressants and anxiolytics as 
pharmacologic aids to smoking cessation, because 
population-based epidemiologic samples have found 
that depression and anxiety are associated with ciga­
rette smoking (Breslau et al. 1991; Kendler et al. 1993). 
Research has also shown that smokers with a history 
of depression are more likely to experience depressive 
symptoms (Covey et al. 1990) and to relapse after quit­
ting (Glassman et al. 1988; Anda et al. 1990) than are 
smokers without such a history.  Some anxiolytics 
(Glassman et al. 1984; Hilleman et al. 1992) have been 
shown to ameliorate symptoms of tobacco withdrawal, 
and preliminary smoking cessation trials using anti­
depressants (Edwards et al. 1989) and anxiolytics 
(Hilleman et al. 1994) have yielded encouraging re­
sults. Among the drugs that have been studied or 
hypothesized to be useful for smoking cessation are 
buspirone hydrochloride, doxepin hydrochloride, and 
fluoxetine hydrochloride.  Although promising, this 
avenue of research is not yet developed enough to 
permit the multipart discussion given to other phar­
macologic agents in this chapter. 
Summary of Pharmacologic Interventions 
Abundant evidence confirms that both nicotine 
gum and the nicotine patch are effective aids to smok­
ing cessation. The efficacy of nicotine gum may de­
pend on the amount of behavioral counseling with 
which it is paired.  The 4-mg dose may be the better 
pharmacologic treatment for heavy smokers or for 
those highly dependent on nicotine. The nicotine patch 
appears to exert an effect independent of behavioral 
support, but absolute abstinence rates increase as more 
counseling is added to patch therapy.  Nicotine nasal 
spray and nicotine inhalers are effective aids for smok­
ing cessation, although their mechanisms of action are 
not entirely clear.  All nicotine replacement therapies 
produce side effects, but these are rarely severe enough 
that patients must discontinue use. Nicotine nasal 
spray appears to have greater potential for inappro­
priate use than other nicotine replacement therapies. 
Nicotine replacement therapies, especially the gum 
and the patch, have been shown to delay but not pre­
vent weight gain. All nicotine replacement therapies 
are thought to work in part by reducing withdrawal 
severity.  The available evidence suggests that they 
do ameliorate some elements of withdrawal, but the 
relationship between withdrawal suppression and 
clinical outcome is inconsistent. 
Bupropion is the first nonnicotine pharma­
cotherapy for smoking cessation to be studied in large-
scale clinical trials. Results suggest that bupropion is 
an effective aid to smoking cessation.  In addition, 
bupropion has been demonstrated to be safe when 
used jointly with nicotine replacement therapy.  In the 
only direct comparison with a nicotine replacement 
product, bupropion achieved quit rates about double 
those achieved with the nicotine patch. Bupropion 
appears to delay but not prevent postcessation weight 
gain. The available literature contains inconsistent 
evidence regarding bupropion-mediated withdrawal 
relief. Bupropion does not appear to work by reduc­
ing postcessation depressive symptomatology, but its 
mechanism of action in smoking cessation remains 
unknown. Further research is needed to characterize 
bupropion’s central nervous system effects, particu­
larly to assess whether the drug partially replaces 
smoking-related positive reinforcement. 
Evidence suggested that clonidine is capable of 
improving smoking cessation rates.  Clonidine is hy­
pothesized to work by alleviating withdrawal symp­
toms. Although clonidine may reduce craving for 
cigarettes after cessation, it does not consistently ame­
liorate other withdrawal symptoms, and its effects on 
weight gain are unknown.  Unpleasant side effects are 
common with clonidine use. 
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Antidepressants and anxiolytics are potentially 
useful agents for smoking cessation. At present, only 
nortriptyline appears to have consistent empirical evi­
dence of smoking cessation efficacy.  However, tricy­
clic antidepressants produce a number of side effects, 
including sedation and various anticholinergic effects. 
Large-Scale Public Health Programs 
The shift in recent years from a clinical to a pub­
lic health perspective in smoking cessation research 
has led to an increased emphasis on developing and 
evaluating cost-effective strategies that can be widely 
disseminated (Lichtenstein and Glasgow 1992). This 
emphasis is reflected in the proliferation of research 
on self-help manuals (see “Self-Help Manuals,” ear­
lier in this chapter and “Community Programs,” later 
in this chapter) and on media- and community-based 
interventions (Flay 1987; Gruman and Lynn 1993). 
As is true for self-help strategies, media-, 
worksite-, and community-based programs have 
promise because they can potentially reach many 
smokers who may try to quit without formal, face-to­
face assistance (Fiore et al. 1990).  Moreover, some evi­
dence suggests that less educated smokers profit from 
media campaigns at least as much as more highly edu­
cated smokers do (Macaskill et al. 1992). (Other large-
scale interventions—educational [Chapter 3] and social 
[Chapter 7]—are discussed separately.) 
Investigators have evaluated an array of such 
programs, but methodological variations across the 
individual trials have hampered comparisons among 
studies (Flay 1987; Schwartz 1992). Moreover, meth­
odological challenges compromise how research on 
these programs may be interpreted.  For instance, on­
going coverage of smoking and its health consequences 
in the general media may alter the effect of research-
based media information. Similarly, secular trends and 
events that could individually affect large populations 
of smokers (e.g., the introduction of a new nicotine 
replacement product) may alter the impact—and 
complicate the assessment—of media campaigns 
conducted around the time of such events. Such chal­
lenges may account for the inconsistencies seen in this 
area of research. 
Media-Based Programs 
Media used to transmit smoking cessation mes­
sages have included television (Brannon et al. 1989; 
Korhonen et al. 1992; Mudde and De Vries 1999), ra­
dio (Farquhar et al. 1990; COMMIT Research Group 
1991), the telephone (Ossip-Klein et al. 1991; Pierce et 
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al. 1992), newspapers (Cummings et al. 1987), and the 
mail (Gritz et al. 1992; McFall et al. 1993). 
The intensity of media-based programs has var­
ied greatly, and these variations may be related to pro­
gram success. For example, one study (Gritz et al. 1992) 
evaluated a minimal mail-based intervention. The in­
vestigators mailed self-help smoking materials to a 
sample of nonvolunteer women who smoked and who 
belonged to a health maintenance organization.  The 
intervention had no impact; at no point during the 18­
month follow-up period were women who had re­
ceived the materials more likely to quit smoking or 
report changes in their motivation to quit than women 
who had not. In contrast, a more intense media cam­
paign evaluated in another study (Orleans et al. 1991) 
yielded encouraging findings, albeit among treatment 
volunteers. The investigators tested the impact of add­
ing telephone calls from a smoking cessation counse­
lor to an intervention that mailed self-help manuals to 
the volunteers. After 16 months, abstinence from 
smoking was reported by 23.0 percent of the volun­
teers who had received adjuvant telephone counsel­
ing and by 15.2 percent of those receiving the self-help 
materials alone. 
Mass media campaigns of intermediate intensity, 
such as televised programs (Flay et al. 1989), gener­
ally produce modest increases in abstinence—increases 
that fall short of the moderate effect of telephone coun­
seling found among volunteers (Orleans et al. 1991). 
The influence of intermediate-intensity interventions 
is difficult to determine precisely, because the results 
of individual trials may be affected by the peculiari­
ties of the specific communities in which they are tested 
and (as previously discussed) by concurrent changes 
in secular attitudes toward smoking behavior.  These 
problems are compounded by the designs of 
communitywide and mass media programs frequently 
failing to include matched control communities for com­
parison. Although more intensive interventions appear 
to increase cessation over time (Flay 1987), the absence 
of well-controlled experimental media trials limit any 
conclusions about a dose-response relationship for 
media-based programs. 
The content of various media-based programs 
can be divided into three categories:  (1) programs that 
present information about the negative health effects 
of smoking and exposure to secondhand smoke and 
attempt to motivate smokers to quit; (2) programs that 
promote the performance of simple cessation-related 
activities, such as calling a hot line, requesting self-
help materials, or enrolling in a smoking cessation 
contest; and (3) programs that mimic intensive clini­
cal interventions (Flay 1987). In general, informational 
   
Surgeon General's Report
 
or motivational campaigns can be effective in chang­
ing smokers’ attitudes, but the effect of such campaigns 
on behavior is not clear, in part because of the paucity 
of well-controlled trials that yield a consistent pattern 
of findings. Research suggests that other types of cam­
paigns have greater potential than informational pro­
grams to influence smoking behavior, especially if the 
campaign has multiple components and intense ex­
posure (Flay 1987; CDC 1996, 1999b; Pierce et al. 1998). 
Worksite Programs 
For many years, advocates for tobacco control 
have been enthusiastic about worksite-based programs, 
because worksites appear to furnish an ideal setting: a 
contained audience, an opportunity for smoker partici­
pation, an environment in which to convey coherent 
and consistent messages, and an opportunity to tie in­
dividual smoking cessation to overarching institutional 
policy.  Much of the early work in this area provided 
some justification for the enthusiasm (USDHHS 1986; 
Glasgow 1987; Fielding and Piserchia 1989), but more 
recent data, described later in this section (Glasgow et 
al. 1995; Sorensen et al. 1996), give pause. 
The main components of smoking cessation efforts 
in the workplace are nonsmoking policies and specific 
assistance for cessation attempts (Gruman and Lynn 
1993). The evolution of worksite smoking policies, in­
timately tied to concerns about the health effects of en­
vironmental tobacco smoke (ETS) (Eriksen 1986; 
USDHHS 1986), is described in some detail in Chapter 
5. Although early assessment suggested that restric­
tive policies had little effect on smoking outside of work 
(Glasgow 1987; Rigotti 1989; Tager 1989), most recent 
studies have demonstrated either reductions in daily 
consumption of cigarettes (Stillman et al. 1990; Borland 
et al. 1991; Jeffery et al. 1994) or increases in smoking 
cessation (Stave and Jackson 1991; Patten et al. 1995; 
Longo et al. 1996). As described in Chapter 5 (see “Clean 
Indoor Air Regulation”), there is persistent movement 
toward increasing restrictions in public workplaces. 
The strategies for smoking cessation within 
workplaces are largely those discussed earlier in this 
chapter: self-help, physician’s advice, and formal treat­
ment (Gruman and Lynn 1993).  As of 1989, about one-
half of worksites that sponsored cessation activities 
offered self-help materials (Fielding and Piserchia 
1989). Although initial dropout rates were high, 
20–26 percent of participants had quit smoking by 
6–12 months after the worksite programs had begun 
(Orleans and Shipley 1982; Glasgow 1987). Such 
proportions compare favorably with those observed 
in general populations. Physician’s advice to quit 
smoking was a component of only about 15 percent of 
the company programs, but in a number of studies, 
this modality seemed to exert an effect similar to that 
observed in general populations: 15–30 percent of par­
ticipants had quit smoking at the one-year follow-up 
(Gruman and Lynn 1993).  The programs offering for­
mal treatment appeared to produce results at the 
worksite that were similar to those found for such pro­
grams outside the workplace. 
A special feature of worksite cessation programs 
is the opportunity to provide incentives, such as com­
petitions. Several studies have documented some ef­
ficacy in this approach. For example, in one study, 33 
percent of participating workers and 25 percent of all 
workers remained abstinent at work (Glasgow 1987). 
In a second study, the use of a competition was associ­
ated with significantly greater success at quitting than 
was reported for persons not participating in the com­
petition (Klesges et al. 1988). In a review of incentive 
programs, from 15 to 60 percent of participants quit 
smoking; the average was around 40 percent (Gruman 
and Lynn 1993).  Some disadvantages of incentives are 
that (1) determining the award may be difficult, (2) 
employees may falsely claim cessation, and (3) non­
smokers may feel slighted (Fiore et al. 1996).  On a 
population basis, incentives have not been found to 
be effective.  In these settings, incentives may be most 
attractive to smokers who were going to attempt quit­
ting in any case (Chapman et al. 1993). 
In contrast, a trial of the Take Heart program, 
which involved 26 heterogeneous worksites, a low-cost 
intervention, random assignment, and use of worker 
and management steering committees, failed to pro­
duce short-term improvements in smoking cessation 
that exceeded the secular trend (Glasgow et al. 1995). 
These results were particularly disheartening in view 
of the methodological strengths of the study and the 
diversity of the workplace settings. The authors offer 
a number of potential reasons for the lack of impact: 
the cessation activities may have been inappropriate; 
the behaviors may have been more resistant to change 
than previously assumed; workers may have had in­
sufficient “ownership” of the project; secular trends 
may have been so strong that they canceled out a mod­
est effect; the variability among worksites may have 
been too great; and, in general, worksite programs may 
not work. 
Similar negative findings were observed by 
Sorensen and colleagues (1996) in an even larger trial 
of 111 worksites randomized to sites receiving or not 
receiving the cessation program.  The Working Well 
Trial involved more than 28,000 workers in 16 states 
and compared seven-day abstinence, six-month 
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abstinence, and changes in smoking prevalence for 
both types of worksites. Changes occurred in the di­
rection hypothesized, but they were small and non­
significant; for example, the six-month abstinence rate 
was only 1.5 percent higher in the program group. 
Similarly, the program sites showed a nonsignificant 
trend toward greater adoption of smoking bans.  The 
authors observed that the overall cessation proportions 
at both types of sites compared favorably with those 
in other worksite programs.  The lack of difference may 
have resulted from the higher than expected cessation 
at control sites, which is a phenomenon reflecting a 
general increase in antismoking awareness. 
These studies postdate recent reviews of worksite 
cessation efforts.  Several early reviews expressed op­
timism about the value of worksite programs but did 
not provide a quantitative assessment (Hallett 1986; 
Bibeau et al. 1988). In a detailed meta-analysis of 20 
worksite programs involving 34 comparisons, Fisher 
and colleagues (1990) found that the mean weighted 
effect size was significantly positive and that an aver­
age of 13 percent of participants had quit smoking af­
ter treatment. Although modest, these effects provide 
some quantitative basis for the enthusiasm for worksite 
programs.  The addition of the two recent large projects 
(Glasgow et al. 1995; Sorensen et al. 1996) may well 
alter the meta-analytic balance. 
Although the worksite setting has aforemen­
tioned features favorable to large-scale programs (in­
cluding the importance of adding to a generalized 
reduction in exposure to ETS), the strategy cannot be 
recommended without qualification. Nonetheless, the 
role of such activities, perhaps enlightened by further 
targeted research, may be important in multicompo­
nent efforts at smoking cessation. 
Community Programs 
Results from a number of long-term trials of 
communitywide programs have recently appeared. 
(See Chapter 7 for a more detailed discussion of these 
projects in the context of approaches used in the 1990s.) 
These trials typically incorporate mass media strate­
gies into larger health education programs.  Some, such 
as the Stanford Five-City Project (Farquhar et al. 1990), 
the Minnesota Heart Health Program (Perry et al. 1992; 
Luepker et al. 1994), and the Pawtucket Heart Health 
Program (Elder et al. 1986; Carleton et al. 1995), have 
been aimed at modifying smoking, as well as other 
risk factors for cardiovascular disease.  Final reports 
suggest that these trials have met with little success in 
promoting smoking cessation. 
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The Stanford Five-City Project (Farquhar et al. 
1990; Fortmann et al. 1993) tested an intensive multi­
media approach, including television, radio, newspa­
per, and mass-distributed printed materials.  All 
materials contained information about modifiable risk 
factors for cardiovascular disease.  The average resi­
dent of a community receiving the program was ex­
posed to more than 500 educational episodes over the 
course of the five-year program.  By the end of this 
period, smoking prevalence—the only risk factor on 
which an impact could be demonstrated—had declined 
13 percent more in the program communities than in 
the control ones.  The Minnesota Heart Health Program 
failed to demonstrate an appreciable impact (Lando et 
al. 1995). The Pawtucket Heart Health Program had 
little impact on smoking behavior; its first attempt at a 
smoking cessation program prompted only 11 smokers 
to quit (Elder et al. 1986, 1987). The final results con­
firmed the lack of impact (Carleton et al. 1995). 
One ambitious community project—COMMIT 
(Community Intervention Trial for Smoking 
Cessation)—focused on smoking cessation and on 
policy strategies to reduce prevalence (COMMIT Re­
search Group 1991; Gruman and Lynn 1993).  In 1986, 
the NCI began COMMIT, the largest randomized 
smoking intervention trial in the world. The design of 
COMMIT included 11 pairs of matched communities— 
10 from across the United States and 1 in Canada.  One 
community from each pair was randomly selected to 
be the site in which volunteers and local agencies car­
ried out COMMIT’s 58 mandated program activities. 
Designed to augment existing community-based efforts 
to reduce smoking, these activities occurred between 
1988 and 1992. 
The primary end point for COMMIT was smok­
ing cessation among heavy smokers. Main goals in­
cluded increasing the priority of smoking as a public 
health issue, increasing the community’s ability to in­
fluence smoking behavior, strengthening the 
community’s existing economic and policy factors 
designed to discourage smoking, and fortifying social 
norms and values that stressed nonsmoking (Gruman 
and Lynn 1993).  Main strategies included training 
health care providers to routinely assess and manage 
nicotine dependence, working with community insti­
tutions and private organizations to create smoke-free 
environments, increasing the availability and visibil­
ity of smoking cessation services, and using the mass 
media and schools to educate communities about the 
dangers of tobacco use. 
Results of COMMIT indicate that even intensive 
community-based programs may not have a demon­
strable impact on smoking behavior (COMMIT 
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Research Group 1995a,b).  Declines in smoking preva­
lence were no greater in program communities than 
in control communities (COMMIT Research Group 
1995b). Although the overall populations in the pro­
gram communities became more aware of available 
resources for smoking cessation, the prevalence of 
smoking cessation among persons who smoked more 
than 25 cigarettes per day did not differ between pro­
gram (18.0 percent) and control communities (18.7 
percent).  Persons who smoked fewer than 25 cigarettes 
per day were significantly more likely to quit in pro­
gram communities than in control communities (30.6 
vs. 27.5 percent), and that result was attributable to 
success among light smokers with less than a college 
education (COMMIT Research Group 1995a). 
Statewide Programs 
Recent statewide initiatives have integrated to­
bacco policy and smoking cessation programs. Al­
though Minnesota was the first state to implement a 
statewide initiative to reduce tobacco use, California 
has provided what is perhaps the most ambitious ex­
ample. Massachusetts has also conducted a similar 
statewide effort based on a tax increase and incorpo­
rating a mass media campaign, policy initiatives, and 
smoking cessation services. These initiatives and oth­
ers are discussed in detail in Chapter 7. 
The state findings are promising.  If this success 
is replicated by other states that adopt a dedicated in­
crease in cigarette excise taxes, or that are able to use 
resources from settlements with the tobacco industry, 
statewide and nationwide initiatives may play an 
important role in achieving the public health goal of 
reducing smoking prevalence among U.S. adults to less 
than 12 percent by the year 2010 (USDHHS 2000). 
Summary of Large-Scale Public Health Programs 
Community- and media-based programs have 
the potential to reach large numbers of smokers who 
are reluctant to seek formal treatment.  Such programs 
could greatly influence smoking prevalence in the 
United States. The results from major randomized tri­
als and community-based efforts are thus especially 
disappointing. Though these projects have set new 
standards for such research and have produced nu­
merous ancillary results of interest, the overall con­
clusions suggest that even large-scale, well-funded 
programs may have difficulty promoting changes in 
smoking behavior.  Similarly, the results to date from 
numerous worksite cessation projects suggest either 
no impact or a small net effect.  On the other hand, 
results of the California and Massachusetts initiatives 
(see Chapter 7) suggest that tobacco taxes may be an 
effective means of funding efforts to reduce tobacco 
use. The states that have devoted money obtained 
from Medicaid settlements with the tobacco industry 
have also had considerable success in implementing a 
comprehensive approach (Chapter 7).  Their results 
suggest that the disappointing outcomes from research 
programs may be related to the reach and penetration 
of these programs and the isolated context in which 
they were conducted. 
Contemporary Issues in Research on Tobacco Addiction
 

Epidemiologic Concerns and 
Clinical Issues 
Because smoking cessation research has focused 
more on improving standard paradigms than on in­
novative approaches (Shiffman 1993b), much of the 
current energy is directed to pursuing well-trod paths. 
But current directions have an internal logic, because 
no new paradigms loom large.  Established approaches 
are perhaps unfairly criticized for lacking innovation. 
As the foregoing discussion demonstrated, valid meth­
ods for treating nicotine addiction are available, but 
they must be better understood and can be improved. 
Despite considerable research on smoking cessation 
during the past 40 years, the essential elements or com­
bination of elements necessary for successful programs 
are difficult to extract.  In a number of key areas, how­
ever, careful research can sharpen interpretation of 
existing results and provide direction for future inves­
tigation and perhaps even innovation. 
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Nicotine Dependence 
Dependence, a central construct in research on 
drug abuse, has been defined as “self-administration 
of a psychoactive drug in a manner that demonstrates 
that the drug controls or strongly influences behav­
ior” (USDHHS 1988, p. 248). Evidence strongly sug­
gests that most smokers are dependent on nicotine 
(USDHHS 1988). However, most researchers agree that 
individual smokers differ in the degree to which they 
are dependent (Fagerström 1978; McMorrow and Foxx 
1983; Pomerleau et al. 1983; Shiffman 1989; Killen et 
al. 1992; Niaura et al. 1994). Some occasional smokers 
may not meet the criteria for physical dependence 
(Shiffman et al. 1991).  These differences in degree of 
nicotine dependence have important implications for 
treatment and research. 
Flaws in the assessment of nicotine dependence 
have impeded progress toward understanding its role 
in smoking cessation. For example, nicotine depen­
dence consists of both physical and behavioral com­
ponents (USDHHS 1988). However, most smoking 
cessation researchers have used the term to refer to 
physical dependence exclusively.  Although items in 
two widely used nicotine-dependence assessment in­
struments (the Fagerström Tolerance Questionnaire 
and its successor, the Fagerström Test for Nicotine De­
pendence) assess the extent to which nicotine controls 
behavior, the instruments are intended to measure 
physical dependence (Fagerström 1983; Fagerström 
and Schneider 1989; Heatherton et al. 1991). Other in­
vestigators have measured dependence by how much 
nicotine smokers typically self-administer (Hurt et al. 
1994) or by the severity of withdrawal symptoms 
(Brigham et al. 1990–91); these two measures are typi­
cally not highly correlated with each other, and nei­
ther is highly correlated with the Fagerström 
questionnaires (Kenford et al. 1994).  Furthermore, the 
scales themselves, especially the Fagerström Tolerance 
Questionnaire, suffer from psychometric limitations 
(Lichtenstein and Mermelstein 1986; Pomerleau et al. 
1989; Tate and Schmitz 1993).  In sum, tobacco research 
is hampered by an inadequate conceptualization of 
nicotine dependence and an inadequate assessment of 
the nicotine dependence construct. 
Because widely used dependence instruments 
such as the Fagerström questionnaire are thought to 
measure physical dependence, it has been hypothesized 
that they can help identify patients who would benefit 
from nicotine replacement therapies (Fagerström and 
Schneider 1989) or from higher doses of these thera­
pies. The evidence for this assertion is mixed, with 
support somewhat more consistent for the nicotine 
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gum than for the nicotine patch (Abelin et al. 1989; 
Fagerström and Schneider 1989; Transdermal Nicotine 
Study Group 1991; Killen et al. 1992; Kenford et al. 
1994; Niaura et al. 1994; Tang et al. 1994).  To the ex­
tent that current measures capture variation in depen­
dence, they would be expected to predict outcome in 
trials not using nicotine replacement and in groups of 
subjects treated with placebo nicotine replacement. 
Although this hypothesized correlation between de­
pendence measures and outcome has been found in 
several studies (Fagerström and Schneider 1989), the 
correlations have tended to be weak (Gritz et al. 1991; 
Kozlowski et al. 1994) and have usually been signifi­
cant only at relatively short-term follow-up points 
(Hall and Killen 1985; Pinto et al. 1987; Gritz et al. 1991; 
Nørregaard et al. 1993).  Specialized assessments of 
nicotine dependence are not recommended in current 
treatment guidelines, and pharmacotherapy is recom­
mended for all tobacco users interested in quitting.  The 
one exception is that highly dependent smokers may 
derive more benefit from 4-mg (as compared with 
2-mg) nicotine gum (Fiore et al. 2000). 
Other measures of nicotine dependence have been 
developed, but these have fared no better than the 
Fagerström questionnaire.  For example, the Heaviness 
of Smoking Index, a derivative, offers no advantage in 
predicting cessation (Kozlowski et al. 1994).  Older mea­
sures of smoking motives, such as the Horn-Waingrow 
Reasons for Smoking Scale (Horn and Waingrow 1966) 
and McKennell’s occasion for smoking scales 
(McKennell 1970), have good psychometric properties 
but questionable construct validity (Shiffman 1993a). 
Continued reconceptualization of nicotine de­
pendence and improved consensus on mechanisms for 
measuring it are critical issues for future study.  Stron­
ger ties to generic issues of substance abuse—already 
begun but not discussed in detail here (see Orleans 
and Slade 1993)—can facilitate such research and im­
prove recognition of behavioral mechanisms that are 
common to the use of all addictive substances. 
Stages of Change 
Smokers differ in their motivation to quit smok­
ing, and these differences are thought to affect treat­
ment prognosis.  The transtheoretical model, advanced 
by Prochaska and DiClemente (1983), provides a theo­
retical structure for assessing these differences and has 
greatly influenced smoking cessation research in re­
cent years. Briefly, the model proposes that smokers 
go through a series of stages (not necessarily linearly) 
on the way to achieving prolonged abstinence from 
smoking: not thinking seriously about quitting in the 
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next six months, thinking seriously about quitting in 
the next six months, planning to quit in the next month, 
actually trying to quit, and trying to remain abstinent. 
If relapse occurs, smokers return to an earlier stage in 
the model. It is hypothesized that smokers in the ini­
tial stages are less ready to quit and thus less likely to 
profit from traditional treatments (see Orleans 1993 for 
a more detailed discussion). 
Some evidence supports the notion that smok­
ers in earlier stages of change fare worse in smoking 
cessation than do smokers in later stages (DiClemente 
et al. 1991; Kristeller et al. 1992; Ockene et al. 1992; 
Rohren et al. 1994).  The finding of interactions between 
treatment assignment and stage membership 
(Prochaska et al. 1993) has led to the recommendation 
that clinical protocols for smoking cessation be based 
on stage assessments (Abrams 1993; Orleans 1993; 
Velicer et al. 1993; Hughes 1994). 
Evidence is not available, however, that linking 
motivational stage to a stage-appropriate strategy 
leads to better outcomes than do nontailored interven­
tions of equal intensity (see Prochaska et al. 1993; Fiore 
et al. 2000), perhaps because motivation to change is 
more a continuum than a set of discrete states 
(Lichtenstein et al. 1994). Nonetheless, the stages-of­
change model has considerable theoretical and empiri­
cal appeal as a typology that is easy to use in 
day-to-day decision making (Wiggins 1988).  Further 
refinement and clarification of this model, coupled 
with continued assessment of its relationship to smok­
ers’ probability of quitting, is a potentially fruitful re­
search area. 
Negative Affect 
A negative affective reaction to quitting tobacco 
use (Baker et al. 1987; Brandon 1994; Hall et al. 1994) 
may be an important predictor of relapse (Shiffman 
1982; Brandon et al. 1990; Piasecki et al. 1997). As 
mentioned previously, depressed persons are less 
likely to quit smoking successfully than persons with­
out a history of depression (Glassman et al. 1988; Anda 
et al. 1990), and depressed persons suffer an increase 
in symptoms after quitting (Covey et al. 1990; Hall et 
al. 1991). These related findings have special impor­
tance because the frequency of clinical depression 
among smokers may exceed that among nonsmokers 
(Frederick et al. 1988; Hall et al. 1991; Brandon 1994). 
The role of adverse psychological states—even 
mild conditions—in prolonging smoking and imped­
ing cessation is an important avenue for further in­
vestigation. For example, depressed or otherwise 
affectively disturbed persons may require special 
interventions to succeed in smoking cessation; at least 
two studies have identified behavioral treatments that 
have boosted success rates among such persons 
(Zelman et al. 1992; Hall et al. 1994). As noted, antide­
pressants and anxiolytics have been proposed as smok­
ing cessation aids and are undergoing clinical trials 
because of their ability to ameliorate negative affects. 
Sex-Specific Differences 
Some studies (Pomerleau et al. 1991; Kenford et 
al. 1993; Swan et al. 1993), but not all (Derby et al. 1994; 
Whitlock et al. 1997; Gritz et al. 1998), have suggested 
that women find it more difficult than men to quit 
smoking. The quit ratio (the proportion of persons who 
have quit smoking out of those who ever smoked) has 
increased at the same rate or at a faster rate among 
women than men in recent years (Fiore et al. 1989; 
Giovino et al. 1994; Husten et al. 1996). An extensive 
review of difference in nicotine effects between men 
and women (Perkins et al. 1999) cites complex differ­
ences in psychological and biologic aspects in the main­
tenance of nicotine self-administration. Women may 
differ from men in the response to withdrawal, possi­
bly mediated by menstrual cycle phase (Perkins et al. 
2000), as well as a variety of nonnicotine effects (Perkins 
et al. 1999). For example, although the same treatments 
benefit both women and men, some treatments (e.g., 
nicotine replacement therapies) may be less efficacious 
in women (Perkins 1996; Wetter et al. 1999; Fiore et al. 
2000). Other reviews of this phenomenon (Fant et al. 
1996; Christen and Christen 1998) confirm the need 
for further exploration of such differences. 
A further difference between men and women 
may be related to genetic factors, particularly differ­
ences by sex in the metabolism of nicotine (Messina et 
al. 1997; Tyndale et al. 1999).  These studies have fo­
cused on differences in the roles of enzymes involved 
in the metabolism of nicotine to cotinine (enzymes 
CYP2A6 and CYP2D6). The considerable variability 
in nicotine metabolism appears to be due to variable 
expression of CYP2A6 (Messina et al. 1997) and may 
play a role, as yet undefined, in gender response to 
therapeutic modalities. Other researchers, using stud­
ies of twins, have postulated that genetic factors may 
play a role in predicting which cigarette smokers 
progress to long-term addiction, an effect that may be 
stronger for men than for women (Heath et al. 1998). 
Withdrawal Symptoms 
The vast majority of smokers become physically 
dependent on nicotine, and these persons commonly 
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display several withdrawal symptoms when deprived 
of the substance (Shiffman and Jarvik 1976; USDHHS 
1988; Hughes et al. 1991b). Conventional wisdom holds 
that two persons who have different degrees of nico­
tine dependence will have different degrees of with­
drawal severity when they quit smoking (Fagerström 
1978; Gritz et al. 1991; Hughes 1993). Withdrawal 
symptoms are presumed to give a conflicting (and of­
ten canceling) motivation to people who have other­
wise been motivated to quit (West 1984; Hughes et al. 
1991b). The severity of the withdrawal is thus expected 
to be a strong predictor of eventual relapse (Gritz et al. 
1991; West 1992; Hughes 1993).  Some research sug­
gests that the various discomforts of abstinence are 
valid indicators of eventual relapse (Baker et al. 1987; 
Anda et al. 1990; Hughes 1992; Zelman et al. 1992). 
Despite the intuitive appeal of this proposed associa­
tion, other studies have found an inconsistent relation­
ship between withdrawal severity and relapse (Hughes 
et al. 1984; Hughes and Hatsukami 1986; Stitzer and 
Gross 1988; West et al. 1989; Transdermal Nicotine 
Study Group 1991; Prochazka et al. 1992; West 1992; 
Hughes 1993). Interpretation of this literature remains 
complicated because researchers use different instru­
ments to assess withdrawal, sometimes reporting total 
withdrawal discomfort and other times reporting re­
sults on a symptom-by-symptom basis, and because 
they assess symptomatology at different time points. 
Improved assessment of withdrawal and consensual 
definitions, coupled with epidemiologic assessment, 
may better clarify the critical connection between the 
withdrawal syndrome and the likelihood of relapse. 
Recent studies demonstrate that there is considerable 
between-subject variability in the time course of smok­
ing withdrawal and suggest that more consistent links 
between withdrawal and relapse may be found if this 
variability is systematically assessed (Piasecki et al. 
1998). 
Weight Gain 
As noted earlier in the discussion of specific 
modalities, weight gain is a common concomitant of 
smoking cessation (Klesges et al. 1989). The average 
smoker gains 5–10 pounds after cessation, and a small 
percentage of smokers gain more than 25 pounds 
(Klesges et al. 1989; Williamson et al. 1991).  The con­
cern that smokers express about gaining weight may 
be great enough to prevent them from attempting to 
quit (Klesges et al. 1988; Gritz et al. 1989; French et al. 
1992). Similarly, persons who quit smoking and who 
do subsequently gain weight may be more likely to 
relapse (Wack and Rodin 1982; Hall et al. 1986).  Two 
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prospective studies, however, found that concern 
about weight did not predict cessation success (French 
et al. 1995; Jeffery et al. 1997).  Innovative strategies 
have failed to reduce weight gain or to improve absti­
nence rates among persons concerned about gaining 
weight (Hall et al. 1992; Pirie et al. 1992). Because 
weight change is a complex metabolic phenomenon 
(about which there is a considerable epidemiologic and 
biologic literature, not reviewed here) that is subject 
to the interplay of behavioral and pharmacologic in­
fluences, further research on the behavior and physi­
ological mechanisms that produce postcessation 
weight gain may suggest new strategies for dealing 
with this problem and may provide insights into 
mechanisms of addiction. 
Early Relapse 
Three recent reports from four trials of the nico­
tine patch have found that any smoking during the 
first two weeks of using either the nicotine or the pla­
cebo patch is a strong predictor of relapse at long-term 
follow-up (Hurt et al. 1994; Kenford et al. 1994; 
Stapleton et al. 1995). For example, Kenford and col­
leagues (1994) analyzed data from two patch trials.  In 
both trials, large proportions (97.1 and 83.3 percent) 
of patients treated with the nicotine patch who smoked 
during the second week of treatment had relapsed by 
the six-month follow-up. Early relapse may predict 
longer-term failure—regardless of the cessation strat­
egy, if any—because physiological and behavioral 
forces may present their most significant challenges 
to smokers during the first two weeks they try to quit. 
Strategies that could shepherd smokers through the 
first two weeks without a single cigarette might be 
expected to improve treatment outcome.  According 
to another view, most lapses during the first two weeks 
of treatment merely identify those smokers who will 
find it difficult to quit no matter what the interven­
tion. Even if given adjunctive interventions to help 
them pass this two-week period without smoking, 
these smokers would be expected to relapse soon af­
ter these adjuncts were withdrawn.  Research on treat­
ments for persons who are strongly addicted and likely 
to relapse early (should they attempt cessation at all) 
is a great challenge for cessation research. 
Dose-Response 
More intense interventions yield better outcomes 
(Kottke et al. 1988; Lichtenstein and Glasgow 1992; 
Fiore et al. 1994c, 2000).  Although this general rela­
tionship has not been precisely explained, outcomes 
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may be influenced by a host of structural factors, in­
cluding session length, session frequency, total num­
ber of sessions, and number and types of treatment 
modalities (e.g., telephone contacts and individual vs. 
group formats). 
More specific issues must be clarified, such as 
determining what level of adjuvant behavioral sup­
port is most cost-effective when used with pharmaco­
therapy.  However, a central question surrounding the 
use of intensive interventions is whether a greater pro­
portion of smokers can be motivated to enroll in such 
treatment.  Debate over whether program refinements 
can improve outcomes may be moot, from a public 
health perspective, if most smokers continue to shy 
away from—or cannot afford to spend the time or 
money needed for—intensive interventions (Fiore et 
al. 1990; Lichtenstein and Hollis 1992). A final area for 
dose-response research concerns the optimal dose for 
nicotine replacement.  Two recent studies (Jorenby et 
al. 1995b; Hughes et al. 1999) have found that dou­
bling the normal patch dose does not improve cessa­
tion outcomes. There may be some benefit, however, 
to combining different smoking cessation pharmaco­
therapies (Blöndal et al. 1999; Jorenby et al. 1999), in­
cluding two different nicotine pharmacotherapies 
(Fiore et al. 2000). 
Treatment Components 
Defining the individual impact of treatment com­
ponents will require controlled trials that systemati­
cally manipulate individual treatment components 
against a background of constant treatment intensity. 
As Lichtenstein and Glasgow (1992) have noted, smok­
ing cessation researchers have largely abandoned this 
line of research because most comparison studies 
(though not all; see Stevens and Hollis 1989) failed to 
find significant treatment effects.  Nonetheless, until 
the combined effects of treatment components can be 
determined, empirical design of multicomponent treat­
ments will be difficult. 
Individualized Treatment 
Investigators have become increasingly inter­
ested in seeking interactions between treatment con­
tent and smokers’ characteristics. Identifying such 
interactions would allow individual smokers to be 
given specific interventions to maximize their chances 
of attaining long-term abstinence. Although subject­
by-treatment interactions have been obtained (Zelman 
et al. 1992; Niaura et al. 1994), these relationships re­
main too elusive to suggest an overall strategic theory. 
Research that incorporates unconfounded compari­
sons of specific ingredients may suggest algorithms 
for matching patient and treatment.  In view of the 
increasing presence of the computer in many people’s 
lives, computer-assisted tailored treatments warrant 
further exploration. Some tailoring and individual­
ization may be appropriate for older smokers whose 
other medical problems and pharmacologic treatment 
must be given special consideration (Rimer and Or­
leans 1993). Currently, however, there is insufficient 
evidence to recommend individually tailored interven­
tions (Fiore et al. 2000). 
An alternative to treatment matching is the strat­
egy of offering smokers increasingly more intensive 
treatments as they continue to have trouble quitting 
(Abrams 1993; Orleans 1993), despite the risk that this 
strategy will reinforce failure.  There is insufficient 
evidence, however, to recommend such a stepped-care 
approach (Fiore et al. 2000).  Research must first re­
veal hierarchies of treatment as well as determine when 
patients should be given more intensive interventions. 
Dissemination and the Role of the Clinician 
Because self-help and minimal clinical interven­
tions are likely to continue to be the preferred method 
of cessation for most smokers, innovative strategies 
must be developed to improve efficacy and delivery 
(Cohen et al. 1989b; Orleans et al. 1991; Fiore et al. 
1995). Some of the most effective of the minimal clini­
cal interventions include the institutionalization of 
system changes as core components of health care 
(Glynn and Manley 1993; Fiore et al. 2000). For ex­
ample, having a screening system in place to identify 
smokers triples clinician intervention (Fiore et al. 2000). 
Dissemination is intimately tied to the willing­
ness of clinicians to advise their patients about smok­
ing. An important area for ongoing research is the 
investigation of strategies that foster this behavioral 
role not only among physicians but also among a broad 
range of health care providers, including dentists, 
nurses, pharmacists, chiropractors, psychologists, phy­
sician assistants, and pulmonary technicians. But it is 
unlikely that behavioral modification for clinicians 
would be sufficient to produce the required dissemi­
nation. Reimbursement policies, financial incentives, 
and underlying institutional support are all critical for 
the effective management of tobacco addiction through 
clinical interventions (Kaplan et al. 1995; Rothenberg 
et al. 1998). 
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Cost-Effectiveness 
Ultimately, the test of clinical modalities for treat­
ment of nicotine addiction will be their survival in the 
current environment of cost containment and managed 
care. Private insurers are unlikely to embrace such treat­
ment unless “they are convinced that there is a market 
for such a product and that it is viable financially” 
(Schauffler and Parkinson 1993, p. 189).  For public in­
surers, demonstration of cost-effectiveness has become 
the de facto standard for adoption of new technology 
(G. Wilensky, cited in Schauffler and Parkinson 1993, 
reference 17), though some may insist on cost-savings, 
a strict standard of proof, for preventive practices. 
Smoking cessation has been called the “gold stan­
dard” of cost-effective interventions (Eddy 1992).  A 
number of studies (and several reviews [Elixhauser 
1990; CDC 1992; Tsevat 1992]) have addressed issues 
of cost-effectiveness in behavioral counseling. 
Cummings and colleagues (1989c) calculated that the 
cost-effectiveness of brief office counseling during a 
routine visit ranges from $705 to $988 per year of life 
saved for men and from $1,204 to $2,058 for women. 
The use of nicotine gum increases the cost-effectiveness 
fourfold. Oster and colleagues (1986) performed a 
similar study incorporating nicotine gum with brief 
office counseling. The costs per year of life saved 
ranged from $4,113 to $6,465 for men and from $6,880 
to $9,473 for women. Both studies noted that these costs 
compare favorably with those derived for other widely 
accepted preventive practices.  Altman and colleagues 
(1987) found that self-help materials cost $22–144 per 
person who quit, a cessation contest costs $129–239, and 
a cessation class costs $235–399. In the setting of acute 
myocardial infarction, Krumholtz and colleagues 
(1993) concluded that a nurse-managed smoking 
cessation program after myocardial infarction was 
cost-effective, particularly when compared with other 
modalities. (These studies are not necessarily reported 
in standardized dollars and are then only roughly com­
parable.) 
An analysis of the cost-effectiveness of imple­
menting the 1996 Agency for Health Care Policy and 
Research-sponsored Clinical Practice Guideline Smok­
ing Cessation reported that cost per quality-adjusted­
life-year saved ranged from $1,108 to $4,542. This 
compares very favorably with $61,744 for annual mam­
mography for women aged 40–49 years and $23,335 
for hypertension screening in 40-year-old men (Crom­
well et al. 1997). 
Because smoking during pregnancy is associated 
with lower birth weight, which in turn has been linked 
to various adverse outcomes of pregnancy, cessation of 
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smoking in pregnancy has been the subject of a num­
ber of economic analyses. Several of these have been 
performed in a managed care setting.  Using patients 
in a study performed by the Maxicare Research and 
Educational Foundation, Ershoff and colleagues (1990) 
weighed the intervention’s programmatic costs against 
the smoking-related increased costs of medical care in­
curred by mothers who continue smoking and by their 
infants. The program consisted of an initial interview, 
smoking counseling by a health educator, and a series 
of self-help books mailed to participants. The nonsmok­
ing message was reinforced at prenatal care visits.  The 
investigators concluded that in a health maintenance 
organization of 100,000 members, the cost savings from 
the cessation program was $13,432, the net benefit was 
$9,202, and the benefit-to-cost ratio was 3.17:1. 
Windsor and colleagues (1988) compared three 
cessation protocols for women in public health mater­
nity clinics: standard care, standard care combined 
with use of a cessation manual developed by the Ameri­
can Lung Association, and standard care combined 
with the use of that manual and a pregnancy-specific 
manual. At the end of pregnancy, smoking cessation 
had been achieved by 2 percent, 6 percent, and 14 per­
cent, respectively, of women in the three groups.  The 
investigators calculated cost-effectiveness as the cost 
per patient divided by the percentage who quit. The 
respective values were $104.00, $118.83, and $50.93.  In 
a second study (Windsor et al. 1993), the treatment 
group in a multicomponent intervention involving 
counseling and support had a cessation rate of 14.3 
percent, and the control group had a rate of 8.5 per­
cent. Under varying assumptions, the economic analy­
sis found that benefit-to-cost ratios ranged from 6.72:1 
to 17.18:1 and that estimated savings from statewide 
use of the program ranged from $247,296 to $699,240. 
Marks and colleagues (1990) estimated the ben­
efits that would accrue from shifting low-birth-weight 
infants into the normal-birth-weight category, from 
averting deaths attributable to prematurity, and from 
avoiding the long-term costs associated with the care 
of premature infants.  They concluded that the ratio of 
savings to costs would be as high as 6:1. If long-term 
costs were omitted, the ratio would still be $3.31 for 
each $1 spent. Finally, in a somewhat different ap­
proach to the problem, Shipp and colleagues (1992) 
tried to identify the break-even point for the cost of a 
smoking cessation program.  Under general circum­
stances, the break-even cost was $32 per pregnant 
woman, but this cost varied from $10 to $237, depend­
ing on the probability of adverse outcomes in various 
populations. 
   
 5.	 	 The evidence is strong and consistent that phar­
macologic treatments for smoking cessation 
(nicotine replacement therapies and bupropion, 
in particular) can help people quit smoking. 
Clonidine and nortriptylene may have some util­
ity as second-line treatments for smoking cessa­
tion, although they have not been approved by 
the FDA for this indication. 
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As Schauffler and Parkinson (1993) point out, 
economic analyses of smoking cessation are often 
based on hypothetical populations, start with differ­
ent assumptions about prevalence and intervention 
effectiveness, and differ in their estimation of out­
comes. Although initial results are encouraging, con­
siderable work is needed to codify the results and make 
them appealing to insurers and employers. In a re­
cent survey, only 8.6 percent of large corporations in 
California had even considered using smoking status 
in their risk ratings, and only 2.2 percent had imple­
mented such a rating. About 20 percent of companies 
offered plans that covered smoking cessation services 
(Schauffler and Parkinson 1993). Perhaps observations 
comparing long-term hospitalized care of smokers and 
nonsmokers will alter this policy.  A recent study esti­
mated that helping one smoker to quit reduces antici­
pated medical costs associated with acute myocardial 
infarction and stroke by $893 over seven years 
(Lightwood and Glantz 1997). Wagner and colleagues 
(1995) point out that smokers have consistently 
Conclusions 
increasing rates of hospitalization over five to six 
years of follow-up. In contrast, smokers who quit 
have increased hospitalization during the year in 
which they quit (probably associated with the medi­
cal reason—e.g., emphysema—for quitting in many 
cases); this rate declines thereafter.  The authors note 
that the cost savings that accrue from reduced utili­
zation would more than pay for effective cessation 
interventions within three to four years. 
The alteration of terminology—from “smoking 
cessation” to “treatment of nicotine dependence”— 
acknowledges the need to make cessation activity con­
sonant both with modern medical practice and with 
the current climate for health care delivery.  The cur­
rent body of evidence suggests that efficacious and 
cost-effective therapeutic modalities are available and 
that such consonance can be achieved. Further inves­
tigation not only of theoretical cost-effectiveness but 
also of actual use-effectiveness will have considerable 
impact on institutionalizing the treatment of nicotine 
addiction. 
1.	 	 Tobacco dependence is best viewed as a chronic 
disease with remission and relapse.  Even though 
both minimal and intensive interventions in­
crease smoking cessation, most people who quit 
smoking with the aid of such interventions will 
eventually relapse and may require repeated at­
tempts before achieving long-term abstinence. 
Moreover, there is little understanding of how 
such treatments produce their therapeutic effects. 
2.	 	 There is mixed evidence that self-help manuals 
are an efficacious aid to smoking cessation.  Be­
cause these materials can be widely distributed, 
such strategies may have a significant public 
health impact and warrant further investigation. 
3.	 	 Programs using advice and counseling—whether 
minimal or more intensive—have helped a sub­
stantial proportion of people quit smoking. 
4.	 	 The success of counseling and advice increases 
with the intensity of the program and may be im­
proved by increasing the frequency and duration 
of contact. 
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Reducing Tobacco Use 
Introduction 
Efforts to regulate the use of tobacco date back 
to its introduction to European colonists of North 
America (see Chapter 2). As noted, these early move­
ments to restrict tobacco use were motivated less by 
health concerns than by complex political, economic, 
and social factors. With the appearance in the 1950s 
of substantial scientific evidence on specific health risks 
of smoking, and with subsequent dissemination of that 
information in the 1960s, general support for a gov­
ernment regulatory response emerged. 
As noted in Chapter 1, such regulatory activities 
do not necessarily fit the traditional concept of “inter­
vention,” but their effect is to change the way people 
use tobacco. Because advertising and promotion are 
perhaps the chief social force for continued tobacco 
use, their regulation—or the failure to regulate them— 
can have substantial effects on smoking prevalence. 
The manner in which the product is manufactured, 
packaged, and distributed can similarly influence 
people’s decision to smoke. Regulation of smoking in 
public places provides an opportunity to reduce the 
quantity of tobacco used, the prevalence of smoking, 
and the exposure of nonsmokers to environmental to­
bacco smoke. The regulation of minors’ access to ciga­
rettes has considerable potential for postponing or 
preventing the uptake of smoking, thereby making a 
long-term impact on the smoking epidemic. Finally, 
personal litigation and the tort system can influence 
the policies and practices of the tobacco industry and 
can have an impact on social perceptions of smoking. 
Thus, if a broad definition of intervention can be 
entertained, each of these regulatory processes can be 
assessed for the nature of its influence on the use of 
tobacco. Unlike assessments of more traditional in­
terventions (see Chapters 3 and 4), evaluation of regu­
latory processes must invoke a different set of 
measurement tools that are less quantitative but not 
necessarily less compelling (see Chapter 1). 
Several key developments in the mid-to-late 
1990s have propelled tobacco regulation in new direc­
tions and into new forums.  Three key events have 
catalyzed these changes. They are discussed briefly 
in the next sections and in greater detail later in this 
chapter in “Further Regulatory Steps” and “Litigation 
Approaches.” 
Food and Drug Administration (FDA) 
Regulations 
First, on August 28, 1996, after receiving public 
comment on a proposed rule, the FDA issued final 
regulations restricting the sale, distribution, advertis­
ing, and promotion of cigarettes and smokeless tobacco 
(Federal Register 1996). Several tobacco companies, re­
tailers, and advertisers sued the FDA to block the 
implementation of the regulations, arguing that the 
agency lacked the jurisdiction or authority to regulate 
these products and that the proposed advertising re­
strictions violated the First Amendment of the United 
States Constitution (Coyne Beahm, Inc. v. Food and Drug 
Administration, No. 2:95CV00591 [N.C. Aug. 10, 1995], 
cited in 10.5 Tobacco Products Litigation Reporter [TPLR] 
3.379 [1995]). 
On April 25, 1997, the federal district court in 
Greensboro, North Carolina, ruled that the FDA had 
the authority to regulate cigarettes and smokeless to­
bacco products, as drug delivery devices, under the 
Federal Food, Drug, and Cosmetic Act (Coyne Beahm, 
Inc. v. U.S. Food & Drug Administration, 966 F. Supp. 
1374 [M.D.N.C. 1997]). The court upheld all of the 
FDA’s 1996 restrictions involving youth access to to­
bacco products and regulating product labeling.  How­
ever, the court “stayed,” or temporarily blocked, 
implementation of most of these provisions.  The only 
FDA regulations that escaped this stay were the pro­
hibition on sales of cigarettes and smokeless tobacco 
to minors and the requirement that retailers check 
photo identification of customers who appear to be 
under 27 years of age. These provisions went into ef­
fect on February 28, 1997.  The age and identification 
provisions remained in force until the Supreme Court’s 
March 21, 2000, decision. 
Most notably, the court invalidated the FDA’s 
restrictions on the advertising and promotion of ciga­
rettes and smokeless tobacco. Both sides in the FDA 
case appealed the decision to the Fourth Circuit of the 
United States Court of Appeals in Richmond, Virginia. 
A three-member panel of the court overturned the 
lower court’s decision and ruled that the FDA lacked 
the authority to regulate tobacco products.  The full 
Fourth Circuit Court of Appeals declined to review 
   
Surgeon General's Report
 
this reversal.  The government petitioned the United 
States Supreme Court for review, and the Supreme 
Court accepted the case in April 1999.  Oral argument 
was held December 1999, and the Court, in a 5 to 4 
decision, upheld the Fourth Circuit’s decision on 
March 21, 2000.  The FDA continued to enforce the age 
and photo identification provisions while the case was 
appealed to the United States Supreme Court.  On 
March 21, 2000, the Supreme Court ruled that although 
premature deaths from tobacco use present “one of the 
most troubling health problems facing our nation to­
day” (Food and Drug Administration v. Brown & 
Williamson, 529 U.S. _____ [2000], 120 S. Ct. 1291), the 
FDA lacks the authority to issue and enforce its tobacco 
regulations. 
These developments, central to most of the regu­
latory efforts covered in this chapter, are discussed in 
detail in the major section “Product Regulation,” later 
in this chapter. 
Initial Attempts at Multistate Settlement 
and Federal Legislation 
Second, on June 20, 1997, a group of 41 state at­
torneys general presented a tobacco settlement pro­
posal to the American public (Tobacco Products Litigation 
Reporter 1997a; see “Legislative Developments” and 
“Master Settlement Agreement,” later in this chapter). 
In essence, the proposal was intended to settle all pend­
ing lawsuits against the tobacco industry brought by 
states and other governmental entities as well as all 
pending class action lawsuits. Although the settlement 
did not include 9 of the 50 states, its scope was inher­
ently national: to enact its stipulated regulations of 
the tobacco industry, the settlement presumed the pas­
sage of congressional legislation that would necessar­
ily affect the legal rights of all Americans.  The 
settlement included provisions for FDA authority, new 
warning labels, advertising restrictions, youth access 
prohibitions, rules to reduce public exposure to envi­
ronmental tobacco smoke, and a provision designed 
to provide financial incentives for tobacco manufac­
turers to reduce sales to underaged consumers. 
Despite its intuitive appeal—that the slow, and 
largely unsuccessful, course of change possible 
through individual lawsuits would be retired for a 
sweeping, national, unified policy that dealt with the 
tobacco problem—the settlement raised concerns from 
the start. Public health advocates recognized that given 
the settlement’s national scope, it was taking on the 
role of being the chief public health policy tool for 
reducing tobacco use.  These critics feared that the 
settlement (and moreover the legislation it presumed) 
would fail in this role. In particular, by limiting future 
lawsuits against the tobacco industry, the settlement 
might in the end benefit the industry more than the 
public. 
A number of bills filed in Congress in 1997 and 
1998 intended to codify the terms of the proposed na­
tional settlement. One of the bills, S. 1415 (National 
Tobacco Policy and Youth Smoking Reduction Act, 
105th Cong., 2nd Sess., S. 1415, Congressional Record, 
144:S5034–S5084), which ultimately departed from the 
settlement proposal in a number of areas, was debated 
on the Senate floor for several weeks. It was vehe­
mently opposed by the tobacco industry and rejected 
by the Senate almost one year to the day after the at­
torneys general announced the proposed national 
settlement. The regulatory implications of the national 
settlement proposal are discussed together with the 
FDA rules, primarily in the “Product Regulation” sec­
tion of this chapter. 
Ultimately, this activity served as prologue to a 
Master Settlement Agreement that was negotiated in 
November 1998. On November 23, 1998, the agree­
ment was reached between state attorneys general and 
major U.S. tobacco companies to settle pending and 
prospective lawsuits by states to recover Medicaid 
expenditures incurred as a result of tobacco use.  Forty-
six states signed the agreement, pending the required 
ratification in state courts (four states settled separate, 
individual lawsuits with the industry). The agreement 
requires tobacco companies to pay $246 billion to states 
over 25 years and to adhere to specified restrictions 
on tobacco advertising and promotion.  Some provi­
sions are also made for improved disclosure of tobacco 
industry documents released in litigation.  A separate, 
parallel agreement with the United States Tobacco Com­
pany was negotiated for smokeless tobacco products. 
Public and Private Litigation 
Third, throughout 1997 and 1998, while federal 
legislation was being filed and debated, the states of 
Mississippi, Florida, Texas, and Minnesota settled their 
lawsuits against the tobacco industry.  Besides produc­
ing sizable settlement funds for the individual states, 
these settlements (in all but Mississippi) feature provi­
sions akin to public health regulations.  For example, 
the Florida settlement (Florida v. American Tobacco Co., 
Civil Action No. 95-1466 AH, secs. II.A.1 and II.A.2 
[Fla., Palm Beach Cty. Aug. 25, 1997]) was the first to 
incorporate a ban on outdoor advertising and to call 
for statewide restrictions on vending machines.  The 
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Minnesota settlement (Minnesota v. Philip Morris Inc., 
No. C1-94-8565 [Minn., Ramsey Cty. May 8, 1998], cited 
in 13.2 TPLR 3.39 [1998]), which followed a trial and 
the release of thousands of incriminating internal docu­
ments from the tobacco industry, contains an even 
wider array of public health restrictions, including a ban 
on promotional items and a national prohibition on com­
mercial placement of tobacco products in movies. 
Settlements of other private suits against the in­
dustry in the late 1990s have also resulted in impor­
tant regulatory measures.  For example, in a class action 
lawsuit alleging that flight attendants were injured by 
exposure to environmental tobacco smoke (Broin v. 
Philip Morris Inc., No. 91-49738 CA [22] [Fla., Dade Cty. 
Oct. 9, 1997], cited in 12.6 TPLR 3.397 [1997]), the to­
bacco industry agreed to support legislation banning 
smoking on all airlines departing from or landing in 
the United States. In a California case, R.J. Reynolds 
Advertising and Promotion 
Reducing Tobacco Use 
Tobacco Company agreed to accept advertising restric­
tions and to fund counteradvertising programs for 
teens. The latter provision was based on a claim that 
the company was violating the California consumer 
protection law by using their Joe Camel advertising 
campaign to target minors (Mangini v. R.J. Reynolds 
Tobacco Co., No. 939359 [Calif. Sept. 8, 1997], cited in 
12.5 TPLR 3.349 [1997]). 
As of September 1998, these nonnational litiga­
tions against the tobacco industry had had a greater 
and more immediate impact on tobacco regulation 
than the delayed FDA rules, proposed national settle­
ment, and defeated federal legislation. Regulation 
through litigation is a new tool for reducing tobacco 
use. Specific regulatory measures contained in these 
smaller-scope settlements are discussed in relevant 
sections of this chapter. 
Introduction 
Industries use various marketing tools and strat­
egies to influence consumer preference, thereby in­
creasing market share and attracting new consumers. 
The tobacco industry is among the most intense in its 
efforts; among U.S. manufacturers, only the automo­
bile industry markets its products more heavily (Cen­
ters for Disease Control [CDC] 1990a).  It may be 
assumed that cigarette manufacturers, like other in­
dustrial entities, direct their money and marketing ef­
forts in ways that will reach consumers they believe 
are most likely to purchase their products.  The ensu­
ing discussion focuses on direct product marketing and 
excludes other promotional and public relations efforts 
that are not product specific. 
advertising and promotion to specific consumer 
groups.  A contentious debate has persisted about 
whether marketing induces demand and what the 
appropriate role of government is in protecting the 
consumer.  Although some of these issues are not fully 
settled, they provide the background for considering 
the reduction of smoking through regulating cigarette 
advertising, promotion, product availability, and prod­
uct presentation. 
The potential influence of cigarette advertising 
and promotion on smoking prevalence has been a sub­
ject of concern and debate for many years (U.S. De­
partment of Health and Human Services [USDHHS] 
1994).1  Much of the concern has focused on whether 
consumers know about the adverse health effects of 
smoking and can make informed choices; whether 
children and adolescents are exposed to and are af­
fected by tobacco advertising and promotion; and 
whether tobacco companies inappropriately target 
In May 1981, a Federal Trade Commission (FTC) 
staff report (see “A Midcourse Assessment,” later in 
this chapter) concluded that consumer knowledge 
about the health effects of cigarette smoking was gen­
erally inadequate (Myers et al. 1981). Since then, adult 
smoking prevalence has declined substantially (from 
33.5 percent in 1980 [Giovino et al. 1994] to 24.7 per­
cent in 1995 [CDC 1997a]), and the general population’s 
knowledge about the adverse health effects of tobacco 
use has improved (in recent years, 80–90 percent of 
1 In the following discussion, advertising refers to company-
funded advertisements that appear in paid media (e.g., broad­
casts, magazines, newspapers, outdoor advertising, and transit 
advertising), whereas promotion includes all company-sponsored 
nonmedia activity (e.g., direct-mail promotion, allowances, 
coupons, premiums, point-of-purchase displays, and entertain­
ment sponsorships). 
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the general population has known that smoking is a 
health hazard [USDHHS 1989, 1998b]). During the 
same period, revenue devoted to advertising and pro­
motion by the tobacco companies has increased from 
$1.24 billion in 1980 to a high of $6.03 billion in 1993 
(FTC 1999) and $5.10 billion in 1996 (FTC 1999). To­
bacco companies spent $5.66 billion on advertising and 
promotion in 1997 (FTC 1999).  The relationship among 
these three events is not straightforward, and consid­
erable ancillary information is needed for proper in­
terpretation.  In particular, the effects that both 
knowledge and advertising and promotion have on 
smoking prevalence are complex.  For example, the 
increase in smoking uptake among women beginning 
in 1967 was associated with the marketing of specific 
cigarette brands for women (Pierce et al. 1994a).  Simi­
larly, an increase in smoking initiation among adoles­
cents during 1985–1989 has been ecologically 
associated with considerable increases in promotion 
expenditures, as exemplified by the Joe Camel cam­
paign (see “A Critical Example: Joe Camel,” later in 
this chapter) (CDC 1995b). Regardless of how these 
associations are interpreted, the actions of the tobacco 
industry bespeak the industry’s belief in corporate 
benefit from a major investment in advertising and 
promotion—an investment that may be interpreted as 
even exceeding an economically optimal level (see 
Chapter 6). 
The tobacco industry has argued that its main 
purpose in advertising is to maintain brand loyalty and 
to capture a greater market share of current smokers 
(USDHHS 1994). Intensive review of the available 
data, however, suggests a positive correlation between 
level of advertising and overall tobacco consumption— 
that is, as advertising funds increase, the amount of 
tobacco products purchased by consumers also in­
creases (USDHHS 1989, 1994; Smee 1992; Pierce and 
Gilpin 1995; also see Chapter 6). Furthermore, several 
judicial opinions (reviewed in “Constitutionality of 
Regulating Tobacco Advertising,” later in this chap­
ter) have questioned whether the enormous invest­
ment in advertising serves only brand loyalty.  It has 
also been argued that a significant part of the expand­
ing budget for tobacco marketing is for promotion to 
specific market segments (Hollie 1985). Other observ­
ers have suggested that marketing campaigns heavily 
target cultural and ethnic minorities through product 
development, packaging, pricing, and brand promo­
tion (Warner et al. 1986; Ernster 1993). 
Underlying these observations is awareness of 
a basic commercial principle:  to continue to be suc­
cessful, a product must not only retain consumers but 
also, over time, gain new consumers. Gaining new 
consumers is necessarily of particular concern to the 
tobacco industry.  Advocates for reducing tobacco use 
have pointed out that if the tobacco industry is to main­
tain current consumption or even slow the ongoing 
decline in smoking, the industry must aggressively 
seek replacement smokers for the estimated 3,500 
Americans who quit smoking each day and for the 
additional 1,200 tobacco customers and former cus­
tomers who die each day of smoking-related illnesses 
(CDC 1993b, 1997b). 
The facts about uptake of tobacco use strongly 
suggest where the industry’s replacement smokers will 
come from.  Epidemiologic studies show that nearly 
all first use of tobacco occurs before high school gradu­
ation (USDHHS 1994). Whether tobacco companies 
deliberately market their products to preadults is dif­
ficult to ascertain. Nonetheless, indirect evidence of 
the importance of advertising and promotion to the 
tobacco industry is provided by surveys that suggest 
that most adolescents can recall certain tobacco adver­
tisements, logos, or brand insignia; these surveys cor­
relate such recall with smoking intent, initiation, or 
level of consumption (Alexander et al. 1983; Goldstein 
et al. 1987; Pierce et al. 1991; Evans et al. 1995). 
The American Medical Association (Utah Delega­
tion 1989), together with a broad range of public health 
organizations, has called for stricter regulation of ciga­
rette advertisements and even for a complete ban— 
resolutions that were reiterated in 1995 (American 
Medical Association House of Delegates 1995).  Many 
public health and smoking prevention groups specifi­
cally seek government regulation to address what they 
consider discriminatory practices of tobacco manufac­
turers in targeting members of minority groups 
(Warner et al. 1986).  These groups claim that adver­
tisements overwhelm smoking prevention messages 
and increase the number of people who smoke each 
year beyond the number that would smoke if adver­
tising and promotion affected only market share.  In­
dustry officials deny targeting and argue that because 
most of the population is now aware of the risks asso­
ciated with tobacco products, citizens can make in­
formed decisions for themselves. More important, the 
tobacco industry claims its First Amendment consti­
tutional right to promote its products (Cotton 1990; 
Tollison and Wagner 1992; see the discussion in “Con­
stitutionality of Regulating Tobacco Advertising,” later 
in this chapter). 
Such arguments and counterarguments have 
been at the heart of a 30-year endeavor to regulate 
advertising and promotion in the tobacco industry.  A 
review of this effort, with some specific examples from 
the United States and other countries, provides insight 
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into the strengths and weaknesses of both sides of 
the argument and suggests several areas for policy 
development. 
Attempts to Regulate Tobacco Advertising 
and Packaging 
Regulatory efforts to restrict the advertising and 
promotion of cigarettes were among the earliest re­
sponses to the 1964 landmark report of the Surgeon 
General’s Advisory Committee, which set forth over­
whelming scientific evidence on the health hazards of 
cigarette smoking.  A week after the January 11, 1964, 
release of the report, the FTC filed a Notice of Rule-
Making Proceeding (January 17, 1964) that appeared 
in the January 22, 1964, Federal Register. The notice set 
forth the agency’s tentative views of how the require­
ments of the Federal Trade Commission Act (Public 
Law 96-252) would apply to the advertising and la­
beling of cigarettes in light of the Advisory 
Committee’s report (Federal Register 1964). In a perti­
nent part, section 5 of the Federal Trade Commission 
Act states that “unfair or deceptive acts or practices 
[are] declared unlawful” and that the commission has 
the power to proceed against them as an administra­
tive agency. 
In its notice of rulemaking, the FTC stated its 
concern with “two ways in which cigarette advertis­
ing may be unlawfully misrepresenting or concealing 
the health hazards of smoking.  First, the Commission 
has reason to believe that many current advertisements 
falsely state, or give the false impression, that ciga­
rette smoking promotes health or physical well-being 
or is not a health hazard, or that smoking the adver­
tised brand is less of a health hazard than smoking 
other brands of cigarettes” (Federal Register 1964, 
p. 530). The FTC also stated that much cigarette ad­
vertising then current portrayed cigarette smoking as 
pleasurable, desirable, compatible with physical fit­
ness, or indispensable to full personal development 
and social success—all without informing the con­
sumer of the health hazards of cigarette smoking. 
The FTC posited that the dangers to health from 
cigarette smoking are so serious that knowledge and 
appreciation of them would be a material factor in in­
fluencing a person’s decision to smoke cigarettes or to 
smoke a particular brand. (This point is considered in 
detail in “Tobacco Packaging and Informed Choice,” 
later in this chapter.)  Affirmative disclosures of these 
health hazards might thus be necessary in cigarette 
advertising that could cloud or obscure public con­
sciousness of these health hazards.  After receiving 
Reducing Tobacco Use 
written comments and materials from interested 
parties and after conducting hearings in March 1964 
on the proposed rule (see the text box “Response From 
the Tobacco Industry—1964”), the FTC issued on June 
22, 1964, the “Statement of Basis and Purpose” regard­
ing its proposed Trade Regulation Rule.  (A Trade 
Regulation Rule is, in effect, an administrative statute 
with the force of law.)  In this document, the commis­
sion announced that it would require warnings on ciga­
rette packages and in advertisements for cigarettes that 
cigarette smoking is dangerous to human health. 
Cigarette Warning Labels 
After participating in hearings before the U.S. 
House of Representatives Committee on Interstate and 
Foreign Commerce on cigarette labeling and FTC rules, 
the commission postponed until 1965 the implemen­
tation of any Trade Regulation Rule.  In that year, the 
Federal Cigarette Labeling and Advertising Act of 1965 
(Public Law 89-92) required that the warning “Cau­
tion: Cigarette Smoking May Be Hazardous to Your 
Health” (Federal Cigarette Labeling and Advertising 
Act, sec. 4) be placed in small print on one of the side 
panels of each cigarette package. The act permitted 
no additional labeling requirement under any federal, 
state, or local law, thus effectively preempting any 
other health messages on cigarette packages.  The act 
also suspended for three years the FTC’s authority to 
require health warnings on cigarette advertising. 
This preemption was strongly opposed in the 
minority view of Representative John E. Moss (D-CA), 
who presented the argument as follows: 
I most strongly object to sections 6 and 7 of this 
bill. Section 6 would prevent the Federal Trade 
Commission, the Food and Drug Administration, 
and the U.S. Public Health Service in administer­
ing their respective laws from imposing any addi­
tional requirement with regard to the labeling of 
cigarettes involving a health warning.  The bill 
would also preclude State and local health authori­
ties from imposing such requirements. 
Section 7, the preemption provision of the bill, 
provides that no cautionary statement with respect 
to smoking and health other than specified in this 
legislation shall be required on any package; and 
that no such statement with respect to smoking 
and health shall be required in advertising for ciga­
rettes packaged in conformity with the labeling 
provisions of this legislation. 
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The Secretary of Health, Education, and Welfare 
has said that preventing any regulatory agency 
from imposing a label warning requirement other 
than that prescribed in the bill is “a position which 
we consider too inflexible.” 
The National Interagency Council on Smoking and 
Health submitted a petition to the committee ask­
ing us “not to approve any legislation which will 
prevent the Federal Trade Commission from car­
rying out its reaffirmed intention of requiring 
health warnings in cigarette advertising” (Moss 
1965, pp. 2365–6). 
Representative Moss concluded his minority report 
with a strong condemnation: 
In summary, I am strongly opposed to those fea­
tures of this legislation which would preclude the 
imposition of more stringent labeling requirements 
or the imposition of health warnings in advertise­
ments which Federal, State, or local health authori­
ties may deem necessary in the future in the proper 
exercise of their respective powers.  We must face 
the facts as presented to us by the Surgeon Gen­
eral, American Cancer Society, American Medical 
Association, American Heart Association, and the 
National Tuberculosis Association.  We must first 
concern ourselves with public health and welfare, 
not legislate to the whims of a special interest 
(Moss 1965, p. 2367). 
In commenting on the 1965 labeling law, the Sec­
retary of the Department of Health, Education, and 
Welfare outlined an alternative view of effective health 
warnings on cigarette packages (Celebrezze 1965). 
Secretary Anthony J. Celebrezze recommended that the 
warning appear in large type on the main faces of the 
package. He commented: 
The statute should require the warning to be 
prominent and conspicuous but should leave the 
precise location and size of the warning on the la­
bel, and related matters, to regulation in the light 
of the expertise and experience of the regulatory 
agency. . . . [Ten]-point type, which is 2 points 
smaller than the type size used in typing this let­
ter, is hardly calculated to invite the consumer’s 
attention. . . . 
If the required warning is in effect negated or dis­
claimed on the label or in accompanying literature 
by words, statements, designs, or other graphic 
material, the warning requirement shall be deemed 
Response From the Tobacco Industry—1964 
In April 1964, in rapid response to the Surgeon At hearings before the House Interstate and General’s report, the tobacco industry published Foreign Commerce Committee on June 25, 1964, 
a voluntary code for advertising and marketing prac- Bowman Gray, Chairman of the Board of R.J. 
tices (Gray 1964). The stated purpose of the code Reynolds Tobacco Company, speaking on behalf of 
was “to establish uniform standards for cigarette the industry, told Congress, “This advertising code 
advertising and to provide means whereby compli- represents a sincere effort by the industry to respond 
ance with this code can be ascertained promptly and to criticism of the industry’s advertising which has 
fairly and on a consistent basis” (p. 141). The code been voiced in some quarters. It is an earnest effort 
was designed to restrict cigarette advertisements at industry self-regulation.  I hope the industry will 
aimed at young people, to limit implied or direct be given reasonable opportunity to implement this 
health claims to those that could be medically and code” (Gray 1964, p. 141). 
scientifically proved, and to curb the so-called viril- The code was to be enforced by an indepen­
ity theme in cigarette advertisements.  The code spe- dent administrator.  All advertisements were to be 
cifically prohibited advertising that suggested that precleared, and violations of the code were subject 
cigarette smoking was essential to “sexual attrac- to a fine of $100,000. Enforcement provisions of the 
tion,” “success,” sophistication, athletic abilities, code were dropped shortly after passage of the Fed-
physical stamina, and “social prominence” (p. 143)— eral Cigarette Labeling and Advertising Act in 1965. 
images that the industry recognized as influencing 
smoking by young people. 
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not to have been met. . . . [Congress should con­
sider giving the department] specific authority to 
prohibit or regulate the use of statements that 
while not clearly negating the warning and while 
literally true or at least not demonstrably false, 
may give the consumer the misleading impression 
that a given cigarette is safer than others 
(Celebrezze 1965, p. 2359). 
These recommendations predate by three decades simi­
lar implementation of warnings in other countries (de­
scribed in “Examples of Product Labeling in Other 
Countries,” later in this chapter); such an approach, 
however, has not been taken in this country. 
The 1965 law also required that the FTC annu­
ally transmit to Congress a report on the effectiveness 
of cigarette labeling, on current cigarette advertising 
and promotion practices, and on recommendations for 
legislation. In June 1967, in its first report to Congress, 
the FTC recommended that the package label be 
changed to “Warning:  Cigarette Smoking Is Danger­
ous to Health and May Cause Death from Cancer and 
Other Diseases” (FTC 1967, p. 30). 
Broadcast Advertising Ban 
In 1969 Congress passed the Public Health Ciga­
rette Smoking Act (Public Law 91-222), which prohib­
ited cigarette advertising on all media subject to 
Federal Communications Commission (FCC) regula­
tion, especially radio and television broadcasting, and 
required that each cigarette package contain the label 
“Warning:  The Surgeon General Has Determined That 
Cigarette Smoking Is Dangerous to Your Health” (Pub­
lic Health Cigarette Smoking Act, sec. 4).  This new 
law also preempted any other health warning require­
ments for cigarette packages.  The prohibition on 
broadcast media advertising became effective on Janu­
ary 2, 1971. The FTC issued complaints against the 
cigarette companies that eventually led to a consent 
decree requiring the companies to add the statutory 
label warning to their advertising in magazines, news­
papers, and outdoor displays (Trade Regulation Reporter 
1973). 
The prohibition on television and radio advertis­
ing was challenged—not by the cigarette companies, 
but by a group of broadcasters—in Capital Broadcasting 
Co. v. Mitchell (333 F. Supp. 582 [D.D.C. 1971]).  That 
case upheld the constitutionality of the congressional 
prohibition by a 2 to 1 vote.  Despite this victory, a so­
bering note was struck in the dissenting opinion of 
Judge J. Skelly Wright.  Far from casting his vote against 
smoking prevention, Judge Wright was concerned that 
upholding the act, and thus upholding the prohibition 
on broadcast advertising, would actually aid the tobacco 
industry.  His reasoning—which proved correct—was 
that the ban would put an end not only to tobacco ad­
vertising but also to the cost-free counteradvertising that 
had been running in the electronic media since 1969, 
when the FCC’s Fairness Doctrine was first held appli­
cable to cigarette advertising. 
The Fairness Doctrine, which was put forth in 
1949 (and ceased applying to tobacco in 1971 after ciga­
rette advertising on radio and television ended), re­
quired that whenever material covering “ ‘a 
controversial issue of public importance’ ” (Banzhaf v. 
FCC, 405 F.2d 1082, 1086 [D.C. Cir. 1968], cert. denied, 
396 U.S. 842, 90 S. Ct. 50 [1969]) was aired, the broad­
caster had an obligation to present, to some degree, 
both sides of the issue. Although the Fairness Doc­
trine had not previously been interpreted to apply to 
advertising, in Banzhaf the Federal Circuit Court of 
Appeals ruled that the FCC had the authority, through 
the Fairness Doctrine, to require that radio and televi­
sion stations carrying cigarette advertising devote (i.e., 
without charging advertising fees) a significant 
amount of broadcast time to presenting the case against 
smoking. (For more on the plaintiff, John F. Banzhaf, 
see “The Attack on Advertising” in Chapter 2.)  In the 
court’s ruling, Chief Judge David Bazelon observed 
that “if we are to adopt [the tobacco industry’s] analy­
sis [of Congress’ intention in enacting the Federal Ciga­
rette Labeling and Advertising Act], we must conclude 
that Congress legislated to curtail the potential flow 
of information lest the public learn too much about 
the hazards of smoking for the good of the tobacco 
industry and the economy.  We are loathe to impute 
such a purpose to Congress absent a clear expression” 
(Banzhaf, p. 1089). 
However, three years later, in Capital Broadcast­
ing Co. v. Acting Attorney General (405 U.S. 1000 [1972], 
aff’d sub nom. Capital Broadcasting Co. v. Mitchell, 333 F. 
Supp. 582 [D.D.C. 1971]), it was Judge Wright’s view 
that the television and radio counteradvertising that 
had arisen from the Fairness Doctrine was so effective 
that the tobacco companies actually favored the chal­
lenged ban. There is some support for this view.  Per 
capita cigarette consumption in the United States, 
which had declined (with some fluctuation) generally 
since the 1964 report to the Surgeon General on the 
health effects of smoking, had leveled off and then in­
creased after cigarette advertising was removed in 1971 
from radio and television.  Some analysts have asserted 
that these changes indicate that the cost-free 
counteradvertisements opposing cigarette use, which 
along with the commercials promoting cigarettes, 
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largely disappeared from the airwaves except for a 
relatively few public service announcements, were 
more effective in discouraging consumption than ciga­
rette commercials were in encouraging consumption 
(Warner 1979).  Moreover, the prohibition of cigarette 
advertising on broadcast stations has allowed the to­
bacco companies to avoid the significant expense of 
advertising on national television and to devote their 
promotional dollars to other media. 
A Midcourse Assessment 
A decade after the broadcast ban, the FTC issued 
a staff report in May 1981 on cigarette advertising 
(Myers et al. 1981). This report asserted that “the domi­
nant themes of cigarette advertising are that smoking 
is associated with youthful vigor, good health, good 
looks and personal, social and professional acceptance 
and success, and that it is compatible with a wide range 
of athletic and healthful activities” (p. 2-13). Although 
such advertising included the required general warn­
ing about the health hazards of cigarette smoking and 
listed the cigarette’s tar and nicotine contents (as de­
termined by FTC testing methods), the advertisements 
otherwise made no mention of the adverse health con­
sequences of smoking cigarettes.  The overriding mes­
sage of cigarette advertising was thus that smoking is 
a positive, desirable experience. 
Details from a nonpublic version of the FTC re­
port revealed, for example, that a primary theme for 
the marketing of Salem cigarettes was the association 
of the cigarette with the lifestyle of young adult males 
who were (in the words of the company’s campaign 
notes) “masculine, contemporary, confident, self-
assured, daring/adventurous, mature” (Banzhaf 1982, 
p. 260). The report quoted from a Doral cigarette cam­
paign that sought to project the image of “an indepen­
dent, self-reliant, self-confident, take-charge kind of 
person” (p. 260) and a campaign that depicted a “Win­
ston man” as “a man’s man who is strong, vigorous, 
confident, experienced, mature” (p. 260).  Taking an­
other tack, the Eve cigarette campaign sought to por­
tray the smoker as a “sophisticated, up-to-date, 
youthful and active woman who seems to have dis­
tinct ideas about what she wants” (p. 261). The cam­
paign for the Lark brand was designed to position it 
as a “youthful, contemporary brand that satisfies the 
lifestyles of the modern smoking public” (p. 260) and 
emphasizes “moments of post-tension and relaxation” 
(pp. 260–1). 
The nonpublic version of the FTC report also 
detailed and quoted from the conclusion of a market­
ing and research firm that had conducted focus group 
interviews to help Ted Bates and Company, Inc., de­
velop a marketable image for Viceroy cigarettes.  The 
report, summarizing the results of the research, as­
serted that many smokers perceived the smoking habit 
as a dirty and dangerous one engaged in only by “very 
stupid people” (Banzhaf 1982, p. 262). The report con­
cluded: “Thus, the smokers have to face the fact that 
they are illogical, irrational and stupid. People find it 
hard to go throughout life with such negative presen­
tation and evaluation of self. The saviors are the ra­
tionalization and repression that end up and result in 
a defense mechanism that, as many of the defense 
mechanisms we use, has its own logic, its own ratio­
nale” (p. 262). 
This marketing analysis went on to state that 
because there “are not any real, absolute, positive quali­
ties or attributes in a cigarette” (Banzhaf 1982, p. 262), 
the most effective advertising is designed to “reduce 
objections” (p. 262) to the product by presenting a pic­
ture or situation ambiguous enough to provide smok­
ers with a rationale for their behavior and a means of 
repressing their health concerns about smoking.  The 
advertisement must thus project the image that ciga­
rettes have clearly beneficial functions, such as improv­
ing the smoker’s self-image and self-acceptance or 
serving as a stimulant or tranquilizer that offers an ac­
ceptable means of self-reward.  Accordingly, the analy­
sis recommended that advertisers should start from “the 
basic assumption that cigarette smoking is dangerous 
to your health” (p. 263) and then try to circumvent the 
problem rather than fight what would be a losing battle. 
A particularly notable element of the report was 
how to persuade young people to smoke: 
For the young smoker, the cigarette is not yet an 
integral part of life, of day-to-day life, in spite of 
the fact that [young smokers] try to project the 
image of a regular, run-of-the-mill smoker.  For 
them, a cigarette, and the whole smoking process, 
is part of the illicit pleasure category. . . . In the 
young smoker’s mind a cigarette falls into the 
same category with wine, beer, shaving, wearing 
a bra (or purposely not wearing one), declaration 
of independence and striving for self-identity.  For 
the young starter, a cigarette is associated with in­
troduction to sex life, with courtship, with smok­
ing “pot” and keeping late studying hours 
(Banzhaf 1982, p. 263). 
The survey then recommended a strategy for attract­
ing young people to start cigarette smoking:  present 
the cigarette as one of a few initiations into the adult 
world and show the cigarette as part of the illicit 
pleasure category of products and activities.  To the 
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degree possible under legal constraints, the strategy 
advised relating the pleasure of smoking cigarettes to 
the pleasures of adult or illicit activities, such as drink­
ing alcohol, smoking marijuana, or having sex (Myers 
et al. 1981). Brown & Williamson Tobacco Corpora­
tion stated that these proposals were never imple­
mented and did not represent their policy. 
In sum, the marketing and research firm recom­
mended that successful cigarette advertising must ei­
ther consciously or unconsciously deal with smoking 
and health issues by repressing the health concerns of 
the consumers of the product and providing a ratio­
nalization for consumption. The 1981 FTC report also 
concluded that the federally mandated health warn­
ing had little impact on the public’s level of knowl­
edge and attitudes about smoking. The report further 
observed that the warning was outworn, abstract, dif­
ficult to remember, and not perceived as personally 
relevant (Myers et al. 1981). These concerns contrib­
uted to Congress’ enactment of the Comprehensive 
Smoking Education Act of 1984 (Public Law 98-474), 
which required four specific, rotating health warnings 
on all cigarette packages and advertisements (Com­
prehensive Smoking Education Act, sec. 4): 
SURGEON GENERAL’S WARNING:  Smoking 
Causes Lung Cancer, Heart Disease, Emphysema, 
and May Complicate Pregnancy. 
SURGEON GENERAL’S WARNING:  Quitting 
Smoking Now Greatly Reduces Serious Risks to 
Your Health. 
SURGEON GENERAL’S WARNING:  Smoking by 
Pregnant Women May Result in Fetal Injury, Pre­
mature Birth, and Low Birth Weight. 
SURGEON GENERAL’S WARNING: Cigarette 
Smoke Contains Carbon Monoxide. 
The Comprehensive Smoking Education Act of 
1984 thus amended the Federal Cigarette Labeling and 
Advertising Act and required warnings to be placed 
on advertisements as well as on cigarette packages. 
The act preempts state and federal attempts to place 
additional warnings on packages, but it preempts only 
state action with regard to advertising.  The FTC re­
tains such jurisdiction under section 5. 
From the first, the exact appearance of warning 
labels (wording, layout, and positioning on packages 
and advertisements) has represented compromises 
between the recommendations of the FTC and smok­
ing prevention advocates and those of the tobacco 
Reducing Tobacco Use
 
industry.  In 1969, for example, the FTC recommended 
a warning on cigarette packages that specifically men­
tioned death, cancer, heart disease, chronic bronchitis, 
and emphysema. The resulting legislation required 
the legend to provide the general warning only that 
smoking is “dangerous” to one’s health (Public Health 
Cigarette Smoking Act of 1969, sec. 4).  Similarly, in its 
1981 report on cigarette advertising, the FTC recom­
mended that new warning labels use a “circle-and­
arrow” format that would be more effective than the 
traditional rectangular format, but Congress did not 
take this approach in the Comprehensive Smoking 
Education Act of 1984.  Also, the new labels did not 
incorporate the FTC’s recommendations to contain 
specific references to addiction, miscarriage, and death 
and to disclose the brand’s yields of tar, nicotine, and 
carbon monoxide. 
Smokeless Tobacco Warning Labels 
Requirements for warning labels on smokeless 
tobacco products lagged behind those on cigarettes by 
more than 20 years.  By the mid-1980s, the strong evi­
dence that smokeless tobacco causes oral cancer, nico­
tine addiction, and other health problems and that its 
use was increasing among boys led Massachusetts to 
adopt legislation requiring warning labels on packages 
of snuff and caused 25 other states to consider similar 
legislation (USDHHS 1989). 
The Massachusetts law was preempted, before it 
could take effect, by the federal Comprehensive 
Smokeless Tobacco Health Education Act of 1986 (Pub­
lic Law 99-252). This law not only required three ro­
tating warning labels on smokeless tobacco packaging 
and in all advertising (except billboards) but also stipu­
lated that the labels have the circle-and-arrow format 
that the FTC had recommended earlier for cigarette 
warnings. The three rotating labels read as follows 
(Comprehensive Smokeless Tobacco Health Education 
Act of 1986, sec. 3): 
WARNING:  This product may cause mouth 
cancer. 
WARNING:  This product may cause gum disease 
and tooth loss. 
WARNING:  This product is not a safe alternative 
to cigarettes. 
Initially, the FTC excluded utilitarian items—such as 
hats, T-shirts, lighters, and jackets—bearing the name 
or logo of smokeless tobacco products.  A consortium 
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of Public Citizen and several prominent health orga­
nizations sued the FTC, arguing that this exclusion was 
contrary to the provisions of the act, which sought a 
comprehensive rather than a narrow use of health 
warnings (Public Citizen v. Federal Trade Commission, 869 
F.2d 1541 [D.C. Cir. 1989]).  The Court of Appeals for 
the District of Columbia ruled for the plaintiff, stating 
that the act was intended to cover utilitarian items, 
since those were among the smokeless tobacco 
industry’s most effective means of promoting its prod­
ucts to adolescents. The court elaborated its point, 
saying that adolescents were less likely than adults to 
read magazines and newspapers and thereby less 
likely to encounter the mandated warnings there. 
Adolescents were also likely to have passed the criti­
cal moment of decision by the time they obtained the 
product itself and encountered its warning label.   Ac­
cordingly, in 1991, the FTC issued a final rule requir­
ing health warnings to be displayed on utilitarian items 
and providing for the manner in which the warnings 
were displayed. 
All advertising of smokeless tobacco products is 
also banned on any medium of electronic communi­
cation subject to the jurisdiction of the FTC. Under 
this act, federal agencies and state and local govern­
ments are preempted from imposing additional health 
warnings on smokeless tobacco products and adver­
tisements (except for billboards, which were excluded 
from this act).  Furthermore, instead of stipulating 
where the labels must be positioned, the act required 
only “conspicuous and prominent” placement (Com­
prehensive Smokeless Tobacco Health Education Act 
of 1986, sec. 3). Implementation was left to the FTC, 
which enacted enabling regulations on November 4, 
1994. 
Regulation of Tobacco Packaging 
Package size of tobacco products has been an­
other area of public health concern and action.  Evi­
dence that levels of tobacco consumption reflect the 
affordability of tobacco products (see Chapter 6) has 
raised concern about selling cigarettes in packs con­
taining fewer than the usual 20 cigarettes.  In many 
countries, cigarettes are sold in packages of 15, 10, or 5 
cigarettes.  These smaller package formats have been 
dubbed “kiddie” packs in Canada by smoking preven­
tion activists (Chrétien 1994). Research has shown that 
young people account for many sales of smaller ciga­
rette packages (Wilson et al. 1987; Nova Scotia Coun­
cil on Smoking and Health 1991; IMPACT Research 
1993), probably because of their low price and ease of 
concealment. 
These findings have led some jurisdictions to 
prohibit the marketing of packages containing fewer 
than 20 cigarettes. An Australian state legislature has 
also passed such a ban (the Western Australia Tobacco 
Control Act of 1990).  In Canada, several provinces 
have banned small package sizes, and the revised fed­
eral Tobacco Sales to Young Persons Act of 1993 na­
tionally banned packages of fewer than 20 cigarettes. 
Another issue of concern regarding tobacco pack­
aging is the use of potentially misleading descriptive 
words in the labeling of some tobacco products (Davis 
et al. 1990). A recent Gallup poll found that words 
such as “slim,” “low tar,” and “light” conveyed mes­
sages viewed as healthful (Gallup Organization, Inc. 
1993, pp. 23, 25). Cohen (1992) reported that tobacco 
companies have long known that their customers 
equate the marketing term “low tar” (p. 85) with health 
benefits. Chapman and colleagues (1986) reported that 
smokers tend to systematically underestimate the ac­
tual tar deliveries of their particular brands, and Gori 
(1990) found that one-half of smokers interviewed in 
the United States and Europe assume that the lower 
the tar rating, the lower the brand’s propensity to cause 
disease. The Coalition on Smoking OR Health (1988) 
has further analyzed how promoting cigarette brands 
as having low tar and low nicotine content communi­
cates a message to consumers that these brands have 
health benefits. 
The use of such descriptive words in cigarette 
brand names has been called into question because 
variations in the way cigarettes are actually smoked 
may mean that the actual yield of toxic constituents 
from cigarettes differs from the levels determined by 
currently accepted testing procedures (Henningfield 
et al. 1994; see “Compensatory Smoking,” later in this 
chapter). For example, smokers of reduced-tar 
cigarettes may (deliberately or not) inhale harder to 
draw more smoke through the denser filter and deep 
into the lungs and may smoke the cigarette down 
closer to the filter, thereby inhaling greater concentra­
tions of toxins. This concern led to the appointment 
of an ad hoc committee of the President’s Cancer Panel 
of the National Cancer Institute (NCI) to evaluate the 
current FTC protocol for testing tar, nicotine, and car­
bon monoxide. One of the conclusions of this panel 
was that “brand names and brand classifications such 
as ‘light’ and ‘ultra light’ represent health claims and 
should be regulated and accompanied, in fair balance, 
with an appropriate disclaimer” (NCI 1996, p. vii). This 
recommendation has not yet been carried out. 
A further aspect of tobacco packaging that is cur­
rently receiving significant attention, although prima­
rily outside the United States, is the possibility of 
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legislated plain (or “generic”) packaging for tobacco 
products.  This initiative is partly motivated by the 
belief that removing much of the brand image of to­
bacco products would not only make the product less 
attractive but also weaken the connection with—and 
thus lessen the effect of—visual and verbal image-
linked efforts to promote particular brands (Mahood 
1995). There is evidence that young people find plain 
packaging less attractive (Beede and Lawson 1992; 
Centre for Health Promotion 1993) and that plain pack­
aging makes health messages more noticeable (Centre 
for Behavioural Research in Cancer 1992).  In Canada, 
the federal government has considered using plain 
packaging for tobacco products (Standing Committee 
on Health 1994; Health Canada 1995b), and the prov­
ince of Ontario, in enacting the Tobacco Products 
Control Act in 1994, authorized the requirement for 
plain packaging on all cigarettes sold in Ontario.  Such 
packaging reforms have not yet been enacted in any 
jurisdiction. 
Examples of Product Labeling in Other Countries 
In recent years, many countries have taken sig­
nificant action on specifying packaging and warning 
labels for tobacco products.  All countries of the Euro­
pean Union must comply with a May 15, 1992, direc­
tive (Council Directive 92/41/EEC 1992 O.J. [L 158]) 
that requires stipulated health warnings on each of the 
main package panels. In Thailand, pursuant to its To­
bacco Products Control Act, which was based on prin­
ciples developed in Canadian regulations (discussed 
later in this section), prominent black-and-white health 
messages are required on the front of the package. 
South Africa and New Zealand require detailed health 
messages on the main package panels; the messages 
are based largely on Australian packaging. 
The messages appearing on Australian cigarette 
packages are based on the work of the Centre for 
Behavioural Research in Cancer (1992).  These mes­
sages were required as of January 1, 1995, and were 
incorporated into a broad effort “to inform smokers of 
the long-term health effects of tobacco use” (Lawrence 
1994, p. 1). The Australian system uses six rotating 
messages covering 25 percent of the front of the ciga­
rette packets. One side of the packet is entirely given 
to the labeling of dangerous constituents, and all 
the labels must be in black and white. Thirty-three 
percent of the rear main packet panel must be covered 
by the same health message given on the front of the 
pack and followed by an elaboration of that message 
(Chapman 1995). 
Reducing Tobacco Use 
Of special interest are the package regulations 
currently in place in Canada.  The Canadian health 
messages were established by regulatory power 
granted under the 1988 federal Tobacco Products Con­
trol Act, which came into effect on January 1, 1989.  This 
legislation gives broad regulatory powers over tobacco 
product packaging. It also gives regulatory authority 
to require package inserts, although this power has not 
yet been acted on. By eventually delegating formula­
tion of the precise warnings to administrative regula­
tion, this legislation took the approach that had been 
recommended 25 years earlier by the U.S. Department 
of Health, Education, and Welfare (Celebrezze 1965; see 
also “Cigarette Warning Labels,” earlier in this chap­
ter). This law also makes clear that the various prov­
inces of Canada can require additional messages and 
that the provision of federal messages does not pre­
empt other messages. The first set of regulations fol­
lowing this law required that four specific rotating 
health messages be placed on the two main panels of 
cigarette packages and be printed in a large typeface; 
this set of regulations stipulated that the messages must 
be “prominently displayed in contrasting colours” (De­
partment of National Health and Welfare 1989, p. 64) 
and cover at least 20 percent of the panel face. 
When the mandated Canadian health messages 
started appearing on tobacco products in 1989, it was 
clear to many public health workers that the language 
of the regulations had left the tobacco companies too 
much room for interpretation and had resulted in less 
prominence and contrast than the regulations had in­
tended. Minister of National Health and Welfare 
Henry Perrin Beatty commented, “It’s very clear that, 
when you look at [the health warning on cigarette 
packs], it’s not designed to stand out. If our experts 
[at the Department of National Defence] knew as much 
about camouflage as the tobacco company did, 
nobody’d ever find our fellows” (Spectator 1989). This 
situation gained more attention when it was revealed 
that a prominent tobacco lobbyist had apparently in­
fluenced development of the regulations (Fraser 1989). 
Health advocates subsequently campaigned to attain 
more prominent messages through revising the regu­
lations (Mahood 1995). 
New legislation was enacted on August 11, 1993 
(Department of National Health and Welfare 1993), and 
all packaging for tobacco products destined for sale in 
Canada had to comply by September 11, 1994.  Among 
these precedent-setting regulations (Mahood 1995) 
were the following requirements: 
•	 	The message must cover at least 25 percent of the 
top of each main panel. 
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•	 	The message must be framed by a stipulated bor­
der (on many packs, this border yields a total mes­
sage area that uses over 40 percent of the surface). 
•	 	 Each of eight rotating messages must be presented 
one-half of the time in black on a white background 
with a black border.  The other one-half of the time, 
the messages must be white on a black background 
surrounded by a white border. 
•	 	One entire side panel must be used to present in­
formation on the toxic constituents. 
•	 	 Every side panel of tobacco cartons must display a 
black-on-white message covering 25 percent of the 
panel area and stating “Cigarettes are addictive and 
cause lung cancer, emphysema, and heart disease” 
(Department of National Health and Welfare 1993, 
p. 3278). 
•	 	 The message must bear no attributions. 
One ironic result of these requirements was that 
cigarettes manufactured in the United States for the 
Canadian market were produced, albeit only for ex­
port, with health messages that conform with the rec­
ommendations provided in 1965 by the U.S. 
Department of Health, Education, and Welfare. 
The Canadian regulations were reversed in 1995, 
when the Supreme Court of Canada held that the 
country’s complete ban on overt tobacco advertise­
ments (another key component of the 1993 regulations) 
and its requirement of unattributed health warnings 
on packages were in violation of the tobacco industry’s 
freedom of expression and the Canadian Charter of 
Rights and Freedoms  (RJR-MacDonald Inc. v. Attorney 
General of Canada, File Nos. 23460, 23490 [Can. Nov. 
29–30, 1994, Sept. 21, 1995], cited in 10.6 TPLR 2.167 
[1995]). These central elements of Canada’s Tobacco 
Products Control Act fell because the Canadian gov­
ernment did not meet its constitutional obligation of 
proving that the approach taken was the least drastic 
means of achieving a public health objective. These 
narrow evidentiary grounds on which the decision was 
made left room for the Canadian government to 
counter.  The government offered a new proposal, 
called Tobacco Control: A Blueprint to Protect the Health 
of Canadians, that reinstated the advertising ban, im­
posed restrictions on brand-name promotion and 
sponsorship, instituted controls over packaging and 
labeling, and increased product regulation and report­
ing requirements. 
In creating a new legal framework, the Canadian 
government would make tobacco a de facto illegal 
product whose sale could be permitted but would be 
subject to specific conditions. This reversal of the 
burden of proof gives constitutional allowance to  the 
advertising restrictions in Canada.  Following the un­
veiling of the Blueprint, the tobacco industry brought 
forward a voluntary proposal to restrict advertising. 
Subsequent resumption of advertising has been con­
troversial, and the industry has been accused of breach­
ing its own code (LeGresley 1996). 
Tobacco Advertising, Commercial Speech, 
and the First Amendment 
Regulation of tobacco advertising in the United 
States is legally problematic.  Although protections 
afforded by the First Amendment to the U.S. Consti­
tution may be modified for commercial speech, includ­
ing advertising, such modification is an area of 
intensive legal debate. The two decades of lawsuits 
described in this section make it clear that a concerted 
and persistent government interest is essential if such 
restriction of free speech is to be upheld in courts.  To 
satisfy legal scrutiny, the government’s efforts must 
clearly show that any restrictions directly and materi­
ally advance its asserted interest—protecting the health 
of the American people. 
The United States Supreme Court has defined 
commercial speech as “expression related solely to the 
economic interests of the speaker and its audience” 
(Central Hudson Gas & Electric v. Public Service Commis­
sion of New York, 447 U.S. 557 [1980]). Commercial 
speech thus includes advertisements by cigarette 
manufacturers that invite consumers to buy their prod­
uct. As the Supreme Court has observed, “For most of 
this Nation’s history, purely commercial advertising 
was not considered to implicate the constitutional pro­
tection of the First Amendment” (United States v. Edge 
Broadcasting Co., 113 S. Ct. 2696, 2703 [1993]).  Restric­
tions on commercial speech were viewed as being simi­
lar to economic regulation and were routinely upheld. 
A midcentury example key to later efforts to restrict 
tobacco advertising occurred when the Supreme Court, 
in Valentine v. Chrestensen (316 U.S. 52 [2d Cir. 1942], 
rev’d), held that the state could prohibit the street dis­
tribution of handbills containing commercial adver­
tising matter (see also Village of Schaumburg v. Citizens 
for a Better Environment, 444 U.S. 620 [1980]). Such pre­
cedents enabled the courts to uphold the 1972 congres­
sional ban on tobacco advertising on radio and 
television (Capital Broadcasting Co., 405 U.S. 1000). 
Subsequent legal scrutiny, however, has acted to re­
verse this trend. 
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Constitutionality of Regulating Advertising 
In 1975, the United States Supreme Court held 
for the first time that commercial advertising in gen­
eral was entitled to protection under the First Amend­
ment. In Bigelow v. Virginia (421 U.S. 809 [1975]), the 
Court struck down a state statute banning commer­
cial advertisements for abortion referral services. The 
Court found that “the relationship of speech to the 
marketplace of products or services does not make 
[commercial advertising] valueless in the marketplace 
of ideas” (p. 826). However, the Court emphasized 
that it was defending not merely commercial speech, 
but speech that contained “material of clear ‘public 
interest’ ” (p. 822). 
The Court also defended commercial speech in a 
case involving advertising of the price of pharmaceu­
ticals. In Virginia State Board of Pharmacy v. Virginia 
Citizens Consumer Council, Inc. (425 U.S. 748 [1976]), 
the Court found that the constitutional protection af­
forded to advertisements of the price of pharmaceuti­
cals was shared by advertisers and recipients of the 
information. The Court noted the importance of in­
formation to consumers: “As to the particular 
consumer’s interest in the free flow of commercial in­
formation, that interest may be as keen, if not keener 
by far, than his interest in the day’s most urgent politi­
cal debate” (p. 763). The Court pointed out that ad­
vertising is disseminating information to the consumer 
about who is producing the product, for what reason, 
and at what price, even if it does not “editorialize on 
any subject, cultural, philosophical, or political” 
(p. 761). 
In that same ruling, however, the Supreme Court 
emphasized that commercial speech would not be af­
forded the same level of protection as other forms of 
speech and therefore that the state can regulate adver­
tising if such regulation is in conformity to a valid 
public interest.  These interests include avoiding de­
ceptive and misleading claims; preventing unlawful 
activities, such as the sale of alcoholic beverages to 
minors; and protecting public health. “The First 
Amendment . . . does not prohibit the State from in­
suring that the stream of commercial information flow 
cleanly as well as freely” (Virginia State Board of Phar­
macy, pp. 771–2). 
Most cases involving regulated advertising are 
assessed through a four-pronged test to determine 
whether the regulations violate the First Amendment. 
This test was set forth in Central Hudson (447 U.S. 557). 
First, the speech being suppressed must have forfeited 
its First Amendment protection by being unlawful 
or deceptive or fraudulent: “The First Amendment’s 
Reducing Tobacco Use 
concern for commercial speech is based on the infor­
mational function of advertising. . . . Consequently, 
there can be no constitutional objection to the suppres­
sion of commercial messages that do not accurately 
inform the public about lawful activity.  The govern­
ment may ban forms of communication more likely to 
deceive the public than to inform it” (p. 563). Second, 
the government must assert a substantial interest in 
regulating the speech. Third, regulating commercial 
speech must directly and materially benefit this gov­
ernment interest.  Fourth, the government must show 
that the means chosen to benefit its interest are no more 
extensive than necessary.  (This four-pronged test is 
discussed more fully in “Constitutionality of Regulat­
ing Tobacco Advertising,” later in this chapter.) 
The level of deference the Supreme Court gives 
to legislatures in meeting these four requirements 
seems to vary.  In some cases, the Court defers to the 
legislative judgment that the speech restriction will be 
effective (Posadas de Puerto Rico Associates v. Tourism 
Company of Puerto Rico, 478 U.S. 328 [1986]; Edge Broad­
casting), while in other cases the Court demands more 
empirical support for the legislature’s assumptions and 
conclusions (Rubin v. Coors Brewing Co., 514 U.S. 476, 
115 S. Ct. 1585 [1995]; 44 Liquormart, Inc. v. Rhode Is­
land, 517 U.S. 484, 116 S. Ct. 1495 [1996]). 
In Posadas de Puerto Rico, the Supreme Court up­
held a statute that prohibited advertising legal gam­
bling casinos to residents.  The Court found that even 
though nonfraudulent advertising that concerned a 
legal activity deserved First Amendment protection, 
the commonwealth’s legislature could take steps to 
regulate it. The government has a substantial interest 
in protecting the health, safety, and welfare of its citi­
zens, and this interest includes reducing the demand 
for gambling among residents through the regulation 
of advertising. The Court accepted the argument by 
the commonwealth that resident gambling would dis­
rupt moral and cultural patterns, cause an increase in 
crime, foster prostitution, and develop corruption.  In 
Board of Trustees of the State University of New York v. 
Fox (492 U.S. 469 [1989]) (also known as Fox III), the 
Court deferred to the legislature and refused to set 
aside a State University of New York statute that pro­
hibited private commercial enterprises from operat­
ing on campus. In Edge Broadcasting (113 S. Ct. 2696), 
the Court upheld a federal statute that prohibited the 
broadcast of lottery advertisements generally but per­
mitted advertisements of state-run lotteries on stations 
licensed to a state that conducts lotteries. The Court 
held that “the State [has] ‘a strong interest in adopting 
and enforcing rules of conduct designed to protect the 
public’ ” (p. 2706). Citing Fox III with approval, the 
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Court said, “Within the bounds of the general protec­
tion provided by the Constitution to commercial 
speech, we allow room for legislative judgments” 
(p. 2707). 
In contrast, in 44 Liquormart, the Supreme Court 
looked closely at the logic of the Rhode Island gov­
ernment in the ban it imposed on liquor price adver­
tising. The Court considered that the Rhode Island 
restriction was a total prohibition and that there was 
too weak a connection between banning speech regard­
ing prices and the state’s assertion that this restriction 
would reduce liquor consumption.  Furthermore, the 
Court was aware of the concern that the legislature 
had been captured by one group of economic competi­
tors (small liquor stores that could not otherwise com­
pete in price wars) and that the law was then drafted 
at the expense of the disfavored economic competitor 
(larger liquor chains).  In the 44 Liquormart decision 
citing the dissent in Rhode Island Liquor Stores Associa­
tion v. Evening Call Pub. Co. (497 A.2d 331 [R.I. 1985]), 
it was “suggested that the advertising ban was moti­
vated, at least in part, by an interest in protecting small 
retailers from price competition” (p. 491, FN4). 
In Coors Brewing Co., the Supreme Court struck 
down a regulation restricting the printing of alcohol 
strength on beer labels.  The Court found that the re­
striction did little to advance the government interest 
in preventing “strength wars” between competing beer 
manufacturers, particularly when other types of alco­
hol were required to list the alcohol potency on their 
labels. Finding that the speech restriction lacked a logi­
cal foundation, the Court viewed the regulation 
skeptically. 
The pattern that emerges from these legal judg­
ments is that where a law restricting commercial speech 
has a solid grounding in logic and empirical data, the 
Court will uphold it. If the regulatory system has a 
faulty connection between its goal and its method, the 
law will fail the third prong of the Central Hudson test 
and be struck down.  In 44 Liquormart, Justice John Paul 
Stevens’ plurality opinion required that the social 
science evidence supporting the legislative rationale di­
rectly and materially tie the government’s goal (reduc­
ing liquor consumption) to its methodology (restricting 
liquor price advertising); the government failed to meet 
this legal requirement.  Furthermore, the Court views 
harshly laws that impose a total ban on speech and thus 
paternalistically deprive consumers of information be­
cause the government perceives that the ban is “for their 
own good.” 
Constitutionality of Regulating Tobacco Advertising 
Government regulations of tobacco product ad­
vertising can withstand legal scrutiny if they are care­
fully crafted and are not overbroad (Edge Broadcasting, 
p. 2705 [citing Fox III, p. 480]). Courts have found state 
and local regulations of tobacco advertising to be pre­
empted by the Federal Cigarette Labeling and Adver­
tising Act when they conclude that the regulation is 
based on “smoking and health.” If the regulation is 
not preempted, then it must pass the four-pronged test 
advanced in Central Hudson. Reasonable regulations 
on tobacco advertising are likely to be upheld. 
Preemption and the Federal Cigarette Labeling and 
Advertising Act 
The Federal Cigarette Labeling and Advertising 
Act preempts a “requirement or prohibition based on 
smoking and health . . . imposed under State law with 
respect to the advertising or promotion of any ciga­
rettes the packages of which are labeled in conformity 
with the provisions of this chapter” (15 U.S.C. [United 
States Code] 1334[b]). In Cipollone v. Liggett Group Inc. 
(505 U.S. 504, 112 S. Ct. 2608 [1992]), the Supreme Court 
interpreted that language narrowly, allowing 
Cipollone to sue the tobacco industry if the claim were 
not based on a failure to warn about smoking and 
health issues in product advertising or promotion.  The 
claim would not be preempted if it were based on more 
generalized state interests, such as preventing inten­
tional fraud or enforcing manufacturer warranties.  In 
Mangini v. R.J. Reynolds Tobacco Co. (22 Cal. App. 4th 
628 [1993]), the California Court of Appeals restated 
the Cipollone holding by declaring that regulations are 
preempted only if they demand a “requirement or pro­
hibition based on smoking and health. . . . imposed 
under State law with respect to. . . . advertising or pro­
motion.” If one of these elements is missing, the state 
law is not preempted. 
State and local governments can still regulate to­
bacco advertising if they justify the law with a valid 
rationale not related to health.  For example, Baltimore 
asserted that its ordinance restricting tobacco adver­
tising on billboards was a reasonable and necessary 
measure for reducing illegal consumption of cigarettes 
by minors (Penn Advertising of Baltimore, Inc. v. Mayor 
and City Council of Baltimore, 862 F. Supp. 1402 [Md. 
1994]). The city claimed that the focus of the ordinance 
was not on protecting the health of young people; the 
language of the ordinance was instead exclusively re­
lated to preventing youth from engaging in illegal 
transactions. (This assertion was made even though 
Baltimore does not criminalize youth purchase or 
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possession of tobacco products; Baltimore criminalizes 
the sale of tobacco to minors.) The district court ac­
cepted this stated intent of the ordinance.  Even when 
legislators who supported the ordinance made certain 
health-related comments, the court discounted these 
as not necessarily being representative of the motives 
of the city council as a whole. 
On appeal by the advertising company that was 
the plaintiff in the case, the Fourth Circuit Court of 
Appeals further held that the Baltimore ordinance was 
not preempted by the Federal Cigarette Labeling and 
Advertising Act because it did not relate to the con­
tent of advertising, but rather to billboard location 
(Penn Advertising of Baltimore, Inc. v. Mayor and City 
Council of Baltimore, 63 F.3d 1318 [4th Cir. 1995]).  The 
court interpreted the ordinance as a limited physical 
restriction in a limited media, for Baltimore allows such 
billboards in parts of the city zoned for commercial 
and industrial use. The court also observed that the 
Baltimore ordinance did not restrict tobacco industry 
advertising in other media, such as newspapers and 
magazines. State or local governments that cannot 
separate such ordinances from health-related issues, 
however, will have difficulty passing the preemption 
test. In Minnesota, for example, the court struck down 
a municipal statute that restricted tobacco advertising 
explicitly to protect health (Chiglo v. City of Preston, 909 
F. Supp. 675 [D. Minn. 1995]). 
The Four-Pronged Test 
Is the Advertising Unlawful or Misleading? 
A central justification for affording constitutional 
protection to advertising is the consumer’s interest in 
the free flow of information (Central Hudson). Public 
health and smoking prevention groups often question 
whether attractive images that portray smoking as a 
socially acceptable, sexual, and athletic activity have 
any informational use to the consumer (Lowenstein 
1988). Despite the emotive, noninformative character 
of cigarette advertising, the tobacco industry might 
argue that restricting such advertising should fail the 
first prong of the Central Hudson test because the prod­
uct being advertised is lawful for adults and its pro­
motion is not directly deceptive or fraudulent. 
Certainly, advertisements that use images to con­
nect health, vitality, and the good life with cigarette 
smoking distort the truth (Law 1992).  Yet the United 
States Supreme Court’s definition of “inherently mis­
leading” refers to advertisements that promote fraud, 
represent overreaching, or create consumer confusion 
(Ohralik v. Ohio State Bar Assn., 436 U.S. 447, 462 [1978]). 
Proscriptions against misleading advertising have not 
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traditionally extended to “puffery” or imagery alone 
(Zauderer v. Office of Disciplinary Counsel of the Supreme 
Court of Ohio, 471 U.S. 626 [1985]). For example, courts 
have held that advertisements for alcoholic beverages 
that project images of drinkers as successful and fun-
loving and do not warn of the dangers of alcohol abuse 
are not legally “misleading” (Oklahoma Telecasters As­
sociation v. Crisp, 699 F.2d 490, 500 [10th Cir. 1983], rev’d 
on other grounds sub nom.; Capital Cities Cable, Inc. v. 
Crisp, 467 U.S. 691 [1984]). By analogy, courts may not 
find that promotions are directly misleading simply 
because they project images of smokers as glamorous 
people and do not mention the associated dangers of 
smoking. 
A cigarette advertisement would be found to be 
misleading, however, if it included unsubstantiated 
health claims. Advertisements could not assert that 
cigarette smoking poses little or no risk to health or 
does not affect breathing.  For example, the FTC chal­
lenged as false and misleading a newspaper advertise­
ment (or advertorial), paid for by R.J. Reynolds Tobacco 
Company, that claimed smoking is not as hazardous 
to health as the public has been led to believe. Al­
though the tobacco company initially stated that the 
statement was not commercial speech because it did 
not invite the public to purchase a particular product, 
the parties entered into a consent decree under which 
R.J. Reynolds agreed to stop the advertisement and to 
avoid future misrepresentation of scientific studies 
(Bureau of National Affairs, Inc. 1990). 
Some proponents of restricting tobacco advertis­
ing argue that courts in the future could find the vi­
sual images projected in cigarette advertisements to 
be inherently deceptive or misleading.  A legal opin­
ion for the American Medical Association concluded, 
“Given what the cigarette advertising does portray, 
what it fails to say, and the vast public ignorance of 
the dangers and addictive quality of smoking, particu­
larly among young persons, it is plain to us that this 
kind of advertising can be proscribed as deceptive or 
misleading” (Blasi and Monaghan 1986, p. 506). Analo­
gously, the Supreme Court has construed the preemp­
tive provisions of the cigarette labeling act to permit 
tort actions against cigarette manufacturers in the in­
stance of fraudulent misrepresentation or conspiracy 
to misrepresent or conceal material facts (Cipollone). 
Furthermore, to the extent that recent documents 
from the tobacco industry show that the industry pur­
posefully marketed to minors, the courts may find this 
to be a deceptive advertising practice that leads to an 
illegal act. There is no constitutional speech protec­
tion for proposing illegal transactions, such as sales of 
cigarettes to minors.  The tobacco company Liggett 
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Group Inc. has admitted that the entire tobacco indus­
try conspired to market cigarettes to children (Settle­
ment Agreement Between Settling States and Brooke Group 
LTD, Liggett & Myers, Inc. and Liggett Group, Inc., cited 
in 13.1 TPLR 3.11 [1998]), and documents obtained in 
litigation from the other tobacco companies and re­
cently made public confirm that tobacco companies 
have purposefully marketed to children as young as 
14 years old (Coughlin et al. 1999). Regulation of some 
tobacco advertising may thus pass the first prong of 
the Central Hudson test (see the discussion of the 
Mangini case in “A Critical Example: Joe Camel,” later 
in this chapter). 
Is the Government’s Interest Substantial? 
Appellate courts have consistently found that 
states have a substantial interest in limiting tobacco 
advertisements (see, for example, Penn Advertising; 
Oklahoma Telecasters; and Dunagin v. City of Oxford, 718 
F.2d 738 [5th Cir. 1983], cert. denied, 467 U.S. 1259 
[1984]). Because of the strong epidemiologic evidence 
associating smoking with lung cancer, heart disease, 
and other causes of morbidity and mortality (USDHHS 
1989), no court would deny that the federal govern­
ment has a compelling interest in reducing smoking. 
As evidence mounts concerning the health hazards of 
environmental exposure to cigarette smoke (Environ­
mental Protection Agency [EPA] 1992; Leary 1993; 
Reynolds 1993; Bero et al. 1994; California EPA 1997), 
the federal government may also exercise its police 
powers to protect nonsmokers. 
The Federal Cigarette Labeling and Advertising 
Act preempts state and local governments from regu­
lating cigarette advertising based on “smoking and 
health.” Instead, as noted, many governments (such 
as those of Baltimore and New York City) are assert­
ing an interest in preventing minors from being in­
volved in illegal transactions. Additional nonhealth 
rationales include avoiding deceptive advertising and 
providing economic (as opposed to health-based) con­
sumer protection. 
Does the Regulation Directly Benefit the Public Interest? 
The third prong of the Central Hudson test requires 
that governmental regulation of commercial speech 
must advance the government interest. The Supreme 
Court has not yet given clear direction as to what level 
of evidence is required to show that such regulation 
directly advances the government interest, but the Court 
is beginning to demand some scientific or statistical 
evidence of efficacy.  In Florida Bar v. Went For It, Inc. 
(515 U.S. 618, 632 [1995]), the Court was satisfied with a 
general assertion by the state that common sense 
dictated that restricting attorneys from advertising by 
direct mail would reduce ethical violations by attorneys 
and have a positive effect on the public’s opinion of at­
torneys. Limited social science evidence was presented, 
yet the restriction was upheld.  On the other hand, in 
44 Liquormart, Justice Stevens’ plurality opinion stated 
that one reason the Rhode Island statute was struck 
down was that the state had not produced evidence 
that its speech restriction would directly and materi­
ally produce the results desired to advance the gov­
ernment interest. 
Even if the courts require empirical support of 
efficacy, tobacco advertising restrictions can still sat­
isfy the third prong of the Central Hudson test. There 
is extensive social science research regarding the ef­
fect of tobacco advertising on the purchasing habits of 
teen smokers and on the positive imagery with which 
children regard and recognize tobacco advertising 
images. After R.J. Reynolds Tobacco Company intro­
duced the Joe Camel advertising campaign in the late 
1980s, the market share of Camel cigarettes among 
teenagers increased at least 20-fold; from the same 
point in time, the previous decline in overall teenage 
smoking prevalence was reversed (CDC 1994b).  An 
association between a rise in young girls’ smoking 
habits and the tobacco industry’s decision to target 
marketing to adolescent girls has also been docu­
mented (Pierce et al. 1994a). 
Some relevant legal judgments suggest that al­
though the courts tend to require more than a 
commonsense assertion of the government’s interest 
in restricting commercial speech, something less than 
empirical evidence may suffice.  For example, although 
Justice Stevens in 44 Liquormart demanded empirical 
evidence, he also recognized there is “some room for 
the exercise of legislative judgment” (p. 508).  The Su­
preme Court in Edenfield v. Fane (113 S. Ct. 1792 [1993]) 
suggested the need for a scientific validation of a con­
nection between regulation and the achievement of a 
substantial state interest:  the Court stated that the 
government “must demonstrate that the harms it re­
cites are real and that its restriction will in fact allevi­
ate them to a material degree” (p. 1800). 
In cases involving advertising restrictions for al­
coholic beverages, the courts have consistently 
accepted—even in the absence of objective scientific 
studies—the reasonable legislative belief that such re­
strictions would lower consumption. The Tenth Cir­
cuit Court of Appeals found it not “constitutionally 
unreasonable for the State of Oklahoma to believe that 
advertising will not only increase sales of particular 
brands of alcoholic beverages but also of alcoholic 
beverages generally” (Oklahoma Telecasters, p. 501). 
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Similarly, the Ohio Supreme Court found that the ad­
vertising of drink prices would encourage and stimu­
late consumption of alcoholic beverages (Queensgate 
Investment Co. v. Liquor Control Commission, 433 N.E.2d 
138, 142, 69 Ohio St. 2d 361 [Ohio 1982]). The adver­
tising prohibition was thought to be closely connected 
to the state’s interest in preventing consumption. 
Courts have found a direct relationship between 
advertising and consumption or abuse in other dan­
gerous products and activities (see, for example, Will­
iams v. Spencer, 622 F.2d 1200 [4th Cir. 1980]; Capital 
Broadcasting). In Central Hudson, the Supreme Court 
found an immediate connection between advertising 
and the demand for electricity.  The Court in Metromedia, 
Inc. v. City of San Diego (453 U.S. 490 [1981]) similarly 
found a link between billboard advertisements and traf­
fic safety.  The Court stated that this link is established 
by the “accumulated, common-sense judgments of 
local lawmakers” (p. 509). 
Claims made on behalf of the tobacco and ad­
vertising industries that tobacco advertising is de­
signed not to increase consumption but only to develop 
brand loyalty and gain an increased market share 
(Boddewyn 1989) may be unpersuasive to the courts 
(Chetwynd et al. 1989; Joossens 1989). Although some 
of the studies showing that advertising increases to­
bacco consumption have methodologies that are 
controversial—such as econometric (Lewit et al. 1981; 
Schneider et al. 1981; Seldon and Doroodian 1989), 
cross-cultural (Hamilton 1976; Reuijl 1982), and adver­
tising recognition (Goldstein et al. 1987; DiFranza et 
al. 1991; Fischer et al. 1991a)—the courts would likely 
accept the legislature’s reasonable belief that what the 
studies show is true. For example, the Ninth Circuit, 
in a 1997 opinion after 44 Liquormart, maintained that 
“common sense suggests that advertising increases 
participation” (Valley Broadcasting Co. v. United States, 
107 F.3d 1328, 1344 [9th Cir. 1997]).  This portion of 
Posadas de Puerto Rico has survived 44 Liquormart. 
In an analogous situation, alcohol industry argu­
ments against the relationship between advertising and 
consumption were rejected by the Fifth Circuit Court 
of Appeals, which held that Mississippi’s ban on intra­
state liquor advertising directly promoted the state’s 
interests in the health and safety of its citizens.  The 
court said that it did not “. . . believe that the liquor in­
dustry spends a billion dollars a year on advertising 
solely to acquire an added market share at the expense 
of competitors. . . . we hold that sufficient reason exists 
to believe that advertising and consumption are linked 
to justify the ban, whether or not ‘concrete scientific evi­
dence’ exists to that effect” (Dunagin, p. 750). Because 
the tobacco industry spends six times as much as the 
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liquor industry on advertising and promotion (FTC 
1995), because smoking remains the leading cause of 
avoidable death in America (McGinnis and Foege 1993), 
and because about 50 million Americans still smoke, 
even small reductions in smoking behavior—whether 
consumption or uptake—resulting from reduced adver­
tising could achieve significant health benefits. 
Cases trying to restrict alcohol advertising have 
also, however, set precedents that may stand in the 
way of comparable cases involving tobacco advertis­
ing. Most notably, in 44 Liquormart, Inc. v. Racine (829 
F. Supp. 543 [R.I. 1993]), the Rhode Island District Court 
judge found that the state’s specific statute banning 
liquor price advertising had had “no significant im­
pact on levels of alcohol consumption” (p. 549). Jus­
tice Stevens, in his plurality opinion, found that the 
statute could not survive without social science evi­
dence because “speculation certainly does not suffice 
when the State takes aim at accurate commercial in­
formation for paternalistic ends” (44 Liquormart, Inc. 
v. Rhode Island, p. 507). 
Yet the Fourth Circuit Court of Appeals, the high­
est court to rule on tobacco advertising restrictions, 
has twice upheld Baltimore’s limitation on tobacco 
advertising. The Fourth Circuit noted several differ­
ences between the liquor price advertising prohibition 
in 44 Liquormart, Inc. v. Rhode Island and the limited re­
strictions in the Baltimore ordinance.  44 Liquormart dealt 
with a total ban on speech directed to adults, whereas 
the Baltimore ordinance was a partial restriction of 
speech that targeted children as consumers of an adult 
product.  The Fourth Circuit Court also held there was 
a close connection between the government’s goal of 
preventing teen participation in illegal transactions and 
the limited speech restriction intended to support that 
goal (Penn Advertising, 63 F.3d 1318; Penn Advertising of 
Baltimore, Inc. v. Mayor and City Council of Baltimore, 101 
F.3d 332 [4th Cir. 1996]).  By contrast, a notable reason 
for the Supreme Court’s rejection of advertising restric­
tions in 44 Liquormart was that the government had 
not proved a clear tie between its interest and the re­
strictions supposedly supporting that interest. 
The Fourth Circuit reaffirmed its decision in Penn 
Advertising after the Supreme Court had asked it to 
review the decision in light of 44 Liquormart. The 
Fourth Circuit specifically stated, “We have read the 
opinion in 44 Liquormart and have considered its im­
pact on the judgment in this case . . . we conclude that 
44 Liquormart does not require us to change our deci­
sion” in this case (Penn Advertising of Baltimore, Inc. v. 
Mayor and City Council of Baltimore, 101 F.3d 332 [4th 
Cir. 1996], cert. denied, 117 S. Ct. 1569 [1997]). 
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Because a restriction like that upheld in Penn 
Advertising cannot constitutionally be a complete ban 
on all advertising of the product, some minors will 
be exposed to some level of adult tobacco advertising. 
This limit in scope does not constitute serious grounds 
for an appeal. A recent decision involving liquor 
regulation notes that the “Supreme Court has made it 
clear in the commercial speech context that 
underinclusiveness of regulation will not necessarily 
defeat a claim that a state interest has been materially 
advanced” (Bad Frog Brewery, Inc. v. New York State Li­
quor Authority, 134 F.3d 87, 99 [2d Cir. 1998]).  In sum, 
the regulation need not cure all ills but it does need to 
advance the state interest in a demonstrably significant, 
rather than a small or otherwise circumstantial, way. 
Is the Regulation of Advertising a Reasonable Fit? 
The Supreme Court has made it clear that this 
standard is not to be confused with the “least restric­
tive means” test. In Edge Broadcasting (p. 2705), the 
Court said that the “requirement of narrow tailoring 
was met if ‘the . . . regulation promotes a substantial 
government interest that would be achieved less ef­
fectively absent the regulation,’ provided that it did 
not burden substantially more speech than necessary 
to further the government’s legitimate interests.”  The 
existence of less restrictive methods of achieving the 
government’s goals does not automatically defeat the 
legislation as it would in political speech cases. In­
stead the Court looks to see if the restriction does not 
sweep more broadly than necessary.  In Florida Bar 
the Court stated, 
In Fox, we made clear that the “least restrictive 
means” test has no role in the commercial speech 
context . . . “What our decisions require,” instead, 
“is a ‘fit’ between the legislature’s ends and the 
means chosen to accomplish those ends, a fit that 
is not necessarily perfect, but reasonable; that rep­
resents not necessarily the single best disposition 
but one whose scope is ‘in proportion to the inter­
est served,’ that employs not necessarily the least 
restrictive means but . . . a means narrowly tai­
lored to achieve the desired objective” (citations 
omitted) (p. 632). 
In practical terms, the decision implies that re­
strictions on tobacco advertising that target areas 
where children gather, such as schools and play­
grounds, do not create a total ban, because the tobacco 
industry will still have many alternative channels to 
communicate with its adult customers. Adults can still 
receive information on price, quality, comparative 
product features, and any other information to help 
them make an informed decision on tobacco products. 
Even if the tobacco industry were limited to commu­
nicating in tombstone format (black letters on a white 
background), the government would not have prohib­
ited the flow of information. 
For a similar reason, 44 Liquormart, Inc. v. Rhode 
Island does not change this analysis. The rationale the 
Supreme Court used there in overturning Rhode 
Island’s alcohol advertising restriction—that the 
statute was a paternalistic ban on the free flow of truth­
ful information—does not apply in tobacco advertis­
ing regulations like those upheld in Penn Advertising, 
because the tobacco industry would still have many 
avenues of communication open to it and could com­
municate all aspects of information. 
Justice Stevens in 44 Liquormart also generally 
rejected a vice exception to commercial speech restric­
tions. In Posadas de Puerto Rico, the Court was willing 
to allow the legislature broad deference to curb speech 
that promoted “vice” activities such as gambling. Jus­
tice Stevens rejected this approach that allowed legis­
latures to ban speech rather than the vice itself.  He 
stated, however, that “a ‘vice’ label that is unaccom­
panied by a corresponding prohibition against the 
commercial behavior at issue fails to provide a prin­
cipled justification for the regulation of commercial 
speech about that activity” (44 Liquormart, Inc. v. Rhode 
Island, p. 514). In the case of restricting tobacco adver­
tising aimed at children, the restriction matches the 
prohibition.  It is illegal to sell tobacco products to 
minors, and therefore the legislature has a principled 
reason to prevent commercial speech in the limited 
area where it has already prohibited the commercial 
activity.  This is in accord with Justice Clarence 
Thomas’ view that a jurisdiction “may not restrict ad­
vertising regarding commercial transactions except to 
the extent that it outlaws or otherwise directly restricts 
the same transactions within its own borders” (p. 525). 
In 44 Liquormart, Justice Sandra Day O’Connor’s 
concurrence set out the guideposts she would use to 
judge commercial speech restrictions.  “The availabil­
ity of less burdensome alternatives to reach the stated 
goal signals that the fit between the legislature’s ends 
and the means chosen to accomplish those ends may 
be too imprecise to withstand First Amendment scru­
tiny.  If alternative channels permit communication of 
the restricted speech, the regulation is more likely to 
be considered reasonable” (44 Liquormart, Inc. v. Rhode 
Island, pp. 529–30 [internal citations omitted]). The 
ruling presupposes that other less restrictive alterna­
tives, such as price increases and access restrictions, 
have been tried (if enacted) and have not completely 
solved the problem. It is reasonable for a legislature 
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to conclude that limited restrictions on commercial 
speech aimed at youth must be a component of an 
overall plan to limit youth involvement with tobacco 
products.  At the same time, the tobacco industry will 
have alternative channels to communicate to adults 
all the information in which adults are interested, in­
cluding price, tar and nicotine levels, and taste. In the 
context of alcohol advertisements, courts have asserted 
that “the state’s concern is not that the public is un­
aware of the dangers of alcohol. . . . The concern in­
stead is that advertising will unduly promote alcohol 
consumption despite known dangers” (Dunagin, cert. 
denied, 467 U.S. 1259). 
The preceding review of relevant cases suggests 
that carefully designed, reasonable government restric­
tion of cigarette advertising would likely meet 
the Supreme Court’s four criteria for restricting 
commercial speech and would therefore be found 
constitutional. 
A Critical Example: Joe Camel 
Perhaps the most discussed tobacco promotion 
of the 1990s—and one that brings together many of 
the issues discussed in the preceding section—is the 
advertising campaign for Camel cigarettes that features 
a cartoon camel character called Old Joe (often referred 
to as Joe Camel). Assertions have been made that this 
campaign improperly targeted minors, seeking to at­
tract them to cigarette smoking.  These concerns were 
heightened in the wake of the 1994 Surgeon General’s 
report on smoking and health, which focused on ado­
lescents (USDHHS 1994). That report’s major conclu­
sions included the following: those who smoke usually 
begin by age 18; most adolescent smokers become ad­
dicted to nicotine; tobacco addiction is associated with 
the later development of other drug addiction; tobacco 
use is related to psychosocial risk factors; and some 
cigarette advertising appears to be particularly effec­
tive on adolescents. 
Critics argue that the cartoon character of Joe 
Camel, which has been used by R.J. Reynolds Tobacco 
Company in its advertising campaign for Camel ciga­
rettes since 1988, has had substantial impact on smok­
ing among underaged youth (DiFranza et al. 1991; 
Fischer et al. 1991a; Breo 1993; CDC 1994b).  The char­
acter appears in print advertising and on promotional 
products disseminated by the company, such as mugs, 
matchbooks, store exit signs, and soft drink can hold­
ers. After a staff investigation, in 1994 the FTC de­
clined, by a 3 to 2 vote, to issue a complaint charging 
that advertising using the Joe Camel character violated 
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section 5 of the Federal Trade Commission Act by in­
ducing minors to smoke. Subsequently, the FTC did 
bring a complaint against R.J. Reynolds on May 28, 
1997, alleging that “the purpose of the Joe Camel cam­
paign was to reposition the Camel brand to make it 
attractive to younger smokers. . . . The Joe Camel cam­
paign induced many of these children and adolescents 
under the age of 18 to smoke Camel cigarettes or in­
creased the risk that they would do so. . . . R.J. 
Reynolds’ actions . . . have caused or were likely to 
cause substantial and ongoing injury to the health and 
safety of children and adolescents under the age of 18 
that is not offset by any countervailing benefits and is 
not reasonably avoidable by these consumers” (In re 
R.J. Reynolds Tobacco Co., Docket No. 9285 [FTC, May 
28, 1997], cited in 12.3 TPLR 8.1, 8.2 [1997]). As late as 
the spring of 1998, Joe Camel memorabilia were still 
being offered for sale in R.J. Reynolds catalogs.  The 
FTC ultimately dismissed its complaint as no longer 
necessary after the November 23, 1998, Master Settle­
ment Agreement banned the use of all cartoon charac­
ters, including Joe Camel, in the advertising, promotion, 
packaging, and labeling of any tobacco product. 
The Federal Trade Commission Act grants no 
private right of enforcement (Holloway v. Bristol-Myers 
Corp., 485 F.2d 986 [D.C. Cir. 1973]).  However, the 
California Unfair Competition Law authorizes actions 
for injunctive relief (a measure sought to prevent a 
given course of action) not only by specified state and 
local officers but also by persons acting for the inter­
est of themselves or the general public. A private ac­
tion was brought in California state court by Janet 
Mangini, who asserted that R.J. Reynolds’ advertising 
practices in the Joe Camel campaign violated the Fed­
eral Trade Commission Act and the California statu­
tory law of unfair competition (Mangini v. R.J. Reynolds 
Tobacco Co., 7 Cal. 4th 1057, 875 P.2d 73 [Cal. 1994], cert. 
denied, 1994 U.S. LEXIS 8361 [Nov. 28, 1994]).  Unfair 
competition is defined to include “any unlawful, un­
fair or fraudulent business act or practice and unfair, 
deceptive, untrue or misleading advertising” (Califor­
nia Business & Professions Code, sec. 17200).  R.J. 
Reynolds, in contesting Mangini’s action, asserted that 
federal law preempted any action in the state courts. 
The Federal Cigarette Labeling and Advertising Act, as 
amended by the Public Health Cigarette Smoking Act 
of 1969, provides that “no requirement or prohibition 
based on smoking and health shall be imposed under 
State law with respect to the advertising or promotion 
of any cigarettes the packages of which are labeled in 
conformity with the provision of this Act” (Public Health 
Cigarette Smoking Act of 1969, sec. 5[b]). 
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The Supreme Court of California rejected the 
preemption argument and held that the cause of ac­
tion against the advertising—that it improperly 
targeted minors—would stand. According to the court, 
the advertising had apparently been effective in tar­
geting adolescents: Camel cigarettes were chosen by 
an estimated 0.5 percent of teenage smokers in 1988 
(the last full year of sales before the Joe Camel cam­
paign) and by an estimated 25–33 percent in 1992 (as 
quoted in the decision; other sources cite a substan­
tial, although smaller, increase [CDC 1994b]).  In 1992, 
teenage smokers accounted for about $476 million of 
Camel sales, a vastly greater amount than the $6 mil­
lion in sales for 1988 (Mangini, p. 1060). The portion 
of the Mangini lawsuit regarding the Joe Camel adver­
tising campaign was settled September 8, 1997, when 
R.J. Reynolds agreed to cease placing Joe Camel on 
California billboards, placing Joe Camel materials in 
magazines and newspapers, and distributing promo­
tional materials through retail mechanisms (Mangini 
v. R.J. Reynolds Tobacco Co., cited in 12.5 TPLR 3.349 
[1997]). It also agreed to pay the cities and counties 
that had joined the action as co-plaintiffs $9 million 
for a counteradvertising campaign, presumably to dis­
pel the lingering effects of the Joe Camel marketing. 
Product Regulation 
action normally brought only under specific federal 
or state law against cigarette advertising. 
In another state, Washington, a private action 
using that state’s law failed to prohibit advertising 
using Joe Camel (Sparks v. R.J. Reynolds Tobacco Co., No. 
C94-783C [W.D. Wa. Dec. 9, 1994], cited in 9.6 TPLR 
2.171 [1994]). Nonetheless, the decision of the Supreme 
Court of California indicates that at least in some in­
stances in some jurisdictions, private parties acting as 
representatives of the general public can bring an 
Thus, as with a number of other legal issues (see 
“Litigation Approaches,” later in this chapter), the
 judicial response to aggressive pursuit of legal policy 
options is still unfolding. Although the process of le­
gally regulating tobacco advertising and promotion 
has been under way for decades, the extent of such 
regulation and its ultimate limits are not yet known. 
The most significant developments in this area 
revolved around the release of—and subsequent 
reaction to—the FDA’s August 10, 1995, preliminary de­
termination. The determination accompanied a pro­
posed rule that sought to restrict the availability and 
marketing of tobacco products to children and adoles­
cents. The FDA’s final determination that it had au­
thority to regulate cigarettes and smokeless tobacco 
products (released on August 28, 1996) is discussed later 
in this chapter, where the analysis of product regula­
tion focuses on “Further Regulatory Steps.” 
Arguably the second most important develop­
ment in this area was the June 20, 1997, proposed agree­
ment that would have settled lawsuits between 41 state 
attorneys general and the tobacco industry.  Because 
the advertising and promotion provisions of that agree­
ment directly presupposed legislation that would have 
upheld the FDA’s asserted jurisdiction to regulate to­
bacco products, this key multistate agreement is, like 
the FDA announcement, discussed later in this chap­
ter, where the analysis of product regulation focuses 
on “Legislative Developments” and “Master Settle­
ment Agreement.” 
Introduction 
Cigarette smoke contains approximately 4,000 
chemicals, including a number of carcinogens and other 
toxic chemicals, such as hydrogen cyanide and oxides 
of nitrogen (USDHHS 1989). Regulating tobacco prod­
ucts requires appropriate assessment of these primary 
and secondary products of combustion and other sub­
stances that may be inhaled. Current tobacco product 
regulation requires that cigarette advertising disclose 
levels of “tar” (an all-purpose term for particulate-
phase constituents of tobacco smoke, many of which 
are carcinogenic or otherwise toxic) and nicotine (the 
psychoactive drug in tobacco products that causes ad­
diction [USDHHS 1988]) in the smoke of manufactured 
cigarettes and that warning labels appear on packages 
and on some (but not all) advertising for manufactured 
cigarettes and smokeless tobacco;2 the current federal 
2 In California, a state suit against tobacco manufacturers for 
failure to comply with the state’s Safe Drinking Water and Toxic 
Substances Enforcement Act of 1986 led to an agreement 
requiring that a warning about the possibility of reproductive 
harm and cancer appear on packages not covered by federal 
requirements (USDHHS 1989). 
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laws preempt, in part, states and localities from impos­
ing other labeling regulations on cigarettes and smoke­
less tobacco (see the previous major section, 
“Advertising and Promotion”). 
Since the mid-1980s, federal law has required 
makers of manufactured cigarettes and of smokeless 
tobacco products to submit lists of additives to the 
tobaccos (but not to filters or papers) in their products 
to the Secretary of Health and Human Services (Com­
prehensive Smoking Education Act, Public Law 98-474, 
sec. 5; Comprehensive Smokeless Tobacco Health Edu­
cation Act of 1986, Public Law 99-252, sec. 4).  Infor­
mation about the quantity of additives used and their 
placement in specific brands is not required, and the 
Secretary is bound by law to safeguard the lists from 
public disclosure.  In 1994, attorneys for six manufac­
turers released to the public the list of ingredients 
added to tobacco in 1993. 
Tobacco products are explicitly protected from 
regulation in various federal consumer safety laws 
(USDHHS 1989). Although regulation requires pub­
lic reporting of some constituents in cigarette smoke, 
cigarette manufacturers are not required to report to a 
governmental body (or to include on product labels 
for consumers) brand-specific information about the 
nicotine content or any other property (e.g., nitro­
samine levels, ammonia level, pesticide residues, 
heavy metals [lead, cadmium, mercury, or chromium], 
pH, or sugar content) of the material that forms the 
tobacco rod of their products.  At the very least, knowl­
edge of the upper bound of nicotine in the tobacco rod 
of cigarettes is important because actual smoking may 
produce constituent levels that vary considerably from 
that in smoke delivery yields reported to the FTC 
(USDHHS 1988; see also “Compensatory Smoking,” 
later in this chapter). Those measurements were con­
ducted by the Tobacco Institute Testing  Laboratory. 
The Comprehensive Smokeless Tobacco Health 
Education Act of 1986 requires smokeless tobacco 
manufacturers to report the total nicotine content of 
their products to the Secretary of Health and Human 
Services (Public Law 99-252, sec. 4), but the Secretary 
may not release the data to the public.  A uniform pro­
tocol implementing this provision was published in 
the March 23, 1999, Federal Register. No federal public 
health laws or regulations apply to cigars, pipe tobac­
cos, or fine-cut cigarette tobaccos (for “roll-your-own” 
cigarettes) in any manner other than prohibiting the 
advertising of small cigars through electronic media 
(USDHHS 1989). 
The Constituents of Smoke From 
Manufactured Cigarettes 
Since 1967, the FTC has regularly published 
tables of tar and nicotine delivery of smoke from manu­
factured cigarettes.  Since 1980, the tables have also 
included a measurement for carbon monoxide 
delivery.  The data are based on results of a standard­
ized, machine-driven test procedure (Pillsbury et al. 
1969) that provides a basis of comparison among vari­
ous brands of cigarettes.  Manufacturers are not re­
quired to print these values on the product package, 
but “ultra low” cigarette brands often include tar and 
nicotine deliveries on the package, presumably to dif­
ferentiate these brands (Davis et al. 1990).  No brand 
having a tar yield above 11 mg prints this information 
on the package. Carbon monoxide deliveries are not 
listed either on packages or in advertising (USDHHS 
1989). 
Regulation by Tar Levels 
The FTC’s tables of tar levels have provided some 
jurisdictions with criteria for regulating tar content by 
levying taxes on higher-tar cigarettes or, in the case of 
countries in the European Union, by altogether ban­
ning high-tar cigarettes. The apparent assumption be­
hind such actions—that discouraging or banning 
consumption of higher-tar cigarettes will result in 
reduced morbidity and mortality from smoking-
related diseases—has been questioned, as is discussed 
in the section “Compensatory Smoking,” later in this 
chapter. 
Tar content has in several instances served as the 
basis for cigarette taxation, on the presumption that 
the taxing structure would provide a competitive ad­
vantage to low-tar brands—an advantage of interest, 
for supposed public health reasons, to the jurisdiction 
levying the tax. For several years beginning in 1971, 
New York City taxed cigarettes that had either tar 
yields over 17 mg or nicotine yields over 1.1 mg an 
additional 3 cents per pack and cigarettes that exceeded 
both thresholds, 4 cents (Long Island Tobacco Co., Inc. v. 
Lindsay, 74 Misc. 2d 445, 343 N.Y.S.2d 759 [N.Y. 1973]). 
Although the levy was upheld by the courts, the law 
seems to have been repealed because of allegations that 
unequal taxation across political boundaries was fos­
tering smuggling (Ranzal 1973). There are no reports 
on the effects this tax may have had on consumption 
patterns. 
In 1978, the British government imposed a 
supplementary tax on cigarettes having a measured 
tar yield greater than 20 mg (Gray and Daube 1980 
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Figure 5.1. Sales-weighted nicotine and tar levels in smoke as percentage of 1982 levels 
*By Federal Trade Commission method.
 

Source:  Kessler 1994b; Federal Trade Commission, unpublished data, 1998.
 

[note misprint in this publication: on page 93, line 3, 
“more” should have been “less”; correction furnished 
by Michael Daube, February 13, 1996]).  Within three 
months of the imposition of the tax, the market share 
of such brands fell from 15 to 3 percent (Michael M. 
Daube, letter to John Slade, February 24, 1995).  A simi­
lar tax was used in Sweden, but it was repealed to 
achieve uniformity with tax policies of the European 
Union (Paul Nordgren, letter to David T. Sweanor, 
December 23, 1994). 
Among countries in the European Union, a 
fixed ceiling on tar content has been used as a regu­
latory method. The European Union has imposed a 
graduated decline in the upper limit of tar deliveries 
permitted for cigarettes sold in member countries.  Be­
ginning January 1, 1993, the ceiling was 15 mg tar 
delivery per cigarette; after December 31, 1997, the 
ceiling was 12 mg (Council Directive 90/239/EEC 
1990 O.J. [L 137]). 
Implications of Nicotine Levels 
The FTC’s tables on nicotine levels have revealed 
a recent change in the ratio of tar to nicotine in ciga­
rettes. Kessler (1994b) has reported that for 1982–1991, 
the ratio of average sales-weighted nicotine yield to 
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tar yield3 in cigarette smoke has risen steadily for each 
of three major tar-yield categories and for the overall 
market (Figure 5.1). Given the addictive properties of 
nicotine and its contribution to cardiovascular disease 
(USDHHS 1988), this change may have important pub­
lic health implications. Moreover, “low-yield” and 
“ultra low-yield” cigarettes in the same period had 
higher nicotine yield to tar ratios than did brands in 
the high tar-yield categories. Consumers who pay 
more heed to the “numbers” for tar levels than to the 
much smaller (but no less important) numbers for 
nicotine levels may be under the illusion that they are 
reducing their health risks and increasing their 
chances of quitting by smoking “low-tar” cigarettes. 
(This illusion is further discussed in “The Low-Tar 
‘Alternative,’ ” later in this chapter.) 
A manufactured cigarette generally contains 
8–10 mg of nicotine (USDHHS 1988), regardless of the 
machine-measured nicotine delivery in the smoke.  Un­
der usual smoking conditions, consumers absorb about 
10–30 percent of the nicotine contained in the tobacco 
rod of the cigarette (USDHHS 1988; Benowitz and 
Henningfield 1994). Some thought has recently been 
given to systematically lowering the nicotine content 
of tobacco products to levels that would not pose a 
threat of addiction (Benowitz and Henningfield 1994; 
Douglas 1994). Benowitz and Henningfield (1994) have 
suggested that addiction is unlikely to be sustained 
below a nicotine dose of about 5 mg per day.  This dose 
is about one-fourth the daily dose commonly ingested 
by tobacco users. To achieve such a ceiling for ciga­
rettes, the nicotine content of the tobacco rod would 
have to be 0.5 mg or less, assuming that the smoker 
consumes about 30 cigarettes per day and receives 30 
percent of the nicotine available.  However, cigarettes 
with such low levels of nicotine may not be popular 
(Campbell 1994). The experience of Philip Morris 
Companies Inc. in trying to sell a low-nicotine-content 
cigarette, “Next,” illustrates this point; the company 
judged the test-marketing of this cigarette a failure. 
Such failure provides indirect support for the impor­
tance of nicotine addiction to the tobacco industry. 
Mandating the reduction of nicotine for the 
purpose of weaning smokers from tobacco products 
was contemplated as a strategy available to the FDA 
in legislation proposed to enable the multistate settle­
ment agreement with the tobacco companies (see 
3 Average sales-weighted nicotine-to-tar yield means that the 
average amount reported here was calculated by taking the yield 
from all brands of cigarettes and weighting each yield by its sales 
figures.  Thus, the yield for a popular cigarette would “count” 
more in the average of all brands than the yield for a less popular 
brand. 
Reducing Tobacco Use 
“Legislative Developments” and “Master Settlement 
Agreement,” later in this chapter).  A similar strategy 
is used in some voluntary stop-smoking programs (e.g., 
Gahagan 1987). But this strategy cannot work unless 
accurate measures are available of the actual nicotine 
uptake that smokers and other tobacco users receive. 
In 1994, the NCI convened an ad hoc expert com­
mittee to determine the adequacy of the standard, 
smoking-machine-based, FTC protocol for determin­
ing the tar and nicotine content of cigarettes.  The com­
mittee concluded that “the FTC test protocol was based 
on cursory observations of human smoking behavior. 
Actual human smoking behavior is characterized by 
wide variations in smoking patterns, which result in 
wide variations in tar and nicotine exposure.  Smok­
ers who switch to lower tar and nicotine cigarettes fre­
quently change their smoking behavior, which may 
negate potential health benefits” (NCI 1996, p. vi). 
In 1996, Massachusetts enacted a law designed 
to obtain reports of brand-specific nicotine levels that 
more closely approximate the uptake by actual smok­
ers of these brands. The statute instructs the state 
Department of Public Health to establish standards for 
nicotine yield ratings that “accurately predict nicotine 
intake for average consumers” (Mass. Gen. Laws ch. 
94, sec. 307B). Each cigarette and smokeless tobacco 
manufacturer must then report, in a manner consis­
tent with these standards, the nicotine yield rating of 
each brand of tobacco products it produces. These 
reports become public records. 
Other Constituents in Cigarette Smoke 
Tar and nicotine measurements have tradition­
ally been used as surrogate measures for other toxic 
constituents in cigarette smoke, because changes in tar 
and nicotine levels presumably are predictive of 
changes in the levels of most other particulates. Stud­
ies suggest otherwise. For example, tar level as mea­
sured by smoking machines is not a good predictor of 
benzo[a]pyrene level (Kaiserman and Rickert 1992).  In 
general, declared tar values are not predictive of 
tobacco-specific nitrosamine levels (Fischer et al. 1990, 
1991b). Similarly, tar delivery is a poor predictor of 
the delivery of gas-phase constituents, such as carbon 
monoxide, hydrogen cyanide, and acrolein (Young et 
al. 1981). 
In Canada, the Department of National Health and 
Welfare (Health Canada) has undertaken a program to 
develop methods for collecting and analyzing toxic 
constituents, other than tar, nicotine, and carbon mon­
oxide, in tobacco smoke. Methods have been devel­
oped to measure the levels of benzo[a]pyrene, the 
   
Surgeon General's Report
 
tobacco-specific nitrosamines, hydrogen cyanide, ben­
zene, formaldehyde, 4-amino-biphenyl, and heavy 
metals such as lead and cadmium (Health Canada 
1995a). The Department of National Health and Wel­
fare intends to require manufacturers to use these test 
methods to provide quantitative reports on these chemi­
cals in tobacco smoke or, in the case of heavy metals, in 
the tobacco itself (Health Canada 1995a). 
Rickert (1994) has described the presence of the 
potent bladder carcinogen 4-amino-biphenyl in the 
sidestream smoke from all 10 brands of cigarettes 
tested in a study for Health Canada. Under occupa­
tional safety regulations, the permissible level of ex­
posure to 4-amino-biphenyl is zero.  Applying these 
standards to cigarette smoke would require either that 
this material be absent from cigarette smoke entirely 
or that cigarette smoke not be permitted in spaces sub­
ject to regulation. 
An important development indicating a possible 
design flaw in the manufacture of cigarettes has been 
the report that cellulose acetate fibers are shed from ciga­
rette filters.  Such fibers, coated with tar, have been ob­
served in the lungs of smokers; this observation suggests 
that these fibers may be long-lived in human tissue and 
may be associated with disease (Pauly et al. 1995). 
Additives to Tobacco Products 
Hundreds of ingredients besides tobacco are used 
in the manufacture of tobacco products.  Additives 
make cigarettes more acceptable to the consumer; they 
can make smoke seem milder (and easier to inhale), 
prolong shelf life, prolong burning, and improve taste. 
These additives may be a single chemical used as a 
humectant or a complex mix of chemicals used as a 
flavorant. 
Cigarette Additives 
The six major cigarette manufacturers reported 
a pooled list of 599 ingredients that were added to the 
tobacco of manufactured cigarettes as of 1994 (R.J. 
Reynolds Tobacco Company 1994).  The list is anno­
tated with references to which materials are approved 
for use as food additives by the FDA (under the cat­
egory “Generally Recognized as Safe”) and are thought 
to be safe by the Flavor and Extract Manufacturers 
Association of the United States. However, that a 
material is regarded as safe when ingested in foods 
provides no assurance of its safety in a tobacco prod­
uct, where it will be combined with other substances, 
heated to high temperatures, and may be inhaled into 
the lungs. 
The American Health Foundation (1990) has 
pointed out the toxic potential of numerous cigarette 
tobacco additives under expected conditions of use. 
Heating and burning may lead to the formation of car­
cinogens from some of the additives used.  For in­
stance, amino acids used as additives are known to 
form compounds of various elements, including 
genotoxic agents (known to damage DNA) and experi­
mental carcinogens, during heating.  Licorice root ex­
tract contains glycyrrhizin, and both are used as 
additives in cigarettes; glycyrrhizin produces carcino­
genic by-products when burned.  The leukemia-
producing agent benzene is a component of cigarette 
smoke that may be formed from the combustion of 
many cigarette additives. Because the Federal Food, 
Drug, and Cosmetic Act requires that a food additive 
“be safe under the conditions of its intended use” (sec. 
321), tobacco additives in manufactured cigarettes may 
not fulfill the specifications of the law were the law 
applied to tobacco. 
The use of additives may reinforce cigarette 
smoking by strengthening the addictive effects of nico­
tine. At least one major domestic cigarette maker uses 
some additives to boost the absorption of nicotine in 
cigarette smoke (Kessler 1994c). Ammonia compounds 
alter the pH of nicotine in tobacco, converting it from 
the protonated, bound form (various nicotine salts) to 
the unprotonated, freebase form.  Freebase nicotine 
more readily enters the smoke stream and has been 
predicted to cross lung and oral cavity membranes 
more quickly than nicotine salts do (Henningfield et 
al. 1995). The broader issue of enhancing the delivery 
of nicotine is discussed in the introductory section of 
“Further Regulatory Steps,” later in this chapter. 
Several European countries regulate cigarette ad­
ditives, but only to a modest extent. In France, the to­
tal percentage of the cigarette that consists of additives 
is listed on the side of the package. Among representa­
tive brands manufactured in the United States but sold 
in France (e.g., Camel, Kent, Marlboro, and Winston), 
the cigarette labels indicate that between 6.2 and 10.0 
percent of each cigarette is composed of additives.  The 
British government maintains a list of “permitted” or 
“approved” additives for smoking tobacco and ciga­
rette paper (Lewis and Davis 1994, p. 206).  The list, 
which had 474 ingredients in 1988, specifies the maxi­
mum level permitted for each specific additive (Lewis 
and Davis 1994). In Canada, the Tobacco Products Con­
trol Act (sec. 10; Department of National Health and 
Welfare 1989) requires manufacturers to report a quar­
terly list of ingredients used in their products.  Cana­
dian producers use far fewer additives—about 50 in 
all—than do American manufacturers. 
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Massachusetts, Minnesota, and Texas have en­
acted laws to require the disclosure of nontobacco in­
gredients in tobacco products (Mass. Gen. Laws ch. 
94, sec. 307B; Minn. Laws ch. 227 [1997]; Vernon’s Texas 
Statutes and Codes Annotated ch. 161, sec. 161.252 
[1997]). Health officials in the Canadian province of 
British Columbia have announced their intention of 
taking similar steps there. 
The Massachusetts law, applicable to cigarettes 
and smokeless tobacco, requires the manufacturer to 
report, in descending order by weight, measure, or nu­
merical count, the identity of each brand’s added con­
stituents other than tobacco, reconstituted tobacco 
sheet, or water. Ingredients that are recognized as safe 
when burned and inhaled are exempted.  The Depart­
ment of Public Health is then instructed to disclose the 
reported information to the public to the extent that 
“there is a reasonable scientific basis for concluding that 
the availability of such information could reduce risks 
to public health” (Mass. Gen. Laws ch. 94, sec. 307B). 
The tobacco industry challenged the statute in 
court on both preemption and trade secret grounds. 
The Federal District Court ruled that nothing in fed­
eral law preempted Massachusetts from taking this 
action, and the court of appeals affirmed (Philip Mor­
ris Inc. v. Harshbarger, 122 F.3d 58 [1st Cir. 1997]).  How­
ever, the same Federal District Court thereafter issued 
a preliminary injunction that prevented the state from 
enforcing the ingredient disclosure provision of the 
statute; the court ruled that doing so would expose 
the trade secrets of the manufacturers (Philip Morris 
Inc. v. Harshbarger, Civil Action No. 96-11599-GAO, 
Civil Action No. 96-11619-GAO, 1997 U.S. Dist. LEXIS 
21012 [D. Mass. Dec. 10, 1997]). That ruling is cur­
rently under appeal. Texas has adopted a similar stat­
ute requiring the tobacco industry to submit a list of 
ingredients and nicotine yield ratings to the Texas 
Department of Health by December 1998 (Vernon’s 
Texas Statutes and Codes Annotated ch. 161, secs. 
161.252, 161.254, 161.255). 
The Minnesota statute requires manufacturers of 
tobacco products to publicly disclose, for each brand, 
whether the product contains detectable levels—in 
either its unburned or its burned states—of ammonia 
or ammonia compounds, arsenic, cadmium, formal­
dehyde, or lead. The industry filed suit in Federal Dis­
trict Court to enjoin the enforcement of the statute but 
agreed to drop the suit as part of its May 1998 settle­
ment of the state’s Medicaid reimbursement lawsuit 
(discussed in “Recovery Claims by Third-Party Health 
Care Payers,” later in this chapter) (Minnesota v. Philip 
Morris Inc., cited in 13.2 TPLR 3.39, 3.45 [1998]). 
Most recently, British Columbia health officials 
announced plans to require cigarette manufacturers 
to disclose to the government all ingredients, includ­
ing additives used to treat the papers and filters. 
Manufacturers would also have to test and report on 
44 poisons that the health officials claim are contained 
in cigarette smoke (Reuters 1998). 
Smokeless Tobacco Additives 
In 1994, ten manufacturers of smokeless tobacco 
products released a list of additives used in their prod­
ucts (Patton, Boggs & Blow 1994). As with the addi­
tive list for cigarette tobacco, the smokeless tobacco 
list notes which of the 562 materials listed have been 
approved for use in foods by the FDA and also notes 
which are regarded as safe by the Federal Emergency 
Management Agency.  As with cigarette tobacco, ap­
plying these safety standards to nonfood substances 
is problematic; however, smokeless tobacco used in an 
unaltered (unburned) state lessens some of the con­
cern over the possible hazards of additives. 
The list of additives to smokeless tobacco in­
cludes sodium carbonate and ammonium carbonate, 
which are alkalinizing agents that increase the level 
of “free” (chemically uncombined) nicotine in moist 
snuff by raising the pH level (Slade 1995).  A division 
of the Swedish Tobacco Company has stated that so­
dium carbonate is added to its moist snuff brands to 
alkalinize the tobacco and thus enhance nicotine 
absorption (Kronquist 1994).  The pH of moist snuff 
products—which is not reported to consumers— 
varies from acidic to alkaline, providing a wide range 
of free-nicotine levels in various products (Djordjevic 
et al. 1995; Henningfield et al. 1995). Products for per­
sons entering the market (such as those that have easy-
to-use unit dosages) are acidic (thus reducing 
absorption) and have very low levels of free nicotine, 
whereas products for more experienced users (such 
as the Copenhagen brand) are alkaline and have high 
levels of free nicotine. The epidemiology of moist snuff 
use among teenagers and young adults indicates that 
most novices start with brands having low levels of 
free nicotine and then graduate to brands with higher 
levels (Tomar and Henningfield 1992; Tomar et al. 
1995). These patterns are consistent with the industry’s 
marketing strategies as reflected in their advertising 
and marketing activities and their internal documents 
(Connolly 1995). 
Sweeteners and flavorings, such as cherry juice 
concentrate, apple juice, chocolate liqueur, and honey, 
are used in various smokeless tobacco products, and 
dominant flavors are often mentioned in the product 
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name (e.g., the Skoal Cherry Long Cut brand). As with 
manufactured cigarettes, these additives increase pal­
atability and may intensify use of smokeless tobacco, 
at least among novices (Freedman 1994). 
The Low-Tar “Alternative” 
As the health hazards of smoking have been in­
creasingly documented, the production of lower-tar 
cigarettes has increased.  The FTC’s tables on average 
sales-weighted tar levels for cigarettes on the U.S. 
market from 1968 through 1987 reflect this shift toward 
lower-tar cigarette brands (USDHHS 1981, 1989).4  The 
public health implications of this shift merit closer 
inspection. 
Compensatory Smoking 
Considerations of product regulation must take 
into account the variability in toxic exposure attribut­
able to specific smoking practices. The overall evi­
dence suggests that many smokers compensate when 
smoking low-delivery cigarettes by inhaling more tar 
and nicotine than are measured by smoking machines 
under standard conditions.  Any potential health ben­
efit implied by machine measurements of lower tar and 
nicotine yields may thus be mitigated by such com­
pensatory smoking. 
Studies have shown that as consumers switched 
to lower-yield cigarettes in Great Britain, they tended 
to smoke more cigarettes each day (Ferris 1984), ap­
parently to compensate for the lower nicotine yield 
per cigarette.  Similar compensatory measures may 
have occurred in the United States.  For example, smok­
ers in Cancer Prevention Study I, conducted during 
the 1960s when lower-yield brands were rare, smoked 
fewer cigarettes per day than smokers in Cancer Pre­
vention Study II, which was conducted during the 
1980s, by which time most smokers used lower-yield 
brands (Thun et al. 1997). Strong evidence suggests 
that smokers increase the number of cigarettes con­
sumed as nicotine availability is reduced, and vice 
versa (USDHHS 1988; Kaufman et al. 1989; Palmer 
et al. 1989; Stellman and Garfinkel 1989; Negri et al. 
1993; Thun et al. 1997). In addition, lower nicotine 
delivery in the FTC test is associated with smoking a 
greater number of cigarettes (USDHHS 1988).  This 
4 Some reports have included data from 1957 to 1967 (e.g., 
USDHHS 1989, p. 88). However, those data are unpublished and 
first appeared in a chart attributed to a personal communication 
from Dr. Helmut Wakeham, then a research scientist with Philip 
Morris Companies Inc. (Wynder and Hecht 1976, p. 151). 
compensatory effect has been confirmed in other stud­
ies (Benowitz et al. 1983; Bridges et al. 1990; Höfer et 
al. 1991; Woodward and Tunstall-Pedoe 1992; Coultas 
et al. 1993); only one published study found no such 
effect (Rosa et al. 1992).  In an abstract, Byrd and col­
leagues (1994) reported no compensatory effect, but 
their small study population may not have been rep­
resentative of all smokers; for instance, the nicotine 
intake seen among the group that smoked the ultra 
low-delivery cigarettes was smaller than that observed 
by others. 
Health Risks From Low-Tar Cigarettes 
Even when compensatory smoking is not ac­
counted for and calculations are derived from 
machine-rated tar levels, the risk of lung cancer is only 
slightly lower from using low-tar cigarettes than from 
using high-tar cigarettes, and reduced tar level has little 
if any impact on the occurrence of other cigarette-
caused lung disease or of heart disease (USDHHS 1981, 
1989; Parish et al. 1995; Wannamethee et al. 1995). 
Giovino and colleagues (1996) have examined 
results from several national surveys of tobacco use 
for attitudes and behaviors related to the use of low-
tar cigarettes.  In these surveys, current smokers of low-
tar brands were found to be more likely than smokers 
of high-tar brands to acknowledge the health risks of 
smoking, to express concerns about these risks, to re­
port that they had been advised by a physician to stop, 
and to report that they had experienced negative health 
consequences from smoking.  These smokers were also 
more likely, however, to believe that smoking a low-
tar brand reduced those risks.  For example, in the 1987 
National Health Interview Survey, 44 percent of smok­
ers reported that they had switched to a low-tar 
cigarette to reduce their health risk, and 48 percent of 
low-tar brand users thought their brand was less haz­
ardous than most other brands (Giovino et al. 1996). 
These attitudes were confirmed by a 1993 Gallup poll 
in which 49 percent of respondents stated that they 
believed that the advertising message in terms such 
as “low tar,” “low nicotine,” or “lower yield” was that 
the “brand [was] safer”; only 4 percent believed that 
the advertisements were “false/misleading” (Gallup 
Organization, Inc. 1993, p. 23). 
The analysis by Giovino and colleagues (1996) 
also suggested that many smokers of low-tar cigarettes 
may have used these brands instead of quitting. Low-
tar users were more likely than high-tar users to have 
tried unsuccessfully to stop smoking. Similarly, a 
greater proportion of people who had successfully quit 
smoking had been high-tar cigarette users.  This latter 
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observation has been confirmed in another survey: 
those who had stopped smoking tended to have been 
higher-tar cigarette smokers (Cohen 1996).  As was 
previously suggested (Kessler 1994b), the higher ra­
tios of nicotine yield to tar yield in lower-tar cigarettes 
than in higher-tar cigarettes could impede efforts to 
quit among persons who smoke lower-tar cigarettes. 
Assessment of consumer attitudes, as well as 
epidemiologic consideration of health risks from 
lower-yield cigarettes, has raised concerns about the 
reporting of FTC test results (Henningfield et al. 1994). 
An ad hoc committee of the President’s Cancer Panel, 
convened in December 1994 (Jenks 1995), concluded 
that consumers misunderstand the FTC test results and 
should be given a range of values for smoke deliver­
ies (reflecting the way cigarettes are actually smoked) 
and that these values should be included on each pack­
age and in all advertisements (NCI 1996). The com­
mittee also concluded that terms such as “light” and 
“ultra light” are in fact health claims that mislead 
consumers. 
Nicotine Replacement Products 
The “safe cigarette,” long sought, has not been 
found (Gori and Bock 1980; USDHHS 1981, 1989; Slade 
1989, 1993), and the axiom that no tobacco product is 
safe when used as intended remains true (USDHHS 
1989). As long as tobacco products are sold, some 
people will be unable to stop using nicotine (Kozlowski 
1987). Novel nicotine delivery devices have been tried 
in test markets (R.J. Reynolds Tobacco Company 1988; 
Slade 1993; Hilts 1994), and several tobacco compa­
nies have patents for various designs (David A. Kessler, 
letter to Scott D. Ballin, February 25, 1994; Slade 1994; 
Hwang 1995b). All designs share the ability to deliver 
nicotine for inhalation with a minimum of, or no, tar— 
thereby avoiding the smoking-associated increased 
risk of cancer (although not the nicotine-associated 
increased risk of cardiovascular disease) (USDHHS 
1988). 
Nicotine replacement products have been devel­
oped and marketed by pharmaceutical companies as 
adjuncts to help people stop smoking (Jarvik and 
Henningfield 1993). As was discussed in Chapter 4 
(see “Pharmacologic Interventions”), concerns over 
possible intentional or unintentional misuse of these 
products have been weighed against the health ben­
efits resulting from their effectiveness as a cessation 
aid. Nicotine gum and nicotine patches, previously 
approved by the FDA as prescription drugs for brief 
use (months), were approved in 1996 for over-the­
counter use, concluding an intense examination of the 
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issues of nicotine availability.  Both a nicotine nasal 
spray and a nicotine inhaler were approved for pre­
scription use. The Drug Abuse Advisory Committee 
(1994) of the FDA has expressed concern about the 
potential abuse liability of the spray and the inhaler, 
because the pharmacokinetics of their delivered dose 
of nicotine comes closer than the gum or patch to what 
occurs through using tobacco products.  Benowitz and 
Pinney (1998) concluded that the benefits from over­
the-counter availability of the gum and patch would 
outweigh the risks. In December 1996, the FDA’s Drug 
Abuse Advisory Committee recommended approval 
of the nicotine inhaler for prescription use (FDA Drug 
Abuse Advisory Committee, draft minutes of Decem­
ber 13, 1996, meeting). 
Nicotine maintenance is not an approved thera­
peutic approach, but some observers have called for a 
coordinated clinical and public health program to ex­
plore this option (Slade et al. 1992). A useful program 
not only must substantially reduce health risks and 
satisfy addicted individuals who cannot otherwise stop 
using tobacco products but also must include realistic 
safeguards to prevent the new onset of nicotine de­
pendence among the young, to prevent relapse among 
those who have already stopped, and to further re­
duce overall smoking prevalence. 
The elements of such a program would include 
research to (1) fully characterize the population that 
would benefit from nicotine maintenance, (2) identify 
potential delivery devices for nicotine or an appropri­
ate analogue, (3) explore fully the safety of these de­
vices as well as the safety of nicotine or the chosen 
analogue (including assessments of potential cardio­
vascular, fetal, cognitive, and performance problems 
consequent to use of the drug, as well as other poten­
tial health effects), and (4) design a drug distribution 
system that would be acceptable to intended users but 
that would substantially limit access by novices to to­
bacco use and by those who have already been suc­
cessful at achieving abstinence from nicotine (Slade et 
al. 1992). 
Product Regulations for Consumer 
Education 
The previous discussion of product regulation 
centered on the contents of the tobacco product itself. 
Another critical focus for product regulation is pack­
aging, a promising field for public information and 
education on smoking and health. Government ac­
tions in this area have included product packaging to 
convey health messages (see “Attempts to Regulate 
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Tobacco Advertising and Packaging,” earlier in this 
chapter). The goal of this packaging strategy, as dis­
cussed in the following section, is to help ensure that 
the purchase of tobacco products occurs only as a trans­
action involving informed consumer choice. Also dis­
cussed is a related, more complex goal for this strategy: 
to help ensure a situation of informed consumer con­
sent rather than simply choice. 
Tobacco Packaging and Informed Choice 
The current required warning labels on U.S. to­
bacco packages are but a single, narrow means by 
which package-based messages can promote informed 
choice among consumers. The vast amount of infor­
mation available on the adverse health effects of to­
bacco use constitutes a wide range of messages that 
can be presented this way (USDHHS 1989). This in­
formation can appear on packages in many ways, 
given the numerous variables such as size, wording, 
placement, colors, graphics, typefaces, and package 
inserts. 
The potential public education value of package-
based health messages is inherent in their exception­
ally large rate of exposure to consumer view.  In the 
United States, about 478 billion cigarettes were con­
sumed in 1997 (Tobacco Institute 1998).  Each of these 
cigarettes will be removed from a package that could 
be viewed by many cigarette users at exactly the time 
they are preparing to engage in the activity such mes­
sages are intended to prevent.  These messages can be 
seen not only immediately before use but also at the 
point of sale or at any time the package is in the pos­
session of the user.  The messages do not have to be 
directed only at tobacco users; any exposed package 
can be viewed by, and can provide information equally 
germane to, users and nonusers alike. 
for 55 percent of smokers, second only to television (59 
percent) and well ahead of newspapers (17 percent) 
(Tandemar Research Inc. 1992; Kaiserman 1993). 
An example of the potential inherent in package 
messages is provided from Canada.  In legislation 
supplementing the Tobacco Products Control Act (sec. 
9), the federal government of Canada not only increased 
the number of rotating messages from four to eight but 
also made new stipulations regarding the messages’ 
size, location, and color (Department of National 
Health and Welfare 1993; for details on these changes, 
see “Examples of Product Labeling in Other Countries,” 
earlier in this chapter). These changes followed stud­
ies undertaken to determine the existing messages’ leg­
ibility, readability, believability, and ease of 
understanding. These studies had indicated that health 
warnings were read about 1.4 times per day (women, 
1.8 times; men, 1.2 times) and that cigarette packs were 
a primary source of tobacco-related health information 
Tobacco Use and Informed Consent 
Although many discussions of tobacco use in­
voke “free choice,” the more rigorous legal concept is 
“informed consent.” As applied to tobacco use, in­
formed consent would obtain only when potential 
purchasers of tobacco products could make fully in­
formed purchase decisions after carefully weighing the 
health risks of using those products.  Thus, like pa­
tients considering whether to undergo potentially 
harmful medical procedures, consumers considering 
whether to use tobacco would have to know which 
health problems are caused by the product’s use, what 
increases in personal risk of these various problems 
occur through this use, what the prognosis is should 
any of these problems arise, and what effect ending or 
adjusting the use could have on these problems. 
Courts of law in this country and elsewhere have ar­
ticulated the duty of product manufacturers to warn 
consumers about product hazards.  A particularly clear 
statement of the principles involved in informed con­
sent is found in an Ontario Court of Appeal decision 
concerning oral contraceptives: 
Once a duty to warn is recognized, it is manifest 
that the warning must be adequate. It should be 
communicated clearly and understandably in a 
manner calculated to inform the user of the na­
ture of the risk and the extent of the danger; it 
should be in terms commensurate with the grav­
ity of the potential hazard, and it should not be 
neutralized or negated by collateral efforts on the 
part of the manufacturer.  The nature and extent 
of any given warning will depend on what is rea­
sonable having regard to all the facts and circum­
stances relevant to the product in question (Buchan 
v. Ortho Pharmaceutical [Canada] Ltd., [1986] 54 
O.R.2d 101 [Ct. App.] [Can.]). 
Similarly, a U.S. court has described an adequate prod­
uct warning in the following way: 
In order for a warning to be adequate, it must pro­
vide “a complete disclosure of the existence and 
extent of the risk involved” (Pavlides v. Galveston 
Yacht Basin, Inc., 727 F.2d 330 [5th Cir. 1984]) citing 
Alman Brothers Farms & Feed Mill, Inc. v. Diamond 
Laboratories, Inc., 437 F.2d 1295, p. 1303 [5th Cir. 
1971]). . . . A warning must (1) be designed so it 
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can reasonably be expected to catch the attention 
of the consumer; (2) be comprehensible and give 
a fair indication of the specific risks involved with 
the product; and (3) be of an intensity justified by 
the magnitude of the risk (Pavlides, p. 338). 
At issue, then, is whether consumers have re­
ceived adequate warning for informed consent to ap­
ply to tobacco use. Although public knowledge about 
the health effects of tobacco use has improved over 
the past 15 years (FTC 1984; USDHHS 1989), evidence 
persists of gaps in understanding. An American Can­
cer Society (ACS) study showed respondents a list of 
selected causes of death and asked which was respon­
sible for the greatest number of deaths (Marttila & 
Kiley, Inc. 1993). The study found that only one in five 
Americans could correctly identify cigarette smoking 
as the listed cause associated with the most deaths. Simi­
lar studies in other countries (Hill and Gray 1984; Gallup 
Canada, Inc. 1988; Environics Research Group Limited 
1991; Health and Welfare Canada 1992 [unpublished 
data]) have found a similar lack of knowledge. 
These studies indicate that the public continues 
to underestimate the magnitude of the risks arising 
from tobacco use.  The resulting inability of consum­
ers to make fully informed decisions about tobacco use 
could be interpreted as a failure on the part of the 
manufacturer to achieve informed consent from users 
of the product.  To date, this issue has not been legally 
addressed, and the previously discussed notion of in­
formed choice, which carries clearer legal implications, 
is generally invoked. 
Further Regulatory Steps 
Although some of the aforementioned product 
regulations address the chemical constituents of to­
bacco use, none directly broaches the issue of whether 
tobacco, as a nicotine delivery system, should be sub­
ject to federal regulation as an addictive product.  In 
March 1994, the Coalition on Smoking OR Health 
([CSH] composed of the American Heart Association, 
the American Lung Association, and the American 
Cancer Society) filed a petition with the FDA to de­
clare all cigarette products to be drugs under section 
201 of the Federal Food, Drug, and Cosmetic Act (CSH 
1994a). This petition followed an earlier one by the 
same coalition requesting the classification of low-tar 
and low-nicotine cigarettes as drugs and similarly clas­
sifying the proposed new R.J. Reynolds Tobacco Com­
pany “smokeless cigarette” as a drug (CSH 1988). 
A few weeks earlier, the FDA had made public 
that it was investigating whether it might assert juris­
diction over tobacco products (Kessler 1994a).  The 
legal basis for such a move requires demonstrating that 
the manufacturers of tobacco products intend to af­
fect the structure or function of their customers’ bod­
ies (21 U.S.C. section 321 [g] [1]). The Commissioner 
of the Food and Drug Administration, David A. 
Kessler, M.D., had indicated in testimony before Con­
gress that there was evidence that pointed to this con­
clusion (Kessler 1994b,c). 
The FDA has concluded that words used by to­
bacco companies to describe some effects of smoking 
(e.g., “satisfaction,” “strength,” and “impact”) are eu­
phemisms that actually describe pharmacologic effects 
of nicotine (Kessler 1994b, p. 150). Dr. Kessler has 
noted that cigarettes are sophisticated, carefully de­
signed devices. Industry patents disclose a detailed 
knowledge of nicotine pharmacology and describe as 
desirable those product refinements that increase the 
efficiency of nicotine delivery.  One company has pat­
ented a series of nicotine analogues having desired 
pharmacologic effects, much as a conventional phar­
maceutical company might develop a new drug that 
produces effects similar to those of an existing drug. 
The FDA has disclosed several specific examples 
of product manipulation to adjust the delivered dose 
of nicotine in cigarettes (Kessler 1994c).  The Brown & 
Williamson Tobacco Corporation has used in cigarettes 
sold in the United States a strain of tobacco (Y-1) that 
had been genetically engineered to have a high nico­
tine content. According to a major American tobacco 
company’s handbook on leaf blending and product 
development, ammonia compounds can be used as 
additives to boost the delivery of nicotine in smoke to 
enhance the “impact” and “satisfaction” from smoke 
(Kessler 1994c, p. 365). In an official prosecution 
memorandum to the U.S. Attorney General, Represen­
tative Martin T. Meehan (D-MA) has asserted that 
product manipulation of Eclipse brand cigarettes 
has taken place. Meehan cites the addition of 
high-nicotine-content tobacco near the filter and the 
addition of potassium carbonate to change the pH of 
the tobacco (or to enhance absorption through the mu­
cous membranes) (Meehan 1994; see “Criminal Pro­
ceedings,” later in this chapter). Moreover, information 
obtained from internal industry documents suggests 
that at least some tobacco companies have long had 
an accurate and detailed knowledge of nicotine phar­
macology.  Dr. Kessler told Congress that “such re­
search would be of interest to the industry only if the 
industry were concerned with the physiological and 
pharmacological effects of nicotine. Certainly, this is 
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not consistent with the industry’s representation that 
nicotine is of interest to it only because of flavour and 
taste” (Kessler 1994c, p. 367). 
Following his testimony before Congress, in a 
speech at Columbia University School of Law, Dr. 
Kessler emphasized the importance of preventing nico­
tine dependence among children and teenagers. Call­
ing it “a pediatric disease” (David A. Kessler. Remarks. 
Presented at the Samuel Rubin Program, Columbia 
University School of Law, New York City, March 8, 
1995, unpublished), he outlined a number of specific 
priorities for public health action: 
A comprehensive and meaningful approach to 
preventing future generations of young people 
from becoming addicted to nicotine in tobacco is 
needed. Any such approach should:  First, reduce 
the many avenues of easy access to tobacco prod­
ucts available to children and teenagers; second, 
get the message to our young people that nicotine 
is addictive, and that tobacco products pose seri­
ous health hazards—and not just for someone else; 
and third, reduce the powerful imagery in tobacco 
advertising and promotion that encourages young 
people to begin using tobacco products (p. 19). 
On August 10, 1995, the FDA announced the 
result of its investigation. The agency stated that evi­
dence appears to indicate that “nicotine in cigarettes 
and smokeless tobacco products is a drug and [that] 
these products are nicotine delivery devices under the 
Federal Food, Drug, and Cosmetic Act” (Federal Regis­
ter 1995a). In August 1995, the FDA issued in the Fed­
eral Register (1) a proposed rule of regulations 
restricting the sale and distribution of cigarettes and 
smokeless tobacco products to protect children and 
adolescents and (2) an analysis of the FDA’s jurisdic­
tion over cigarettes and smokeless tobacco.  The FDA 
requested comments on its proposed regulations and 
analysis of its jurisdiction, and indicated that it would 
give serious consideration to comments filed with the 
agency concerning the evidence amassed during its 
investigation. The Clinton administration also sug­
gested that Congress could eliminate the need for this 
rulemaking by passing new legislation to affirm the 
FDA’s authority over tobacco products and address 
the issue of tobacco use among minors. 
In its legal analysis of its proposed jurisdiction 
over tobacco products, the FDA argued that cigarettes 
and tobacco products “affect the structure or any func­
tion of the body” (key language for invoking the 
agency’s authorizing legislation) and that it is the in­
tent of tobacco manufacturers that their products have 
addictive effects (Federal Register 1995a). The argument 
was presented as a logical chain of inference:  the ad­
dictive properties of tobacco are “widely known and 
foreseeable” by tobacco manufacturers; consumers use 
the product to satisfy their addiction; and tobacco 
manufacturers know of the addiction, know of con­
sumers’ use, and have facilitated that use (Federal Reg­
ister 1995a). An extensive analysis, including internal 
documents from tobacco companies, was used to elu­
cidate these assertions (Federal Register 1995a). The 
FDA presented a further legal discussion of whether 
the cigarette is a device and postulates that the ciga­
rette is “a consciously engineered instrument . . . to 
effectuate the delivery of a carefully controlled amount 
of the nicotine to a site in the human body where it 
can be absorbed” (Federal Register 1995a). 
The proposed regulations centered on restricting 
the availability and appeal of tobacco products to chil­
dren and adolescents and consisted of the following 
provisions: 
•	 	The tobacco industry would be required to spend 
at least $150 million per year to support smoking 
prevention education for children. 
•	 	Tobacco sales would be prohibited to those under 
18 years of age, and vendors would be required to 
see photo identification as proof of age. 
•	 	 Vending machines, self-service displays, and mail-
order sales would be prohibited, as would the sale 
of individual cigarettes or packs of fewer than 20 
cigarettes. 
•	 	 The sale or gift of promotional items bearing brand 
names, logos, or other brand identity would be 
prohibited. 
•	 	 Free samples would be banned. 
•	 	 Only black-and-white text advertising for cigarette 
products would be permitted in publications for 
which more than 15 percent of the readership is 
under age 18 and in publications with more than 2 
million young readers. 
•	 	 Outdoor tobacco advertising would be prohibited 
within 1,000 feet of schools and playgrounds. All 
other outdoor tobacco advertising would have to 
be in black-and-white text. 
•	 	Sponsorship of sporting or entertainment events 
using specific brand names or product identifica­
tion would be prohibited, although the use of com­
pany names would not. 
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The proposed regulations stirred immediate 
action from the tobacco industry.  Four lawsuits 
were filed immediately after the Federal Register 
announcement. A lawsuit filed by tobacco companies 
in federal court in Greensboro, North Carolina, as­
serted that the FDA had no jurisdiction over cigarettes. 
The plaintiffs were Brown & Williamson Tobacco Cor­
poration, Liggett Group Inc., Lorillard Tobacco Com­
pany, Philip Morris, and R.J. Reynolds Tobacco 
Company (Wall Street Journal 1995). Parts of the ad­
vertising industry, which has a large stake in the out­
come of the proposed regulations, also filed suit on 
the grounds of infringement of First Amendment rights 
(American Advertising Federation v. Kessler, Civil Action 
No. 2:95CV00593 [M.D.N.C. Aug. 10, 1995], cited in 10.5 
TPLR 3.401 [1995]). In addition, a smokeless tobacco 
company (United States Tobacco Co. v. Food and Drug 
Administration , Civil Action No. 6:95CV00665 
[M.D.N.C. Sept. 19, 1995]) and a trade group repre­
senting convenience stores (National Association of Con­
venience Stores v. Kessler, Civil Action No. 2:95CV00706 
[M.D.N.C. Oct. 4, 1995]) filed suit. 
By the January 2, 1996, close of the public com­
ment period on the proposed rules, the FDA had re­
ceived more than 95,000 individual comments, the 
largest outpouring of public response in the agency’s 
history.  From March 18 to April 19, 1996, the FDA re­
opened the comment period for the limited purpose 
of seeking comments on the statements of three former 
Philip Morris employees about that company’s alleged 
manipulation of nicotine in the design and production 
of cigarettes and to seek comments on further expla­
nations of certain provisions in the proposed rule. 
The review process culminated in a Rose Gar­
den ceremony at the White House on August 23, 1996, 
in which President Clinton announced the publication 
of the final FDA rules.  To emphasize that the FDA’s 
central intent was to reduce tobacco use among young 
people, these final rules essentially regrouped the regu­
lations from the original announcement into two cat­
egories: reducing minors’ access to tobacco products 
and reducing the appeal of tobacco products to mi­
nors. The only notable changes to the former rules 
were that the ban on mail-order sales was eliminated 
and the ban on vending machines and self-service 
displays was relaxed to allow exceptions for certain 
nightclub and other “adults-only” facilities totally in­
accessible to persons under the age of 18. Similarly, 
the limitation to black-and-white text for in-store 
advertising excepted adults-only facilities if the adver­
tising was not visible from the outside. 
In place of its original regulation requiring the 
tobacco industry to spend at least $150 million each 
year to support tobacco prevention education for chil­
dren, the final rules were less explicit.  The FDA pro­
posed to require the six tobacco companies with a 
significant share of sales to minors to educate that 
population about the health risks of using tobacco 
products.  This action would be pursued under pro­
cesses dictated by section 518(a) of the Federal Food, 
Drug, and Cosmetic Act (FDCA).  Under the act, the 
FDA may require manufacturers to inform the 
consumer about unreasonable health risks of their 
products. 
The various provisions were to be phased in be­
tween six months and two years from August 28, 1996, 
the date of publication in the Federal Register. Two prin­
cipal hurdles to quick and full implementation of the 
FDA regulations soon emerged.  First, as noted above, 
several tobacco companies, retailers, and advertisers 
had sued the FDA to block implementation of the regu­
lations. Second, various legislative proposals, which 
began circulating in Congress both before and after 
publication of the FDA’s final rule, threatened to alter 
or bar the FDA’s regulation of tobacco products. 
Judicial Developments and the Status of FDA 
Regulations 
Three briefs filed on October 15, 1996, on behalf 
of the plaintiffs in these suits moved for summary judg­
ment, arguing that the proposed regulations exceed 
the agency’s jurisdiction and are contrary to congres­
sional intent, that tobacco products are not “drugs” or 
“devices” within the agency’s statutory grant of au­
thority, and that the advertising restrictions are a vio­
lation of the First Amendment (Mealey’s Litigation 
Reports: Tobacco 1996b). 
On April 25, 1997, the federal district court in 
Greensboro, North Carolina, ruled that the FDA pos­
sessed the authority to regulate cigarettes and smoke­
less tobacco products as drug delivery devices under 
the FDCA (Coyne Beahm, Inc. v. U.S. Food & Drug Ad­
ministration, 966 F. Supp. 1374 [M.D.N.C. 1997]).  The 
ruling, however, marked a considerably qualified vic­
tory for the FDA. Although the court upheld all of the 
agency’s restrictions involving youth access and label­
ing, the court temporarily blocked implementation of 
most of these provisions.  Only the FDA’s prohibition 
on sales of cigarettes and smokeless tobacco to minors 
and the requirement that retailers check photo identifi­
cation of customers who are under 27 years of age es­
caped the court’s stay.  These provisions went into effect 
on February 28, 1997, and remained in force until March 
21, 2000, the date of the Supreme Court decision. 
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Notably, the court invalidated the FDA’s restric­
tions on advertising and promotion of cigarettes and 
smokeless tobacco on the basis that they exceeded the 
agency’s statutory jurisdiction. The pertinent federal 
statute, 21 U.S.C. section 360j(e), provides, in part, that 
the government may “require that a device be re­
stricted to sale, distribution or use . . . upon such other 
conditions as the Secretary may prescribe.”  The FDA 
had argued that it was authorized to restrict the “sale, 
distribution or use” of tobacco products pursuant to 
section 360j(e) and that its advertising and promotion 
restrictions were valid because advertising and pro­
motion constitutes an “offer of sale” (Coyne Beahm, 
p. 1398). Judge William L. Osteen Sr. disagreed.  The 
court reasoned that the word “sale” as employed in 
the statute did not encompass the advertising or pro­
motion of a product.  The court also ruled that the 
“section’s grant of authority to FDA to impose ‘other 
conditions’ on the sale, distribution, or use of restricted 
devices [does] not authorize FDA to restrict advertis­
ing and promotion” (p. 1398).  Furthermore, because 
the court ruled that the FDA was not authorized to 
restrict advertising and promotion, the court did not 
reach or discuss arguments that these provisions 
violated the First Amendment to the United States 
Constitution. 
Most important, however, Judge Osteen agreed 
with the FDA’s contention that tobacco products fall 
within the “drug” and “device” definitions of the 
FDCA. To position its authority within these defini­
tions, the FDA had to have demonstrated that tobacco 
products are “intended to affect the structure or any 
function of the body” (21 U.S.C. section 321 [g][1][C]). 
Judge Osteen ruled that the effects of tobacco prod­
ucts are “intended” within the meaning of the FDCA 
and that tobacco products affect the structure or func­
tion of the body within the meaning of that act. The 
court also ruled that pursuant to its “device authori­
ties,” the FDA could regulate tobacco products as 
medical devices. 
Both sides in the case appealed the decision 
to the Fourth Circuit of the United States Court of 
Appeals in Richmond, Virginia.  The government 
and the tobacco companies presented oral arguments 
to a three-member panel of this court on August 11, 
1997. The case became inactive following the death of 
one of the panel judges on February 22, 1998.  A new 
judge was appointed, and on June 9, 1998, the three-
member panel conducted a second hearing on the 
appeal. 
The Court of Appeals Ruling on FDA Authority 
On August 14, 1998, the Fourth Circuit Court of 
Appeals overturned the lower court decision and ruled 
in a 2 to 1 decision that the FDA lacks the authority to 
regulate tobacco products (Brown & Williamson Tobacco 
Corp. v. Food & Drug Administration, No. 97-1604 [4th 
Cir. 1998]).  The majority opinion (Judge H. Emory 
Widener Jr.) found that the FDA had based its deter­
mination of authority solely on literal interpretations 
of “drug” and “device” in the FDCA but did not con­
sider statutory language as a whole, the legislative his­
tory, and the history of evolving congressional 
regulation in the area, including consideration of other 
relevant statutes. Judge Widener held that there is an 
internal inconsistency in the FDA’s claim of authority 
to regulate tobacco under the FDCA, since a declara­
tion that cigarettes are unsafe (the basis of the FDA’s 
claim) necessitates a ban on cigarette sales—an action 
that would be opposed by powerful economic and 
political forces.  Widener reasoned that although the 
FDA would have the authority to grant exemptions to 
the ban because potential public health benefits might 
outweigh harms, such exemptions would undermine 
the agency’s essential view that cigarettes are unsafe. 
The only exemption open to the FDA would thus be 
based on social and economic rather than health-
related considerations. A well-known catch would 
then come into play: social and economic consider­
ations are within the purview of Congress, not the 
FDA. Judge Widener pointed out that Congress had 
been aware for decades that the FDA lacked the au­
thority to regulate tobacco on social and economic 
grounds, had rejected attempts to give the FDA such 
authority, and had enacted numerous pieces of legis­
lation that did not grant such authority. 
The dissenting opinion (Judge Kenneth K. Hall) 
took the position that the intrinsic contradiction in the 
FDA’s authority under the FDCA is irrelevant:  “. . . 
whether the regulations contravene the statute is a 
question wholly apart from whether any regulations 
could be issued. . . . It is no argument to say that the 
FDA can do nothing because it could have done more” 
(Brown & Williamson, p. 48). The opinion proposed 
that the FDA’s current position is a response to “the 
increasing level of knowledge about the addictive 
nature of nicotine and the manufacturer’s deliberate 
design to enhance and sustain the addictive effect of 
tobacco products” (p. 50). Judge Hall stated that prec­
edents in administrative law clearly indicate latitude 
for an agency to change its approach in the light of 
new information. He further asserted that earlier con­
gressional action did not have the benefit of the level 
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of evidence gathered by the FDA in forming its cur­
rent position. Finally, he pointed out that the term 
“sale, distribution and use” (p. 58) is not fully defined 
in the FDCA and is therefore subject to agency inter­
pretation.  This term “can reasonably be construed to 
include all aspects of a product’s journey from the fac­
tory to the store and to the home” (p. 58).  Thus, the 
judge reasoned, the authority to regulate tobacco pro­
motion should be upheld. The full Fourth Circuit 
Court of Appeals declined to review this reversal.  The 
government petitioned the United States Supreme 
Court for review, and the United States Supreme Court 
accepted the case in April 1999.  Oral argument was 
held December 1999, and the Court, in a 5 to 4 deci­
sion, upheld the Fourth Circuit’s decision on March 
21, 2000. 
The U.S. Supreme Court Ruling on FDA Authority 
On March 21, 2000, by a 5 to 4 vote, the United 
States Supreme Court affirmed the Fourth Circuit de­
cision and overturned the FDA’s assertion of jurisdic­
tion over cigarettes and smokeless tobacco products 
(Food and Drug Administration v. Brown & Williamson 
Tobacco Corp., 529 U.S. _____ [2000], 120 S. Ct. 1291). 
As a result, the FDA no longer has regulatory author­
ity to enforce the final rule it issued in 1996. 
Justice Sandra Day O’Connor wrote the majority 
opinion for the Court. In ruling against the FDA, she 
noted that “The agency has amply demonstrated that 
tobacco use, particularly among children and adoles­
cents, poses perhaps the single most significant threat 
to public health in the United States” (p. 1315). Nev­
ertheless, the majority ruled that Congress had pre­
cluded the FDA from asserting jurisdiction over 
tobacco products as customarily marketed because 
“Such authority is inconsistent with the intent that Con­
gress has expressed” (p. 1297) in the Federal Food, Drug, 
and Cosmetic Act and other tobacco-specific statutes. 
Justice O’Connor noted the unusual nature of 
both the case the Court was deciding and the role of 
tobacco in the United States. She wrote: 
Owing to its unique place in American history and 
society, tobacco has its own unique political history. 
Congress, for better or for worse, has created a dis­
tinct regulatory scheme for tobacco products, 
squarely rejected proposals to give the FDA juris­
diction over tobacco, and repeatedly acted to pre­
clude any agency from exercising significant 
policymaking authority in the area (p. 1315). 
Reducing Tobacco Use 
Justice Stephen Breyer wrote the dissenting opin­
ion. He disagreed with the majority view that Con­
gress never intended the FDA to have the authority to 
assert jurisdiction over tobacco products.  In summa­
rizing why the four justices in the dissent believed the 
FDA had acted lawfully, Justice Breyer wrote: 
The upshot is that the Court today holds that a regu­
latory statute aimed at unsafe drugs and devices 
does not authorize regulation of a drug (nicotine) 
and a device (a cigarette) that the Court itself finds 
unsafe. Far more than most, this particular drug 
and device risks the life-threatening harms that 
administrative regulation seeks to rectify (p. 1331). 
Legislative Developments 
In an effort to clarify the public health perspec­
tive on potential legislation, on September 17, 1997, 
President Clinton outlined the principles he believed 
must be at the heart of any national tobacco legisla­
tion (Hohler 1997): 
•	 	A comprehensive plan to reduce youth smoking, 
including tough penalties if targets are not met. 
•	 Full authority for the FDA to regulate tobacco 
products. 
•	 An end to the tobacco industry’s practice of 
marketing and promoting tobacco to children. 
•	 	Broad document disclosure (especially of those 
documents relating to marketing tobacco to 
children). 
•	 	 Progress toward other public health goals, such as 
reducing environmental tobacco smoke (ETS), ex­
panding smoking cessation programs, strengthen­
ing international efforts to control tobacco, and 
providing funds for health research. 
•	 	 Protection for tobacco farmers and their communities. 
A number of bills intended to enable the enact­
ment of the June 20, 1997, multistate settlement agree­
ment were introduced into the U.S. Senate in late 1997 
and early 1998. In March 1998, the Senate Commerce 
Committee bill introduced by Senator John McCain 
(R-AZ) became the focus of all settlement-related 
legislative activity in the Senate. The Commerce 
Committee endorsed a preliminary version of a sub­
stitute bill, S. 1415, on March 30, 1998, by a vote of 19 
to 1. On May 1, 1998, the Commerce Committee’s ver­
sion of the bill—S. 1415.RS (the “McCain Committee 
   
Surgeon General's Report
 
Bill”)—was reported by Senator McCain to the full 
Senate. Among other things, the McCain Committee 
Bill would have done the following: 
•	 	Required the tobacco industry to pay $516 billion 
($147.5 billion more than was specified in the June 
20th multistate settlement agreement) over 25 years 
to help states and the federal government bear the 
medical costs of smoking-related illness. 
•	 	Raised cigarette taxes by $1.10 per pack over five 
years. 
•	 Preserved the FDA’s ability to regulate the 
tobacco industry in ways that the June 20th agree­
ment did not. 
•	 	Drastically reduced cigarette marketing, advertis­
ing, and promotion (Kelder 1998). 
In addition, the Floor Manager’s Amendment to 
the bill would have established a detailed regulatory 
scheme to be administered by the FDA (S. 1415.RS 
[Floor Manager’s Amendment of May 18, 1998, 105th 
Cong., 2nd Sess.]). First, the FDA could designate de­
monstrably safer products as “reduced risk tobacco 
products” (sec. 913[a][2][A]).  Second, the FDA would 
have the authority to promulgate performance stan­
dards, including “the reduction or elimination of nico­
tine yields” (sec. 907[a][2][A][I]) and “the reduction 
or elimination of other constituents or harmful com­
ponents of the product” (sec. 907[a][2][A][ii]).  The 
agency would follow normal administrative proce­
dures, unless it sought to eliminate “all cigarettes, all 
smokeless tobacco products, or any similar class of 
tobacco products” (sec. 907[b][3][A]) or to require “the 
reduction of nicotine yields of a tobacco product to 
zero” (sec. 907[b][3][B]).  In that event, the amendment 
stipulated, “the standard may not take effect before a 
date that is 2 years after the President notifies the Con­
gress that a final regulation imposing the restriction 
has been issued” (sec. 907[b][3][B]). Third, the Floor 
Manager’s Amendment would have required that the 
FDA be given the additive information specified in the 
settlement agreement within six months of enactment 
(sec. 904[a][3]). 
The amendment would also have required that 
manufacturers share with the FDA “all documents . . . 
relating to research activities, and research findings, 
conducted, supported, or possessed by the manufac­
turer (or agents thereof) to the health, behavioral, 
or physiologic effects of tobacco products, their con­
stituents, ingredients, and components, and tobacco 
additives” (sec. 904[a][4]) or “to marketing research 
involving the use of tobacco products” (sec. 904[a][5]). 
Tobacco product advertising would be required to in­
clude a “brief statement of the uses of the tobacco prod­
uct and relevant warnings, precautions, side effects, 
and contraindications” (sec. 903[a][8][B][i]). Further­
more, the FDA would be given explicit power to im­
pose “restrictions on the access to, and the advertising 
and promotion of, the tobacco product” (sec. 906[d][1]). 
Senate bill 1415 was vehemently opposed by the 
tobacco industry.  On April 8, 1998—nine days after 
the Commerce Committee endorsed the preliminary 
version of the McCain Committee Bill—Steven F. Gold­
stone, RJR Nabisco’s chief executive officer, announced 
that his company was pulling out of the congressional 
process for developing comprehensive tobacco legis­
lation. Blaming Congress for failing to stick to the 
terms of the June 20th agreement, Mr. Goldstone, 
speaking to the National Press Club in Washington, 
DC, declared his company’s intention not to sign the 
consent decrees to voluntarily limit advertising that 
were part of the McCain Committee Bill.  Philip Mor­
ris, Brown & Williamson, United States Tobacco, and 
Lorillard made similar announcements shortly after 
Mr. Goldstone’s speech. 
In retrospect, one can conclude that this tobacco 
company brinkmanship—when paired with a widely 
disseminated, industry-sponsored advertising cam­
paign that portrayed the McCain Committee Bill as a 
vast “tax-and-spend” proposal—was a major force in 
scuttling the proposed legislation. Emboldened by the 
effect that the industry-sponsored advertising campaign 
had on public opinion, the tobacco industry’s Senate 
allies greatly altered the McCain Committee Bill, cul­
minating in the Floor Manager’s Amendment on May 
18, 1998. Some of these amendments would have in­
creased the bill’s potential harmful impact on public 
health. For example, in this final form, the bill had been 
shorn of almost all of its funds for initiatives to fund 
tobacco use reduction, and the tobacco industry had 
been given a potential means of immunity in the form 
of caps on plaintiffs’ attorneys’ fees (Kelder 1998). 
On June 17, 1998, the McCain Committee Bill died 
after four weeks of intense debate and political ma­
neuvering. In the absence of congressional action to 
enact the proposed settlement, individual state law­
suits proceeded.  Four states—Mississippi, Florida, 
Texas, and Minnesota—have settled their suits with 
the tobacco industry.  Because these settlements in­
volve the recovery of Medicaid payments made by the 
states, they are discussed with other such litigation 
approaches, later in this chapter (see “Recovery Claims 
by Third-Party Health Care Payers”). 
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Master Settlement Agreement 
On November 23, 1998, 11 tobacco companies 
executed a legal settlement with 46 states, the District 
of Columbia, and five commonwealths and territories. 
The plaintiffs had sued the tobacco industry to recoup 
Medicaid costs for the care of persons injured by 
tobacco use. The suit alleged that the companies had 
violated antitrust and consumer protection laws, had 
conspired to withhold information about adverse 
health effects of tobacco, had manipulated nicotine lev­
els to maintain smoking addiction, and had conspired 
to withhold lower-risk products from the market. 
In the settlement, the companies agreed to pay 
states $246 billion over 25 years. But in addition, the 
settlement agreement contained a number of impor­
tant public health provisions (see the text box). The 
agreement placed significant marketing restrictions on 
the industry by prohibiting direct advertising and pro­
motion aimed at young people, by limiting brand name 
sponsorship at events that might be frequented by 
youth, by requiring the removal of street advertising 
without restrictions on counteradvertising, by placing 
substantial restrictions on lobbying and on the suppres­
sion of research findings, and by requiring major con­
tributions from the industry to cessation and prevention 
Clean Indoor Air Regulation 
Reducing Tobacco Use 
activities (Wilson 1999).  In addition, the agreement dealt 
with such issues as legal fees, court supervision, civil 
liabilities restrictions, and public disclosure.  Unlike the 
1997 settlement, the 1998 settlement contained no pro­
visions regarding FDA  authority. 
The agreement raised a number of issues for 
states, but foremost among these has been the compe­
tition between tobacco control efforts and other state 
spending priorities. The National Governors Associa­
tion issued a policy statement that reaffirmed states’ 
entitlement and asserted that the federal government 
had no legitimate claim to settlement funds. The asso­
ciation committed to spending “a significant portion of 
the settlement funds on smoking cessation programs, 
health care, education, and programs benefitting chil­
dren” but reserved the right to make funding decisions 
tailored to states’ individual needs (National Governors 
Association 1999). By mid-1999, 27 states had allocated 
their first and second settlement payments. Of these, 
23 had specified some portion of the money for public 
health activities, and 16 had specifically designated 
spending for tobacco control and prevention efforts. 
Specific issues related to the allocation of Master Settle­
ment Agreement funds to tobacco control efforts in 
states are discussed in Chapter 7. 
Introduction 
If the regulation of tobacco products themselves 
has been characterized by slow and incremental ad­
vances, the regulation of where and how tobacco prod­
ucts are used—that is, the regulation of exposure, 
particularly of nonsmokers, to ETS—has encountered 
comparatively little resistance. Public and private 
steps to regulate ETS have become both more com­
mon and more restrictive over the past several decades. 
There are various reasons for this broad and rapid 
implementation. One reason is that the public health 
necessity of regulating ETS exposure is manifest:  ETS 
is known to cause acute and chronic diseases in non­
smokers (National Academy of Sciences 1986; 
USDHHS 1986; National Institute for Occupational 
Safety and Health 1991; EPA 1992; California EPA 
1997). Moreover, this demonstrated health threat is 
unentangled with legal or ethical issues of “informed 
choice” or “informed consent” (see “Product Regula­
tion,” earlier in this chapter)—hence a popular name 
for this exposure, passive smoking. Regulating ETS 
exposure also has important implications for reduc­
ing smoking: studies have shown that restricting 
smoking in public settings increases the likelihood that 
smokers in these settings smoke fewer cigarettes or 
quit smoking entirely (Petersen et al. 1988; Borland et 
al. 1990a; Stillman et al. 1990; Sorensen et al. 1991a; 
Woodruff et al. 1993).  It has been estimated that the 
combined effect of general smoking cessation and 
smoking reduction in public settings could decrease 
total cigarette consumption by as much as 40 percent 
(Woodruff et al. 1993), although this conclusion may 
be questioned based on assessment of worksite inter­
ventions (see “Worksite Programs” in Chapter 4).  A 
second reason for the expansion of ETS regulations is 
that their public support, a key marker for successful 
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Major Provisions of the Master Settlement Agreement 
In addition to the monetary payments from the tobacco industry to states, the settlement pro­
vided for other requirements and restrictions: 
Youth Access 
•	 No free samples except in an enclosed area 
where operator ensures that no underage 
persons are present. 
•	 	 No gifts to youth in exchange for buying tobacco 
products. 
•	 	 No gifts through the mail without proof of age. 
•	 	Prohibits sale, manufacture, or distribution of 
cigarettes in packages of fewer than 20 until 
December 31, 2001. 
Marketing 
•	 	No brand name sponsorship of concerts, team 
sporting events, or events with a significant 
youth audience. 
•	 	 No sponsorship of events in which paid partici­
pants are underage. 
•	 	Bans use of tobacco brand names in stadiums 
and arenas. 
•	 	 Bans use of cartoon characters in tobacco adver­
tising, packaging, and promotions. 
•	 	Bans payments to promote tobacco products in 
entertainment settings, such as movies. 
•	 	 Bans distribution and sale of merchandise with 
brand name tobacco logos. 
Lobbying 
•	 	 Prohibits industry from supporting diversion of 
settlement funds to nonhealth uses. 
•	 	 Restricts industry from lobbying against restric­
tions of advertising on or in school grounds. 
•	 	 Prohibits new challenges by the industry to state 
and local tobacco control laws enacted before 
June 1, 1998. 
Outdoor Advertising 
•	 	 Bans transit and outdoor advertising, including 
billboards. 
•	 Tobacco billboards and transit ads to be 
removed. 
•	 	At industry expense, states could substitute 
advertising discouraging youth smoking. 
Cessation and Prevention 
•	 	 The tobacco industry will contribute $25 million 
annually for 10 years to support a charitable 
foundation established by the National Associa­
tion of Attorneys General to study programs to 
reduce teen smoking and to prevent diseases 
associated with tobacco use. The foundation, 
since named the American Legacy Foundation, 
is governed by a board and will carry out a sus­
tained national advertising and education pro­
gram to counter tobacco use by young people 
and educate consumers about the health hazards 
of tobacco use. It will also evaluate the effec­
tiveness of counteradvertising campaigns, 
model classroom educational programs, and ces­
sation programs and will disseminate the results. 
Other activities include commissioning and 
funding studies on the factors that influence 
youth smoking, developing training programs 
for parents, and monitoring youth smoking to 
determine the reasons for increases or failures 
to decrease tobacco use rates. 
•	 	The industry will contribute $1.45 billion over 
five years to support the National Public Edu­
cation Fund, which will carry out a national sus­
tained advertising and education program to 
counter youth tobacco use and to educate con­
sumers about tobacco-related diseases.  The to­
bacco industry will continue to contribute $300 
million annually to the fund as long as the par­
ticipating tobacco companies hold 99.05 percent 
of the market. 
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implementation, is implicit: national studies suggest 
that most of the U.S. public experiences discomfort and 
annoyance from ETS exposure (CDC 1988, 1992b), and 
smaller-scale surveys have found that the great ma­
jority of both nonsmokers and smokers favors smok­
ing restrictions in various public locations, including 
the workplace, restaurants, and bars (CDC 1991). A 
third reason is that employers might be expected to 
support ETS regulations, because prohibiting smok­
ing in the workplace can help employers realize lower 
maintenance and repair costs of buildings and prop­
erty, lower insurance costs, and higher productivity 
among nonsmokers (Mudarri 1994). Employer sup­
port, however, may be influenced by other factors (see 
“Effectiveness of Clean Indoor Air Restrictions,” later 
in this chapter). 
Not surprisingly, during the 1980s the tobacco 
industry identified ETS regulation as the single most 
important issue confronting the industry’s economic 
future (Chapman et al. 1990). The industry is con­
cerned that the increasing focus on ETS may cause the 
public and policymakers to view smoking as an envi­
ronmental issue with broad social consequences in­
stead of as a personal behavior involving individual 
choice. The tobacco industry is also concerned about 
legal backlash from possible ETS-related litigation 
against employers and about revenue losses from pos­
sible decreased cigarette consumption due to smok­
ing restrictions (Chapman et al. 1990).  An example of 
the latter concern may be found in California, where 
workplace restrictions extant in 1990 have reduced 
consumption by an estimated 148 million packs per 
year, at a value of $203 million in pretax sales (Wood­
ruff et al. 1993). 
Health Consequences of Exposure to ETS 
The detrimental health effects of exposure to ETS 
are well established (National Research Council 1986; 
USDHHS 1986, 2000b; EPA 1992; California EPA 1997). 
The most comprehensive review of the respiratory ef­
fects of ETS to date is the 1992 report of the EPA, which 
states that ETS is a human lung carcinogen that annu­
ally accounts for approximately 3,000 lung cancer 
deaths among adult nonsmokers in the United States. 
Autopsy reviews (Trichopoulos et al. 1992) and stud­
ies of ETS metabolites in body fluids (Hecht et al. 1993) 
provide biologic support for epidemiologic studies 
linking ETS and lung cancer.  ETS also has subtle but 
significant effects on the respiratory health (including 
cough, phlegm production, and reduced lung function) 
of adult nonsmokers. 
Reducing Tobacco Use
 
Among children, ETS has far-reaching health ef­
fects. ETS causes bronchitis and pneumonia, account­
ing for an estimated 150,000–300,000 annual cases in 
infants and young children, and causes middle ear 
diseases (infections and effusions).  ETS causes addi­
tional episodes of asthma and increases its severity, 
worsening an estimated 400,000–1,000,000 cases 
annually.  As a risk factor for new cases of asthma, 
ETS may account for 8,000–26,000 annual cases (EPA 
1992; California EPA 1997). 
In an important ruling, Judge Osteen of the U.S. 
District Court annulled Chapters 1–6 and the Appen­
dices to the EPA’s 1992 report (EPA 1992; Flue-Cured 
Tobacco Cooperative Stabilization Corp. v. United States 
Environmental Protection Agency, 4 F. Supp. 2d 435 
[M.D.N.C. 1998]). The decision was a mix of proce­
dural and scientific concerns. Judge Osteen found that 
the EPA had not complied with the procedural require­
ments of the Radon Gas and Indoor Air Quality Re­
search Act of 1986, had acted beyond congressional 
intent, and had violated administrative law procedure 
by drawing conclusions about ETS prior to conclud­
ing a scientifically sound risk-assessment study.  The 
judge was also concerned with the amount of evidence 
in the record supporting EPA’s final basis for its plau­
sibility hypothesis, with some of the animal labora­
tory tests that he felt were inconclusive but were cited 
as compelling evidence of the dangers of ETS, and with 
the EPA’s choice of epidemiologic studies to support 
its findings. 
Considerable information appeared after the 
EPA’s 1992 report that supported its general conclu­
sions (Brownson et al. 1992a; Stockwell et al. 1992; 
Fontham et al. 1994; Cardenas et al. 1997). A recent 
meta-analysis of workplace ETS exposure and increased 
risk of lung cancer also provided needed epidemiologic 
support (Wells 1998).  The ninth EPA report on carcino­
gens was released in the year 2000 and lists ETS as a 
known carcinogen for the first time (USDHHS 2000). 
Since the 1992 EPA report, further evidence link­
ing ETS and heart disease has been assembled as well. 
(Glantz and Parmley 1995; Steenland et al. 1996; Cali­
fornia EPA 1997; Kawachi et al. 1997; Law et al. 1997; 
Howard et al. 1998; Valkonen and Kuusi 1998; Wells 
1998). If ETS is a causal risk factor for coronary heart 
disease, it likely accounts for many more deaths from 
heart disease than from lung cancer (EPA 1992; Wells 
1994). A review of 12 epidemiologic studies has esti­
mated that ETS accounts for as many as 62,000 annual 
deaths from coronary heart disease in the United States 
(Wells 1994).  However, because smoking is but one of 
the many risk factors in the etiology of heart disease, 
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quantifying the precise relationship between ETS and 
this disease is difficult. 
Strong evidence is also accumulating that ETS is a 
risk factor for sudden infant death syndrome (Jinot and 
Bayard 1994; DiFranza and Lew 1995; Klonoff-Cohen 
et al. 1995; Anderson and Cook 1997; California EPA 
1997; Alm et al. 1998; Dybing and Sanner 1999).  In a 
large U.S. study, maternal exposure during pregnancy 
and postnatal exposure of the newborn to ETS increased 
the risk of this syndrome (Schoendorf and Kiely 1992). 
Other Consequences of ETS 
Separate from their concerns about direct health 
effects, most nonsmokers are annoyed by ETS expo­
sure (CDC 1988; Brownson et al. 1992b).  U.S. survey 
data have suggested that 71 percent of all respondents, 
including 43 percent of current smokers, are annoyed 
by ETS (CDC 1988). Similarly, data from urban St. 
Louis and Kansas City, Missouri, have shown that 66 
percent of all respondents and nearly 40 percent of 
current smokers were annoyed by ETS exposure 
(Brownson et al. 1992b).  The term “annoyance,” a 
seemingly minor attribute, has some nontrivial rami­
fications. Public attitudes toward smoking, an amal­
gam of concerns about health and social interactions, 
have changed in the past decade, as is discussed in 
greater detail in the section “Effectiveness of Clean 
Indoor Air Restrictions,” later in this chapter.  The find­
ings from one survey suggested that the proportion of 
Americans who favored a total ban on smoking in res­
taurants and workplaces increased from less than one-
fifth in 1983 to almost one-third in 1992 (Gallup 
Organization, Inc. 1992).  The proportion favoring no 
restrictions fell from as high as 15 percent in 1983 to 5 
percent in 1992.  Similarly, by 1992, more than 90 per­
cent of respondents favored restrictions or a total ban 
on smoking in trains and buses as well as in hotels 
and motels. More than 90 percent “agreed” or 
“strongly agreed” that ETS is injurious to children, 
pregnant women, and older adults.  Thus, an impor­
tant consequence of information on ETS has been a 
changing social norm regarding smoking and an evolv­
ing foundation for clean indoor air regulations. 
Because of the consequences of ETS, employers 
are likely to save costs by implementing policies for 
smoke-free workplaces.  Savings include those associ­
ated with fire risk, damage to property and furnish­
ings, cleaning costs, workers compensation, disability, 
retirement, injuries, life insurance, absenteeism, pro­
ductivity losses, and synergistic occupational risks 
such as asbestos exposure (Kristein 1989).  Such costs 
were estimated at $1,000 per smoking employee in 1988 
dollars. In a recent report on the savings associated 
with a nationwide, comprehensive policy on clean in­
door air, the EPA estimated that such a law would save 
$4 billion to $8 billion per year in operational and 
maintenance costs of buildings (Mudarri 1994). 
Prevalence of Exposure to ETS 
Exposure to ambient tobacco smoke is wide­
spread.  The 1988 National Health Interview Survey 
reported that an estimated 37 percent of the 79.2 mil­
lion U.S. nonsmoking workers worked in places that 
permitted smoking in designated and other areas and 
that 59 percent of these experienced moderate or great 
discomfort from ETS exposure in the workplace 
(National Center for Health Statistics 1989). Since the 
advent of urinary cotinine screening, firmer documen­
tation of ETS has become available. In a study of 663 
nonsmokers attending a cancer screening, Cummings 
and colleagues (1990) found that 76 percent of partici­
pants were exposed to ETS in the four days preceding 
the interview.  The authors concluded that the work­
place and the home were the primary sources of ETS 
exposure among these nonsmokers. The best single 
predictor of urinary cotinine was the number of smok­
ers among friends and family members seen regularly 
by the study participant. In a study of 881 nonsmok­
ing volunteers, Marcus and colleagues (1992) found 
that employees in workplaces that were “least restric­
tive” (i.e., allowed smoking in numerous locations) 
were more than four times more likely to have detect­
able saliva cotinine concentrations than employees 
from smoke-free workplaces were (p. 45). 
The largest study of population exposure to ETS 
with biochemical markers is the CDC’s Third National 
Health and Nutrition Examination Survey, conducted 
from 1988 to 1991 on a nationally representative sample 
of 16,818 persons aged 2 months and older (Pirkle 
1996). Serum cotinine was measured in 10,642 partici­
pants aged 4 years and older.  The data indicate high 
concordance between reported ETS exposure and se­
rum cotinine level.  Among nontobacco users, 87.9 
percent had detectable levels of serum cotinine, and 
the level was significantly and independently associ­
ated with both the number of smokers in the house­
hold and the number of hours of work exposure.  The 
authors concluded that both the work and the house­
hold environments make important contributions to 
the widespread exposure to ETS experienced by chil­
dren and adults. 
Some improvement in ETS exposure has been 
noted. A study from California found that nonsmokers’ 
self-reported exposure to ETS at work declined from 
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29 percent in 1990 to 22 percent in 1993 (Patten et al. 
1995b). This decline was not as pronounced, however, 
among some sociodemographic subgroups, such as 
African Americans, Asian Americans, and persons 
with less than a high school education. During the 
same period, the percentage of employees reporting 
that they worked in smoke-free workplaces greatly 
increased (from 35 to 65 percent).  Survey data from 
Missouri in 1993 indicated that 41 percent of the popu­
lation were exposed to ETS in the workplace and 18 
percent in the home environment (Brownson et al. 
1995a). Among subgroups, younger persons, men, 
Hispanics, and persons with less than a high school 
education had more workplace exposure to ETS.  Simi­
larly, data from rural Missouri showed higher preva­
lence of workplace ETS exposure among younger 
persons, men, African Americans, and persons with 
less than a high school education (Brownson et al. 
1995a). Emmons and colleagues (1992) analyzed en­
tries in diaries recording ETS exposure among 186 
persons who were former smokers or had never 
smoked. Approximately 50 percent of the daily ETS 
exposure was attributed to the workplace, and 10 per­
cent was attributed to the home environment.  How­
ever, for persons who lived with a smoker, more 
exposure occurred in the home than in the workplace. 
Relatively few population-based data that spe­
cifically examine the levels of ETS exposure in the 
workplace have been collected. Such data may be 
important, because exposure levels likely vary greatly 
by workplace, and recent studies have indicated that 
higher levels of ETS (measured by intensity or dura­
tion of ETS exposure) increase the risk of lung cancer 
in nonsmokers (Brownson et al. 1992a; Stockwell et al. 
1992; Fontham et al. 1994). In a review of existing stud­
ies, Siegel (1993) found that ETS concentrations var­
ied widely by location; mean levels of nicotine 
measured in the ambient air were 4.1 μg/m3 for of­
fices overall, 4.3 μg/m3 for residences with at least one 
smoker, 6.5 μg/m3 for restaurants, and 19.7 μg/m3 for 
bars. In a survey of 25 Massachusetts worksites, 
Hammond and colleagues (1995) found that the type 
of worksite smoking policy had a great effect on nico­
tine concentrations. Levels of nicotine ranged from 
8.6 μg/m3 in open offices that allowed smoking to 0.3 
μg/m3 in worksites that banned smoking. 
Legal Foundation for Regulation 
of Public Smoking 
The legal foundation for regulating public 
smoking is based on case law pertaining mainly to the 
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protection of the health of workers.  Under common 
law (the body of law based on court decisions rather 
than government laws or regulations), employers must 
provide a work environment that is reasonably free of 
recognized hazards.  Courts have ruled that common-
law duty requires employers to provide nonsmoking 
employees protection from the proven health hazards 
of ETS exposure (Sweda 1994). 
Three pioneering cases have demonstrated the 
basis for this protection.  In Shimp v. New Jersey Bell 
Telephone Co. (368 A.2d 408, 145 N.J. Super. 516 [1976]), 
a secretary who was allergic to cigarette smoke sought 
an injunction requiring a smoking ban.  The court or­
dered the employer to provide a safe working envi­
ronment by restricting smoking to a nonwork area. 
Similarly, in the case of Smith v. Western Electric Co. 
(643 S.W.2d 10 [Mo. App. 1982]), the Missouri Court 
of Appeals overturned a lower court and forced the 
employer to “assume its responsibility to eliminate the 
hazardous conditions caused by tobacco smoke” (p. 
13). Finally, in Lee v. Department of Public Welfare (No. 
15385 [Mass. Mar. 31, 1983], cited in 1.2 TPLR 2.82 
[1986]), a social worker sued her employer, seeking 
relief from ETS exposure at work.  The Massachusetts 
Superior Court ruled in favor of the plaintiff and re­
quired a smoke-free workplace.  Additional protections 
to employees are extended by federal statute, such as 
the Americans with Disabilities Act of 1990 (ADA) 
(Public Law 101-336), and by rulings in workers com­
pensation claims. 
Status of Restrictions to Limit Smoking in 
Public Places 
Although the health risks of ETS exposure be­
gan to be publicized in the early 1970s (NCI 1991), 
momentum to regulate public smoking increased only 
in 1986, when reports by the Surgeon General 
(USDHHS 1986) and the National Academy of Sciences 
(1986) concluded that ETS is a cause of lung cancer in 
nonsmokers. Since then, government and private busi­
ness policies that limit smoking in public places have 
become increasingly common and restrictive (Rigotti 
and Pashos 1991). The designation of ETS as a class A 
(known human) carcinogen by the EPA (1992) stimu­
lated further restrictions on smoking in public places 
(Brownson et al. 1995a), but a recent court ruling set 
aside that report (see “Health Consequences of Expo­
sure to ETS,” earlier in the chapter). 
Although many of the regulatory efforts discussed 
herein focus on government’s passage of a law or an 
ordinance, other regulations can be implemented by 
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Table 5.1. Summary of landmark events in the development of U.S. policies for clean indoor air 
Year Event 
1971 The Surgeon General proposes a federal smoking ban in public places. 
1972 The first report of the Surgeon General to identify environmental tobacco smoke (ETS) as a health risk 
is released. 
1973 Arizona becomes the first state to restrict smoking in several public places and to reduce ETS exposure 
because it is a health risk. 
The Civil Aeronautics Board requires no-smoking sections on all commercial airline flights. 
1974 Connecticut passes the first state law to apply smoking restrictions to restaurants. 
1975 Minnesota passes a comprehensive statewide law for clean indoor air. 
1977 Berkeley, California, becomes the first community to limit smoking in restaurants and other public 
places. 
1983 San Francisco passes a law to place private workplaces under smoking restrictions. 
1986 A report of the Surgeon General focuses entirely on the health consequences of involuntary smoking; 
ETS is proclaimed a cause of lung cancer in healthy nonsmokers. 
The National Academy of Sciences issues a report on the health consequences of involuntary smoking. 
Americans for Nonsmokers’ Rights becomes a national group; it had originally formed as California 
GASP (Group to Alleviate Smoking Pollution). 
1987 The U.S. Department of Health and Human Services establishes a smoke-free environment in all of its 
buildings, affecting 120,000 employees nationwide. 
Minnesota passes a law requiring all hospitals in the state to ban smoking by 1990. 
A Gallup poll finds, for the first time, that a majority (55 percent) of all U.S. adults favor a complete 
ban on smoking in all public places. 
1988 A congressionally mandated smoking ban takes effect on all domestic airline flights of two hours or less. 
New York City’s ordinance for clean indoor air takes effect, banning or severely limiting smoking in 
various public places and affecting 7 million people. 
California implements a statewide ban on smoking aboard all intrastate airplane, train, and bus trips. 
1990 A congressionally mandated smoking ban takes effect on all domestic airline flights of six hours or 
less. 
The U.S. Environmental Protection Agency (EPA) issues a draft risk-assessment on ETS. 
1991 CDC’s National Institute for Occupational Safety and Health issues a bulletin recommending that 
secondhand smoke be reduced to the lowest feasible concentration in the workplace. 
1992 Hospitals applying for accreditation by the Joint Commission on the Accreditation of Healthcare 
Organizations are required to develop a policy to prohibit smoking by patients, visitors, employees, 
volunteers, and medical staff. 
The EPA releases its report classifying ETS as a group A (known human) carcinogen, placing ETS in the 
same category as asbestos, benzene, and radon. 
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1993	 	 Los Angeles passes a ban on smoking in all restaurants. 
The U.S. Postal Service eliminates smoking in all facilities. 
Congress enacts a smoke-free policy for WIC (Special Supplemental Food Program for Women, 
Infants, and Children) clinics.
 

A working group of 16 state attorneys general releases recommendations for establishing smoke-free
 

policies in fast-food restaurants.
 

Vermont bans smoking in all public buildings and many private buildings open to the public.
 

1994	 	 The U.S. Department of Defense prohibits smoking in all indoor military facilities. 
The Occupational Safety and Health Administration proposes a rule that would ban smoking in most 
U.S. workplaces.
 

San Francisco passes a ban on smoking in all restaurants and workplaces.
 

The Pro-Children’s Act requires persons providing federally funded children’s services to prohibit
 

smoking in those facilities. 
1995 New York City passes a comprehensive ordinance effectively banning smoking in most workplaces. 
Maryland enacts a smoke-free policy for all workplaces except hotels, bars, restaurants, and private
 

clubs.
 

California passes comprehensive legislation that prohibits smoking in most enclosed workplaces.
 

Vermont’s smoking ban is extended to include restaurants, bars, hotels, and motels, except those
 

holding a cabaret license. 
1996 The U.S. Department of Transportation reports that about 80 percent of nonstop scheduled U.S. airline 
flights between the United States and foreign points will be smoke free by June 1, 1996. 
1997	 	 President Clinton signs an executive order establishing a smoke-free environment for federal 
employees and all members of the public visiting federally owned facilities. 
The California EPA issues a report determining that ETS is a toxic air contaminant. 
Settlement is reached in the class action lawsuit brought by flight attendants exposed to ETS. 
1998	 	 The U.S. Senate bans smoking in the Senate’s public spaces. 
California law takes effect banning smoking in bars unless a bar has a separately ventilated smoking 
area. 
Reducing Tobacco Use 
Table 5.1. Continued 
agencies with special authority.  An example of a non­
government regulatory action is the recent adoption of 
an accrediting standard that prohibits smoking in hos­
pital buildings (Joint Commission on Accreditation of 
Healthcare Organizations 1992; Longo et al. 1995). 
Government Restrictions 
Several of the noteworthy events in clean indoor 
air regulation are shown in Table 5.1.  These events 
include federal, state, and local activities. 
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Federal Laws and Regulations 
The most notable federal regulation of ETS is the 
requirement that domestic airline flights be smoke free. 
The regulation was first enacted in 1988 for domestic 
flights lasting two hours or less and was renewed in 
1989 for domestic flights lasting six hours or less (Table 
5.1). Since the early 1970s, the Interstate Commerce 
Commission (ICC) has required that smoking on 
interstate buses be confined to the rear of the bus 
and that smoking sections constitute no more than 10 
percent of total seating capacity.  Similar ICC regula­
tion for trains was repealed in 1979.  In 1987, congres­
sional legislation that threatened to withhold federal 
funds influenced the State of New York’s Metropoli­
tan Transportation Authority to ban smoking on 
the MTA Long Island Rail Road (USDHHS 1989). 
Currently, the Occupational Safety and Health Admin­
istration is considering regulations that would either 
prohibit smoking in all workplaces or limit it to sepa­
rately ventilated areas (Federal Register 1994). Further­
more, the federal government has instituted 
increasingly stringent regulations on smoking in its 
own facilities, and the Pro-Children’s Act of 1994 (Pub­
lic Law 103-227, secs. 1041–1044) prohibits smoking in 
facilities in which federally funded children’s services 
are provided on a regular or routine basis. 
State Laws and Regulations 
As of December 31, 1999, smoke-free indoor air 
to some degree or in some public places was required 
by 45 states and the District of Columbia. These re­
strictions vary widely, from limited restrictions on 
public transportation to comprehensive restrictions in 
worksites and public places (CDC, Office on Smoking 
and Health, State Tobacco Activities Tracking and 
Evaluation System, unpublished data). In 1973, Ari­
zona became the first state in which public smoking 
was regulated in recognition of ETS as a public health 
hazard (Table 5.1).  Five states (Alabama, Kentucky, 
New Mexico, North Carolina, and Wyoming) have ei­
ther no legislation or legislation that preempts locali­
ties from enacting any law to restrict smoking in public 
places (see also Figure 5.2). 
As of December 31, 1999, laws restricting smok­
ing in government worksites were present in 43 states 
and the District of Columbia: 29 limit smoking to des­
ignated areas, 2 require either no smoking or desig­
nated smoking areas with separate ventilation, and 11 
prohibit smoking entirely.  Twenty-one states have 
laws restricting smoking in private worksites: 20 limit 
smoking to designated areas, and 1 (California) re­
quires either no smoking or separate ventilation for 
smoking areas. Thirty-one states have laws that 
N
um
be
r 
of
 o
rd
in
an
ce
s Public places 
Workplaces 
Restaurants 
19651963 119751973197119691967 1997199519931991198919871985198319811979977 
Year 
300 

250 

200
 
150
 
100
 
50 

0 

Note:  The category “state” includes the District of Columbia.
 
Source:  National Cancer Institute, State Cancer Legislative Database, unpublished data, August 31, 1998.
 
Figure 5.2. Cumulative number of state laws and amendments enacted for clean indoor air, 1963–1998
 
   Regulatory Efforts 201
 
 
regulate smoking in restaurants; of these, only Utah 
and Vermont completely prohibit smoking in restau­
rants, and California requires either no smoking or 
separate ventilation for smoking areas (CDC, Office 
on Smoking and Health, State Tobacco Activities 
Evaluation System, unpublished data). 
In 1994, Maryland proposed a regulation that 
would prohibit smoking in most workplaces in the state, 
including restaurants and bars (Maryland Register 1994). 
Despite strong support among both nonsmokers and 
smokers for restrictions on public smoking in the state 
(Shopland et al. 1995), this proposal was aggressively 
challenged by the tobacco industry (Spayd 1994), which 
questioned the state’s legal authority to regulate smok­
ing through administrative rule rather than law.  In early 
1995, the original regulation was modified by legisla­
tive action to permit some exceptions for the hospital­
ity industry, and the rules went into effect.  In October 
1994, the state of Washington also enacted an extensive 
indoor workplace ban. In this instance, a temporary 
injunction was dismissed by the state court, and the ban 
went into effect without litigation (CSH 1994b). 
In North Carolina, legislation was enacted on July 
15, 1993 (HB 957), that required that smoking be per­
mitted in at least 20 percent of space in state-controlled 
buildings but also formally required nonsmoking 
areas.  An important preemption clause prohibited 
local regulatory boards from enacting more restrictive 
regulations for public or private buildings after Octo­
ber 15, 1993. During that three-month “window of op­
portunity,” 89 local agencies passed new measures 
providing some increased protection from ETS.  De­
spite the rush to new restrictions, researchers estimated 
that by the year 2000, the preemption would prevent 
59 percent of private employees in North Carolina from 
being protected from ETS (Conlisk et al. 1995). 
Local Ordinances 
The modern era of local ordinances for clean in­
door air began in the early 1970s (Pertschuk 1993). In 
1977, Berkeley, California, became the first community 
to limit smoking in restaurants and other public places 
(Table 5.1).  After the release of the 1986 Surgeon 
General’s report on the health consequences of ETS, the 
rate of passage of local ordinances accelerated (Figure 
5.3). By 1988, nearly 400 local ordinances to restrict 
smoking had been enacted throughout the United States 
(Pertschuk and Shopland 1989). The trend toward 
smoke-free local ordinances has accelerated since 1989 
(Rigotti and Pashos 1991; Pertschuk 1993). As of June 
30, 1998, public smoking was restricted or banned in 
820 local ordinances.  Of those that specified which 
Reducing Tobacco Use 
agency was responsible for enforcement, 44 percent cited 
health departments or boards of health, 19 percent 
named city managers, 5 percent said police departments, 
and 6 percent identified other agencies (Americans for 
Nonsmokers’ Rights, unpublished data, June 30, 1998). 
The effectiveness of various enforcement mechanisms 
and the level of compliance achieved are not known. 
Data from Wisconsin suggest that implementation may 
be just as important as legislation in achieving policy 
goals (Nordstrom and DeStefano 1995). 
One study examined the impact a local ordinance 
had on restaurant receipts (CDC 1995a).  Contrary to 
some prior claims, an analysis of restaurant sales after 
a ban on smoking in this community (a small suburb 
of Austin, Texas) showed no adverse economic effect. 
In a series of ecologic analyses, Glantz and Smith (1994, 
1997) analyzed the effect of smoke-free restaurant and 
bar ordinances on sales tax receipts.  Over time, such 
ordinances had no effect on the fraction of total retail 
sales that went to eating and drinking places. The 
authors asserted that claims of economic hardship for 
restaurants and bars that establish smoke-free policies 
have not been substantiated. 
Private Sector Restrictions on Smoking 
in Workplaces 
Two national data sets are available to ascertain 
the level of workplace smoking restrictions among pri­
vate firms in the United States. A survey conducted 
by the Bureau of National Affairs, Inc. (1991), estimated 
that 85 percent of large workplaces had policies 
restricting smoking. The percentage of smoke-free 
workplaces has increased dramatically, from 2 percent 
in 1986 to 7 percent in 1987 and to 34 percent in 1991. 
Similarly, data from the 1992 National Survey of 
Worksite Health Promotion Activities indicated that 87 
percent of workplaces with 50 or more employees regu­
lated smoking in some manner and that 34 percent were 
smoke free (USDHHS 1993).  The 1995 Update of the 
Business Responds to AIDS Benchmark Survey con­
ducted by CDC also found that 87 percent of worksites 
with 50 or more employees had a smoking policy of 
some kind (National Center for Health Statistics 1997). 
The prevalence of smoking policies in small 
workplaces, where the majority of Americans work, 
is less well studied. A comprehensive examination 
of workplace smoking policies from the NCI’s tobacco 
use supplement to the Current Population Survey 
(n = 100,561) indicated that most indoor workers sur­
veyed (81.6 percent) reported that an official policy 
governed smoking at their workplaces, and nearly 
half reported that the policy could be classified as 
   202 Chapter 5
 
 
Surgeon General's Report
 
“smoke-free”—that is, that smoking was not permit­
ted either in workplace areas or in common public-
use areas (Gerlach 1997).  This proportion varied by 
sex, age, ethnicity, and occupation:  blue-collar and 
service occupations had significantly less access to 
smoke-free environments.  Though data were not spe­
cifically reported by workplace size, the range of occu­
pations suggests that the survey included a substantial 
proportion of persons who work in smaller workplace 
environments.  But for all workplace sizes, the data 
suggest that access to smoke-free environments could 
be substantially improved. 
Effectiveness of Clean Indoor 
Air Restrictions 
Although it is generally accepted that regulatory 
changes influence nonsmokers’ exposure to ETS and 
smokers’ behavior, relatively few evaluation studies 
quantify these effects over time. Evaluating such 
changes is hampered by the complex interaction of 
social forces that shape behavior, by the decline in 
smoking and smoke exposure in the overall popula­
tion, and by the overlapping effects of concomitant 
regulatory policies (e.g., a new law for clean indoor 
air passed at or around the time of an increase in the 
cigarette excise tax).  Controlling for such potential 
confounding factors in studies is difficult. 
Population-Based Studies 
Effects on Nonsmokers’ Exposure to ETS 
Despite the widespread implementation of re­
strictions against public smoking, few population-
based studies have examined whether these 
restrictions have reduced nonsmokers’ exposure to 
ETS. One such study from California used data col­
lected in 1990 and 1991 to examine the association be­
tween the strength of local ordinances for clean indoor 
air and cross-sectional data on nonsmokers’ exposure 
to ETS in the workplace (Pierce et al. 1994b).  Expo­
sure to ETS in the workplace ranged from 25 percent 
of workplaces in areas with a strong local ordinance 
to 35 percent in areas with no local ordinance. 
Figure 5.3. Cumulative number of local laws and amendments enacted for clean indoor air, 1979–1998
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In measuring the impact of a statewide law for 
clean indoor air, researchers in Missouri examined self-
reported data on ETS exposure from 1990 through 1993 
(Brownson et al. 1995a).  Nonsmokers’ exposure to ETS 
in the workplace declined slightly the year the law was 
passed and substantially more after the law went into 
effect.  Exposure to ETS in the home remained con­
stant over the study period; this finding suggests that 
the declining workplace exposure was more likely 
linked to the smoking regulations than to the overall 
declining smoking prevalence observed during the 
study period. Despite improvements over time, ETS 
exposure in the workplace remained at 35 percent in 
the final year of the study (1993). Other data from 
California indicate that nonsmokers employed in 
workplaces with no policy or a policy not covering 
their part of the workplace were eight times more likely 
to be exposed to ETS (at work) than those employed 
in smoke-free workplaces (Borland et al. 1992). 
Attitudes Toward Restrictions and Bans 
Studies of awareness and attitudes toward work­
place smoking restrictions and bans have been con­
ducted in cross-sectional samples of the general 
population and among employees affected by bans. 
In a 1989 survey of 10 U.S. communities, most respon­
dents favored smoking restrictions or smoke-free 
environments in all locations, including workplaces, 
government buildings, restaurants, hospitals, and bars 
(CDC 1991). Although support for smoking restric­
tions was higher among nonsmokers, across the 10 
communities, 82–100 percent of smokers favored re­
strictions on smoking in public places. Support was 
highest for smoking bans in indoor sports arenas, hos­
pitals, and doctors’ offices.  A 1993 survey from eight 
states showed greater support for ending smoking in 
fast-food restaurants and at indoor sporting events 
than in traditional restaurants and indoor shopping 
malls (CDC 1994a). 
Support for proposed changes may differ from 
support for actual, implemented changes. Yet in stud­
ies of smoke-free hospitals, patients, employees, and 
physicians have overwhelmingly supported the policy 
(Rigotti et al. 1986; Becker et al. 1989; Hudzinski and 
Frohlich 1990; Baile et al. 1991; Offord et al. 1992).  In 
some instances, a majority of smokers support a 
smoke-free hospital (Becker et al. 1989).  Studies of 
smoking restrictions and bans in other industries 
also have found that nonsmokers overwhelmingly 
favor smoke-free workplaces (Petersen et al. 1988; 
Borland et al. 1990b; Gottlieb et al. 1990; Sorensen et 
al. 1991b). Time—and consequent habituation—can 
make changes more acceptable.  In a prospective study 
of a smoking ban in a large workplace, Borland and 
colleagues (1990b) found that attitudes of both non­
smokers and smokers toward the smoke-free work­
place were more favorable six months after such a 
policy was implemented. Although most smokers re­
ported being inconvenienced, they also reported that 
they recognized the overall benefits of the policy.  Two 
studies from Massachusetts found that one and two 
years after two local laws for clean indoor air were 
enacted, 65 percent of the businesses surveyed favored 
the law (Rigotti et al. 1992, 1994). The authors con­
cluded that a self-enforcement approach achieved high 
levels of awareness (about 75 percent) and intermedi­
ate levels of compliance (about 50 percent) (Rigotti et 
al. 1994). 
Effects of Restrictions and Bans on Nonsmokers’ 
Exposure to ETS 
As has been found in population-based research, 
studies conducted in individual workplaces have 
found that smoke-free workplaces have been effective 
in reducing nonsmokers’ exposure to ETS.  Effective­
ness has been measured by the perceived change in 
air quality in the workplace after a smoke-free policy 
was instituted (Biener et al. 1989; Gottlieb et al. 1990) 
and by measurement of nicotine vapor before and af­
ter such a policy (Stillman et al. 1990). Conversely, 
workplace policies that allow smoking in designated 
areas without separate ventilation result in substan­
tial exposure to ETS for nonsmokers (Repace 1994). 
An analysis of the effects of a smoke-free 
workplace in The Johns Hopkins Medical Institutions 
found that concentrations of nicotine vapor had de­
clined in all areas except restrooms at one to eight 
months after the ban (Stillman et al. 1990). In most 
areas, nicotine concentrations after the ban were be­
low the detectable level of 0.24 μg/m3. 
Effects of Restrictions on Smoking Behavior 
An additional benefit from regulations for clean 
indoor air may be a reduction in smoking prevalence 
among workers and the general public. For example, 
in a multivariate analysis, moderate or extensive laws 
for clean indoor air were associated with a lower smok­
ing prevalence and a higher proportion of quitters 
(Emont et al. 1993). Another study also found an as­
sociation between local smoking restrictions and smok­
ing prevalence (Rigotti and Pashos 1991). 
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Table 5.2. Summary of studies on the effects of a smoke-free workplace on smoking behavior 
Authors/year Location Industry Sample size 
Andrews 1983 Boston, Massachusetts Hospital 965 
Rigotti et al. 1986 Boston, Massachusetts Hospital pediatric unit  93 
Rosenstock et al. 1986 Puget Sound, Washington Health maintenance 447 
organization 
Petersen et al. 1988 Connecticut Insurance company  1,210 
Becker et al. 1989 Baltimore, Maryland Children’s hospital  704 
Biener et al. 1989 Providence, Rhode Island Hospital  535 
Scott and Gerberich 1989 Midwestern United States Insurance company  452 
Borland et al. 1990b Australia Public service  2,113 
Centers for Disease Pueblo, Colorado Psychiatric hospital  1,032 
Control 1990c 
Gottlieb et al. 1990 Texas Government agency  1,158 
Hudzinski and Frohlich 1990 New Orleans, Louisiana Hospital  1,946 
Stillman et al. 1990 Baltimore, Maryland Hospital  2,877 
Baile et al. 1991 Tampa, Florida Hospital  349 
Borland et al. 1991 Australia Telecommunications 620 
company 
Sorensen et al. 1991a New England Telephone company  1,120 
Brenner and Mielck 1992 Germany National random 439 
sample 
Goldstein et al. 1992 Augusta, Georgia Hospital 1,997 
Offord et al. 1992 Rochester, Minnesota Hospital 10,579 
Wakefield et al. 1992b Australia Representative 1,929 
sample 
Jeffery et al. 1994 Minneapolis-St. Paul, Minnesota Diverse worksites 32 worksites; 
total number 
of individuals 
not reported 
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Reducing Tobacco Use

 Change in individual or overall smokers’ consumption 
Not reported 
Change in prevalence 
–8.5% at 20 months follow-up 
–2.3 cigarettes per shift (P < 0.01) at 12 months follow-up; no change in 
overall consumption 
No significant change 
–2.0 cigarettes per day (P < 0.003) at 4 months follow-up No significant change 
–5.6 cigarettes per day at 12 months follow-up 1.6% at 12 months follow-up 
No change at 6 months follow-up –1.2% at 6 months follow-up 
–3.9 cigarettes per day at work at 12 months follow-up No significant change 
22.5% of smokers decreased consumption at 7 months follow-up –5.1% at 7 months follow-up 
–7.9 cigarettes per day in smokers of 25 or more cigarettes per day 
at 6 months follow-up 
–1.0% at 6 months follow-up 
–3.5 cigarettes per day at work at 13 months follow-up; –1.8 cigarettes 
per day over 24 hours 
–4.0% at 13 months follow-up 
 12.0% reduction in consumption of 15 or more cigarettes per day at 
work at 6 months follow-up (P < 0.001) 
–3.4% at 6 months follow-up 
25% of smokers no longer smoked at work at 12 months follow-up Not reported 
–3.3 cigarettes per day at 6 months follow-up (P = 0.0001) –5.5% at 6 months follow-up 
40% of smokers decreased consumption at 4 months follow-up –1.5% at 4 months follow-up 
–3.5 cigarettes per day at 18 months follow-up (P < 0.05) –3.1% at 18 months follow-up 
Not reported 21% of smokers quit at 20 months 
follow-up 
–1.8 cigarettes per day in men, –1.4 cigarettes per day in women Cessation proportion of 30% 
57% of smokers reported they had cut down on number of cigarettes 
smoked 
9% of smokers stated they had quit 
because of the ban 
Not reported –2.9% at 30 months follow-up 
–5 cigarettes per day on workdays vs. leisure days Not reported 
–1.2 cigarettes per day –2% at 24 months follow-up 
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In recent years, researchers have increasingly 
recognized the role of the environment5 in influencing 
individual smoking behavior through perceived cues 
(NCI 1991; McKinlay 1993; Brownson et al. 1995b), many 
of which have their origins in generally held rules about 
acceptable behaviors (i.e., social norms) (Robertson 
1977). Smokers frequently respond to environmental 
cues when deciding whether to smoke at a given time 
(NCI 1991). For example, a smoker may receive a per­
sonal, habit-derived cue to smoke after a meal or on a 
work break, but this cue may be weakened (and even­
tually even canceled) by a social, policy-derived cue not 
to smoke if the person is in a smoke-free restaurant or 
worksite (Brownson et al. 1995b). 
Numerous studies have assessed the potential 
effects of workplace smoking bans on employee 
smoking behavior (Table 5.2).  These studies have been 
conducted in health care settings (Andrews 1983; 
Rigotti et al. 1986; Rosenstock et al. 1986; Becker et al. 
1989; Biener et al. 1989; CDC 1990c; Hudzinski and 
Frohlich 1990; Stillman et al. 1990; Baile et al. 1991; 
Goldstein et al. 1992; Offord et al. 1992), government 
agencies (Gottlieb et al. 1990), insurance companies 
(Petersen et al. 1988; Scott and Gerberich 1989), and 
telecommunications companies (Borland et al. 1991; 
Sorensen et al. 1991a) and among random samples of 
the working population (Brenner and Mielck 1992; 
Wakefield et al. 1992b).  Most of the studies based in 
hospitals or health maintenance organizations that 
banned smoking found a decrease in the average num­
ber of cigarettes smoked per day.  Several of the hos­
pital studies found significant declines in the overall 
prevalence of smoking among employees at 6–20 
months follow-up (Andrews 1983; Stillman et al. 1990). 
Studies of smoking behavior in other industries have 
found similar results; in most settings, daily consump­
tion, overall smoking prevalence, or both had de­
creased at 6–20 months after workplaces were made 
smoke free. 
In a population-based study of California resi­
dents, the prevalence of smoking was 14 percent in 
smoke-free workplaces and 21 percent in workplaces 
with no smoking restrictions (Woodruff et al. 1993). 
Consumption among continuing smokers was also 
lower in smoke-free workplaces, and the percentage 
of smokers contemplating quitting was higher.  In 1992, 
Patten and colleagues (1995a) followed up a large 
sample of persons (first interviewed in 1990) to deter­
mine the influences a change in worksite setting might 
have had on smoking. These researchers observed 
a statistically nonsignificant increase in smoking 
5 The term “environment” is defined broadly to include the legal, 
social, economic, and physical environment (Cheadle et al. 1992). 
prevalence among the group that changed from a 
smoke-free workplace to one at which smoking was 
permitted. The prevalence of smoking among other 
groups was unchanged or had declined.  Although 
these results are tentative, particularly in view of sam­
pling difficulties during the follow-up interview, they 
signal the potential impact workplace policies can have 
on smoking behavior. 
Case Studies of State and Local Smoking 
Restrictions 
Recent reviews have presented case studies on 
the passage of state and local laws for clean indoor air 
(Samuels and Glantz 1991; Fourkas 1992; Jacobson et 
al. 1992; Traynor et al. 1993).  These studies describe 
the issues that states and local communities dealt with 
in enacting smoking restrictions in public places. 
In a case study of six states, the ability of key leg­
islators to support legislation and the existence of an 
organized smoking prevention coalition were key de­
terminants of whether statewide legislation was en­
acted for clean indoor air (Jacobson et al. 1992). 
Although the enactment of such legislation was not 
guaranteed when these factors were favorable, enact­
ment was unlikely when they were unfavorable.  Two 
other factors were cited as key in enacting legislation 
in the six states studied: an active executive branch 
that pressured the legislature to act, especially by mak­
ing such legislation an executive policy priority, and 
existing local ordinances that created a policy environ­
ment favorable to the enactment of statewide smok­
ing restrictions. 
The study found that coalitions that succeeded 
in enacting legislation to restrict smoking in public 
places featured organized commitment, including both 
a full-time staff and a professional lobbyist.  Success­
ful coalitions also had established close working rela­
tionships with key legislative sponsors to develop 
appropriate policy alternatives and to coordinate leg­
islative strategy.  Finally, effective coalitions used me­
dia and grassroots campaigns to mobilize public 
support for smoking restrictions. 
Another important component in the legislative 
debate was how the issue of smoking restrictions was 
framed. In all six states reviewed, the tobacco industry 
tried to shift the focus from the credibility of the scien­
tific evidence on the health hazards of ETS to the con­
troversial social issue of personal freedom;  specifically, 
the industry lobbied extensively for including nondis­
crimination clauses in legislation to restrict smoking 
(Malouff et al. 1993).  Another common strategy that 
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the tobacco industry has used is to support the pas­
sage of state laws that preempt more stringent local 
ordinances (Brownson et al. 1995b). 
Because of the possible countereffect of preemp­
tive legislation and because of the difficulty in enact­
ing statewide legislation, public health advocates have 
suggested that advocates for reducing tobacco 
use should devote more resources to enacting local 
ordinances (Samuels and Glantz 1991; Fourkas 1992; 
Minors’ Access to Tobacco 
Reducing Tobacco Use
 
Jacobson et al. 1992). A local strategy can usually im­
pose more stringent smoking restrictions than state­
wide legislation does. Like the study of Jacobson and 
colleagues (1992) on statewide initiatives, a study of 
local initiatives found that two key ingredients for 
success were the presence of a strong smoking pre­
vention coalition and sympathetic political leadership 
within the elected body (Samuels and Glantz 1991). 
Introduction 
Minors’ access to tobacco products is an area of 
regulation relatively free from the social and legal de­
bate that often arises from other regulatory efforts. 
Even the staunchest opponents of reducing tobacco use 
concede that tobacco use should be limited to adults 
and that retailers should not sell tobacco products to 
children and adolescents.  Yet as was discussed in de­
tail in the Surgeon General’s report on smoking among 
young people, a significant number of minors use to­
bacco, and a significant number of them obtain their 
tobacco through retail and promotional transactions, 
just as adults do (USDHHS 1994; CDC 1996a,b; Kann 
et al. 1998). Whether intended exclusively for adults 
or not, these commercial transactions are supported 
by vast resources.  The multibillion-dollar tobacco in­
dustry spends a large proportion of its marketing dol­
lars to support a vast network of wholesale and retail 
activity.  In 1997, cigarette makers spent $2.44 billion 
on promotional allowances to the wholesale and re­
tail trade and an additional $1.52 billion on coupons 
and retail value-added promotions (FTC 1999).  These 
figures were 42 percent and 26 percent, respectively, 
of the entire $5.1 billion spent on advertising and pro­
moting cigarettes in the United States that year. 
In general, the availability of cigarettes to the 
adult population has not been a regulatory issue since 
the first quarter of the 20th century (see Chapter 2), 
although recent FDA statements about nicotine levels 
in cigarettes have raised the possibility of some regu­
lation of adult use (see “Further Regulatory Steps,” 
earlier in this chapter). The primary regulatory focus 
for cigarette access has been on reducing the sale of 
tobacco products to minors (Forster et al. 1989; 
Hoppock and Houston 1990; Thomson and Toffler 
1990; Altman et al. 1992; CDC 1992a; Cummings et al. 
1992; Federal Register 1993, 1996). Broad-based public 
support for limiting minors’ access to tobacco has de­
veloped in the relatively brief time (since the mid­
1980s) that this issue has been in the public eye 
(DiFranza et al. 1987, 1996; CDC 1990a,b,c, 1993a, 
1994a, 1996a,d; Jason et al. 1991; Hinds 1992; Keay et 
al. 1993; Landrine et al. 1994, 1996; USDHHS 1994). 
Reducing the commercial availability of tobacco 
to minors is a potential avenue for reducing adoles­
cent use. Growing evidence suggests that tobacco 
products are widely available to minors.  Uniformly, 
surveys find that teenagers believe they can easily 
obtain cigarettes (see, for example, Forster et al. 1989; 
Johnston et al. 1992; CDC 1996a; Cummings et al. 1998; 
University of Michigan 1999). As noted, this access is 
by no means confined to borrowing cigarettes from 
peers or adults or stealing them at home or from stores; 
purchase from commercial outlets is an important 
source for minors who use tobacco.  An estimated 255 
million packs of cigarettes were illegally sold to mi­
nors in 1991 (Cummings et al. 1994), and daily smok­
ers aged 12–17 years smoked an estimated 924 million 
packs of cigarettes in 1997 (DiFranza and Librett 1999). 
Between 20 and 70 percent of teenagers who smoke 
report purchasing their own tobacco; the proportion 
varies by age, social class, amount smoked, and fac­
tors related to availability (Forster et al. 1989; Response 
Research, Incorporated 1989; CDC 1992a, 1996a,d; 
Cummings et al. 1992, 1998; Cummings and Coogan 
1992–93; Mark Wolfson, Ami J. Claxton, David M. 
Murray, and Jean L. Forster, Socioeconomic status and 
adolescent tobacco use: the role of differential avail­
ability, unpublished data).  In a review of 13 local 
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over-the-counter access studies published between 
1987 and 1993, illegal sales to minors ranged from 32 
to 87 percent with an approximate weighted-average 
of 67 percent. Several local studies published in 1996 
and 1997 found somewhat lower over-the-counter 
sales rates to minors: 22 percent (Klonoff et al. 1997) 
and 29 percent  (CDC 1996) in two separate studies in 
California and 33 percent in Massachusetts (DiFranza 
et al. 1996). Nine studies of vending machine sales to 
minors published between 1989 and 1992 found ille­
gal vending machine sales ranging from 82 to 100 per­
cent with an approximate weighted-average of 88 
percent (USDHHS 1994). Comparison of the results of 
these research studies with the results of later statewide 
Synar surveys (see below) is problematic for four 
reasons:  (1) the research studies were generally local 
surveys of a town, city, or county, whereas the Synar 
surveys are based on statewide samples; (2) the sam­
pling methods vary across the research studies; (3) store 
inspection methodologies vary; and (4) some of the 
research studies contain results of several surveys, 
often pre- and post-intervention (USDHHS 1998a). 
Several factors suggest that widespread reduc­
tion in commercial availability may result in reduced 
prevalence or delayed onset of tobacco use by young 
people: the reported importance of commercial 
sources to minors, the easy commercial availability 
that has been demonstrated, and the reductions in 
commercial availability demonstrated when legal re­
strictions have been tightened, as outlined below (Ja­
son et al. 1991; DiFranza et al. 1992; Hinds 1992; Forster 
et al. 1998). One psychological study supports the po­
tential impact of limiting minors’ access to cigarettes 
(Robinson et al. 1997). In this investigation of 6,967 
seventh graders of mixed ethnicity, the best predictor 
of experimentation with cigarettes was the perception 
of easy availability.  Regular smoking was heavily in­
fluenced by cost (see Chapter 6). 
Direct studies of factors that influence minors’ 
access have produced mixed results, however.  Sev­
eral investigators found that state laws on minimum 
age for purchasing tobacco products did not by them­
selves have a significant effect on cigarette smoking 
among youth (Wasserman et al. 1991; Chaloupka and 
Grossman 1996).  Other studies have provided evi­
dence in single communities (without comparison 
groups) that compliance with youth access regulations 
does lead to reductions in regular smoking by adoles­
cents (Jason et al. 1991; DiFranza et al. 1992). In a 
nonrandomized, controlled community trial (three 
intervention and three control communities), Rigotti 
and colleagues (1997) found that although illegal sales 
rates to minors decreased significantly more in the 
control communities than in the intervention commu­
nities, there was no difference between control and 
intervention communities in either self-reported 
access to tobacco from commercial sources or in smok­
ing behavior among youth. The authors suggest that 
illegal sales rates were not reduced sufficiently in the 
intervention communities to cause a decrease in com­
mercial access that was substantial enough to impact 
youth smoking. Noting that these studies were lim­
ited by their scope or sample size, Chaloupka and 
Pacula (1998) analyzed data from the 1994 Monitor­
ing the Future surveys on 37,217 youths. Using per­
sonal and ecologic variables in a two-part multivariate 
model to estimate cigarette demand by youth and av­
erage daily cigarette consumption, the investigators 
found that adolescents are less likely to smoke and that 
those who smoke consume fewer cigarettes in the fol­
lowing settings: where prices are higher, in states that 
use cigarette excise tax revenues for tobacco control 
activities, where there are stronger restrictions on 
smoking in public places, and in states that have 
adopted comprehensive approaches to measuring re­
tailer compliance with youth access laws. The authors 
concluded that comprehensive approaches, including 
enforcement of minors’ access laws, will lead to a re­
duction in youth smoking. A large, community-based 
clinical trial—seven intervention and seven control 
communities—also found an intervention effect 
(Forster et al. 1998). In this study, communities that 
developed new ordinances, changes in merchant poli­
cies and practices, and changes in enforcement prac­
tices experienced a significantly smaller increase in 
adolescent smoking than did the control communities. 
Further exploration of this issue may be required to 
substantiate the impact of the enforcement of minors’ 
access laws. 
As commercial sales to minors are decreased, 
there is evidence that minors may shift their attempts 
to obtain cigarettes to “social” sources, e.g., other ado­
lescents, parents, or older friends (Hinds 1992; Forster 
et al. 1998). One study found that adult smokers aged 
18 and 19 years were the most likely group of adults 
to be asked by a minor for cigarettes (Ribisl 1999).  This 
study did not assess how frequently minors asked 
other minors for tobacco. There is also evidence, how­
ever, that minors who provide tobacco to other minors 
are more likely to purchase tobacco than other minors 
who smoke (Wolfson 1997), and in any event, some of 
the cigarettes provided by minors to other minors were 
initially purchased from commercial sources (Forster 
et al. 1997). Whether the source is social or commer­
cial, it is clear that a comprehensive approach to re­
ducing minors’ access is needed; smokers of all ages 
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in addition to tobacco retailers must avoid provision 
of tobacco to minors. 
Efforts to Promote Adoption and 
Enforcement of Minors’ Access Laws 
Public organizations at the federal, state, and lo­
cal levels have become active in encouraging state and 
local jurisdictions to adopt and enforce minors’ access 
laws. The NCI-ACS collaboration known as ASSIST 
(American Stop Smoking Intervention Study) has iden­
tified reducing minors’ access to tobacco products as 
one of its goals for its 17 demonstration states. The 
Robert Wood Johnson Foundation’s SmokeLess States 
program also encourages funded states to address 
minors’ access. The USDHHS has widely distributed 
a model state law as a result of an investigation by the 
Office of Inspector General (OIG) reporting little or no 
enforcement of state laws on minimum ages for to­
bacco sales (OIG 1990; USDHHS 1990). Growing Up 
Tobacco Free:  Preventing Nicotine Addiction in Children 
and Youth, a report from the Institute of Medicine 
(IOM), includes an extensive study of minors’ access 
and a series of recommendations about state and local 
laws in this area (Lynch and Bonnie 1994).  A group of 
25 state attorneys general formed a working group on 
the issue and released a set of recommendations re­
garding retail sales practices and legislation aimed at 
reducing tobacco sales to minors (Working Group of 
State Attorneys General 1994). 
Reducing Tobacco Use 
advocates for Synar-like restriction of youth smoking 
and those opposed to the Synar approach used the 
draft regulations to encourage states to adopt laws that 
in these parties’ differing views were the minimum 
necessary for states to comply with the Synar Amend­
ment (Federal Register 1993; DiFranza 1994c; DiFranza 
and Godshall 1994). These anticipatory responses, to­
gether with the opinions and concerns they elicited, 
were analyzed in a study conducted in 1995 by 
Downey and Gardiner (1996). An interim report from 
the OIG in 1995 indicated that states were finding the 
implementation process difficult.  Although 85 percent 
of states performed some inspections, the majority did 
not use a rigorous sampling scheme.  Fifty-six percent 
reported no statewide enforcement activity (OIG 1995). 
Efforts to curb illegal sales to minors have also 
occurred at the federal level.  The former FDA pro­
gram (see description in Chapter 7) was a major effort 
for several years. Probably the most sustained and 
widespread attention to the issue of minors’ access 
laws and their enforcement was precipitated by the 
U.S. Congress, which in 1992 adopted the Synar 
Amendment as part of the Alcohol, Drug Abuse, and 
Mental Health Administration Reorganization Act 
(Public Law 102-321, sec. 1926), which amended the 
Public Health Service Act.  This provision requires 
states (at the risk of forfeiting federal block grant funds 
for substance abuse prevention and treatment) to adopt 
laws establishing minimum ages for tobacco sales, to 
enforce the law, and to show progressive reductions 
in the retail availability of tobacco products to minors. 
The implementation of the Synar Amendment, which 
initially was to go into effect during fiscal year 1994, 
was delayed because regulations about how states 
were to implement the statute had not yet been final­
ized. During the considerable lag between passage of 
the amendment and the issuance of final regulations, 
The draft regulations were finalized in early 1996 
after a review of comments from the health commu­
nity, state agencies, and the tobacco industry.  Respon­
sibility for implementation was placed with the 
Substance Abuse and Mental Health Services Admin­
istration (SAMHSA), which in the course of 1996 con­
ducted two technical assistance meetings with states 
and issued three separate guidance documents.  Un­
der these regulations, the Synar Amendment requires 
the 50 states, the District of Columbia, and U.S. juris­
dictions to do the following: 
•	 	 Have in effect a law prohibiting any manufacturer, 
retailer, or distributor of tobacco products from sell­
ing or distributing such products to any person 
under the age of 18. 
•	 	 Enforce such laws in a manner that can be reason­
ably expected to reduce the extent to which tobacco 
products are available to persons under the age 
of 18. 
•	 	 Conduct annual random, unannounced inspections 
to ensure compliance with the law; inspections are 
to be conducted to provide a valid sampling of out­
lets accessible to underaged youth. 
•	 	Develop a strategy and time frame for achieving 
an inspection failure rate of less than 20 percent 
among outlets accessible to underaged youth. 
•	 	Submit an annual report detailing the state’s ac­
tivities in enforcing the law, the success achieved, 
methods used, and plans for future enforcement. 
In the event of noncompliance with these regu­
lations, the Secretary of Health and Human Services 
is directed by statute (42 U.S.C. section 300X-26[c]) to 
make reductions of from 10 percent (for the first 
applicable fiscal year) to 40 percent (for the fourth 
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applicable fiscal year) in the noncompliant state’s fed­
eral block grant for substance abuse programs. Al­
though no additional monies have been appropriated 
to offset the costs of complying with these regulations, 
states may use block grant funds for certain Synar­
related administrative activities, such as developing 
and maintaining a list of retail outlets, designing the 
sampling methodology, conducting Synar survey in­
spections, and analyzing the survey results. 
In the several years following the issuance of the 
final Synar regulation, some significant advances have 
been made in enforcement of youth access laws. All 
states have laws prohibiting sale or distribution and 
they are enforcing those laws (USDHHS 1998a).  Fur­
ther, the median rate at which retailers failed to com­
ply with laws prohibiting tobacco sales to minors in 
1998 was 24.4 percent compared with the median 
rate of 40 percent in 1997 and pre-1997 studies that 
found violation rates ranging from 60 to 90 percent 
(USDHHS, in press).  In the course of implementing 
Synar, every state has been required to establish a sam­
pling methodology that measures the statewide retailer 
violation rate within a known confidence interval and 
to establish inspection protocols for conducting the 
statewide survey of tobacco retailers.  These protocols 
include restrictions on the ages of minor inspectors and 
to establish procedures for recruiting and training of 
both minor inspectors and adult escorts. Addition­
ally, the random, unannounced inspections conducted 
by the states in compliance with the Synar regulation 
provide the largest body of statewide data available 
on the level of retailer noncompliance. 
Twenty-two states and two U.S. jurisdictions 
modified their youth access laws within a year of 
implementing Synar inspections. These changes im­
proved the states’ ability to enforce the law by clarify­
ing responsibility for enforcement, defining violations, 
clarifying penalties, restricting vending machine sales, 
and establishing a list of tobacco vendors through re­
tail licensure or vendor registration (USDHHS, in 
press). 
In spite of these advances in enforcement of 
youth access laws, states also encountered difficulties 
while attempting to comply with the Synar mandate. 
The Synar regulation does not allow for the allocation 
of federal dollars (e.g., the Substance Abuse Preven­
tion and Treatment Block Grant) to be used for enforce­
ment. For many states, this proved to be a significant 
problem, because enforcement of youth access laws 
had not been previously viewed as a priority, and states 
were unwilling to redirect already limited funds for 
prevention and treatment services to law enforcement. 
Some states addressed the problem by  earmarking 
revenue derived from fines, fees, or taxes.  Other states 
implemented collaborative enforcement efforts among 
several agencies so that the financial burden would be 
shared.  And still other states relied heavily on the use 
of volunteer youth inspectors and adult escorts 
(USDHHS 1998a). As the FDA became active in the 
youth access issue, a few states were able to use FDA 
funding for enforcement to cover some of the cost of 
Synar inspections in 1998. 
Another obstacle to enforcement involved devel­
oping a valid random sample of tobacco outlets in the 
state when there was no accurate or current list of ven­
dors available. Although a few states addressed this 
problem by working to pass retailer licensing laws at 
the state level, states initially had to build lists by rely­
ing on information from wholesale tobacco distribu­
tors and vending machine distributors and by 
searching existing lists that inadvertently identify to­
bacco vendors (e.g., convenience store association 
membership lists) (USDHHS 1999). 
Other less frequently cited obstacles to enforce­
ment included fear of lawsuits from cited vendors, 
concerns with the liability issues associated with work­
ing with youth, and opposition to conducting enforce­
ment from state and local officials, law enforcement, 
and the general public in regions of the country where 
the economy is tied to the production of tobacco 
(USDHHS 1999). 
In addition to federal and state efforts targeting 
illegal tobacco sales to minors, a great amount of local 
activity has occurred. Many local ordinances have re­
sulted from the work of various groups, particularly 
in California, Massachusetts, and Minnesota (DiFranza 
1994a,b; Kropp 1995; Forster et al. 1996, 1998). These 
ordinances—which may, for example, prohibit vend­
ing machine sales or all self-service sales of tobacco, 
require the tobacco sellers to be aged 18 years or older, 
require checking identification before sale, specify civil 
penalties for violators of the minimum-age law, require 
posting that law at the point of purchase, and require 
compliance checks with a specified timetable—permit 
creative responses at the local level to the minors’ ac­
cess problem.  Compared with state officials, local of­
ficials deal with fewer retailers and a more limited set 
of constraints and are freer to tailor their policy to lo­
cal conditions. Tobacco interests are less influential at 
the local level, because industry representatives are 
more likely to be perceived as outsiders, and their cam­
paign contributions are less likely to be important to 
local officials; moreover, community members and 
local advocacy groups are often more effective against 
tobacco interests at this level than they are in statewide 
policy arenas (Sylvester 1989). Policy implementation 
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is also likely to be more consistent at the local level, be­
cause local advocates can monitor the process and be­
cause enforcement officials are more likely to have been 
a part of the policy’s adoption. However, many of the 
policies at the federal, state, and local levels are inter­
related:  the federal Synar Amendment is implemented 
through state laws and has led to enforcement at the 
state and local level (USDHHS 1998a). The former FDA 
enforcement program operated through contracts with 
state agencies or organizations to conduct compliance 
checks in communities across the states.  State agen­
cies often fund local coalitions and projects, and local 
efforts influence and support efforts at the state level. 
For example, much of the local activity in California 
and Massachusetts would not have been possible 
without actions implemented at the state level, spe­
cifically designated funding. 
Laws enacted by states pertaining to minors’ ac­
cess to tobacco as of December 31, 1999, have been 
compiled by the CDC (CDC, Office on Smoking and 
Health, State Tobacco Activities Tracking and Evalua­
tion System, unpublished data)(Table 5.3).  Dates of 
enactment or amendment indicate that some legisla­
tive change occurred in all but one state from January 
1990 to December 1997 (National Cancer Institute, State 
Cancer Legislative Database, unpublished data, Octo­
ber 6, 1998). 
Restrictions on Distribution of Samples 
Tobacco product samples provide a low-cost or 
no-cost initiation to their use and thus encourage ex­
perimentation at early ages. Many states or other ju­
risdictions have laws that prohibit not only sales but 
also any samples distribution of tobacco to minors, 
whereas some laws specify exceptions permitting par­
ents or guardians to provide tobacco to their children. 
All states have a specific restriction on the distribu­
tion of free samples to minors, and a few states or lo­
cal jurisdictions prohibit free distribution altogether 
because of the difficulty of controlling who receives 
these samples. A ban on product sample distribution 
can extend to coupons for free tobacco products.  In 
Minnesota, the attorney general levied a $95,000 civil 
penalty against the Brown & Williamson Tobacco Cor­
poration for allowing such coupons to be redeemed in 
the state (Minnesota Attorney General 1994).  The re­
ports from both the IOM (Lynch and Bonnie 1994) and 
the Working Group of State Attorneys General (1994) 
recommended a ban on the distribution of free tobacco 
products.  The final FDA rules issued in August 1996 
would have prohibited the distribution of free samples 
(see “Further Regulatory Steps,” earlier in this 
Reducing Tobacco Use 
chapter). The proposed multistate settlement pre­
sumed congressional legislation that would uphold 
those rules (see “Legislative Developments” and “Mas­
ter Settlement Agreement,” earlier in this chapter). 
Regulation of Means of Sale 
How tobacco can be sold may also be regulated 
to make it more difficult for minors to purchase it.  His­
torically, the first such restrictions adopted have been 
regulations of cigarette vending machines, which are 
an important source of cigarettes for younger smok­
ers (Response Research, Incorporated 1989; Cummings 
et al. 1992, 1998; CDC 1996d). These regulations have 
taken the form of total bans, restrictions on placement 
(e.g., being within view of an employee instead of in 
coatrooms or entrances, or not being near candy or 
soda machines), restrictions on the types of businesses 
where vending machines may be located (e.g., limited 
to liquor-licensed businesses, private businesses, or 
businesses where minors are not permitted), and re­
strictions on characteristics of the machines themselves 
(e.g., requiring electronic locking devices or coin slugs 
purchased over a sales counter) (Forster et al. 1992a; 
DiFranza et al. 1996). The final FDA rules would have 
prohibited vending machines except in certain night­
clubs and other adults-only facilities totally inaccessible 
to persons under age 18. The proposed multistate settle­
ment anticipated legislation supporting this prohibition. 
Forty-one states and the District of Columbia 
have laws that restrict minors’ access to vending ma­
chines, including two states, Idaho and Vermont, that 
have enacted legislation totally banning vending ma­
chines. However, many of the state vending machine 
laws are weak.  For example, 21 states and the District 
of Columbia do not restrict placement if the machine 
is supervised, and New Jersey bans vending machines 
in schools only (CDC, Office on Smoking and Health, 
unpublished data, 2000). However, more than 290 lo­
cal jurisdictions, including New York City, have been 
able to adopt and enforce outright bans on cigarette 
vending machines or to severely restrict them to loca­
tions, such as taverns, where minors are often excluded 
(American Nonsmokers’ Rights Foundation, unpub­
lished data, 2000). 
Representatives of tobacco manufacturers and 
retailers have strongly opposed bans on cigarette vend­
ing machines and have argued instead for weaker re­
strictions, if any, especially for what they term “adult” 
locations (Minnesota Automatic Merchandising 
Council 1987; Adkins 1989; Parsons 1989; Grow 1990; 
Moylan 1990; Pace 1990; Gitlin 1991). Many of these 
locations, including bars and other liquor-licensed 
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Table 5.3. Provisions of state laws relating to minors’ access to tobacco as of December 31, 1999 
Prohibits 
purchase, 
Minimum age Tobacco Vending possession, 
for tobacco license machine Enforcement Sign-posting and/or use 
State sales required restrictions authority requirements* by minors 
Alabama 19 yes no yes no yes 
Alaska 19 yes† yes no yes yes‡ 
Arizona 18 no yes no no yes 
Arkansas 18 yes yes yes yes yes 
California§ 18 no yes no yes yes 
Colorado 18 no yes yes yes yes 
Connecticut§ 18 yes† yes yes yes yes 
Delaware§ 18 yes yes yes yes yes 
District of Columbia 18 yes† yes no yes no 
Florida§ 18 yes yes yes yes yes 
Georgia 18 yes yes yes yes yes 
Hawaii 18 no yes no yes yes 
Idaho 18 no yesΔ yes no yes 
Illinois§ 18 no yes yes no¶ yes 
Indiana§ 18 no yes yes yes yes 
Iowa§ 18 yes† yesΔ yes no yes 
Kansas 18 yes† yes no yes yes 
Kentucky§ 18 yes† yes yes yes yes 
Louisiana§ 18 yes yes yes yes yes** 
Maine 18 yes yes yes yes yes 
Maryland 18 yes† no no no yes 
Massachusetts§ 18 yes no no yes no 
Michigan§ 18 yes yes no yes yes†† 
Minnesota 18 yes yes yes no yes 
Mississippi§ 18 yes yes yes yes yes§§ 
*Refers to the requirement to post the minimum age for purchase of tobacco products. 
†Excludes chewing tobacco or snuff. 
‡Except minors at adult correctional facilities.
 

§Some or all tobacco control legislation includes preemption.
 

ΔRequires businesses that have vending machines to ensure that minors do not have access to the machines;
 

however, the law does not specify the type of restriction, such as limited placement, locking device, or 
supervision. 
¶Signage required for sale of tobacco accessories, but not for tobacco. 
**Except persons who are accompanied by a parent, spouse, or legal guardian 21 years of age or older or in a 
**private residence. 
††A pupil may not possess tobacco on school property.
 

Source:  Centers for Disease Control and Prevention, Office on Smoking and Health, State Tobacco Activities
 

Tracking and Evaluation System, unpublished data.
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Reducing Tobacco Use 
Table 5.3. Continued 
Prohibits 
State 
Minimum age 
for tobacco 
sales 
Tobacco 
license 
required 
Vending 
machine 
restrictions 
Enforcement 
authority 
Sign-posting 
requirements 
purchase, 
possession, 
and/or use 
by minors 
Missouri 18 no no no yes no 
Montana§ 18 yes yes yes yes yes‡‡ 
Nebraska 18 yes§§ yes no no yes 
Nevada§ 18 yes §§ yes yes no no 
New Hampshire 18 yes yes yes yes yes 
New Jersey§ 18 yes† yes yes yes no 
New Mexico§ 18 no yes yes yes yes 
New York§ 18 yes yes yes yes no 
North Carolina§ 18 no†§§ΔΔ yes no yes yes 
North Dakota 18 yes§§ yes no no yes 
Ohio 18 yes† yes no yes no 
Oklahoma§ 18 yes† yes yes yes yes 
Oregon§ 18 no yes yes yes yes 
Pennsylvania§ 18 yes† no no no no‡‡ 
Rhode Island 18 yes† yes yes yes yes¶¶ 
South Carolina§ 18 yes no no no no 
South Dakota§ 18 no yes yes no yes 
Tennessee§ 18 no yes yes yes yes 
Texas 18 yes yes yes yes yes 
Utah§ 18 yes yes yes no yes 
Vermont 18 yes yes yes yes yes 
Virginia§ 18 no yes yes yes yes 
Washington§ 18 yes† yes yes yes yes 
West Virginia§ 18 no no yes no yes 
Wisconsin§ 18 yes yes no yes yes 
Wyoming§ 18 no yes no yes yes 
Total 51 35 44 33 36 42 
‡‡A pupil may not possess or use tobacco on school property.
 

§§Except vending machines.
 

ΔΔA retail license exists for those retailers who manufacture their own tobacco products or deal in nonpaid
 

tobacco products. 
¶¶On any public street, place, or resort. 
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businesses, do not prohibit minors’ entry and have 
been shown to be readily accessible to underaged buy­
ers (Forster et al. 1992b; Wakefield et al. 1992a; 
Cismoski and Sheridan 1993). Because less-restrictive 
measures must be consistently implemented to be ef­
fective, and because such implementation is difficult, 
the USDHHS (1994) and the IOM (Lynch and Bonnie 
1994) recommend a total ban on cigarette vending 
machines. The 1996 FDA rules would have excluded 
locations that are inaccessible to minors, but the 
multistate settlement proposed a total ban. 
Restrictions on vending machines are a category 
of regulation of self-service cigarette sales.  A general 
ban on self-service would require that tobacco be 
physically obtained from a salesperson and be stored 
so that products are not directly accessible to custom­
ers. In one study of 489 over-the-counter purchase 
attempts, minors were successful at purchasing in 33 
percent of locations where cigarettes were behind the 
counter and 45 percent of locations where cigarettes 
were openly available (Forster et al. 1995).  In another 
study, stores that did not give customers access to to­
bacco products were less likely to sell to minors (12.8 
percent) than stores that permitted direct contact with 
tobacco products (30.6 percent)(Wildey et al. 1995a). 
Finally, data suggest that shoplifting is an important 
commercial source of tobacco to underaged youth 
(Cummings et al. 1992, 1995; Cismoski and Sheridan 
1994; Lynch and Bonnie 1994; Forster et al. 1995; Wildey 
et al. 1995b; CDC 1996d; Roswell Park Cancer Insti­
tute 1997). Shoplifting may be deterred by regulations 
that specify that until the moment of purchase, single 
packs, any amount less than a carton, or all tobacco 
products must be physically handled by an employee 
only (Cismoski 1994; Wildey et al. 1995a; Caldwell et 
al. 1996). 
Several states have addressed the issue of self-
service sales of tobacco products.  For example, Idaho 
and Minnesota restrict self-service sales to only those 
stores that do not allow minors to enter and that ob­
tain most of their sales from tobacco.  Texas prohibits 
self-service sales in any location accessible to minors. 
Three hundred and ten localities have chosen to re­
strict tobacco sales by prohibiting self-service displays 
(American Nonsmokers’ Rights Foundation, unpub­
lished data, 2000). Opposition to this measure is 
generally organized by tobacco distributors and 
retailers, who fear the loss of slotting fees—payments 
(often substantial) to retailers for advantageous 
placement of tobacco products and for point-of­
purchase advertising in their business (Gersten 1994; 
Thomas A. Briant, letter to Litchfield Tobacco Retail­
ers, February 16, 1995; Caldwell et al. 1996).  The IOM 
recommends a ban on self-service displays (Lynch and 
Bonnie 1994), and the Working Group of State Attor­
neys General (1994) recommends to tobacco retailers 
that they eliminate such displays. That this recom­
mendation is not unreasonably burdensome has been 
demonstrated by one study in which 28 percent of re­
tailers in 14 communities complied voluntarily (Forster 
et al. 1995) and by another study involving 15 cities in 
northern California (Kropp 1995).  The 1996 FDA rules 
would also have prohibited self-service displays 
except in certain adults-only facilities; the proposed 
national settlement further stipulated that in 
non-adults-only facilities, tobacco products must be 
out of reach or otherwise inaccessible or invisible to 
consumers. 
Anecdotal reports have suggested that single or 
loose cigarettes are sold in some locations.  Such sales 
are often prohibited by state or local law, at least im­
plicitly because single cigarettes do not display the 
required state tax stamp or federal warning.  Fre­
quently, single cigarettes are kept out of sight and are 
available only by request.  Researchers in California 
found that even after a state law explicitly banned the 
sale of single cigarettes, almost one-half of tobacco re­
tailers sold them to their customers (Klonoff et al. 1994). 
The study found that the stores that made loose ciga­
rettes available sold them to almost twice as many 
minors as they did to adults. That finding lends sup­
port to the argument that single cigarette sales are an 
important avenue to addiction for some youth. A re­
cent study in Central Harlem has produced similar 
results: 70 percent of the licensed outlets sold single 
cigarettes to minors (Gemson et al. 1998).  The IOM, 
the 1996 FDA rules, and the proposed multistate settle­
ment have all recommended that the sale of loose or 
single cigarettes be explicitly prohibited (Lynch and 
Bonnie 1994). 
Regulation Directed at the Seller 
All states now have a law specifying the mini­
mum purchaser’s age for legal sale of tobacco prod­
ucts. For all but two states, that age is 18; Alabama 
and Alaska specify age 19.  Almost two-thirds of the 
states and many local jurisdictions require tobacco 
retailers to display signs that state the minimum age 
for sale. Some regulations specify the size, wording, 
and location of these signs. Other regulations specify 
the minimum age for salespersons; these regulations 
recognize the difficulty young sellers may experience 
in refusing to sell cigarettes to their peers. 
Most of these laws define violation either as 
a criminal offense (e.g., misdemeanor or gross 
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misdemeanor), with accompanying penalties, or as a 
civil offense, with specified civil penalties (e.g., fines 
and license suspension). Civil offense laws are thought 
to make enforcement easier and are therefore more 
likely to be carried out, since they do not generally 
require court appearances.  Many state or local laws 
specify penalties only against the salesperson. Apply­
ing penalties to business owners, who generally set 
hiring, training, supervising, and selling policies, is 
considered essential to preventing the sale of tobacco 
to minors, although tobacco retailers have vigorously 
opposed these measures (Skretny et al. 1990; Feighery 
et al. 1991; McGrath 1995a,b). 
More than one-half of the states and some local 
jurisdictions require that tobacco retailers obtain li­
censes for over-the-counter sales, but smokeless to­
bacco is exempted by 13 of these states (CDC, Office 
on Smoking and Health, unpublished data). Licen­
sure sometimes is simply a mechanism for collecting 
taxes or generating revenue; in other states and cities, 
conditions are attached that relate to minors’ access. 
In addition to civil penalties, retail licensure for tobacco 
represents another approach for facilitating youth ac­
cess law enforcement efforts and strengthening sanc­
tions for violators of the law.  Retail licensure can 
facilitate the identification of retailers.  The lack of a 
current and accurate list of tobacco vendors has been 
cited by many states involved in Synar enforcement 
as a serious impediment to efficient enforcement 
(USDHHS 1999). Retail licensure can also create an 
incentive for retail compliance. License suspensions 
or revocations could be imposed as penalties for vio­
lation of youth access laws, resulting in revenue loss 
for retailers.  Licensure would also provide a source 
of funds to pay for enforcement and retailer educa­
tion when licensing fees or fines for violations are ear­
marked for such education purposes. Finally, retail 
licensure provides a mechanism for administrative 
adjudication of youth access law violations. License 
holders who fail to comply with the law could be held 
accountable before the licensing authority. 
No published empirical research examines the 
effects of tobacco retail licensure on either enforcement 
efforts or retail compliance.  Studies on policies tar­
geted to increase retail compliance, however, suggest 
several specific elements of licensure policies that 
should be present in order to increase the likelihood 
of positive effects.  The points below outline the ways 
in which licensure policies could be used to enhance 
retail compliance efforts. 
Reducing Tobacco Use 
•	 	 Licensure laws must explicitly link the privilege of 
selling tobacco products to retail compliance with 
youth access laws (Levinson 1999). 
•	 	 Licensure should cover both retail stores and vend­
ing machines (Levinson 1999). 
•	 	 License holders should be required to renew their 
license annually (Levinson 1999; USDHHS 1999). 
•	 	License holders should be fined for violation of 
youth access laws (Levinson 1999). 
•	 	 Fines should be high enough to encourage vendors 
to comply with youth access laws but not so high 
as to risk loss of community or judicial support for 
the imposition of penalties (Lynch and Bonnie 
1994). 
•	 	Fines should be graduated so that greater conse­
quences are associated with increased number of 
violations. Repeated violations should lead to li­
cense suspension or revocation (CDC 1995a; NCI 
n.d.). 
•	 	 License fees should be sufficient to cover the aver­
age cost of compliance checks (CDC 1995a). 
•	 	 The revenue from fines should subsidize the costs 
of enforcement (Working Group of State Attorneys 
General 1994). 
In addition to these items, several other policy 
elements have been suggested for incorporation into 
licensure laws. These licensure policy components 
should communicate clear and consistent messages 
about the illegality of tobacco sales to minors and 
should promote societal norms intolerant of youth ac­
cess law violations (Kropp 1996). These elements in­
clude mandatory posting of warning signs within clear 
sight of consumers, mandatory checking of age iden­
tification, state provision of merchant and clerk edu­
cation about youth access law requirements (i.e., 
consequences for violations and techniques for im­
proving merchants’ and clerks’ skills at detecting un­
derage youth and refusing sales), restrictions or bans 
on self-service displays, and ensuring that clerks are 
at or above the legal purchase age. 
Without enforcement provisions, however, li­
censing laws are not effective measures to restrict mi­
nors’ access. Before 1996, only 16 states with licensing 
laws specified the agency with enforcement responsi­
bility, despite recommendations (USDHHS 1990; 
Lynch and Bonnie 1994; Working Group of State At­
torneys General 1994) that states adopt a licensing re­
quirement that has civil penalties and a designated 
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enforcement agent.  In its 1998 report, SAMHSA indi­
cates that all but one state requiring licenses have a 
designated enforcement agency (USDHHS 1998a; see 
“Enforcement of Laws on Minimum Ages for Tobacco 
Sales,” later in this chapter). 
State laws and local ordinances can be a mecha­
nism for increasing retailer awareness of youth access 
laws and retailer ability to comply with the law.  Of­
ten referred to as responsible vendor laws, this type of 
legislation can require retailer education and training 
as a condition of retail tobacco licensure or simply re­
quire education and training for all tobacco vendors. 
Numerous studies have shown the potential benefit 
of comprehensive merchant education and training 
programs in helping to reduce illegal sales to minors 
(Altman et al. 1989, 1991, 1999; Feighery 1991; Keay 
1993; Cummings et al. 1998). In many instances, rep­
resentatives of tobacco retailers have supported the 
passage of responsible vendor laws  (McGrath 1995a,b; 
Thomas A. Briant, Letter to Litchfield Tobacco Retail­
ers, February 16, 1995) when these laws also exempt 
business owners from penalties or specify lower pen­
alties for tobacco sales to minors if owners have trained 
their employees. Under such conditions, employee 
training would relieve retailers of responsibility for on­
going supervision and monitoring of employee behav­
ior and likely result in decreasing the impact of youth 
access laws. It should be noted, however, that as a 
result of both Synar and FDA attention to the problem 
of youth access to tobacco, several states have worked 
to ensure the modification of youth access and/or re­
tail licensure laws to mandate vendor education and 
training without the incorporation of clauses reliev­
ing retailer responsibility (USDHHS 1998a).  These ef­
forts recognize that responsible vendor laws have the 
potential to be an effective way to increase the ability 
of retailers and clerks to comply with the law by accu­
rately detecting underage purchases and confidently 
and safely refusing sales. 
The general availability of tobacco products in 
retail outlets that have pharmacies has led to some 
concerns. In the United States, stores that have phar­
macies usually sell tobacco products, contrary to a 1971 
policy recommendation of the American Pharmaceu­
tical Association (1971) that cited the inconsistency of 
selling cigarettes with their function as health institu­
tions. A few small chains and a growing number of 
independent stores with pharmacies are tobacco free, 
but all large chains and most independent stores sell 
tobacco products.  Pharmacies (and stores that have 
pharmacies) that sell tobacco products are as likely as 
other outlets to sell to minors (Brown and DiFranza 
1992). On the other hand, a study has shown that 
pharmacists who work in stores that do not sell to­
bacco have a better understanding of the dangers of 
tobacco than do pharmacists who work in stores that 
sell tobacco, and they also feel more confident that they 
can help customers who use tobacco stop (Davidson 
et al. 1988). Two-thirds of pharmacists surveyed in 
Minnesota believed that members of the profession 
should not work in stores that sell tobacco products 
(Martinez et al. 1993), and many felt that the contigu­
ity of tobacco products and pharmaceuticals produces 
professional dissonance (Taylor 1992; Kamin 1994). 
Both the Canadian Medical Association and the Ameri­
can Medical Association are opposed to tobacco sales 
in pharmacies and in stores that have pharmacies 
(Staver 1987; Sullivan 1989). The Canadian provincial 
government of Ontario banned such sales in 1994 (An 
Act to Prevent the Provision of Tobacco to Young Per­
sons and to Regulate its Sale and Use by Others, Stat­
utes of Orleans, ch. 10, sec. 3[6] [1994] [Can.]). 
Regulation Directed at the Buyer 
State and local jurisdictions are increasingly im­
posing sanctions against minors who purchase, at­
tempt to purchase, or possess tobacco products (CDC 
1996c; Forster et al. 1996). These laws are favored by 
some law enforcement officials and tobacco retailers 
because of the potential deterrent value (Parsons 1989; 
Talbot 1992).  Some advocates for reducing tobacco use 
argue, however, that such laws are part of an effort to 
deflect responsibility for illegal tobacco sales from re­
tailers to underaged youth; that these laws are not an 
efficient substitute for laws regulating merchants, be­
cause so many more minors than retailers are involved; 
and that sanctions against minors are more difficult to 
enforce than those against retailers (Carol 1992; 
Cismoski 1994; Lynch and Bonnie 1994; Mosher 1995; 
Wolfson and Hourigan 1997).  Other advocates have 
insisted that some of the responsibility must devolve 
on the purchaser and that laws prohibiting possession 
should be vigorously enforced (Talbot 1992).  Although 
not taking a stand on the advisability of purchase and 
possession laws, the Working Group of State Attor­
neys General (1994) recommended that such laws 
should be considered only after effective retail regula­
tions are already in place. 
Enforcement of Laws on Minimum Ages 
for Tobacco Sales 
Although laws on the minimum age for tobacco 
sales have been part of many state statutes for decades, 
only in the past few years has attention been focused 
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on enforcing these laws by federal, state, or local agen­
cies (Lynch and Bonnie 1994; Federal Register 1996; 
USDHHS, in press).  As more information has become 
available about the implementation and effects of vari­
ous minors’ access laws, it is becoming clear that orga­
nized enforcement efforts are essential to realizing the 
potential of these laws. Enforcement of minimum-age 
laws is more likely to occur when enforcement is self-
supporting through license fees and revenues from pen­
alties and when the penalty schedule includes civil 
penalties that are large enough to be effective but are 
seen as reasonable and simple to administer (Working 
Group of State Attorneys General 1994).  Law enforce­
ment officials have sometimes balked at applying crimi­
nal penalties against clerks and retailers for selling 
tobacco to minors. Enforcement may be more effective 
if sanctions can be imposed on managers or business 
owners rather than, or in addition to, salespersons 
(Working Group of State Attorneys General 1994). 
Moreover, the 1992 enactment of the Synar 
Amendment (Public Law 102-321, sec. 1926, discussed 
in the introduction to this section) has forcibly brought 
this issue to the fore, because the amendment requires 
states to enact and enforce legislation restricting the 
sale and distribution of tobacco products to minors. 
As a result, all states have laws prohibiting the sale 
and distribution of tobacco to minors and all states 
enforce these laws through a statewide coordinated 
program. Additionally, all states have now designated 
a lead agency and all but one have an agency respon­
sible for enforcing their minimum-age law (Table 5.4) 
(USDHHS, in press).  In addition to federal and state 
enforcement efforts, a number of local jurisdictions 
around the country have begun actively enforcing the 
law against tobacco sales to minors, and local ordi­
nances can include a schedule of required compliance 
checks (Lynch and Bonnie 1994; Working Group of 
State Attorneys General 1994; Forster et al. 1996; 
DiFranza et al. 1998). 
Compliance checks are most often carried out by 
having an underaged buyer, under the supervision of 
a law enforcement officer, licensing official, or some 
other designated adult, attempt to purchase tobacco. 
In jurisdictions where the minor is held legally at fault 
if a purchase is made (and where no exceptions are 
made for compliance checks), minors participating in 
compliance checks are sometimes instructed not to 
complete the purchase even if the salesperson is will­
ing; in these cases, the retailer is considered to be in 
noncompliance with the youth access law if the pur­
chase is entered into the cash register (Hoppock and 
Houston 1990; Cummings et al. 1996). 
Reducing Tobacco Use
 
Several innovative civil enforcement approaches 
have been attempted in California. The district attor­
neys in Sonoma and Napa Counties have used the Cali­
fornia Business and Professions Code section 17200 to 
file civil lawsuits against store owners whose outlets 
repeatedly sold tobacco to minors.  Civil enforcement 
has proved to be more efficient than criminal citations 
and has resulted in fines and penalties as well as reduc­
tions in tobacco sales to minors (Kropp and Kuh 1994). 
Increased emphasis on enforcement, coupled 
with passage of laws against possession of tobacco by 
minors, may result in enforcement resources being 
selectively funneled to apprehending underaged 
smokers rather than penalizing the merchants who sell 
tobacco to these minors. A survey of 222 police chiefs 
in Minnesota revealed that although more than 90 per­
cent were enforcing the law against minors’ posses­
sion, 40 percent reported applying penalties to minors, 
and only 6 percent reported any enforcement against 
merchants (Forster et al. 1996). 
A vigorous and multidimensional campaign has 
been mounted by the tobacco industry and its allies to 
prevent or undermine effective enforcement of minors’ 
access laws and to resist the proposal that retailers be 
held accountable for their stores’ compliance.  Since 
1992, laws sponsored by the tobacco industry but os­
tensibly intended to bring states into compliance with 
requirements of the Synar Amendment have been 
passed in Georgia, Idaho, Kentucky, Louisiana, Mary­
land, Mississippi, North Carolina, Oklahoma, South 
Dakota, and Tennessee (DiFranza 1994c; DiFranza and 
Godshall 1994). Tobacco industry representatives and 
their allies have lobbied successfully for the inclusion 
of language such as “knowingly” or “intentionally” 
in the law prohibiting sale of tobacco to minors; the 
impact of such language may be to render the law 
unenforceable. Industry interests have sought to in­
clude various restrictions on how, how often, and by 
whom enforcement or compliance testing can be con­
ducted. Examples of these restrictions include oppos­
ing employing teens in compliance testing or requiring 
that only very young teens can function as buyers, in­
sisting that enforcement be done only by the alcohol 
control authority or some other state agency, oppos­
ing compliance checks carried out by advocacy groups 
or for public health research, and opposing require­
ments that compliance checks occur on a specified 
schedule. The industry has further proposed imme­
diate reentry and confrontation after an illicit sale—a 
procedure that could compromise collecting evidence. 
Industry representatives have also consistently main­
tained that merchants ought not to be responsible for 
the costs incurred in complying with minimum-age 
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Table 5.4.  	Agencies responsible for enforcing state laws on minimum age for tobacco sales as of fiscal 
year 1998 
State/Territory Lead agency Enforcement agency 
Alabama Alcoholic Beverage Control Board Alcoholic Beverage Control Board 
Alaska Department of Health and Social Services, Attorney General’s Office 
Division of Alcoholism and Drug Abuse 
Arizona Department of Health Services, Office of Department of Health Services, Office 
Substance Abuse and General Mental Health of Substance Abuse and General Mental 
Health 
Arkansas Department of Health, Bureau of Alcohol Tobacco Control Board 
and Drug Abuse Prevention 
California Department of Health Services Department of Health Services 
Colorado Department of Human Services, Alcohol State and local law enforcement 
and Drug Abuse Division 
Connecticut Department of Mental Health and Social Department of Revenue Services 
Services, Office of Addiction Services 
Delaware Department of Public Safety, Alcoholic Department of Public Safety, Alcoholic 
Beverage Control Commission Beverage Control Commission 
District of Department of Human Services, Addiction Department of Consumer and Regulatory 
Columbia Prevention and Recovery Administration Affairs and the Metropolitan Police 
Department 
Florida Department of Business and Professional Department of Business and Professional 
Regulation, Division of Alcoholic Beverages Regulation, Division of Alcoholic 
and Tobacco Beverages and Tobacco 
Georgia Department of Public Safety Department of Public Safety 
Hawaii Department of Health, Alcohol and Drug Department of Health with Department 
Abuse Division of the Attorney General 
Idaho Department of Health and Welfare, FACS Department of Health and Welfare, FACS 
Division, Bureau of Mental Health and Division, Bureau of Mental Health and 
Substance Services Substance Services 
Illinois Liquor Control Commission No one agency responsible for 
enforcement 
Indiana Family and Social Services Administration, Indiana Alcoholic Beverage Commission 
Division of Mental Health Excise Police 
Iowa Department of Public Health, Division of Department of Public Health, Division of 
Substance Abuse and Health Promotion Substance Abuse and Health Promotion 
Kansas Department of Social and Rehabilitation Department of Revenue, Alcoholic 
Services, Alcohol and Drug Abuse Services Beverage Control Board 
Kentucky Department of Alcoholic Beverage Control Department of Agriculture (specified 
state law) with the Department of 
Alcoholic Beverage Control (appointed) 
Source:  U.S. Department of Health and Human Services, in press. 
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Reducing Tobacco Use 
Table 5.4. Continued 
State/Territory Lead agency	 	 Enforcement agency
 

Louisiana	 	 Department of Revenue and Taxation, Department of Revenue and Taxation, 
Office of Alcoholic Beverage and Tobacco Office of Alcoholic Beverage and Tobacco 
Control Control 
Maine	 	 Department of Mental Health and Mental Department of Mental Health and Mental 
Retardation, Office of Substance Abuse Retardation, Office of Substance Abuse 
Maryland	 	 Department of Health and Mental Hygiene, 
Alcohol and Drug Abuse Administration 
State Comptroller’s Office 
Massachusetts	 	 Department of Public Health, Bureau of Department of Public Health, Tobacco 
Substance Abuse Services Control Program with the Attorney 
General’s Office 
Michigan	 	 Department of Community Health, Bureau Department of Community Health, Bureau 
of Substance Abuse Services of Substance Abuse Services 
Minnesota	 	 Department of Human Services, Chemical Department of Human Services, Chemical 
Dependency Program Division Dependency Program Division 
Mississippi	 	 Department of Mental Health, Division of 
Alcohol and Drug Abuse 
Office of Attorney General 
Missouri	 	 Department of Mental Health, Division of Department of Mental Health, Division of 
Alcohol and Drug Abuse Alcohol and Drug Abuse 
Montana	 	 Department of Public Health and Human Department of Public Health and Human 
Services, Division of Addictive and Mental Services, Division of Addictive and 
Disorders Mental Disorders 
Nebraska	 	 Department of Health and Human Services Nebraska State Patrol 
Nevada	 	 Attorney General of the State of Nevada State Attorney General 
New Hampshire	 	 Department of Health and Human Services, Department of Health and Human 
Bureau of Substance Abuse Services Services, Bureau of Substance Abuse 
Services 
New Jersey	 	 Department of Health and Senior Services Department of Health and Senior Services 
with local health agencies 
New Mexico	 	 Department of Regulation and Licensing, Department of Regulation and Licensing, 
Alcohol and Gaming Division Alcohol and Gaming Division (statutory), 
Department of Health and Department of 
Public Safety (by executive order) 
New York	 	 Department of Health, Office of Alcoholism 37 local county health units and 10 district 
and Substance Abuse Services offices of the state’s Department of Health 
North Carolina	 	 Department of Human Resources, Division 
of Mental Health, Developmental Disabilities 
and Substance Abuse Services 
Local police and sheriff’s departments 
North Dakota	 	 Department of Human Services, Division of State and local law enforcement agencies 
Mental Health and Substance Abuse Services are responsible for enforcing state and 
local laws prohibiting tobacco sales to 
minors. The Department of Human 
Services, Division of Mental Health and 
Substance Abuse Services, is responsible 
for conducting compliance surveys. 
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Table 5.4. Continued 
State/Territory Lead agency Enforcement agency 
Ohio Department of Alcohol and Drug Addiction Department of Alcohol and Drug 
Services Addiction Services 
Oklahoma Alcoholic Beverage Law Enforcement Alcoholic Beverage Law Enforcement 
Commission Commission 
Oregon Department of Human Resources, Office of Oregon State Police 
Alcohol and Drug Abuse Programs 
Pennsylvania Department of Health, Office of Alcohol Department of Health, Office of Alcohol 
and Drug Abuse Programs and Drug Abuse Programs 
Rhode Island Department of Health, Division of Substance Department of Health, Division of 
Abuse Substance Abuse (The Division of 
Substance Abuse transferred from the 
Rhode Island Department of Health to the 
Department of Mental Health, Retardation, 
and Hospitals on September 1, 1998.) 
South Carolina Department of Alcohol and Other Drug Department of Revenue and Taxation 
Abuse Services 
South Dakota Department of Human Services, Division of Division of Alcohol and Drug Abuse 
Alcohol and Drug Abuse coordinates enforcement with the Attorney 
General’s Office and 66 county state’s 
attorneys 
Tennessee Department of Agriculture Department of Agriculture 
Texas Commission on Alcohol and Drug Abuse State Comptroller 
and Department of Health 
Utah Department of Human Services, Division of Department of Human Services, Division 
Substance Abuse of Substance Abuse 
Vermont Department of Liquor Control Enforcement and Licensing Division of the 
Department of Liquor Control 
Virginia Department of Agriculture and Consumer Alcohol Beverage Control Board 
Services 
Washington Department of Social and Health Services, Liquor Control Board 
Division of Alcohol and Substance Abuse 
West Virginia Department of Health and Human Resources, Alcohol Beverage Administration 
Division of Alcoholism and Drug Abuse 
Wisconsin Department of Health and Family Services, Department of Health and Family Services, 
Bureau of Substance Abuse Services Bureau of Substance Abuse Services 
Wyoming Department of Health, Division of Behavioral Local law enforcement agencies 
Health and Substance Abuse Program 
American Samoa Department of Human and Social Services, Department of Public Health 
Social Services Division 
Guam Department of Mental Health and Substance Department of Mental Health and 
Abuse Substance Abuse 
Marshall Islands Office of the Attorney General Chief Prosecutor of the Office of the Police 
Commissioner 
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Table 5.4. Continued
Reducing Tobacco Use 
  
State/Territory Lead agency Enforcement agency 
Micronesia Department of Health No single agency; enforcement by local 
police and health departments 
Northern Marianas Department of Public Health Department of Public Health 
Palau Ministry of Justice, Bureau of Public Safety Bureau of Public Safety 
with Ministry of Commerce and Trade 
(responsible for licensing) 
Puerto Rico Department of Health, Mental Health and Department of Treasury 
Anti-Addiction Services Administration 
Virgin Islands Department of Health, Division of Mental Department of Licensing and Consumer 
Health, Alcoholism and Drug Dependency Affairs 
Services 
laws, such as the costs of making tobacco inaccessible 
to minors or of having merchants monitor their own 
staff (DiFranza 1994c; DiFranza and Godshall 1994). 
Despite, or in some cases in response to, these indus­
try efforts, many states have successfully strengthened 
their youth access laws and/or removed industry-
inspired loopholes and provisions for affirmative de­
fense. Six states amended state law to permit minors 
to participate in compliance checks conducted for en­
forcement purposes. Twenty-three states now have 
this provision in their minors’ access law. Two states 
passed legislation that will provide a more accurate list 
of tobacco retailers for compliance checks and three 
states added provisions that address funding for en­
forcement and education programs (USDHHS, in press). 
The reports from both the IOM (Lynch and 
Bonnie 1994) and the Working Group of State Attor­
neys General (1994) include strong recommendations 
that active enforcement of minors’ access laws be 
implemented, that merchants be held responsible for 
sales in their stores, and that access laws supported 
by the tobacco industry be rejected. 
Using another type of enforcement, some private 
groups and states have conducted lawsuits against 
commercial outlets that violate minors’ access laws. 
A selection of these cases, one of which also named a 
tobacco company as a codefendant, is discussed in 
“Enhancing Prohibitory Regulation by Private Litiga­
tion,” later in this chapter. 
Traditional law enforcement agencies often re­
sist conducting tobacco enforcement for a number of 
reasons. They believe that tobacco enforcement diverts 
limited resources from other more pressing crime and 
that the public does not support the use of officers for 
such enforcement. They have also argued that the ill-
feeling of members of the business community gener­
ated by the issuance of citations negatively affects other 
enforcement efforts. Finally, the officers themselves 
frequently resist because they do not want to facilitate 
potential job loss for a clerk for what they perceive to 
be a “minor” infraction or because they believe that 
prosecutors and judges will be reluctant to penalize 
(USDHHS 1999). 
Other agencies can be a suitable alternative for 
the conduct of enforcement. Chief among them are 
public health departments, which recognize the im­
portance of conducting enforcement, and alcohol bev­
erage control agencies (ABCs), which are highly 
experienced in conducting undercover compliance 
checks. ABCs retain a staff of inspectors that are fa­
miliar with the protocols that may be employed dur­
ing retail inspections (i.e., consummated and 
unconsummated buys). ABCs also tend to recognize 
a connection between alcohol and tobacco enforcement 
and accept the importance of conducting tobacco in­
spection for practical reasons if not for health reasons. 
This, in turn, results in less of a philosophical resis­
tance to actually issuing citations for violations. Fi­
nally, because ABC authorities regularly engage in 
enforcement directed at retailers, tobacco enforcement 
conducted by this agency will not likely generate 
as negative a backlash from retailers and the general 
public as enforcement conducted by traditional law 
enforcement (USDHHS 1999). 
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State Settlements 
All four states that settled their lawsuits against 
the tobacco industry in 1997–1998 won youth access re­
strictions in their settlement agreements.  (The events 
leading up to these four settlements, along with their 
implications as a litigational tool for reducing tobacco 
use nationwide, are discussed in “Recovery Claims by 
Third-Party Health Care Payers,” later in this chapter.) 
For example, the tobacco industry defendants in the state 
of Florida case agreed to support new state laws or regu­
lations to prohibit the sale of cigarettes in vending 
machines, except in adult-only locations or facilities 
(Florida v. American Tobacco Co., Civil Action No. 95-1466 
AH, sec. II.A.2 [Fla., Palm Beach Cty. Aug. 25, 1997]). 
The industry also agreed to support new state laws in 
Florida to increase civil penalties for sales of tobacco 
products to minors (including retail license suspension 
or revocation) and to strengthen civil penalties for the 
possession of tobacco by minors. The Florida settlement 
(sec. II.B) further requires the tobacco industry to pay 
$200 million for a two-year pilot program to reduce to­
bacco use by minors, including enforcement, media, 
educational, and other youth-directed programs.  Youth 
access provisions of the Texas settlement that pertain to 
new state laws mirror the terms of the Florida agree­
ment (Texas v. American Tobacco Co., No. 5-96CV-91 [E.D. 
Tex. Jan. 16, 1998], secs. 7[a–c]). 
The state of Minnesota won the most compre­
hensive array of public health and youth access restric­
tions to date when it settled its case after a highly 
publicized trial in 1998 (Minnesota v. Philip Morris Inc., 
cited in 13.2 TPLR 3.39). One provision of the Minne­
sota settlement forbids tobacco manufacturers from di­
rectly or indirectly opposing state statutes or 
regulations intended to reduce tobacco use by minors. 
A list of legislative proposals covered by the prohibi­
tion is attached to the settlement agreement (Schedule 
B) and includes the following measures: 
•	 	Expansion of self-service restrictions and removal 
of the current exception for cigars. 
•	 	 Amendment of the current law for restricting youth 
access to vending machines to clarify that machines 
with automatic locks and machines that use tokens 
are covered. 
•	 	“Enhanced or coordinated funding” for enforce­
ment efforts under sales-to-minors provisions of the 
criminal code or the statute and ordinances involv­
ing youth access. 
•	 	 Laws to “encourage or support the use of technol­
ogy to increase the effectiveness of age-of-purchase 
laws” (e.g., programmable scanners or scanners to 
read drivers’ licenses). 
•	 	 Restrictions on wearing, carrying, or displaying to­
bacco indicia in school-related settings. 
•	 	 Establishment or enhancement of nonmonetary in­
centives for youth not to smoke (e.g., expand com­
munity services programs for youth). 
Moreover, prohibiting tobacco companies from 
challenging the enforceability or constitutionality of 
current Minnesota laws encompasses some key youth 
access statutes, such as those pertaining to the sale of 
tobacco to minors (Minnesota Statutes sec. 609.685) and 
the distribution of samples (Minnesota Statutes sec. 
325.77) (Minnesota v. Philip Morris Inc., cited in 13.2 TPLR 
3.39, sec. IV.A.2).  Another injunctive provision, forbid­
ding the tobacco industry from targeting children 
through advertising, promotion, or marketing, also 
prohibits the industry from “taking any action the pri­
mary purpose of which is to initiate, maintain or in­
crease the incidence of underage smoking in 
Minnesota” (Minnesota v. Philip Morris Inc., No. C1-94­
8565 [Minn., Ramsey Cty. May 8, 1998], cited in 13.2 
TPLR 2.112, 2.113 [1998]). 
The Minnesota settlement also includes a large 
industry-funded program to reduce teen smoking.  The 
program includes counteradvertising, classroom edu­
cation, community partnerships, research, advocacy, 
and prevention components (Minnesota v. Philip Mor­
ris Inc., cited in 13.2 TPLR 3.39, sec. VIII.A.2). 
Although Mississippi (the first state to settle) did 
not initially secure public health restrictions, it later 
imported some of those contained in the sweeping 
Minnesota settlement by exercising the “most favored 
nation” clause (discussed in “Recovery Claims by 
Third-Party Health Care Payers,” later in this chapter) 
in its original settlement agreement (PR Newswire 
1998a). Intended to ensure that Mississippi would re­
ceive the benefits any later similar settlement might 
receive, the most favored nation clause also enabled 
the state to substantially increase the dollar amount of 
its settlement with the industry.  Furthermore, although 
the revised agreement prohibits Mississippi from gain­
ing any additional monetary benefit based on future 
state settlements, it does not limit the incorporation of 
additional public health provisions or financial adjust­
ments in the event that Congress adopts national to­
bacco legislation. 
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Preemption of Local Action by State Policy 
As noted earlier in this section (see “Efforts to 
Promote Adoption and Enforcement of Minors’ Access 
Laws”), the initiative to address minors’ access, as well 
as many creative solutions, has come from the local 
level. In state legislatures, the balance of power be­
tween forces for and against reducing tobacco use is 
most often tipped in favor of tobacco use. The reverse 
is often true at the local level, where jurisdictions have 
enacted innovative approaches that have been evalu­
ated by researchers.  At the state level, however, to­
bacco industry representatives have sought to preclude 
legislative or enforcement authority at the local level 
by including preemption language, usually attached 
to weak statewide restrictions. 
As of 1998, 30 states had preemptive tobacco con­
trol laws, although they vary widely in the kind of re­
strictions they preempt (CDC 1999).  No preemptive 
tobacco control laws have been enacted since July 1996. 
The tobacco industry has adopted preemption as a 
main strategy to undermine, overturn, and prohibit 
future efforts to adopt local policies to reduce tobacco 
use (Siegel et al. 1997; Gorovitz et al. 1998).  For in­
stance, in 1991 and 1992, the tobacco industry spent 
more than $2 million to lobby for the repeal of local 
clean indoor air ordinances (Traynor et al. 1993).  In 
California in one year alone, the industry spent $18.9 
million on an initiative to repeal all local ordinances 
for reducing tobacco use and to eliminate local author­
ity to enact new ordinances (Siegel et al. 1997). 
A memorandum of the 1991 Smokeless Tobacco 
Council described a strategy to oppose local ordinances 
Litigation Approaches 
Reducing Tobacco Use
 
and advance statewide antitobacco bills containing 
preemption clauses (Siegel et al. 1997).  In addition, 
the Tobacco Institute stated that a priority for 1993 was 
to “encourage and support statewide legislation pre­
empting local laws, including smoking, advertising, 
sales, and vending restrictions” (Tobacco Institute 
1992). This strategy would work against the passage 
of strong tobacco control laws at the local level and 
would relieve logistical difficulties of the tobacco in­
dustry in devoting resources toward multiple local 
jurisdictions (Siegel et al. 1997; Gorovitz et al. 1998). 
Even when a preemption clause is not specifi­
cally included, tobacco industry representatives have 
argued that state laws that address minors’ access are 
intended to preempt local action, and that argument 
has been used by at least one court to invalidate more 
restrictive local ordinances (DiFranza 1993).  Both the 
IOM (Lynch and Bonnie 1994) and the Working Group 
of State Attorneys General (1994) recommend that state 
laws include language specifically stating that they are 
not meant to preempt stronger local ordinances. 
One of the U.S. health objectives for 2000 was to 
reduce to zero the number of states with preemptive 
smoke-free indoor air laws (Objective 3.25) (National 
Center for Health Statistics 1997); an objective proposed 
for 2010 is to reduce the number of states with any pre­
emptive tobacco control laws to zero (USDHHS 2000a). 
Most states have preemptive tobacco control laws, and 
19 have preemptive provisions for minors’ access laws. 
Thus, achievement of the 2000 objective is unlikely (CDC 
1999). 
Introduction 
Society deploys various regulatory controls to 
confront risks arising from dangerous products or 
practices. As has been discussed in previous sections 
in this chapter, these controls include those intrinsic 
to the practice itself, such as preventive design and 
safety procedures built into a product or into the tech­
nology of its use, as well as external regulation by gov­
ernment agencies and private parties, such as property 
owners, employers, or insurers.  Certain institutions 
also absorb and spread losses when a practice does 
result in injuries, such as relief institutions that assist 
victims and social and private insurance that compen­
sates the injured. Another regulatory control, intro­
duced here, is private law (referred to generally in this 
section as litigation and held distinct from the more 
sweeping legislative scope of public law). In the course 
of vindicating the claims of injured persons, private 
law generates, broadcasts, and reinforces safety 
standards.  The various controls are not independent 
but interact in complex ways. For example, preven­
tive design may stem from the imposition or anticipa­
tion either of government regulation or of liability 
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established through private law; similarly, employers 
or insurers may institute preventive regulations to limit 
the cost of remedial measures resulting from private 
law decisions. 
Private Law as a Means of Risk Control 
Private law remedies combine existing public 
standards with a public institution—the courts—that 
is passive in accepting these standards but is also, ac­
cordingly, reactive when the standards change.  In pri­
vate law, the initiative to enforce a change or decision 
is shifted away from an enterprise or a government to 
private actors—typically, victims or their surrogates. 
This diffusion of the enforcement initiative is matched 
by the decentralized pronouncement of liability stan­
dards, which are less often established at a given mo­
ment than they are formulated over time, largely by 
courts responding incrementally to specific cases 
brought before them.  Private law standards are con­
text sensitive, incorporating changing popular values 
and understandings. In the United States, this incor­
poration of popular views is accelerated by the use of 
civil juries. 
Tort as a Private Law Control 
In the tort system, which applies to actionable 
wrongful acts other than breach of contract (tort is a 
Middle English word meaning “injury”), information 
about instances in which injurers (and their insurers) 
are forced to compensate victims coalesces slowly into 
a body of knowledge that, acknowledged by other 
potential injurers, generates various preventive effects 
(Calabresi 1970).  However, because each instance of 
remedy involves individualized determination of li­
ability and damages, the production of these preven­
tive effects by the tort system is highly inefficient.  The 
process is also very expensive, because a large portion 
of the money that the tort system extracts from injur­
ers is consumed by the tort process itself (Kakalik and 
Pace 1986). Nonetheless, although relatively inefficient 
for compensating specific classes of injuries, the tort 
system effectively generates overall preventive effects 
and is flexible and adaptive (American Law Institute 
1991; Galanter 1994). 
U.S. Reliance on Private Law Controls 
Societies differ in the way they deploy this alter­
native set of controls.  The United States has tended to 
rely more heavily on private law controls than do other 
industrialized countries (Kagan 1991; Galanter 1994). 
The expansive U.S. system of private remedy is con­
joined with a lesser emphasis on administrative controls 
and social insurance (Pfennigstorf and Gifford 1991). 
Where excessive risks are associated with a prod­
uct or practice, the U.S. tort system typically acts to 
shift part of the cost of these risks back to the produc­
ers and users. Such litigation campaigns follow a fa­
miliar course toward preventing particular risks:  after 
a period of innovation and experimentation, a few 
successful lawsuits provide a model and incentive for 
other lawyers and plaintiffs; the threat of a mounting 
tide of litigation (and occasionally an actual tide) leads 
to a flow of compensation, modifications in the use or 
design of the product, and occasionally bankruptcy of 
the defendant; and eventually the litigation abates as 
product modifications break the link to risk (McGovern 
1986; Galanter 1990; Sanders 1992; Hensler and 
Peterson 1993; Durkin and Felstiner 1994; Schmit 1994). 
Potential Public Health Benefits of Tobacco 
Litigation 
As applied to lawsuits against the tobacco indus­
try, private litigation has the potential to do the 
following: 
•	 	Enlist a new cadre of skilled, resourceful, and re­
lentless advocates on the side of reducing tobacco 
use—the incentive being the contingency fees 
plaintiffs’ attorneys would receive if they won or 
settled cases against the industry. 
•	 	Force the industry to raise prices dramatically to 
cover their actual or anticipated liabilities. Studies 
suggest that such higher costs would lower tobacco 
consumption—especially among children and 
teenagers, who are more price-sensitive than adults 
(Daynard 1988; Hanson and Logue 1998).  For ex­
ample, after Philip Morris raised its wholesale ciga­
rette prices by 10 percent in one year to cover legal 
settlements with four states, a Wall Street stock ana­
lyst estimated that these increases reduced overall 
consumption of [Philip Morris] cigarettes by nearly 
3 percent (Hwang 1998). 
•	 Encourage the manufacture of safer (to the 
extent possible) products, which have lower liabil­
ity risks. For instance, a noncarcinogenic nicotine 
delivery device, though retaining the health risks 
of nicotine, could create less liability both to indi­
vidual users and to third-party health care payers. 
•	 	Discontinue dishonest practices that increase the 
risk of liability, especially for punitive damages. 
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Deterring such “intentional torts” is a main goal of 
the civil justice system. 
•	 	Delegitimize the industry politically by exposing 
patterns of unsavory practices. For example, many 
politicians discontinued taking tobacco company 
contributions in the late 1990s, largely because the 
discovery process in pending lawsuits revealed in­
dustry misconduct (Abramson 1998). Loss of po­
litical esteem or loyalty would ease the way for 
effective tobacco control legislation. 
•	 	Educate the public about the risks of tobacco use, 
since lawsuits attract extensive, free media coverage. 
•	 	Compensate injured parties, including smokers, 
afflicted nonsmokers, their families, and the health 
care compensation system (Daynard 1988). 
The First Two Waves of Tobacco Litigation 
Starting in the 1950s, injured smokers tried to use 
the emergence of product liability to secure remedies 
from the tobacco companies.  During the first two 
waves of tobacco litigation, hundreds of lawsuits were 
filed against U.S. tobacco companies by individuals 
claiming tobacco-related injuries to health.  (By one 
count, 808 cases were filed between 1954 and 1984 
[Bernstein Research 1994].)  Not one of the claims re­
sulted in any plaintiff, or plaintiff’s attorney, receiv­
ing any financial compensation. 
The First Wave 
The first wave of tobacco litigation was launched 
in 1954, inspired by the appearance in the early 1950s 
of scientific reports and popular magazine articles that 
indicated that smoking caused lung cancer.  Although 
convinced that this new information would weigh in 
as evidence of culpability, the plaintiffs’ attorneys were 
overmatched. The tobacco companies presented a con­
certed defense in every claim, no matter how small 
the damages sought, and through all stages of litiga­
tion. From the earliest cases, the tobacco companies 
retained lawyers from the country’s most prestigious 
law firms and directed them to spare no expense in 
exhausting their adversaries’ resources before trial 
(Rabin 1993). Plaintiffs’ attorneys, typically operating 
from small practices under a contingent fee arrange­
ment with clients who could not afford protracted liti­
gation, found themselves both outnumbered and 
outspent on all fronts. 
Only a handful of the first-wave tobacco cases 
ever came to trial. Those that did found the courts 
unwilling to impose strict liability on the tobacco in­
dustry.  Plaintiffs typically brought suit against tobacco 
companies under one or both of two theories: negli­
gence and implied warranty.  Under a theory of negli­
gence, plaintiffs tried to show that the tobacco 
companies knew enough about the potential harm of 
tobacco products to induce them to “engage in [fur­
ther] research . . . adopt warnings, or, at a minimum, 
refrain from advertising that suggested the absence of 
any health concerns” (Rabin 1993, p. 114).  However, 
because plaintiffs’ attorneys could offer no evidence 
at that time that the tobacco industry was aware of the 
potential harm of their products, this negligence theory 
met with failure. 
Most plaintiffs’ cases relied on the theory of im­
plied warranty, which imputes strict liability even in 
the absence of negligence. The mere marketing of a 
product that was not of merchantable quality or rea­
sonably fit for use would thus support legal recovery 
of damages (Rabin 1993). The plaintiff’s ability to rely 
on negligence or implied or express warranty was 
greatly constrained by two circumstances:  since 1965, 
health warnings had been mandated on tobacco prod­
ucts and on some advertising (see “Cigarette Warning 
Labels,” earlier in this chapter), and the tobacco in­
dustry had avoided making direct claims that their 
products had positive health effects.  Since early 1966, 
then, smokers could no longer argue (or at least not 
easily) that the tobacco companies had not warned 
them of the hazards posed in using their products 
(Schwartz 1993). The doctrine of implied warranty, in 
particular, thus seemed invalid to plaintiffs who were 
seeking damages from the tobacco industry. 
In general, the courts of that time were unrecep­
tive to strict liability arguments.  The courts regarded 
the manufacturer as “an insurer against foreseeable 
risks—but not against unknowable risks” (Lartigue v. 
R.J. Reynolds Tobacco Co., 317 F.2d 19, 37 [5th Cir. 1963], 
cert. denied, 375 U.S. 865 [1963]) or against “the harm­
ful effects of which no developed human skill or fore­
sight can afford” (p. 23).  The American Law Institute, 
a prestigious and influential association of lawyers, 
judges, and academics, adopted this outlook in its 1973 
commentary on section 402A of the Restatement (Sec­
ond) of Torts, which deals with strict liability for de­
fective products.  The nonbinding yet authoritative 
influence of the restatement sounded “the death knell 
for the first wave of tobacco litigation” (Rabin 1993, p. 
117; Givelber 1998). 
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The Second Wave 
A second wave of tobacco litigation began in 
1983, inspired by the success that lawyers had recently 
achieved in suing asbestos companies: they had not 
only recovered substantial verdicts (and fees) but also 
effectively ended the production and use of asbestos 
in the United States. 
As was the case with the first wave of tobacco 
litigation, in the second wave the “lawyers’ litigation 
strategies rather than their legal arguments . . . consti­
tuted the first line of defense” (Rabin 1993, p. 121). The 
tobacco industry continued to successfully pursue the 
strategy it had developed during the first wave, tak­
ing countless depositions and filing and arguing ev­
ery motion it could, thus threatening to inflict heavy 
financial losses on any plaintiff’s attorney (Daynard 
1994a,b). This strategy was summarized by J. Michael 
Jordan, an attorney who successfully defended R.J. 
Reynolds Tobacco Company in the 1980s, in an inter­
nal memo to his colleagues: “[T]he aggressive pos­
ture we have taken regarding depositions and 
discovery in general continues to make these cases ex­
tremely burdensome and expensive for plaintiffs’ law­
yers. . . . To paraphrase General Patton, the way we 
won these cases was not by spending all of [RJR]’s 
money, but by making that other son of a bitch spend 
all of his” (Haines v. Liggett Group, Inc., 814 F. Supp. 
414, 421 [D.N.J. 1993]). 
To try to overcome the disparity of legal resources 
that had overwhelmed the first-wave cases, plaintiffs’ 
attorneys sometimes pooled resources on a case-by­
case basis. The Tobacco Products Liability Project, a 
nonprofit advocacy group established at Northeastern 
University in 1984 to encourage lawsuits against the 
tobacco industry as a public health strategy, served as 
a clearinghouse of relevant information for attorneys, 
potential plaintiffs, medical experts, and the media.  It 
began holding annual conferences in 1985, at which 
participants share information about new legal tactics, 
as well as solve problems about emerging difficulties. 
Besides pooling resources and sharing strategies, 
plaintiffs’ attorneys needed to find an effective legal 
strategy.  To find a new theory, plaintiffs’ counsel 
shifted their focus from implied or express warranty 
to strict liability, which became a more attractive strat­
egy as courts applied strict liability and comparative 
fault principles to defective product cases concerning 
many other products (Edell 1987; Rabin 1993). Smok­
ers’ awareness of risks and, accordingly, their 
“freedom of choice” (Rabin 1993, p. 122) became the 
linchpins of the tobacco industry’s defense against 
these liability tactics. Though consistently denying the 
reality of the risks, the tobacco industry paradoxically 
argued (with great success) that smokers had freely cho­
sen to smoke and had thereby assumed what risks there 
might be of smoking and had negligently contributed 
to their own harm. To prove the plaintiff’s assumption 
of risk, counsel for the tobacco industry generally 
needed to show that the injured smoker, knowing the 
dangers and risks involved in smoking, chose to smoke 
anyway.  To prove contributory negligence, the tobacco 
defense typically showed that, by smoking, the injured 
smoker breached a personal duty to protect himself or 
herself from injury and thereby contributed to the harm 
suffered (Kelder and Daynard 1997). 
Just as it had aided the tobacco industry in ne­
gating charges of negligence and warranty during the 
first wave of tobacco litigation, the Federal Cigarette 
Labeling and Advertising Act’s imposition of a warn­
ing label on cigarette packaging and advertising 
greatly strengthened the industry’s countercharge that 
plaintiffs had legally assumed their own health risk 
and were guilty of contributory negligence.  As a re­
sult, jurors were responsive to the industry’s defense. 
In essence, jurors tended to blame plaintiffs for their 
disease instead of identifying the tobacco industry as 
the makers of the product that caused the disease 
(Daynard 1994a,b).  When counsel for plaintiffs pointed 
to the addictive nature of tobacco, which arguably lim­
ited the smoker’s ability to make a free choice, defense 
counsel rebutted by pointing to the large number of 
former smokers who successfully quit (Rabin 1993). 
Taking the freedom-of-choice defense one step 
further, defense counsel typically drew on, and pre­
sented to the jury, information demonstrating that the 
claimant’s lifestyle was overly risky by choice or was 
even in some way immoral. By presenting this some­
what extraneous material obtained through aggressive 
pretrial discovery, the defense “appear[ed] to have had 
considerable success in trying not just the plaintiff’s 
decision to smoke but his or her character more gen­
erally” (Rabin 1993, p. 124). The resulting “full-dress 
morality play” seemed to have effectively negated any 
jury sympathy for the plaintiff’s plight (p. 124). 
The case that culminated and best symbolized the 
uphill battle of second-wave plaintiffs was filed by Rose 
Cipollone, a dying smoker, in 1983.  The case reached 
the jury in 1988, four years after her death, and the jury 
awarded the plaintiffs $400,000.  But this verdict, 
subsequently overturned on appeal, was only one 
moment in a protracted legal battle. As one analyst 
describes, in Cipollone v. Liggett Group Inc., “. . . over 
100 motions were filed, and most of the motions were 
argued.  There were also four interlocutory applications, 
one resulting in the grant of an appeal and the Third 
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Circuit’s initial decision on preemption, . . . an appeal 
from the final judgment to the Court of Appeals fol­
lowing a trial of about four months, . . . and two peti­
tions for certiorari to the Supreme Court of the United 
States, one of which was granted resulting in the his­
toric argument before that Court” (Kelder 1994, p. 4). 
After nearly a decade, Cipollone, the quintessen­
tial second-wave case, was sent back to the trial court 
by the United States Supreme Court.  The Court ruled 
that although the Federal Cigarette Labeling and Ad­
vertising Act of 1965 did not invalidate any claims in 
private litigation, its successor, the Public Health Ciga­
rette Smoking Act of 1969, preempted any claims based 
on the manufacturers’ failure to warn after 1969 in its 
advertising and promotions (Cipollone v. Liggett Group 
Inc., 505 U.S. 504, 112 S. Ct. 2608 [1992]).  However, the 
Court left open to the plaintiff the option of proceed­
ing under a wide range of legal theories, including 
theories of breach of express warranty, defective de­
sign, fraudulent misrepresentation, and conspiracy to 
defraud. But the difficulties of mustering a sufficient 
showing that such violations by the defendants were 
the proximate cause of Mrs. Cipollone’s injuries (as 
well as the cause of her death in 1984) persuaded the 
plaintiff’s counsel that there was little likelihood of a 
significant recovery (Lowell 1992).  In 1992, five months 
after the Supreme Court ruling, the New Jersey fed­
eral district court approved the request of the Cipollone 
estate’s lawyer to withdraw from the case. 
It had been a lengthy, expensive effort for the 
plaintiff’s counsel:  $500,000 in out-of-pocket expenses 
and approximately $2 million in attorney and para­
legal time (Kelder 1994). Posttrial proceedings cost an 
additional $150,000 in out-of-pocket expenses and 
$900,000 in attorney and paralegal time. Time maga­
zine estimated that the cigarette industry spent at 
least $75 million defending the Cipollone case (Koepp 
1988). Michael Pertschuk, co-director of the Advocacy 
Institute, a public interest group dedicated to reduc­
ing tobacco use, has estimated that altogether tobacco 
companies were spending approximately $600 million 
per year defending the 50 or so cases pending against 
them (Stone 1994). Tobacco defendants’ reputation for 
relentless legal battle dissuaded many lawyers from 
entering the fray.  Even formidable litigants such as 
the asbestos producers refrained from trying to em­
broil the tobacco manufacturers as being jointly respon­
sible for asbestos injuries (Rabin 1993). 
The Aftermath of the First Two Waves 
The collapse of the Cipollone case was widely 
viewed as signaling the end of the second wave of 
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tobacco litigation. Commentators advanced various 
explanations for the failure of tobacco litigation, in­
cluding superior lawyering resources, coordination, 
and tactics (Rabin 1993), as well as popular resistance 
in the form of jury reluctance to award damages to 
smokers (Schwartz 1993). Many observers concluded 
that product liability litigation had a limited role to 
play in the regulation of tobacco.  Rabin (1993) found 
that tobacco presents an instance of “the effective lim­
its of tort law,” because “tort law and tort process seem 
to conspire against any effective role for the tobacco 
litigant” (p. 127).  Schwartz (1993) concurred “that tort 
law does not have a major role to play in the develop­
ment of public policy for smoking in the 1990s” (p. 132). 
At that juncture, tobacco litigation seemed to il­
lustrate that the incidence and outcome of litigation 
are influenced by the identity, resources, and status of 
the parties and by the incentives and strategies of their 
lawyers. Striking differences have been noted between 
the large organization with a continuing interest in an 
area of legal controversy and the individual litigant 
who typically seeks a remedy only once (Galanter 
1974). One-time litigants tend to be represented by 
lawyers who practice in smaller units that have less 
capacity for coordination and less capacity to invest 
strategically in litigation. The monetary stakes—and 
thus the incentives—are also lower for these smaller 
litigants than for their corporate opponents, who can 
extract full benefit from the information and experi­
ence generated by litigation expenditures (Galanter 
1974; Schwartz 1993). 
Nonetheless, at the end of the second wave of to­
bacco litigation, it was argued that the tobacco indus­
try was not untouchable and that its proud record of 
never, at that point, having paid a penny to its victims 
masked a high vulnerability to litigation (Daynard 1988, 
1993a,b, 1994a,b; Daynard and Morin 1988).  The 
industry’s “scorched earth” litigation tactics (Daynard 
1994a) had indeed made suing tobacco companies pro­
hibitively expensive for most plaintiffs and their attor­
neys. Also, the industry’s firm and widely publicized 
policy of never settling cases further discouraged liti­
gation, because plaintiffs’ attorneys, working on con­
tingency fees, realized that they could not expect to be 
paid unless and until they had succeeded at trial and 
on subsequent appeals. Furthermore, the low volume 
of cases in the first and second waves allowed the in­
dustry to concentrate its legal resources against the few 
plaintiffs’ attorneys who ventured forth against it. 
But a very different scenario was also possible. 
Although the low-volume litigation environment of 
the first and second waves favored the defendants, a 
high-volume environment might favor plaintiffs.  As 
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happened with asbestos litigation, courts facing the 
problem of clearing large numbers of tobacco cases off 
their dockets would need to find ways to expedite 
them. Firm trial deadlines, case consolidations, and 
class actions would likely be favored; scorched earth 
defense tactics would no longer be permitted. Defen­
dants would no longer be able to focus all their atten­
tion and legal resources on defeating a few plaintiffs. 
Some cases thus might break through the industry’s 
defenses, and these victories would provide both prac­
tical examples and moral support for plaintiffs’ attor­
neys. At some point, the defendants might realize that 
their nonsettlement policy had ceased to discourage 
plaintiffs and would begin settling. At that point, the 
third wave of tobacco litigation—virtually a tidal 
wave—would have begun (Daynard 1994a). 
Given a pre-1994 legal environment characterized 
by a low volume of tobacco litigation, few lawyers 
could afford to ignore the highly unfavorable cost/ 
benefit ratio that would likely meet any effort to bring 
a lawsuit against the tobacco industry.  No single law­
yer, however motivated, could hope to change this situ­
ation through his or her own efforts.  The transition 
from the low-volume to the high-volume scenario 
would require public events that signaled clearly to 
lawyers that the environment was changing (Daynard 
1994a). 
Paradoxically, although the Cipollone case was 
widely viewed as emblematic of why plaintiffs’ attor­
neys were well advised to avoid tobacco litigation, it 
was also a crucial forerunner for the events that would 
soon change the litigation environment.  Specifically, 
the Supreme Court’s 1992 decision in the case— 
though of no avail to the resource-depleted plaintiffs’ 
attorneys—presented other plaintiffs’ attorneys with 
a range of potentially devastating legal theories. The 
trial itself had provided documentary evidence— 
which, as it turned out, represented the tip of the 
iceberg—that could be used to help establish the ele­
ments of a plaintiff’s claims against the cigarette manu­
facturers (Daynard and Morin 1988; Daynard 1993a,b). 
spiracy based on evidence that cigarette manufactur­
ers had joined together beginning in the 1950s to plan 
and carry out a strategy for marketing cigarettes while 
concealing the harmful and addictive nature of this 
product in the face of the developing scientific evidence 
of their dangers; and (5) a “Good Samaritan” theory, 
whereby plaintiffs could argue that the tobacco com­
panies, having pledged in 1954 to objectively investi­
gate the possible dangers of smoking, were obliged to 
carry out their promise and take reasonable action on 
what they found (Daynard 1988). 
Among the legal theories advanced in the first 
two waves that remained viable after Cipollone were 
(1) a theory that cigarettes were defective and unnec­
essarily dangerous, because evidence discovered by 
plaintiffs’ attorneys and antismoking activists strongly 
suggested that the tobacco industry had known for 
many years how to make cigarettes that were less likely 
to cause cancer; (2) a theory that cigarettes were 
defective, because they contained tobacco adulterated 
with many nontobacco carcinogenic substances; (3) a 
theory that cigarettes were defective, because of the 
dangers inherent to tobacco; (4) a theory of civil con­
Potential support for some or all of these ap­
proaches had surfaced during the tortuous process of 
the Cipollone case. Documents uncovered in the case 
provided evidence that the tobacco industry had 
fraudulently misrepresented the safety of their prod­
uct and deliberately concealed knowledge about the 
harmful and addictive nature of cigarettes.  The evi­
dence suggested that the tobacco industry had con­
spired to defraud the American public by pretending 
that it was conducting good-faith efforts to uncover 
the links between smoking and health and by falsely 
assuring the public that the results were negative or 
inconclusive (Daynard and Morin 1988).  Some ana­
lysts predicted that future fraud and conspiracy claims 
would be strengthened when the court documents 
from Haines were released to plaintiffs’ attorneys or 
when other documentary evidence of tobacco indus­
try misdeeds was uncovered (Daynard 1993a,b).  In 
the additional trove of documents reviewed by Judge 
H. Lee Sarokin in Haines—many of them relating to 
the Council for Tobacco Research’s “special projects” 
division—was information that might support a find­
ing that “the industry research which might indict 
smoking as a cause of illness was diverted to secret 
research projects and that the publicized efforts were 
primarily directed at finding causes other than smok­
ing for the illnesses being attributed to it” (Haines v. 
Liggett Group, Inc., Civil No. 84-678 [HLS] [D.N.J. 1992], 
cited in 7.1 TPLR 2.1 [1992]). Calling the tobacco in­
dustry “the king of concealment and disinformation” 
(Haines v. Liggett Group Inc., 975 F.2d 81, 88 [3d Cir. 
1992])—a remark that led an appellate court to dis­
qualify Judge Sarokin from further consideration of 
the case on the grounds that he failed to appear im­
partial (p. 98)—Judge Sarokin concluded that the docu­
ments he had reviewed were not protected by 
the attorney-client privilege, as the industry had 
claimed, because the industry’s attorneys had been 
participating in an ongoing fraud, and the documents 
were therefore discoverable under the well-recognized 
crime/fraud exception (Haines, cited in 7.1 TPLR 2.1). 
The same court that disqualified Judge Sarokin from 
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further consideration of the case also agreed that the 
evidence cited by him would support his conclusion 
that the crime/fraud exception would apply (Haines, 
975 F.2d 81). 
The Third Wave of Tobacco Litigation 
The third wave of tobacco litigation was sparked 
by two key events. On February 25, 1994, FDA Com­
missioner David Kessler, relying primarily on a docu­
ment discovered in the Cipollone case, sent a letter to 
the CSH reporting that the FDA had received “mount­
ing evidence” that “the nicotine ingredient in cigarettes 
is a powerfully addictive agent” and that “cigarette 
vendors control the levels of nicotine that satisfy this 
addiction” (Kessler 1994a). The letter made front-page 
news. The second event occurred three days later, 
when an ABC television Day One report alleged that 
tobacco companies manipulated the nicotine levels in 
cigarettes (Daynard 1994b). 
A series of journalistic and congressional inves­
tigations ensued in the spring of 1994, and internal 
Brown & Williamson Tobacco Corporation documents 
were leaked to the press.  These documents indicated 
that the company had studied nicotine for years, that 
its internal stance on several issues related to smoking 
and health differed from what it was telling the 
public, that it possessed findings regarding the 
addictiveness of nicotine and the health dangers of 
smoking and ETS that had been withheld, and that 
Brown & Williamson attorneys were involved in the 
management of the research projects (Hanauer et al. 
1995). When on April 14, 1994, the chief executive 
officers of the seven leading U.S. tobacco comp­
anies testified under oath before a congressional 
subcommittee—and a large television news audience— 
that they did not believe that nicotine was addictive, 
the industry’s public credibility plummeted.  Suddenly 
the industry appeared to millions of people, includ­
ing plaintiffs’ attorneys, as dishonest, disreputable, and 
legally vulnerable (Daynard 1994a; Seattle Post-
Intelligencer 1994; see “Nature, Extent, and Focus of the 
Criminal Investigation,” later in this chapter). 
Further revelations about the tobacco industry’s 
knowledge of the harmfulness of smoking and the 
addictiveness of nicotine, as well as about the 
industry’s misbehavior, subsequently surfaced in sev­
eral forms: 
•	 Philip Morris documents indicated that the 
company’s researchers studied and wrote about the 
pharmacologic effects of nicotine on smokers (Hilts 
and Collins 1995). 
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•	 	Documents obtained from Brown & Williamson 
and its parent, British-American Tobacco Company, 
were analyzed (Hanauer et al. 1995). 
•	 	 Investigative journalists obtained documents from 
R.J. Reynolds Tobacco Company (Levy 1995). 
•	 	In November 1995, Dr. Jeffrey Wigand, Brown & 
Williamson’s former vice president for research, tes­
tified under deposition (Tobacco Products Litigation 
Reporter 1995c). 
•	 	Sworn statements were given to the FDA (first 
made public on March 18, 1996) in which three 
former Philip Morris employees (Ian L. Uydess, 
Ph.D., a former associate senior scientist; Jerome 
Rivers, a shift manager at a cigarette manufactur­
ing plant in Richmond, Virginia; and William A. 
Farone, Ph.D., the director of applied research at 
Philip Morris’ tobacco unit) stated that Philip Mor­
ris not only believes it is in the nicotine delivery 
business but also controls nicotine levels in its 
brands (Tobacco Products Litigation Reporter 
1996a,b,c). 
•	 	The FDA analyzed both the public evidence and 
the additional evidence that its investigators gath­
ered about the tobacco industry’s past and present 
knowledge of, and behavior toward, the addictive 
quality of the nicotine in its products (Federal Reg­
ister 1995b). 
•	 	 On March 20, 1997, Liggett Group Inc., the smallest 
domestic cigarette manufacturer, admitted that nico­
tine was addictive and that the industry had tar­
geted minors. Liggett turned over incriminating 
industry documents to the attorneys general and 
class action attorneys whose cases the company had 
agreed to settle (Attorneys General Settlement Agree­
ment, cited in 12.1 TPLR 3.1 [1997]). 
•	 	 Beginning in 1997, first hundreds, then thousands, 
and finally millions of industry documents began to 
surface after being uncovered through the discovery 
process in litigation by the Minnesota attorney gen­
eral and Blue Cross and Blue Shield. These docu­
ments began appearing on Internet Web sites of the 
Commerce Committee of the U.S. House of Repre­
sentatives (http://www.house.gov/commerce), 
Minnesota Blue Cross and Blue Shield (http:// 
www.mnbluecrosstobacco.com), and the Minnesota 
District Court (http://www.courts.state.mn.us/ 
district). The analysis of these documents has only 
begun, but they appear to support a wide range of 
legal claims against the industry. 
   
Surgeon General's Report
 
This third wave of tobacco litigation is more di­
verse than its predecessors, in part because of the new 
wealth of factual information available to plaintiffs’ 
attorneys. The series of revelations described above 
has generated a new set of allegations. For example, 
the industry has consistently claimed that nicotine is 
not pharmacologically active, that it is not addictive, 
and that anyone who smokes makes a free choice to 
do so. But as was made clear by the FDA’s 1995 State­
ment of Jurisdiction over cigarettes as drug-delivery 
devices; the documents of Philip Morris Companies 
Inc., Brown & Williamson–British-American Tobacco 
Company, and R.J. Reynolds Tobacco Company relat­
ing to nicotine; and the information being provided 
by whistle-blowers such as Jeffrey Wigand and Ian 
Uydess, the industry was well aware of the pharma­
cologically active, addictive, and harmful nature of its 
products and was not forthright with its customers, 
the public, and public authorities about these facts. 
There is also evidence that the industry understood 
its consumers’ need for adequate nicotine to sustain 
their addictions and that the industry designed its 
products accordingly. 
The tobacco industry also has claimed that 
there is no definitive proof that smoking causes dis­
eases such as cancer and heart disease. Yet the discov­
ered company documents show that by the 1960s 
various tobacco companies had proved in their own 
laboratories that cigarette tar causes cancer in labora­
tory animals (Daynard and Morin 1988; Hanauer et 
al. 1995). Finally, the industry has claimed that it is 
committed to determining the scientific truth about the 
health effects of tobacco by conducting internal inves­
tigations and by funding external research.  However, 
the Brown & Williamson–British-American Tobacco 
Company documents indicate that rather than con­
ducting objective scientific research, Brown & 
Williamson attorneys have been involved in selecting 
and disseminating information from internal as well 
as external scientific projects for decades.  An example 
of the latter is the industry’s misrepresenting the work 
of the Council for Tobacco Research as objective scien­
tific research on smoking and health.  All research find­
ings from this council are sent through the industry’s 
attorneys, thereby gaining the protection of attorney-
client privilege and potentially enabling the industry 
to choose which findings it will release and how it will 
present those findings to the public.  The potential for 
this practice was suggested when certain Brown & 
Williamson–British-American Tobacco Company 
documents were found to include directions for dis­
posing of damaging documents held by the company’s 
research department (Hanauer et al. 1995).  This 
conduct by the industry arguably misled the public 
and caused them to buy tobacco products; it also de­
flates the free choice argument the tobacco industry 
has used to deter further government regulation of its 
products and to defend itself in products liability law­
suits (Hanauer et al. 1995). 
The information outlined above has generated a 
host of claims put forward by plaintiffs in the third wave 
of tobacco litigation. Some of these are similar to claims 
raised in the first two waves but have a much fuller 
factual support. These common-law (judge-created) 
legal theories include fraud, fraudulent concealment, 
and negligent misrepresentation; negligence; negligent 
performance of a voluntary undertaking; breach of 
express and implied warranties; strict liability; and 
conspiracy.  Other, statutory (statute-created) claims 
new to tobacco litigation include violation of consumer 
protection statutes, antitrust claims, unjust enrichment/ 
indemnity, and civil violations that invoke prosecu­
tion under the federal Racketeer Influenced and Cor­
rupt Organizations Act (Kelder and Daynard 1997). 
Common-Law Claims 
An illustrative use of currently available evidence 
to support a common-law legal theory of fraudulent 
misrepresentation is Count Five of the complaint filed 
in April 1998 by 21 Blue Cross and Blue Shield plans 
against the tobacco industry (Blue Cross and Blue Shield 
of New Jersey v. Philip Morris [E.D.N.Y. Apr. 29, 1998], 
cited in 13.2 TPLR 3.51 [1998]). Among the allegations 
listed in Count Five are the following (Blue Cross and 
Blue Shield, p. 3.95): 
301. Defendants represented and promised to 
those who advance and protect the public health 
and provide or pay for health care and health care 
services that they would discover and disclose all 
material facts about the effects of cigarette smok­
ing and other tobacco product use on human 
health, including addiction. 
302. Defendants have made and continue to make 
representations, statements and promises about 
the safety of cigarettes, other tobacco products and 
nicotine in general and their effect on human 
health and addiction. Such representations, state­
ments and promises were and remain materially 
false, incomplete and fraudulent at the time 
Defendants made them, and Defendants knew or 
had and continue to have reason to know of their 
falsity. Only Defendant Liggett has recently con­
ceded that the nicotine in cigarettes is addictive; 
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Liggett made this admission for the first time only 
in March 1997. 
303. In testimony before Congress in January 1998, 
executives of other Tobacco Companies tried to 
have it both ways concerning the question of ad­
diction. They stated that they personally did not 
think nicotine was addictive, but conceded that 
under some definitions, it would be considered 
addictive. 
304. In view of the documentary record establish­
ing that the Tobacco Companies have known for 
years with certainty that nicotine is addictive, such 
testimony is dishonest and part of an on-going 
attempt to disseminate false and misleading 
information. 
305. At all relevant times Defendants intention­
ally, willfully or recklessly misrepresented mate­
rial facts about the human health hazards of 
tobacco use, including addiction, and the associa­
tion of cigarette smoking and other tobacco prod­
uct use with various diseases of the heart, lung 
and other vital organs. 
306. Because of Defendants’ secret internal re­
search, Defendants’ knowledge of the material 
facts about tobacco use, health and addiction was 
and is superior to the knowledge of the BC/BS 
[Blue Cross and Blue Shield] Plans’ members who 
purchased, used and consumed the Tobacco Com­
panies’ cigarettes and other nicotine tobacco prod­
ucts. Defendants’ knowledge of the material facts 
about tobacco use, health and addiction was and 
is also superior to that of the BC/BS Plans, which 
undertook to provide health care financing for 
their members. Public access to these facts is 
limited because such facts are exclusively within 
Defendants’ control. 
313. The BC/BS Plans reasonably and justifiably 
relied on Defendants’ materially false, incomplete 
and misleading representations about tobacco use, 
health and addiction. As a result of such reliance, 
the BC/BS Plans did not take, or would have taken 
sooner, actions to minimize the losses resulting 
from tobacco-related injuries and diseases and to 
discourage and reduce cigarette and other nicotine 
product use and the costs associated therewith by 
the BC/BS Plans’ members. 
Reducing Tobacco Use 
314. As a direct, foreseeable and proximate result 
of the foregoing conduct of Defendants, the BC/ 
BS Plans have suffered damages through payments 
for the costs of medical care due to smoking. 
315. As direct and proximate result of Defendants’ 
fraudulent misrepresentations and nondisclosures, 
the BC/BS Plans have suffered and will continue 
to suffer substantial injuries and damages for 
which the BC/BS Plans are entitled to recovery, 
and for which Defendants are jointly and sever­
ally liable. 
Statutory Claims 
The newer claims include a variety of theories 
based on federal and state statutes. As with the 
common-law claims, these statute-based actions are 
illustrated in the April 1998 complaint that 21 Blue 
Cross and Blue Shield plans filed against the tobacco 
industry. 
Consumer Protection 
Consumer protection claims are based on state 
statutes, which vary somewhat from state to state but 
generally forbid unfair methods of competition and 
unfair or deceptive acts or practices in commerce.  A 
typical set of consumer protection allegations is that 
of Blue Cross and Blue Shield of Florida (Blue Cross 
and Blue Shield, p. 3.102). It makes the following 
allegations: 
378. In the conduct of trade or commerce, De­
fendants have engaged and do engage in unfair 
methods of competition, unconscionable acts or 
practices and unfair or deceptive acts or practices 
including but not limited to the following: 
a.	 	 Intentionally, willfully and knowingly seeking 
to addict persons, including BC/BS Florida 
members and their children, to the use of haz­
ardous cigarettes and other nicotine tobacco 
products, knowing that such addiction physi­
cally changes and damages smokers’ brain 
structures and creates and constitutes a sub­
stantial unfair impediment or interference in 
the smokers’ ability to choose whether to con­
tinue smoking, making the transaction no 
longer an arm’s length one between an equally 
willing buyer and seller, which is similar to 
many other deceptive and/or unfair devices 
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and practices that affect bargaining power or 
relative information; 
b.	 	 Targeting people with deceptive advertising 
by misrepresenting the characteristics, ingre­
dients, uses or benefits of Defendants’ tobacco 
products; and 
c.	 	 Engaging for decades in a wide variety of mis­
representations and fraudulent concealment of 
material facts, directly or by implication, in­
cluding but not limited to: (1) misrepresenta­
tions and fraudulent concealment of the 
addictive nature of nicotine and of the adverse 
health consequences of nicotine tobacco prod­
ucts; (2) misrepresentations and fraudulent 
concealment about Defendants’ ability to ma­
nipulate and their practice of manipulating 
nicotine levels and the addictive qualities of 
nicotine tobacco products; (3) misrepresenta­
tions that the Defendants would provide the 
public and governmental authorities with ob­
jective, scientific information regarding ciga­
rettes and other tobacco products; (4) 
fraudulent concealment of certain aspects of 
cigarettes and other tobacco products, includ­
ing the availability of safer, less-addictive 
products as a substitute to cigarettes and other 
tobacco products; (5) causing a likelihood of 
confusion about the source, sponsorship, ap­
proval or certification of cigarettes and other 
tobacco products; (6) misrepresenting that 
nicotine tobacco products have sponsorship, 
approval, characteristics, ingredients or ben­
efits that they do not have and that Defendants 
knew that they did not have; (7) misrepresent­
ing that cigarettes and other tobacco products 
were of a particular quality or grade, when 
Defendants knew that they were not; (8) en­
gaging in unconscionable trade practices; 
(9) fraudulently promoting filter and low-tar 
cigarettes as safer; (10) fraudulently manipu­
lating scientific research into the health haz­
ards of smoking; and (11) fraudulently creating 
their “research councils” and using them to 
spread false information about their products 
and to promote false information that ciga­
rettes or other tobacco products were safe 
or that adverse health effects had not been 
established. 
379. The conduct described above and through­
out this Complaint constitutes deceptive and 
unfair methods of competition, unconscionable 
acts or practices and unfair or deceptive acts or 
practices all impacting the public interest, in vio­
lation of Fla. Stat. § [section] 501.204. 
380. As a direct and proximate result of such 
wrongful activity, BC/BS Florida has suffered 
losses and will continue to suffer substantial losses 
and injuries to its business or property, including 
but not limited to its being required to pay and 
paying the costs of medical care for disease, ill­
ness, addiction and adverse health consequences 
caused by cigarettes and other tobacco products. 
Antitrust 
The federal government and most states have 
antitrust laws.  These are designed to prevent busi­
nesses in the same industry from cooperating in ways 
that deprive consumers or other entities of benefits 
they would otherwise receive from a competitive 
marketplace. 
Count Three of the complaint by the 21 Blue Cross 
and Blue Shield plans explains how antitrust theory 
applies in a tobacco case (Blue Cross and Blue Shield, 
p. 3.93): 
281. Since the early 1950s, and continuing until 
the present date, the Defendant Tobacco Compa­
nies, aided and abetted by the other Defendants 
herein, have violated Section 1 of the Sherman Act, 
15 U.S.C. § 1, by entering into, adhering to and 
continuing to observe the terms of a combination 
or conspiracy in unreasonable restraint of trade 
and commerce in the market for cigarettes in the 
United States. Such illegal concerted action has 
eliminated commercial competition that would 
have existed but for the conspiracy. Specifically, 
Defendants have conspired: (1) to suppress inno­
vation and competition in product quality 
by agreeing not to engage in research, develop­
ment, manufacture and marketing of less harmful 
cigarettes and other nicotine products; (2) to sup­
press output in a market, and to engage in con­
certed refusal to deal, by agreeing to keep at zero 
the output of less harmful cigarettes and other 
nicotine products; and (3) to suppress competition 
in marketing by agreeing not to take business from 
one another by making claims as to the relative 
safety of particular brands, whether or not such 
claims would have been truthful. But for the 
conspiracy, competition in the market for cigarettes 
in the United States would have been far more 
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vigorous, and consumers and others would have 
reaped enormous benefits. 
282. But for the conspiracy, one or more of the 
Tobacco Companies would have developed a com­
mercially successful, less harmful cigarette; such 
a cigarette would have garnered a substantial share 
of the cigarette market; and those who used that 
product rather than conventional cigarettes would 
have had significantly fewer health problems. As 
a consequence of the above, the BC/BS Plans 
would have incurred substantially lower costs. 
283. A relevant market in which Defendants’ vio­
lations occurred is the manufacture and sale of 
cigarettes and other nicotine products in the 
United States. Because, inter alia, such products 
are physically addictive, they are not reasonably 
interchangeable with other consumer products, 
nor are they characterized by cross-elasticity of 
price with other consumer products. Within this 
broad relevant market there would have existed, 
but for Defendants’ conspiracy, a relevant 
submarket for the manufacture and sale in the 
United States of less harmful cigarettes and other 
nicotine products which would still have delivered 
nicotine but which would have had materially less 
deleterious health effects than the products actu­
ally manufactured and sold by Defendants. Such 
products would have proven attractive to many 
smokers, who would have chosen to buy them if 
they had been available. 
284. Because Defendants have conspired to sup­
press output of less harmful cigarettes and other 
nicotine products, and to refuse to deal in such 
products, their conduct is unreasonable per se 
under the Section 1 of the Sherman Act. There is, 
moreover, no colorable justification for the con­
certed action alleged herein, which is unrelated to 
any lawful business transaction, does not promote 
efficiency, does not advance the interests of con­
sumers and does not promote interbrand or 
intrabrand competition. 
285. Antitrust law protects competition over in­
novation and product quality just as it protects 
price competition. Defendants willfully violated 
antitrust law by agreeing to suppress competition 
related to the safety of their products. It was clearly 
foreseeable that this antitrust violation would 
injure smokers’ health, and it was just as foresee­
able that the violation would, at the same time, 
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cause those financially responsible for smokers’ 
health care to suffer an injury in their business or 
property, by paying increased costs and expenses 
for health care services and products. These two 
kinds of injury are inextricably intertwined. Each 
flows directly from the anticompetitive effects of 
the illegal conduct. The harm suffered by the BC/ 
BS Plans is the precise type of harm that a con­
spiracy to suppress competition related to prod­
uct safety would be likely to cause. Accordingly, 
this harm reflects the anticompetitive effects of the 
violation. 
Antitrust violations permit the injured party to receive 
treble damages as well as attorneys’ fees. 
Federal Racketeer Influenced and Corrupt 
Organizations (RICO) Act 
The federal government and some states have 
statutes designed to control or eradicate “racketeer 
influenced and corrupt organizations.”  “Racketeer­
ing” is defined as a pattern of violations of specified 
criminal statutes (“predicate acts”) (18 U.S.C. section 
1961[1]). Among these statutes are those criminalizing 
mail and wire fraud (18 U.S.C. sections 1341, 1343). 
The evidence put forth that the industry committed 
these predicate acts is similar to the evidence that it 
committed common-law fraud (Blue Cross and Blue 
Shield, p. 3.88, para. 260[a]): 
The Defendants engaged in schemes to defraud 
members of the public, including the BC/BS Plans 
and their members, regarding the health conse­
quences associated with using nicotine tobacco 
products. Those schemes have involved suppres­
sion of information regarding the health conse­
quences associated with smoking, as well as 
fraudulent misrepresentations and omissions rea­
sonably calculated to deceive persons of ordinary 
prudence and comprehension. Defendants’ mis­
representations and fraudulent concealment of 
material facts, directly or by implication, include 
but are not limited to the following: misrepresen­
tations and fraudulent concealment of the addic­
tive nature of nicotine and the adverse health 
consequences of tobacco products; misrepresen­
tations that such health effects of addictiveness 
were unknown or unproven; misrepresentations 
about Defendants’ ability to manipulate and about 
the manipulation of nicotine levels and the addic­
tive qualities of cigarettes; misrepresentations that 
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they would provide the public and governmental 
authorities with objective, scientific information 
regarding all phases of smoking and health; and 
fraudulent concealment of certain aspects of smok­
ing and health, including the availability of safer 
cigarettes and less addictive cigarettes. Defendants 
executed or attempted to execute such schemes 
through the use of the United States mails and 
through transmissions by wire, radio and televi­
sion communications in interstate commerce. 
The federal RICO Act makes it unlawful to receive in­
come derived, directly or indirectly, from a pattern of 
racketeering activity or to participate, directly or indi­
rectly, in the conduct of an enterprise’s affairs through 
a pattern of racketeering activity.  The relevance of the 
RICO Act to tobacco litigation was also delineated in 
the Blue Cross and Blue Shield plans’ complaint (Blue 
Cross and Blue Shield, p. 3.92): 
271. At all relevant times, the Tobacco Institute, 
CTR (formerly TIRC) and STRC [the Smokeless To­
bacco Research Council] have constituted an en­
terprise within the meaning of 18 U.S.C. § 1961(4) 
or, in the alternative, each Defendant has consti­
tuted an enterprise within the meaning of 18 U.S.C. 
§ 1961(4). Each enterprise is an ongoing organiza­
tion. Each enterprise and its activities affect inter­
state commerce in that the enterprise is engaged 
in the business of maximizing the sales of ciga­
rettes and other nicotine products. 
272. As alleged above, Defendants have engaged 
in a pattern of racketeering activity that dates from 
1953 through the present and threatens to continue 
into the future. These racketeering acts generated 
income for Defendants because they contributed 
to: the suppression and concealment of scientific 
and medical information regarding the health ef­
fects of nicotine products; the suppression of a 
market for alternative safer or less addictive to­
bacco products; the manipulation of nicotine to 
create and sustain addiction to Defendants’ prod­
ucts; the targeting of teenagers and children and 
minorities with marketing and advertising 
designed to addict them, all to protect and ensure 
continued sales of Defendants’ unsafe and addic­
tive tobacco products; and the avoidance and shift­
ing of smoking related health care costs to others 
including the BC/BS Plans by the methods stated 
above, including illicit litigation tactics such as 
unfounded claims of attorney-client privilege and 
other means. 
273. Defendants have used or invested their illicit 
proceeds, generated through the pattern of rack­
eteering activity, directly or indirectly in the ac­
quisition of an interest in, or in the establishment 
or operation of each enterprise, in violation of 18 
U.S.C. § 1962(a). Defendants’ use and investment 
of these illicit proceeds in each enterprise is for 
the specific purpose and has the effect of control­
ling the material information distributed to the 
public concerning the health effects of smoking; 
suppressing and concealing scientific and medi­
cal information regarding the adverse health ef­
fects of smoking and the alternatives of safer or 
less-addictive cigarettes; devising means for ma­
nipulating nicotine to create and sustain addiction 
to Defendants’ products; directing marketing and 
advertising toward minorities, teenagers and chil­
dren to addict them; and enticing more individu­
als to smoke or to use Defendants’ unsafe nicotine 
tobacco products. 
274. Each Defendant also conspired to violate 18 
U.S.C. § 1962(a), in violation of 18 U.S.C. § 1962(d). 
As detailed above, the conspiracy began in 1953, 
continues to the present and threatens to continue 
into the future. The object of the conspiracy was 
and is to protect the Tobacco Companies’ business 
operations by investing their illicit proceeds, gen­
erated through a pattern of racketeering activity, 
in each enterprise. Each Defendant agreed to join 
the conspiracy, agreed to invest racketeering-
generated proceeds in each enterprise in order to 
continue enterprise operations and agreed to the 
commission of and knowingly participated in at 
least two predicate acts within ten years of each 
other. Each Defendant knew that those predicate 
acts were part of racketeering activity that would 
further the conspiracy. 
275. Defendants’ violations of 18 U.S.C. §§ 1962 (a) 
and (d) have proximately caused direct injury to 
the business and property of the BC/BS Plans 
because the BC/BS Plans have been required to 
incur significant, concrete financial costs and ex­
penses attributable to tobacco-related diseases; have 
been unable to participate in a market for alterna­
tive less harmful or less addictive nicotine prod­
ucts, or to advise, suggest, promote, subsidize or 
require their members to use alternative products 
such as safer or less addictive tobacco products or 
other nicotine delivery devices; and have not been 
as effective as they would otherwise have been in 
helping their members not to use hazardous tobacco 
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products. In absence of the Defendants’ violation 
of 18 U.S.C. §§ 1962 (a) and (d), these costs and ex­
penses would have been substantially reduced. 
Finally, the RICO Act provides a civil remedy for enti­
ties that have been financially injured as a result of 
RICO violations (18 U.S.C. section 1964[c]). As with 
the antitrust laws, the remedy includes treble damages 
and the recovery of attorneys’ fees. 
Taken together, the allegations in the case brought 
by the 21 Blue Cross and Blue Shield plans provide an 
important summary of the legal approaches that are 
now available to plaintiffs but were not available to 
earlier third-wave cases. 
Individual Third-Wave Cases 
Some third-wave cases involve only minor modi­
fications of standard second-wave product liability 
claims by individual smokers against cigarette mak­
ers. In September 1995, one such case achieved the 
distinction of being the first clear plaintiff’s victory 
after Cipollone. A state court jury awarded $2 million, 
including $700,000 in punitive damages, to a smoker 
who had developed mesothelioma (a cancer associated 
with asbestos exposure) after smoking asbestos-filtered 
Kent cigarettes in the 1950s.  The defendant had won 
four of these filter cases since 1991. While awaiting 
appeals, observers speculated whether the result sig­
nified a change in public perceptions (Hwang 1995a; 
MacLachlan 1995c). Ultimately, the jury’s awards of 
both compensatory and punitive damages were up­
held on appeal (Horowitz v. Lorillard Tobacco Co., No. 
965-245 [Super. Ct. San Francisco Cty. 1995], cert. de­
nied, 118 S. Ct. 1797 [1998]). 
In what is perhaps the most important damage 
recovery case to date (Tobacco Products Litigation Re­
porter 1996d), on August 9, 1996, a jury in Jacksonville, 
Florida, awarded $750,000 to Grady Carter, a former 
air traffic controller who smoked from age 17 in 1947 
until cancer was diagnosed in 1991. Grady and his 
wife, Mildred, sued Brown & Williamson Tobacco 
Corporation on the grounds of negligence and strict 
liability.  The jury found that the Lucky Strike ciga­
rettes that were manufactured by the defendant were 
“unreasonably dangerous and defective” (Tobacco 
Products Litigation Reporter 1996d, p. 1.114).  Of special 
significance was that the plaintiff’s attorney did not 
have to undergo the burdensome discovery process 
that industry attorneys had used successfully in the 
past. The means of avoiding this process was a spe­
cial court order issued to ease the management of the 
large number of tobacco liability cases filed in that 
jurisdiction (In re Cigarette Cases [Fla., Duval Cty. Jan. 
23, 1996], cited in 11.1 TPLR 2.3 [1996]; Ward 1996). 
Doubt was cast on the impact of the case, however, 
when a Florida appellate court overturned the jury’s 
findings on the basis that the plaintiff had failed to file 
his claim within Florida’s four-year statute of limita­
tions (Brown & Williamson Corp. v. Carter, No. 96-4831, 
1998 Fla. App. LEXIS 7477 [Fla. Dist. Ct. App. June 22, 
1998]). 
In an individual damage recovery action similar 
to Carter and brought by Norwood Wilner (the same 
plaintiff attorney who had successfully argued the 
Carter case), a jury found Brown & Williamson Tobacco 
Corporation liable for the wrongful death of smoker 
Roland Maddox and awarded his family just over $1 
million in compensatory and punitive damages 
(Widdick/Maddox v. Brown & Williamson Tobacco Corp., 
No. 97-03522-CA, Div. CV-H [Fla. 4th Cir. Jacksonville 
1998]). Attorney Wilner has taken two other tobacco 
cases to trial that have resulted in jury verdicts for the 
defense, and it is estimated that he had 150 additional 
cases pending as of July 1998 (Connor v. R.J. Reynolds 
Tobacco Co., No. 95-01820-CA, Div. CV-H [Fla. Cir. 
Duval Cty. May 5, 1997]; Karbiwnyk v. R.J. Reynolds To­
bacco Co., No. 95-04697-CA, Div. CV-H [Fla. Cir. Duval 
Cty. Oct. 31, 1997]; Economist 1998). 
The growth of individual tobacco litigation dur­
ing the third wave has been exponential.  For example, 
R.J. Reynolds Tobacco Company reported in July 1995 
that 68 cases of all sorts were pending against it; the 
number had risen to 203 cases in July 1996 and to 448 
cases as of August 7, 1997 (Daynard 1997). 
Aggregation Devices 
The third wave got much of its impetus from the 
use of procedural devices and legal theories that ag­
gregated claims.  Aggregation raised the potential 
value of each case for plaintiffs’ attorneys, increasing 
their willingness to invest large amounts of money and 
time in pursuing them. This process denied the in­
dustry the ability to discourage such cases by escalat­
ing litigation costs, a strategy that had served it well 
during the previous two waves of tobacco litigation 
(see “The Aftermath of the First Two Waves,” earlier 
in this chapter). The most important of these aggrega­
tion devices have been class actions and third-party 
payer reimbursement actions. 
Class Actions 
The class action device figures prominently in the 
third wave of tobacco litigation.  This set of procedures 
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enables a group of persons suffering from a common 
injury to bring a suit to secure a definitive judicial rem­
edy for that injury on behalf of all members of the 
group.  Class action procedures have two principal 
forms—one for cases that seek a single remedy for the 
common benefit of a category of plaintiffs (Federal 
Rules of Civil Procedure, Rule 23[b][1]), and a some­
what more complicated one known as (Rule 23[b][3] 
procedures) for cases that seek the resolution of a large 
number of individual claims that share common fac­
tual or legal issues (Federal Rules of Civil Procedure, 
Rule 23[b][3]). 
Tobacco class actions have, in the main, raised 
two types of issues. One type, exemplified by the 
claims in the Castano case (Castano v. American Tobacco 
Co., No. 94-1044 [E.D. La. Feb. 17, 1995], cited in 10.1 
TPLR 2.1 [1995], rev’d 84 F.3d 734 [5th Cir. 1996]) and 
its progeny, seeks recovery for the cost of treating ad­
dicted smokers for their addictions and for monitor­
ing their medical condition for signs of impending 
disease. It does not, however, seek recovery for the 
cost of treating tobacco-caused diseases, nor for the 
other costs (tangible or intangible) to smokers and their 
families that flow from tobacco-caused disease. The 
other type of issue, exemplified by the claims in the 
Engle case (Engle v. R.J. Reynolds Tobacco Co., No. 94­
08273 CA [20] [Fla., Dade Cty. Oct. 31, 1994], cited in 
9.5 TPLR 2.147 [1994], aff’d 672 So. 2d 39 [1996]), seeks 
damages for the full range of costs that flow from 
tobacco-caused diseases. The Castano case involves a 
much larger number of plaintiffs than Engle, but each 
plaintiff seeks a much smaller recovery. 
been more willing to permit Rule 23(b)(3)-type proce­
dures for Engle-type claims, where class action proce­
dures promise to simplify the trials of a smaller (but 
still very large) number of serious individual claims 
(Engle, 672 So. 2d 39; Broin v. Philip Morris Cos., No. 92­
1405 [Fla., Dade Cty. Mar. 15, 1994], cited in 9.1 TPLR 
2.1 [1994]; Richardson v. Philip Morris, Inc., No. 
96145050/CE212596 [Md. Cir. Ct. Baltimore City Jan. 
28, 1998]). 
To date, both Castano- and Engle-type claims have 
been brought under the more complex Rule 23(b)(3) 
class action procedures designed for the resolution of 
individual claims that share common legal or factual 
issues. Courts have generally been reluctant to allow 
these procedures for Castano-type claims, with the 
courts particularly concerned about the individualized 
proceedings on behalf of millions of addicted smok­
ers, each making relatively small claims, that would 
follow from a favorable resolution of the common is­
sues (Castano v. American Tobacco Co., 84 F.3d 734 [5th 
Cir. 1996]; Small v. Lorillard Tobacco Co., 1998 WL 398176 
[N.Y.A.D. 1 Dept. July 16, 1998]; Barnes v. American 
Tobacco Co., No. 96-5903 [E.D. Pa. Aug. 22, 1997], va­
cated 176 F.R.D. 479 [1997], cited in 12.4 TPLR 2.227 
[1997]). The possibility of using the simpler class ac­
tion procedure for Castano-type claims, which would 
seek a single judicial order setting up an insurance-
type fund that claimants could draw on as they used 
addiction-related medical or pharmaceutical services, 
has not been fully explored.  By contrast, courts have 
For a class action of either type to be certified, 
four technical requirements must be met.  First, the 
members of the proposed plaintiff class must be so 
numerous that joining each plaintiff to the suit would 
be impractical. Second, the claims of each member of 
the class must turn on some questions of law or fact 
that are common to all the members of the class. Third, 
claims of the class representatives must not be antago­
nistic to those of the other members of the class. 
Fourth, the representative plaintiffs and their attorneys 
must be able to fairly and adequately represent the 
interests of the entire class (Federal Rules of Civil Pro­
cedure, Rule 23[a]).  Where members of the class have 
conflicting interests, the class may be divided into sub­
classes represented by different attorneys (Federal 
Rules of Civil Procedure, Rule 23[c][4][A]). 
Besides meeting these four requirements, a Rule 
23(b)(3) class action needs to surmount two other sig­
nificant hurdles.  First, the court must determine that 
the action is “manageable,” meaning that a reasonable 
plan for trying the entire case, including the individual 
claims, can be devised. Second, the common issues 
must “predominate” over the individual issues, leav­
ing the court to make the judgment whether the ben­
efits likely to be obtained from trying the case as a class 
action outweigh the difficulties likely to be encoun­
tered in doing so (Federal Rules of Civil Procedures, 
Rule 23[b][3]). 
Once a Rule 23(b)(3) class is certified, the class 
representatives must undertake the onerous and ex­
pensive process of notifying each member of the class. 
This is necessary because Rule 23(b)(3) class members 
have the significant right to opt out of the class and 
pursue their claims individually. 
The class action device solves the problem of 
aggregation, reduces the imbalance of resources often 
found between the parties, achieves economies of scale, 
and avoids duplicative litigation. The great advan­
tage of the class actions being pursued in the third 
wave of tobacco litigation is that resources are 
expended on behalf of thousands or millions of class 
members rather than on behalf of a single individual 
(Kelder and Daynard 1997).  This advantage provides 
more of a level playing field and means that the 
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tobacco companies will not be able to successfully pur­
sue their usual first- and second-wave strategy of forc­
ing opponents to spend exorbitant sums of money 
until, nearly bankrupted, they are forced to withdraw 
(Kelder and Daynard 1997).  In its unanimous deci­
sion, the appellate court in Broin, after considering and 
rejecting defense objections to the plaintiffs’ request 
for class certification, alluded to the great promise that 
the class action strategy holds for plaintiffs challeng­
ing the tobacco industry: “. . . if we were to construe 
the rule to require each person to file a separate law­
suit, the result would be overwhelming and financially 
prohibitive.  Although defendants would not lack the 
financial resources to defend each separate lawsuit, the 
vast majority of class members, in less advantageous 
financial positions, would be deprived of a remedy. 
We decline to promote such a result” (Broin, cited in 
9.1 TPLR 2.4). 
But with these benefits come new problems. 
Only common issues can be dealt with in a class pro­
ceeding, thus leaving individualized features to be 
dealt with in separate trials. As noted, some or many 
potential class members may choose to opt out of the 
class to pursue individual cases, thereby reducing the 
advantage of eliminating duplicative litigation. If 
some class members are more severely injured than 
others, intractable conflict may arise over distributing 
the proceeds (Coffee 1986, 1987).  If the injury is con­
tinuing outside the class, as it is in the case of tobacco 
use, there is the problem of providing for future plain­
tiffs (Hensler and Peterson 1993).  These problems are 
overlaid and compounded by issues involving the le­
gal agents representing the plaintiffs.  Class actions 
are organized and managed by entrepreneurial law­
yers, and their interests and those of the client class 
may diverge (Coffee 1986).  Finally, there is the dan­
ger that the class action device elevates the stakes so 
high that defendants and plaintiffs settle without reso­
lution of other (nonmonetary) merits of the claim. Just 
which of these problems are sufficiently salient to dis­
courage use of the class action device in the several 
varieties of tobacco cases is still an issue. 
Castano v. American Tobacco Co., filed March 29, 
1994, in federal court in New Orleans (MacLachlan 
1994–95), was an unparalleled attempt by a coalition 
of traditional plaintiffs’ lawyers, mass disaster lawyers, 
and class action specialists from around the country to 
diminish the organizational advantages enjoyed by the 
tobacco industry during the first two waves of tobacco 
litigation. Each of a coalition of 62 law firms pledged 
$100,000 annually to fund a massive class action suit, 
on behalf of millions of nicotine-dependent smokers, 
charging the tobacco industry with promoting 
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addiction and thus disabling smokers from quitting 
(Janofsky 1994a; Shapiro 1994a; Curriden 1995).  The 
plaintiffs requested damages for economic losses and 
emotional distress, as well as medical monitoring and 
injunctive relief. In February 1995, the district court 
granted the plaintiffs’ request for class certification 
conditionally and in part (Castano, cited in 10.1 TPLR 
2.1). Judge Okla Jones II granted certification for is­
sues of fraud, breach of warranty (express or implied), 
intentional tort, negligence, strict liability, and con­
sumer protection issues. Certification was denied for 
other issues, including the questions of causation, in­
jury, and defenses regarding the claims of each smoker. 
Normally, a trial judge’s decision to certify a class 
is not subject to review by a higher court until the trial 
court has reached a final disposition of the whole case, 
which may be years later.  But Judge Jones in Castano 
granted special permission to allow the defendants to 
appeal his class certification decision to the United 
States Court of Appeals for the Fifth Circuit (Collins 
1995c). On May 23, 1996, a three-judge panel of the 
appellate court vacated Judge Jones’ decision and re­
manded the case back to the district court with instruc­
tions to dismiss the class action. The court of appeals 
reasoned that the variations in the state laws of the 50 
states in which the injuries occurred classwide, com­
bined with trial management problems not addressed 
by the district court, justified decertification of the 
nationwide class (Castano, 84 F.3d 734). 
The coalition of lawyers that formed around 
Castano opted to pursue another approach and began 
to file statewide class actions shortly after the decerti­
fication by the court of appeals. By mid-1998, the coa­
lition had filed 26 such cases (Torry 1998). 
Another class action, Engle v. R.J. Reynolds Tobacco 
Co., No. 94-08273 CA (20) (Fla., Dade Cty.), cited in 9.3 
TPLR 3.293 (1994), filed in a Florida state court May 5, 
1994, on behalf of smokers suffering from “diseases 
like lung cancer and emphysema,” sought billions of 
dollars in damages from the seven leading tobacco 
companies, the Council for Tobacco Research U.S.A. 
Inc., and the Tobacco Institute, a tobacco-financed 
public relations association (Janofsky 1994a, p. 11).  The 
suit alleged that by denying that smoking is addictive 
and by suppressing research on the hazards of smok­
ing, the tobacco industry has deceived the public about 
the dangers of using tobacco products (Janofsky 1994c). 
On October 31, 1994, Engle, filed by a personal injury 
lawyer who chose to remain apart from the Castano 
coalition, had the distinction of becoming the first 
tobacco-related class action lawsuit to be granted class 
certification (Engle v. R.J. Reynolds Tobacco Co., No. 94­
08273 CA [20] [Fla., Dade Cty. Oct. 31, 1994], cited in 
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9.5 TPLR 2.147 [1994]). When the defendants sought 
to overturn the class certification, the Florida Supreme 
Court upheld it, paving the way for the case to go to 
trial (R.J. Reynolds Co. v. Engle, 672 So. 2d 39 [Fla. Ct. 
App. 1996]). A jury selection for the trial began on 
July 6, 1998 (Economist 1998). 
Recovery Claims by Third-Party Health 
Care Payers 
In the late 1970s, a number of scholars and advo­
cates began urging legal theories and statutory reforms 
that would permit third-party health care payers to col­
lect the expenses of caring for tobacco-caused disease 
from the manufacturers themselves (Garner 1977; 
Daynard 1993a,b, 1994a; Gangarosa et al. 1994).  Such 
claims involve complex questions about ascertaining the 
amount of tobacco-caused injury and the apportionment 
of damages attributable to each defendant. The stakes 
in these potential cases are undoubtedly large:  one 
study estimates that 7.1 percent of total medical care 
expenditures in the United States is attributable to 
smoking-related illnesses (CDC 1994c).  Another study 
estimates that tobacco use is responsible for about 18 
percent of all Medicaid expenses (Clymer 1994).  How­
ever, calculation of such effects invites the counter­
argument (albeit amoral) that tobacco’s costs to the state 
are offset in part by the savings afforded by the prema­
ture deaths of smokers (Geyelin 1995). 
Beginning in 1994, the governments of three 
states—Minnesota, Mississippi, and West Virginia— 
as well as Blue Cross and Blue Shield of Minnesota, 
filed lawsuits to secure reimbursement from the 
tobacco industry for health care expenditures for ail­
ments arising from tobacco use.  Three years later, 41 
states had filed such legal actions. Since this settle­
ment has not yet been embodied in the congressional 
legislation necessary to give it the force of law (see 
“Legislative Developments” and “Master Settlement 
Agreement,” earlier in this chapter), four states— 
Florida, Minnesota, Mississippi, and Texas—have 
settled their claims with the tobacco industry.  Addi­
tional third-party payers—such as labor union pen­
sion funds and Blue Cross and Blue Shield plans 
(whose joint case is described in detail in “Common-
Law Claims,” earlier in this chapter) in states other 
than Minnesota—also began to file suit against the 
industry in 1997 and 1998. 
Medicaid Reimbursement Cases 
on the basis of common-law theories of restitution, 
unjust enrichment, and nuisance to recover the state’s 
outlays for treating the tobacco-related illnesses of 
welfare recipients (Janofsky 1994a; Woo 1994c; Moore 
v. American Tobacco Co., Cause No. 94:1429 [Miss., Jack­
son Cty. Feb. 21, 1995], cited in 10.1 TPLR 2.13 [1995]). 
The first state to do so, Mississippi, embraced a strat­
egy that merited the attention of other third-party 
claimants. Rather than proceeding in a trial court on a 
theory of subrogation (whereby the state would have 
acted in the place of injured smokers to recover claims 
the state had paid to those smokers), Moore chose to 
proceed in equity (i.e., before a single judge in a 
nonjury proceeding) on theories of unjust enrichment 
and restitution (Kelder and Daynard 1997).  Moore’s 
equity claims were grounded in the notion developed 
in the literature that the State of Mississippi had been 
injured directly by the behavior of the tobacco industry 
because Mississippi’s taxpayers had been forced to pay 
the state’s Medicaid costs due to tobacco-related 
illnesses. 
Mississippi filed suit on May 23, 1994, against 
tobacco manufacturers, wholesalers, and trade groups 
The state planned to use statistical analysis to il­
lustrate the percentage of Medicaid costs that can be 
attributed to tobacco use. If the lawsuit succeeded, 
the defendants would pay for Medicaid costs under a 
formula that calculates liability according to market 
share (Lew 1994).  The lawsuit sought tens of millions 
of dollars in damages, including punitive damages as 
well as recovery for future tobacco-related expendi­
tures (Woo 1994c).  Lawyers from 11 private plaintiffs’ 
law firms participated in the suit. Instead of promis­
ing the private lawyers a percentage of the potential 
damages, the state sought to compel the tobacco com­
panies to pay the lawyers’ fees (Woo 1994c). 
Superficially, this state case (and that of other 
states) resembled subrogation claims, in which a party 
who pays a claim (typically an insurer) may pursue 
that claim, acting in the place of the original claimant 
and subject to the defenses that might be raised against 
him or her.  But the Mississippi complaint avoided 
asserting the claims of the health care recipients; in­
stead, it asserted the proprietary claims of the state as 
a health care funder (distinct from any claims of those 
whose health was injured by tobacco). 
This proprietary stance is significant because, as 
detailed earlier in this section, the tobacco companies 
won many of the first- and second-wave cases by as­
serting the defenses of assumption of risk and con­
tributory negligence or by asserting that the smoker’s 
willfulness, not the industry’s misbehavior, was the 
proximate cause of the smoker’s smoking and conse­
quent illness. These defenses should not be available 
to the tobacco industry in medical cost reimbursement 
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suits because these suits are not brought on behalf of 
injured smokers.  They are brought, instead, on behalf 
of the states themselves to recover the medical costs 
they have been forced to pay to care for indigent smok­
ers. The tobacco industry cannot plausibly argue that 
the states chose to smoke or that they contributed to 
the financial harm caused to them (Daynard 1994b; 
Kelder and Daynard 1997). 
The decision in the Mississippi medical cost re­
imbursement suit demonstrates that this commonsense 
argument can prevail, even in states that lack special 
legislation that creates an independent cause of action 
for the state. The tobacco industry defendants in Moore 
v. American Tobacco Co. filed a motion for judgment on 
the pleadings on October 14, 1994. The defendants 
argued that, under Mississippi law, assignment/sub­
rogation was the state’s exclusive remedy for pursu­
ing the recovery of medical benefits from potentially 
liable third parties.  Further, the defendants argued that 
because Mississippi’s counts for restitution, indemnity, 
and nuisance in the complaint did not assert a subro­
gation claim, they had to be dismissed. Alternatively, 
the defendants argued that the case should be trans­
ferred to a Mississippi circuit court, where thousands 
of jury trials would have to be conducted (Kelder and 
Daynard 1997). 
In response, Mississippi Attorney General Mike 
Moore pointed out that “this ‘remedy,’ as the industry 
knows, would be cost prohibitive and exhaustive of 
our State’s limited judicial resources” (Moore v. Ameri­
can Tobacco Co., No. 94:1429 [Miss., Jackson Cty. Oct. 
14, 1994], cited in 9.5 TPLR 3.597, 3.598 [1994]). He ar­
gued that “although the Medicaid Law did further 
codify the State’s right to be subrogated, this right is 
in addition to, and not in derogation of, the State’s statu­
tory and common law remedies.  There is no language 
in the Medicaid Law that implies an exclusive rem­
edy, and well-settled rules of statutory interpretation 
require a construction that the Medicaid Law expanded, 
not contracted, the State’s remedies [emphasis in origi­
nal]” (p. 3.598). 
On February 21, 1995, Chancellor William H. 
Myers, presiding over the Chancery Court of Jackson 
County, denied the tobacco industry defendants’ mo­
tions to obtain a judgment on the pleadings and to re­
move the claim from the chancery court to a 
Mississippi circuit court.  The court simultaneously 
granted the state’s motion to strike the affirmative 
defenses of the defendants; the tobacco industry thus 
could not rely on the defenses of assumption of risk 
and contributory negligence, which have proved a 
mainstay in earlier battles—and which might have 
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been allowed had the state proceeded on a theory of 
subrogation (Tobacco Products Litigation Reporter 1995a). 
On July 2, 1997, Mississippi settled its claims so 
that it would receive at least $3.3 billion over 25 years, 
with annual payments of at least $135 million continu­
ing in perpetuity.  A provision of the settlement agree­
ment guaranteeing Mississippi most favored nation 
(MFN) treatment, which meant that Mississippi would 
get the benefit of any better agreement that another 
state might achieve, was little noticed at the time but 
has since proved immensely important; additional 
settlement terms from later industry arrangements 
with the other three states have been granted to 
Mississippi. 
The second state to bring suit against the tobacco 
industry was Minnesota (Minnesota v. Philip Morris Inc., 
No. C1-94-8565 [Minn., Ramsey Cty. Nov. 29, 1994], 
cited in 9.3 TPLR 3.273 [1994]). Minnesota’s suit al­
leged an antitrust conspiracy and an elaborate course 
of fraudulent behavior on the part of the defendants. 
Specifically, the tobacco companies were alleged to 
have violated the state’s laws against consumer fraud, 
unlawful trade practices, deceptive trade practices, and 
false advertising, as well as violated the duty they vol­
untarily undertook to take responsibility for the 
public’s health, to cooperate closely with public health 
officials, and to conduct independent research and dis­
close to the public objective information about smok­
ing and health. The suit sought various damages, 
including restitution, forfeiture of tobacco profits, at­
torneys’ fees, and treble damages for several statutory 
violations. Blue Cross and Blue Shield of Minnesota, 
the state’s largest private medical insurer, joined as a 
co-plaintiff with the state (Woo 1994b).  Like most other 
states that brought Medicaid reimbursement cases, 
Minnesota and the insurer retained private counsel to 
provide representation under a contingency fee 
arrangement. 
Following a three-month trial and in the midst 
of closing arguments, Minnesota settled its case—the 
last of the four states to do so—on May 8, 1998. The 
industry agreed to pay about $6.1 billion to Minne­
sota and $469 million to Blue Cross and Blue Shield of 
Minnesota (which was also a plaintiff) over 25 years, 
an amount substantially larger proportionately than 
the three earlier state settlements, resulting in substan­
tial increases in their settlement packages under the 
MFN clauses. The industry also agreed to the follow­
ing public health concessions (Minnesota v. Philip 
Morris Inc., cited in 13.2 TPLR 2.112): 
• Disband the Council for Tobacco Research. 
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•	 	Not pay for tobacco placement for movies (a pro­
vision that inherently extends beyond Minnesota’s 
borders). 
•	 	Stop offering or selling in Minnesota nontobacco 
merchandise, such as jackets, caps, and T-shirts, 
bearing the name or logo of tobacco brands. 
•	 	 Remove all tobacco billboards in Minnesota within 
six months and eliminate such ads on buses, taxis, 
and bus shelters. 
•	 	Refrain from targeting minors in future advertis­
ing and promotions. 
•	 Refrain from misrepresenting the evidence on 
smoking and health. 
•	 	Refrain from opposing in Minnesota certain new 
laws designed to reduce youth tobacco use, as well 
as clean indoor air laws that could adversely affect 
the industry. 
•	 Institute new lobbying disclosure rules for 
Minnesota. 
•	 	Release internal indexes to millions of previously 
secret industry documents, thereby providing a 
means for attorneys and researchers to find relevant 
information more easily. 
•	 	 Maintain at industry expense for 10 years a deposi­
tory of millions of tobacco documents in Minne­
apolis and another such depository in Great Britain. 
•	 	Instruct retailers in Minnesota to move cigarettes 
behind the counter to restrict minors’ access to 
those cigarettes. 
•	 	Pay out $440 million in fees to the private attor­
neys who represented the plaintiffs. 
•	 	Give Minnesota its own MFN clause, limited to 
improved public health provisions in future state 
settlements. 
Through the MFN process, many of the public 
health concessions that Minnesota obtained from the 
industry are also being incorporated in the prior state 
agreements (Branson 1998). 
sue on behalf of the entire class of smokers on Medic­
aid, to use statistical proof of causation, to bar assump­
tion of risk as a defense, and to permit recovery 
according to the defendants’ share of the cigarette mar­
ket (Rohter 1994; Woo 1994a).  Apparently having sec­
ond thoughts about the statute (which had passed by 
a wide margin), the state legislature considered repeal­
ing it, eliciting a vow from Florida’s Governor Lawton 
Chiles to veto a repeal (Hwang 1995a).  After an un­
successful last-minute attempt by the tobacco compa­
nies to have the Florida Supreme Court bar state 
agencies from initiating a lawsuit under the statute, 
Florida filed its medical cost reimbursement suit on 
February 21, 1995, seeking $4.4 billion (Florida, cited in 
10.1 TPLR 3.1; Geyelin 1995). 
The Florida case (Florida v. American Tobacco Co., 
No. 95-1466AO [Fla., Palm Beach Cty. Feb. 21, 1995], 
cited in 10.1 TPLR 3.1 [1995] [Complaint]; Geyelin 1995) 
was the first conforming with a statute tailored for the 
purpose of establishing such a claim. In May 1994, 
Florida amended this little-used statute, which pro­
vided for recovery by the state from third parties 
responsible for Medicaid costs, to permit the state to 
The complaint in the Florida lawsuit contains 
extended factual allegations regarding the defendants’ 
knowledge (or lack of knowledge) about the harmful­
ness of tobacco. Raising the familiar causes of action, 
the complaint also emphasizes the tobacco industry’s 
alleged violations of consumer protection laws.  Spe­
cifically, it criticizes the industry’s use of advertising 
to target minors. 
The Florida Supreme Court narrowly upheld the 
liability law, on which the state’s case is based, in a 4 
to 3 ruling that produced equivocal results for both 
sides. The court agreed with the defendants that the 
state could only use the law to recover damages in­
curred since July 1, 1994, and that the names of indi­
vidual Medicaid recipients would have to be supplied 
so that the tobacco companies could challenge their 
claims (Agency for Health Care Administration v. Associ­
ated Industries of Florida, 678 So. 2d 1239 [Fla. 1996]). 
But the majority decision left most of the law’s key 
provisions intact.  The presiding state circuit court 
judge, Harold J. Cohen, next ordered both parties to 
try to resolve the dispute by engaging in mediation, 
which broke off after four days and produced no re­
sults (Kennedy 1996). Judge Cohen then dismissed 15 
counts of the state’s 18-count claim against the tobacco 
industry in a ruling issued September 1996 (Florida v. 
American Tobacco Co., No. CL 95-1466 AH [Fla., Palm 
Beach Cty. Sept. 16, 1996]).  The following month, how­
ever, he rejected the defendants’ request to depose the 
hundreds of thousands of Medicaid recipients 
supplied to the court by the state in compliance with 
the supreme court decision. The judge held that the 
hundreds of thousands of recipients need only be iden­
tified by case number, not by name (Florida v. Ameri­
can Tobacco Co., No. CL 95-1466 AH [Fla., Palm Beach 
Cty. Oct. 18, 1996], cited in 11.7 TPLR 2.236 [1996]).  In 
yet another setback for the defendants, Judge Cohen 
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permitted the state to add a count of racketeering to 
its claim (MacLachlan 1996–1997). 
Florida settled its case on August 25, 1997, for at 
least $11 billion over 25 years, with annual payments 
of at least $440 million continuing thereafter.  It ob­
tained its own MFN clause, as well as an additional 
$200 million for a two-year initiative to reduce youth 
smoking, an agreement to ban cigarette billboards and 
transit advertisements, and an agreement by the in­
dustry to lobby for a ban on cigarette vending ma­
chines. As a consequence of Mississippi’s MFN clause, 
Florida received similar benefits. 
The Texas suit was innovative in that it was 
brought in federal rather than state court.  The case 
was also the first to include claims under the federal 
RICO Act.  On January 16, 1998, Texas settled its claims 
for at least $14.5 billion over 25 years, with annual 
payments of at least $580 million continuing thereaf­
ter, as well as public health provisions similar to those 
negotiated by Florida and its own MFN clause. 
Although West Virginia was one of the first three 
states to file a suit against the tobacco companies, its 
case did not fare as neatly as those of Mississippi, Min­
nesota, and the later-arrived Florida and Texas.  Filed 
on September 20, 1994 (McGraw v. American Tobacco Co., 
No. 94-1707 [W.Va. Cir. Ct. Kanawha Cty. Sept. 20, 
1994], cited in 9.4 TPLR 3.516 [1994]), West Virginia’s 
suit named 23 defendants, including Kimberly-Clark 
Corporation, developer of a process once used in 
Europe—but never, according to a company spokes­
person, in the United States—to control nicotine lev­
els in tobacco products (Hwang and Ono 1995), and 
United States Tobacco Company, the largest manufac­
turer of chewing tobacco and snuff.  The West Virginia 
action “asks the Court for damages to cover what West 
Virginia has paid providing medical care to people af­
flicted with tobacco-related illness, and what the state 
will pay in the future for tobacco victims. The lawsuit 
also seeks punitive damages to prevent a repetition of 
such conduct in the future” (West Virginia Attorney 
General 1994, p. 2). Citing an “intentional and uncon­
scionable campaign to promote the distribution and 
sale of cigarettes to children,” the complaint also re­
quires that the defendants be enjoined from “aiding, 
abetting or encouraging the sale . . . of cigarettes to 
minors” (p. 4) and be fined $10,000 for each violation 
of the injunction. West Virginia’s complaint is signed 
by lawyers from five private firms, including a promi­
nent asbestos litigation firm that is also involved in 
the Mississippi case. 
Unlike the Mississippi and Minnesota claims, 
the West Virginia case met with early difficulties.  On 
May 3, 1995, Kanawha County Circuit Court Judge 
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Irene C. Berger dismissed 8 of the suit’s 10 counts, 
including fraud, misrepresentation, and conspiracy, as 
being outside of the state attorney general’s powers. 
Ironically, Berger ’s decision is based in part on a 
decision that Attorney General Darrell V. McGraw Jr. 
himself, the named plaintiff in the suit, authored when 
he served on West Virginia’s Supreme Court, holding 
that the state attorney general lacked common-law 
authority (i.e., he could bring only statutory claims). 
The two remaining counts of the West Virginia action 
dealt with consumer and antitrust charges (Mac-
Lachlan 1995a). 
On May 13, 1996, Judge Berger permitted the 
West Virginia Public Employees Insurance Agency Fi­
nance Board to join as co-plaintiffs.  This ruling “es­
sentially revived” (Mealey’s Litigation Reports: Tobacco 
1996a) the case by providing the state with a means of 
hiring legal counsel after the tobacco companies won 
an October 1995 order barring the attorney general 
from retaining private law firms on a contingency fee 
basis (MacLachlan 1995a,b,c). 
Among the numerous other states currently try­
ing to recoup Medicare expenditures, Oklahoma 
stands out for an innovation in its suit. The Oklahoma 
suit names, among other defendants, three industry 
law firms: Shook, Hardy and Bacon of Kansas City, 
Missouri; Jacob, Medinger and Finnegan of New York; 
and Chadbourne and Parke of New York.  Shook, 
Hardy and Bacon has represented tobacco companies 
since 1954 (Kelder and Daynard 1997).  The suit ac­
cuses the law firms of helping the tobacco companies 
conceal the health risks of smoking and alleges they 
kept documents confidential by falsely claiming they 
were protected by attorney-client privilege (Oklahoma 
v. R.J. Reynolds Tobacco Co., No. CJ961499L [Okla., 
Cleveland Cty. Aug. 22, 1996], cited in 11.7 TPLR 3.901 
[1996]). 
Other notable settlements mentioned earlier in 
this chapter include the Liggett Group Inc.’s 1997 
settlement with most of the states, in return for a frac­
tion of future profits, public admissions of the dan­
gers and addictiveness of nicotine and the past 
misbehavior of the industry, and disclosure of secret 
industry documents (Tobacco Products Litigation Re­
porter 1997a). The same year brought in another key 
settlement—that of R.J. Reynolds Tobacco Company 
and a dozen California cities and counties, which had 
alleged that R.J. Reynolds’ Joe Camel campaign was 
aimed at minors (see “A Critical Example: Joe Camel,” 
earlier in this chapter). R.J. Reynolds agreed to dis­
continue the campaign in California and to give the 
plaintiffs $9 million for a counteradvertising campaign 
(Mangini, cited in 12.5 TPLR 3.349). In October 1997, 
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the industry settled the first phase of a class action 
brought on behalf of nonsmoking flight attendants for 
substantial money and other concessions (Broin, cited 
in 12.6 TPLR 3.397). This case is discussed in detail in 
“Claims of Nonsmokers,” later in this chapter. 
Finally, at the time of writing, a group of state 
attorneys were holding discussions about settling some 
or all of the remaining state cases. According to pub­
lished reports, as a starting point “the states have de­
cided to use the [public health] concessions gained by 
Minnesota as part of its $6.5 billion settlement” (Meier 
1998a). 
Other Third-Party Reimbursement Cases 
Although the parties seeking recovery in Medic­
aid reimbursement cases are public officials, the cases 
are based on private law theories of recovery—that is, 
the officials proceed not as authoritative public regu­
lators but as holders of rights conferred by the general 
law.  Such use of private law recovery as an instru­
ment of state policy suggests further possibilities of 
analogous suits by private funders of health care and 
may provide incentives for attorneys to organize such 
suits. Health insurers, widely seen as reluctant to en­
force their rights to recoup from third parties, may be 
mindful of such opportunities in an increasingly com­
petitive health care setting. 
Indeed, Blue Cross and Blue Shield of Minnesota 
was a co-plaintiff with the State of Minnesota in its 
action against the tobacco industry.  In 1996, the Min­
nesota Supreme Court unanimously rejected an indus­
try challenge that co-plaintiff Blue Cross and Blue 
Shield could not remain in the case.  This ruling per­
mitted the insurance company and the state to pursue 
their claims directly against the defendants, rather than 
on behalf of individual smokers (Minnesota v. Philip 
Morris Inc., 551 N.W.2d 490 [Minn. 1996]).  When the 
industry settled with the State of Minnesota in May 
1998, it also settled with Blue Cross and Blue Shield of 
Minnesota—for $469 million to be paid over a five-
year period (Weinstein 1998a). 
In March 1998, two Minnesota health mainte­
nance organizations filed a separate suit against the 
industry, with claims paralleling those in the Minne­
sota case that was still in trial (Howatt 1998). The fol­
lowing month, Blue Cross and/or Blue Shield Plans 
in 37 states combined in three legal actions to sue the 
major tobacco companies and their public relations 
firms to recover damages allegedly caused by a con­
spiracy to addict their insurance plan members to ciga­
rettes (e.g., Blue Cross and Blue Shield, cited in 13.2 TPLR 
3.51; National Law Journal 1998). 
These plans are alleging that tobacco companies 
conducted an “ongoing conspiracy and deceptive, il­
legal and tortious acts” that have resulted in the plain­
tiffs suffering “extraordinary injury in their business 
and property,” having been required to expend many 
millions of dollars on costs attributable to tobacco-
related diseases caused by defendants who “know­
ingly embarked on a scheme to addict millions of 
people, including members of the [Blue Cross and Blue 
Shield] Plans, to smoking cigarettes and other tobacco 
products—all with the intent of increasing their an­
nual profits . . . [and forcing] others to bear the cost of 
the diseases and deaths caused by the conspiracy” 
(Blue Cross and Blue Shield, p. 3.52). 
The plans allege a conspiracy to hide the health 
effects of tobacco products, violations of federal rack­
eteering laws and of antitrust laws, and unjust enrich­
ment, among other theories (Tobacco Products Litigation 
Reporter 1998). They request damages in the forms of 
payments for treatments of tobacco-related diseases, 
court orders to require corrections of unlawful behav­
ior, damages in excess of $1 billion for past and future 
harm, and other forms of relief. 
Bankruptcy trusts representing the interests of 
injured plaintiffs who have made claims against the 
asbestos industry filed suit against the tobacco indus­
try in late 1997 (Bourque 1997).  The trusts allege that 
they paid claims to victims of asbestos exposure whose 
injuries were substantially caused by either active or 
passive exposure to cigarette smoke.  Alleging the 
unjust enrichment of the tobacco companies at the ex­
pense of the trusts, the latter seek to recover expendi­
tures and payments made to the asbestos settlement 
class and seek punitive damages against the defen­
dants (Tobacco Products Litigation Reporter 1997b). 
The trusts allege that among persons exposed to 
asbestos, direct or indirect exposure to tobacco smoke 
is a substantial contributing factor in both the devel­
opment of cancer and the frequency and severity of 
symptoms of asbestosis, a disease from which many 
asbestos workers suffer.  The trusts also allege that to­
bacco companies knew or should have known that 
their products would cause these injuries (Falise v. 
American Tobacco Co., No. 97-CV-7640 [E.D.N.Y. Dec. 
31, 1997], cited in 12.8 TPLR 3.504 [1997]). 
The asbestos trusts accuse the tobacco companies 
of suppressing the truth concerning the nature of their 
products and their carcinogenic effects.  They allege 
that tobacco industry products were at least partly re­
sponsible for the illnesses suffered by asbestos plain­
tiffs.  The trusts thus want the tobacco companies to 
pay a share of the billions of dollars in damages 
awarded to those plaintiffs (Bourque 1997). 
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Small Claims Tribunals to Recover the Cost of 
Quitting 
Related to these expansive addiction suits are a 
series of more limited claims based on the addictive 
properties of cigarettes.  As with large suits, small 
claims for the recovery of costs related to quitting to­
bacco use depend on whether judges and juries ac­
cept the addiction argument that underlies the product 
liability portion of the third wave of tobacco litigation. 
In this scaled-down version, claims for modest 
amounts might be brought in small claims courts, ob­
viating some of the litigation advantages enjoyed by 
the manufacturers.  In one case, an individual smoker 
sued Philip Morris Companies Inc. for $1,154 in a 
Washington State small claims court to recover the 
costs of consulting a doctor, buying nicotine patches, 
and joining a health club—all activities undertaken to 
help the plaintiff quit smoking cigarettes (Hayes 1993; 
Janofsky 1993). Because the court rejected the suit on 
the preliminary ground that the statute of limitations 
had expired, the substantive merits of the claim were 
not considered (Montgomery 1993). 
In July 1998, an Australian appellate court al­
lowed a formerly addicted smoker to proceed before 
the New South Wales consumer claims tribunal with 
a $1,000 claim for the cost of a stop-smoking program, 
as well as for mental suffering caused by the addic­
tion and the effort to quit (Australian News Network 
1998). Were a timely small claims case to succeed, the 
recovery would be small. Incentives for lawyers to 
supply and plaintiffs to consume the legal services 
needed to pursue such a claim might be provided by 
statutory provision allowing winning plaintiffs to re­
cover attorneys’ fees. Or if such claims could be suffi­
ciently standardized and simplified, they might 
proceed without lawyers (e.g., by preparing “kits” to 
enable plaintiffs to represent themselves). 
Other Cost Reduction Procedures 
Several other procedures have been used or may 
be available to reduce the costs—for plaintiffs, their 
attorneys, and the courts—of resolving individual 
claims. One such procedure is to combine pretrial and 
perhaps trial proceedings for several, or even many, 
cases. In July 1998, a California court ordered that 
proceedings in a variety of actions pending in various 
California courts be combined (Associated Press 1998). 
Earlier, a Tennessee court ordered several pending in­
dividual cases to be combined for trial (Mass Tort Liti­
gation Reporter 1998). Asbestos trials have occasionally 
combined hundreds and even thousands of individual 
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claims (Acands, Inc. v. Abate, 710 A.2d 944 [Md. Ct. Spec. 
App. 1998]). These procedures permit courts to achieve 
substantial efficiencies with the formalities of class 
action certification. Efficiencies can also be obtained 
by case management orders that set firm schedules for 
trials and pretrial proceedings (In re Cigarette Cases, 
cited in 11.1 TPLR 2.3). 
Another procedure available in some jurisdic­
tions is “offensive collateral estoppel,” which exempts 
future plaintiffs from retrying issues on which specific 
defendants have lost in prior trials (Blonder-Tongue 
Laboratories v. University of Illinois Foundation, 402 U.S. 
313, 91 S. Ct. 1434 [1971]). This device has not yet been 
used in tobacco litigation. 
Claims of Nonsmokers 
ETS Claims Against Manufacturers 
Although most litigation involving adverse 
health effects from exposure to ETS has not directly 
involved tobacco companies, a line of cases has devel­
oped during the 1990s naming tobacco companies as 
defendants and targeting the companies’ behavior in 
attempting to, as a British-American Tobacco Company 
Ltd. document from 1988 put it, “keep the controversy 
alive”—referring to the industry’s common strategy 
of shifting the focus from personal health to personal 
freedom (Boyse 1988; Chapman 1997). 
Claims of nonsmokers asserting damages from 
ETS have been filed on behalf of both individual and 
class plaintiffs.  As nonsmokers, alleged victims of ETS 
are not vulnerable to the defense that they knowingly 
subjected themselves to the dangers of tobacco use. 
Butler v. American Tobacco Co. ([Miss., Jones Cty. May 
12, 1994], cited in 9.3 TPLR 3.335 [1994] [Amended 
Complaint]), filed May 13, 1994, seeks damages from 
six tobacco companies and others for the lung cancer 
death of Burl Butler, a nonsmoker and “paragon of 
clean living” (Greising and Zinn 1994, p. 43), who al­
legedly contracted the disease after inhaling custom­
ers’ tobacco smoke for 35 years while working at his 
barber shop (Kraft 1994). Butler became the first case 
in which documents allegedly stolen from Brown & 
Williamson Tobacco Corporation by one of its former 
employees were admitted into evidence, despite 
objections by the defendants that attorney-client 
privilege prohibited disclosure.  Lawyers for Butler’s 
estate contend that “the documents will show, among 
other things, that tobacco companies manipulated and 
suppressed scientific research for years to mislead their 
customers about smoking’s dangers” (Ward 1996). 
State Circuit Court Judge Billy Joe Landrum postponed 
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commencement of the trial on motion by the plaintiffs 
to allow new defendants to be added to the action. The 
amended complaint now contends that manufactur­
ers of talcum powder used by Butler in his barber shop 
“knew or should have known that Environmental To­
bacco Smoke can act synergistically with . . . Talc, to 
cause respiratory diseases, including lung cancer, and 
other health problems” (Butler v. Philip Morris Inc., Civil 
Action No.:94-5-53 [Miss., Jones Cty. Mar. 4, 1996], cited 
in 11.3 TPLR 3.307, 3.315 [1996] [Second Amended 
Complaint and Request for Trial by Jury]).  A new trial 
date has not yet been set. 
Another case involved a woman who had never 
smoked but who was subjected to prolonged and re­
peated exposure to ETS since childhood and died of 
lung cancer in 1996 at the age of 44 (Buckingham v. R.J. 
Reynolds Tobacco Co., 713 A.2d 381 [N.H. 1998]). Two 
years before her death, Roxanne Ramsey-Buckingham 
sued the major tobacco companies and a local store in 
strict liability and under Restatement (Second) of Torts, 
section 389. She alleged “that the defendants knew or 
should have known that it was unlikely that their prod­
ucts would be made reasonably safe prior to their cus­
tomary and intended use, and that it was foreseeable 
that Ms. Ramsey-Buckingham would be endangered 
by ETS from the defendants’ cigarettes” (p. 383).  A 
superior court judge dismissed her lawsuit in 1995 on 
the basis that New Hampshire does not recognize a 
strict liability cause of action under section 389. 
However, the New Hampshire Supreme Court rein­
stated the lawsuit in May 1998, ruling that “section 
389 is not a form of strict liability because it requires 
the defendant’s knowledge of the product’s danger­
ous condition and does not require that the product 
be defective. . . . The comments to section 389 make it 
clear that a bystander, assuming he is within the 
scope of foreseeability of risk, is owed a duty under 
law and may recover on a showing of breach, dam­
age, and causation” (p. 385). The case was sent back 
to the trial court for further proceedings. 
One case that was tried before a jury in March 
1998 resulted in a verdict for the defendants.  In that 
case, RJR Nabisco Holdings, Corps. v. Dunn (657 N.E.2d 
1220 [Ind. 1995]) a nonsmoking nurse who worked for 
17 years at a Veterans Administration Hospital died of 
lung cancer at the age of 56. Her widower sued a group 
of tobacco companies, claiming that her exposure to 
ETS from her patients at the hospital had killed her.  A 
six-person jury returned a verdict for the defendants. 
Interviewed after the trial, some of the jurors explained 
that they had had doubts as to whether the cancer that 
killed Mrs. Wiley had originated in the lungs or, as 
the tobacco companies’ lawyers had argued, in the 
pancreas and had then spread to the lungs (Dieter 1998). 
The most prominent ETS case with tobacco com­
pany defendants has been Broin v. Philip Morris Cos., 
which was brought against the six major cigarette 
manufacturers in 1991.  Seven current and former non­
smoking flight attendants, who contracted lung can­
cer or other ailments and who face an increased risk of 
disease as a result of exposure to ETS on airplanes, filed 
a class action suit on behalf of thousands of flight at­
tendants harmed by exposure to ETS on flights that 
predated the federal ban on smoking on domestic air­
line flights. In 1992, a Dade County circuit judge dis­
missed the class action aspect of the complaint, but two 
years later, a three-judge panel of the District Court of 
Appeal of Florida, Third District, unanimously reversed 
the order of dismissal and ordered that the class action 
allegations be reinstated (Broin, cited in 9.1 TPLR 2.1). 
In late December 1996, the Circuit Court for Dade 
County authorized the mass notification of some 
150,000 to 200,000 flight attendants so they could ei­
ther sign up as plaintiffs or exclude themselves from 
the case to pursue their own suits if they wished. In 
June 1997, jury selection in the trial began. More than 
three months later, midway through the companies’ 
presentation of their defense, the parties announced a 
proposed settlement whereby the defendants would 
pay $300 million to establish the Broin Research Foun­
dation. The settlement would permit flight attendants 
harmed by ETS exposure aboard airlines to sue the 
tobacco companies, regardless of statute of limitations 
issues. In the event of such individual actions, the de­
fendants would assume the burden of proof on the is­
sue of whether ETS exposure is capable of causing 
disease in nonsmokers. Dade County Circuit Judge 
Robert P. Kaye approved the proposed settlement on 
February 3, 1998, calling it “fair, reasonable, adequate 
and in the best interests of the class,” but challengers 
to the settlement have appealed (Broin v. Philip Morris 
Cos., No. 91-49738 CA [22] [Fla., Dade Cty.  Feb. 3, 1998], 
cited in 13.1 TPLR 2.79 [1998]). As of August 1998, the 
appeal was pending. 
One workplace setting that has generated sub­
stantial exposure to ETS has been casinos. In 1997, 
nine casino dealers filed a class action lawsuit against 
17 tobacco companies and organizations.  The lawsuit 
seeks tens of millions of dollars in damages and class 
certification of up to 45,000 casino dealers working in 
Nevada, along with their estates and family members. 
The plaintiffs in this case, Badillo v. American Tobacco 
Co. (No. CV-N-97-00573-DWH [D. Nev. 1997]), are also 
seeking to get medical monitoring for the dealers who 
have had years of exposure to ETS on the job.  In April 
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1998, a federal judge denied all of the motions to 
dismiss by the defendants, except for The American 
Tobacco Company, which has merged with Brown & 
Williamson Tobacco Corporation. 
In April 1998, a group of nonsmoking casino 
workers filed a lawsuit in New Jersey Superior Court 
against several tobacco companies and the industry’s 
trade association, the Tobacco Institute, because the 
workers were being made sick by their exposure to 
ETS at work (Smothers 1998). 
Suing Tobacco Companies Over Failure to Disclose 
Harm From ETS 
In a unique case from California, the City Attor­
ney of Los Angeles filed suit in July 1998, against 16 
tobacco companies (those that sell cigarettes, cigars, 
or pipe tobacco) and 15 retailers on the grounds that 
they are violating Proposition 65, an initiative statute 
passed by the voters of California in 1986. That law, 
known as the Safe Drinking Water and Toxic Enforce­
ment Act of 1986 and contained in California Health 
and Safety Code section 25249.6, provides that “no 
person in the course of doing business shall knowingly 
and intentionally expose any individual to a chemical 
known to the state to cause cancer or reproductive tox­
icity without first giving clear and reasonable warn­
ing to such individual.” 
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their agents, the Retailer Defendants, have each 
individually violated Proposition 65” (California v. Philip 
Morris Inc., No. BC194217 [Calif., Los Angeles Cty.  July 
14, 1998], cited in 13.4 TPLR 3.195 [1998]). 
The lawsuit specifically lists 46 chemicals referred 
to as carcinogenic constituents of tobacco smoke and 8 
(arsenic, cadmium, carbon disulfide, carbon monoxide, 
lead, nicotine, toluene, and urethane) as reproductive 
toxicants. The city attorney’s complaint cites a number 
of prominent government studies:  The Health Conse­
quences of Involuntary Smoking, the 1986 report of the U.S. 
Surgeon General on smoking and health; Environmental 
Tobacco Smoke:  Measuring Exposures and Assessing Health 
Effects, published in 1986 by the National Research 
Council; Respiratory Health Effects of Passive Smoking: 
Lung Cancer and Other Disorders, a report issued by the 
U.S. Environmental Protection Agency in January 1993; 
and Health Effects of Exposure to Environmental Tobacco 
Smoke, published by the California Environmental Pro­
tection Agency in September 1997.  The complaint al­
leges that “Notwithstanding this overwhelming body 
of governmental information, and notwithstanding their 
own knowledge of these facts since at least 1981, the 
Tobacco Defendants have each knowingly and intention­
ally concealed from, and thereby deceived, every non­
smoking individual exposed to environmental tobacco 
smoke by the sale and use of tobacco products in Cali­
fornia. By these acts of knowing and intentional con­
cealment and deception, the Tobacco Defendants, and 
The City of Los Angeles’ lawsuit will likely ben­
efit from a court decision rendered in 1997 in a federal 
court located some 3,000 miles away.  A nonsmoker in 
Florida filed a lawsuit against various tobacco com­
panies, alleging that she suffers from severe emphy­
sema and an array of other injuries as a result of 
prolonged exposure to ETS from the normal and fore­
seeable use of the companies’ products.  The compa­
nies filed a motion to dismiss her case, contending that 
the Federal Cigarette Labeling and Advertising Act 
preempts claims based on state law duties to dissemi­
nate information relating to smoking and health.  A 
judge in the U.S. District Court for the Southern Dis­
trict of Florida denied the motion to dismiss, conclud­
ing that the federal act’s preemption of state 
regulations “based on smoking and health” does not 
preempt regulations involving ETS.  “The Court finds 
it unlikely that Congress intended the word ‘smok­
ing’ to mean inhaling second-hand smoke,” since the 
“Congressional reports make clear the purpose of the 
[federal act] is not to inform non-smokers of the haz­
ards of breathing second-hand smoke but rather to 
inform smokers and potential smokers of the dangers 
of actively smoking” (Wolpin v. Philip Morris, Inc., No. 
96-1781-CIV-KING, 1997 WL 535218 [S.D. Fla.  Aug. 
18, 1997]). The court also ruled that the federal act did 
not by implication preempt a claim based on harm 
from ETS (Sweda 1998). 
ETS Cases Against Nontobacco Parties 
Injunctive relief from ETS. In 1976, Donna 
Shimp (see “Legal Foundation for Regulation of Pub­
lic Smoking,” earlier in this chapter), an office worker 
in New Jersey, sought intervention from the courts to 
provide her relief from exposure to ETS at her worksite 
(Shimp, 368 A.2d 408).  The court ruled that the evi­
dence was “clear and overwhelming. Cigarette smoke 
contaminates and pollutes the air, creating a health 
hazard not merely to the smoker but to all those around 
her who must rely upon the same air supply.  The right 
of an individual to risk his or her own health does not 
include the right to jeopardize the health of those who 
must remain around him or her in order to properly 
perform the duties of their jobs” (p. 415). In granting 
an injunction to ensure that Shimp be provided a 
smoke-free workplace, the New Jersey Superior Court 
provided a clear example of taking seriously the health 
concerns of nonsmokers who are forced to breathe ETS. 
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The Shimp decision preceded most of the medical stud­
ies that have demonstrated the adverse health effects 
of ETS. In the 22 years since Shimp, lawsuits designed 
to protect nonsmokers from the health hazards caused 
by involuntary exposure to ETS have escalated. 
A 1982 decision from the Missouri Court of Ap­
peals gave additional momentum to nonsmoking 
workers seeking legal relief from on-the-job exposure 
to ETS. In Smith (643 S.W.2d 10), the Missouri Court 
of Appeals reversed a trial court’s dismissal of a law­
suit brought by a nonsmoking worker who was seek­
ing an injunction—a form of direct intervention by a 
court—to prevent his employer from exposing him to 
tobacco smoke in the workplace. The court of appeals 
ruled that if Paul Smith were to prove his allegations 
at trial, then “by failing to exercise its control and as­
sume its responsibility to eliminate the hazardous con­
dition caused by tobacco smoke, defendant [Western 
Electric Co.] has breached and is breaching its duty to 
provide a reasonably safe workplace” (p. 13).  Al­
though the nonsmoking worker eventually lost his case 
after it was sent back to the trial court, the court of 
appeals decision remains as a precedent that will help 
similar cases survive motions to dismiss (Sweda 1998). 
The following year, a nonsmoking social worker 
in Attleboro, Massachusetts, was granted a temporary 
restraining order (which by law could last no more 
than 10 days) against smoking in the open office area 
where she worked with about 39 coworkers, 15 of 
whom smoked. In Lee (cited in 1.2 TPLR 2.82), a supe­
rior court judge denied a motion by the employer to 
dismiss the case, ruling that “an employer has no duty 
to make the work place safe if, and only if, the risks at 
issue are inherent in the work to be done.  Otherwise, 
the employer is required to ‘take steps to prevent in­
jury that are reasonable and appropriate under the cir­
cumstances’. . . . Accordingly, this court cannot say that 
plaintiff’s claim fails to make out a legally cognizable 
basis for relief” (p. 2.83).  The case was settled in Janu­
ary 1985 when the employer, the Commonwealth of 
Massachusetts, agreed to provide the plaintiff, Marie 
Lee, and the other nonsmoking workers there, with a 
separate nonsmoking area with ventilation separate 
from the ventilation in the smoking area.  As it turned 
out, only 4 of the office’s 40 workers chose to work in 
the smoking area (Sweda 1998). 
Handicap Discrimination/Americans 
With Disabilities Act 
A new theory for ensuring ETS protection for 
nonsmokers involved using the ADA.  As the ratio­
nale for applying the ADA to the workplace, Parmet 
and colleagues (1996) explained: “The ADA was en­
acted in 1990 to provide a ‘clear and comprehensive 
national mandate for the elimination of discrimination 
against individuals with disabilities’ [42 U.S.C. section 
12101(b)(1)]. The act prohibits discrimination against 
individuals with disabilities on the job [42 U.S.C. sec­
tion 12112(a)] and in places of ‘public accommodation’ 
[42 U.S.C. section 12182(a)], as well as by state and lo­
cal governments [42 U.S.C. section 12132]” (p. 909). 
Initially, some plaintiffs did not succeed in ac­
quiring relief from ETS under the ADA.  For example, 
in Harmer v. Virginia Electric and Power Co. (831 F. Supp. 
1300 [E.D. Va. 1993]), an employee suffering from bron­
chial asthma sued his employer, contending that in 
failing to ban smoking at the workplace, the company 
had violated the ADA by discriminating against him 
because of his disability.  Harmer contended that after 
he requested a smoke-free work environment, the com­
pany retaliated against him by reducing his job au­
thority and failing to promote him.  Though 
recognizing Harmer’s disability, the district court dis­
missed the claim, saying that he “still must show that 
he is entitled to a complete smoking ban as a reason­
able accommodation to his disability, and he is unable 
to do so” (p. 1306). This was so “because the many 
smoking limitations that the employer had put in place, 
coupled with improvements such as the installation 
of air filtration devices, were sufficient to enable the 
plaintiff to work. Of course, a patient more severely 
disabled might have required further accommoda­
tions” (Parmet et al. 1996, p. 912). 
In Emery v. Caravan of Dreams, Inc. (879 F. Supp. 
640 [N.D. Tex. 1995]), two women hypersensitive to 
ETS filed suit under the ADA, contending that they 
were effectively precluded from attending musical 
performances at the defendant’s establishment because 
smoking was permitted there.  After a one-day, jury-
waived trial, a federal judge ruled against the plain­
tiffs, but noted that they should have brought their 
claim under the ADA’s reasonable accommodation 
provision, instead of the section of the act that bars 
the establishment of rules that “screen out” disabled 
people (p. 643). 
A different result had occurred in a case from Con­
necticut. In Staron v. McDonald’s Corp. (51 F.3d 353 [2d 
Cir. 1995]), plaintiffs brought an action under the ADA, 
42 U.S.C. section 12101, saying that the presence of to­
bacco smoke in the defendants’ restaurants was prevent­
ing the plaintiffs from having the opportunity to benefit 
from the defendants’ goods and services.  The plain­
tiffs, all of whom have adverse reactions to ETS, also 
alleged that the defendants’ restaurants are places of 
public accommodation under 42 U.S.C. section 12181. 
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After a district judge granted the defendants’ motion to 
dismiss the case, the United States Court of Appeals for 
the Second Circuit reversed, ruling that “we find that 
plaintiffs’ complaints do on their face state a cognizable 
claim against the defendants under the Americans with 
Disabilities Act” (p. 355).  The court noted that “the de­
termination of whether a particular modification is ‘rea­
sonable’ involves a fact-specific, case-by-case inquiry 
that considers, among other factors, the effectiveness of 
the modification in light of the nature of the disability 
in question and the cost to the organization that would 
implement it [p. 356]. . . . We see no reason why, under 
the appropriate circumstances, a ban on smoking could 
not be a reasonable modification” (p. 357). 
An Illinois woman suffering from chronic severe 
allergic rhinitis and sinusitis sought a smoke-free work 
environment and sued her former employer after it 
“repeatedly refused to provide” the plaintiff with a 
reasonable accommodation to her disability.  After fil­
ing an ADA claim with the Equal Employment Op­
portunity Commission and a worker’s compensation 
claim, she was terminated. A federal judge in Homeyer 
v. Stanley Tulchin Associates, Inc. (No. 95 C 4439, 1995 
WL 683614 [N.D. Ill. Nov. 17, 1995]) granted the de­
fendants’ motion to dismiss, saying that the plaintiff 
“does not, and cannot, allege that her sensitivity to 
[ETS] substantially limits her ability to find employ­
ment as a typist generally.  Thus, Homeyer is not a 
qualified individual with a disability, and, accordingly, 
is not entitled to the protection of the ADA” (p. 3). 
However, the United States Circuit Court of Ap­
peals for the Seventh Circuit unanimously reversed 
the district court’s ruling and sent the case back for 
trial. Noting that the district court had ignored 
Homeyer ’s claim that she was disabled in that her 
breathing, an essential life activity, was affected by ETS, 
the court of appeals ruled that “we cannot say at this 
stage that it would be impossible for her to show that 
her chronic severe allergic rhinitis and sinusitis either 
alone or in combination with ETS substantially limits 
her ability to breathe” (Homeyer v. Stanley Tulchin As­
sociates, Inc., 91 F.3d 959, 962 [7th Cir. 1996]). 
In October 1997, a New York jury awarded 
$420,300 to an asthmatic prison guard, Keith Muller 
(Muller v. Costello, No. 94-CV-842 (FJS) (GJD), 1996 WL 
191977 [N.D.N.Y. May 20, 1996]), who had been fired 
after he had made numerous complaints about the ef­
fect of ETS exposure on his health.  While serving as a 
correctional officer, Muller had become seriously ill— 
including numerous occasions when he had to be taken 
to a hospital directly from the prison where he 
worked—after being exposed to ETS. After Muller’s 
treating physician had recommended that he work in 
Reducing Tobacco Use
 
a smoke-free environment, the New York State Depart­
ment of Correctional Services instead provided him 
with a mask that, according to Muller, made him even 
more ill.  Furthermore, wearing the mask had subjected 
Muller to widespread ridicule, putting him in even 
greater personal danger from the breakdown in the 
respect that the inmates had for him. Whereas a judge 
in 1996 had barred the plaintiff’s negligence and civil 
rights claims in Muller v. Costello, the court allowed 
Muller’s ADA claim to proceed. 
Ruling on posttrial motions, the judge reduced 
the award to $300,000 because of the cap on compen­
satory damages contained in 42 U.S.C. section 
1981a(b)(3). The court also rejected the defendant’s 
motion to vacate or reduce the verdict as excessive, 
ruling that the “plaintiff submitted evidence of dis­
crimination that had taken place over a period of years 
during which time he was forced to endure mental 
suffering, embarrassment, economic hardship, actual 
termination and physical injury.  In view of this evi­
dence, the Court finds that the jury award of $300,000 
is not excessive and does not shock the conscience as a 
matter of law” (Muller v. Costello, 997 F. Supp. 299, 303 
[N.D.N.Y. 1998]). 
In a more recent case, three asthmatic women 
sued Red Lobster and Ruby Tuesday restaurants un­
der the ADA.  The plaintiffs in Edwards v. GMRI, Inc. 
(No. 119S93 [Md., Montgomery Cty. Nov. 26, 1997], 
cited in 13.1 TPLR 3.1 [1998]) said that they attempted 
to patronize the defendants’ restaurants but were 
forced to leave because of the ETS there.  In their com­
plaint, the plaintiffs stated that the defendants’ “fail­
ure to establish a policy prohibiting smoking in their 
restaurants throughout the state discriminates against 
the Plaintiffs on the basis of their disability in their 
use and enjoyment of” the restaurants (p. 3.3). 
Seepage of Smoke From One Dwelling 
Unit to Another 
The 1990s have seen the development of cases in 
which a nonsmoker living in an apartment or condo­
minium unit is being adversely affected by smoke en­
tering his or her dwelling space from elsewhere.  In 
June 1998, a Boston Housing Court judge ruled in fa­
vor of nonsmoking tenants who were being evicted 
for nonpayment of rent (50-58 Gainsborough Street Re­
alty Trust v. Reece and Kristy Haile, No. 98-02279, Bos­
ton Housing Court [1998]). After pleading with the 
landlord for several months to do something about 
the problem of smoke from a first-floor nightclub 
constantly entering their second-floor apartment 
and disrupting their ability to use and enjoy their 
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apartment, the tenants got no relief. After they with­
held their monthly rent payments of $1,450, the land­
lord brought an action in housing court seeking their 
eviction. The court ruled that “the evidence does dem­
onstrate to the Court that the tenants’ right to quiet 
enjoyment [of their apartment] was interfered with be­
cause of the second hand smoke that was emanating 
from the nightclub below” (p. 34).  The court ruled 
that “as the tenants describe the second hand smoke 
within their apartment at nighttime, the apartment 
would be unfit for smokers and non-smokers alike” 
(p. 7). That interference with the quiet enjoyment of 
the tenants’ apartment was a defense to the effort to 
evict them. Also, the court found for the tenants in 
the amount of $4,350—the same amount that the ten­
ants had withheld over the course of three months. 
In Dworkin v. Paley (93 Ohio App. 3d 383, 638 
N.E.2d 636 [Ohio Ct. App. 1994]), Dworkin, a non­
smoker, entered into a one-year lease with Paley to 
reside in a two-family dwelling; the lease was later 
renewed for an additional one-year term. During the 
second year, Paley, a smoker, moved into the dwelling 
unit below Dworkin’s. Two weeks later, Dworkin 
wrote to Paley to tell her that her smoking was annoy­
ing him and causing him physical discomfort, noting 
that the smoke came through the common heating and 
cooling systems shared by the two units.  Within a 
month, Dworkin vacated the premises. Eight months 
later, he brought a legal action to terminate the lease 
and recover his security deposit from Paley.  The law­
suit, which alleged that Paley had breached the cov­
enant of quiet enjoyment and statutory duties imposed 
on landlords (including doing “whatever is reasonably 
necessary to put and keep the premises in a fit and 
habitable condition,” p. 387) was dismissed on a mo­
tion for summary judgment. However, the Cuyahoga 
County Court of Appeals reversed the dismissal, 
concluding that a review of the affidavits in the case 
“reveals the existence of general issues of material fact 
concerning the amount of smoke or noxious odors 
being transmitted into appellant’s rental unit” (p. 387). 
The case was thus sent back to the trial court. 
In June 1998, a prominent New York law firm, 
Weil, Gotshal & Manges LLP, sued the owner and land­
lord of the office building where it is located, as well 
as the tenant located one floor below, because of ETS 
seepage into its office space.  The firm alleges in its 
lawsuit, that as a result of the smoke infiltrating into 
its 29th floor offices, “some of WG&M’s partners, as­
sociates and employees have suffered illness, discom­
fort, irritation and endangerment to their health and 
safety, and/or have been unable to use or occupy their 
offices or workstations on the WG&M 29th Floor 
Premises” (Weil, Gotshal & Manges LLP v. Longstreet As­
sociates, L.P. [N.Y., N.Y. Cty. June 12, 1998], cited in 13.4 
TPLR 3.188 [1998]). 
Many landlords are not waiting to be sued.  The 
Building Owners and Managers Association Interna­
tional, a trade association for 16,000 office landlords 
and owners, has been advising its members to lessen 
their risk of ETS liability by banning smoking when­
ever possible. During the past two years, the propor­
tion of member office buildings that banned smoking 
increased from 68 to 80 percent (White 1998). 
United States Supreme Court Ruling on ETS in 
Prisons—Eighth Amendment Issues 
Perhaps the most frequent area of litigation in­
volving exposure to ETS has come in a setting where 
the exposure is both involuntary and inescapable— 
prisons. A landmark case that eventually reached the 
United States Supreme Court started in Nevada when 
a nonsmoking prisoner was housed in the same cell as 
a heavy smoker (McKinney v. Anderson, 924 F.2d 1500 
[9th Cir. 1991]).  The nonsmoker brought a civil rights 
lawsuit against the prison officials, claiming that his 
Eighth Amendment right to be protected from cruel 
and unusual punishment was being violated due to 
his constant exposure to ETS.  Although his case was 
thrown out initially by a district court in Nevada, the 
lawsuit was reinstated by the United States Court of 
Appeals for the Ninth Circuit. The court ruled that 
even if the inmate could not show that he suffered from 
serious, immediate medical symptoms caused by ex­
posure to ETS, compelled exposure to that smoke is 
nonetheless cruel and unusual punishment if at such 
levels and in such circumstances as to pose an unrea­
sonable risk of harm to the inmate’s health. 
On June 18, 1993, the Supreme Court ruled in a 7 
to 2 decision that McKinney’s case could go forward. 
The Court affirmed “the holding of the Court of Ap­
peals that McKinney states a cause of action under the 
Eighth Amendment by alleging that petitioners [the 
prison officials] have, with deliberate indifference, ex­
posed him to levels of ETS that pose an unreasonable 
risk of serious damage to his future health” (Helling v. 
McKinney, 113 S. Ct. 2475  [1993]). 
ETS and Child Custody Cases 
Disagreements between parents who are divorc­
ing can, of course, cover a wide variety of subjects. 
One of the issues that has increasingly become a sig­
nificant subject of disputes that have ended up before 
a judge in probate court has been the exposure to ETS 
on the part of a child or children caught up in a 
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custody battle. Over the past 11 years, there have been 
recorded cases in at least 20 states (Sweda 1998).  One 
of the earliest was Wilk v. Wilk (In re Wilk v. Wilk, 781 
S.W.2d 217 [Mo. App. 1989]).  The trial court in this 
case granted primary custody of the children to the 
mother, who had been advised by a doctor that the 
children, one of whom was asthmatic, should not 
be taken to the father’s home because he smoked.  The 
Missouri Court of Appeals ruled that the trial court 
did not err in awarding custody of the minor children 
to the mother. 
In a case from Kansas, an ex-wife with custody 
sought permission to move with her children to an­
other state; the ex-husband responded with a motion 
to obtain custody.  The district court did make the 
change by awarding custody to the ex-husband after 
finding that the ex-wife’s smoking had harmed the 
children. The ex-wife appealed, arguing that there had 
been no evidence to prove that her smoking had caused 
her children’s health problems.  The court of appeals 
affirmed the district court’s change of custody, noting 
that there was evidence that her smoking had harmed 
the children:  “That finding is supported by the testi­
mony of three doctors that second-hand smoke aggra­
vated the children’s health problems and placed them 
at risk for further health problems” (In re Aubuchon, 
913 P.2d 221 [Kan. Ct. App. Mar. 22, 1996]). 
In some cases, the smoking issue is not sufficient 
to produce a change of custody.  For example, in Helm 
v. Helm (01-A-01-9209-CH00365, 1993 WL 21983 [Tenn. 
App. Feb. 3, 1993]), the trial court awarded custody of 
a five-year-old child to the father.  The mother appealed 
the divorce decree, arguing before the Court of Ap­
peals of Tennessee that the father smoked around the 
child. The court said that “Other than exposure to vio­
lent movies and cigarette smoke, no evidence is cited 
that the father has neglected or mistreated the child” 
(p. 2). The trial court’s judgment was affirmed, with 
the mother being accorded visitation rights. In Baggett 
v. Sutherland (No. CA 88-224, 1989 WL 5399 [Ark. App. 
Jan. 25, 1989]), a nonsmoking father attempted to ob­
tain a change in custody on the basis of, among other 
things, the fact that the mother smoked in the pres­
ence of children who were allergic to smoke.  Although 
the lower court had found that circumstances were not 
so changed as to warrant a change in custody, it did 
acknowledge that smoking was detrimental to the chil­
dren. The mother was forbidden to smoke in the home 
or allow anyone else to smoke in the home; the judge 
“made it clear that he would exercise continuing ju­
risdiction over the parties to insure compliance with 
that order” (p. 3). 
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Rulings in other cases have been the product 
of compromise.  In Northcutt v. Northcutt, a 1997 case, 
a nonsmoking father objected to ETS around his 
2-year-old son, who has asthma and has had repeated 
respiratory infections, bronchitis, allergies, and ear­
aches (Sweda 1998). As part of a joint custody agree­
ment, a Warren County, Tennessee, judge ordered the 
mother to keep her son away from ETS. Each parent 
was to have custody for six months per year. 
Victims of Smoking-Related Fires 
Smoking is the leading cause of deaths and inju­
ries by residential fire.  According to the Building and 
Fire Research Laboratory of the National Institute of 
Standards and Technology, cigarettes start more fatal 
fires than any other ignition source, causing about 30 
percent of all fire deaths in this country.  For example, 
in 1989, 44,000 cigarette-ignited fires caused 1,220 
deaths, 3,358 injuries, and $481 million in property 
damage (Karter 1993). 
In 1984, Congress passed the Cigarette Safety Act 
(Public Law 98-567), creating a Technical Study Group 
to assess the feasibility of developing a less incendi­
ary cigarette.  The group concluded that changing a 
standard cigarette’s diameter, paper porosity, and to­
bacco density would produce a cigarette that would 
not transfer enough heat to cause a fire when dropped 
on most upholstery (Technical Study Group on Ciga­
rette and Little Cigar Fire Safety 1987).  The tobacco 
industry maintains that even if such cigarettes could 
be manufactured, when smoked they would not burn 
as thoroughly as current brands, meaning that fire-safe 
cigarettes would deliver more tar, nicotine, and car­
bon monoxide to the smoker (Levin 1987). 
The prospect of technologies for making less in­
cendiary cigarettes raises the question of whether the 
manufacturers might be held liable for failure to in­
corporate such a feature.  Until now, product liability 
litigation for fires caused by cigarettes has met with 
no more success than smokers’ claims for injuries to 
health. The first such case to produce a judicial deci­
sion, Lamke v. Futorian Corp. (709 P.2d 684 [Okla. 1985]), 
involved a fire started when a cigarette ignited a sofa, 
resulting in severe burns to much of the plaintiff’s 
body.  The Oklahoma Supreme Court applied the so-
called consumer expectation test to find that the ciga­
rettes in question were not dangerous to an extent 
beyond what would be expected by the ordinary con­
sumer.  The consumer expectation test, which evolved 
from comments to section 402A of the Restatement 
(Second) of Torts, today survives as the law in a mi­
nority of jurisdictions (American Law Institute 1995). 
   
6 A summary judgment is a judgment granted without a formal 
trial when it appears to the court that there is no genuine issue of 
fact and that the moving party is entitled to judgment as a matter 
of law. 
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The prevailing view, endorsed by the current draft of 
the Restatement (Third) of Torts, would determine li­
ability for defective product design by a risk-benefit 
standard that evaluates the quality of the manufac­
turer’s design decision by reviewing whether the 
manufacturer properly weighed the comparative costs, 
safety, and mechanical feasibility of one or more alter­
native designs (Green 1995).  In Lamke, the court found 
that evidence regarding the feasibility of manufactur­
ing a less incendiary cigarette was irrelevant to con­
siderations of consumer expectation, but such evidence 
might be found persuasive in a jurisdiction following 
a risk-benefit standard for determining design defects. 
Whether the tobacco companies suppressed research 
and product development regarding fire-safe cigarettes 
is under investigation by the antitrust division of the 
U.S. Department of Justice (Shapiro 1994c). 
Fire claims by smokers would face many of the 
familiar obstacles to recovery but, as two pending 
claims illustrate, many of the potential plaintiffs in fire 
litigation are not smokers but third parties untainted 
by the decision to smoke. In Kearney v. Philip Morris 
Cos. ([D. Mass. May 11, 1992], cited in 7.2 TPLR 3.65 
[1992]), suit was brought on behalf of a woman who 
died in a fire started by her husband’s cigarette.  The 
plaintiff’s attorneys focused “on the issue of additives 
and other manufacturing techniques that cigarette 
makers use to ensure that cigarettes will stay lit even 
if they aren’t being smoked” (Wilke and Lambert 1992). 
On February 16, 1996, Judge Robert E. Keeton granted 
summary judgment6 in favor of Philip Morris, hold­
ing that even under the more forgiving standard of 
liability for design defect, “fatal gaps” existed in evi­
dence submitted by the plaintiff in supporting her 
claim that adoption of an alternative design by the 
company would have prevented the fire started by Mr. 
Kearney’s cigarette (Kearney v. Philip Morris Inc., 916 F. 
Supp. 61, 66 [D. Mass. 1996]). 
Another cigarette-caused fire claim seeks recov­
ery based on the fire-related injuries received by a 
21-month-old infant trapped in her child car seat 
(Shipman v. Philip Morris Cos., Cause No. 26294 [Tex., 
Johnson Cty. Oct. 7, 1994], cited in 10.1 TPLR 3.91 
[1995]). 
Enhancing Prohibitory Regulation by Private 
Litigation 
Enforcing Minors’ Access Laws 
Although selling cigarettes to minors is prohib­
ited in all states and the District of Columbia, retail 
store employees frequently ignore the law (Lew 1992). 
Enforcing these widespread and important statutes is 
typically left to government officials who have com­
peting commitments and limited sanctioning powers. 
A pioneering suit, brought by tobacco activists against 
a Massachusetts convenience store chain, sought to 
supplement this ineffectual arrangement by private 
enforcement. The initiative first took the form of a test 
case, sponsored by the Tobacco Products Liability 
Project, charging that Philip Morris was engaged in a 
“civil conspiracy” with the convenience store chain to 
sell cigarettes to minors.  A divided Massachusetts 
Supreme Court found the conspiracy unproven (Kyte 
v. Philip Morris Inc., 408 Mass. 162, 556 N.E.2d 1025 
[Mass. 1990]). The plaintiffs then refocused the suit 
directly against the convenience store chain, alleging 
that it had violated the Massachusetts Consumer Pro­
tection Act, which allows consumers to bring civil suits 
directly against vendors for money damages and in­
junctions. The suit terminated in a settlement in which 
the chain agreed to demand proof of age from would-
be cigarette purchasers.  In 1992, the Tobacco Prod­
ucts Liability Project launched a project to research the 
legal basis for such suits in all 50 states and to provide 
informational and strategic support for such litigation 
(Lew 1992). 
After the settlement in Kyte, the attorney general 
in Massachusetts, acting under the state’s consumer 
protection laws (Mass. Ann. Laws ch. 93a, sec. 1) be­
gan to conduct tests using minors posing as custom­
ers to gauge retailer compliance with state bans on 
tobacco sales to persons under 18 years of age (Mass. 
Ann. Laws ch. 270, sec. 6). Settlements were reached 
with several supermarket chains in 1994 for monetary 
damages as well as implementation of measures de­
signed to reduce the risk of further illegal tobacco sales 
to minors (Tobacco Products Liability Project 1996).  By 
1998, state attorneys general offices in 26 states began 
working with the National Association of Attorneys 
General and the Tobacco Control Resource Center 
(1998) to develop approaches to prevent illegal tobacco 
sales to minors. 
Kyte presents an instance of a lawyer functioning 
as a private attorney general to secure the enforcement 
of underenforced public standards.  This case suggests 
that restrictions on sales to minors might be enforced 
more effectively by establishing informational net­
works and incentives (such as the recovery of attor­
neys’ fees) to facilitate widespread and routine 
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exertions by lawyers. Such private enforcement is a 
well-established feature of a number of regulatory re­
gimes, including consumer credit regulations, securi­
ties laws governing insider trading, and bounties paid 
for apprehending persons who defraud the govern­
ment. In devising such strategies, the risks of underuse, 
overuse, and abuse must be identified to frame a 
scheme of incentives that yields optimum results. 
One state’s highest court has upheld the legal 
validity of using the civil provisions of consumer pro­
tection statutes to enforce penal laws prohibiting to­
bacco sales to minors. The California Supreme Court 
held that a private and for-profit enterprise had stand­
ing under that state’s consumer protection laws to 
maintain a private action in the public interest, even 
though the underlying penal statute contained no pro­
visions for a private right of action (Stop Youth Addic­
tion, Inc. v. Lucky Stores, Inc., 17 Cal. 4th 553, 557, 71 
Cal. Rptr. 2d 731 [1998]). 
Restrictions on Advertising 
State and local laws restricting the advertising 
and promotion of tobacco products (see “Advertising 
and Promotion,” earlier in this chapter) provide an­
other occasion for private initiatives. The California 
Supreme Court held that federal preemption did not 
extend to bar a suit claiming that the “Joe Camel” ad­
vertising campaign targeted minors and thus violated 
California’s ban on unfair business practices (see “A 
Critical Example: Joe Camel,” earlier in this chapter) 
(Mangini, 875 P.2d 75).  This suit, like Kyte, invites con­
sideration of the benefits and costs of the private at­
torney general device. Such an evaluation must 
compare the performance of private efforts with ac­
tual rather than idealized governmental regulatory ac­
tivity.  For example, the FTC did secure a consent 
decree against the Pinkerton Tobacco Company (In re 
Pinkerton Tobacco Co., 115 F.T.C. 60, 1992 F.T.C. LEXIS 
35 [Jan. 9, 1992]) to cease promotion of its smokeless 
products at a televised tractor pull. On the other hand, 
after FTC staff lawyers recommended in 1994 that the 
FTC charge R.J. Reynolds Tobacco Company with us­
ing the Joe Camel campaign to promote cigarettes to 
children, the commissioners voted 3 to 2 to take no 
action (FTC:Watch 1994). 
Reducing Tobacco Use 
a consent decree in which the arena admitted no 
wrongdoing but agreed to remove cigarette advertis­
ing from sites where it would be seen on television 
(Thomas and Schwartz 1995). The government’s en­
forcement capacity in this area could be amplified if 
there were sufficient incentives for private litigants. 
The presence of private attorneys general may 
add to the limited resources of public regulators.  The 
U.S. Department of Justice recently settled a lawsuit 
against Madison Square Garden for circumventing the 
1971 federal ban on broadcast advertising of cigarettes 
by placing cigarette advertising where it would be dis­
played in television broadcasts.  The case ended with 
The International Dimension of Tobacco Litigation 
Tobacco Litigation Abroad 
The first and second waves of tobacco litigation 
were uniquely U.S. phenomena, but the third wave 
has an international dimension that its predecessors 
lacked. Only a few years after a 1990 survey reported 
that “there has been no history of tobacco litigation in 
the [European Community]” (Cooper 1990, p. 291), 
counterparts of many of the third-wave litigation ini­
tiatives have appeared in other countries. In Austra­
lia, employees injured by ETS have recovered 
substantial damages from their employers (Daynard 
1994a). A public interest group, the Consumer’s Fed­
eration of Australia, secured a judicial declaration that 
the Tobacco Institute of Australia Ltd. had falsely 
claimed that “there is little evidence and nothing which 
proves scientifically that cigarette smoke causes dis­
ease in non-smokers” (Daynard 1994a, p. 60). A French 
public interest group, acting as private attorneys gen­
eral, successfully enforced bans against tobacco adver­
tisements on radio and television (Gourlain v. Societe 
Nationale D’Exploitation Industrielle des Tabacs et 
Allumettes [SEITA] [Tribunal de Grande Instance de 
Montargis Dec. 19, 1996], cited in 11.8 TPLR 3.1073 
[1996]). In Canada, a class action suit based on addic­
tion was filed against Canada’s three largest tobacco 
manufacturers.  To show that the tobacco companies 
knew of nicotine’s addictiveness, the suit relied on 
documents uncovered in the United States (Van Rijn 
1995). In England, the Legal Aid Board granted cer­
tificates of eligibility for legal aid to fund 200 cases 
brought by smokers alleging that tobacco manufactur­
ers had failed to meet their legal duty to minimize the 
risks of smoking (PR Newswire 1995).  Legal Aid’s 
willingness to finance the litigation comes after a three-
year battle for funding, led by the British group Ac­
tion on Smoking and Health (Milbank 1995). 
Foreign Plaintiffs in the American Courts 
Overseas sales are an increasingly important sec­
tor of the American tobacco industry: exports grew 
from 8 percent of total production in 1984 to 35 per­
cent in 1996 (MacKenzie et al. 1994; U.S. Department 
of Agriculture 1996).  The absence of warnings on the 
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packaging of exports and the aggressive promotional 
activity might help foreign plaintiffs who brought 
claims in U.S. courts overcome some of the barriers 
that have protected tobacco companies from domestic 
plaintiffs. However, such litigation would face other 
formidable obstacles, including the problem of estab­
lishing a substantive right to recover according to for­
eign law and an expanded notion of the responsibilities 
of multinational corporations for merchandise sold 
overseas. Such an expansion seems unlikely in the 
light of the reluctance of U.S. courts to provide a fo­
rum for foreign victims of corporate misconduct. This 
reluctance was dramatized in the litigation arising 
from the 1984 chemical plant explosion in Bhopal, In­
dia (Jasanoff 1985; Cassels 1993; Galanter 1994).  Al­
though the U.S. courts decided that the case should be 
tried in India rather than in the United States (In re 
Union Carbide Corp. Gas Plant Disaster at Bhopal, India 
in December, 1984, 634 F. Supp. 842 [S.D.N.Y. 1986], aff’d 
in part 809 F.2d 195 [2d Cir. 1987], cert. denied, 484 U.S. 
871, 108 S. Ct. 199 [1987]), the U.S. parent company 
was required, as a condition of moving the case to 
India, to submit to the jurisdiction of the Indian courts. 
A number of rulings in the Bhopal litigation also cre­
ated the basis for enhanced liability of U.S. multina­
tional corporations for their overseas operations. In a 
later proceeding, a U.S. court acknowledged that a for­
eign government might establish itself as the exclu­
sive representative of victims of a mass tort (Bano Bi v. 
Union Carbide Chems. & Plastics Co., 984 F.2d 582 [2d 
Cir. 1993]).  If any of the current third-wave claims 
flourish, foreign claims will likely be presented to U.S. 
lawyers and filed in U.S. courts. 
On May 12, 1998, the Republic of Guatemala be­
came the first nation to file a lawsuit against the U.S. 
tobacco industry for the recovery of public health care 
expenses (Davis 1998) (Guatemala v. Tobacco Institute 
[D.C. May 12, 1998], cited in 13.3 TPLR 3.121 [1998]). 
Counterthrust: Tobacco Industry Initiation of 
Litigation and Other Tactics 
The Tobacco Industry Response to the Science of ETS 
In its 1993 lawsuit filed in U.S. District Court in 
Greensboro, North Carolina, the tobacco industry 
accused the EPA of using improper procedures, includ­
ing statistical manipulation, to arrive at a predeter­
mined conclusion and sought “a declaration that EPA’s 
classification of ETS as a Group A [known human] 
carcinogen and the underlying risk assessment are 
arbitrary, capricious, violative of the procedures re­
quired by law, and unconstitutional” (Flue-Cured Tobacco 
Cooperative Stabilization Corp. v. United States Environ­
mental Protection Agency [M.D.N.C. June 22, 1993], cited 
in 8.2 TPLR 3.97 [1993]). As discussed earlier in this 
chapter (see “Health Consequences of Exposure to 
ETS”), on July 17, 1998, U.S. District Judge William L. 
Osteen Sr. issued a ruling whereby the court annulled 
Chapters 1–6 and the Appendices to EPA’s Respiratory 
Health Effects of Passive Smoking: Lung Cancer and Other 
Disorders (EPA 1992; Meier 1998b).  The judge reached 
his conclusion only after having denied the EPA’s mo­
tion to dismiss the case even though the EPA had never 
taken, and indeed had no authority to take, final agency 
action (e.g., the adoption of a regulation restricting 
smoking) based on its report (Flue-Cured Tobacco Coop­
erative Stabilization Corp. v. United States Environmental 
Protection Agency, 857 F. Supp. 1137 [M.D.N.C. 1994]). 
This lawsuit, filed in 1993, was not the first in­
stance of the tobacco industry attacking scientists and 
their work on ETS. Internal industry memos were cited 
in an article in April 1998 in the Wall Street Journal: 
“Determined to keep reports about second-hand 
smoke from mushrooming, the tobacco industry mo­
bilized a counter attack in the mid-1980s to systemati­
cally discredit any researcher claiming perils from 
passive smoke” (Hwang 1998). In a February 25, 1985, 
letter, Anthony Colucci, who was a top scientist at R.J. 
Reynolds Tobacco Company, wrote to H.E. Osmon, a 
director of public affairs at R.J. Reynolds:  “. . . we an­
ticipate that if [then-EPA scientist James] Repace runs 
true to form there will be a good deal of media copy 
written about their [Repace’s and naval researcher 
Alfred Lowrey’s] analyses and thus we should begin 
eroding confidence in this work as soon as possible” 
(Hwang 1998). 
A British-American Tobacco Company memo 
from 1988 details a meeting at which Philip Morris 
unveiled its plans to organize the “selection, in all pos­
sible countries, of a group of scientists either to criti­
cally review the scientific literature on ETS to maintain 
controversy, or to carry out research on ETS.  In each 
country a group of scientists would be carefully se­
lected, and organized by a national coordinating sci­
entist” (Boyse 1988, p. 2). The Philip Morris plan begins 
by drawing up a list of “European scientists who have 
had no previous association with tobacco companies” 
(p. 2). The scientists are then contacted and 
asked if they are interested in problems of Indoor 
Air Quality: tobacco is not mentioned at this stage. 
CVs are obtained and obvious “anti-smokers” or 
those with “unsuitable backgrounds” are filtered 
out. The remaining scientists are sent a literature 
pack containing approximately 10 hours of 
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reading matter, including “anti-ETS” articles.  They 
are asked for a genuine opinion as independent 
consultants, and if they indicate an interest in pro­
ceeding further a Philip Morris scientist makes 
contact. Philip Morris then expects the group of 
scientists to operate within the confines of deci­
sions taken by PM scientists to determine the gen­
eral direction of research, which apparently would 
then be “filtered” by lawyers to eliminate areas of 
sensitivity (p. 2). 
As this observer notes, “Although the industry is 
in great need of concerted effort and action in the ETS 
area, the detailed strategy of Philip Morris leaves some­
thing to be desired.  The excessive involvement of ex­
ternal lawyers at this very basic scientific level is 
questionable” (Boyse 1988, p. 275). Chapman (1997) 
has described this 1988 memo as one that “promises to 
blow apart the façade that the tobacco industry carries 
out neutral research into passive smoking” (p. 1569). 
A study published in May 1998 in the Journal of 
the American Medical Association (Barnes and Bero 1998) 
concluded that of the 37 percent (39 out of 106) of ar­
ticles reviewed that concluded that ETS is not harmful 
to health, 74 percent (29 out of 39) of these were written 
by authors with tobacco industry affiliations.  In this 
survey, the authors included articles whose stated or 
implied purpose was to review the scientific evidence 
that ETS is associated with one or more health outcomes. 
Articles were excluded if they did not focus specifically 
on the health effects of ETS or if they were not written 
in English. The authors noted, “In multiple logistic re­
gression analyses controlling for article quality, peer 
review status, article topic, and year of publication, the 
only factor associated with concluding that passive 
smoking is not harmful was whether an author was 
affiliated with the tobacco industry” (p. 1566).  The au­
thors also found that the “conclusions of review articles 
are strongly associated with the affiliations of their au­
thors. Authors of review articles should disclose po­
tential financial conflicts of interest, and readers should 
consider authors’ affiliations when deciding how to 
judge an article’s conclusions” (p. 1566). 
Other Industry-Sponsored Opposition to State 
Tobacco Control Initiatives and Advocates 
Florida legislation authorizing the state to recover 
tobacco-related health spending; the suit was ulti­
mately unsuccessful (Agency for Health Care Adminis­
tration v. Associated Industries of Florida, No. 86,213 [Fla. 
June 27, 1996], cited in 11.4 TPLR 2.113 [1996]).  Simi­
larly, the Governor of Mississippi, along with the to­
bacco industry, brought unsuccessful proceedings in 
the Mississippi Supreme Court to stop the Mississippi 
Medicaid reimbursement suit from going forward (In 
re Kirk Fordice as Governor of Mississippi [Miss. S. Ct.], 
cited in 12.1 TPLR 2.5 [1997]; In re Corr-Williams Tobacco 
Co. [Miss. S. Ct.], cited in 12.1 TPLR 2.1 [1997]). The 
tobacco industry also filed preemptive challenges on 
federal constitutional grounds to other state lawsuits 
even before these suits were filed (e.g., Philip Morris 
Inc. v. Harshbarger, Civil Action No. 95-12574-GAO 
[Mass. Nov. 22, 1996], cited in 11.8 TPLR 2.259 [1996]; 
Philip Morris Inc. v. Graham, Case No. 960904948 CV 
[Utah Dist. Ct. Salt Lake Cty.], cited in 12.1 TPLR 2.46 
[1997]; Philip Morris Inc. v. Blumenthal, No. 97- 7122 [2d 
Cir. 1997], cited in 12.5 TPLR 2.305 [1997]), and the in­
dustry has tried to remove these suits from state to 
federal court once they were filed (e.g., Massachusetts 
v. Philip Morris Inc., No. 96-10014-GAO [D. Mass. May 
20, 1996], cited in 11.3 TPLR 2.33 [1996]; Louisiana v. 
American Tobacco Co., No. 96-0908 [La. July 16, 1996], 
cited in 11.5 TPLR 2.164 [1996]; Maryland v. Philip Mor­
ris Inc., No. CCB-96-1691 [Md. July 31, 1996], cited in 
11.5 TPLR 2.167 [1996]; Connecticut v. Philip Morris Inc., 
No. CV960153440S [Conn. Oct. 9, 1996], cited in 11.7 
TPLR 2.238 [1996]). 
Tobacco interests have used the courts 
proactively against other measures to prevent smok­
ing. The proliferation of third-wave litigation against 
the tobacco industry has been matched by a more ag­
gressive use of litigation by tobacco interests.  For ex­
ample, the industry and its allies filed a preemptive 
challenge, on state constitutional grounds, to the 
Arguably, the most sweeping litigation measure 
taken by the tobacco industry was initiated on August 
10, 1995, when Philip Morris and others filed suit to 
block the FDA from regulating the sale, promotion, and 
distribution of cigarettes to minors. Discussed earlier 
in this chapter (see “Further Regulatory Steps”), the 
suit challenged the agency’s authority to regulate ciga­
rettes under the Federal Food, Drug, and Cosmetic Act. 
The lawsuit further charged that the proposed regula­
tions would violate the tobacco companies’ freedom 
of speech and would impair their ability to compete 
(Collins 1995b). 
Tobacco companies have also used litigation tac­
tically to impede the flow of damaging information. 
Brown & Williamson Tobacco Corporation brought suit 
against a paralegal aide accused of stealing confiden­
tial and potentially incriminating documents (Wyatt, 
Tarrant & Combs v. Williams, 892 S.W.2d 584 [Ky. 1995]). 
The documents, some of which were ultimately ob­
tained by members of Congress, have shown that the 
tobacco manufacturers not only knew of both the 
addictive and the carcinogenic properties of tobacco 
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use but also concealed the evidence for decades 
(Shapiro 1994b).  R.J. Reynolds brought suit (R.J. 
Reynolds Tobacco Co. v. John Does, 94-CVS-5867 [N.C., 
Forsyth Cty. 1994], cited in 9.4 TPLR 2.95 [1994]) to stop 
the solicitation of damaging information from tobacco 
insiders (National Law Journal 1994). In March 1994, 
Philip Morris filed a $10 billion libel suit in Virginia 
circuit court against the American Broadcasting Com­
pany (ABC) television network, a reporter, and a pro­
ducer of the network’s magazine program Day One. 
The suit concerned a broadcast segment that focused 
on Philip Morris’ chief competitor, R.J. Reynolds To­
bacco Company, and that accused R.J. Reynolds (and, 
in effect, the entire tobacco industry) of increasing the 
levels of nicotine in cigarettes to cause addiction among 
smokers (Chamberlain 1994; Janofsky 1994b). R.J. 
Reynolds subsequently filed a similar suit. In August 
1995, after a siege of unusually aggressive discovery 
(Frankel 1995), ABC agreed to apologize for its “mis­
take” in accusing the manufacturers of “spiking” nico­
tine and to pay for Philip Morris’ legal expenses, 
reportedly some $15 million (Freedman et al. 1995). 
ABC preferred to avoid the rigors of further litigation 
even though “the network’s own lawyers felt they had 
a 65 percent chance of winning the case” (Landler 
1995). Philip Morris subsequently took out full-page 
advertisements in the New York Times, Washington Post, 
Wall Street Journal, and other newspapers, proclaim­
ing ABC’s capitulation.  That Philip Morris chose to 
respond to the news report with legal action, rather 
than mounting an aggressive advertising campaign as 
it has done in the past, is seen as reflecting the 
company’s decision to turn over responsibility for 
public relations to its lawyers (Landler 1995). 
Tobacco companies have heavily funded organi­
zations that oppose smoke-free laws and policies.  The 
National Smokers Alliance (NSA), for example, pur­
ports to be a membership organization on behalf of 
smokers. When NSA’s Senior Vice President Gary 
Auxier was asked why his organization, which boasts 
that it is “a nonprofit, grass-roots membership organi­
zation with more than 3 million members,” in fiscal 
year 1996 collected only $74,000 from dues (enough 
for 7,400 members) while its total receipts were more 
than $9 million, Auxier chose not to answer (Levin 
1998). The NSA has vigorously attacked the smoke-
free bar law in California, including publicizing bar 
owners who have engaged in civil disobedience (PR 
Newswire 1998b).  Regarding this and other media-
attracting actions, Morain (1998) points out, “Assist­
ing that group is one of the world’s largest public 
relations firms, Burson-Marsteller.  The company has 
a long-standing account with the tobacco industry and 
is renowned for its ability to generate news coverage. 
As the organizers tell it, they’re merely tapping the 
grass roots of the body politic, giving a voice to every­
day people. Opponents deride the [supposed grass-
roots] campaign as ‘Astroturf’ ” (p. A23). 
In opposing a lawsuit based on harm from ETS, 
Philip Morris tried to subpoena scientific researchers’ 
raw data that support epidemiologic research on the 
link between ETS and lung cancer.  A state judge re­
jected the company’s attempt to get the raw data, citing 
a 1990 Louisiana privacy law.  The court found that “en­
forcement of the subpoenas would leave the research­
ers with the knowledge throughout continuation of their 
studies [that] the fruits of their labors had been appro­
priated by and were being scrutinized by a not unbi­
ased third party whose interests were arguably 
antithetical to theirs” (In re Philip Morris Inc., 706 So. 2d 
665, 1998 La. App. LEXIS 138 [4th Cir. Jan. 28, 1998]). 
One important industry tactic is to attack the in­
tegrity of leading tobacco control researchers and ad­
vocates (Sweda and Daynard 1996).  For example, a 
group called Californians for Scientific Integrity (CSI) 
sued the University of California in 1997, in part, over 
Dr. Stanton Glantz’s 1994 study on the economic im­
pact of smoke-free restaurant laws.  Public officials 
around the country have used that study to support 
passage of clean indoor air laws in their cities and 
towns. Funded by the NSA (Sullivan 1997), the CSI 
lawsuit alleged that public funds were used improp­
erly in supporting the study.  Earlier in 1997, the NSA 
had paid $10,000 to Michael Evans, clinical professor 
of managerial economics at the J.L. Kellogg Graduate 
School of Management at Northwestern University, to 
write a report that attacked the Glantz study on smoke-
free restaurants  (Price 1997). In November 1997, Sac­
ramento County Superior Court Judge Joe S. Gray 
dismissed the CSI lawsuit, saying that “there were no 
grounds for the case” (Weinstein 1997b).  A lawyer for 
the university wrote in a brief that led to the dismissal 
that the “true agenda of this action was patently 
obvious—to muzzle scientists whose research publi­
cations and speech on subjects relating to tobacco, to­
bacco control and the politics of tobacco have been a 
thorn in the side of the tobacco industry for decades” 
(Weinstein 1997b). 
Industry-Sponsored Litigation Against Local 
Tobacco Control Efforts 
The tobacco industry has used litigation, as well 
as the threat of litigation, to try to thwart local mea­
sures to reduce tobacco use.  For example, R.J. Reynolds 
Tobacco Company financed a 1994 lawsuit filed by lo­
cal restaurant owners in Puyallup, Washington (Suttle 
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1994). The suit alleged that the recently enacted ordi­
nance requiring that restaurants be smoke free was 
preempted because state law permitted smoking sec­
tions in restaurants and that the city had unlawfully 
and substantially deprived the plaintiffs of their rights 
guaranteed by the U.S. Constitution. Even though the 
legal arguments seemed dubious, the City Council 
decided to repeal the ordinance rather than expend 
the funds necessary to fight the lawsuit (Sweda and 
Daynard 1996). 
In contrast, a board of health regulation banning 
all public smoking in Northampton, Massachusetts, 
was unsuccessfully challenged in 1994 (Alexander’s 
Restaurant, Inc. v. City of Northampton, Civil Action No. 
94-307 [Mass. Super. Ct. Oct. 25, 1994]). 
Philip Morris joined with some local businesses 
to file a lawsuit on February 1, 1994, against the city of 
San Francisco to try to block an ordinance banning 
smoking in public buildings (Holding 1994; Schmeltzer 
and Arndt 1994).  The plaintiffs argued that the ordi­
nance was preempted by state rules governing work­
place health and safety.  However, five months later, 
California Governor Pete Wilson signed into law a 
measure banning smoking in most indoor workplaces 
and allowing local governments to enforce even stricter 
antismoking ordinances.  The tobacco industry shifted 
away from its lawsuit against San Francisco and spon­
sored Proposition 188, an initiative that would elimi­
nate local smoking laws and replace them with a 
weaker statewide standard (Epstein and Russell 1994). 
Although the tobacco industry spent $18.9 million on 
behalf of Proposition 188, about 18 times the amount 
spent by opponents, California voters resoundingly 
rejected the measure.  Proposition 188 garnered less 
than 30 percent of the vote (Morain and Ellis 1994). 
Local restrictions against cigarette vending ma­
chines have increasingly come under attack by ciga­
rette distribution companies suing in several states 
(Schmit 1994; Sullivan 1994). In one such instance, the 
Massachusetts Supreme Judicial Court unanimously 
upheld a Provincetown bylaw that banned cigarette 
vending machines from that town (Take Five Vending, 
Ltd. v. Town of Provincetown, 415 Mass. 741, 615 N.E.2d 
576, 1993 Mass. LEXIS 440 [Mass. Mar. 4, 1993]). 
In addition to the above-mentioned cases, other 
local ordinances forbidding tobacco use in public 
places and regulating various forms of outdoor adver­
tising have been challenged. As discussed earlier in 
this chapter (see the case description of Penn Advertis­
ing of Baltimore, Inc. v. Mayor and City Council of Balti­
more in a subsection of “Constitutionality of Regulating 
Tobacco Advertising”), the outcomes of these chal­
lenges have been mixed. 
Anticipatory Effects 
Law works not only by coercive imposition but 
also by signals about authoritative (and potentially 
changeable) norms and about the potential disposition 
of legal coercion.  Litigation may have an effect not 
only on those who are parties to it but also on other 
potential legal actors (plaintiffs, defendants, and at­
torneys who learn about the litigation) (Galanter 1983). 
Depending on the outcome of a litigation, similarly 
situated injured parties, for example, may abandon or 
modify—or conversely, may decide to continue—their 
risk-creating behavior or may be either encouraged to 
make a legal claim or discouraged from claiming.  Law­
yers may be encouraged to mount or discouraged from 
mounting claims or defenses. Uninvolved actors (such 
as potential business partners) who anticipate dealing 
with parties or potential parties may respond to liti­
gation signals by modifying (or even terminating) their 
dealings with those parties. Such signals may be de­
rived not only from authoritative decisions but also 
from the process of the litigation itself, which may ex­
hibit advantages to be gained or costs to be avoided. 
For example, news organizations viewing the fierce 
and expensive industry response to critical depiction 
may hesitate to portray industry practices negatively 
(Freedman and Stevens 1995). 
More often, third-wave tobacco litigation pro­
vides dramatic evidence of the indirect, anticipatory 
effects of litigation on reducing tobacco use.  In early 
1995, three prominent manufacturers recoiled from 
business dealings with cigarette makers to avoid the 
risk of getting embroiled in liability litigation.  The 
Manville Corporation sued R.J. Reynolds Tobacco 
Company for a declaratory judgment that the corpo­
ration does not have a contract to supply fiberglass 
for cigarette filters (Appleson 1995).  A few days later, 
Harley-Davidson, Inc., responding to a 1993 suit by 
the Lorillard Tobacco Company to enforce an agree­
ment licensing the motorcycle maker’s name for a 
brand of cigarettes, countersued, alleging that tobacco 
liability risks reduced Lorillard’s ability to fulfill 
its contract (Rose and Hwang 1995). Papermaker 
Kimberly-Clark Corporation (which had been named 
a defendant in the West Virginia health care provider 
suit), the world leader in tobacco papers, decided to 
sell its cigarette paper business. The company denied 
that liability fears or shareholder activism played any 
part in its decision, but analysts said that such con­
cerns were dominant factors (Collins 1995a).  Other 
companies, such as Pfizer, have adopted policies “pro­
hibiting units from doing business with Big Tobacco 
and its suppliers” (Mallory 1995, p. 39). 
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Another set of actors responsive to signals about 
liability are insurers.  Presumably, virtually all of the 
suppliers and professionals who serve cigarette mak­
ers carry liability insurance. The tobacco manufactur­
ers themselves have been insured for at least some 
liability risks, although the amount of insurance cov­
erage of the tobacco companies is unknown (Reidy and 
Carter 1995). If any of these insured parties are found 
liable for promoting or selling tobacco products, the 
insurers can be expected to contest coverage, using as 
defenses against liability to the insured many of the 
same arguments that plaintiffs use to establish the li­
ability of the insured.  If, for example, liability involves 
attribution to the industry of knowledge of a causal 
link to disease or concealment of that information, then 
to defeat coverage, the insurer may likewise claim that 
the insured had wrongfully and knowingly obtained 
coverage for a business practice whose dangers were 
concealed from the insurer.  “In effect,” note two ana­
lysts, “the insurance industry will have to prove the 
very thing the policyholder is trying to deny in the 
tobacco-related suits” (Reidy and Carter 1995, p. S38). 
Thus a “breakthrough” by tobacco plaintiffs may lead 
to a “second front” of liability battles between tobacco 
defendants and their insurers. 
Indeed, in 1996, Imperial Tobacco Limited (No. 
500-05-014084-964 [Canada S. Ct., Prov. of Quebec, 
Dist. of Montreal Jan. 12, 1996], cited in 11.1 TPLR 3.39 
[1996]) filed suit in the Superior Court of Quebec 
against two Toronto-based liability insurance 
companies—American Home Insurance Company 
and Commercial Union Assurance Company of 
Canada—demanding that they pay legal costs and 
any damages arising from a class action suit filed 
against Imperial in Ontario by Mr. David Caputo and 
three other persons in 1995.  The Canadian class ac­
tion suit, which has not yet been resolved, seeks dam­
ages on behalf of nicotine-addicted persons who have 
suffered because of their addiction to nicotine.  Impe­
rial claims to have had policies issued by the insurers 
obligating them to reimburse Imperial for legal costs 
incurred in the class action and to pay any further costs 
they may incur in this matter. The tobacco company 
is, in essence, asking the Superior Court of Quebec for a 
declaration that the two named insurance companies 
must pay all of Imperial’s legal fees and all sums 
awarded by an eventual finding of liability by the 
Ontario court (Tobacco Products Litigation Reporter 1995b). 
Finally, the investment community is greatly in­
terested in the potential effects of legal liability on the 
future profitability and solvency of the tobacco com­
panies. Tobacco cases are closely tracked by invest­
ment analysts, and “even interim events in peripheral 
cases can propel share prices in one direction or an­
other” (Orey 1995, p. 70).  The overhang of potential 
liability casts a shadow on tobacco stocks. Opinions 
differ about just how much these stocks are discounted 
for liability, but there is general agreement that the re­
moval of the liability shadow would be worth many 
billions in increased stock value.  This volatile combi­
nation of possible liability and latent value means that 
any breach in the previously impregnable liability 
ramparts would inaugurate a period of pronounced 
instability among tobacco investors. Some analysts 
imagine a zone of agreement that would locate a com­
prehensive settlement, which would in turn unlock 
the unrealized value of tobacco stocks while provid­
ing generously for the victims of tobacco. However, 
because present litigants cannot preclude future 
plaintiffs, it remains unclear whether litigation can 
provide the finality and closure that a comprehen­
sive settlement would require.  Litigation can set off 
ramifying effects and in general advance a formerly 
sluggish or obstructed state of affairs, but it is not 
clear whether it can contain these effects or design 
an all-encompassing resolution or policy. 
Criminal Proceedings 
Another arena in which attention is being given 
to the activities of the tobacco industry is the criminal 
justice system. Since 1995, the U.S. Department of Jus­
tice has conducted an ongoing investigation of the al­
leged violation of federal criminal laws by tobacco 
companies, tobacco company executives, tobacco 
industry-supported trade and scientific associations, 
and other entities that have conducted business with 
the tobacco industry. 
The Justice Department initiated a formal inves­
tigation of the tobacco industry in response to the fil­
ing in 1994 of a comprehensive legal analysis, referred 
to as a prosecution memorandum, by Representative 
Martin T. Meehan (D-MA) with the U.S. Attorney Gen­
eral (Hohler 1994; Mallory 1994, 1995; Meehan 1994; 
Schwartz 1994; Miga 1995; Reuters 1996; Rodriguez 
and Taylor 1998).  The prosecution memorandum pe­
titioned the Justice Department to consider allegations 
that tobacco companies, tobacco company executives, 
and others had violated multiple criminal laws by pro­
viding false information to the FDA and the U.S. Sur­
geon General (18 U.S.C. section 1001), committing 
perjury in testimony before Congress (18 U.S.C. sec­
tion 1621), perpetrating mail and wire fraud (18 U.S.C. 
sections 1341 and 1343, respectively), engaging in de­
ceptive advertising practices (15 U.S.C. section 52), and 
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violating federal conspiracy and racketeering laws (18 
U.S.C. sections 371 and 1962, respectively) (Meehan 
1994; Shane 1997; Corporate Crime Reporter 1998; 
Clifford E. Douglas. The criminal investigation of the 
tobacco industry. Speech to the 13th Annual Confer­
ence of the Tobacco Products Liability Project; May 31, 
1998; Boston; unpublished data). 
Nature, Extent, and Focus of the Criminal 
Investigation 
The Justice Department’s investigation began as 
a preliminary inquiry focused on alleged perjury aris­
ing out of testimony delivered under oath by seven 
tobacco company executives who stated before a con­
gressional subcommittee on April 14, 1994, that they 
did not believe that nicotine is addictive. The initial 
inquiry was later expanded to a formal grand jury in­
vestigation to address broader allegations that tobacco 
companies had, among other things, violated 18 U.S.C. 
section 1001. 
Section 1001 prohibits the making of false state­
ments to agencies and officials of the federal govern­
ment (Hilts 1995; Novak and Freedman 1995; Appleson 
1996; Blum 1996; Freedman 1996; Thomas and 
Schwartz 1996; Stohr 1997). In contrast to the level of 
proof required for a showing of perjury, section 1001 
does not require a showing that a person knowingly 
lied under oath. It also allows prosecution for the with­
holding of information. Besides addressing potential 
section 1001 violations, the investigation continues to 
focus on other allegations of criminal conduct, includ­
ing fraud, conspiracy, and racketeering (Cole and Tay­
lor 1998; Corporate Crime Reporter 1998; Davis and Duffy 
1998; Douglas, unpublished data; Duffy and Taylor 
1998; Meier 1998c). 
As of mid-1998, two federal grand juries were con­
sidering evidence of alleged tobacco industry wrong­
doing. One grand jury was assigned to hear evidence 
presented by prosecutors from the Fraud Section of the 
Justice Department’s Criminal Division regarding the 
broad allegations of criminal misconduct described 
above. The second grand jury was assigned to review 
information presented by the U.S. attorney for the East­
ern District of New York.  The work of the second grand 
jury concerned a related criminal investigation whose 
focus is an alleged conspiracy by major tobacco manu­
facturing companies to suppress legitimate medical re­
search and promote biased research through the 
industry-sponsored Council for Tobacco Research.  The 
Justice Department coordinated these complementary 
investigations (Cohen and Geyelin 1996; Thomas and 
Schwartz 1997; Davis and Duffy 1998). 
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A third criminal investigation was begun in 1995 
to determine whether a major cigarette manufactur­
ing company may have committed securities fraud by 
failing to disclose all it knew about nicotine. Under 
securities laws, companies are required to disclose sig­
nificant information that may affect their stock price. 
The third investigation was initiated by the U.S. attor­
ney for the Southern District of New York, following 
the publication of an investigative news article that 
reported that, based on a review of 2,000 pages of pre­
viously undisclosed documents, Philip Morris Com­
panies Inc. had conducted many years of secret 
research into the pharmacologic effects of nicotine on 
the human brain and central nervous system (Freed­
man and Lambert 1995; Hilts and Collins 1995). The 
securities fraud investigation subsequently was con­
solidated with the main Justice Department investi­
gation (Philip Morris Companies Inc. 1998). 
Federal prosecutors have interviewed witnesses, 
compiled comprehensive company dossiers, and is­
sued subpoenas, all under the supervision of the U.S. 
Attorney General. Several of the major cigarette manu­
facturing companies, such as R.J. Reynolds Tobacco 
Company and Philip Morris Companies Inc., as well 
as others, confirmed publicly that they are the subject 
of federal criminal investigations relating to the mat­
ters described above and that employees of the com­
panies have received requests for information, 
including orders to produce internal documents and 
subpoenas to testify before the grand juries (Goshko 
1995; Hilts 1995; Miga 1995; Associated Press 1996a,b; 
Bloomberg Business News 1996a,b; Federal Filings-
Dow Jones News 1996; Johnston 1996; Jones 1996; 
Reuters 1996; Thomas and Schwartz 1996; Tribune 
News Services 1996; Weiser and Schwartz 1996; Shaffer 
1997; Philip Morris Companies Inc. 1998). 
In an April 1998 announcement that it had 
reached a cooperation agreement with a cigarette 
manufacturing company in support of the criminal 
investigation, the Justice Department identified five 
main subject matter areas on which it was focused (U.S. 
Department of Justice 1998). These were industry 
knowledge of the health consequences of smoking 
cigarettes and the addictive nature of nicotine; the tar­
geting of children and adolescents by the industry; the 
manipulation of nicotine by the industry; control of 
research by the Council for Tobacco Research, includ­
ing special projects conducted under the auspices of 
the council; and lawyer involvement in directing re­
search or crafting false or misleading statements by 
any of the tobacco companies to the Congress, the FDA, 
and the American consumers concerning the above. 
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The announcement of the cooperation agreement 
was interpreted by legal experts as a sign that the crimi­
nal investigation was accelerating and the Justice De­
partment was likely to file broad conspiracy charges 
against major cigarette companies in the future (Cole 
and Taylor 1998; Corporate Crime Reporter 1998; Dou­
glas, unpublished; Duffy and Taylor 1998; Keil 1998; 
Levin and Ostrow 1998; Schwartz 1998a). 
Key Sources of Evidence 
The gathering of evidence by the Justice Depart­
ment was advanced by the increased availability of an 
array of outside resources.  These included the results 
of the extensive investigation of the tobacco industry 
conducted by the FDA from 1994 to 1996.  The FDA’s 
administrative record and investigative files were 
made available to the Justice Department, providing 
prosecutors and investigators with a significant body 
of information concerning tobacco manufacturers’ 
knowledge of the addictive nature of nicotine and of 
the manipulation and control of the substance (Federal 
Register 1995b, 1996). 
Another important source of information for Jus­
tice Department officials was the voluminous hearing 
record produced over a 10-month period in 1994 by 
the Subcommittee on Health and the Environment of 
the Committee on Energy and Commerce in the U.S. 
House of Representatives (1995a,b,c,d). The subcom­
mittee, chaired by U.S. Representative Henry A. 
Waxman (D-CA), held numerous hearings in which 
testimony was obtained from a variety of witnesses, 
including the commissioner of the FDA, other federal 
government health officials, experts in nicotine addic­
tion, tobacco company representatives, and former 
tobacco company scientists, among many others. In 
addition, Representative Waxman made available hun­
dreds of previously secret nicotine research documents 
from the largest cigarette manufacturer by reading 
them into the public record on the floor of the House 
of Representatives in July 1995 (Associated Press 1995; 
Congressional Record 1995a,b; Schwartz 1995). 
A third significant source of evidence in support 
of the Justice Department’s criminal investigation 
was the emergence of internal tobacco company docu­
ments and testimony obtained in private lawsuits 
brought against tobacco industry defendants.  Start­
ing in 1994, these civil cases were initiated by state at­
torneys general, private classes of allegedly addicted 
and injured smokers, and individual plaintiffs, as de­
scribed earlier in this chapter (see “The Third Wave of 
Tobacco Litigation”).  The simultaneous litigation of 
numerous civil suits and the Justice Department’s 
pursuit of its criminal investigation have produced a 
notable synergy.  Millions of previously undisclosed 
tobacco industry documents that were obtained 
through the discovery process in civil lawsuits became, 
in many instances, readily accessible to federal pros­
ecutors (Curriden and Rodrigue 1997; Geyelin 1998; 
Meier 1998c; Rodriguez and Taylor 1998; Scherer and 
Rybak 1998; Schwartz 1998c). 
Initial Results of the Criminal Investigation 
The Justice Department’s ongoing investigation 
resulted in a first conviction in 1998. Under the terms 
of an agreement with the government, a biotechnol­
ogy company, DNA Plant Technology Corporation, 
pleaded guilty to a misdemeanor charge of conspir­
ing to break a law that had made it illegal to export 
tobacco seeds. The company was found to have en­
gaged in such unlawful conduct in cooperation with a 
leading cigarette manufacturing company, identified 
as an unindicted coconspirator, with whom it had 
contracted to patent and develop a genetically altered 
tobacco code-named Y-1, which contained approxi­
mately twice the nicotine of ordinary tobacco.  Accord­
ing to the Justice Department, the prosecution 
memorandum submitted by Representative Meehan, 
and the FDA, one of the goals of the cigarette com­
pany in conspiring with the biotechnology company 
was to develop a reliable source of supply of high-
nicotine tobaccos that could then be used to control 
and manipulate the nicotine levels in several popular 
cigarette brands (Meehan 1994; Federal Register 1995b, 
1996; Meier 1998d; Neergaard 1998; Schwartz 1998b; 
Schwartz and Connolly 1998; Taylor 1998; Taylor and 
Rodriguez 1998; Weinstein 1998b). 
Beginning in 1997, the threat of criminal liability 
led certain individuals associated with the tobacco in­
dustry, such as Thomas S. Osdene, Ph.D., former Di­
rector of Research for Philip Morris Companies Inc., 
and Roger R. Black, current Director of Leaf Blending 
for Brown & Williamson Tobacco Corporation, to 
decline to answer questions under oath, choosing 
instead to invoke the Fifth Amendment right against 
self-incrimination (Geyelin 1997; Meier 1997; Weinstein 
1997a; Anderson 1998).  Some officials sought immu­
nity from prosecution in exchange for their coopera­
tion. Such offers were met with mixed responses from 
the Justice Department. Typically they were rejected, 
but in one publicized instance a request for immunity 
was granted (Geyelin 1997; Stohr 1997; Weinstein 
1997a). The Justice Department granted immunity to 
Janis A. Bravo, a scientist formerly with DNA Plant 
Technology Corporation and coholder of the patent for 
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a high-nicotine tobacco plant called Y-1, developed for 
Brown & Williamson Tobacco Corporation. 
Prognosis for Future Actions Through the Criminal 
Justice Process 
Federal prosecutors possess considerable discre­
tion both in terms of bringing charges against alleged 
wrongdoers and, in the event a strong case is devel­
oped, in seeking concessions from criminal targets in 
the plea-bargaining process.  In light of these options, 
the Justice Department may seek to require tobacco 
manufacturing companies to modify their advertising 
and marketing practices so as to render them unap­
pealing to young people, stop manipulating nicotine 
or using nicotine-enhancing chemicals, pay the fed­
eral government significant monetary penalties, and 
submit to regulation by the FDA (Corporate Crime Re­
porter 1998; Douglas, unpublished data). 
Given the breadth and complexity of the crimi­
nal investigation of the tobacco industry, as well as the 
substantial burdens of proof that prosecutors must 
satisfy pursuant to the federal criminal statutes noted 
above, it is not possible to predict the outcome of the 
current criminal investigative process.  From its incep­
tion, the investigation was anticipated to be a lengthy, 
complicated operation, in part because of the 
government’s responsibility to process and review 
millions of pages of documents obtained from the to­
bacco industry and other sources (Thomas and 
Schwartz 1996). 
With the Justice Department’s accumulation of 
a growing body of evidence, including company 
documents and grand jury testimony, as well as the 
cooperation of the Liggett Group Inc. in support of 
the government’s investigation, some legal experts 
have described the investigation as likely to result in 
further action (Cole and Taylor 1998; Corporate Crime 
Reporter 1998; Douglas, unpublished data; Duffy and 
Taylor 1998; Keil 1998; Levin and Ostrow 1998; 
Schwartz 1998a). One recent indicator that the issu­
ance of indictments might be near was the delivery 
by Justice Department officials of letters to Brown & 
Williamson Tobacco Corporation and its officials, for­
mally notifying them that they are the targets of a 
criminal investigation and that they face possible 
prosecution (Davis and Duffy 1998; Meier 1998c; Wall 
Street Journal 1998). 
Further criminal action against the tobacco in­
dustry also raises the likelihood of diluting the influ­
ence of the industry’s political lobby, thereby 
strengthening the ability of public health proponents 
to advocate for more stringent regulation of the 
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manufacture, sale, distribution, advertising, and pro­
motion of tobacco products (Douglas 1998). 
Comment 
After 40 years in which two waves of product 
liability litigation proved unavailing, there has been a 
recent upsurge of investment and innovation in to­
bacco litigation. This third wave of litigation departs 
from its predecessors in various ways: 
•	 	 It moves away from exclusive reliance on smokers 
as plaintiffs, because so many cases have been de­
cided against them as the victims of their own, in­
formed behavior choices. Plaintiffs now include 
states, cities, pension funds, private health care pro­
viders, and persons exposed to ETS, none of whom 
can be blamed for smoking in the face of warnings. 
•	 	It multiplies the range of legal issues. Instead of 
focusing exclusively on common-law tort doctrine, 
third-wave litigation also invokes various statutory 
claims under consumer, antitrust, and other pro­
tective legislation. 
•	 	 It expands from the classic private lawsuit by a dis­
crete plaintiff to the class action device. 
•	 	 It expands from solely seeking monetary damages 
to including claims for injunctive relief, medical 
monitoring, and the recovery of attorneys’ fees. 
•	 	 It shifts from a pure model of private law to mixed 
strategies in which private law is used to effectu­
ate public policy by defending public fiscal inter­
ests and by enhancing the performance of statutory 
and regulatory controls of tobacco. 
•	 	It enlarges the roster of claimants’ lawyers from 
those who specialize in representing individual 
plaintiffs in personal injury cases to include mass 
tort specialists and entrepreneurial securities class 
action lawyers. These attorneys, who typically 
practice in larger firms than individual plaintiff at­
torneys and have greater financial resources, are 
joined in more complex coalitions, including alli­
ances with government lawyers. 
Considerable uncertainty surrounds each of the 
several third-wave litigation initiatives and their 
potential contribution to reducing tobacco use.  The 
prospect of using private law in these ways has cap­
tured attention only recently.  In a wide-ranging 1993 
review of tobacco policy (Rabin and Sugarman 1993), 
virtually all of the attention to private law was devoted 
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to smokers’ product liability litigation.  The newer le­
gal theories that are now available to plaintiffs have 
considerable potential. Just how these initiatives will 
fare depends both on developments within the legal 
system and on forces outside it. 
Normally, law incorporates and reflects public 
opinion. In a setting where smoking declines and be­
comes disreputable, particularly among the educated 
and influential (Zimring 1993), where smokers are in­
creasingly viewed either as victims of coercion and 
addiction or as a minority group becoming more dis­
tanced from others (Gusfield 1993), and where evi­
dence accumulates that the tobacco companies 
aggressively recruit new smokers and suppress knowl­
edge of harmful effects of smoking, the law can be ex­
pected to respond to pressures to extend accountability 
and to provide remedies, if not to smokers then to those 
who are otherwise adversely affected by smoking. 
However, other forces are working against an 
enlarged role for the civil justice system in the effort to 
reduce tobacco use.  Important groups, displeased with 
the expansion of legal accountability, have mounted a 
protracted and influential campaign to curtail the civil 
justice system and weaken the position of claimants 
within it (Galanter 1993, 1994). Apart from these ex­
ternal constraints, the very magnitude of tobacco 
injury—the vast number of potential claimants 
involved—raises apprehension about the courts’ in­
stitutional capacities to respond.  Driven by the desire 
to conserve their scarce resources, courts will find ways 
to ration the judicial attention bestowed on any siz­
able set of related cases (Sanders 1992). As the size of 
the potential victim class increases, the chances for 
individualized judicial resolution decrease.  It has been 
argued that the litigation about Agent Orange, the 
Conclusions 
Bhopal disaster, and asbestos-related injury should be 
viewed as instances in which the sheer number of 
claims “simply overwhelm[ed] the capacity of legal 
institutions to meet victim compensation needs” and 
led to improvisation of formulaic administrative solu­
tions (Durkin and Felstiner 1994, p. 159; cf. Henderson 
and Twerski 1991, on judicial aversion to such mas­
sive projects). 
A balanced assessment of the possible contribu­
tion of private law initiatives to the effort to reduce 
tobacco use must consider not only the costs and ben­
efits of the various initiatives but also the likelihood 
of accomplishing similar results by other institutional 
means (Komesar 1994). Typically, private law involves 
high transaction costs (Galanter 1994). Private law is 
by definition the creature of independent actors whose 
operations are not centrally managed and are at most 
partially and intermittently coordinated; each actor is 
trying to maximize its own gains as it defines them. 
No single initiative or the sum of such efforts will nec­
essarily produce an optimal policy to reduce tobacco 
use. Yet private law may be a valuable component in 
reducing tobacco use precisely because it is an arena 
in which multiple courses of action are advanced by 
energetic champions who are open to new ideas and 
who, independent of government, can undertake in­
novative and even risky initiatives without securing 
official approval or competing for priority with other 
political commitments. Such initiatives may thus be 
able to stimulate and shape policy solutions. Other 
than as an agent or catalyst, however, it seems unlikely 
that the judicial forum, in a setting involving politi­
cally powerful actors and an unpredictable number of 
inchoate future claimants, will itself provide the ulti­
mate policy resolution. 
Advertising and Promotion 2.	 	 Current regulation in the United States is con­
siderably less restrictive than that in several other 
countries, notably Canada and New Zealand.1. Since 1964, numerous attempts to regulate ad-vertising and promotion of tobacco products 
have had only modest success in restricting such 
activity. 3. Current case law supports the contention that ad-vertising does not receive the protections of free 
speech under the First Amendment to the Con­
stitution that noncommercial speech does. 
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Product Regulation 
1.	 	 Warning labels on cigarette packages in the 
United States are weaker and less conspicuous 
than those of other countries. 
2.	 	 Smokers receive very little information regard­
ing chemical constituents when they purchase a 
tobacco product.  Without information about 
toxic constituents in tobacco smoke, the use of 
terms such as “light” and “ultra light” on pack­
aging and in advertising may be misleading to 
smokers. 
3.	 	 Because cigarettes with low tar and nicotine con­
tents are not substantially less hazardous than 
higher-yield brands, consumers may be misled 
by the implied promise of reduced toxicity un­
derlying the marketing of such brands. 
4.	 	 Additives to tobacco products are of uncertain 
safety when used in tobacco. Knowledge about 
the impact of additives is negligible and will 
remain so as long as brand-specific information 
on the identity and quantity of additives is 
unavailable. 
5.	 	 Regulation of tobacco product sale and promo­
tion is required to protect young people from in­
fluences to take up smoking. 
Clean Indoor Air Regulation 
1.	 	 Although population-based data show declining 
ETS exposure in the workplace over time, ETS 
exposure remains a common public health haz­
ard that is entirely preventable. 
2.	 	 Most state and local laws for clean indoor air re­
duce but do not eliminate nonsmokers’ exposure 
to ETS; smoking bans are the most effective 
method for reducing ETS exposure. 
3.	 	 Beyond eliminating ETS exposure among non­
smokers, smoking bans have additional benefits, 
including reduced smoking intensity and poten­
tial cost savings to employers. Optimal protec­
tion of nonsmokers and smokers requires a 
smoke-free environment. 
Minors’ Access to Tobacco 
1.	 	 Measures that have had some success in reduc­
ing minors’ access include restricting distribu­
tion, regulating the mechanisms of sale, enforcing 
minimum age laws, having civil rather than 
criminal penalties, and providing merchant edu­
cation and training. Requiring licensure of to­
bacco retailers provides both a funding source 
for enforcement and an incentive to obey the law 
when revocation of the license is a provision of 
the law. 
2.	 	 The effect of reducing minors’ access to tobacco 
products on smoking prevalence requires further 
evaluation. 
Litigation Approaches 
1.	 	 Two historic waves of tobacco litigation were ini­
tiated by private citizens, were based largely on 
theories of negligence and implied warranty, and 
were unsuccessful. 
2.	 	 A third wave has brought in new types of claim­
ants, making statutory as well as common-law 
claims and using more efficient judicial proce­
dures.  Although several cases have been settled 
for substantial money and have yielded public 
health provisions, many other cases remain un­
resolved. 
3.	 	 Private law initiative is a diffuse, uncentralized 
activity, and the sum of such efforts is unlikely 
to produce optimal results for a larger policy to 
reduce tobacco use. On the other hand, the liti­
gation actions of individuals are likely to be a 
valuable component in some larger context of 
strategies to make tobacco use less prevalent. 
   
Surgeon General's Report 
References 
Abramson J. Tobacco industry steps up flow of cam­
paign money. New York Times, Mar 8, 1998; Sect 1:1 
(col 5). 
Acands, Inc. v. Abate, 710 A.2d 944 (Md. Ct. Spec. App. 
1998). 
Adkins LW. A Minnesota councilwoman’s crusade to 
ban cigarette machines. Adweek’s Marketing Week 
1989;30(43):2. 
Agency for Health Care Administration v. Associated In­
dustries of Florida, 678 So. 2d 1239 (Fla. 1996). 
Agency for Health Care Administration v. Associated In­
dustries of Florida, No. 86,213 (Fla. June 27, 1996), cited 
in 11.4 TPLR 2.113 (1996). 
Alexander HM, Callcott R, Dobson AJ, Hardes GR, 
Lloyd DM, O’Connell DL, Leeder SR. Cigarette smok­
ing and drug use in school children: IV—factors asso­
ciated with changes in smoking behaviour. International 
Journal of Epidemiology 1983;12(1):59–66. 
Alexander’s Restaurant, Inc. v. City of Northampton, Civil 
Action No. 94-307 (Mass. Super. Ct. Oct. 25, 1994). 
Alm B, Milerad J, Wennergren G, Skjaerven R, Oyen 
N, Norvenius G, Daltveit AK, Helweg-Larsen K, 
Markestad T,  Irgens LM. A case-control study of 
smoking and sudden infant death syndrome in the 
Scandinavian countries, 1992 to 1995. The Nordic Epi­
demiological Study. Archives of Diseases in Children 
1998;78(4):329–34. 
Alman Brothers Farms & Feed Mill, Inc. v. Diamond Labo­
ratories, Inc., 437 F.2d 1295 (5th Cir. 1971). 
Altman DG, Carol J, Chalkley C, Cherner J, DiFranza 
J, Feighery E, Forster J, Gupta S, Records J, Slade J, 
Talbot B, Tye J. Report of the tobacco policy research 
study group on access to tobacco products in the 
United States. Tobacco Control 1992;1(Suppl):S45–S51. 
Altman DG, Foster V, Rasenick-Douss L, Tye JB. Re­
ducing the illegal sale of cigarettes to minors. Journal 
of the American Medical Association 1989;261(1):80–3. 
Altman DG, Rasenick-Douss L, Foster V, Tye JB. Sus­
tained effects of an educational program to reduce sales 
of cigarettes to minors. American Journal of Public Health 
1991;81(7):891–3. 
Altman DG, Wheelis AY, McFarlane M, Lee H, 
Fortmann SP. The relationship between tobacco access 
and use among adolescents: a four community study. 
Social Science & Medicine 1999;48(6):759–75. 
American Advertising Federation v. Kessler, Civil Action 
No. 2:95CV00593 (M.D.N.C. Aug. 10, 1995), cited in 10.5 
TPLR 3.401 (1995) (Complaint for Declaratory Judg­
ment and Injunctive Relief). 
American Health Foundation. Comments on Tobacco 
Additives. Valhalla (NY): American Health Foundation, 
1990. 
American Law Institute. Reporters’ Study on Enterprise 
Responsibility for Personal Injury. Philadelphia: Ameri­
can Law Institute, 1991. 
American Law Institute. Restatement of the Law (Third). 
Torts: Products Liability. Tentative draft no. 2, § 2: cat­
egories of product defect. Philadelphia: American Law 
Institute, 1995:12–127. 
American Medical Association House of Delegates. 
Report of Reference Committee D. Chicago: American 
Medical Association, 1995. 
American Pharmaceutical Association. Professional 
Affairs. 2. Smoking and health. Journal of the American 
Pharmaceutical Association 1971;NS11(5):270–1. 
Anderson C. Sealing refused for deposition in tobacco 
case. New York Law Journal, Feb 2, 1998:1(col 3). 
Anderson HR, Cook DG. Passive smoking and sud­
den infant death syndrome: review of the epidemio­
logical evidence. Thorax 1997;52(11):1003–9. 
Andrews JL Jr. Reducing smoking in the hospital: an 
effective model program. Chest 1983;84(2):206–9. 
262 Chapter 5
 

   Regulatory Efforts 263
 
Appleson G. Harley-Davidson, Manville unlikely pair 
in tobacco war. Reuter Business Report, Mar 23, 1995. 
Available from Dialog(R)File 611:Reuters. 
Appleson G. Justice shifts focus of tobacco probe: 
source. Reuters (news wire), July 11, 1996. 
Associated Press. Tobacco studies detailed. New York 
Times, July 25, 1995;Sect B:7. 
Associated Press. Philip Morris alerts employees to 
government probe. Apr 6, 1996a. Available from 
Dialog(R)File 258:Associated Press. 
Associated Press. Report: Philip Morris executives sub­
poenaed. Aug 29, 1996b. Available from Dialog(R)File 
258:Associated Press. 
Associated Press. Judge orders five California tobacco 
lawsuits consolidated for trial. July 21, 1998. Available 
from Dialog(R)File 258:Associated Press. 
Attorneys General Settlement Agreement, cited in 12.1 
TPLR 3.1 (1997). 
Australian News Network. Smoking council welcomes 
court decision. The Australian, July 24, 1998. 
Bad Frog Brewery, Inc. v. New York State Liquor Author­
ity, 134 F.3d 87 (2d Cir. 1998). 
Badillo v. American Tobacco Co., No. CV-N-97-00573­
DWH (D. Nev. 1997). 
Baggett v. Sutherland, No. CA 88-224, 1989 WL 5399 
(Ark. App. Jan. 25, 1989). 
Baile WF, Gibertini M, Ulschak F, Snow-Antle S, 
Hann D. Impact of a hospital smoking ban: changes in 
tobacco use and employee attitudes. Addictive Behav­
iors 1991;16(6):419–26. 
Bano Bi v. Union Carbide Chems. & Plastics Co., 984 F.2d 
582 (2d Cir. 1993). 
Banzhaf JF III. Comprehensive Smoking Prevention Edu­
cation Act: Appendix to Hearings Before the Subcommittee 
on Health and the Environment of the House Committee on 
Energy and Commerce, 97th Congress, 2nd Sess. 256 
(1982) (statement submitted for the record by Action 
on Smoking and Health). 
Banzhaf v. FCC, 405 F.2d 1082 (D.C. Cir. 1968), cert. de­
nied, 396 U.S. 842, 90 S. Ct. 50 (1969). 
Reducing Tobacco Use 
Barnes DE, Bero LA. Why review articles on the health 
effects of passive smoking reach different conclusions. 
Journal of the American Medical Association 1998;279 
(19):1466–70. 
Barnes v. American Tobacco Co., No. 96-5903 (E.D. Pa. 
Aug. 22, 1997), vacated 176 F.R.D. 479 (1997), cited in 
12.4 TPLR 2.227 (1997). 
Becker DM, Conner HF, Waranch HR, Stillman F, 
Pennington L, Lees PSJ, Oski F. The impact of a total 
ban on smoking in the Johns Hopkins Children’s Cen­
ter. Journal of the American Medical Association 1989; 
262(6):799–802. 
Beede P, Lawson R. The effect of plain packages on 
the perception of cigarette health warnings. Public 
Health 1992;106(4):315–22. 
Benowitz NL, Hall SM, Herning RI, Jacob P III, Jones 
RT, Osman A-L. Smokers of low-yield cigarettes do not 
consume less nicotine. New England Journal of Medi­
cine 1983;309(3):139–42. 
Benowitz NL, Henningfield JE. Establishing a nicotine 
threshold for addiction: the implications for tobacco 
regulation. New England Journal of Medicine 1994;331(2): 
123–5. 
Benowitz NL, Pinney J. Nicotine preparations in smok­
ing. In: Korting HC, Shäfer-Korting M, editors. The 
Benefit/Risk Ratio: A Handbook for the Rational Use of 
Potentially Hazardous Drugs. Boca Raton (FL): CRC 
Press, 1998:307–18. 
Bernstein Research. Tobacco litigation: turbulence 
ahead, but stocks still overdiscounting risks. Reiterate 
outperforms [memorandum]. New York: Sanford C. 
Bernstein & Co., Oct. 12, 1994. 
Bero LA, Galbraith A, Rennie D. Sponsored symposia 
on environmental tobacco smoke. Journal of the Ameri­
can Medical Association 1994;271(8):612–7. 
Biener L, Abrams DB, Follick MJ, Dean L. A compara­
tive evaluation of a restrictive smoking policy in a gen­
eral hospital. American Journal of Public Health 1989; 
79(2):192–5. 
Bigelow v. Virginia, 421 U.S. 809 (1975). 
Blasi V, Monaghan HP. The First Amendment and ciga­
rette advertising. Journal of the American Medical Asso­
ciation 1986;256(4):502–9. 
   
Surgeon General's Report
 
Blonder-Tongue Laboratories v. University of Illinois Foun­
dation, 402 U.S. 313, 91 S. Ct. 1434 (1971). 
Bloomberg Business News. Philip Morris employees 
get subpoenas. New York Times, Sept 4, 1996a;Sect D:2. 
Bloomberg Business News. Philip Morris executives 
ordered to testify before a federal jury. New York Times, 
Aug 31, 1996b:22 (col 5). 
Blue Cross and Blue Shield of New Jersey v. Philip Morris 
(E.D.N.Y. Apr. 29, 1998), cited in 13.2 TPLR 3.51 (1998). 
Blum A. Justice Dept. reportedly changes tack vs. to­
bacco. National Law Journal, Sept 16, 1996;Sect A:7. 
Board of Trustees of the State University of New York v. 
Fox, 492 U.S. 469 (1989). 
Boddewyn JJ. There is no convincing evidence for a 
relationship between cigarette advertising and con­
sumption. British Journal of Addiction 1989;84(11): 
1255–61. 
Borland R, Chapman S, Owen N, Hill D. Effects of 
workplace smoking bans on cigarette consumption. 
American Journal of Public Health 1990a;80(2):178–80. 
Borland R, Owen N, Hill D, Chapman S. Changes in 
acceptance of workplace smoking bans following their 
implementation: a prospective study. Preventive Medi­
cine 1990b;19(3):314–22. 
Borland R, Owen N, Hocking B. Changes in smoking 
behaviour after a total workplace smoking ban. Aus­
tralian Journal of Public Health 1991;15(2):130–4. 
Borland R, Pierce JP, Burns DM, Gilpin E, Johnson M, 
Bal D. Protection from environmental tobacco smoke 
in California: the case for a smoke-free workplace. 
Journal of the American Medical Association 1992;268(6): 
749–52. 
Bourque K. Union pension funds and asbestos com­
panies join in fight against tobacco companies. Tobacco 
on Trial 1997;6:6–9. 
Boyse S. Note on a Special Meeting of the UK Industry 
on Environmental Tobacco Smoke, Feb 17, 1988, 
London;<http://www.gate.net/~jcannon/documents/ 
880217b1.txt>; accessed: February 15, 1999. 
Branson R. Miss. new tobacco payments should go for 
health. The Commercial Appeal, July 8, 1998;Sect B:1. 
Brenner H, Mielck A. Smoking prohibition in the work­
place and smoking cessation in the Federal Republic 
of Germany. Preventive Medicine 1992;21(2):252–61. 
Breo DL. Kicking butts—AMA, Joe Camel, and the 
“black-flag”war on tobacco. Journal of the American 
Medical Association 1993;270(16):1978–84. 
Bridges RB, Combs JG, Humble JW, Turbek JA, Rehm 
SR, Haley NJ. Population characteristics and cigarette 
yield as determinants of smoke exposure. Pharmacol­
ogy, Biochemistry and Behavior 1990;37(1):17–28. 
Broin v. Philip Morris Cos., No. 92-1405 (Fla., Dade Cty. 
Mar. 15, 1994), cited in 9.1 TPLR 2.1 (1994). 
Broin v. Philip Morris Cos., No. 91-49738 CA (22) (Fla., 
Dade Cty. Feb. 3, 1998), cited in 13.1 TPLR 2.79 (1998) 
(Order Granting Verified Petition for Final Approval 
of Settlement and Payment of Attorneys Fees and Costs 
by Settling Defendants and Final Judgment). 
Broin v. Philip Morris Inc., No. 91-49738 CA (22) (Fla., 
Dade Cty. Oct. 9, 1997), cited in 12.6 TPLR 3.397 (1997) 
(Settlement Agreement). 
Brown LJ, DiFranza JR. Pharmacy promotion of to­
bacco use among children in Massachusetts. American 
Pharmacy 1992;NS32(5):45–8. 
Brown & Williamson Tobacco Corp. v. Carter, No. 96-4831, 
1998 Fla. App. LEXIS 7477 (Fla. Dist. Ct. App. June 22, 
1998). 
Brown & Williamson Tobacco Corp. v. Food & Drug Ad­
ministration, No. 97-1604 (4th Cir. 1998). 
Brownson RC, Alavanja MCR, Hock ET, Loy TS. Pas­
sive smoking and lung cancer in nonsmoking women. 
American Journal of Public Health 1992a;82(11):1525–30. 
Brownson RC, Davis JR, Jackson-Thompson J, Wilker­
son JC. Environmental tobacco smoke awareness and 
exposure: impact of a statewide clean indoor air law 
and the report of the US Environmental Protection 
Agency. Tobacco Control 1995a;4(2):132–8. 
Brownson RC, Jackson-Thompson J, Wilkerson JC, 
Davis JR, Owens NW, Fisher EB Jr. Demographic and 
socioeconomic differences in beliefs about the health 
effects of smoking. American Journal of Public Health 
1992b;82(1):99–103. 
264 Chapter 5
 

   Regulatory Efforts 265
 

Brownson RC, Koffman DM, Novotny TE, Hughes RG, 
Eriksen MP. Environmental and policy interventions 
to control tobacco use and prevent cardiovascular dis­
ease. Health Education Quarterly 1995b;22(4):478–98. 
Buchan v. Ortho Pharmaceutical (Canada) Ltd., (1986) 54 
O.R.2d 92 (Ct. App.) (Can.). 
Buckingham v. R.J. Reynolds Tobacco Co., 713 A.2d 381 
(N.H. 1998). 
Bureau of National Affairs, Inc. Cigarette maker settles 
FTC charges of false ads regarding health effects. An­
titrust and Trade Regulation Report 1990;58(1471):964. 
Bureau of National Affairs, Inc. Smoking in the Work­
place: 1991—SHRM-BNA Survey No. 55. Bulletin to 
Management. Washington: Bureau of National Affairs, 
Inc., 1991. 
Butler v. American Tobacco Co. (Miss., Jones Cty. May 
12, 1994), cited in 9.3 TPLR 3.335 (1994) (Amended 
Complaint). 
Butler v. Philip Morris Inc., Civil Action No.: 94-5-53 
(Miss., Jones Cty.  Mar. 4, 1996), cited in 11.3 TPLR 3.307 
(1996) (Second Amended Complaint and Request for 
Trial by Jury). 
Byrd GD, Robinson JH, Caldwell WS, deBethizy JD. 
Inter-individual variation of nicotine uptake among 
smokers. Poster presented at the International Sym­
posium on Nicotine; July 21–4, 1994; Montreal. 
Calabresi G. The Costs of Accidents: A Legal and Economic 
Analysis. New Haven (CT): Yale University Press, 1970. 
Caldwell MC, Wysell MC, Kawachi I. Self-service 
tobacco displays and consumer theft [letter]. Tobacco 
Control 1996;5(2):160–1. 
California Environmental Protection Agency. Health 
Effects of Exposure to Environmental Tobacco Smoke. Fi­
nal Report. Sacramento (CA): California Environmen­
tal Protection Agency, Office of Environmental Health 
Hazard Assessment, 1997. 
California v. Philip Morris Inc., No. BC194217 (Calif., Los 
Angeles Cty. July 14, 1998), cited in 13.4 TPLR 3.195 
(1998). 
Reducing Tobacco Use
 
Campbell WI. Regulation of Tobacco (Part I): Hearings 
Before the Subcommittee on Health and the Environment 
of the House Committee on Energy and Commerce, 103rd 
Congress, 2nd Sess. 542 (1994) (statement on behalf of 
Philip Morris, Inc.). 
Capital Broadcasting Co. v. Acting Attorney General, 405 
U.S. 1000 (1972), aff ’d sub nom. Capital Broadcasting Co. 
v. Mitchell, 333 F. Supp. 582 (D.D.C. 1971). 
Capital Cities Cable, Inc. v. Crisp, 467 U.S. 691 (1984). 
Cardenas VM, Thun MJ, Austin H, Lally CA, Clark 
WS, Greenberg RS, Heath CW Jr. Environmental to­
bacco smoke and lung cancer mortality in the Ameri­
can Cancer Society’s Cancer Prevention Study II. 
Cancer Causes and Control 1997;8(1):57–64. 
Carol J. It’s a good idea to criminalise purchase and 
possession of tobacco by minors—NOT! Tobacco Con­
trol 1992;1(4):296–7. 
Cassels J. The Uncertain Promise of Law: Lessons from 
Bhopal. Toronto: University of Toronto Press, 1993. 
Castano v. American Tobacco Co., No. 94-1044 (E.D. La. 
Feb. 17, 1995), cited in 10.1 TPLR 2.1 (1995), rev’d 84 
F.3d 734 (5th Cir. 1996). 
Celebrezze AJ. Agency reports. In: United States Code: 
Congressional and Administrative News. 89th Congress— 
First Session, 1965. Vol. 2. St. Paul (MN): West Publish­
ing Co., 1965:2356–61. 
Centers for Disease Control. Passive smoking: beliefs, 
attitudes, and exposures—United States, 1986. Morbid­
ity and Mortality Weekly Report 1988;37(15):239–41. 
Centers for Disease Control. Cigarette advertising— 
United States, 1988. Morbidity and Mortality Weekly 
Report 1990a;39(16):261–5. 
Centers for Disease Control. Cigarette sales to 
minors—Colorado, 1989. Morbidity and Mortality 
Weekly Report 1990b;39(44):794–5, 801. 
Centers for Disease Control. Evaluation of an employee 
smoking policy—Pueblo, Colorado, 1989–90. Morbid­
ity and Mortality Weekly Report 1990c;39(38):673–6. 
   
Surgeon General's Report
 
Centers for Disease Control. Public attitudes regard­
ing limits on public smoking and regulation of tobacco 
sales and advertising—10 U.S. communities, 1989. 
Morbidity and Mortality Weekly Report 1991;40(21): 
344–5, 351–3. 
Centers for Disease Control. Accessibility of cigarettes 
to youths aged 12–17 years—United States, 1989. Mor­
bidity and Mortality Weekly Report 1992a;41(27):485–8. 
Centers for Disease Control. Discomfort from environ­
mental tobacco smoke among employees at worksites 
with minimal smoking restrictions—United States, 
1988. Morbidity and Mortality Weekly Report 1992b; 
41(20):351–4. 
Centers for Disease Control and Prevention. Minors’ 
access to tobacco—Missouri, 1992, and Texas, 1993. 
Morbidity and Mortality Weekly Report 1993a;42(7): 
125–8. 
Centers for Disease Control and Prevention. Smoking 
cessation during previous year among adults—United 
States, 1990 and 1991. Morbidity and Mortality Weekly 
Report 1993b;42(26):504–7. 
Centers for Disease Control and Prevention. Attitudes 
toward smoking policies in eight states—United States, 
1993. Morbidity and Mortality Weekly Report 1994a; 
43(43):786–9. 
Centers for Disease Control and Prevention. Changes 
in the cigarette brand preferences of adolescent 
smokers—United States, 1989–1993. Morbidity and Mor­
tality Weekly Report 1994b;43(32):577–81. 
Centers for Disease Control and Prevention. Medical-
care expenditures attributable to cigarette smoking— 
United States, 1993. Morbidity and Mortality Weekly 
Report 1994c;43(26):469–72. 
Centers for Disease Control and Prevention. Assess­
ment of the impact of a 100% smoke-free ordinance on 
restaurant sales—West Lake Hills, Texas, 1992–1994. 
Morbidity and Mortality Weekly Report 1995a;44(19): 
370–2. 
Centers for Disease Control and Prevention. Trends in 
smoking initiation among adolescents and young 
adults—United States, 1980–1989. Morbidity and Mor­
tality Weekly Report 1995b;44(28):521–5. 
Centers for Disease Control and Prevention. Accessi­
bility of tobacco products to youths aged 12–17 years— 
United States, 1989 and 1993. Morbidity and Mortality 
Weekly Report 1996a;45(6):125–30. 
Centers for Disease Control and Prevention. Estimates 
of retailers willing to sell tobacco to minors— 
California, August–September 1995 and June–July 
1996. Morbidity and Mortality Weekly Report 1996b; 
45(50):1095–9. 
Centers for Disease Control and Prevention. State To­
bacco Control Highlights—1996. Atlanta: Centers for 
Disease Control and Prevention, National Center for 
Chronic Disease Prevention and Health Promotion, 
Office on Smoking and Health, 1996c. 
Centers for Disease Control and Prevention. Tobacco 
use and usual source of cigarettes among high school 
students—United States, 1995. Morbidity and Mortality 
Weekly Report 1996d;45(20):413–8. 
Centers for Disease Control and Prevention. Cigarette 
smoking among adults—United States, 1995. Morbid­
ity and Mortality Weekly Report 1997a;46(51):1217–20. 
Centers for Disease Control and Prevention. Smoking-
attributable mortality and years of potential life lost— 
United States, 1984. Morbidity and Mortality Weekly 
Report 1997b;46(20):444–51. 
Centers for Disease Control and Prevention. Preemp­
tive state tobacco-control laws—United States, 1982– 
1998. Morbidity and Mortality Weekly Report 1999; 
47(51–52):1112–4. 
Central Hudson Gas & Electric v. Public Service Commis­
sion of New York, 447 U.S. 557 (1980). 
Centre for Behavioural Research in Cancer for Minis­
terial Council on Drug Strategy Tobacco Task Force. 
Health Warnings and Contents Labelling on Tobacco Prod­
ucts. Melbourne (Australia): Anti-Cancer Council of 
Victoria, 1992. 
Centre for Health Promotion. Effects of Plain Cigarette 
Packaging Among Youth. Toronto: University of Toronto, 
1993. 
Chaloupka FJ, Grossman M. Price, tobacco control poli­
cies and youth smoking. Working paper no. 5740. Cam­
bridge (MA): National Bureau of Economic Research, 
1996. 
266 Chapter 5
 

   Regulatory Efforts 267
 
Chaloupka FJ, Pacula RL. Limiting youth access to to­
bacco: the early impact of the Synar Amendment on 
youth smoking. Paper presented at the Third Biennial 
Pacific Rim Allied Economic Organizations Confer­
ence; Jan 14, 1998; Bangkok (Thailand). 
Chamberlain E. Philip Morris sues ABC for $10 bil­
lion. Tobacco on Trial, Apr 29, 1994:3–5. 
Chapman S. Industry down again down under [let­
ter]. Tobacco Control 1995;4(1):17–8. 
Chapman S. Tobacco industry memo reveals passive 
smoking strategy. British Medical Journal 1997;314 
(7094):1569. 
Chapman S, Borland R, Hill D, Owen N, Woodward S. 
Why the tobacco industry fears the passive smoking 
issue. International Journal of Health Services 1990;20(3): 
417–27. 
Chapman S, Wilson D, Wakefield M. Smokers’ under­
standings of cigarette yield labels. Medical Journal of 
Australia 1986;145(8):376, 378–9. 
Cheadle A, Wagner E, Koepsell T, Kristal A, Patrick D. 
Environmental indicators: a tool for evaluating com­
munity-based health-promotion programs. American 
Journal of Preventive Medicine 1992;8(6):345–50. 
Chetwynd J, Brodie RJ, Harrison R. The influence of 
advertising on tobacco consumption: a reply to 
Boddewyn. British Journal of Addiction 1989;84(11): 
1263–5. 
Chiglo v. City of Preston, 909 F. Supp. 675 (D. Minn. 1995). 
Chrétien J. Government Action Plan on Smuggling. 
Ottawa (Canada): Office of the Prime Minister, House 
of Commons, 1994. 
Cipollone v. Liggett Group Inc., 505 U.S. 504, 112 S. Ct. 
2608 (1992). 
Cismoski J. Blinded by the light: the folly of tobacco 
possession laws against minors. Wisconsin Medical Jour­
nal 1994;93(11):591–8. 
Cismoski J, Sheridan M. Availability of cigarettes to 
under-age youth in Fond du Lac, Wisconsin. Wiscon­
sin Medical Journal 1993;92(11):626–30. 
Reducing Tobacco Use
 
Cismoski J, Sheridan M. Tobacco acquisition practices 
of adolescents in two Wisconsin communities. Wiscon­
sin Medical Journal 1994;93(11):585–91. 
Clymer A. Addiction center sees Medicare imperiled 
by rising bill for smoking and drinking. New York Times, 
May 17, 1994;Sect A:14 (col 1). 
Coalition on Smoking OR Health. Classification of low 
tar and low nicotine cigarettes as drugs under the Food, 
Drug and Cosmetic Act (petition before the Food and 
Drug Administration). Washington: Apr 25, 1988. 
Coalition on Smoking OR Health. Classification of all 
cigarette products as drugs under section 201 of the 
Federal Food, Drug, and Cosmetic Act (petition be­
fore the Food and Drug Administration). Washington: 
Mar 7, 1994a. 
Coalition on Smoking OR Health. State Legislated Ac­
tions on Tobacco Issues. Washington: Coalition on Smok­
ing OR Health, 1994b. 
Coffee JC Jr. Understanding the plaintiff’s attorney: the 
implications of economic theory for private enforce­
ment of law through class and derivative actions. 
Columbia Law Review 1986;86(May):669–727. 
Coffee JC Jr. The regulation of entrepreneurial litiga­
tion: balancing fairness and efficiency in the large class 
action. University of Chicago Law Review 1987;54(Sum­
mer):877–937. 
Cohen JB. Research and policy issues in Ringold and 
Calfee’s treatment of cigarette health claims. Journal of 
Public Policy and Marketing 1992;11(1):82–6. 
Cohen JB. Consumer/smoker perceptions of Federal 
Trade Commission tar ratings. In: The FTC Cigarette 
Test Method for Determining Tar, Nicotine, and Carbon 
Monoxide Yields of U.S. Cigarettes. Report of the NCI Ex­
pert Panel. Smoking and Tobacco Control Monograph 
No. 7. Bethesda (MD): US Department of Health and 
Human Services, Public Health Service, National 
Institutes of Health, National Cancer Institute, 
1996:127–34. NIH Publication No. 96-4028. 
Cohen LP, Geyelin M. Probe reopens into nonprofit 
tobacco group. Wall Street Journal, Feb 8, 1996;Sect A:3. 
Cole J, Taylor J. Liggett to cooperate in tobacco probe. 
Wall Street Journal, Apr 29, 1998;Sect A:3. 
   
Surgeon General's Report
 
Collins G. Paper maker to spin off tobacco units. New 
York Times, May 10, 1995a;Sect D:1 (col 5). 
Collins G. Teen-agers and tobacco: the reaction; com­
panies sue to prevent control of cigarette sales. New 
York Times, Aug 11, 1995b;Sect A:18 (col 5). 
Collins G. Tobacco suit’s plaintiffs suffer a court set­
back. New York Times, May 16, 1995c;Sect D:1 (col 2). 
Congressional Record. 104th Cong., 1st Sess., 1995a, 
141:H7470–H7476. 
Congressional Record. 104th Cong., 1st Sess., 1995b, 
141:H7646–H7683. 
Conlisk E, Siegel M, Lengerich E, Mac Kenzie W, Malek 
S, Eriksen M. The status of local smoking regulations 
in North Carolina following a state preemption bill. 
Journal of the American Medical Association 1995;273 
(10):805–7. 
Connecticut v. Philip Morris Inc., No. CV 9601534405 
(Conn. Oct. 9, 1996), cited in 11.7 TPLR 2.238 (1996). 
Connolly GN. The marketing of nicotine addiction by 
one oral snuff manufacturer. Tobacco Control 1995; 
4(1):73–9. 
Connor v. R.J. Reynolds Tobacco Co., No. 95-01820-CA, 
Div. CV-H (Fla. Cir. Duval Cty. May 5, 1997) (jury ver­
dict for defense). 
Cooper H. Tobacco litigation: a comparative analysis 
of the United States and European Community ap­
proaches to combatting the hazards associated with 
tobacco products. Brooklyn Journal of International Law 
1990;16(2):275–303. 
Corporate Crime Reporter. Indictments against tobacco 
companies, executives to be handed down within 
months, Douglas predicts. Corporate Crime Reporter 
1998;12(19):1, 12–16. 
Cotton P. Tobacco foes attack ads that target women, 
minorities, teens, and the poor. Journal of the American 
Medical Association 1990;264(12):1505–6. 
Coughlin PJ; Janecek FJ Jr; Milberg, Weiss, Bershad, 
Hynes & Lerach LLP. A Review of R.J. Reynolds’ In­
ternal Documents Produced in Mangini vs. R.J. Reynolds 
Tobacco Company, Civil Number 939359—The Case that 
Rid California and the American Landscape of “Joe 
Camel”; <http://galen.library.ucsf.edu/tobacco/ 
mangini/report/index.html>; accessed: February 18, 
1999. 
Coultas DB, Stidley CA, Samet JM. Cigarette yields of 
tar and nicotine and markers of exposure to tobacco 
smoke. American Review of Respiratory Disease 1993;148 
(2):435–40. 
Council Directive 90/239/EEC of 17 May 1990, 1990 
Official Journal of the European Community (L 137) 36. 
Council Directive 92/41/EEC of 15 May 1992, 1992 
Official Journal of the European Community (L 158) 35. 
Coyne Beahm, Inc. v. Food and Drug Administration, No. 
2:95CV00591 (N.C. Aug. 10, 1995), cited in 10.5 TPLR 
3.379 (1995) (Complaint). 
Coyne Beahm, Inc. v. U.S. Food & Drug Administration, 
966 F. Supp. 1374 (M.D.N.C. 1997). 
Cummings KM, Coogan K. Organizing communities 
to prevent the sale of tobacco products to minors. In­
ternational Quarterly of Community Health Education 
1992–93;13(1):77–86. 
Cummings KM, Hyland A, Saunders-Martin T, Perla 
J, Coppola PR, Pechacek TF. Evaluation of an enforce­
ment program to reduce tobacco sales to minors. Ameri­
can Journal of Public Health 1998;88(6):932–6. 
Cummings KM, Markello SJ, Mahoney M, Bhargava 
AK, McElroy PD, Marshall JR. Measurement of cur­
rent exposure to environmental tobacco smoke. Ar­
chives of Environmental Health 1990;45(2):74–9. 
Cummings KM, Pechacek T, Shopland D. The illegal 
sale of cigarettes to US minors: estimates by state. 
American Journal of Public Health 1994;84(2):300–2. 
Cummings KM, Saunders-Martin T, Clarke H, Perla J. 
Monitoring vendor compliance with tobacco sales 
laws: payment vs no payment approaches [letter]. 
American Journal of Public Health 1996;86(5):750–1. 
268 Chapter 5
 

   Regulatory Efforts 269
 
Cummings KM, Sciandra E, Pechacek TF, Orlandi M, 
Lynn WR, for the COMMIT Research Group. Where 
teenagers get their cigarettes: a survey of the purchas­
ing habits of 13–16 year olds in 12 US communities. 
Tobacco Control 1992;1(4):264–7. 
Cummings KM, Vito D, Gabrel C. Tobacco, alcohol, 
and other drug use behaviors among adolescents in 
Erie County, New York. Journal of Public Health Man­
agement Practice 1995;1(2):23–30. 
Curriden M. Hurdle cleared for tobacco suit. American 
Bar Association Journal 1995;81(May):22–3. 
Curriden M, Rodrigue G. State’s tobacco suit aids 
criminal probe. Federal inquiry focuses on roles played 
by industry law firms. Dallas Morning News, Oct 6, 
1997;Sect A:1. 
Davidson L, Slade J, Stang CL. Knowledge and atti­
tudes about tobacco among pharmacists who do and 
who do not sell tobacco. In: Aoki M, Hisamichi S, 
Tominaga S, editors. Smoking and Health 1987: Proceed­
ings of the 6th World Conference on Smoking and Health, 
Tokyo, 9–12 November 1987. Amsterdam: Excerpta 
Medica, 1988:343–5. 
Davis A. Guatemala sues tobacco firms to recover 
health-care costs. Wall Street Journal, May 13, 1998;Sect 
B:13. 
Davis A, Duffy B. Double trouble? Criminal probes 
dogging industry. Wall Street Journal, July 10, 1998;Sect 
B:1. 
Davis RM, Healy P, Hawk SA. Information on tar and 
nicotine yields on cigarette packages. American Jour­
nal of Public Health 1990;80(5):551–3. 
Daynard RA. Tobacco liability litigation as a cancer 
control strategy. Journal of the National Cancer Institute 
1988;80(1):9–13. 
Daynard RA. Filter tips: more ways to smoke the to­
bacco companies; litigation. Washington Monthly 1993a; 
25(1–2):18. 
Daynard RA. Smoking out the enemy: new develop­
ments in tobacco litigation. Trial 1993b;29:16–23. 
Daynard RA. Catastrophe theory and tobacco litiga­
tion. Tobacco Control 1994a;3(1):59–64. 
Reducing Tobacco Use 
Daynard RA. The third wave of tobacco products 
liability cases. Trial 1994b;30:34–40. 
Daynard RA. Litigation by states against the tobacco 
industry. Tobacco On Trial 1997;3(Aug):3. 
Daynard RA, Morin L. The Cipollone documents: fol­
lowing the paper trail to tobacco industry liability. Trial 
1988;24:50–4. 
Department of National Health and Welfare. Tobacco 
products control regulation. Canada Gazette, Part II 
1989;123(2):64. 
Department of National Health and Welfare. Tobacco 
products control regulations, amendment. Canada Ga­
zette, Part II 1993;127(16):3277–84. 
Dieter M. Impact of Wiley case on other suits argued; 
tobacco industry sees other wins, but foes disagree. 
Louisville Courier-Journal, Mar 21, 1998;Sect A:1. 
DiFranza JR. Synar regulations. Tobacco Access Law 
News, Nov 1993;21:1. 
DiFranza JR. Sabotaging enforcement efforts. Tobacco 
Access Law News, May 1994a;24:1–8. 
DiFranza JR. Synar update. Tobacco Access Law News, 
Oct 1994b;26:1–8. 
DiFranza JR. The empire strikes back. Tobacco Access 
Law News, July 1994c;25:1–8. 
DiFranza JR, Carlson RP, Caisse RE Jr. Reducing youth 
access to tobacco [letter]. Tobacco Control 1992;1(1):58. 
DiFranza JR, Celebucki CC, Seo HG. A model for the 
efficient and effective enforcement of tobacco sales laws. 
American Journal of Public Health 1998;88(7):1100–1. 
DiFranza J, Godshall B. Tobacco industry lobbies to 
sabotage Synar law. Tobacco-Free Youth Reporter 1994; 
6(3):7–10. 
DiFranza JR, Lew RA. Effect of maternal cigarette 
smoking on pregnancy complications and sudden in­
fant death syndrome. Journal of Family Practice 1995; 
40(4):385–94. 
DiFranza J, Librett J. State and federal revenues from 
tobacco consumed by minors. American Journal of Pub­
lic Health 1999;89(7):1106–8. 
   
Surgeon General's Report
 
DiFranza JR, Norwood BD, Garner DW, Tye JB. Legis­
lative efforts to protect children from tobacco. Journal of 
the American Medical Association 1987;257(24):3387–9. 
DiFranza JR, Richards JW, Paulman PM, Wolf-Gillespie 
N, Fletcher C, Jaffe RD, Murray D. RJR Nabisco’s car­
toon camel promotes Camel cigarettes to children. Jour­
nal of the American Medical Association 1991;266(22): 
3149–53. 
DiFranza JR, Savageau JA, Aisquith BR. Youth access 
to tobacco: the effects of age, gender, vending machine 
locks, and “It’s the Law” programs. American Journal 
of Public Health 1996;86(2):221–4. 
Djordjevic MV, Hoffmann D, Glynn T, Connolly GN. 
US commercial brands of moist snuff, 1994. I. Assess­
ment of nicotine, moisture, and pH. Tobacco Control 
1995;4(1):62–6. 
Douglas CE. The Tobacco Industry’s Use of Nicotine as a 
Drug: What Do the Recent Revelations Mean for Tobacco 
Control? New York: American Council on Science and 
Health, 1994. 
Douglas CE. Criminal action against the tobacco in­
dustry: serving the public health. In: Abstracts. 126th 
Annual Meeting and Exposition; Nov 15–18, 1998; 
Washington, DC. Washington: American Public Health 
Association, 1998:1. 
Downey LA, Gardiner JA. Reducing Youth Access to To­
bacco: A Partial Inventory of State Initiatives. Chicago: 
University of Illinois at Chicago, 1996. 
Drug Abuse Advisory Committee. Abuse liability as­
sessment of nicotine nasal spray. Transcription of meet­
ing no. 27 of the US Food and Drug Administration, 
Center for Drug Evaluation and Research, Drug Abuse 
Advisory Committee; Aug 1, 1994; Silver Spring (MD). 
Duffy B, Taylor J. Liggett’s cooperation with investi­
gators changes politics of tobacco legislation. Wall 
Street Journal, May 1, 1998;Sect A:16. 
Dunagin v. City of Oxford, 718 F.2d 738 (5th Cir. 1983), 
cert. denied, 467 U.S. 1259 (1984). 
Durkin T, Felstiner WLF. Bad arithmetic: disaster liti­
gation as less than the sum of its parts. In: Jasanoff S, 
editor. Learning from Disaster: Risk Management after 
Bhopal. Philadelphia: University of Pennsylvania Press, 
1994:158–79. 
Dworkin v. Paley, 93 Ohio App. 3d 383, 638 N.E.2d 636 
(Ohio Ct. App. 1994). 
Dybing E, Sanner T. Passive smoking, sudden infant 
death syndrome (SIDS) and childhood infections. Hu­
man Experimental Toxicology 1999;18(4):202–5. 
Economist. The tobacco wars: looking for a landmark. 
Economist, July 11, 1998;Business Sect:66. 
Edell MZ. Risk utility analysis of unavoidably unsafe 
products. Seton Hall Law Review 1987;17:623–55. 
Edenfield v. Fane, 113 S. Ct. 1792 (1993). 
Edwards v. GMRI, Inc., No. 119S93 (Md., Montgomery 
Cty. Nov. 26, 1997), cited in 13.1 TPLR 3.1 (1998). 
Emery v. Caravan of Dreams, Inc., 879 F. Supp. 640 (N.D. 
Tex. 1995). 
Emmons KM, Abrams DB, Marshall RJ, Etzel RA, 
Novotny TE, Marcus BH, Kane ME. Exposure to envi­
ronmental tobacco smoke in naturalistic settings. 
American Journal of Public Health 1992;82(1):24–8. 
Emont SL, Choi WS, Novotny TE, Giovino GA. Clean 
indoor air legislation, taxation, and smoking behaviour 
in the United States: an ecological analysis. Tobacco 
Control 1993;2(1):13–7. 
Engle v. R.J. Reynolds Tobacco Co., No. 94-08273 CA (20) 
(Fla., Dade Cty. May 5, 1994), cited in 9.3 TPLR 3.293 
(1994). 
Engle v. R.J. Reynolds Tobacco Co., No. 94-08273 CA (20) 
(Fla., Dade Cty. Oct. 31, 1994), cited in 9.5 TPLR 2.147 
(1994) (Order Granting Motion for Class Certification). 
Engle v. R.J. Reynolds Tobacco Co., No. 94-08273 CA (20) 
(Fla., Dade Cty. Oct. 31, 1994), cited in 9.5 TPLR 2.147 
(1994), aff’d 672 So. 2d 39 (1996). 
Environics Research Group Limited. Awareness of Health 
Hazards Due to Smoking. Toronto: Environics Research 
Group Limited, 1991. 
Environmental Protection Agency. Respiratory Health 
Effects of Passive Smoking: Lung Cancer and Other Disor­
ders. Washington: Environmental Protection Agency, 
Office of Research and Development, Office of Air and 
Radiation, 1992. Publication No. EPA/600/6-90/006F. 
270 Chapter 5
 

   Regulatory Efforts 271
 

Epstein E, Russell S. Campaign watch: Wilson blasts 
tobacco firm’s ballot initiative. San Francisco Chronicle, 
July 22, 1994;Sect A:5. 
Ernster VL. Women and smoking [editorial]. Ameri­
can Journal of Public Health 1993;83(9):1202–4. 
Evans N, Farkas A, Gilpin E, Berry C, Pierce JP. Influ­
ence of tobacco marketing and exposure to smokers 
on adolescent susceptibility to smoking. Journal of the 
National Cancer Institute 1995;87(20):1538–45. 
Falise v. American Tobacco Co., No. 97-CV-7640 (E.D.N.Y. 
Dec. 31, 1997), cited in 12.8 TPLR 3.504 (1997). 
Federal Filings-Dow Jones News. RJ Reynolds gets 
subpoened by D.C. grand jury. Federal Filings-Dow 
Jones News (newswire), Aug 16, 1996. 
Federal Register. Federal Trade Commission. Advertis­
ing and labeling of cigarettes (16 CFR 408), 29 Fed. Reg. 
530 (1964). 
Federal Register. US Department of Health and Human 
Services. Substance abuse prevention and treatment 
block grants: sale or distribution of tobacco products 
to individuals under 18 years of age (45 CFR Part 96), 
58 Fed. Reg. 45156 (1993). 
Federal Register. US Department of Labor, Occupational 
Safety and Health Administration. Indoor air quality 
(29 CFR Parts 1910, 1915, 1926, and 1928), 59 Fed. Reg. 
15968 (1994). 
Federal Register. US Department of Health and Human 
Services, Food and Drug Administration. Analysis re­
garding the Food and Drug Administration’s jurisdic­
tion over nicotine-containing cigarettes and smokeless 
tobacco products, 60 Fed. Reg. 41453 (1995a). 
Federal Register. US Department of Health and Human 
Services, Food and Drug Administration. Regulations 
restricting the sale and distribution of cigarettes and 
smokeless tobacco to protect children and adolescents 
(21 CFR Parts 801, 803, 804, and 897), 60 Fed. Reg. 41314 
(1995b). 
Federal Register. US Department of Health and Human 
Services, Food and Drug Administration. Regulations 
restricting the sale and distribution of cigarettes and 
smokeless tobacco to protect children and adolescents 
(21 CFR Parts 801, 803, 804, 807, 820, and 897), 61 Fed. 
Reg. 44396 (1996). 
Reducing Tobacco Use 
Federal Register. US Department of Health and Human 
Services. Notice regarding requirement for annual sub­
mission of the quantity of nicotine contained in smoke­
less tobacco products manufactured, imported, or 
packaged in the United States, 64 Fed. Reg. 14085 (1999). 
Federal Trade Commission. Report to Congress: Pursu­
ant to the Federal Cigarette Labeling and Advertising Act. 
Washington: Federal Trade Commission, 1967. 
Federal Trade Commission. Report to Congress: Pursu­
ant to the Federal Cigarette Labeling and Advertising Act 
for the Year 1981. Washington: Federal Trade Commis­
sion, 1984. 
Federal Trade Commission. Report to Congress for 1993: 
Pursuant to the Federal Cigarette Labeling and Advertis­
ing Act. Washington: Federal Trade Commission, 1995. 
Federal Trade Commission. Report to Congress for 1997: 
Pursuant to the Federal Cigarette Labeling and Advertis­
ing Act. Washington: Federal Trade Commission, 1999. 
Feighery E, Altman DG, Shaffer G. The effects of com­
bining education and enforcement to reduce tobacco 
sales to minors: a study of four northern California 
communities. Journal of the American Medical Associa­
tion 1991;266(22):3168–71. 
Ferris RP. The role of smoking behaviour in product 
development: some observations on the psychologi­
cal aspects of smoking behaviour. Paper presented at 
the Smoking Behaviour-Marketing Conference; July 
9–12, 1984; Montreal. 
50-58 Gainsborough Street Realty Trust v. Reece and Kristy 
Haile, No. 98-02279, Boston Housing Court (1998). 
Fischer S, Castonguay A, Kaiserman M, Spiegelhalder 
B, Preussmann R. Tobacco-specific nitrosamines in 
Canadian cigarettes. Journal of Cancer Research and Clini­
cal Oncology 1990;116(6):563–8. 
Fischer PM, Schwartz MP, Richards JW Jr, Goldstein 
AO, Rojas TH. Brand logo recognition by children aged 
3 to 6 years: Mickey Mouse and Old Joe the Camel. 
Journal of the American Medical Association 1991a; 
266(22):3145–8. 
   
 
 
Surgeon General's Report
 
Fischer S, Spiegelhalder B, Preussmann R. Tobacco-
specific nitrosamines in commercial cigarettes: possi­
bilities for reducing exposure. In: O’Neill IK, Chen J, 
Bartsch H, editors. Relevance to Human Cancer of N-
Nitroso Compounds, Tobacco Smoke and Mycotoxins. New 
York: Oxford University Press, 1991b. IARC Scientific 
Publication No. 105. 
Fishman JA, Allison H, Knowles SB, Fishburn BA, 
Woollery TA, Marx WT, Shelton DM, Husten CG, 
Eriksen MP. State laws on tobacco control—United 
States, 1998. Morbidity and Mortality Weekly Report 
1999;48(SS-3):21–62. 
Florida v. American Tobacco Co., No. 95-1466AO (Fla., 
Palm Beach Cty. Feb. 21, 1995), cited in 10.1 TPLR 3.1 
(1995) (Complaint). 
Florida v. American Tobacco Co., No. CL 95-1466 AH (Fla., 
Palm Beach Cty. Sept. 16, 1996) (Order Granting, in 
Part, Defendants’ Motions to Dismiss). 
Florida v. American Tobacco Co., No. CL 95-1466 AH (Fla., 
Palm Beach Cty. Oct. 18, 1996), cited in 11.7 TPLR 2.236 
(1996) (Order Denying Defendants’ Motion to Strike 
Plaintiffs’ “List of Medicaid Recipients”). 
Florida v. American Tobacco Co., Civil Action No. 95-1466 
AH (Fla., Palm Beach Cty. Aug. 25, 1997) (Settlement 
Agreement). 
Florida Bar v. Went For It, Inc., 515 U.S. 618 (1995). 
Flue-Cured Tobacco Cooperative Stabilization Corp. v. 
United States Environmental Protection Agency (M.D.N.C. 
June 22, 1993), cited in 8.2 TPLR 3.97 (1993). 
Flue-Cured Tobacco Cooperative Stabilization Corp. v. 
United States Environmental Protection Agency, 857 F. 
Supp. 1137 (M.D.N.C. 1994). 
Flue-Cured Tobacco Cooperative Stabilization Corp. v. 
United States Environmental Protection Agency, 4 F. Supp. 
2d 435 (M.D.N.C. 1998). 
Fontham ETH, Correa P, Reynolds P, Wu-Williams A, 
Buffler PA, Greenberg RS, Chen VW, Alterman T, Boyd 
P, Austin DF, Liff J. Environmental tobacco smoke and 
lung cancer in nonsmoking women: a multicenter 
study. Journal of the American Medical Association 
1994;271(22):1752–9. 
Food and Drug Administration v. Brown & Williamson, 
529 U.S. _____ (2000), 120 S. Ct. 1291. 
Forster J, Wolfson M, Claxton A, Murray D. Perceived 
tobacco availability and minors’ purchase success in 
fourteen Minnesota cities. Paper presented at the an­
nual meeting of the American Public Health Association; 
Oct 29–Nov 2, 1995; San Diego (CA). 
Forster JL, Hourigan M, McGovern P. Availability of 
cigarettes to underage youth in three communities. 
Preventive Medicine 1992a;21(3):320–8. 
Forster JL, Hourigan ME, Kelder S. Locking devices 
on cigarette vending machines: evaluation of a city 
ordinance. American Journal of Public Health 1992b; 
82(9):1217–9. 
Forster JL, Klepp K-I, Jeffery RW. Sources of cigarettes 
for tenth graders in two Minnesota cities. Health Edu­
cation Research 1989;4(1):45–50. 
Forster JL, Komro KA, Wolfson M. Survey of city ordi­
nances and local enforcement regarding commercial 
availability of tobacco to minors in Minnesota, United 
States. Tobacco Control 1996;5(1):46–51. 
Forster JL, Murray DM, Wolfson M, Blaine TM, Wagen­
aar AC, Hennrikus DJ. The effects of community poli­
cies to reduce youth access to tobacco. American Journal 
of Public Health 1998;88(8):1193–8. 
Forster JL, Wolfson M, Murray DM, Wagenaar AC, 
Claxton AJ. Perceived and measured availability of 
tobacco to youths in 14 Minnesota communities: the 
TPOP study. American Journal of Preventive Medicine 
1997;13(3):167–74. 
44 Liquormart, Inc. v. Racine, 829 F. Supp. 543 (R.I. 1993). 
44 Liquormart, Inc. v. Rhode Island, 517 U.S. 484, 116 S. 
Ct. 1495 (1996). 
Fourkas T, editor. Tobacco Control in California Cities: A 
Guide for Action. Sacramento (CA): California Depart­
ment of Health Services, 1992. 
Frankel A. Blowing smoke. The American Lawyer 1995; 
17(6):68–77. 
Fraser G. Strength of warnings on tobacco use reduced 
by lobbying, group charges. Globe and Mail (Toronto) 
June 26, 1989;Sect A:1 (col 1). 
272 Chapter 5
 

   Regulatory Efforts 273
 

Freedman A. Consolidated U.S. tobacco probe focuses 
on companies’ statements. Wall Street Journal, Sept 3, 
1996;Sect B:8. 
Freedman AM. Juiced up: how a tobacco giant doc­
tors snuff brands to boost their “kick.” Wall Street Jour­
nal, Oct 26, 1994;Sect A:1 (col 6). 
Freedman A, Jensen E, Stevens A. Why ABC settled 
with the tobacco industry. Wall Street Journal, Aug 24, 
1995;Sect B:1 (col 3). 
Freedman A, Lambert W. Tobacco probe examines se­
curities aspect. Wall Street Journal, July 27, 1995;Sect 
B:7. 
Freedman A, Stevens A. Philip Morris is putting TV 
journalism on trial in its suit against ABC. Wall Street 
Journal, May 23, 1995;Sect A:1 (col 6). 
FTC:WATCH. FTC closing its Camel cigarettes inves­
tigation without action. FTC:WATCH 1994;414:2–3. 
Gahagan DD. Switch Down and Quit: What the Cigarette 
Companies Don’t Want You to Know About Smoking. Berke­
ley (CA): Ten Speed Press, 1987. 
Galanter M. Why the “haves” come out ahead: specu­
lations on the limits of legal change. Law & Society Re­
view 1974;9(1):95–160. 
Galanter M. Reading the landscape of disputes: what 
we know and don’t know (and think we know) about 
our allegedly contentious and litigious society. UCLA 
Law Review 1983;31(4):4–71. 
Galanter M. Case congregations and their careers. Law 
& Society Review 1990;24(2):371–95. 
Galanter M. News from nowhere: the debased debate 
on civil justice. Denver University Law Review 1993;71(1): 
77–113. 
Galanter M. The transnational traffic in legal remedies. 
In: Jasanoff S, editor. Learning From Disaster: Risk Man­
agement After Bhopal. Philadelphia: University of Penn­
sylvania Press, 1994:133–57. 
Gallup Canada, Inc. for the Canadian Cancer Society. 
Final Report on a Survey of Canadians’ Knowledge of and 
Attitudes Toward the Harmful Effects of Smoking. Toronto: 
Gallup Canada, 1988. 
Reducing Tobacco Use 
Gallup Organization, Inc. for the American Lung As­
sociation. Survey of the Public’s Attitudes Toward Smok­
ing. Princeton (NJ): Gallup Organization, 1992. 
Gallup Organization, Inc. for the Coalition on Smok­
ing OR Health. The Public’s Attitudes Toward Cigarette 
Advertising and Cigarette Tax Increase. Princeton (NJ): 
Gallup Organization, 1993. 
Gangarosa RE, Vandall FJ, Willis BM. Suits by public 
hospitals to recover expenditures for the treatment of 
disease, injury and disability caused by tobacco and 
alcohol. Fordham Urban Law Journal 1994;22:81–139. 
Garner DW. Cigarettes and welfare reform. Emory Law 
Journal 1977;26:269–335. 
Gemson D, Moats HL, Watkins BX, Ganz ML, Robin­
son S, Healton E. Laying down the law: reducing ille­
gal tobacco sales to minors in central Harlem. American 
Journal of Public Health 1998;88(6):936–9. 
Gerlach KK, Shopland DR, Hartman AM, Gibson JT, 
Pechacek TF. Workplace smoking policies in the United 
States: results from a national survey of more than 
100,000 workers. Tobacco Control 1997;6(3):199–206. 
Gersten R. St. Peter gets tough on cigarette sales to 
youths. Mankato Free Press, Dec 13, 1994:15 (col 1). 
Geyelin M. Tobacco companies are set back by actions 
in Florida, Mississippi. Wall Street Journal, Feb 22, 1995; 
Sect B:4 (col 4). 
Geyelin M. Former researcher at Philip Morris sought 
immunity. Wall Street Journal, May 16, 1997;Sect B:13. 
Geyelin M. Release of tobacco documents ordered. Wall 
Street Journal, Mar 9, 1998;Sect A:3. 
Giovino GA, Schooley MW, Zhu B-P, Chrismon JH, 
Tomar SL, Peddicord JP, Merritt RK, Husten CG, 
Eriksen MP. Surveillance for selected tobacco-use 
behaviors—United States, 1900–1994. Morbidity and 
Mortality Weekly Report 1994;43(SS-3):1–43. 
   
Surgeon General's Report
 
Giovino GA, Tomar SL, Reddy MN, Peddicord JP, Zhu 
B-P, Escobedo LG, Eriksen MP. Attitudes, knowledge, 
and beliefs about low-yield cigarettes among adoles­
cents and adults. In: The FTC Cigarette Test Method for 
Determining Tar, Nicotine, and Carbon Monoxide Yields 
of U.S. Cigarettes. Report of the NCI Expert Committee. 
Smoking and Tobacco Control Monograph No. 7. 
Bethesda (MD): US Department of Health and Human 
Services, Public Health Service, National Institutes of 
Health, National Cancer Institute, 1996:39–57. NIH 
Publication No. 96-4028. 
Gitlin R. Minnesota bans spur cigarette machine wars. 
American Automatic Merchandiser 1991;33(10):12–6. 
Givelber D. Cigarette law. Indiana Law Journal 1998; 
73(Summer):867–901. 
Glantz SA, Parmley WW. Passive smoking and heart 
disease: mechanisms and risk. Journal of the American 
Medical Association 1995;273(13):1047–53. 
Glantz SA, Smith LR. The effect of ordinances requir­
ing smoke-free restaurants on restaurant sales. Ameri­
can Journal of Public Health 1994;84(7):1081–5. 
Glantz SA, Smith LRA. The effect of ordinances requir­
ing smoke-free restaurants and bars on revenues: a 
follow-up. American Journal of Public Health 1997;87(10): 
1687–93. 
Goldstein AO, Fischer PM, Richards JW Jr, Creten D. 
Relationship between high school student smoking 
and recognition of cigarette advertisements. Journal of 
Pediatrics 1987;110(3):488–91. 
Goldstein AO, Westbrook WR, Howell RE, Fischer PM. 
Hospital efforts in smoking control: remaining barri­
ers and challenges. Journal of Family Practice 1992;34(6): 
729–34. 
Gori GB. Consumer perception of cigarette yields: is 
the message relevant? Regulatory Toxicology and Phar­
macology 1990;12(1):64–8. 
Gori GB, Bock FG, editors. A Safe Cigarette? Banbury 
Report 3. Cold Spring Harbor (NY): Cold Spring Har­
bor Laboratory, 1980. 
Gorovitz E, Mosher J, Pertschuk M. Preemption or pre­
vention?: lessons from efforts to control firearms, al­
cohol, and tobacco. Journal of Public Health Policy 1998; 
19(1):36–50. 
Goshko J. Federal grand juries to investigate testimony 
by tobacco firm officials. The Washington Post, July 26, 
1995;Sect A:5. 
Gottlieb NH, Eriksen MP, Lovato CY, Weinstein RP, 
Green LW. Impact of a restrictive work site smoking 
policy on smoking behavior, attitudes, and norms. Jour­
nal of Occupational Medicine 1990;32(1):16–23. 
Gourlain v. Societe Nationale d’Exploitation Industrielle 
des Tabacs et Allumettes (SEITA) (Tribunal de Grande 
Instance de Montargis Dec. 19, 1996), cited in 11.8 TPLR 
3.1073 (1996). 
Gray B. Cigarette Labeling and Advertising: Hearings Be­
fore the House Committee on Interstate and Foreign Com­
merce, 88th Congress, 2nd Sess. 137 (1964) (statement 
on behalf of the tobacco industry). 
Gray N, Daube M, editors. Guidelines for Smoking Con­
trol. 2nd ed. UICC Technical Report Series. Vol. 52. 
Geneva: International Union Against Cancer, 1980. 
Green MD. Tribute—Dean John W. Wade: the schizo­
phrenia of risk-benefit analysis in design defect litiga­
tion. Vanderbilt Law Review 1995;48(Apr):609–29. 
Greising D, Zinn L. Where there’s secondhand 
smoke. . . . Business Week, Aug 8, 1994;3384:43–4. 
Grow D. Legislation is lesson in felling giants of to­
bacco. Minneapolis Star Tribune, Apr 1, 1990;Metro/ 
State News Sect:1B (col 1). 
Guatemala v. Tobacco Institute (D.C. May 12, 1998), cited 
in 13.3 TPLR 3.121 (1998). 
Gusfield JR. The social symbolism of smoking and 
health. In: Rabin RL, Sugarman SD, editors. Smoking 
Policy: Law, Politics, and Culture. New York: Oxford 
University Press, 1993:49–68. 
Haines v. Liggett Group, Inc., Civil No. 84-678 (HLS) 
(D.N.J. 1992), cited in 7.1 TPLR 2.1 (1992). 
Haines v. Liggett Group, Inc., 975 F.2d 81 (3d Cir. 1992). 
Haines v. Liggett Group, Inc., 814 F. Supp. 414 (D.N.J. 
1993). 
274 Chapter 5
 

   Regulatory Efforts 275
 
 
 
Hamilton JL. The effect of cigarette advertising bans 
on cigarette consumption. In: Steinfeld J, Griffiths W, 
Ball K, Taylor RM, editors. Smoking and Health. II. Health 
Consequences, Education, Cessation Activities, and Gov­
ernmental Action. Proceedings of the 3rd World Con­
ference on Smoking and Health, June 2–5, 1975, New 
York. Washington: US Department of Health, Educa­
tion and Welfare, Public Health Service, National In­
stitutes of Health, National Cancer Institute, 
1976:829–40. DHEW Publication No. (NIH) 77-1413. 
Hammond SK, Sorensen G, Youngstrom R, Ockene JK. 
Occupational exposure to environmental tobacco 
smoke. Journal of the American Medical Association 
1995;274(12):956–60. 
Hanauer P, Slade J, Barnes DE, Bero L, Glantz SA. Law­
yer control of internal scientific research to protect 
against products liability lawsuits: the Brown and 
Williamson documents. Journal of the American Medi­
cal Association 1995;274(3):234–40. 
Hanson JD, Logue KD. The costs of cigarettes: the eco­
nomic case for ex post incentive-based regulation. Yale 
Law Journal 1998;107:1167–361. 
Harmer v. Virginia Electric and Power Co., 831 F. Supp. 
1300 (E.D. Va. 1993). 
Hayes AS. Ex-smoker’s small-claims suit could light a 
litigation fuse. Wall Street Journal, Mar 24, 1993;Sect B:1 
(col 4). 
Health Canada. Tobacco Demand Reduction Strategy: Year 
One Review and Update. Ottawa (Canada): Health 
Canada, 1995a. 
Health Canada. When Packages Can’t Speak: Possible 
Impacts of Plain and Generic Packaging of Tobacco Prod­
ucts. Expert Panel Report. Ottawa (Canada): Health 
Canada, 1995b. 
Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunne­
mann KD, Hoffmann D. A tobacco-specific lung car­
cinogen in the urine of men exposed to cigarette smoke. 
New England Journal of Medicine 1993;329(21):1543–6. 
Helling v. McKinney, 113 S. Ct. 2475 (1993). 
Helm v. Helm, 01-A-01-9209-CH00365, 1993 WL 21983 
(Tenn. App. Feb. 3, 1993). 
Reducing Tobacco Use
 
Henderson JA Jr, Twerski AD. Stargazing: the future 
of American products liability law. New York Univer­
sity Law Review 1991;66(Nov):1332–42. 
Henningfield JE, Kozlowski LT, Benowitz NL. A pro­
posal to develop meaningful labeling for cigarettes. 
Journal of the American Medical Association  1994; 
272(4):312–4. 
Henningfield JE, Radzius A, Cone EJ. Estimation of 
available nicotine content of six smokeless tobacco 
products. Tobacco Control 1995;4(1):57–61. 
Hensler DR, Peterson MA. Understanding mass per­
sonal injury litigation: a socio-legal analysis. Brooklyn 
Law Review 1993;59(3):961–1062. 
Hill D, Gray N. Australian patterns of tobacco smok­
ing and related health beliefs in 1983. Community Health 
Studies 1984;8(3):307–22. 
Hilts PJ. Little smoke, little tar, but full dose of nico­
tine. New York Times, Nov 27, 1994;Sect A:1 (col 3). 
Hilts PJ. U.S. turning to grand juries to scrutinize to­
bacco industry. New York Times, July 26, 1995;Sect A:1. 
Hilts P, Collins G. Documents disclose Philip Morris 
studied nicotine’s effect on the body. New York Times, 
June 8, 1995;Sect A:1. 
Hinds MW. Impact of a local ordinance banning to­
bacco sales to minors. Public Health Reports 1992;107(3): 
355–8. 
Höfer I, Nil R, Bättig K. Nicotine yield as determinant 
of smoke exposure indicators and puffing behavior. 
Pharmacology, Biochemistry and Behavior 1991;40(1): 
139–49. 
Hohler B. Alleging tobacco conspiracy, Meehan to urge 
US grand jury inquiry. Boston Globe, Dec 14, 1994;3. 
Hohler B. Clinton offers own plan on tobacco. Boston 
Globe Sept 18, 1997;Sect A:3. 
Holding R. Taking a break—outdoors lawsuit challenges 
S.F. smoking ban. San Francisco Chronicle, Feb 2, 1994;Sect 
A:15. 
Hollie PG. Segmented cigarette market. New York Times, 
Mar 23, 1985;Business Day Sect:29 (col 3). 
   
Surgeon General's Report
 
Holloway v. Bristol-Myers Corp., 485 F.2d 986 (D.C. Cir. 
1973). 
Homeyer v. Stanley Tulchin Associates, Inc., No. 95 C 4439, 
1995 WL 683614 (N.D. Ill. Nov. 17, 1995). 
Homeyer v. Stanley Tulchin Associates, Inc., 91 F.3d 959 
(7th Cir. 1996). 
Hoppock KC, Houston TP. Availability of tobacco 
products to minors. Journal of Family Practice 1990;30(2): 
174–6. 
Horowitz v. Lorillard Tobacco Co., No. 965-245 (Super. 
Ct. San Francisco Cty. 1995), cert. denied, 118 S. Ct. 1797 
(1998). 
Howard DJ, Ota RB, Briggs LA, Hampton M, Pritsos 
CA. Environmental tobacco smoke in the workplace 
induces oxidative stress in employees, including in­
creased production of 8-hydroxy-2'-deoxyguanosine. 
Cancer Epidemiology, Biomarkers & Prevention 1998; 
7(2):141–6. 
Howatt G. New challenges in tobacco case; Medica, 
HealthPartners sue to recover health costs. Minneapo­
lis Star Tribune, Mar 12, 1998;Sect 1:A. 
Hudzinski LG, Frohlich ED. One-year longitudinal 
study of a no-smoking policy in a medical institution. 
Chest 1990;97(5):1198–202. 
Hwang SL. Florida legislature moves to cripple tobacco 
lawsuit. Wall Street Journal, May 9, 1995a;Sect B:6 
(col 5). 
Hwang SL. Library search hints of electrifying news 
from big tobacco. Wall Street Journal, Feb 6, 1995b;Sect 
A:1 (col 4). 
Hwang SL. Tobacco memos detail passive-smoke 
attack. Wall Street Journal, Apr 28, 1998;Sect B:1. 
Hwang SL, Ono Y. Companies crush out ties to ciga­
rettes. Wall Street Journal, Apr 3, 1995;Sect B:1 (col 4). 
IMPACT Research. Client Study, Pack Brand, Five-
Cigarette Pack: Results. Quebec (Canada): IMPACT 
Research, 1993. File 13-4092H. 
Imperial Tobacco Limited v. Commercial Union Assurance 
Co. of Canada, No. 500-05-014084-964 (Canada S. Ct., 
Prov. of Quebec, Dist. of Montreal Jan. 12, 1996), cited 
in 11.1 TPLR 3.39 (1996). 
In re Aubuchon, 913 P.2d 221 (Kan. Ct. App. Mar. 22, 
1996). 
In re Cigarette Cases (Fla., Duval Cty. Jan. 23, 1996), cited 
in 11.1 TPLR 2.3 (1996). 
In re Corr-Williams Tobacco Co. (Miss. S. Ct.), cited in 12.1 
TPLR 2.1 (1997). 
In re Kirk Fordice as Governor of Mississippi (Miss. S. Ct.), 
cited in 12.1 TPLR 2.5 (1997). 
In re Philip Morris Inc., 706 So. 2d 665, 1998 La. App. 
LEXIS 138 (4th Cir. Jan. 28, 1998). 
In re Pinkerton Tobacco Co., 115 F.T.C. 60, 1992 F.T.C. 
LEXIS 35 (F.T.C. Jan. 9, 1992). 
In re R.J. Reynolds Tobacco Co., Docket No. 9285 (F.T.C., 
May 28, 1997), cited in 12.3 TPLR 8.1 (1997). 
In re Union Carbide Corp. Gas Plant Disaster at Bhopal, 
India in December, 1984, 634 F. Supp. 842 (S.D.N.Y. 1986), 
aff’d in part 809 F.2d 195 (2nd Cir. 1987), cert. denied, 
484 U.S. 871, 108 S. Ct. 199 (1987). 
In re Wilk v. Wilk, 781 S.W.2d 217 (Mo. App. 1989). 
Jacobson PD, Wasserman J, Raube K. The Political Evo­
lution of Anti-smoking Legislation. Santa Monica (CA): 
RAND Corporation, 1992. 
Janofsky M. Big tobacco watching a small-claims court. 
New York Times, June 21, 1993;Sect D:3 (col 1). 
Janofsky M. Ailing smokers sue the tobacco industry. 
New York Times, May 7, 1994a;Sect 1:11 (col 1). 
Janofsky M. Mississippi seeks damages from tobacco 
companies. New York Times, May 24, 1994b;Sect A:12 
(col 5). 
Janofsky M. Philip Morris accuses ABC of libel. New 
York Times, Mar 25, 1994c;Sect A:15 (col 1). 
276 Chapter 5
 

   Regulatory Efforts 277
 
Jarvik ME, Henningfield JE. Pharmacological adjuncts 
for the treatment of tobacco dependence. In: Orleans 
CT, Slade J, editors. Nicotine Addiction: Principles and 
Management. New York: Oxford University Press, 1993: 
245–61. 
Jasanoff S. Remedies against hazardous exports: com­
pensation, products liability and criminal sanctions. 
In: Ives JH, editor. Transnational Corporations and Envi­
ronmental Control Issues: The Export of Hazard. Boston: 
Routledge & Kegan Paul, 1985:142–60. 
Jason LA, Ji PY, Anes MD, Birkhead SH. Active en­
forcement of cigarette control laws in the prevention 
of cigarette sales to minors. Journal of the American 
Medical Association 1991;266(22):3159–61. 
Jeffery RW, Kelder SH, Forster JL, French SA, Lando 
HA, Baxter JE. Restrictive smoking policies in the 
workplace: effects on smoking prevalence and ciga­
rette consumption. Preventive Medicine 1994;23(1): 
78–82. 
Jenks S. Low-tar cigarettes pose hidden health threat, 
panel says. Journal of the National Cancer Institute 
1995;87(1):15–6. 
Jinot J, Bayard S. Respiratory health effects of passive 
smoking: EPA’s weight-of-evidence analysis. Journal 
of Clinical Epidemiology 1994;47(4):339–49. 
Johnston D. Federal thrust against tobacco gets new 
vigor. New York Times, Mar 18, 1996; Sect A:1. 
Johnston LD, O’Malley PM, Bachman JG. Smoking, 
Drinking, and Illicit Drug Use among American Second­
ary School Students, College Students, and Young Adults, 
1975–1991: Volume I, Secondary School Students. 
Bethesda (MD): US Department of Health and Human 
Services, Public Health Service, National Institutes of 
Health, National Institute on Drug Abuse, 1992. NIH 
Publication No. 93-3480. 
Joint Commission on Accreditation of Healthcare Or­
ganizations. Accreditation Manual for Hospitals. Volume 
1: Standards. Oakbrook Terrace (IL): Joint Commission 
on Accreditation of Healthcare Organizations, 1992. 
Jones C. Former research official to testify: grand jury 
probing the tobacco industry. Richmond Times-Dispatch, 
Sept 16, 1996;Sect A:1. 
Reducing Tobacco Use
 
Joossens L. The influences of advertising on tobacco 
consumption: comments on Boddewyn & Chapman. 
British Journal of Addiction 1989;84(11):1279–81. 
Kagan RA. Adversarial legalism and American gov­
ernment. Journal of Policy Analysis and Management 
1991;10(3):369–406. 
Kaiserman MJ. The effectiveness of health warning 
messages. Tobacco Control 1993;2(3):267–9. 
Kaiserman MJ, Rickert WS. Carcinogens in tobacco 
smoke: benzo[a]pyrene from Canadian cigarettes and 
cigarette tobacco. American Journal of Public Health 
1992;82(7):1023–6. 
Kakalik JS, Pace NM. Costs and Compensation Paid in Tort 
Litigation: Testimony Before the Joint Economic Committee 
of the U.S. Congress. Santa Monica (CA): RAND Corpo­
ration, Institute for Civil Justice, 1986. P-7243-ICJ. 
Kamin AZ. Pharmacy dean opposes tobacco. New York 
Times, Nov 27, 1994;New Jersey Weekly Sect:8 (col 4). 
Kann L, Kinchen SA, Williams BI, Ross JG, Lowry R, 
Hill CV, Grunbaum JA, Blumson PS, Collins JL, 
Kolbe LJ. Youth risk behavior surveillance—United 
States, 1997. Morbidity and Mortality Weekly Report 1998; 
47(SS-3):1–89. 
Karbiwnyk v. R.J. Reynolds Tobacco Co., No. 95-04697­
CA, Div. CV-H (Fla. Cir. Duval Cty. Oct. 31, 1997) (jury 
verdict for defense). 
Karter MJ Jr. Fire loss in the United States in 1992. Na­
tional Fire Protection Association Journal 1993;87(5): 
78–87. 
Kaufman DW, Palmer JR, Rosenberg L, Stolley P, 
Warshauer E, Shapiro S. Tar content of cigarettes in 
relation to lung cancer. American Journal of Epidemiol­
ogy 1989;129(4):703–11. 
Kawachi I, Colditz GA, Speizer FE, Manson JE, Stamp-
fer MJ, Willett WC, Hennekens CH. A prospective 
study of passive smoking and coronary heart disease. 
Circulation 1997;95(10):2374–9. 
Kearney v. Philip Morris Cos. (D. Mass. May 11, 1992), 
cited in 7.2 TPLR 3.65 (1992) (Complaint). 
Kearney v. Philip Morris Inc., 916 F. Supp. 61 (D. Mass. 
1996). 
   
Surgeon General's Report
 
Keay KD, Woodruff SI, Wildey MB, Kenney EM. Ef­
fect of a retailer intervention on cigarette sales to mi­
nors in San Diego County, California. Tobacco Control 
1993;2(2):145–51. 
Keil R. Brooke Group’s Liggett to cooperate in tobacco 
probe. Bloomberg (news wire), Apr 28, 1998. 
Kelder G. Fight the future or everything you always 
wanted to know about how the tobacco industry (a.k.a. 
the cigarette smoking men) killed the McCain Bill but 
were afraid to ask. Tobacco Control Update 1998;2(3–4): 
5–21. 
Kelder GE. First class certifications in the third wave 
of tobacco litigation herald the beginning of the end 
for the tobacco industry. Tobacco on Trial 1994 (Oct):1, 
3–7. 
Kelder GE, Daynard RA. The role of litigation in the 
effective control of the sale and use of tobacco. Stanford 
Law and Policy Review 1997;8(1):63–98. 
Kennedy J. Talks break off in bid to end tobacco suit; 
the state and cigarette makers traded charges after 
negotiations failed to settle Florida’s $1 billion claim. 
Orlando Sentinel, July 27, 1996;Metro Sect:C1. 
Kessler DA. Letter from Food and Drug Administra­
tion re regulation of cigarettes as drugs, cited in 9.1 
TPLR 8.1 (1994a). 
Kessler DA. Statement on nicotine-containing ciga­
rettes. Tobacco Control 1994b;3(2):148–58. 
Kessler DA. The control and manipulation of nicotine 
in cigarettes. Tobacco Control 1994c;3(4):362–9. 
Klonoff EA, Fritz JM, Landrine H, Riddle RW, Tully-
Payne L. The problem and sociocultural context of 
single-cigarette sales. Journal of the American Medical 
Association 1994;271(8):618–20. 
Klonoff-Cohen HS, Edelstein SL, Lefkowitz ES, Srini­
vasan IP, Kaegi D, Chang JC, Wiley KJ. The effect of 
passive smoking and tobacco exposure through breast 
milk on sudden infant death syndrome. Journal of the 
American Medical Association 1995;273(10):795–8. 
Koepp S. Tobacco’s first loss. Time 1988;131(26):48–50. 
Komesar NK. Imperfect Alternatives: Choosing Institu­
tions in Law, Economics, and Public Policy. Chicago: Uni­
versity of Chicago Press, 1994. 
Kozlowski LT. Less hazardous smoking and the pur­
suit of satisfaction [editorial]. American Journal of Pub­
lic Health 1987;77(5):539–41. 
Kraft BP. Second-hand smoke suit seeks $650 mln from 
industry. Reuter European Business Report, May 13, 1994. 
Available from Dialog(R)File 611:Reuters. 
Kristein MM. Economic issues related to smoking in 
the workplace. New York State Journal of Medicine 1989; 
89(1):44–7. 
Kronquist L. Snusets Innehåll (The content of snuff). 
Gothenburg (Sweden): Gothia Tobak, 1994. 
Kropp R. A Report on Reducing Tobacco Sales to Minors 
by Prohibiting the Sale of Tobacco Products by Means of 
Self-Service Merchandising and Requiring Only Vendor-
Assisted Tobacco Sales. Petaluma (CA): North Bay Health 
Resources Center, 1995. 
Kropp R. Enforcement of Minimum Age-of-Sale Tobacco 
Laws. Petaluma (CA): North Bay Health Resources 
Center, 1996. 
Kropp R, Kuh S. A Civil Enforcement Strategy to Reduce 
Tobacco Sales to Minors in Two California Counties. 
Petaluma (CA): North Bay Health Resources Center, 
1994. 
Kyte v. Philip Morris Inc., 408 Mass. 162, 556 N.E.2d 1025 
(Mass. 1990). 
Lamke v. Futorian Corp., 709 P.2d 684 (Okla. 1985). 
Landler M. Philip Morris revels in rare ABC news apol­
ogy for report on nicotine. New York Times, Aug 28, 
1995;Sect D:5 (col 1). 
Landrine H, Klonoff EA, Alcaraz R. Asking age and 
identification may decrease minors’ access to tobacco. 
Preventive Medicine 1996;25(3):301–6. 
Landrine H, Klonoff EA, Fritz JM. Preventing cigarette 
sales to minors: the need for contextual, sociocultural 
analysis. Preventive Medicine 1994;23(3):322–7. 
Lartigue v. R.J. Reynolds Tobacco Co., 317 F.2d 19 (5th 
Cir. 1963), cert. denied, 375 U.S. 865 (1963). 
278 Chapter 5
 

   Regulatory Efforts 279
 
Law SA. Addiction, autonomy, and advertising. Iowa 
Law Review 1992;77(3):909–55. 
Law MR, Morris JK, Wald NJ. Environmental tobacco 
smoke exposure and ischaemic heart disease: an evalu­
ation of the evidence. British Medical Journal 1997; 
315(7114):973–80. 
Lawrence C. Summer campaign to confront smokers 
[press release]. Canberra (Australia): Minister for 
Health and Human Services, Dec 21, 1994. 
Leary WE. U.S. ties secondhand smoke to cancer. New 
York Times, Jan 8, 1993;Sect A:14 (col 4). 
Lee v. Department of Public Welfare, No. 15385 (Mass. 
Mar. 31, 1983), cited in 1.2 TPLR 2.82 (1986). 
LeGresley EM. Out of the jaws of success: anatomy of 
a pyrrhic victory for Canada’s tobacco industry. Cana­
dian Law Newsletter 1996;29(Spring):35–47. 
Levin M. Controversy heats up over safer smokes. Los 
Angeles Times, Oct 20, 1987;View Sect (Pt 5):1 (col 6). 
Levin M. Smoker group’s thick wallet raises questions; 
funding: alliance amassed $45.9 million but very little 
from members’ dues, IRS reports show. Other records 
cite backing from tobacco firms. Los Angeles Times, Mar 
29, 1998;Sect A:21. 
Levin M, Ostrow R. Big tobacco’s Liggett Group agrees 
to aid federal probe. Los Angeles Times, Apr 29, 1998; 
Sect A:1. 
Levinson A. Licensing tobacco sales: some ideas and 
suggestions. Paper prepared for the Fourth National 
Synar Technical Assistance Workshop; March 28–31, 
1999; Arlington (VA). 
Levy D. RJR memo targeted teen market. USA Today, 
Oct 6, 1995;Sect D:1. 
Lew JB. Legal intervention to prevent cigarette sales 
to children. World Smoking & Health 1992;17(2):19–20. 
Lew JB. Mississippi sues tobacco companies for Med­
icaid costs; Florida passes Medicaid reimbursement 
law. Tobacco on Trial, May 31, 1994:3–5. 
Lewis K, Davis RM. Name your poison: global action 
on additives. Tobacco Control 1994;3(3):204–6. 
Reducing Tobacco Use 
Lewit EM, Coate D, Grossman M. The effects of gov­
ernment regulation on teenage smoking. Journal of Law 
and Economics 1981;24(3)545–69. 
Long Island Tobacco Co., Inc. v. Lindsay, 74 Misc. 2d 445, 
343 N.Y.S.2d 759 (N.Y. 1973). 
Longo DR, Brownson RC, Kruse RL. Smoking bans in 
US hospitals: results of a national survey. Journal of the 
American Medical Association 1995;274(6):488–91. 
Louisiana v. American Tobacco Co., No. 96-0908 (La. July 
16, 1996), cited in 11.5 TPLR 2.164 (1996). 
Lowell AM. Cipollone v. Liggett Group, Inc.: the ef­
fect of the Federal Cigarette Labeling and Advertising 
Act on state common law claims. American Journal of 
Trial Advocacy 1992;16(Winter):477–96. 
Lowenstein DH. “Too much puff”: persuasion, pater­
nalism, and commercial speech. University of Cincin­
nati Law Review 1988;56(4):1205–49. 
Lynch BS, Bonnie RJ, editors. Growing Up Tobacco Free: 
Preventing Nicotine Addiction in Children and Youths. 
Washington: National Academy Press, 1994. 
MacKenzie TD, Bartecchi CE, Schrier RW. The human 
costs of tobacco use (second of two parts). New En­
gland Journal of Medicine 1994;330(14):975–80. 
MacLachlan C. Plaintiffs’ bar aims, once more, at to­
bacco. National Law Journal, Dec 26, 1994–Jan 2, 1995; 
Sect A:14 (col 1). 
MacLachlan C. Cigarette makers claim gain in court. 
National Law Journal, May 15, 1995a;Sect B:1 (col 1). 
MacLachlan C. Help wanted for Mass. tobacco suit. 
National Law Journal, Apr 17, 1995b;Sect A:6. 
MacLachlan C. Questions abound for tobacco jury. 
National Law Journal, Sept 18, 1995c;Sect B:1 (col 1). 
MacLachlan C. More RICO counts seen for tobacco. 
National Law Journal, Dec 30, 1996–Jan 6, 1997;Sect A:7. 
Mahood G. Canadian tobacco warning system. Tobacco 
Control 1995;4(1):10–4. 
Mallory M. Marty’s smoking gun. Business Week, Dec 
26, 1994:75. 
   
Surgeon General's Report
 
Mallory M. For Reynolds, where there’s smokeless. . . . 
Business Week, Mar 27, 1995:39. 
Malouff J, Slade J, Nielsen C, Schutte N, Lawson E. US 
laws that protect tobacco users from employment dis­
crimination. Tobacco Control 1993;2(2):132–8. 
Mangini v. R.J. Reynolds Tobacco Co., 22 Cal. App. 4th 
628 (1993). 
Mangini v. R.J. Reynolds Tobacco Co., 7 Cal. 4th 1057, 
875 P.2d 73 (Cal. 1994), cert. denied, 1994 U.S. LEXIS 
8361 (Nov. 28, 1994). 
Mangini v. R.J. Reynolds Tobacco Co., No. 939359 (Calif. 
Sept. 8, 1997), cited in 12.5 TPLR 3.349 (1997) (Settle­
ment and Consolidation Agreement). 
Marcus BH, Emmons KM, Abrams DB, Marshall RJ, 
Kane M, Novotny TE, Etzel RA. Restrictive workplace 
smoking policies: impact on nonsmokers’ tobacco ex­
posure. Journal of Public Health Policy 1992;13(1):42–51. 
Martinez PJ, Knapp J, Kottke TE. Beliefs and attitudes 
of Minnesota pharmacists regarding tobacco sales and 
smoking cessation counselling. Tobacco Control 1993; 
2(4):306–10. 
Marttila & Kiley, Inc. Highlights from an American Can­
cer Society Survey of U.S. Voter Attitudes Toward Ciga­
rette Smoking. Boston: Marttila & Kiley, Inc., 1993. 
Maryland v. Philip Morris Inc., No. CCB-96-1691 (Md. 
July 31, 1996), cited in 11.5 TPLR 2.167 (1996). 
Maryland Register. Title 09. Department of Licensing 
and Regulation. Prohibition on smoking in an enclosed 
workplace. Maryland Register 1994;21(15):1304. 
Mass Tort Litigation Reporter. Tennessee court consoli­
dates five cases for a phased trial. Mass Tort Litigation 
Reporter 1998(March):12. 
Massachusetts v. Philip Morris Inc., No. 96-10014-GAO 
(D. Mass. May 20, 1996), cited in 11.3 TPLR 2.33 (1996). 
McGinnis JM, Foege WH. Actual causes of death in 
the United States. Journal of the American Medical Asso­
ciation 1993;270(18):2207–12. 
McGovern FE. Toward a functional approach for man­
aging complex litigation. University of Chicago Law Re­
view 1986;53(2):440–92. 
McGrath DJ. House panel rejects tobacco licensing bill. 
Minneapolis Star Tribune, Mar 15, 1995a;News Sect:2B. 
McGrath DJ. Panel OKs bill on tobacco sales to mi­
nors. Minneapolis Star Tribune, Mar 9, 1995b;News 
Sect:2B. 
McGraw v. American Tobacco Co., No. 94-1707 (W.Va. 
Cir. Ct. Kanawha Cty. Sept. 20, 1994), cited in 9.4 TPLR 
3.516 (1994). 
McKinlay JB. The promotion of health through planned 
sociopolitical change: challenges for research and 
policy. Social Science and Medicine 1993;36(2):109–17. 
McKinney v. Anderson, 924 F.2d 1500 (9th Cir. 1991). 
Mealey’s Litigation Reports: Tobacco. Tobacco companies 
again seek dismissal of counts in West Virginia case. 
Mealey’s Litigation Reports: Tobacco 1996a;10(7). 
Mealey’s Litigation Reports: Tobacco. Tobacco industry, 
others seek summary judgment in challenge to FDA 
authority. Mealey’s Litigation Reports: Tobacco 1996b; 
10(13). 
Meehan M. Letter and prosecution memo from Con­
gressman Martin Meehan to Attorney General Janet 
Reno, cited in 9.6 TPLR 8.123 (1994). 
Meier B. Tobacco researcher said to decline to testify. 
New York Times, May 15, 1997;Sect B:15 (col 4). 
Meier B. In latest tobacco negotiations, states lack clear 
health goals. New York Times, July 27, 1998a;Sect A:10 
(col 1). 
Meier B. Judge voids study linking cancer to second­
hand smoke. New York Times, July 20, 1998b;Sect A:14 
(col 1). 
Meier B. Tobacco company subject of investigation, 
officials say. New York Times, May 11, 1998c;Sect A:13. 
Meier B. U.S. brings its first charges in the tobacco in­
vestigation. New York Times, Jan 8, 1998d;Sect A:17. 
Metromedia, Inc. v. City of San Diego, 453 U.S. 490 (1981). 
Miga A. Fed juries subpoena tobacco co. executives. 
Boston Herald, July 26, 1995;Sect 1:3. 
280 Chapter 5
 

   Regulatory Efforts 281
 
Milbank D. British government will help smokers sue. 
Wall Street Journal, Feb 3, 1995;Sect B:1 (col 3). 
Minnesota Attorney General. Attorney General obtains 
settlement with cigarette manufacturer [press release]. 
St. Paul (MN): State of Minnesota, Office of the Attor­
ney General, May 3, 1994. 
Minnesota Automatic Merchandising Council. Ciga­
rette vending legislation fact sheet [memo]. Minneapo­
lis: Minnesota Automatic Merchandising Council, Feb 
24, 1987. 
Minnesota v. Philip Morris Inc., No. C1-94-8565 (Minn., 
Ramsey Cty. Nov. 29, 1994), cited in 9.3 TPLR 3.273 
(1994). 
Minnesota v. Philip Morris Inc., 551 N.W.2d 490 (Minn. 
1996). 
Minnesota v. Philip Morris Inc., No. C1-94-8565 (Minn., 
Ramsey Cty. May 8, 1998), cited in 13.2 TPLR 2.112 
(1998) (Consent Judgment). 
Minnesota v. Philip Morris Inc., No. C1-94-8565 (Minn., 
Ramsey Cty. May 8, 1998), cited in 13.2 TPLR 3.39 (1998) 
(Settlement Agreement and Stipulation for Entry of 
Consent Judgment). 
Montgomery N. Ex-smoker who lost in court won ad­
mirers ready to follow his lead. Seattle Times, July 4, 
1993;Sect B:3. 
Moore v. American Tobacco Co., No. 94:1429 (Miss., Jack­
son Cty. Oct. 14, 1994), cited in 9.5 TPLR 3.597 (1994) 
(Memorandum in Support of Plaintiff’s Motion to 
Strike Challenges to the Sufficiency of the Complaint 
and the Subject Matter Jurisdiction of the Chancery 
Court). 
Moore v. American Tobacco Co., Cause No. 94:1429 (Miss., 
Jackson Cty. Feb. 21, 1995), cited in 10.1 TPLR 2.13 
(1995). 
Morain D. Behind fuming bar owners is savvy, well-
heeled group. Los Angeles Times, Jan 30, 1998;Sect A:1. 
Morain D, Ellis V. California elections/propositions; 
voters approve “three strikes” law, reject smoking mea­
sure; proposal for government-run health care system, 
gasoline tax to fund rail projects are also defeated. Los 
Angeles Times, Nov 9, 1994;Sect A:3 (col 2). 
Reducing Tobacco Use 
Mosher JF. The merchants, not the customers: resist­
ing the alcohol and tobacco industries’ strategy to 
blame young people for illegal alcohol and tobacco 
sales. Journal of Public Health Policy 1995;16(4):412–32. 
Moss JE. Minority views on the Federal Cigarette La­
beling and Advertising Act. In: United States Code: Con­
gressional and Administrative News. 89th Congress—First 
Session, 1965. Vol. 2. St. Paul (MN): West Publishing 
Co., 1965:2365–7. 
Moylan MJ. Ban is another loss for smokers. Chicago 
Tribune, Feb 25, 1990;Sect 1:21 (col 5). 
Mudarri DH. The Costs and Benefits of Smoking Restric­
tions: An Assessment of the Smoke-Free Environment Act 
of 1993 (H.R. 3434). Washington: Environmental Pro­
tection Agency, Office of Radiation and Indoor Air, 
Indoor Air Division, 1994. 
Muller v. Costello, No. 94-CV-842 (FJS)(GJD), 1996 WL 
191977 (N.D.N.Y. May 20, 1996). 
Muller v. Costello, 997 F. Supp. 299 (N.D.N.Y. 1998). 
Myers ML, Iscoe C, Jennings C, Lenox W, Minsky E, 
Sacks A. Staff Report on the Cigarette Advertising Inves­
tigation. Washington: Federal Trade Commission, 1981. 
National Academy of Sciences. Environmental Tobacco 
Smoke: Measuring Exposures and Assessing Health Effects. 
Washington: National Academy Press, 1986. 
National Association of Convenience Stores v. Kessler, Civil 
Action No. 2:95CV00706 (M.D.N.C. Oct. 4, 1995). 
National Cancer Institute. Strategies to Control Tobacco 
Use in the United States: A Blueprint for Public Health 
Action in the 1990’s. Smoking and Tobacco Control 
Monograph No. 1. Bethesda (MD): US Department of 
Health and Human Services, Public Health Service, 
National Institutes of Health, National Cancer Insti­
tute, 1991. NIH Publication No. 92-3316. 
National Cancer Institute. The FTC Cigarette Test Method 
for Determining Tar, Nicotine, and Carbon Monoxide Yields 
of U.S. Cigarettes. Report of the NCI Expert Commit­
tee. Smoking and Tobacco Control Monograph No. 7. 
Bethesda (MD): US Department of Health and Human 
Services, Public Health Service, National Institutes of 
Health, National Cancer Institute, 1996. NIH Publica­
tion No. 96-4028. 
   
Surgeon General's Report
 
National Cancer Institute. Youth Access to Tobacco: A 
Guide to Developing Policy. Bethesda (MD): National 
Institutes of Health, National Cancer Institute, n.d. 
National Center for Health Statistics. Vital and Health 
Statistics: Current Estimates From the National Health 
Interview Survey, 1988. Hyattsville (MD): US Depart­
ment of Health and Human Services, Public Health 
Service, Centers for Disease Control, National Center 
for Health Statistics, 1989. DHHS Publication No. 
(PHS) 89-1501. 
National Center for Health Statistics. Healthy People 
2000 Review, 1997. Hyattsville (MD): US Department 
of Health and Human Services, Public Health Service, 
Centers for Disease Control and Prevention, National 
Center for Health Statistics, 1997. DHHS Publication 
No. (PHS) 98-1256. 
National Governors Association. Tobacco Settlement 
Funds; <http://www.nga.org/Pubs/Policies/EC/ec06. 
asp>; accessed: December 6, 1999. 
National Institute for Occupational Safety and Health. 
Environmental Tobacco Smoke in the Workplace: Lung Can­
cer and Other Health Effects. Current Intelligence Bulle­
tin 54. Cincinnati: US Department of Health and 
Human Services, Public Health Service, Centers for 
Disease Control, National Institute for Occupational 
Safety and Health, 1991. DHHS Publication No. 
(NIOSH) 91-108. 
National Law Journal. Insurer, Minnesota team to sue 
tobacco. National Law Journal, Aug 29, 1994;Newsline 
Sect:B2 (col 1). 
National Law Journal. New tobacco suits filed. National 
Law Journal, May 11, 1998;New Account Sect:B2. 
National Research Council. Environmental Tobacco 
Smoke: Measuring Exposures and Assessing Health Effects. 
Washington: National Academy Press, 1986. 
Neergaard L. Cigarette maker named in plot. Ann Ar­
bor News, Jan 8, 1998;Sect A:10. 
Negri E, Franzosi MG, La Vecchia C, Santoro L, Nobili 
A, Tognoni G on behalf of GISSI-EFRIM Investigators. 
Tar yield of cigarettes and risk of acute myocardial in­
farction. British Medical Journal 1993;306(6892):1567–70. 
Nordstrom DL, DeStefano F. Evaluation of Wisconsin 
legislation on smoking in restaurants. Tobacco Control 
1995;4(2):125–8. 
Nova Scotia Council on Smoking and Health. Students 
& Tobacco: The 1990 Nova Scotia Council on Smoking & 
Health Survey. Final Report. Halifax (Canada): Nova 
Scotia Department of Health and Fitness, 1991. 
Novak V, Freedman A. Tobacco industry facing 2 crimi­
nal investigations. Wall Street Journal, July 25, 1995:Sect 
A:3. 
Office of Inspector General. Youth Access to Cigarettes. 
Washington: US Department of Health and Human 
Services, Office of Inspector General, Office of Evalu­
ation and Inspections, 1990. OEI-02-90-02310. 
Office of Inspector General. State Oversight of Tobacco 
Sales to Minors. Washington: US Department of Health 
and Human Services, Office of Inspector General, Of­
fice of Evaluation and Inspections, 1995. OEI-02-94­
00270. 
Offord KP, Hurt RD, Berge KG, Frusti DK, Schmidt L. 
Effects of the implementation of a smoke-free policy 
in a medical center. Chest 1992;102(5):1531–6. 
Ohralik v. Ohio State Bar Assn., 436 U.S. 447 (1978). 
Oklahoma Telecasters Association v. Crisp, 699 F.2d 490 
(10th Cir. 1983), rev’d on other grounds sub nom. 
Oklahoma v. R.J. Reynolds Tobacco Co., No. CJ961499L 
(Okla., Cleveland Cty. Aug. 22, 1996), cited in 11.7 TPLR 
3.901 (1996). 
Orey M. Smoke signals on Wall Street. American Law­
yer 1995 (May):68–74. 
Pace E. New York City moves against cigarette ma­
chines. New York Times, Oct 16, 1990;Sect A:1 (col 2). 
Palmer JR, Rosenberg L, Shapiro S. “Low yield” ciga­
rettes and the risk of nonfatal myocardial infarction in 
women. New England Journal of Medicine 1989;320(24): 
1569–73. 
282 Chapter 5
 

   Regulatory Efforts 283
 
Parish S, Collins R, Peto R, Youngman L, Barton J, Jayne 
K, Clarke R, Appleby P, Lyon V, Cederholm-Williams 
S, Marshall J, Sleight P for the International Studies of 
Infarct Survival (ISIS) Collaborators. Cigarette smok­
ing, tar yields, and non-fatal myocardial infarction: 
14,000 cases and 32,000 controls in the United King­
dom. British Medical Journal 1995;311(7003):471–7. 
Parmet WE, Daynard RA, Gottlieb MA. The physi­
cian’s role in helping smoke-sensitive patients to use 
the Americans with Disabilities Act to secure smoke-
free workplaces and public spaces. Journal of the Ameri­
can Medical Association 1996;276(11):909–13. 
Parsons J. Proposed cigarette machine ban is amended. 
Minneapolis Star Tribune, Dec 7, 1989;News Sect B:3 
(col 3). 
Patten CA, Gilpin E, Cavin SW, Pierce JP. Workplace 
smoking policy and changes in smoking behaviour in 
California: a suggested association. Tobacco Control 
1995a;4(1):36–41. 
Patten CA, Pierce JP, Cavin SW, Berry CC, Kaplan RM. 
Progress in protecting non-smokers from environmen­
tal tobacco smoke in California workplaces. Tobacco 
Control 1995b;4(2):139–44. 
Patton, Boggs & Blow. Smokeless Tobacco Ingredient List 
as of April 4, 1994. Washington: Patton, Boggs & Blow, 
1994. 
Pauly JL, Allaart HA, Rodriguez MI, Streck RJ. Fibers 
released from cigarette filters: an additional health risk 
to the smoker? Cancer Research 1995;55(2):253–8. 
Pavlides v. Galveston Yacht Basin, Inc., 727 F.2d 330 (5th 
Cir. 1984). 
Penn Advertising of Baltimore, Inc. v. Mayor and City 
Council of Baltimore, 862 F. Supp. 1402 (Md. 1994). 
Penn Advertising of Baltimore, Inc. v. Mayor and City 
Council of Baltimore, 63 F.3d 1318 (4th Cir. 1995). 
Penn Advertising of Baltimore, Inc. v. Mayor and City 
Council of Baltimore, 101 F.3d 332 (4th Cir. 1996), cert. 
denied, 117 S. Ct. 1569 (1997). 
Reducing Tobacco Use 
Pertschuk M, editor. Major Local Tobacco Control Ordi­
nances in the United States. Smoking and Tobacco Con­
trol Monograph No. 3. Bethesda (MD): US Department 
of Health and Human Services, Public Health Service, 
National Institutes of Health, 1993. NIH Publication 
No. 93-3532. 
Pertschuk M, Shopland DR, editors. Major Local Smok­
ing Ordinances in the United States: A Detailed Matrix of 
the Provisions of Workplace, Restaurant, and Public Places 
Smoking Ordinances. Bethesda (MD): US Department 
of Health and Human Services, Public Health Service, 
National Institutes of Health, Americans for Nonsmok­
ers’ Rights, 1989. NIH Publication No. 90-479. 
Petersen LR, Helgerson SD, Gibbons CM, Calhoun CR, 
Ciacco KH, Pitchford KC. Employee smoking behav­
ior changes and attitudes following a restrictive policy 
on worksite smoking in a large company. Public Health 
Reports 1988;103(2):115–20. 
Pfennigstorf W, Gifford DG. A Comparative Study of 
Liability Law and Compensation Schemes in Ten Countries 
and the United States. Oak Brook (IL): Insurance Re­
search Council, 1991. 
Philip Morris Companies Inc. Annual Report (SEC Form 
10-K) (filing with Securities and Exchange Commis­
sion), Mar 6, 1998. 
Philip Morris Inc. v. Blumenthal, No. 97-7122 (2d Cir. 
1997), cited in 12.5 TPLR 2.305 (1997). 
Philip Morris Inc. v. Graham, Case No. 960904948 CV 
(Utah Dist. Ct. Salt Lake Cty. Feb. 13, 1997), cited in 
12.1 TPLR 2.46 (1997). 
Philip Morris Inc. v. Harshbarger, Civil Action No. 95­
12574-GAO (Mass. Nov. 22, 1996), cited in 11.8 TPLR 
2.259 (1996). 
Philip Morris Inc. v. Harshbarger, Civil Action No. 96­
11599-GAO, Civil Action No. 96-11619-GAO, 1997 U.S. 
Dist. LEXIS 21012 (D. Mass. Dec. 10, 1997). 
Philip Morris Inc. v. Harshbarger, 122 F.3d 58 (1st Cir. 
1997). 
Pierce JP, Gilpin EA. A historical analysis of tobacco 
marketing and the uptake of smoking by youth in the 
United States: 1890–1977. Health Psychology 1995; 
14(6):500–8. 
   
Surgeon General's Report
 
Pierce JP, Gilpin E, Burns DM, Whalen E, Rosbrook B, 
Shopland D, Johnson M. Does tobacco advertising tar­
get young people to start smoking? Evidence from 
California. Journal of the American Medical Association 
1991;266(22):3154–8. 
Pierce JP, Lee L, Gilpin EA. Smoking initiation by ado­
lescent girls, 1944 through 1988: an association with 
targeted advertising. Journal of the American Medical 
Association 1994a;271(8):608–11. 
Pierce JP, Shanks TG, Pertschuk M, Gilpin E, Shopland 
D, Johnson M, Bal D. Do smoking ordinances protect 
non-smokers from environmental tobacco smoke at 
work? Tobacco Control 1994b;3(1):15–20. 
Pillsbury HC, Bright CC, O’Connor KJ, Irish FW. Tar 
and nicotine in cigarette smoke. Journal of the Associa­
tion of Official Analytical Chemists 1969;52(3):458–62. 
Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, 
Maurer KR. Exposure of the US population to envi­
ronmental tobacco smoke: the Third National Health 
and Nutrition Examination Survey, 1988 to 1991. Jour­
nal of the American Medical Association 1996;275(16): 
1233–40. 
Posadas de Puerto Rico Associates v. Tourism Company of 
Puerto Rico, 478 U.S. 328 (1986). 
Price J. Economist trashes anti-smokers’ study of eat­
ery business; optimistic conclusions “unwarranted.” 
Washington Times, Apr 24, 1997;Sect A:9. 
PR Newswire. Tobacco litigation given go-ahead in 
Britain. Feb 1, 1995; Financial News Sect. Available 
from Dialog(R)File 613:PR Newswire. 
PR Newswire. Mississippi tobacco settlement revised 
to reflect impact of Minnesota settlement. PR News-
wire, July 6, 1998a; Domestic News Sect. 
PR Newswire. Prohibition news update. PR Newswire, 
June 18, 1998b; State and Regional News Sect. 
Public Citizen v. Federal Trade Commission, 869 F.2d 1541 
(D.C. Cir. 1989). 
Queensgate Investment Co. v. Liquor Control Commission, 
433 N.E.2d 138, 69 Ohio St. 2d 361 (Ohio 1982). 
Rabin RL. Institutional and historical perspectives on 
tobacco tort liability. In: Rabin RL, Sugarman SD, edi­
tors. Smoking Policy: Law, Politics, and Culture. New 
York: Oxford University Press, 1993:110–30. 
Rabin RL, Sugarman SD, editors. Smoking Policy: Law, 
Politics, and Culture. New York: Oxford University 
Press, 1993. 
Ranzal E. Troy asks repeal of nicotine levy. New York 
Times, Oct 10, 1973;35 (col 1). 
Reidy A, Carter R. Tobacco litigation: looking for cover. 
Legal Times, Mar 6, 1995; Focus on Insurance Sect:S37 
(col 1). 
Repace JL. Risk management of passive smoking at 
work and at home. St. Louis University Public Law Re­
view 1994;13(2):763–85. 
Response Research, Incorporated. Findings for the Study 
of Teenage Cigarette Smoking and Purchasing Behavior. 
Chicago: Response Research, Incorporated, 1989. NB 
6246. 
Reuijl JC. On the Determination of Advertising Effective­
ness: An Empirical Study of the German Cigarette Market. 
Boston: Kluwer-Nijhoff Publishing, 1982. 
Reuters. Philip Morris gets subpoena from federal 
grand jury. Aug 31, 1996. Available from Dialog(R)File 
497:Sun-Sentinel Co. 
Reuters. British Columbia lays out tough tobacco list­
ings. Reuters (news wire), June 22, 1998. 
Reynolds T. EPA finds passive smoking causes lung 
cancer. Journal of the National Cancer Institute 1993; 
85(3):179–80. 
Rhode Island Liquor Stores Association v. Evening Call Pub. 
Co., 497 A.2d 331 (R.I. 1985). 
Ribisl KM, Norman GJ, Howard-Pitney B, Howard KA. 
Which adults do underaged youth ask for cigarettes? 
American Journal of Public Health 1999;89(10):1561–4. 
Richardson v. Philip Morris Inc., No. 96145050/CE212596 
(Md. Cir. Ct. Baltimore City Jan. 28, 1998). 
Rickert WS. Quantitation of Class A Carcinogens in To­
bacco Smoke from Cigarettes: 4-Amino-Biphenyl. Kitchener 
(Canada): Labstat Incorporated, Analytical Services 
Division, 1994. 
284 Chapter 5
 

   Regulatory Efforts 285
 
Rigotti NA, Bourne D, Rosen A, Locke JA, Schelling TC. 
Workplace compliance with a no-smoking law: a 
randomized community intervention trial. American 
Journal of Public Health 1992;82(2):229–35. 
Rigotti NA, DiFranza, JR, Chang Y, Tisdale T, Kemp B, 
Singer DE. The effect of enforcing tobacco-sales laws 
on adolescents’ access to tobacco and smoking behav­
ior. New England Journal of Medicine 1997;337(15): 
1044–51. 
Rigotti NA, Pashos CL. No-smoking laws in the United 
States: an analysis of state and city actions to limit 
smoking in public places and workplaces. Journal of 
the American Medical Association 1991;266(22):3162–7. 
Rigotti NA, Pikl BH, Cleary P, Singer DE, Mulley AG. 
The impact of banning smoking on a hospital ward: 
acceptance, compliance, air quality and smoking be­
havior. Clinical Research 1986;34(2):833A. 
Rigotti NA, Stoto MA, Schelling TC. Do businesses 
comply with a no-smoking law? Assessing the self-
enforcement approach. Preventive Medicine 1994;23(2): 
223–9. 
R.J. Reynolds Co. v. Engle, 672 So. 2d 39 (Fla. Ct. App. 
1996). 
R.J. Reynolds Tobacco Co. v. John Does, 94-CVS-5867 
(N.C., Forsyth Cty. Aug. 12, 1994), cited in 9.4 TPLR 
2.95 (1994) (Temporary Restraining Order). 
R.J. Reynolds Tobacco Company. Chemical and Biologi­
cal Studies on New Cigarette Prototypes That Heat Instead 
of Burn Tobacco. Winston-Salem (NC): R.J. Reynolds 
Tobacco Company, 1988. 
R.J. Reynolds Tobacco Company. Cigarette Ingredients: 
A Complete List and Background. Winston-Salem (NC): 
R.J. Reynolds Tobacco Company, 1994. 
RJR-MacDonald Inc. v. Attorney General of Canada, File 
Nos. 23460, 23490 (Can. Nov. 29–30, 1994, Sept. 21, 
1995), cited in 10.6 TPLR 2.167 (1995). 
RJR Nabisco Holdings, Corps. v. Dunn, 657 N.E.2d 1220 
(Ind. 1995). 
Robertson I. Sociology. New York: Worth Publishers, 
1977. 
Reducing Tobacco Use
 
Robinson LA, Klesges RC, Zbikowski SM, Glaser R. 
Predictors of risk for different stages of adolescent 
smoking in a biracial sample. Journal of Consulting and 
Clinical Psychology 1997;65(4)653–62. 
Rodriguez E, Taylor J. Meehan brief leveling fraud 
charges against tobacco firms gets credibility. Wall 
Street Journal, Mar 9, 1998;Sect A:20. 
Rohter L. Florida prepares new basis to sue tobacco 
industry. New York Times, May 27, 1994;Sect A:1 
(col 1). 
Rosa M, Pacifici R, Altieri I, Pichini S, Ottaviani G, 
Zuccaro P. How the steady-state cotinine concentra­
tion in cigarette smokers is directly related to nicotine 
intake. Clinical Pharmacology and Therapeutics 1992; 
52(3):324–9. 
Rose RL, Hwang SL. Harley is suing to get its name 
off cigarettes. Wall Street Journal, Mar 23, 1995;Sect B:1 
(col 3). 
Rosenstock IM, Stergachis A, Heaney C. Evaluation of 
smoking prohibition policy in a health maintenance 
organization. American Journal of Public Health 1986; 
76(8):1014–5. 
Roswell Park Cancer Institute. Survey of Alcohol, To­
bacco, and Drug Use Among Ninth Grade Students, 1996: 
Erie County, 1996. Buffalo (NY): Roswell Park Cancer 
Institute, Department of Cancer Control and Epide­
miology, 1997. 
Rubin v. Coors Brewing Co., 514 U.S. 476, 115 S. Ct. 1585 
(1995). 
Samuels B, Glantz SA. The politics of local tobacco 
control. Journal of the American Medical Association 1991; 
266(15):2110–7. 
Sanders J. The Bendectin litigation: a case study in the 
life cycle of mass torts. Hastings Law Journal 1992; 
43(Jan):301–418. 
Scherer R, Rybak DC. Tobacco foes win a vast memo 
arsenal. Christian Science Monitor, May 11, 1998:1. 
Schmeltzer J, Arndt M. Under siege in cigarette wars, 
tobacco titans counterattack. Chicago Tribune, Mar 25, 
1994;News Sect:1 (col 2). 
   
Surgeon General's Report
 
Schmit JT. The role of the work place, business plain­
tiffs, and mass torts in products liability litigation. Jour­
nal of Insurance Regulation 1994;12(4):530–53. 
Schneider L, Klein B, Murphy KM. Governmental 
regulation of cigarette health information. Journal of 
Law and Economics 1981;24(3):575–612. 
Schoendorf KC, Kiely JL. Relationship of sudden in­
fant death syndrome to maternal smoking during and 
after pregnancy. Pediatrics 1992;90(6):905–8. 
Schwartz GT. Tobacco liability in the courts. In: Rabin 
RL, Sugarman SD, editors. Smoking Policy: Law, Poli­
tics, and Culture. New York: Oxford University Press, 
1993:131–60. 
Schwartz J. Lawmaker asks Reno to take up tobacco 
probe. The Washington Post, Dec 14, 1994; Sect A:15. 
Schwartz J. Tobacco firm’s nicotine studies assailed on 
Hill. The Washington Post, July 25, 1995;Sect A:8. 
Schwartz J. Cigarette company turns U.S. informant. 
The Washington Post, Apr 29, 1998a;Sect A:1. 
Schwartz J. Firm pleads guilty to criminal charge in 
tobacco probe. The Washington Post, Jan 24, 1998b;Sect 
A:4. 
Schwartz J. Tobacco firms ordered to turn over docu­
ments. The Washington Post, Mar 8, 1998c;Sect A:2. 
Schwartz J, Connolly C. Nicotine conspiracy alleged. 
The Washington Post, Jan 8, 1998;Sect A:1. 
Scott C-JE, Gerberich SG. Analysis of a smoking policy 
in the workplace. American Association of Occupational 
Health Nursing Journal 1989;37(7):265–73. 
Seattle Post-Intelligencer. Tobacco is not addictive, top 
executives say but they do concede on nicotine levels, 
other major issues. Seattle Post-Intelligencer, Apr 15, 
1994;Sect A:3. 
Seldon BJ, Doroodian K. A simultaneous model of ciga­
rette advertising: effects on demand and industry re­
sponse to public policy. Review of Economics and 
Statistics 1989;71(4):673–7. 
Settlement Agreement Between Settling States and Brooke 
Group LTD, Liggett & Myers, Inc. and Liggett Group, Inc., 
cited in 13.1 TPLR 3.11 (1998). 
Shaffer D. Feds sniff around Minnesota tobacco civil 
lawsuit. Saint Paul Pioneer Press, Feb 19, 1997;Sect A:1. 
Shane S. Criminal probes shadow tobacco. Baltimore 
Sun, June 20, 1997;News Sect:1A. 
Shapiro E. A crafty lawyer turns up the heat on 
tobacco. Wall Street Journal, May 19, 1994a;Sect B:1 
(col 3). 
Shapiro E. The insider who copied tobacco firm’s 
secrets. Wall Street Journal, June 20, 1994b;Sect B:1 
(col 3). 
Shapiro E. U.S. probes whether tobacco concerns 
agreed not to sell “fire-safe” cigarettes. Wall Street Jour­
nal, Mar 8, 1994c;Sect A:2 (col 3). 
Shimp v. New Jersey Bell Telephone Co., 368 A.2d 408, 145 
N.J. Super. 516 (1976). 
Shipman v. Philip Morris Cos., Cause No. 26294 (Tex.,
 

Johnson Cty. Oct. 7, 1994), cited in 10.1 TPLR 3.91 (1995).
 

Shopland DR, Hartman AM, Repace JL, Lynn WR.
 

Smoking behavior, workplace policies, and public
 

opinion regarding smoking restrictions in Maryland.
 

Maryland Medical Journal 1995;44(2):99–104.
 

Siegel M. Involuntary smoking in the restaurant work­

place: a review of employee exposure and health ef­

fects. Journal of the American Medical Association 1993;
 

270(4):490–3.
 

Siegel M, Carol J, Jordan J, Hobart R, Schoenmarklin
 

S, DuMelle F, Fisher P. Preemption in tobacco control.
 

Review of an emerging public health program. Journal
 

of the American Medical Association 1997;278(10):858–63.
 

.
 

Skretny MT, Cummings KM, Sciandra R, Marshall J.
 

An intervention to reduce the sale of cigarettes to
 

minors. New York State Journal of Medicine 1990;90(2):
 

54–5.
 

Slade J. The tobacco epidemic: lessons from history.
 

Journal of Psychoactive Drugs 1989;21(3):281–91.
 

Slade J. Nicotine delivery devices. In: Orleans CT, Slade
 

J, editors. Nicotine Addiction: Principles and Management.
 

New York: Oxford University Press, 1993:3–23.
 

286 Chapter 5
 

   Regulatory Efforts 287
 
Slade J. Regulation of Tobacco Products (Part 1): Hearings 
Before the Subcommittee on Health and the Environment 
of the House Committee on Energy and Commerce, 103rd 
Congress, 2nd Sess. 147 (1994) (statement on behalf of 
the American Society of Addiction Medicine). 
Slade J. Are tobacco products drugs? Evidence from 
US Tobacco [editorial]. Tobacco Control 1995;4(1):1–2. 
Slade J, Connolly GN, Davis RM, Douglas CE, Henning-
field JE, Hughes JR, Kozlowski LT, Myers ML. Report 
of the Tobacco Policy Research Study Group on tobacco 
products. Tobacco Control 1992;1(Suppl):S4–S9. 
Small v. Lorillard Tobacco Co., 1998 WL 398176 (N.Y.A.D. 
1 Dept. July 16, 1998). 
Smee C. Effect of Tobacco Advertising on Tobacco Consump­
tion: A Discussion Document Reviewing the Evidence. 
London: Department of Health, Economics and Op­
erational Research Division, 1992. 
Smith v. Western Electric Co., 643 S.W.2d 10 (Mo. App. 
1982). 
Smothers R. Workers challenge casinos’ role as a ha­
ven for smokers. New York Times, May 25, 1998;Sect 
B:1 (col 2). 
Sorensen G, Rigotti NA, Rosen A, Pinney J, Prible R. 
Effects of a worksite nonsmoking policy: evidence for 
increased cessation. American Journal of Public Health 
1991a;81(2):202–4. 
Sorensen G, Rigotti NA, Rosen A, Pinney J, Prible R. 
Employee knowledge and attitudes about a work-site 
nonsmoking policy: rationale for further smoking re­
strictions. Journal of Occupational Medicine 1991b;33(11): 
1125–30. 
Sparks v. R.J. Reynolds Tobacco Co., No. C94-783C (W.D. 
Wa. Dec. 9, 1994), cited in 9.6 TPLR 2.171 (1994). 
Spayd L. Court ruling puts new smoking ban on hold 
in Md. The Washington Post, Aug 13, 1994;Sect D:1 
(col 4). 
Spectator. “Camouflaged” warning has Beatty smok­
ing. The Spectator (Hamilton, Ontario), May 31, 1989; 
Sect C:10 (col 4). 
Reducing Tobacco Use
 
Standing Committee on Health. Towards Zero Consump­
tion: Generic Packaging of Tobacco Products. Ottawa 
(Canada): Canada Communication Group—Publishing, 
Public Works and Government Services Canada, 1994. 
Staron v. McDonald’s Corp., 51 F.3d 353 (2d Cir. 1995). 
Staver S. AMA to urge pharmacies to remove tobacco 
products. American Medical News, Dec 18, 1987:8 (col 1). 
Steenland K, Thun M, Lally C, Heath C Jr. Environmen­
tal tobacco smoke and coronary heart disease in the 
American Cancer Society CPS-II cohort. Circulation 
1996;94(4):622–8. 
Stellman SD, Garfinkel L. Lung cancer risk is propor­
tional to cigarette tar yield: evidence from a prospec­
tive study. Preventive Medicine 1989;18(4):518–25. 
Stillman FA, Becker DM, Swank RT, Hantula D, Moses 
H, Glantz S, Waranch HR. Ending smoking at The 
Johns Hopkins Medical Institutions: an evaluation 
of smoking prevalence and indoor air pollution. Jour­
nal of the American Medical Association 1990;264(12): 
1565–9. 
Stockwell HG, Goldman AL, Lyman GH, Noss CI, 
Armstrong AW, Pinkham PA, Candelora EC, Brusa MR. 
Environmental tobacco smoke and lung cancer risk in 
nonsmoking women. Journal of the National Cancer In­
stitute 1992;84(18):1417–22. 
Stohr G. Tobacco companies, officials face widening 
criminal probe. Bloomberg (news wire),  June 25, 1997. 
Stone PH. Smoking out the opposition. The National 
Journal, Apr 16, 1994;26(16):925. 
Stop Youth Addiction, Inc. v. Lucky Stores, Inc., 17 Cal. 
4th 553, 71 Cal. Rptr. 2d 731 (1998). 
Sullivan JF. Bans on cigarette machines are upheld. New 
York Times, Apr 1, 1994;Sect B:5 (col 4). 
Sullivan K. Smokers to appeal UCSF research suit; to­
bacco group had alleged Glantz misused funds; case 
was dismissed. San Francisco Examiner, Dec 2, 1997;Sect 
A:7. 
Sullivan P. CMA targets drugstores in latest antitobacco 
drive. Canadian Medical Association Journal 1989; 
141(1):66. 
   
 
Surgeon General's Report
 
Suttle G. Puyallup ban goes up in smoke after tobacco-
financed lawsuit. Tacoma News Tribune, Dec 20, 1994; 
Sect A:1. 
Sweda EL Jr. Summary of Legal Cases Regarding Smok­
ing in the Workplace and Other Places. Boston: Tobacco 
Control Resource Center, 1994. 
Sweda EL Jr. Summary of Legal Cases Regarding Smok­
ing in the Workplace and Other Places. Boston: Tobacco 
Control Resource Center, 1998. 
Sweda EL Jr, Daynard RA. Tobacco industry tactics. 
British Medical Bulletin 1996;52(1):183–92. 
Sylvester K. The tobacco industry will walk a mile to 
stop an anti-smoking law. Governing 1989;2(8):34–40. 
Take Five Vending, Ltd. v. Town of Provincetown, 415 Mass. 
741, 615 N.E.2d 576, 1993 Mass. LEXIS 440 (Mass. Mar. 
4, 1993). 
Talbot B. “Adolescent smokers’ rights laws.” Tobacco 
Control 1992;1(4):294–5. 
Tandemar Research Inc. Tobacco Health Warning Mes­
sages, Inserts and Toxic Constituent Information Study. 
Final Report. Toronto: Tandemar Research, 1992. TR 
16379. 
Taylor HG. Pharmacists who choose not to sell tobacco. 
American Pharmacy 1992;NS32(5):49–52. 
Taylor J. DNA plant technology pleads guilty in U.S. 
investigation of cigarette makers. Wall Street Journal, 
Jan 26, 1998;Sect B:5. 
Taylor J, Rodriguez E. U.S. brings first charge in the 
tobacco inquiry. Wall Street Journal, Jan 8, 1998;Sect A:3. 
Technical Study Group on Cigarette and Little Cigar 
Fire Safety. Toward a Less Fire-Prone Cigarette. Final Re­
port. Washington: Consumer Product Safety Commis­
sion, 1987. 
Texas v. American Tobacco Co., No. 5-96CV-91 (E.D. Tex. 
Jan. 16, 1998) (Comprehensive Settlement Agreement 
and Release). 
Thomas P, Schwartz J. Madison Square Garden to move 
cigarette ads; U.S. action affects TV broadcasts at arena. 
The Washington Post, Apr 5, 1995;Sect A:12. 
Thomas P,  Schwartz J. U.S. widens tobacco investiga­
tion. The Washington Post, Sept 8, 1996;Sect A:1. 
Thomas P,  Schwartz J. Government intensifies tobacco 
company probe. The Washington Post, May 3, 1997;Sect 
A:18. 
Thomson B, Toffler WL. The illegal sale of cigarettes 
to minors in Oregon. Journal of Family Practice 1990; 
31(2):206–8. 
Thun MJ, Day-Lally C, Myers DG, Calle EE, Flanders 
WD, Zhu B-P, Namboodiri MM, Heath CW Jr. Trends 
in tobacco smoking and mortality from cigarette use 
in Cancer Prevention Studies I (1959 through 1965) and 
II (1982 through 1988). In: Changes in Cigarette-Related 
Disease Risks and Their Implication for Prevention and 
Control. Smoking and Tobacco Control Monograph No. 
8. Bethesda (MD): US Department of Health and Hu­
man Services, Public Health Service, National Insti­
tutes of Health, National Cancer Institute, 1997:305–82. 
NIH Publication No. 97-1213. 
Tobacco Control Resource Center. Tobacco Retailer Re­
sponsibility Initiative: Project Update #1 . Boston: Tobacco 
Control Resource Center, 1998. 
Tobacco Institute. The Tax Burden on Tobacco. Histori­
cal Compilation. Vol. 32. Washington: Tobacco Insti­
tute, 1998. 
Tobacco Institute. Tobacco Activity at the Federal, 
State and Local Levels—1992: Priorities for 1993, 
Dec 1992; <http://www.tobaccoinstitute.com/ 
getall img.asp?DOCID=TIMN0018602/8614>;  
accessed: September 9, 1999. 
Tobacco Products Liability Project. Stop Cigarette Sales 
to Kids: A 50-State Legal Manual. 1996 ed. Boston: North­
eastern University School of Law, 1996. 
Tobacco Products Litigation Reporter. Affirmative de­
fenses struck down by court in Mississippi Medicaid 
reimbursement suit; special legislation like that passed 
in Florida not needed by other states wishing to sue 
tobacco industry. 10.1 Tobacco Products Litigation Re­
porter 1.3 (1995a). 
Tobacco Products Litigation Reporter. Canadian tobacco 
giant forced to haul insurers into court. 10.8 Tobacco 
Products Litigation Reporter 1.197 (1995b). 
288 Chapter 5
 

   Regulatory Efforts 289
 
Tobacco Products Litigation Reporter. Transcript of depo­
sition of Jeffrey S. Wigand. 11.1 Tobacco Products Litiga­
tion Reporter 3.1 (1995c). 
Tobacco Products Litigation Reporter. Declaration of Ian 
L. Uydess, Ph.D. to the Food and Drug Administra­
tion. 11.2 Tobacco Products Litigation Reporter 8.1 (1996a). 
Tobacco Products Litigation Reporter. Declaration of 
Jerome Rivers to the Food and Drug Administration. 
11.2 Tobacco Products Litigation Reporter 8.11 (1996b). 
Tobacco Products Litigation Reporter. Declaration of Wil­
liam A. Farone to the Food and Drug Administration. 
11.2 Tobacco Products Litigation Reporter 8.13 (1996c). 
Tobacco Products Litigation Reporter. Florida Attorney 
Norwood “Woody” Wilner wins landmark victory in 
Carter v. American Tobacco Company. 11.5 Tobacco Prod­
ucts Litigation Reporter 1.114 (1996d). 
Tobacco Products Litigation Reporter. Proposed tobacco 
industry settlement. 12.3 Tobacco Products Litigation 
Reporter 3.203 (1997a). 
Tobacco Products Litigation Reporter. Recent develop­
ments: asbestos settlement trustees file suit against 
tobacco companies to recover reimbursement for pay­
ments made to smokers. 12.8 Tobacco Products Litiga­
tion Reporter 1.102 (1997b). 
Tobacco Products Litigation Reporter. Recent develop­
ments: twenty Blue Cross/Blue Shield plans file suit 
against tobacco companies. 13.2 Tobacco Products Liti­
gation Reporter 1.17 (1998). 
Tollison RD, Wagner RE. The Economics of Smoking. 
Boston: Kluwer Academic Publishers, 1992. 
Tomar SL, Giovino GA, Eriksen MP. Smokeless tobacco 
brand preference and brand switching among US ado­
lescents and young adults. Tobacco Control 1995; 
4(1):67–72. 
Tomar SL, Henningfield JE. Review of the evidence 
that pH is a determinant of nicotine dosage from oral 
use of smokeless tobacco. Tobacco Control 1997;6(3): 
219–25. 
Torry S. Tobacco giants try to settle with states; 37 cases 
pending against companies. The Washington Post, July 
10, 1998;Sect A:1. 
Reducing Tobacco Use 
Trade Regulation Reporter. FTC complaints, orders, 
stipulations. In: Trade Regulation Reporter. Federal Trade 
Commission Complaints and Orders 1970–1973. 12th ed. 
New York: Commerce Clearing House, 1973:21,919. 
Traynor MP, Begay ME, Glantz SA. New tobacco in­
dustry strategy to prevent local tobacco control. Jour­
nal of the American Medical Association 1993;270(4): 
479–86. 
Tribune News Services. Grand jury demands Philip 
Morris testimony, files in fraud inquiry. Chicago Tri­
bune, Aug 31, 1996;Sect 1:6. 
Trichopoulos D, Mollo F, Tomatis L, Agapitos E, 
Delsedime L, Zavitsanos X, Kalandidi A, Katsouyanni 
K, Riboli E, Saracci R. Active and passive smoking and 
pathological indicators of lung cancer risk in an au­
topsy study. Journal of the American Medical Association 
1992;268(13):1697–701. 
United States Tobacco Co. v. Food and Drug Administra­
tion, Civil Action No. 6:95CV00665 (M.D.N.C. Sept. 19, 
1995). 
United States v. Edge Broadcasting Co., 113 S. Ct. 2696 
(1993). 
University of Michigan. Cigarette smoking among 
American teens continues gradual decline [press re­
lease]. Ann Arbor (MI): Institute for Social Research, 
University of Michigan, December 17, 1999. 
US Department of Agriculture. Tobacco: World Markets 
and Trade. Circular Series. Washington: US Department 
of Agriculture, Foreign Agricultural Service, 1996. 
FT-10-96. 
US Department of Health and Human Services. The 
Health Consequences of Smoking: The Changing Cigarette. 
A Report of the Surgeon General. Washington: US De­
partment of Health and Human Services, Public Health 
Service, Office on Smoking and Health, 1981. DHHS 
Publication No. (PHS) 81-50156. 
US Department of Health and Human Services. The 
Health Consequences of Involuntary Smoking. A Report of 
the Surgeon General. Rockville (MD): US Department 
of Health and Human Services, Public Health Service, 
Centers for Disease Control, Center for Health Promo­
tion and Education, Office on Smoking and Health, 
1986. DHHS Publication No. (CDC) 87-8398. 
   
 
Surgeon General's Report
 
US Department of Health and Human Services. The 
Health Consequences of Smoking: Nicotine Addiction. A 
Report of the Surgeon General. Rockville (MD): US De­
partment of Health and Human Services, Public Health 
Service, Centers for Disease Control, Center for Health 
Promotion and Education, Office on Smoking and 
Health, 1988. DHHS Publication No. (CDC) 88-8406. 
US Department of Health and Human Services. Re­
ducing the Health Consequences of Smoking: 25 Years of 
Progress. A Report of the Surgeon General. Atlanta: US 
Department of Health and Human Services, Public 
Health Service, Centers for Disease Control, National 
Center for Chronic Disease Prevention and Health Pro­
motion, Office on Smoking and Health, 1989. DHHS 
Publication No. (CDC) 89-8411. 
US Department of Health and Human Services. Model 
Sale of Tobacco Products to Minors Control Act: A Model 
Law Recommended for Adoption by States or Localities to 
Prevent the Sale of Tobacco Products to Minors. Atlanta: 
US Department of Health and Human Services, Pub­
lic Health Service, Centers for Disease Control, Na­
tional Center for Chronic Disease Prevention and 
Health Promotion, Office on Smoking and Health, 
1990. 
US Department of Health and Human Services. 1992 
National Survey of Worksite Health Promotion Activities: 
Summary. Washington: US Department of Health and 
Human Services, Public Health Service, 1993. 
US Department of Health and Human Services. Pre­
venting Tobacco Use Among Young People: A Report of the 
Surgeon General. Atlanta: US Department of Health and 
Human Services, Public Health Service, Centers for 
Disease Control and Prevention, National Center for 
Chronic Disease Prevention and Health Promotion, 
Office on Smoking and Health, 1994. 
US Department of Health and Human Services. Synar 
Regulation Implementation: Report to Congress on FFY 
1997 State Compliance. Rockville (MD): US Department 
of Health and Human Services, Substance Abuse and 
Mental Health Services Administration, Center for 
Substance Abuse Prevention, 1998a. Publication No. 
(SMA) 98-3186. 
US Department of Health and Human Services. Tobacco 
Use Among U.S. Racial/Ethnic Minority Groups—African 
Americans, American Indians and Alaska Natives, Asian 
Americans and Pacific Islanders, and Hispanics: A Report of 
the Surgeon General. Atlanta: US Department of Health 
and Human Services, Centers for Disease Control and 
Prevention, National Center for Chronic Disease Pre­
vention and Health Promotion, Office on Smoking and 
Health, 1998b. 
US Department of Health and Human Services. En­
forcement of Tobacco Sales Laws: Guidance from Experi­
ence in the Field. CSAP Implementation Guide. Rockville 
(MD): US Department of Health and Human Services, 
Substance Abuse and Mental Health Services Admin­
istration, 1999. DHHS Publication No. (SMA) 99-3317. 
US Department of Health and Human Services. Healthy 
People 2010 (Conference edition, in two volumes). 
Washington: US Department of Health and Human 
Services, 2000a. 
US Department of Health and Human Services. 9th 
Report on Carcinogens. Research Triangle Park (NC): US 
Department of Health and Human Services, Public 
Health Service, National Toxicology Program, 2000b. 
US Department of Health and Human Services. Synar 
Regulation Implementation: Report to the Secretary on FFY 
1998 State Compliance. Rockville (MD): US Department 
of Health and Human Services, Substance Abuse and 
Mental Health Services Administration, Center for 
Substance Abuse Prevention, in press. 
US Department of Justice. Justice Department reaches 
agreement with Liggett & Myers for cooperation in 
tobacco probe [press release]. Washington: US Depart­
ment of Justice, Apr 28, 1998. 
US House of Representatives. Health Effects of Smoke­
less Tobacco: Hearing Before the Subcommittee on Health 
and the Environment of the House Committee on Energy 
and Commerce, 103rd Congress, 2nd Sess. (1994). Wash­
ington: US Government Printing Office, 1995a. Serial 
No. 103-163. 
US House of Representatives. Regulation of Tobacco 
Products (Part 1): Hearings Before the Subcommittee on 
Health and the Environment of the Committee on Energy 
and Commerce, 103rd Congress, 2nd Sess. (1994). Wash­
ington: US Government Printing Office, 1995b. Serial 
No. 103-149. 
290 Chapter 5
 

   Regulatory Efforts 291
 
US House of Representatives. Regulation of Tobacco 
Products (Part 2): Hearings Before the Subcommittee on 
Health and the Environment of the Committee on Energy 
and Commerce, 103rd Congress, 2nd Sess. (1994). Wash­
ington: US Government Printing Office, 1995c. Serial 
No. 103-153. 
US House of Representatives. Regulation of Tobacco 
Products (Part 3): Hearings Before the Subcommittee on 
Health and the Environment of the Committee on Energy 
and Commerce, 103rd Congress, 2nd Sess. (1994). Wash­
ington: US Government Printing Office, 1995d. Serial 
No. 103-171. 
Utah Delegation. Resolution no. 96. Total tobacco ad 
ban legislation. Paper presented at the American Medi­
cal Association House of Delegates 43rd interim meet­
ing; Dec 3–6, 1989; Honolulu (HI). 
Valentine v. Chrestensen, 316 U.S. 52 (2d Cir. 1942). 
Valkonen M, Kuusi T. Passive smoking induces athero­
genic changes in low-density lipoprotein. Circulation 
1998;97(20):2012–6. 
Valley Broadcasting Co. v. United States, 107 F.3d 1328 
(9th Cir. 1997). 
Van Rijn N. Class action suit filed against tobacco gi­
ants: Toronto lawyer says U.S. probe spurred action. 
Toronto Star, Jan 15, 1995;News Sect:A5. 
Village of Schaumburg v. Citizens for a Better Environment, 
444 U.S. 620 (1980). 
Virginia State Board of Pharmacy v. Virginia Citizens Con­
sumer Council, Inc., 425 U.S. 748 (1976). 
Wakefield M, Carrangis J, Wilson D, Reynolds C. Ille­
gal cigarette sales to children in South Australia. To­
bacco Control 1992a;1(2):114–7. 
Wakefield MA, Wilson D, Owen N, Esterman A, Rob­
erts L. Workplace smoking restrictions, occupational 
status, and reduced cigarette consumption. Journal of 
Occupational Medicine 1992b;34(7):693–7. 
Wall Street Journal. Nicotine attack: cigarette regulation 
is formally proposed; industry sues to halt it. Wall Street 
Journal, Aug 11, 1995;Sect A:1 (col 6). 
Reducing Tobacco Use 
Wall Street Journal. Brown & Williamson is subject of 
inquiry by justice agency. Wall Street Journal, May 12, 
1998;Sect B:11. 
Wannamethee SG, Shaper AG, Whincup PH, Walker M. 
Smoking cessation and the risk of stroke in middle-aged 
men. Journal of the American Medical Association 
1995;274(2):155–60. 
Ward J. Tobacco-case judge warns lawyers in paper 
dispute. Louisville Courier-Journal, Feb 22, 1996;Busi­
ness Sect:10b. 
Warner KE. Clearing the airwaves: the cigarette ad ban 
revisited. Policy Analysis 1979;5(4):435–50. 
Warner KE, Ernster VL, Holbrook JH, Lewit EM, 
Pertschuk M, Steinfeld JL, Tye JB, Whelan EM. Pro­
motion of tobacco products: issues and policy options. 
Journal of Health Politics, Policy and Law 1986;11(3): 
367–92. 
Wasserman J, Manning WG, Newhouse JP, Winkler JD. 
The effects of excise taxes and regulations on cigarette 
smoking. Journal of Health Economics 1991;10(1):43–64. 
Weil, Gotshal & Manges LLP v. Longstreet Associates, L.P. 
(N.Y., N.Y. Cty. June 12, 1998), cited in 13.4 TPLR 3.188 
(1998). 
Weinstein H. Key tobacco witness gets immunity, 
sources say. Los Angeles Times, July 13, 1997a; Sect A:1. 
Weinstein H. Suit seeking to stop UC tobacco foe is 
dismissed. Los Angeles Times, Dec 2, 1997b;Sect A:3. 
Weinstein H. Big tobacco settles Minnesota lawsuit for 
$6.6 billion. Los Angeles Times, May 9, 1998a;Sect A:1. 
Weinstein H. U.S. accuses company of high-nicotine 
plot. Los Angeles Times, Jan 8, 1998b;Sect A:1. 
Weiser B, Schwartz J. Seeking tobacco data, FBI 
searches home of Philip Morris ex-researcher. The 
Washington Post, Apr 10, 1996;Sect A:12. 
Wells AJ. Passive smoking as a cause of heart disease. 
Journal of the American College of Cardiology 1994;24(2): 
546–54. 
Wells AJ. Heart disease from passive smoking in the 
workplace. Journal of the American College of Cardiology 
1998;31(1):1–9. 
   
 
Surgeon General's Report
 
West Virginia Attorney General. West Virginia Attor­
ney General McGraw files historic lawsuit against to­
bacco industry [press release]. Charleston (WV): State 
of West Virginia, Office of the Attorney General, Sept 
20, 1994. 
White E. Today, where there’s smoke, there’s a neigh­
bor’s lawsuit. Wall Street Journal, July 13, 1998; 
Sect B:1. 
Widdick/Maddox v. Brown & Williamson Tobacco Corp., 
No. 97-03522-CA, Div. CV-H (Fla. 4th Cir. Jacksonville 
1998). 
Wildey MB, Woodruff S, Agro A, Keay KD, Kenney 
EM, Conway TL. Sustained effects of educating retail­
ers to reduce cigarette sales to minors. Public Health 
Reports 1995b;110(5):625–9. 
Wildey MB, Woodruff SI, Pampalone SZ, Conway TL. 
Self-service sale of tobacco: how it contributes to youth 
access. Tobacco Control 1995a;4(4):355–61. 
Wilke JR, Lambert W. Cigarette firms’ fire liability is 
tested. Wall Street Journal, May 12, 1992;Sect B:7 
(col 1). 
Williams v. Spencer, 622 F.2d 1200 (4th Cir. 1980). 
Wilson DH, Wakefield MA, Esterman A, Baker CC. 
15’s: they fit everywhere—especially the school bag: a 
survey of purchases of packets of 15 cigarettes by 14 
and 15 year olds in South Australia. Community Health 
Studies 1987;11(1 Suppl):16S–20S. 
Wilson JJ. Summary of the Attorneys General Master 
Tobacco Settlement Agreement, March 1999; <http:// 
www.ncsl.org/statefed/tmsasumm.htm>; accessed: 
December 14, 1999. 
Wolfson M, Forster JL, Claxton AJ, Murray DM. Ado­
lescent smokers’ provision of tobacco to other adoles­
cents. American Journal of Public Health 1997;87(4): 
649–51. 
Wolfson M, Hourigan M. Unintended consequences 
and professional ethics: criminalization of alcohol and 
tobacco use by youth and young adults. Addiction 
1997;92(9):1159–64. 
Wolpin v. Philip Morris, Inc., No. 96-1781-CIV-KING, 
1997 WL 535218 (S.D. Fla. Aug. 18, 1997). 
Woo J. Cigarette makers take on states seeking 
payments for smokers’ ills. Wall Street Journal, July 8, 
1994a;Sect B:7 (col 1). 
Woo J. Minnesota and state’s Blue Cross sue tobacco 
firms to recover health costs. Wall Street Journal, Aug 18, 
1994b;Sect A:2 (col 2). 
Woo J. Mississippi wants tobacco firms to pay its cost of 
treating welfare recipients. Wall Street Journal, May 24, 
1994c;Sect A:2 (col 3). 
Woodruff TJ, Rosbrook B, Pierce J, Glantz SA. Lower 
levels of cigarette consumption found in smoke-free 
workplaces in California. Archives of Internal Medicine 
1993;153(12):1485–93. 
Woodward M, Tunstall-Pedoe H. Do smokers of lower 
tar cigarettes consume lower amounts of smoke com­
ponents? Results from the Scottish Heart Health Study. 
British Journal of Addiction 1992;87(6):921–8. 
Working Group of State Attorneys General. No Sale: 
Youth, Tobacco and Responsible Retailing. Developing Re­
sponsible Retail Sales Practices and Legislation to Reduce 
Illegal Tobacco Sales to Minors. Findings and Recommen­
dations. Baltimore: State of Maryland, Office of the 
Attorney General, 1994. 
Wyatt, Tarrant & Combs v. Williams, 892 S.W.2d 584 (Ky. 
1995). 
Wynder EL, Hecht S, editors. Lung Cancer. UICC Tech­
nical Report Series. Vol. 25. Workshops on the Biology 
of Human Cancer Report No. 3. Geneva: International 
Union Against Cancer, 1976. 
Young JC, Robinson JC, Rickert WS. How good are the 
numbers for cigarette tar at predicting deliveries of 
carbon monoxide, hydrogen cyanide, and acrolein? 
Journal of Toxicology and Environmental Health 1981;7(5): 
801–8. 
Zauderer v. Office of Disciplinary Counsel of the Supreme 
Court of Ohio, 471 U.S. 626 (1985). 
Zimring FE. Comparing cigarette policy and illicit drug 
and alcohol control. In: Rabin RL, Sugarman SD, edi­
tors. Smoking Policy: Law, Politics, and Culture. New 
York: Oxford University Press, 1993:95–109. 
292 Chapter 5
 

Chapter 6
 

Economic Approaches
 

Introduction 295
 

Supply of Tobacco and Tobacco Products 295
 

Tobacco Price Supports 298
 

Minimum Prices, Nonrecourse Loans, and Quotas 300
 

Effects of Price Supports on Market Prices 300
 

Assessments to Offset Federal Costs of Price Supports 301
 

Discussion 302
 

Evolution of the U.S. Cigarette Industry 306
 

Economic Implications of Concentrated Tobacco Production 308
 

High Tobacco Concentration and the Impact of Prevention Policies 308
 

Discussion 311
 

Trade Policy, Tobacco, and Tobacco Products 311
 

Past Tobacco-Related Trade Policy 312
 

Section 301 of the Trade Act of 1974 312
 

Multinational Trade Agreements 316
 

Discussion and Recent Developments 318
 

Economic Impact of the U.S. Tobacco Industry 320
 

Effect of Price on Demand for Tobacco Products 322
 

Studies Using Aggregate Data 323
 

Studies Using Individual-Level Data 327
 

Behavioral Economics Studies of Cigarette Demand 335
 

Studies of Smokeless Tobacco Use and Price 335
 

Cigarette Prices and Other Substance Use 336
 

Discussion 337
 

Taxation of Tobacco Products 337
 

Rationales for Tobacco Taxation 338
 

Historical or Comparative Standard 338
 

Cigarette Taxes and Cigarette Prices 341
 

International Tobacco Taxes 345
 

Discussion 350
 

Fairness Standard and Optimal Cigarette Taxes 350
 

Equity, Incidence, and Distribution of the Tobacco Tax Burden 350
 

Estimates of the Costs of Smoking 352
 

Theoretically Optimal Cigarette Taxes 353
 

Cigarette Taxes and Health 355
 

Tobacco Taxation and Revenues 357
 

Conclusions 359
 

References 360
 

294 Chapter 6
Surgeon General's Report
   Economic Approaches 295
 

 
  
Reducing Tobacco Use 
Introduction 
This chapter reviews recent research on economic 
aspects of tobacco production and the use of tobacco 
products in the United States.  Much of the chapter 
focuses on the impact of various governmental 
policies related to tobacco. As was the case with the 
regulatory effects examined in Chapter 5, the “interven­
tions” recounted here require a broader definition and 
a different set of measurement tools (see Chapter 1). 
The chapter first considers the supply of tobacco 
and tobacco products.  The history of tobacco and the 
evolution of the cigarette industry in the United States 
are briefly discussed. More comprehensive summa­
ries can be found in the 1992 Surgeon General’s report 
Smoking and Health in the Americas (U.S. Department of 
Health and Human Services [USDHHS] 1992) and in 
several sources cited herein.  Tobacco-related supply-
side policies are reviewed in more detail.  In particular, 
the tobacco support program is closely examined, and 
its economic implications are discussed. That section 
is followed by a discussion of the impact of tobacco 
taxes and other prevention policies on prices in the 
highly concentrated U.S. cigarette markets.  U.S. trade 
policy relating to tobacco and tobacco products is re­
viewed, followed by a discussion of the domestic and 
international impact of these policies. Finally, the 
Supply of Tobacco and Tobacco Products 
economic impact of tobacco on the U.S. economy and 
its implications for policy are described. 
In the second part of the chapter, economic stud­
ies of the demand for tobacco are reviewed.  Although 
several factors affect the demand for tobacco products, 
this section focuses on the effects of tobacco prices (par­
ticularly as they are raised by increasing tobacco taxes) 
on demand. Recent econometric and other informa­
tive studies of the demand for tobacco products are 
described. (A more detailed review of early studies is 
contained in the 1989 Surgeon General’s report Reduc­
ing the Health Consequences of Smoking: 25 Years of 
Progress [USDHHS 1989].) 
The third part of the chapter focuses on the most 
important economic policy in the campaign to reduce 
tobacco use—higher cigarette excise taxes.  This sec­
tion reviews the alternative rationales for imposing 
cigarette and other tobacco taxes, including a histori­
cal or comparative approach, one based on the eco­
nomic costs of cigarette smoking, one focused on the 
health benefits of higher taxes, and one based on the 
revenue potential of the taxes. Discussion of the ap­
propriate level of the taxes suggested by each approach 
follows its review. 
Tobacco is a truly American plant.  The first 
known evidence of tobacco use is depicted in carvings 
on a Mayan temple in Chiapas, Mexico, that date from 
A.D. 600–900 (Wagner 1971).  Europeans were first in­
troduced to tobacco in 1492 when American Indians 
presented gifts of the substance to Christopher Colum­
bus. On Columbus’ return home, tobacco was intro­
duced to Spain and throughout Europe.  Tobacco was 
widely grown by early English settlers in America and 
was exported from the colonies to England, where it 
was reexported to many other destinations.  Colonial 
tobacco exports to England grew from 100,000 pounds 
in 1620 to 100 million pounds just before the Revolu­
tionary War, making tobacco the single most important 
commodity exported from the colonies to England 
(Johnson 1984).  Indeed, tobacco was so important in 
some colonies that it was sometimes used as the unit 
of account (Johnson 1984). 
The high tariffs imposed by England on tobacco 
and other imports from the colonies contributed to the 
start of the Revolutionary War.  In the newly formed 
United States, tobacco soon became the leading agri­
cultural export commodity.  The tobacco industry 
played a significant part in the U.S. economy of the 
19th and early 20th centuries. Although tobacco con­
sumption has declined in recent years, it is still eco­
nomically important in major tobacco-producing states. 
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In many ways, tobacco is an ideal crop to grow. 
It grows under a variety of soil and climatic condi­
tions and thrives under specific but fairly common cir­
cumstances. The tobacco plant has prodigious leaf 
growth yet takes up relatively little field space, and 
the financial return for tobacco is both absolutely and 
relatively high compared with other agricultural com­
modities (Goodman 1993). For example, in 1993, the 
per acre value of tobacco in the United States, $3,780, 
was well above the values for other crops (Grise 1995). 
Because of these factors, tobacco is grown in more than 
120 countries and thus is the most widely grown non­
food crop in the world (cotton acreage substantially 
exceeds that of tobacco, but tobacco is grown in about 
twice as many countries as cotton is). In the United 
States, tobacco is a highly profitable crop for other rea­
sons, including agricultural price supports that guar­
antee relatively high prices; the availability of loans 
from government, or tobacco companies, or both; the 
provision of seed, fertilizer, and other agricultural in­
put from external sources; and export subsidies (Food 
and Agriculture Organization of the United Nations 
1990). Counter to these profitable arrangements, to­
bacco growing is relatively labor-intensive, demands 
heavy use of fertilizers and pesticides, and often re­
quires the use of fuel for tobacco curing. 
Tobacco is a storable product, and its quality ini­
tially improves with age.  After being harvested, tobacco 
goes through several steps in a processing course, in­
cluding sorting and grading (according to type and 
quality) and curing and drying by various techniques 
(including flue, fire, sun, and air curing).  Most of this 
processing is done on the tobacco farm before the prod­
uct is sold to the producers of cigarettes and other to­
bacco products. 
Several types of tobacco are grown in the United 
States and throughout the world.  Burley and flue-
cured tobacco, the primary ingredients in cigarettes, 
are the most important of the domestically grown types 
of tobacco; they account for about 93 percent of total 
production (Tables 6.1 and 6.2).  Most burley tobacco 
is grown in Kentucky and flue-cured tobacco is grown 
primarily in North Carolina. These two states account 
for about two-thirds of domestically grown tobacco. 
Although several other types of tobacco are 
grown in 14 other states, about one-quarter of the to­
tal domestic production is concentrated in Georgia, 
South Carolina, Tennessee, and Virginia.  Other im­
portant types of domestically grown tobacco include 
Maryland tobacco, an important component of ciga­
rettes because it burns slowly; fire-cured tobacco, 
which is used in snuff; dark air-cured and sun-cured 
tobaccos, which are used in chewing tobacco and small 
dark cigars; and other types used for cigar leaf (Johnson 
1984). 
In 1992, the United States had about 124,000 
farms producing tobacco, down sharply from 330,000 
in 1964 (U.S. Department of Agriculture [USDA] 
1998a). Tobacco was grown on an estimated 644,000 
acres in 1999, down sharply from its recent peak of 
836,000 acres in 1997.  In 1998, tobacco farms produced 
almost 1.5 billion pounds of tobacco at a total value of 
approximately $2.7 billion.  After inflation is accounted 
for, however, the value of domestically grown tobacco 
has fallen since 1980. More than 1.4 billion pounds of 
domestically grown tobacco were used in 1998, with 
less than two-thirds of this used domestically, while 
the remainder was exported (Table 6.3). 
Domestic consumption of domestically grown, 
unmanufactured tobacco fell steadily from the 1950s 
through the early 1990s, from a peak of almost 1.6 bil­
lion pounds in 1952 to about 900 million pounds in 
1993 (Table 6.3).  After rising for a few years, domestic 
consumption of domestically grown tobacco fell to just 
over 900 million pounds in 1998. Declining prevalence 
of tobacco use is not the only—or even the main— 
factor behind the long-term decrease; domestically pro­
duced cigarettes contain about 35 percent less tobacco 
than they did 40 years ago (Womach 1994b).  Further­
more, the use of imported tobacco in domestically pro­
duced cigarettes has greatly increased in recent years. 
In 1950, the imported tobacco content of domestically 
produced cigarettes was approximately 6 percent.  By 
1993, this proportion had risen to about 40 percent. 
The increased use of foreign tobacco is partly due 
to improvements in the quality of this tobacco, its rela­
tively low price, reduced barriers to trade in tobacco, 
and the increased market penetration of lower-quality 
generic cigarettes, which include a higher share of im­
ported tobacco. 
The decline in the domestic use of tobacco grown 
in the United States has been offset somewhat by in­
creased exports of domestically grown tobacco.  How­
ever, unmanufactured exports peaked at 765 million 
pounds in 1978 and have fallen fairly steadily since; in 
1998, total exports were 539 million pounds (Table 6.3). 
The largest export markets for U.S.-grown tobacco in 
recent years have been Japan, Germany, the Nether­
lands, and Turkey (USDA 1998a). 
The combination of declining U.S. tobacco ex­
ports and increased tobacco production in foreign 
countries (particularly Argentina, Brazil, Malawi, and 
Zimbabwe) has reduced the U.S. share in world to­
bacco exports. In 1960, the United States’ share of world 
tobacco exports was 27 percent.  By 1997, this share had 
fallen to 11 percent.  Moreover, in 1993, the United States 
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Table 6.1.  Burley tobacco production and value, 1975–1998 
Average price Real price Real farm 
Production to farmers to farmers* Farm value value* 
Crop year (million lbs.) (cents/lb.) (cents/lb.) (million $) (million $) 
1975 640 105.5 196.1 675.1 1,254.8 
1976 664 114.2 200.7 758.3 1,332.7 
1977 613 120.0 198.0 735.6 1,213.9 
1978 614 131.2 201.2 805.8 1,235.8 
1979 472 145.2 200.0 685.6 944.4 
1980 558 165.9 201.3 925.7 1,123.4 
1981 726 180.7 198.8 1,311.9 1,443.2 
1982 777 181.0 187.6 1,406.4 1,457.4 
1983 527 177.3 178.0 934.4 938.1 
1984 674 187.6 180.6 1,264.4 1,217.0 
1985 542 159.7 148.4 865.6 804.4 
1986 420 156.5 142.8 657.3 599.7 
1987 428 156.3 137.6 669.0 588.9 
1988 468 161.0 136.1 753.5 636.9 
1989 498 167.2 134.8 832.7 671.5 
1990 592 175.3 134.1 1,037.8 794.0 
1991 657 178.8 131.3 1,174.7 862.5 
1992 700 181.5 129.4 1,270.5 905.6 
1993 627 181.6 125.7 1,138.6 788.0 
1994 568 184.1 124.2 1,045.7 705.6 
1995 480 185.5 121.7 890.4 584.3 
1996 516 192.2 122.5 991.8 632.1 
1997 629 188.5 117.4 1,185.7 738.7 
1998† 590 190.3 116.7 1,123.3 688.9 
*Real price to farmers and real farm value are obtained by dividing the nominal average price and farm value 
 by the national Consumer Price Index; the average of 1982–1984 is the benchmark. 
†Subject to revision.
 

Sources:  U.S. Department of Agriculture 1996, 1999a; U.S. Department of Labor 1999.
 

lost to Brazil its historically dominant position as the 
leading exporter of tobacco (Womach 1994b). 
These trends for domestically grown, unmanufac­
tured tobacco have not been observed for domestic pro­
duction of the chief manufactured tobacco product—the 
cigarette (Table 6.3).  Although total annual domestic 
consumption fell fairly steadily from a 1982 peak of 634 
billion cigarettes to an estimated 435 billion in 1999,  total 
domestic cigarette consumption peaked in 1996. The 
difference is the result of large increases in the export 
of domestically produced cigarettes.  In 1985, the 
United States exported 58.9 billion cigarettes.  Exports 
peaked in 1996 at more than 240 billion cigarettes, al­
most one-third of total domestic production in that 
year.  Since 1996, however, cigarette exports have 
fallen, to an estimated 150 billion by 1999. 
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Table 6.2.  Flue-cured tobacco production and value, 1975–1998 
Average price Real price Real farm 
Production to farmers to farmers* Farm value value* 
Crop year (million lbs.) (cents/lb.) (cents/lb.) (million $) (million $) 
1975 1,415 99.8 185.5 1,412.2 2,624.9 
1976 1,316 110.4 194.0 1,452.9 2,553.4 
1977 1,124 117.6 194.1 1,321.8 2,181.2 
1978 1,206 135.0 207.1 1,628.1 2,497.1 
1979 974 140.0 192.8 1,363.3 1,877.5 
1980 1,086 144.5 175.4 1,569.3 1,904.5 
1981 1,144 166.4 183.1 1,903.6 2,094.2 
1982 994 178.5 185.0 1,774.3 1,838.6 
1983 855 177.9 178.6 1,521.0 1,527.2 
1984 850 181.1 174.3 1,539.4 1,481.6 
1985 789 171.9 159.8 1,356.3 1,260.5 
1986 667 152.7 139.3 1,018.5 929.3 
1987 683 158.7 139.7 1,083.9 954.2 
1988 796 161.3 136.3 1,283.9 1,085.3 
1989 838 167.4 135.0 1,402.8 1,131.3 
1990 920 167.3 128.0 1,539.2 1,177.6 
1991 882 172.3 126.5 1,519.7 1,115.8 
1992 901 172.6 123.0 1,555.1 1,108.4 
1993 892 168.1 116.3 1,499.5 1,037.7 
1994 807 169.8 114.6 1,370.3 924.6 
1995 854 179.4 117.7 1,532.1 1,005.3 
1996 897 183.4 116.9 1,645.1 1,048.5 
1997 1,014 172.0 107.2 1,744.1 1,086.7 
1998† 815 175.5 107.7 1,430.0 877.5 
*Real price to farmers and real farm value are obtained by dividing the nominal average price and farm value 
 by the national Consumer Price Index; the average of 1982–1984 is the benchmark. 
†Subject to revision.
 

Sources:  U.S. Department of Agriculture 1996, 1999a; U.S. Department of Labor 1999.
 

Tobacco Price Supports 
and consequently raise tobacco prices and the incomes 
of tobacco farmers. These and other agricultural coop-
eratives were largely responding to the steep reduc­
tions in the prices of tobacco and other agricultural 
products during the recession of 1921.  The coopera­
tives had little success and were eventually disbanded. 
Despite being such a profitable crop, tobacco, like 
other U.S. crops, has benefited from agricultural price 
supports that have been in place for much of the 20th 
century.  In the 1920s, before these supports were in 
place, tobacco cooperatives had formed in various re-
gions in an attempt to control the supply of tobacco 
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Table 6.3.  	Selected production and trade statistics for U.S.-grown, unmanufactured tobacco and for 
U.S.-produced cigarettes, 1975–1999 
Pounds of tobacco*  (millions) Number of cigarettes† (billions) 
Actual use 
Total Domestic Total Domestic 
Year production Total use Exports production consumption‡ Exports 
1975 2,182 1,941 1,286 655 651.2 607.2 50.2 
1976 2,136 1,907 1,229 678 693.4 613.5 61.4 
1977 1,913 1,895 1,202 693 665.9 617.0 66.8 
1978 2,054 1,955 1,190 765 695.9 616.0 74.4 
1979 1,527 1,869 1,175 694 704.4 621.5 79.7 
1980 1,786 1,759 1,109 649 714.1 631.5 82.0 
1981 2,064 1,762 1,065 697 736.5 640.0 82.6 
1982 1,994 1,662 1,034 628 694.2 634.0 73.6 
1983 1,429 1,532 936 596 667.0 600.0 60.7 
1984 1,728 1,621 955 666 668.8 600.4 56.5 
1985 1,511 1,620 1,000 620 665.3 594.0 58.9 
1986 1,163 1,572 981 591 658.0 583.8 63.9 
1987 1,191 1,688 1,115 573 689.4 575.0 100.2 
1988 1,370 1,565 1,010 555 694.5 562.5 118.5 
1989 1,367 1,677 1,096 582 677.2 540.0 141.8 
1990 1,625 1,794 1,163 631 709.7 525.0 164.3 
1991 1,664 1,616 976 640 694.5 510.0 179.2 
1992 1,722 1,590 960 630 718.5 500.0 205.6 
1993 1,614 1,436 898 538 661.0 485.0 195.5 
1994 1,583 1,604 1,080 523 725.5 486.0 220.2 
1995 1,268 1,491 958 533 746.5 487.0 231.1 
1996 1,503 1,698 1,068 630 754.5 487.0 243.9 
1997 1,714 1,494 962 532 719.6 480.0 217.0 
1998 1,489 1,440 901 539 679.7 485.0 201.3 
1999§ 1,267 Δ Δ Δ 635.0 435.0 150.0 
*Marketing year, beginning July 1 for flue-cured and cigar wrapper and October 1 for all other types. 
†Calendar year.  May contain imported tobacco. 
‡Allows for estimated inventory change.
 

§Preliminary estimate.
 

ΔNot available.
 

Sources:  U.S. Department of Agriculture 1997c, 1998a, 1999a.
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The price support system came into existence a 
decade later.  In response to the impact that the 1930s’ 
Great Depression had on farmers, Congress passed the 
Agricultural Adjustment Act of 1933 (Public Law 73­
10) to control the supply of tobacco and other agricul­
tural products whose prices had fallen sharply.  The 
intent of this and subsequent agricultural price support 
programs was to support the income of farmers and 
stabilize the quantity and prices of agricultural com­
modities. These programs also gave tobacco farmers 
some ability to counteract the economic power of the 
highly concentrated cigarette producers (Warner 1988). 
Minimum Prices, Nonrecourse Loans, and Quotas 
The federal program for tobacco price supports 
involves specific economic interventions and assis­
tance. To stabilize the price and quantity of tobacco 
produced, the program guarantees minimum market 
prices and establishes marketing quotas. Minimum 
(or support) prices are essentially determined by past 
tobacco prices adjusted for changes in cost indexes. 
When unable to find a private buyer at a price at or 
above the support level, a tobacco farmer is eligible 
for a nonrecourse government loan from a local price 
stabilization cooperative. This type of loan allows for 
a commodity, in this case tobacco, to be used as collat­
eral for the loan at the support price. Under annual 
contracts with the cooperatives, USDA’s Commodity 
Credit Corporation loans funds it has borrowed from 
the U.S. Treasury (in the past, at less than market rates 
of interest [Johnson 1984]).  Each cooperative processes 
and stores the tobacco it has received as the farmer’s 
collateral, and the Commodity Credit Corporation 
collects interest on the loan.  The cooperative then at­
tempts to sell the tobacco. If the cooperative can re­
ceive a price above the support price, the proceeds are 
used to repay the loan, and any excess receipts go to 
the tobacco farmer.  This process has created the ap­
pearance that tobacco farmers are not being directly 
subsidized (Johnson 1984). 
Marketing quotas, determined by the U.S. Secre­
tary of Agriculture, are intended to be sufficient to meet 
the domestic and foreign demand for U.S. tobacco at a 
price above the government support price. Originally, 
tobacco could be grown only on land that had been 
assigned a quota, which was based on that farm’s pro­
portion of tobacco produced when the program was 
initiated (with a limited amount of new production 
allowed each year). Consequently, almost the only way 
to begin growing tobacco was to buy or rent a farm 
that had been granted the right to grow tobacco.  In 
1961, farmers who grew flue-cured tobacco approved 
intracounty lease and transfers of allotments; burley 
tobacco farmers followed suit in 1971. For the first 
several decades, these quotas were implemented 
through national acreage allotment systems.  The acre­
age allotments were replaced by poundage quotas in 
1965 for flue-cured tobacco and in 1971 for burley to­
bacco. The switch to poundage quotas increased flex­
ibility for tobacco growers. In any given year, tobacco 
farmers could sell up to 10 percent more than their 
quota if yields exceeded expectations (because of fa­
vorable weather conditions, for example). In the fol­
lowing year, however, farmers would have to sell 
proportionately less than that quota.  The opposite 
would apply when yields fell short of expectations. If 
yields fell short for several years, tobacco farmers could 
accumulate excess quotas up to an amount equal to 
their normal quota. This arrangement resulted in a 
more stable supply of flue-cured and burley tobacco 
(Johnson 1984). 
Every three years, tobacco farmers vote on whether 
to continue the price support program and whether to 
approve any substantive changes in the system.  If the 
referendum is approved by a two-thirds majority, 
tobacco farmers are subject to marketing quotas. 
Effects of Price Supports on Market Prices 
Despite the numerous factors that affect the sup­
ply and demand for tobacco, the quota and price 
support system keeps market prices at or above the 
support level. This effect has been evident—and its 
correction attempted—almost from the outset.  As a 
result of the Agricultural Adjustment Act of 1933, to­
bacco prices increased almost immediately.  These in­
creases resulted from limits on output achieved by 
voluntary agreement.  In 1934, Congress passed the 
Tobacco Control Act (Public Law 73-483) to deter non­
cooperative tobacco farmers from overproducing and 
taking advantage of the relatively high prices result­
ing from the reduced supplies of participating farm­
ers. This act led to sharp reductions in tobacco 
production and consequently to a steep rise in tobacco 
prices. In early 1936, however, the United States Su­
preme Court found sections of the Agricultural Ad­
justment Act unconstitutional, which led Congress to 
repeal the Tobacco Control Act as well. 
In 1935, Congress enacted the Tobacco Inspec­
tion Act (Public Law 74-314), which required the USDA 
to provide tobacco grading (or quality evaluation) ser­
vices at no cost to tobacco growers.  In 1936, the Soil 
Conservation and Domestic Allotment Act (Public Law 
74-461) was passed. This act covered tobacco, as well 
as most other agricultural products covered by the 
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Agricultural Adjustment Act of 1933, and rewarded 
farmers for diverting production from soil-depleting 
crops (including tobacco) to soil-conserving crops.  The 
limited success of the Soil Conservation and Domes­
tic Allotment Act led to the passage in 1938 of the sec­
ond Agricultural Adjustment Act (Public Law 75-430). 
The new act included quotas for tobacco and other 
agricultural products and imposed penalties on farm­
ers who violated their quotas. Even with subsequent 
amendments, the tobacco price support program es­
tablished by the Agricultural Adjustment Act of 1938 
is essentially the same today. 
The Agricultural Adjustment Act of 1938 set the 
support price at 75 percent of parity (where parity re­
flects average tobacco prices from 1919 through 1929). 
At the beginning of World War II and later through 
the Agricultural Act of 1949 (Public Law 81-439), this 
proportion was raised to 90 percent of parity, which 
was based on average prices for the preceding 10 years. 
In 1960, to slow the rate of growth in tobacco prices, 
Congress set new support levels based on the 1959 level 
and a three-year moving average of prices paid by 
farmers. Similarly, in 1980, the support prices for the 
eight lowest quality grades of tobacco were lowered 
directly. 
Assessments to Offset Federal Costs 
of Price Supports 
Until new legislation was passed in the 1980s, 
the costs to the federal government from operating the 
tobacco support program were substantial.  In 1981 
alone, the total administrative cost of the program was 
$13.1 million. Moreover, the federal government, 
through the Commodity Credit Corporation, bore all 
costs if the local cooperatives were unable to sell the 
tobacco they received as collateral for the nonrecourse 
loans. By April 1982, losses from unpaid loan princi­
pal totaled $57 million, and interest losses amounted 
to $591 million by the end of 1981 (General Account­
ing Office [GAO] 1982). These losses spurred opposi­
tion to the tobacco support program, which was being 
threatened with dissolution.  To reduce some of the 
costs of operating the program, in 1981 Congress 
amended the Tobacco Inspection Act, imposing fees 
on tobacco growers sufficient to cover the cost of the 
grading services provided by the USDA. 
Far more significant changes to the tobacco sup­
port program were introduced by the No Net Cost 
Tobacco Program Act of 1982 (Public Law 97-218), 
which was mandated by the Agriculture and Food Act 
of 1981 (Public Law 97-98). The act was intended to 
reduce the losses of the tobacco support program by 
Reducing Tobacco Use 
imposing an assessment on every pound of tobacco 
brought to market under the loan program.  The as­
sessments were supposed to generate revenues suffi­
cient to offset all future losses from these loans.  Thus, 
aside from the administrative costs, the tobacco sup­
port program was supposed to operate at no net cost 
to taxpayers. Other changes were introduced through 
the act. Rather than distributing excess receipts from 
the sale of loan tobacco to farmers, these profits were 
retained by the Commodity Credit Corporation.  Farm­
ers of flue-cured tobacco could sell their right to grow 
tobacco to other active tobacco growers in the same 
county; moreover, institutional owners of these rights 
were required to sell them by December 1984.  Finally, 
the U.S. Secretary of Agriculture was given the author­
ity to slow the growth in the support price by allow­
ing the price to increase by as little as 65 percent of the 
increase implied by the parity formula.  These changes 
led four relatively small associations of tobacco grow­
ers (growers of cigar tobacco in three areas) to stop 
participating in the support program (Miller 1994). 
Initially, assessments were expected to be rela­
tively low because of the size of past losses. However, 
as a result of the tobacco support program, U.S. sup­
port prices were well above tobacco prices in world 
markets, which led producers of cigarettes and other 
tobacco products to increase their use of imported to­
bacco. At the same time, reductions in quotas were 
limited by statute. Consequently, the quantity of to­
bacco produced exceeded the quantity demanded at 
the support price, and the surplus was used as collat­
eral for nonrecourse loans (Miller 1994).  By 1985, with 
a growing stock of U.S.-grown tobacco under loan, the 
no-net-cost assessment on flue-cured tobacco was high: 
25 cents per pound (Miller 1994). (The assessment on 
burley tobacco would have been 30 cents per pound 
but was limited to 4 cents by legislation.) 
The high assessments, the growing importance 
of imported tobacco in the production of cigarettes and 
other tobacco products, the increasing stocks of tobacco 
under loan, and the falling quotas of the early to mid­
1980s created a crisis for tobacco farmers and the to­
bacco support program (Northup 1993).  Congress 
responded by making several changes to the support 
program (Tobacco Program Improvements) contained 
in the Consolidated Omnibus Budget Reconciliation 
Act of 1985 (Public Law 99-272). The 1985 act lowered 
the tobacco support price by 26 cents per pound for 
both flue-cured and burley tobacco.  In addition, both 
buyers and sellers of surplus tobacco were required to 
bear part of the burden of running the program (grow­
ers of other types of tobacco continued to be respon­
sible for the full assessment). These changes were 
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meant to encourage the use of domestically grown to­
bacco over imported tobacco in the manufacturing of 
cigarettes and other tobacco products (Miller 1994). 
Also as a result of this legislation, the amount of 
flue-cured and burley tobacco that could be sold with­
out penalty was reduced from 110 percent of quota to 
103 percent.  The formulas used to determine the sup­
port prices for flue-cured and burley tobacco were also 
changed. These prices were now based on their levels 
in the preceding year, and adjustments were to be made 
from a five-year moving average of prices and changes 
in the cost of production.  Past prices would be given 
two-thirds weight, and the remainder would be based 
on production costs (which included general variable 
expenditures but excluded costs of land, overhead, 
assessments, and other expenses not directly related 
to tobacco growing).  The legislation also brought the 
major cigarette manufacturers into the quota-setting 
process, because they would be annually providing 
the U.S. Secretary of Agriculture with their intended 
purchases of tobacco.  These manufacturers would be 
penalized if they did not purchase at least 90 percent 
of this intended amount. 
When these changes took place, U.S. cigarette com­
panies agreed to buy all future surplus stocks of tobacco 
(for the next eight years for flue-cured tobacco and the 
next five years for burley tobacco). Some of the exist­
ing stocks under loan were sold at sharp discounts; the 
federal government absorbed the losses. These changes 
were somewhat successful in reducing surplus tobacco 
stocks as well as the amount of tobacco brought under 
loan in any given year.  Over the next five years, stocks 
of tobacco declined by nearly 40 percent, and total loan 
outlays fell by nearly 90 percent. 
To fund deficit reduction of the federal budget, 
the Omnibus Budget Reconciliation Act of 1990 (Pub­
lic Law 101-508) added further marketing assessments 
on all commodity price support programs between 
1991 and 1995; the marketing assessments were sub­
sequently extended through 1998 (USDA 1997c).  To­
bacco growers and buyers each paid an additional 
assessment equal to 0.5 percent of the support price 
level. These additional assessments generated esti­
mated revenues of more than $28 million in fiscal year 
1997 (Womach 1999). 
To further curb the use of imported tobacco, the 
Omnibus Budget Reconciliation Act of 1993 (Public 
Law 103-66) included the requirement that, beginning 
in 1994, domestically produced cigarettes include a 
minimum of 75 percent domestically grown tobacco. 
If this law was violated, the cigarette manufacturer was 
assessed on the amount of foreign-grown tobacco used 
in excess of the 25-percent limit.  The assessment rate 
was determined by the difference between average 
prices of imported and domestic tobacco. Those pro­
ducers who used an excess of imported tobacco were 
further required to make up the shortfall by purchas­
ing tobacco stocks under loan. The act also subjected 
imported tobacco to the no-net-cost assessments be­
ginning in 1994. Effective September 13, 1995, how­
ever, the domestic content requirement was dropped 
as part of a presidential tariff-rate quota proclamation 
because of its inconsistency with the General Agree­
ment on Tariffs and Trade (GATT). 
In general, the tobacco quotas have fallen in re­
cent years, while support prices, after adjustment for 
inflation, have fallen sharply (Tables 6.4 and 6.5).  As 
of March 31, 1995, the principal and interest value of 
tobacco loan inventory was $1.6 billion (Robert H. 
Miller, Tobacco loan status report, unpublished data), 
which was down significantly from the $2.75 billion 
held as of June 30, 1986 (Warner 1988). 
The no-net-cost assessment for the 2000 crop of 
flue-cured tobacco is 2.5 cents per pound for the pro­
ducer and 2.5 cents per pound for the purchaser.  Simi­
larly, the no-net-cost assessment for the 2000 crop of 
burley tobacco is 3 cents per pound for both the grower 
and the buyer. 
In fiscal year 2000, the federal government bud­
geted approximately $14 million for administering the 
tobacco support program (Womach 1999).  In total, the 
directly tobacco-related activities of the USDA gener­
ated an estimated $174 million in net revenues in fis­
cal year 1999. The positive net revenues are the result 
of revenues generated by the loan program and vari­
ous assessments that more than offset the expenditures 
on the tobacco program and other tobacco-related 
activities (including subsidized tobacco crop insurance, 
tobacco inspection and grading, tobacco research, data 
collection and analysis, and other activities) (Womach 
1999). 
Discussion 
Several conclusions emerge from analyses of the 
tobacco support program. The program’s success in 
stabilizing tobacco prices is particularly evident when 
they are compared with the prices of other agricultural 
commodities (including those covered by their own 
support programs).  One result of the price stability is 
that output has also been relatively stable.  As Johnson 
(1984) notes, “growing tobacco has been as close to a 
sure thing as one can find in U.S. agriculture” (p. 55). 
The quantity of tobacco grown domestically 
is artificially low as a result of the supply restrictions 
created by the tobacco support program.  Consequently, 
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Table 6.4.  Characteristics of the tobacco support program: flue-cured tobacco, 1975–2000 
National National Real average No-net-cost assessment† 
marketing average support (cents/lb.) 
quota support price price* 
Year (million lbs.) (cents/lb.) (cents/lb.) Producers Buyers 
1975 1,491 93.2 173.2 
1976 1,268 106.0 186.3 
1977 1,116 113.8 187.8 
1978 1,117 121.0 185.6 
1979 1,095 129.3 178.1 
1980 1,094 141.5 171.7 
1981 1,013 158.7 174.6 
1982 1,013 169.9 176.1 3.0 
1983 910 169.9 170.6 7.0 
1984 804 169.9 163.5 7.0 
1985 775 169.9 157.9‡ 2.50 
1986 729 143.8 131.2 2.50 1.50 
1987 707 143.5 126.3 2.00 2.00 
1988 754 144.2 121.9 1.13 1.13 
1989 891 146.8 118.4 1.12 1.12 
1990 878 148.8 113.8 1.00 1.00 
1991 878 152.8 112.2 1.00 1.00 
1992 892 156.0 111.2 1.00 1.00 
1993 892 157.7 109.1 1.00 3.00 
1994 803 158.3 106.8 3.00 5.00 
1995 935 159.7 104.8 0.80 1.80 
1996 874 160.1 102.0 1.00 1.80 
1997 974 162.1 101.0 1.00 1.00 
1998 814 162.8 99.9 1.00 1.00 
1999 666 163.2 98.0 1.00 1.00 
2000 543 164.0 95.6§ 2.50 2.50 
*Real average support price is obtained by dividing the nominal support price by the national Consumer 
  Price Index; the average of 1982–1984 is the benchmark. 
†No-net-cost assessment includes marketing budget deficit assessments from 1991 through 1998. 
‡The effective support price in 1985 was 165.0 cents/lb. by reduction of certain grades.
 

§Preliminary estimate.
 

Sources:  U.S. Department of Agriculture 1997b, 1999a,b.
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Table 6.5.  Characteristics of the tobacco support program: burley tobacco, 1975–2000 
National National Real average No-net-cost assessment‡ 
marketing average support (cents/lb.) 
quota support price* price† 
Year (million lbs.) (cents/lb.) (cents/lb.) Producers Buyers 
1975 670 96.1 178.6 
1976 635 109.3 192.1 
1977 636 117.3 193.6 
1978 614 124.7 191.3 
1979 614 133.3 183.6 
1980 614 145.9 177.1 
1981 660 163.6 180.0 
1982 680 175.1 181.5 1.0 
1983 647 175.1 175.8 5.0 
1984 582 175.1 168.5 9.0 
1985 524 148.8 138.3 4.0 
1986 493 148.8 135.8 2.75 1.25 
1987 464 148.8 131.0 2.00 2.00 
1988 473 150.0 126.8 0.80 0.80 
1989 587 153.2 123.5 1.00 1.00 
1990 601 155.8 119.2 1.00 1.00 
1991 724 158.4 116.3 1.00 1.00 
1992 668 164.9 117.5 1.00 1.00 
1993 602 168.3 116.5 1.00 3.50 
1994 536 171.4 115.7 4.50 4.60 
1995 546 172.5 113.2 1.00 1.00 
1996 631 173.7 110.7 1.00 1.00 
1997 704 176.0 109.7 1.00 1.00 
1998 635 177.8 109.1 3.00 3.00 
1999 451 178.9 107.4 3.00 3.00 
2000 247 180.5 105.2§ 3.00 3.00 
*The support price was reduced from 178.8 cents/lb. and the no-net-cost assessment was reduced from
 30 cents/lb. by Public Law 99-157, sec. 6 (1985). 
†Real average support price is obtained by dividing the nominal support price by the national Consumer
 

 Price Index; the average of 1982–1984 is the benchmark.
 

‡No-net-cost assessment includes marketing budget deficit assessments from 1991 through 1998.
 

§Preliminary estimate.
 

Sources:  U.S. Department of Agriculture 1997a; 1998a,b; 1999a, 2000.
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prices for domestically grown tobacco are artificially 
high. Some estimates of the distortions resulting from 
the support program were provided by Sumner and 
Alston (1985) in their analysis of the economic conse­
quences of removing the tobacco price support system. 
Their estimates were based on a detailed simultaneous 
equations model of the supply and demand for tobacco 
and tobacco products (cigarettes) that allows for sub­
stitution between domestic and foreign tobacco in ciga­
rette production.  The authors estimated that domestic 
tobacco output would rise by 50–100 percent or more 
if supply restrictions were eliminated.  This large in­
crease in the quantity of tobacco supplied would lead to 
sharp reductions in tobacco prices.  As a result of the 
increase in output, tobacco prices would fall by 20–30 
percent, and the variability of tobacco prices would in­
crease.  However, overall revenues from tobacco grow­
ing would rise by 15–60 percent or more. 
Moreover, this analysis predicted that the sharp 
drop in domestic tobacco prices that would follow the 
removal of supply restrictions would lead domestic 
producers of cigarettes and other tobacco products to 
use less foreign-grown tobacco.  These estimates as­
sumed the elimination of the program in 1983 and thus 
do not take into account the more recent changes in its 
operation. More recent estimates from Zhang and col­
leagues (2000) suggest that the conclusions of Sumner 
and Alston (1985) still apply.  For example, they esti­
mated that the price support program raised tobacco 
leaf prices by 36 cents a pound in 1994. This price is 
about 21 percent above the estimated price in the ab­
sence of the support program. 
The removal of the support program would also 
make domestic tobacco growers more competitive in 
world markets. In the 1980s, U.S. tobacco prices ex­
ceeded world market prices by 40–60 cents per pound 
(Warner 1988).  Although part of the differential can 
be explained by the higher quality of U.S. tobacco, a 
significant factor is the U.S. tobacco support program. 
Sumner and Alston (1985) predicted that U.S. tobacco 
exports would have grown by about 100 percent if the 
tobacco support program had been eliminated in 1983. 
This change would have had an adverse impact on 
foreign tobacco growers, as producers of foreign ciga­
rettes and other tobacco products increased their use 
of tobacco grown in the United States. 
Although the artificially high prices resulting 
from the support program tend to increase the income 
of small tobacco farmers, they likely receive relatively 
less benefit from the program than the tobacco quota 
owners. Because most small tobacco farmers rent some 
or all of their allotments from the quota owners at a 
significant cost (Watkins 1990), these farmers pay rents 
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equivalent to the excess value created by the support 
program.  In the absence of the program, reduced in­
come for these farmers would likely be offset by the 
resulting reduced rent they paid.  Quota owners, on 
the other hand, have been estimated to lose about $800 
million annually were the support program eliminated 
(Sumner and Alston 1985). 
Despite the differing likely effects on quota own­
ers and small tobacco growers, eliminating the tobacco 
support program would probably not alter existing 
trends in the concentration of tobacco production into 
larger farms (Sumner and Alston 1985).  Rucker and 
colleagues (1995) have estimated that eliminating the 
program’s intercounty restrictions on the transfer of 
tobacco quotas would have little overall impact beyond 
redistributing wealth from some tobacco growers and 
quota owners to others. (Consequently, these research­
ers suggest that the restrictions have remained in ef­
fect not because the gains associated with them are 
large but because the political costs of removing them 
are.) Moreover, removing supports would cause a 
movement away from regions where the costs of grow­
ing tobacco are relatively high toward those where 
costs are relatively low.  The loss of income to quota 
owners would lead to reductions in personal income 
of up to 2–3 percent for counties that are highly de­
pendent on tobacco; larger losses would occur in the 
relatively high-cost counties. However, total incomes 
would rise in areas that experienced a great expan­
sion in tobacco growing. In comparison, the effect of 
altering another government program would be con­
siderable. Increases in cigarette excise taxes are also 
likely to bring significant losses to quota owners. 
Sumner and Wohlgenant (1985) estimated that dou­
bling the federal cigarette excise tax in 1983 would 
lower quota owners’ lease income by an average of 13 
percent, or about $44 million. 
As a result of the sharp drop in the price of to­
bacco, cigarette prices could fall.  Tobacco costs, how­
ever, are a relatively small component of cigarette 
prices. Grise (1995) estimates that the 40- to 50-cent 
per pound drop in tobacco prices resulting from the 
elimination of the support program would reduce ciga­
rette prices by only 1–2 percent.  Zhang and colleagues 
(2000) estimate an even smaller impact, concluding that 
cigarette prices are 0.52 percent higher than they would 
be in the absence of the support program.  As noted 
by Sumner and Alston (1985), a reduction in cigarette 
prices would lead to a rise in U.S. cigarette exports. 
Moreover, estimates of the price responsiveness of ciga­
rette demand (described in “Effect of Price on Demand 
for Tobacco Products,” later in this chapter) suggest 
that the reduction would lead to an increase of no more 
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than 1 percent in cigarette smoking.  At least part of 
the increase would come from increased smoking 
among young people. 
Opponents of the tobacco support program sug­
gest that it can be removed with little impact on the 
farmers it is intended to benefit. For example, the less 
than 2-percent reductions in cigarette price that would 
result from eliminating the support program could be 
more than offset by an increased excise tax on ciga­
rettes. A portion of the revenues generated from the 
tax hike could be used to help tobacco farmers diver­
sify into other crops (through low-interest loans, 
grants, or other programs) or to purchase the farmer’s 
tobacco base to retire it from tobacco growing (Northup 
1993). Similarly, some of the funds could be used to 
develop nonfarm businesses, train farmers for other 
occupations, provide income support, and offer other 
economic support for local economies in transition 
(Womach 1994a). 
Critics also point out that the support program 
creates indirect political consequences:  the depen­
dence created by the support program results in a 
strong political constituency, composed of tobacco 
farmers and holders of tobacco allotments, that can 
impede legislation to reduce tobacco use (Taylor 1984; 
Warner 1988; Zhang and Husten 1998).  In the absence 
of the support program, tobacco growing would likely 
become much more concentrated (Sumner and Alston 
1985).  Warner (1988) has observed that the reduction 
in numbers would lead to reduced political influence. 
Moreover, he describes the apparent inconsistency 
present when one arm of the federal government seem­
ingly endorses tobacco production by continuing an 
economic support program even as another engages in 
numerous activities to reduce tobacco use (Warner 1988). 
Evolution of the U.S. Cigarette Industry 
Through much of the 19th century, most of the 
demand for tobacco products centered on smokeless 
tobacco and cigars (see Chapter 2). Cigarettes were 
relatively less popular, although the demand for them 
increased gradually during the middle of the century 
(USDHHS 1992). The watershed year for the cigarette, 
however, was 1881, when James Albert Bonsack an­
nounced his development of a machine that replaced 
hand-rolling as the primary means of making ciga­
rettes. The mechanization of production significantly 
reduced the costs of manufacturing cigarettes and, 
consequently, reduced cigarette prices.  The steep de­
clines in cigarette prices relative to the prices of other 
tobacco products, due largely to Bonsack’s cigarette 
machine, contributed significantly to the rapid rise in 
the popularity of cigarettes during the late 19th and 
early 20th centuries (Wagner 1971). 
James Buchanan Duke was the first cigarette pro­
ducer to acquire rights to the new machines, which he 
installed in 1884. Duke entered into long-term con­
tracts with Bonsack to use the machines at a cost lower 
than Bonsack would make them available to other 
producers.  Because of the resulting substantial cost 
advantage in production for his company, Duke 
successfully waged price wars with other producers 
while still earning relatively high profits.  Over the next 
decade, the Duke family formed a holding company, 
which was composed of their firm and several com­
petitors they had acquired.  By 1889, as a result of its 
aggressive pricing and marketing strategies, the hold­
ing company effectively monopolized U.S. cigarette 
markets (controlling more than 90 percent of the mar­
ket), as well as portions of the markets for other to­
bacco products.  Eventually, in an attempt to avoid 
antitrust prosecution under the Sherman Act, the 
Dukes converted the holding company into The Ameri­
can Tobacco Company.  By 1901, The American Tobacco 
Company dominated all of the U.S. tobacco markets 
except cigars. The company was also a considerable 
presence in cigarette markets around the world. 
In response to allegations that The American To­
bacco Company was abusing its market position, the 
U.S. Department of Justice charged the firm with vio­
lating the Sherman Act.  In 1911, the Supreme Court 
dissolved the company, thereby creating several new 
firms from the conglomerate, including a new Ameri­
can Tobacco Company (which later became American 
Brands, Inc.), Liggett & Myers Tobacco Company, R.J. 
Reynolds Tobacco Company, and Lorillard Tobacco 
Company.  The American Tobacco Company was also 
divested of its foreign holdings (Imperial Tobacco Ltd. 
and British-American Tobacco Company Ltd. [B.A.T. 
Company]). Imperial Tobacco Ltd. eventually mo­
nopolized cigarette manufacturing in Great Britain, 
and B.A.T. Company concentrated on manufacturing 
in British colonies and elsewhere.  Both companies 
ultimately resumed some operations in the United 
States (Johnson 1984). Although Imperial Tobacco Ltd. 
eventually dropped out of U.S. markets, B.A.T. Indus­
tries PLC, the parent company of B.A.T. Company, 
owns Brown & Williamson Tobacco Corporation, a 
large U.S. cigarette manufacturer. 
R.J. Reynolds Tobacco Company (which had no 
cigarette production after the breakup) soon devel­
oped a new type of cigarette by using burley tobacco, 
which was quickly copied by the other producers.  By 
the 1920s, the cigarette producers were competing 
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aggressively in promoting their main brand—for ex­
ample, R.J. Reynolds Tobacco Company’s Camel, The 
American Tobacco Company’s Lucky Strike, and 
Liggett & Myers Tobacco Company’s Chesterfield.  In 
addition, firms on the competitive fringe attempted to 
compete through price with their so-called 10-cent 
brands (Robert 1967). (For a more detailed discussion 
of the domestic operations of U.S. cigarette firms be­
fore World War II, see the Surgeon General’s report 
Smoking and Health in the Americas [USDHHS 1992]). 
The U.S. Department of Justice eventually chal­
lenged the four producers’ coordinated wholesale and 
retail pricing practices. In 1941, on the basis of con­
duct starting as early as 1933, these producers were 
charged with violating the Sherman Act by conspir­
ing to restrain trade in an attempt to monopolize the 
industry.  Their wholesale tobacco-purchasing prac­
tices were deemed to be monopsonistic—that is, char­
acteristic of a market situation where one buyer exerts 
a disproportionate influence—and their retail pricing 
was thought to reflect collusive behavior.  In 1946, bas­
ing its decision on the novel legal concept of “conscious 
parallelism,” the Supreme Court upheld a jury deci­
sion that found the firms guilty.  The uniformity of 
prices at both the wholesale and the retail level (a result 
that could occur in any highly competitive market), 
the near-synchronous increases in prices, and the rais­
ing of wholesale prices when labor costs were falling 
were viewed by the court as evidence of tacit collusion. 
Reducing Tobacco Use
 
As a result, the firms were fined up to $250,000 each, a 
relatively minor penalty compared with their profits. 
Johnson (1984) and others have noted that the 
Court’s decision was not supported by purely eco­
nomic reasoning.  There was little if any evidence that 
cigarette firms were jointly restricting output to raise 
cigarette prices and, consequently, profitability.  Simi­
larly, there was no evidence that the firms limited 
their wholesale purchases of tobacco to depress to­
bacco prices and production costs and, consequently, 
to increase profits. 
The Court’s decision had little impact on the sub­
sequent structure of the U.S. cigarette industry.  The 
practical result has been that, from 1946 until today, 
the combined market shares of the six major firms (five 
after the merger of Brown & Williamson and Ameri­
can Brands, Inc.) has exceeded 99 percent, although 
individual market shares have changed significantly 
(Table 6.6). 
More important in changing relative market 
shares was the release of information during the 1950s 
and 1960s on the health consequences of cigarette 
smoking. In the 1950s, Philip Morris Companies Inc., 
R.J. Reynolds Tobacco Company, and Lorillard Tobacco 
Company aggressively marketed filtered cigarettes 
(Marlboro, Winston, and Kent, respectively), which 
were perceived as less dangerous than standard 
unfiltered cigarettes; The American Tobacco Company 
and Liggett & Myers Tobacco Company were not as 
Table 6.6.  Domestic market shares of U.S. cigarette firms, selected years
 

R.J. Philip Brown & American Liggett &
 

Year Reynolds Morris Williamson Brands  Lorillard Myers Total
 

1913 0.2 NA* NA 35.3 22.1 34.1 91.7 
1925 41.6 0.5 NA 21.2 1.9 26.6 91.8 
1940 21.7 9.6 7.8 29.5 5.4 20.6 94.6 
1955 25.8 8.5 10.5 32.9 6.1 15.6 99.4 
1970 31.8 16.8 16.9 19.3 8.7 6.5 100.0 
1975 32.5 23.8 17.0 14.2 7.9 4.4 99.8 
1980 32.8 30.8 13.7 10.7 9.8 2.2 100.0 
1985 31.7 35.8 11.8 7.4 8.2 5.0  99.9 
1991 27.8 43.4 11.1 7.0 7.3 3.4 100.0 
1996 24.6 47.8 17.2 NA 8.4 1.9 99.9 
*NA = Not available.
 

Sources:  Tennant 1950; Overton 1981; Clarifeld 1983;  Standard & Poor ’s 1989, 1993; Federal Trade
 

Commission 1997.
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successful in marketing their competing brands 
(Johnson 1984).  Similarly, after the 1964 release of the 
U.S. Surgeon General’s first report on the health conse­
quences of cigarette smoking, and after the Federal 
Trade Commission’s (FTC) publishing of tar and nico­
tine content in the late 1960s, Philip Morris Companies 
Inc. and R.J. Reynolds Tobacco Company introduced 
and aggressively marketed low-tar and low-nicotine 
cigarettes (again, products perceived as healthier than 
existing cigarettes), whereas the other companies were 
less successful.  As a result of the brand loyalty these 
two firms were able to establish at this time, they came 
to dominate cigarette markets; in 1996, the two firms 
had a combined market share of 72.4 percent. 
Another notable change in the tobacco industry, 
beginning in the 1960s, was the diversification of the 
cigarette-manufacturing companies.  Perhaps in part to 
offset the impact that the campaign to reduce tobacco 
use had on the industry’s profitability, the six major 
domestic cigarette producers acquired or merged with 
U.S. firms in a variety of nontobacco markets, includ­
ing food, alcoholic beverages, and transportation. Both 
U.S. and international cigarette producers significantly 
expanded their international activities. Diversification 
was relatively easy because of the high profitability from 
cigarettes and the low long-term debt of these firms 
(Overton 1981). By 1972, no major domestic cigarette 
company was completely dependent on tobacco for its 
revenue (Johnson 1984).  During the 1980s, diversifica­
tion strategies and successes among the six firms var­
ied markedly; some firms returned to a focus on 
cigarettes and other tobacco products, whereas others 
diversified further.  By the late 1980s, a three-tiered 
classification of world cigarette producers, based on 
their international activities, had emerged:  those in­
volved in most global tobacco markets (Philip Morris 
Companies Inc., B.A.T. Industries PLC, R.J. Reynolds 
Tobacco Company, and Rothmans International Tobacco 
Ltd.); those with some international, but not global, 
activities (including American Brands, Inc.); and smaller 
firms concentrating primarily on their domestic mar­
kets (including Liggett & Myers Tobacco Company and 
Lorillard Tobacco Company) (USDHHS 1992). 
Economic Implications of Concentrated Tobacco 
Production 
The concentration of production among relatively 
few firms in the cigarette industry has implications for 
cigarette pricing, marketing, product development, and 
other activities. Clearly, the cigarette industry is an 
oligopoly; no more than six firms have controlled vir­
tually all cigarette output in the United States for the 
past 80 years (Table 6.6).  Economic theory suggests 
that firms in oligopolistic industries have substantial 
market power in that their production decisions will 
have a significant impact on price. Moreover, these 
firms recognize their interdependence.  That is, each 
firm recognizes that its pricing and marketing strate­
gies have a significant impact on the sales and profit­
ability of its competitors, as well as on its own sales 
and profitability.  Consequently, each firm understands 
that its competitors are likely to respond to any changes 
in its own pricing, marketing, or other strategies. 
Economic theory provides several possibilities 
regarding the conduct and performance of firms in an 
oligopolistic industry.  At one extreme, if entry is easy 
and if sunk (nonrecoverable) costs are low, firms in an 
oligopolistic industry will behave competitively.  That 
is, firms will have little market power (their output 
decisions will have little impact on market prices), 
prices will reflect the costs of production, and firms 
will not earn excessive profits.  At the other extreme, 
firms could behave collusively, jointly restricting out­
put, raising prices well above costs, and earning very 
high profits. Most theoretical models of oligopolistic 
industries suggest behavior between the two extremes: 
prices and profitability will be above and output will 
be below what would result from highly competitive 
behavior, and output will be higher and prices and prof­
itability will be lower than their levels in a monopo­
lized or highly collusive industry. 
Casual empiricism suggests that cigarette prices 
have historically been well above costs, thereby allow­
ing cigarette producers to achieve a rate of return well 
above that earned in most other industries. Even after 
the health consequences of cigarette smoking became 
apparent, the U.S. tobacco industry led all U.S. indus­
tries in profitability (Miles 1982).  Moreover, in the two 
major antitrust cases brought against the cigarette in­
dustry in the 20th century, firms were found guilty in 
1911 of monopolization and in 1946 of a conspiracy to 
restrain trade (collusion). Most industry analysts sug­
gest that the primary source of market power in the 
cigarette industry is the entry barriers resulting from 
marketing efforts, which create significant brand loy­
alties that are nearly impossible for a new producer to 
overcome. 
High Tobacco Concentration and the Impact of 
Prevention Policies 
The high concentration of the cigarette industry 
and the apparent market power this concentration 
engenders have implications for the effects of changes 
in cigarette taxes and other prevention policies on the 
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pricing, marketing, and other strategies of cigarette 
firms. For example, the historically high profitability 
of existing cigarette producers provides them with the 
resources needed to successfully develop and market 
new products, as was seen in the development and 
introduction of filtered cigarettes in the 1950s and low-
tar and low-nicotine cigarettes in the 1960s in response 
to the initial reports linking cigarette smoking to lung 
cancer.  More recently, in response to the increased 
awareness of the harmful effects of environmental to­
bacco smoke (ETS) on nonsmokers and the widespread 
restrictions on smoking that have been designed to 
protect nonsmokers, R.J. Reynolds Tobacco Company 
introduced its Eclipse brand in several test markets 
beginning in mid-1996, and Philip Morris Companies 
Inc. is currently testing its Accord brand in the United 
States and Japan. Both are ostensibly “smokeless” ciga­
rettes, primarily heating rather than burning tobacco; 
consequently, both generate less secondhand smoke 
than conventional cigarettes. 
Economic theory can predict some effects of in­
creases in excise taxes on price, output, and profitabil­
ity.  At one extreme, tax increases in a perfectly 
competitive market with constant costs of production 
should result in price increases of the same magnitude 
with no impact on long-run profitability.  Reductions 
in output would depend on the effect that price has 
on demand. At another extreme, standard models for 
a monopolized market suggest that producers and 
consumers would share the burden of the tax increase 
but consumers would pay a greater share of the tax, 
because demand is less sensitive than production to 
price. Output and profitability would fall, with smaller 
reductions in both—again because demand is less sen­
sitive to price. Recent advances in the theoretical and 
empirical study both of oligopolistic behavior and of 
the supply of addictive goods have yielded several 
interesting predictions.  Perhaps most interesting is the 
possibility that prices will increase by more than the 
amount of the tax increase when excise taxes are raised. 
Several early studies of these relationships pro­
duced generally inconsistent conclusions concerning 
how much cigarette prices would increase after an in­
crease in cigarette taxes (Barzel 1976; Johnson 1978; 
Sumner 1981; Sumner and Ward 1981; Bulow and 
Pfleiderer 1983; Bishop and Yoo 1985; Sullivan 1985; 
Sumner and Wohlgenant 1985; Ashenfelter and 
Sullivan 1987). One general weakness of these stud­
ies was their failure to account for the dynamic inter­
action of firms in an oligopolistic industry.  Instead, 
the studies generally assumed that rules for the firms’ 
behavior were established, and then, with observed 
prices and taxes, the studies worked backward to 
Reducing Tobacco Use 
determine the degree of competition within the indus­
try (Harris 1987). 
More recent studies have addressed these weak­
nesses. Harris (1987) used the estimates obtained from 
several studies of cigarette demand and supply to 
evaluate the impact of doubling the federal cigarette 
excise tax in 1983; moreover, Harris’ framework al­
lowed the change in the tax to affect the interaction of 
firms in the industry.  Using data on wholesale and 
retail cigarette prices as well as the costs of produc­
tion, Harris concluded that the 8-cent increase in the 
tax led to a 17-cent increase in the retail price of ciga­
rettes. He further argued that the price increase above 
the tax hike could not be accounted for by increases in 
production costs. Instead, this increase was attributed 
to the recognized interdependence of cigarette firms 
in an oligopolistic industry; that is, the firms recog­
nize that their profitability would rise if all could suc­
cessfully restrict output and raise prices.  However, 
because formal agreements on output and prices are 
illegal, the firms are alert to other bases on which they 
can coordinate their behavior.  Harris suggested that 
such a base was the announced increase in the federal 
tax, scheduled for January 1, 1983, which served as a 
coordinating mechanism for a joint oligopolistic price 
increase.  As Barnett and colleagues (1995) note, Har­
ris’ analysis fails to account for existing trends in ciga­
rette prices. Barnett and colleagues argue that Harris 
attributed too much of the coordinated rise in price to 
the increase in the federal tax, because the upward 
trend in prices predates the consideration of the tax 
hike. The authors suggest that producers used the in­
troduction of discount cigarettes in 1981 to coordinate 
the earlier price hikes for premium brands, because 
the lower-priced “generic brands” would keep more 
price-sensitive smokers in the market. The spirit of 
this argument is the same as Harris’, because both sug­
gested that certain events served as focal points allow­
ing firms to engage in more collusive behavior without 
appearing to establish a formal agreement. 
Keeler and colleagues (Sung et al. 1994; Barnett 
et al. 1995; Keeler et al. 1996) used national- and state-
level data to estimate the effects of cigarette tax in­
creases on price. Their empirical models have been 
used to examine the interaction of cigarette supply and 
demand in determining cigarette prices.  By using 
alternative assumptions about firm behavior, these 
studies formally account for the oligopolistic aspects 
of the cigarette industry in their empirical models of 
cigarette supply.  At least some of these models also 
account for the addictive nature of cigarette demand. 
In a study using data on all U.S. states from 1960 
through 1990, Keeler and colleagues (1996) conclude 
   
 
Surgeon General's Report
 
that the oligopolistic behavior of the industry results 
in increases in cigarette prices that exceed increases in 
state excise taxes. A 1-cent increase in the state tax 
would raise retail prices in that state by an average of 
1.11 cents. Moreover, the researchers conclude that 
producers selectively lower prices in states with stron­
ger state and local antismoking laws, offsetting the 
impact of tobacco control policies.  Similarly, a study 
using data on 11 western states for the same period 
predicts that the state cigarette price would rise by 1.27 
cents for every 1-cent increase in the state cigarette tax 
(Sung et al. 1994). 
Another study by Barnett and colleagues (1995) 
suggests that increases in federal cigarette excise taxes 
would generate larger increases in cigarette prices than 
those that would result from state tax hikes.  These 
investigators attribute this phenomenon to the increase 
in sales across state borders, which can result from a 
state tax increase and can thereby limit the impact of 
the tax increase on price.  A 1-cent increase in the fed­
eral cigarette tax was predicted to raise cigarette prices 
by just over 1.0 cent, whereas a comparable increase 
in state cigarette taxes would yield an estimated retail 
price increase of about 0.9 cents.  The investigators con­
clude that the industry has been less competitive since 
1980; they attribute this finding both to the relatively 
lax enforcement of antitrust laws associated with the 
deregulatory climate of the 1980s and to the focal 
points that triggered more collusive behavior. 
Basing their analysis on a published economic 
model of addictive behavior (Becker and Murphy 
1988), Becker and colleagues (1994) suggest an alter­
native explanation for the observation that cigarette 
prices increase more than cigarette taxes increase:  to­
bacco companies raise prices to obtain maximum profit 
from current smokers, for whom cost concerns alone 
will likely motivate reducing but not quitting their 
addictive behavior; these increased profits are intended 
to help offset future losses from the reduced demand 
that will occur among would-be new smokers, who 
will be put off by any price increase, whether from 
taxes or other causes. As is discussed later in this chap­
ter (in “Effect of Price on Demand for Tobacco Prod­
ucts”), addiction is to some extent a wild card in 
estimates of price and demand. Becker and colleagues 
(1994) express this only-apparent paradox as follows: 
“If smokers are addicted and if the industry is oligopo­
listic, an expected rise in future taxes and hence in fu­
ture prices induces a rise in current prices even though 
current demand falls when future prices are expected 
to increase” (p. 413). The same effect would apply to 
other anticipated changes in policies that would be ex­
pected to reduce future cigarette smoking.  The authors 
explain this hypothesis as follows: cigarette firms with 
market power may set relatively low prices to “hook” 
consumers on their addictive product, thus raising the 
future demand for their cigarettes; policies (including 
tax increases) that reduce future smoking also reduce 
the firms’ profitability of maintaining low prices.  Nev­
ertheless, the relatively low prices of these forward-
looking firms (compared with those of more myopic 
firms) will still exceed the marginal and average costs 
of production and distribution.  A similar hypothesis 
has been used to explain studies that found that ciga­
rette producers appear to advertise beyond the profit-
maximizing level (Showalter 1991). These firms may 
be engaging in excessive advertising (i.e., more than 
can be recouped through brand switching among cur­
rent smokers) to attract new consumers and hoping to 
later benefit from a higher demand for cigarettes as a 
result of these newly addicted consumers. 
The rapid increases in cigarette prices since the 
early 1980s, which are only partly explained by increases 
in taxes and costs, thus reflect profit-maximizing 
behavior by a highly concentrated cigarette industry 
that anticipates decreased future demand as additional 
efforts to reduce tobacco use are implemented (Becker 
et al. 1994). An empirical application of this model to 
the supply and demand for cigarettes (Showalter 1991) 
supports these hypotheses concerning the behavior of 
firms with market power that are selling an addictive 
product. 
A second group of empirical studies has focused 
on the relationships between industry concentration, 
restrictions on cigarette advertising, cigarette prices, 
and market power.  One such analysis supports the 
conventional wisdom that advertising is an important 
competitive strategy in developing and maintaining 
brand loyalty for firms in the cigarette industry 
(Nguyen 1987). Another analysis, using an empirical 
model that allows firms in an oligopolistic industry to 
have some degree of market power, concludes that 
advertising raises market power and, consequently, 
profitability in the cigarette industry (Tremblay and 
Tremblay 1995).  A likely explanation of this effect is 
that by fostering loyalty to existing brands, cigarette 
advertising raises barriers to other brands that try to 
enter the market and share in the profits. 
Several studies (Porter 1986; Mitchell and 
Mulherin 1988; Eckard 1991) have concluded that ban­
ning cigarette advertising from television and radio 
made the industry even less competitive, thereby fur­
ther raising profitability.  One such study attributed 
the increases in cigarette prices after the advertising 
ban to the reduced competition resulting from the ban 
(Porter 1986).  This conclusion was supported, to some 
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extent, by the observation by Doron (1979) that ciga­
rette firms apparently favored the 1971 ban on televi­
sion and radio advertising, although the firms’ concerns 
about counteradvertising may have played a role as well 
(see “Advertising and Promotion” in Chapter 5). 
Discussion 
The highly concentrated, oligopolistic structure 
of the U.S. cigarette industry has important implica­
tions for the effects of increases in cigarette excise taxes 
and of stronger prevention policies on cigarette prices. 
Much of the recent research on the supply of cigarettes 
has found that the cigarette industry became less com­
petitive in response to the 1971 ban on cigarette ad­
vertising on television and radio. One consequence 
of this reduced competition was that cigarette prices 
rose more rapidly than they would have otherwise. 
Moreover, this research suggested that further reduc­
tions have occurred in competition since the early 
1980s, partly because of the relaxed regulatory climate 
for business. Increases in cigarette excise taxes and 
stronger prevention policies have also contributed to 
the reduced competition.  The net result of the in­
creased market power of cigarette producers is that 
cigarette prices have risen more rapidly than produc­
tion costs have increased.  In addition, increases in ciga­
rette taxes during this period resulted in greater than 
a 1:1 increase in cigarette prices. 
Two recent activities, however, suggest that price 
competition in the cigarette industry is increasing at 
both the wholesale and the retail levels.  In 1993, ciga­
rette manufacturers experimented with price reduc­
tions on premium brand cigarettes through coupon 
and promotional activities beginning in April.  This 
experiment was soon followed by a 25-percent drop 
in wholesale cigarette prices, which resulted in a sharp 
decline in retail prices (USDA 1994b).  Although prices 
were eventually raised, these activities indicate that 
there may be greater price competition among ciga­
rette producers in the future.  Similarly, the recent 
growth of low-price stores specializing in the sale of 
cigarettes, such as the Cigarettes Cheaper! chain in the 
San Francisco area and Puff ‘N’ Stuff in northern Illi­
nois, has also reduced the retail price of cigarettes. 
These stores, which depend on high volume to profit, 
charge significantly less for cigarettes than supermar­
kets and other outlets do. For example, in mid-1994, a 
carton of premium cigarettes that cost $18–22 in many 
outlets in California sold for $14.99 at Cigarettes 
Cheaper!, and some name brands sold for even less 
(Schevitz 1994). 
Reducing Tobacco Use 
In contrast, the proposed June 20, 1997, national 
tobacco settlement would have reduced competition 
in the cigarette industry by granting cigarette compa­
nies an antitrust exemption to achieve the aims of the 
agreement.  In its analysis of the proposed settlement, 
the FTC (1997) concluded that, based on past behav­
ior and the structure of the industry, firms were likely 
to coordinate substantial price increases that would 
likely exceed the cost of the payments required by the 
agreement.  Given this, the FTC concluded that the 
proposed settlement might generate substantial prof­
its for cigarette producers. 
Trade Policy, Tobacco, and Tobacco 
Products 
Although acreage devoted to tobacco production 
has fallen worldwide, technological improvements 
have led to overall increases in tobacco production 
(Roemer 1993). In 1999, estimated global production 
of tobacco was more than 6 million metric tons; more 
than 60 percent of this was accounted for by four coun­
tries: China (34.9 percent), India (9.7 percent), the 
United States (9.4 percent), and Brazil (8.2 percent). 
In some producing countries (e.g., Zimbabwe), nearly 
all tobacco production is exported. 
Up to 85 percent of global tobacco production is 
used for cigarettes.  In 1996, global cigarette produc­
tion was nearly 6 trillion cigarettes; more than half of 
this production was accounted for by three areas: 
China (30.0 percent), the European Community (13.7 
percent), and the United States (13.1 percent) (USDA 
1997c). Although cigarette consumption is falling in 
industrialized countries, global consumption is rising 
because of significant increases in developing coun­
tries. This global increase in demand has created op­
portunities for U.S. and other global cigarette firms to 
expand. World trade in cigarettes has grown steadily 
for at least the past 30 years. U.S. cigarette firms capi­
talized on this growth, expanding cigarette exports 
from an average of 24.3 billion per year in the late 1960s 
to a peak of almost 250 billion in 1996; as a result, do­
mestic cigarette production rose even as domestic sales 
declined rapidly. 
Through the 1990s, nearly 30 percent of all ciga­
rettes produced in the United States were exported.  The 
major U.S. cigarette exporters are Philip Morris Com­
panies Inc., R.J. Reynolds Tobacco Company, and Brown 
& Williamson Tobacco Corporation; these companies 
account for more than 99 percent of U.S. cigarette ex­
ports (FTC 1997).  In 1981, the three firms formed the 
U.S. Cigarette Export Association to compete more 
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effectively in foreign markets (this type of association 
is exempt from antitrust law under the Webb-
Pomerene Act). 
As Grise (1990) notes, trade in tobacco and to­
bacco products would be even higher if not for gen­
eral trade policies and, in particular, widespread 
agricultural and industrial policies that protect domes­
tic tobacco growers and producers of tobacco prod­
ucts. Numerous countries have policies that support 
domestic tobacco growing; in the United States, ex­
amples are the tobacco support program and the short-
lived mandatory minimum content of domestic 
tobacco in domestic cigarettes.  Likewise, both tariff 
and nontariff barriers to trade in tobacco and tobacco 
products have been erected around the world.  These 
barriers include quotas, restricted product lists, ex­
change controls, prior deposits, mixing regulations, 
licensing requirements, and limits on advertising and 
other promotional activities (Grise 1990).  Moreover, 
in several countries (including Japan, South Korea, and 
Thailand), various aspects of the manufacture and dis­
tribution of cigarettes have long been controlled by 
government monopolies that have largely prevented 
the import of foreign cigarettes (GAO 1992). 
When tariff and nontariff barriers to trade are 
used to protect domestic tobacco and tobacco prod­
ucts, total supply of these products is usually lower 
than it would be otherwise, whereas domestic supply 
is higher.  In the case of tobacco products, this arrange­
ment has public health benefits resulting from the gen­
erally higher prices and reduced consumption of the 
protected products.  Domestic suppliers benefit by 
supplying more at higher prices.  Foreign suppliers, 
however, are likely to lose in this arrangement, because 
their access to these markets is limited and costs of 
supplying the markets are higher.  In addition, restric­
tions on advertising and promotion in given countries 
are likely to make it difficult for new firms to success­
fully enter newly opened markets where existing 
brands are firmly entrenched. 
Past Tobacco-Related Trade Policy 
In general, tobacco products exported from the 
United States are specifically exempted from federal 
laws and regulations concerning the export of poten­
tially harmful products, including the Federal Hazard­
ous Substances Act (Public Law 86-613), the Toxic 
Substances Control Act (Public Law 94-469), and the 
Controlled Substances Act (Public Law 91-513) (GAO 
1992). Similarly, although federal regulations (1) re­
quire that all cigarette packaging and advertising in 
the United States contain health warning labels and 
(2) prohibit television and radio cigarette advertising, 
there are no federal regulations or laws concerning the 
packaging or advertising of domestically produced 
cigarettes that will be exported (GAO 1992). 
Various U.S. policies and programs have been 
used to help domestic tobacco growers and cigarette 
companies expand into foreign markets (Connolly and 
Chen 1993). These policies include the USDA’s Food 
for Peace Program, which sent more than $1 billion in 
domestically produced tobacco to developing countries 
in the 1970s and early 1980s, and the 1984 Export Credit 
Guarantee Program, which exported domestically 
grown tobacco and helped U.S. cigarette producers 
enter Mideast markets (including Algeria, Egypt, Iraq, 
and Turkey) (Taylor 1984).  Perhaps the most impor­
tant, however, is Section 301 of the Trade Act of 1974 
(Public Law 93-618) and its subsequent amendments. 
Section 301 of the Trade Act of 1974 
The Trade Act of 1974 was initiated by the Nixon 
administration when it sought permission to begin the 
Tokyo Round of GATT.  GATT, an international trade 
agreement honored by nearly 120 countries, governs 
various aspects of international trade. (GATT is dis­
cussed in greater detail in  “Multinational Trade Agree­
ments,” later in this chapter.)  The first of these 
agreements was reached among 23 nations shortly af­
ter the conclusion of World War II.  Since then, seven 
rounds have occurred, including the Uruguay Round, 
which concluded in April 1994 after more than seven 
years of negotiations. 
The Trade Act of 1974 included in its final legis­
lation various measures with the stated purpose of 
promoting free trade.  One of these measures was Sec­
tion 301, which gave the President the authority to in­
vestigate cases where trade and other practices of 
foreign countries were considered unjustifiable, unrea­
sonable, or discriminatory in that they limited the abil­
ity of U.S. firms to sell their goods and services in 
foreign markets. 
Section 301 expanded the authority given to the 
President by the Trade Expansion Act of 1962 (Public 
Law 87-794). That earlier legislation allowed for inves­
tigations of unjustifiable trade sanctions (those that di­
rectly violated GATT).  Consequently, the act applied 
only to goods covered by GATT (which at the time ex­
cluded agricultural products, including tobacco). Sec­
tion 301 expanded presidential authority to include 
trade in all U.S. goods and services and allowed the in­
vestigation of practices that were unreasonable but did 
not necessarily violate GATT.  If negotiations were not 
successful in reducing or eliminating the unjustifiable 
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or unreasonable limits on trade, Section 301 authorized 
the President to impose retaliatory trade sanctions.  Ini­
tially, Section 301 received little attention, although it 
would later become a widely used tool of U.S. trade 
policy (Nivola 1993). 
Section 301 of the Trade Act of 1974 was strength­
ened by the Trade and Tariff Act of 1984 (Public Law 
98-573) and the Omnibus Trade and Competitiveness 
Act of 1988 (Public Law 100-418). Now known as “Su­
per 301,” the section required the U.S. Trade Repre­
sentative to annually identify countries and their 
practices that consistently limited market access to U.S. 
firms. More important, if negotiations failed to elimi­
nate the unfair trading practices of these countries, 
mandatory retaliatory measures were to be imposed 
unless the President deemed these measures harmful 
to U.S. economic interests. 
Four Section 301 cases in the late 1980s dealt with 
cigarettes:  cases against Japan in 1985 and Taiwan in 
1986 were initiated by the U.S. Trade Representative 
at the President’s request, and cases against South 
Korea in 1988 and Thailand in 1989 were the result of 
the U.S. Cigarette Export Association’s petitioning of 
the U.S. Trade Representative.  Threats of retaliatory 
sanctions under Section 301 led to agreements with 
each country; as a result, U.S. cigarette firms were per­
mitted access to those markets. The opening of the 
markets resulted in aggressive tobacco advertising by 
U.S. firms (Roemer 1993). Each of the four newly 
“opened” countries has laws, regulations, and ordi­
nances concerning cigarette advertising and promo­
tion. The governments of some of the countries have 
alleged that U.S. cigarette companies have violated 
restrictions on advertising and promotion. 
A brief review of the four Section 301 cases fol­
lows; more details are contained in reports from the 
GAO (1990, 1992), and an empirical analysis of their 
impact on cigarette smoking is contained in Chaloupka 
and Laixuthai (1996). 
Japan 
The tobacco industry in Japan is largely monopo­
lized by the company Japan Tobacco Inc.  In 1979, Ja­
pan was the subject of two Section 301 cases, one 
involving cigars, which was prompted by the Cigar 
Association of America, and a second related to pipe 
tobacco, which was initiated at the request of the As­
sociated Tobacco Manufacturers.  The two cases were 
resolved in an agreement with Japan, which reduced 
market restrictions and lowered import duties (GAO 
1990). 
Reducing Tobacco Use 
Before 1986, the domestic cigarette monopoly 
was protected from foreign competition through tar­
iffs of 28 percent on all imported cigarettes and through 
Japanese distribution practices, which discriminated 
against imported cigarettes.  The threat of Section 301 
sanctions led to an October 1986 agreement that elimi­
nated Japanese cigarette tariffs and changed excise tax 
payment procedures and other distribution practices 
that adversely affected imports of U.S. cigarettes.  Ex­
isting Japanese policies related to cigarette advertis­
ing and other promotional practices were not affected 
by the agreement. 
The agreement resulted in a significant expan­
sion of U.S. cigarette firms in Japan. Japanese imports 
of U.S. cigarettes more than tripled in 1987 alone and 
continued to rise in 1988 and 1989, by which time the 
market share of U.S. firms was more than 15 percent 
(Grise 1990). This growth appeared to have slowed or 
stopped in the early 1990s. Total U.S. cigarette exports 
to Japan ranged from 54.0 billion to 57.7 billion annu­
ally during 1991–1993. 
A downward trend during the 1970s and 1980s in 
per capita cigarette consumption in Japan appears to 
have reversed itself after the Japanese cigarette markets 
were opened to U.S. firms.  Overall per capita consump­
tion appears to have remained steady or increased 
slightly in recent years.  However, among Japanese 
women, smoking prevalence rose from 8.6 percent in 
1986 (before the agreement) to 18.2 percent by 1991.  The 
1991 rates were even higher among young adult women 
(27 percent) (Connolly and Chen 1993). 
Part of this increase may be the result of adver­
tising and promotional activities by U.S. cigarette firms 
in Japan. Between 1987 and 1990, total expenditures 
on cigarette advertising and promotion by U.S. ciga­
rette companies in Japan nearly doubled.  Most of these 
expenditures were on television advertising, which is 
allowed in Japan (but subject to some restrictions). 
Before the agreement, the domestic monopoly did not 
engage in extensive advertising. Afterward, it signifi­
cantly expanded its advertising and promotional ef­
forts. As a result, cigarette advertising moved from 
40th to 2nd place in total television advertising in Ja­
pan (Sesser 1993). 
Taiwan 
Virtually all aspects of the tobacco industry in Tai­
wan are controlled by a state-run monopoly.  In 1986, 
the U.S. Trade Representative threatened Taiwan with 
retaliatory trade sanctions over several governmental 
policies that limited the market access of U.S. cigarette 
companies. These policies included quotas and tariffs 
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on imported cigarettes, a ban on the retail sale of im­
ported cigarettes, and a ban on print advertising of 
imported cigarettes.  An agreement was reached in De­
cember 1986 that reduced tariffs and eliminated other 
barriers, thereby allowing U.S. cigarette companies 
greater access to the Taiwanese cigarette market.  The 
agreement also contained several restrictions relating 
to cigarette packaging (which was required to have a 
specified health warning label) as well as advertising 
and promotional activities (e.g., the distribution of free 
samples was limited and point-of-purchase promo­
tions were restricted to licensed establishments). 
The agreement greatly increased U.S. cigarette 
companies’ access to the Taiwanese cigarette market. 
In 1987 alone, total U.S. cigarette shipments to Taiwan 
increased 24-fold, and the market share of U.S. ciga­
rette companies rose from 2 to 17 percent (Grise 1990); 
by 1997, the market share of imported cigarettes had 
risen to 30 percent (Hsieh and Yin 1998).  Moreover, 
Taiwan’s imports of relatively higher-quality U.S. to­
bacco rose, as the portion of U.S. tobacco in Taiwanese 
cigarettes increased from 35 to 55 percent to better com­
pete with imported cigarettes (Grise 1990). However, 
per capita consumption of cigarettes, after increasing 
somewhat during the 1970s and early 1980s, fell from 
1987 through 1996, due to public and private antismok­
ing policies (Hsieh and Yin 1998).  Smoking prevalence 
among Taiwanese women significantly increased in the 
late 1980s and has remained stable throughout the 
1990s (Hsieh and Yin 1998). 
Advertising and promotion of U.S. cigarettes af­
ter the agreement are likely to have contributed to the 
large rise in the market share of U.S. cigarette compa­
nies in Taiwan.  Before the agreement, the only adver­
tising and promotion permitted by the Taiwan Tobacco 
& Wine Monopoly Bureau were new product announce­
ments and the use of billboards in the bureau’s branch 
offices and distribution centers (GAO 1992).  In 1987, 
spending on advertising and promotional activities by 
U.S. cigarette firms in Taiwan rose sharply but fell 
somewhat in the next three years.  Nevertheless, total 
spending rose by 43.8 percent from 1987 to 1990 (GAO 
1992). Given preagreement restrictions on advertis­
ing and promotion, almost all of these expenditures 
would have been for point-of-purchase and magazine 
advertising. Advertising by the Taiwanese cigarette 
monopoly, however, was limited even further after the 
agreement. 
Authorities in Taiwan have alleged that point-of­
purchase promotional activities by U.S. cigarette com­
panies have violated the terms of the 1986 agreement 
(GAO 1992). The agreement limits these activities to li­
censed wholesale, distribution, and retail establishments, 
which the Taiwan Tobacco & Wine Monopoly Bureau 
defines as those with a permit registering them as 
profit-seeking enterprises. Taiwanese authorities con­
tend that U.S. cigarette firms have distorted this defi­
nition to include unlicensed retailers selling cigarettes, 
resulting in widespread advertising and unauthorized 
sales of U.S. cigarettes (GAO 1992). 
After 1987, the government of Taiwan enacted 
several strong tobacco control policies, largely in re­
sponse to the liberalization of cigarette trade resulting 
from the Section 301 agreement (Hsieh and Yin 1998). 
Many of these policies were initially rejected by the 
U.S. Trade Representative as unfair or discriminatory 
toward the tobacco industry and in violation of the 
1986 agreement. One contentious issue pertained to 
the health warning labels proposed for cigarette ad­
vertising and packaging. The Taiwanese government 
initially proposed a set of strong, rotating health warn­
ing labels that would appear on the front of cigarette 
packaging and on all advertising. In response to the 
U.S. Trade Representative’s opposition, the content of 
the label was changed to “excessive smoking is dan­
gerous to health,” and the label was placed on the side 
of packaging (Hsieh and Yin 1998).  Eventually, in 1992, 
the labels were changed to include six rotating warn­
ings communicating more specific information about 
the hazards of smoking. 
The dispute over the Smoking-Hazards Preven­
tion Act, introduced in 1991 with the stated aim of pro­
tecting the public health by preventing and controlling 
damage from tobacco products, was even more con­
tentious (GAO 1992). The aim of the act would be ac­
complished by prohibiting smoking by those under 
18 years of age, banning vending machine sales of to­
bacco products, limiting the tar and nicotine content 
of all cigarettes, requiring that the packaging of all to­
bacco products include not only health warning labels 
but also tar and nicotine content in Chinese, and ban­
ning all tobacco advertising and certain other promo­
tional activities. The act was immediately challenged 
by the U.S. Trade Representative as a unilateral viola­
tion of the 1986 agreement that allowed U.S. cigarette 
companies to advertise in Taiwan (GAO 1992).  Sesser 
(1993) reports that a confidential position paper drafted 
by the U.S. Trade Representative in January 1992 stated 
that the proposal was an attempt to protect the Tai­
wanese cigarette monopoly from foreign competition 
and that the various measures proposed would have 
little impact on smoking. In July 1993, the Clinton 
administration’s U.S. Trade Representative, Michael 
Kantor, stated that his office would not challenge the 
act if it was enacted (Sesser 1993). Six years after its 
introduction, the Smoking-Hazards Prevention Act was 
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finally enacted with compromise clauses that permit 
cigarette advertising in magazines (Hsieh and Yin 1998). 
South Korea 
South Korea’s Tobacco & Ginseng Corporation 
controls all aspects of that country’s tobacco growing 
and production, which had traditionally been pro­
tected by high tariffs imposed on foreign cigarettes. 
In 1982, South Korea enacted and aggressively en­
forced legislation making it a criminal offense to sell, 
buy, or possess foreign cigarettes (Eddy and Walden 
1993). Beginning in 1987, almost all cigarette adver­
tising and other promotional activities were banned 
by the Tobacco Monopoly Act.  After petitioning by 
the U.S. Cigarette Export Association in January 1988, 
the U.S. Trade Representative investigated these prac­
tices. In response to the threat of retaliatory sanctions 
on South Korean textile exports to the United States, a 
Record of Understanding was signed by the two coun­
tries in May 1988. This agreement opened South Ko­
rean cigarette markets to U.S. firms by eliminating the 
ban on the sale of foreign cigarettes, reducing the tar­
iff on imported cigarettes, allowing the distribution of 
free samples, and allowing some print advertising of 
cigarettes and the sponsorship of sporting events. The 
agreement also prohibited advertising that targeted 
women and young people (smoking is prohibited in 
South Korea for persons under 20 years of age).  Fi­
nally, all cigarette packaging and magazine advertis­
ing were required to include a health warning label. 
Although cigarette smoking had been increasing 
steadily in South Korea during the 1980s, the rate of 
growth in smoking more than tripled when cigarette 
markets were opened to foreign competition (Roemer 
1993). Much of the increase appeared to have been the 
result of dramatic increases in smoking prevalence 
among young people. From 1988 to 1989 alone, smok­
ing prevalence among male teenagers rose from 18 to 
30 percent, and smoking prevalence among female teen­
agers increased from 2 to 9 percent (Sesser 1993).  Much 
of the increase in consumption was accounted for by 
the increased use of imported cigarettes.  Import share 
in the market rose from 0.06 percent before the agree­
ment to nearly 8.5 percent in 1994 and continued to in­
crease steadily (U.S. Department of Commerce, Tobacco 
Export Task Force Analysis, unpublished data, Novem­
ber 13, 1995). Part of the increase may be attributable to 
an increase in advertising by U.S. cigarette companies 
in South Korea after the liberalization of cigarette trade. 
In late 1988, South Korea passed the Tobacco Business 
Act (effective January 1, 1989), which limited adver­
tising and promotional efforts to point-of-purchase 
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advertising, magazine advertising, and sponsorship of 
public events (GAO 1992). In 1991, the Korea Tobacco 
Association (comprising the U.S. Cigarette Export As­
sociation firms and the Korean tobacco monopoly) out­
lined a self-regulating voluntary marketing agreement 
to comply with the Record of Understanding and the 
Tobacco Business Act. 
Nevertheless, the South Korean government in­
dicates that some promotional activities of U.S. ciga­
rette companies violate the spirit of the Tobacco 
Business Act.  These allegations concern distribution 
of free cigarettes, advertising placement for televised 
events sponsored by U.S. tobacco firms, the distribu­
tion of nontobacco “gifts” bearing company trade­
marks, and the targeting of youth.  Although no formal 
actions related to these violations were initiated, the 
Koreans did begin renegotiating the Record of Under­
standing with the United States in 1995. In August 
1995, the United States government agreed to modify 
the market access agreement with the Koreans to al­
low them greater flexibility to impose nondiscrimina­
tory, health-based measures that restrict the use of 
tobacco products, including limitations on tobacco 
product advertising. 
Thailand 
Perhaps the most publicized and contentious 
Section 301 dispute was initiated by the U.S. Trade 
Representative in response to petitioning by the U.S. 
Cigarette Export Association in April 1989 over 
Thailand’s virtual ban on the import of cigarettes and 
complete ban on cigarette advertising and other pro­
motional activities in that country.  The complaint cited 
various restrictions on the importation and sale of ciga­
rettes and referred to discriminatory duties and taxes 
on cigarette imports (GAO 1992).  All aspects of the 
domestic tobacco markets in Thailand are controlled 
by a government-run monopoly, which stopped its 
own cigarette advertising and promotion in April 1988. 
However, foreign companies continued their activities, 
which prompted a total government ban on cigarette 
advertising in Thailand in February 1989.  The formal 
investigation began in May.  After no agreement could 
be reached, the U.S. Trade Representative consented 
to submit the complaint to the GATT dispute resolu­
tion process. 
The panel created by GATT investigated the U.S. 
complaint that the import barriers and advertising 
restrictions were a violation of the international 
agreement’s principles.  In October 1990, the GATT 
Council sustained the panel’s recommendations and 
ruled that the ban on imports was a violation of the 
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GATT treaty.  However, the council upheld the high 
Thai cigarette excise taxes (applied to both domestic 
and foreign cigarettes) and the right of the government 
to restrict the overall supply of cigarettes.  Regarding 
the Thai advertising ban, the council noted that GATT 
allows member nations to use various policies to pro­
tect public health if the policies are applied to both 
domestic and foreign products.  A cigarette advertis­
ing ban that made it difficult for new foreign firms to 
compete with existing domestic firms was ruled justi­
fiable under the treaty, because allowing advertising 
could stimulate the demand for cigarettes, particularly 
among youth (Contracting Parties to the General 
Agreement on Tariffs and Trade 1991; Roemer 1993). 
This decision was based on Article XX of GATT, which 
states that: 
Subject to the requirement that such measures are 
not applied in a manner which would constitute a 
means of arbitrary or unjustifiable discrimination 
between countries where the same conditions pre­
vail, or a disguised restriction on international 
trade, nothing in this Agreement shall be construed 
to prevent the adoption or enforcement by any 
contracting parties of measures . . . necessary to 
protect human . . . health [or] necessary to secure 
compliance with laws or regulations which are not 
inconsistent with the provisions of this Agreement. 
The GATT ruling led to an agreement in Novem­
ber 1990 between the United States and Thailand that 
allowed the importation of U.S. cigarettes into Thai­
land. Imported cigarettes were then subject to the same 
laws and regulations as those marketed by the Thai 
Tobacco Monopoly (GAO 1992).  Thus, U.S. cigarettes 
would be taxed the same and subjected to the same 
supply restrictions, and the advertising and promo­
tion of these cigarettes (including the use of cigarette 
company logos, trademarks, and other symbols on 
nontobacco products) would be prohibited.  The Thai 
government, however, has indicated that U.S. cigarette 
companies have tried to circumvent the ban on pro­
motional activities by tactics such as sponsoring sport­
ing events and placing cigarette logos or symbols in 
televised programming.  No formal complaints have 
been filed. 
After its success in upholding the ban on adver­
tising and promotion, the Thai government in 1992 
enacted two laws restricting smoking:  the Non Smok­
ers Health Protection Act and the Tobacco Products 
Control Act.  The first act restricted smoking in desig­
nated public places. The second was a comprehen­
sive act that required that all tobacco products disclose 
their ingredients, allowed the Ministry of Public Health 
to determine all aspects of labeling, including health 
warnings, and banned the following: smoking by 
those under 18 years of age (imposing fines on viola­
tors); vending machine sales; distributing free samples, 
exchanges, and gifts of cigarettes; tobacco advertising 
(including, under the Thai definition of advertising, 
the use of cigarette logos and other symbols on 
nontobacco products) except in international maga­
zines and live telecasts originating outside Thailand; 
advertising products with the same name as tobacco 
products; producing, importing, advertising, and sell­
ing products imitating tobacco products; and selling 
cigarettes not complying with the labeling provisions 
(Roemer 1993). 
The cigarette trade agreement that opened the 
Thai cigarette market to U.S. firms has led to a rise in 
imports from less than 1 percent of the market before 
the agreement to about 4 percent in 1993.  Because of 
current trends, this change is likely to increase sub­
stantially in the future (e.g., U.S. cigarette exports to 
Thailand rose by more than 56 percent from 1992 to 
1993). Part of the increase may be the result of in­
creased smoking prevalence among women and young 
people in Thailand (USDA 1994a). 
Multinational Trade Agreements 
The North American Free Trade Agreement 
In 1993, the United States approved the North 
American Free Trade Agreement (NAFTA), a compre­
hensive agreement that eliminated most of the barri­
ers to trade between the United States, Canada, and 
Mexico; implementation began January 1, 1994. This 
agreement further reduced already low trade barriers 
between the United States and Canada resulting from 
an earlier free trade agreement.  More important, the 
new agreement substantially reduced existing trade 
barriers between the United States and Mexico by 
eliminating all nontariff barriers to trade and by phas­
ing out most tariffs.  Mexican tariffs on U.S. tobacco 
and tobacco products were initially set at 50 percent; 
the 1998 rate was 25 percent.  Supporters of the agree­
ment argued that it would lower prices, lead to a net 
increase in jobs (particularly in export industries), and 
spur economic growth in all three countries.  Oppo­
nents countered that U.S. firms would have an incen­
tive to shift production to Mexico to reduce labor and 
other operating costs, thereby leading to a net reduc­
tion in U.S. employment. 
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 Before the agreement, some trends in tobacco 
production in the United States, Canada, and Mexico 
were similar.  Total tobacco production and acreage 
devoted to tobacco growing in 1990 were well below 
their 1981 levels in all three countries, but downward 
trends in the United States had reversed by 1987.  Simi­
larly, in recent years, tobacco production in Mexico has 
been expanding (USDA 1997d). During the 1980s and 
early 1990s, cigarette consumption fell sharply in both 
the United States and Canada but rose in Mexico.  At 
least part of the increase in the Mexican demand for 
cigarettes resulted from increases in income, which 
contributed to a shift to the consumption of higher-
quality cigarettes among Mexican smokers (USDA 
1992). Since 1994, however, cigarette imports into 
Mexico have fallen as consumer purchasing power 
declined; no imports were expected in 1997 (USDA 
1997d). 
Trade in tobacco among the three countries was 
relatively limited before the agreement.  Mexican ex­
ports of tobacco to the United States were about 5 per­
cent of total exports, or less than 2 percent of total U.S. 
tobacco imports. Similarly, less than 4 percent of U.S. 
tobacco imports came from Canada, and about 7 per­
cent of U.S. tobacco exports went to Canada. Finally, 
almost no tobacco was exported from the United States 
to Mexico (USDA 1992). 
Trade in tobacco products (mainly cigarettes) was 
even more limited before the agreement.  In 1990, just 
over 0.1 percent of total U.S. cigarette exports went to 
Mexico, and only 0.07 percent went to Canada.  Simi­
larly, there was no trade in cigarettes between Canada 
and Mexico. The only exception was for exports of 
cigarettes from Canada to the United States, which 
were almost 64 percent of total Canadian cigarette ex­
ports and almost 20 percent of total Canadian produc­
tion (USDA 1992).  However, as is discussed later in 
this chapter (see “International Tobacco Taxes”), most 
of these cigarettes were reintroduced into a Canadian 
black market to evade the significantly higher Cana­
dian cigarette taxes (Sweanor and Martial 1994). 
Because of the earlier free trade agreement be­
tween the United States and Canada, NAFTA does not 
appear to have had a significant impact on trade in 
tobacco and tobacco products between the two coun­
tries. If anything, the reduction in Canadian cigarette 
taxes in 1994 has led to a substantial reduction in Ca­
nadian cigarette exports to the United States, as the 
smaller differential in cigarette prices reduced the in­
centive to export cigarettes to the United States for 
bootlegging back into Canada. 
The agreement’s elimination of Mexican import li­
censes on tobacco and cigarettes, and gradual reduction 
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in Mexican tariffs on tobacco and tobacco products, 
however, were expected to increase Mexican imports 
of both flue-cured and burley tobacco as well as ciga­
rettes from the United States (USDA 1992).  The elimi­
nation of U.S. tariffs on Mexican tobacco and the 
improved quality of this tobacco were also expected 
to result in increased Mexican tobacco exports to the 
United States. Privatization of the unmanufactured 
tobacco industry in Mexico, however, has changed the 
nature of the industry and has led to an improvement 
in the quality of Mexican leaf tobacco (USDA 1997d). 
The slow elimination of tariffs and the improved qual­
ity of domestically grown tobacco, coupled with the 
decline in the value of the peso, appear to have lim­
ited the impact of NAFTA on trade between the United 
States and Mexico in tobacco and tobacco products. 
This may change, however, as tariffs are further re­
duced and, eventually, eliminated and if the peso con­
tinues its recent strengthening against the dollar. 
Uruguay Round of GATT 
This latest GATT agreement, which concluded in 
April 1994, involved 117 countries, and many other 
nonmembers have agreed to abide by its provisions. 
Formal approval of the agreement by the U.S. Con­
gress came at the end of 1994. 
Several basic principles are outlined in GATT:  a 
commitment to achieving free trade by limiting and 
eventually eliminating tariff and nontariff barriers to 
trade, the nondiscriminatory application of any restric­
tions on trade to all member countries, the compensa­
tion of trading partners for any damages resulting from 
changes in trade barriers, and the negotiated settle­
ment of any trade disputes through an orderly pro­
cess rather than through retaliation.  However, GATT 
has had no enforcement power. 
Since the conclusion of its first round in 1947, 
GATT has led to sharp reductions in tariffs and other 
impediments to trade in manufactured goods.  Before 
the most recent round, GATT had not been applied to 
trade in agricultural commodities or services. The 1994 
Uruguay Round, however, significantly expanded 
GATT’s coverage to include trade in agricultural prod­
ucts, services, and more.  Moreover, the new agree­
ment created the World Trade Organization, a 
permanent forum for GATT members to address trade-
related issues among member countries. This forum 
strengthened GATT’s ability to resolve trade disputes. 
Supporters of the GATT treaty have argued that it 
will lead to a substantial increase in world trade to the 
economic benefit of all countries involved. For example, 
President Bill Clinton stated in the introduction to the 
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Uruguay Round Agreements Act that the treaty, when 
fully implemented, would add $100–200 billion to the 
U.S. economy annually and would create hundreds of 
thousands of new jobs. He went on to note that be­
cause the United States is the world’s largest trading 
nation, it would be the biggest beneficiary of the treaty 
(U.S. Congress 1994). 
The Uruguay Round of GATT was expected to 
benefit the U.S. tobacco industry by reducing the his­
torically high tariffs on tobacco and tobacco products 
imposed in numerous countries and by reducing other 
widely used nontariff barriers to trade.  For example, 
the European Community would reduce tariffs on ci­
gars by 50 percent, tariffs on cigarettes and other manu­
factured tobacco products by 36 percent, and tariffs 
on unmanufactured tobacco by 20 percent, and the 
Philippines would reduce tariffs on leaf tobacco, ci­
gars, and cigarettes by 10 percent (USDA 1994b).  Simi­
larly, foreign access to U.S. markets would rise, as U.S. 
tariffs on cigar wrappers would be eliminated.  At the 
same time, U.S. tariffs on cigar filler and binder to­
bacco, cigars, and most cigarettes would be reduced 
by 55 percent; tobacco stems and refuse by 20 percent; 
and other unmanufactured tobacco and smoking to­
bacco by 15 percent (USDA 1994b). 
More important, Section 422 of the Uruguay 
Round Agreements Act allowed the President of the 
United States to waive Section 1106(a) of the Omnibus 
Budget Reconciliation Act of 1993 if he determined that 
this action was necessary or appropriate to comply 
with international trade agreements that include the 
United States. As noted previously, the 1993 legisla­
tion requiring that cigarettes manufactured in the 
United States include a minimum of 75 percent do­
mestically grown tobacco or face penalties was waived 
by President Clinton’s tariff rate-quota proclamation 
in September 1994. 
The reductions in tobacco-related trade barriers 
achieved in the Uruguay Round appear to have had a 
dramatic impact on global trade in tobacco and tobacco 
products (Chaloupka and Corbett 1998). From 1994 to 
1997, for example, there was a 12.5-percent increase in 
unmanufactured tobacco exports globally, following a 
decade of almost no growth; similarly, global cigarette 
exports rose by 42 percent from 1993 to 1996, while glo­
bal cigarette consumption rose by 5 percent (Chaloupka 
and Corbett 1998). As discussed previously, however, 
the GATT Council’s resolution of the tobacco-related 
dispute between Thailand and the United States clearly 
indicates that the adoption and implementation of 
strong tobacco control policies aimed at improving 
public health is consistent with the liberalization of 
trade. 
Discussion and Recent Developments 
The threat of retaliatory trade sanctions under 
Section 301 of the Trade Act of 1974 has successfully 
opened some foreign markets to U.S. cigarette manu­
facturers, thereby significantly expanding trade in to­
bacco products between the United States and these 
countries. Chaloupka and Laixuthai (1996), in their 
empirical examination of these agreements, concluded 
that the market share of U.S. cigarette companies in 
the affected countries was 600 percent higher, on av­
erage, in 1991 than it would have been in the absence 
of these agreements.  More important, they concluded 
that overall cigarette smoking rose as a result of the 
Section 301 agreements.  Chaloupka and Laixuthai 
(1996) estimated that per capita cigarette consumption 
in 1991 was 10 percent higher, on average, in the four 
countries than it would have been had the markets 
remained closed to U.S. cigarettes.  They attributed the 
increase in smoking to greater competition in the ciga­
rette markets, resulting in lower cigarette prices and 
increased cigarette advertising.  In addition, they pre­
dicted that similar actions in other historically closed 
countries would lead to similar increases in cigarette 
smoking. 
Similarly, the implementation of multinational 
agreements liberalizing trade, including trade in to­
bacco and tobacco products, is likely to further increase 
U.S. exports of tobacco and tobacco products to coun­
tries around the world.  A probable consequence of 
this increase is that the prices of cigarettes and other 
tobacco products will fall as trade barriers are reduced 
or eliminated and competition is enhanced. As is dis­
cussed in detail later in this chapter (see “Effect of Price 
on Demand for Tobacco Products”), reductions in price 
will stimulate the use of cigarettes, particularly among 
adolescents and young adults. Because of the substan­
tial health consequences associated with cigarette 
smoking, one likely result of the increased liberaliza­
tion of trade in tobacco and tobacco products, then, is 
a global increase in morbidity and mortality related to 
cigarette smoking and other tobacco use.  Recent esti­
mates confirm the relationship between trade liberal­
ization and tobacco use. Taylor and colleagues (in 
press) conclude that reductions in trade barriers glo­
bally have led to increased tobacco use, with the larg­
est impact in low- and middle-income countries. 
The apparent conflict between some U.S. policies 
that promote free trade and help U.S. firms enter for­
eign tobacco markets and other U.S. policies that both 
discourage smoking domestically and support interna­
tional efforts to reduce tobacco use has been described 
in two GAO reports. The reports were completed at 
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the request of congressional members concerned about 
U.S. efforts to open foreign cigarette markets.  In the 
second report, the GAO (1992) presented the U.S. Trade 
Representative’s position “that as long as cigarettes re­
main a legal commodity in the United States and abroad, 
there is no legal basis to deny cigarette manufacturers 
assistance in gaining market access. Thus, when [the 
U.S. Trade Representative] determines that unfair for­
eign trade barriers, such as import restrictions and dis­
criminatory practices, hinder the import and marketing 
of U.S. cigarettes abroad, it negotiates for their removal” 
(p. 23). Similarly, the U.S. Trade Representative main­
tained that the USDHHS’s “jurisdiction does not extend 
to trade policy—it does not have a foreign affairs man­
date. Its clear responsibility lies in the domestic realm, 
not the international one” (p. 24). 
In the first report on this predicament, the GAO 
(1990) had offered three alternatives for reconciling 
those apparent conflicts in U.S. policy. 
•	 	 If Congress believes that trade concerns should 
dominate, it may choose to do nothing to alter ef­
forts aiding U.S. cigarette exporters even while it 
continues to promote awareness (domestically and 
internationally) of the health consequences of smok­
ing and to encourage efforts to reduce smoking. 
•	 	 If Congress believes that health considerations 
should have primacy, it may grant the USDHHS 
the responsibility to decide whether to pursue 
trade initiatives involving products with substan­
tial health consequences (including cigarettes and 
other tobacco products). 
•	 	 Rather than having one policy dominate, Congress 
could require that health matters be included in 
the trade policy process through the participation 
of the USDHHS so that these issues could be con­
sidered case by case. 
Several factors indicate that the apparent di­
chotomy between trade and health policy is changing 
in favor of the third approach suggested by the GAO. 
For example, in 1989 a bill was introduced in Congress 
to (1) require U.S. cigarette firms in foreign markets to 
operate under the same guidelines as they do in do­
mestic markets, (2) mandate health warning labels on 
all exported tobacco products, and (3) strongly discour­
age the executive branch from assisting U.S. tobacco 
company efforts to open foreign tobacco markets 
(Roemer 1993). Later that year, as a result of the U.S. 
Trade Representative’s investigation of Thailand’s 
trade practices, a public hearing on the case was held. 
Reducing Tobacco Use 
Numerous congressmen, public health officials, and 
others (including former U.S. Surgeon General C. 
Everett Koop) testified against tobacco-related U.S. 
trade policies (Eddy and Walden 1993).  Although nei­
ther effort was successful (the bill did not pass, and 
the hearing produced no change in trade policy), both 
linked the issue of the health consequences of tobacco 
use to U.S. trade policy.  The 1990 GAO report, for ex­
ample, was the direct result of the failed 1989 bill. 
More recently, interagency discussions between 
the office of the U.S. Trade Representative and offi­
cials from the USDHHS have pursued the harmoniza­
tion of trade and health policy while representatives 
from the USDHHS have participated in recent nego­
tiations with Taiwan, South Korea, and others concern­
ing cigarette trade issues (Holzman 1997). Moreover, 
the U.S. Trade Representative has shown greater sen­
sitivity to public health concerns and has not opposed 
nondiscriminatory tobacco control legislation in other 
countries (Bloom 1998; National Cancer Policy Board 
1998). This position has been formalized as part of the 
Doggett Amendment to the Department of Commerce 
and Related Agencies Appropriations Act, 1998, that 
allows for the use of Section 301 in very limited cir­
cumstances. Specifically, the Doggett Amendment, 
sponsored by Lloyd Doggett (D-TX), states that: 
None of the funds provided by this Act shall be 
available to promote the sale or export of tobacco 
or tobacco products, or to seek the reduction or 
removal by any foreign country of restrictions on 
the marketing of tobacco or tobacco products, ex­
cept for restrictions which are not applied equally 
to all tobacco or tobacco products of the same type 
(Public Law 105-119, Section 618). 
Similar guidelines were distributed by the Clinton 
administration to all diplomatic posts in February 1998. 
These guidelines state that: 
In light of the serious health consequences of to­
bacco use, the U.S. Government will not promote 
the sale or export of tobacco or tobacco products 
or seek the reduction or removal by any foreign 
country of nondiscriminatory restrictions on 
the marketing of tobacco or tobacco products.  At 
the same time, the U.S. Government will continue 
to seek elimination of discriminatory trade prac­
tices and will strive to ensure that U.S. firms are 
accorded the same treatment in foreign countries 
as that country’s own firms and firms from other 
countries (The National Economic Council and 
The National Security Council of the White House, 
   
Surgeon General's Report
 
Final Guidelines on Health, Trade, and Commer­
cial Issues, facsimile transmission to all diplomatic 
and consular posts, February 16, 1998). 
Moreover, as part of the guidelines, U.S. diplomatic 
“posts are encouraged to assist and promote tobacco-
control efforts in host countries.” 
Several important issues remain unresolved. 
Perhaps most important is the opening of Chinese ciga­
rette markets to U.S. and other multinational tobacco 
companies as part of China’s World Trade Organiza­
tion accession. With more than 300 million cigarette 
smokers (67 percent of men but only 7 percent of 
women), China is a particularly attractive market for 
international cigarette producers.  In recent years, U.S. 
and other multinational tobacco companies have en­
tered the Chinese tobacco markets through joint ven­
tures with the Chinese government’s tobacco 
monopoly, the China National Tobacco Corporation 
(Holzman 1997). 
Economic Impact of the U.S. Tobacco 
Industry 
Tobacco growing played a key role in the devel­
opment and growth of the U.S. economy.  Throughout 
much of the 20th century, however, the importance of 
tobacco to the overall economy has diminished sig­
nificantly, although its regional and local importance 
in some areas remains high.  Several recent studies 
provide more detailed evidence concerning the eco­
nomic importance of tobacco to the U.S. economy. 
A recent study by American Economics Group, 
Inc. ([AEG] 1996), which was funded by the tobacco 
industry, provides some information concerning the 
impact of tobacco on the U.S. economy in 1994. The 
report updates similar previous reports by other firms, 
including that by Price Waterhouse (1992).  AEG di­
vided the macroeconomic effects of tobacco into those 
affecting the core sector, which includes tobacco pro­
duction and distribution, and those affecting the sup­
plier sector, which consists of industries producing and 
distributing intermediate goods for the core sector (in­
cluding the goods and services used in cigarette pro­
duction). The analysis also separately considered 
expenditure-induced impacts, which depend on the 
multiplier effects associated with spending by those 
in the core and supplier sectors, and tobacco-related 
tax revenues, including those raised by tobacco taxes, 
general sales taxes on tobacco products, and income 
and other taxes on tobacco industry employees and 
firms. The study estimated that in 1994, more than 1.8 
million persons were employed, earning $54.3 billion 
in wages and benefits, as a result of the tobacco busi­
ness in the United States. Total estimated tax revenues 
from tobacco were almost $36 billion in 1994.  The re­
port concluded that tobacco made a significant contri­
bution in every state and the District of Columbia. 
Several recent studies, however, have indicated 
that these estimates significantly overstated the eco­
nomic impact of tobacco on the U.S. economy.  At the 
request of the Coalition on Smoking OR Health (CSH), 
Arthur Andersen Economic Consulting (1993) re­
viewed the Price Waterhouse estimates for 1990.  They 
concluded that, as a result of several methodological 
flaws, the Price Waterhouse “employment and job loss 
figures are grossly inflated” (p. 1).  For example, of the 
681,351 jobs Price Waterhouse attributed to tobacco in 
its core and supplier sectors, only 259,616 were directly 
related to tobacco growing, manufacturing, warehous­
ing, and wholesaling. Of the difference, 166,791 were 
retail jobs and 254,944 were supplier jobs, most of which 
were not devoted full-time to tobacco.  Thus, stating 
that these jobs depended on tobacco was inaccurate. 
Other studies questioned the Price Waterhouse 
assumption that every one job that is dependent on 
tobacco creates, through the multiplier effect, an addi­
tional 2.35 jobs throughout the economy.  This assumed 
effect would result because those who purchase tobacco 
products would generate income for those who produce 
and those who distribute tobacco, who in turn would 
spend this income on other goods and services—thereby 
generating income for others, as this effect spread even 
further.  Warner (1994) and Arthur Andersen Economic 
Consulting (1993) noted that this multiplier effect is 
likely to significantly overstate the impact of tobacco, 
because it implicitly makes the incorrect assumption 
that money spent on tobacco would not be spent else­
where in the absence of tobacco.  Instead, those funds 
not spent on tobacco would be spent on other goods 
and services, creating jobs and generating income that 
would also be spent. 
Warner and Fulton (1994) addressed these issues 
by using a macroeconomic model to consider the net 
impact of tobacco on the economy of one state, Michi­
gan. The Price Waterhouse study had estimated that 
direct tobacco-related employment in Michigan was 
7,724 in 1990 and that all tobacco-related employment 
in Michigan totaled 69,575. Warner and Fulton (1994) 
estimated that in 1992 in Michigan, 7,843 jobs directly 
depended on tobacco but that only an additional 11,284 
jobs were either indirectly related to tobacco or induced 
by spending from those whose jobs were dependent 
on tobacco. (This estimate for indirect tobacco-related 
jobs did not consider [as the Price Waterhouse estimate 
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did] the impact of income derived from tobacco pro­
duction and distribution in the rest of the nation and 
spent on products produced in Michigan.)  These re­
searchers further estimated that, in the absence of to­
bacco, total employment in Michigan would have risen 
by about 5,600 because of a redistribution of spending 
away from tobacco products to other goods and ser­
vices, including those more integral to the Michigan 
economy.  As a result of the changes in employment, 
total incomes in Michigan would have been $226 mil­
lion higher in 1992 in the absence of tobacco. This 
amount resulted not only from incomes associated 
with new jobs but also from higher incomes for those 
with existing jobs (in part because of a change in job 
mix from lower-income to higher-income jobs in the 
absence of tobacco). 
Warner and colleagues (1996) extended this 
analysis to examine the impact of tobacco on the re­
gional economies of the United States. The research­
ers examined the effects of reducing or eliminating 
domestic expenditures on tobacco on nine regional 
economies (the eight regions defined by the U.S. De­
partment of Commerce, Bureau of Economic Analy­
sis, subdividing the Southeast into two parts based on 
tobacco growing and producing).  They estimated that 
the elimination of spending on tobacco products in 
1993 would have led to 303,000 fewer jobs in the South­
east tobacco region, while increasing jobs in all other 
regions by about the same amount. By the year 2000, 
they estimated that, under this scenario, the loss in jobs 
in the tobacco region would fall to about 222,000 as 
the regional economy adjusts, while the net impact 
nationally would be an increase in jobs of 133,000.  A 
more realistic scenario—one that doubles the recent 
rate of decline in tobacco use—is estimated to have 
smaller effects on employment.  Warner and colleagues 
(1996) estimated a loss of 36,600 jobs in the tobacco 
region by the year 2000, an amount equal to 0.2 per­
cent of total regional employment. They concluded that 
the industry’s claims concerning job losses resulting 
from reduced tobacco use are significantly overstated 
and that the impact of tobacco on employment should 
not be a primary concern, given the magnitude of the 
toll it takes on health. 
The AEG and Price Waterhouse reports were lim­
ited also because they presented static estimates of the 
economic impact of tobacco (Arthur Andersen Economic 
Consulting 1993). That is, the reports ignored underly­
ing trends in the domestic demand for cigarettes, trends 
in the import and export of tobacco and tobacco prod­
ucts, and changes in agricultural and manufacturing 
technologies that themselves are reducing employment 
in tobacco growing and manufacturing.  Warner and 
Reducing Tobacco Use 
Fulton (1994) considered these factors by predicting the 
net impact that eliminating tobacco-related revenues 
would have on the Michigan economy if existing down­
ward trends in tobacco sales continued:  by 2005, the 
loss of revenue from tobacco in Michigan would yield 
a net gain of 1,500 jobs in the state. 
A similar issue was considered in two recent re­
ports of the USDA (1993, 1997c).  The reports noted 
that the large declines in tobacco production through­
out the 1980s had a relatively minor impact on the 
macroeconomics of major tobacco-growing regions. 
Indeed, total personal income, adjusted for inflation, 
grew by 14–57 percent from 1979 through 1989 in the 
nine major regions analyzed; the average growth in 
all U.S. tobacco-growing counties was 28 percent 
(USDA 1993). This phenomenon was attributed to the 
relatively small share of tobacco in these diverse re­
gional economies (on average, less than 1 percent of 
total income was accounted for by tobacco in tobacco-
growing counties).  Even though acreage devoted to 
tobacco growing has declined over time, rising prices 
have helped to keep gross income from tobacco grow­
ing relatively stable, while clearly reducing the share 
of tobacco in local economies (USDA 1997c). 
Critics of higher cigarette excise taxes and other 
policies to reduce tobacco use have argued that the 
macroeconomic consequences of these policies would 
be significant, particularly for some state and local 
economies. For example, economist Dwight R. Lee 
predicted that the 75-cent increase in the federal ciga­
rette excise tax included in the proposed 1993 Health 
Security Act would lead to a loss of about 82,000 jobs 
and $1.9 billion in incomes in the tobacco sector, which 
would cause an additional loss of 192,000 jobs and an 
attendant loss of income throughout the economy (U.S. 
House of Representatives 1994).  He further noted that 
southern states would be particularly hard hit by this 
tax increase. 
Similar arguments, based on the AEG and Price 
Waterhouse analyses, were made in the recent debate 
over proposed national tobacco legislation.  For rea­
sons noted previously, predictions based on these es­
timates are almost certain to substantially overstate the 
effects of higher tobacco taxes and stronger preven­
tion policies on the U.S. macroeconomy.  As discussed 
previously, Warner and colleagues’ (1996) regional 
analysis of the economic role of tobacco concluded that 
tobacco has a negative net economic impact in all 
but the most tobacco-dependent region.  Thus, it ap­
pears inappropriate to raise concerns about adverse 
economic impact in opposing policy measures that 
would discourage tobacco use. 
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Moreover, many supporters of legislation calling 
for increases in the cigarette excise tax have urged that 
measures be included to mitigate the possible adverse 
economic impact of the higher taxes for tobacco-
producing regions.  For example, Richard J. Durbin 
(D-IL) suggested that part of the revenues from higher 
cigarette excise taxes could be earmarked for efforts 
to help tobacco farmers switch to other crops, thereby 
easing the transition for tobacco-producing regions. 
Likewise, the CSH (1994) recommended that a portion 
of new tobacco tax revenues be earmarked for buying 
out tobacco allotments, constructing infrastructure and 
modernizing equipment for agricultural diversifica­
tion, and stimulating economic development in areas 
relatively dependent on tobacco. Similarly, President 
Clinton called for assistance for tobacco farmers and 
their communities to be included in any tobacco legis­
lation sent to him (USDA 1998a). 
A final objection to the AEG and Price Water-
house estimates is that they failed to consider the health 
and other consequences of cigarette smoking (Arthur 
Andersen Economic Consulting 1993). In one sense, 
they underestimated the economic contribution of 
cigarette smoking.  As Schelling (1986) and Warner 
(1994) note with some irony, the employment figures 
in these and other industry-funded studies do not 
include the income that tobacco generates for health 
care personnel, undertakers, and a variety of other per­
sons whose jobs are related to the negative health con­
sequences of tobacco use; nor do these industry 
estimates include the considerable income derived 
from specifically smoking-related services, such as air 
filtration systems. The total amount spent in the 
United States to treat smoking-related illnesses has 
been estimated to exceed the total amount spent on 
tobacco products (Centers for Disease Control and 
Prevention [CDC] 1994; Warner 1994).  Similarly, as 
described in greater detail later in this chapter (in 
“Estimates of the Costs of Smoking”), the Price 
Waterhouse study did not include other economic costs 
associated with cigarette smoking, such as lost pro­
ductivity due to smoking-related morbidity and mor­
tality.  Finally, as Northup (1993) states, the Price 
Waterhouse estimates of employment dependent on 
tobacco invite a disturbing comparison, for they im­
ply that “one person must die each year to sustain two 
jobs. Put another way, at least twenty-two people must 
die to support the forty-four year career of a [tobacco 
industry] employee. Surely, no one would argue that 
this is an acceptable trade-off.  It is absurd for the to­
bacco industry to use lost jobs as a rationale for not 
saving lives” (p. 86). 
Effect of Price on Demand for Tobacco Products
 

One of the fundamental laws of economics is that 
of the downward-sloping demand curve: as the price 
of a product rises, the quantity demanded of that prod­
uct falls. In the terminology of economists, this inverse 
relationship arises from the process known as the 
consumer’s constrained utility maximization.  That is, 
when facing a given set of prices, consumers will try to 
maximize the benefits or satisfaction they receive from 
consuming, but these efforts are constrained by the con­
sumers’ available resources, including income and time. 
The demand for tobacco products is different 
from the demands for most other consumer goods 
because of the addictive drug (nicotine) found in these 
products.  The key implication that addiction has for 
demand is that past consumption decisions will be 
an important determinant of current choices. For 
example, to an addicted smoker, one of the benefits of 
continued cigarette smoking is avoiding nicotine 
withdrawal. In the past, many researchers viewed ad­
dictive consumption as an irrational behavior not con­
ducive to standard economic analysis (e.g., Elster 1979; 
Winston 1980; Schelling 1984).  This view implied that 
the demand for addictive products, including tobacco, 
did not follow the basic laws of economics, including 
that of the downward-sloping demand function that 
ordinarily applies when constraints (such as cost) are 
raised against use. However, as will be described later 
in this section, numerous studies of cigarette smoking 
and other tobacco use, including several recent stud­
ies that explicitly account for tobacco’s addictive na­
ture, find a strong inverse relationship between price 
and consumption. 
To economists, price includes not only the money 
price of purchasing a product but also the time and 
other costs associated with buying and using that prod­
uct. Measures that limit minors’ access to tobacco, for 
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example, may discourage underaged smoking by rais­
ing the time and potential legal costs associated with 
obtaining these products.  Similarly, sufficiently strin­
gent restrictions on smoking in public places will raise 
the costs of smoking, whether by forcing people out­
doors if they want to smoke (thereby increasing time 
and perhaps comfort costs) or by imposing fines for 
smoking in restricted areas (thereby increasing money 
costs). 
The health consequences associated with ciga­
rette smoking are another important component of the 
price of cigarettes.  As consumers perceive greater 
health risks from cigarette smoking, their demand for 
cigarettes tends to fall.  This effect is clearly seen in 
the reductions in smoking prevalence and average 
cigarette consumption that occurred soon after the re­
lease of the 1964 Surgeon General’s report on smok­
ing and health, which for the first time drew 
widespread public attention to the health problems 
caused by cigarette smoking (U.S. Department of 
Health, Education, and Welfare 1964).  Thus, when 
economists and others study the demand for tobacco 
products, efforts are made to include not only money 
prices but also measures that reflect the other costs of 
consuming these products. 
In addition to price, several other factors affect 
the demand for any product.  Disposable income, 
for example, is an important determinant of demand. 
In general, as income rises, so does consumption of 
most goods. Economists define these goods as nor­
mal goods. Inferior goods, on the other hand, are those 
for which demand falls as income rises. An indivi­
dual’s tastes or preferences will also affect demand. 
Because these tastes are difficult to observe and mea­
sure, certain sociodemographic characteristics are usu­
ally included as proxies in studies of the demand for 
tobacco. These characteristics include sex, ethnicity, 
education, religious beliefs, marital status, and employ­
ment status. 
Finally, because the addictive nature of tobacco 
use has been clearly documented, many recent stud­
ies of demand have tried to account for the effects of 
past consumption on current consumption.  Many of 
these studies were based on a model that applies the 
standard rational, utility-maximizing paradigm of eco­
nomics to the consumption of addictive substances 
(Becker and Murphy 1988). This model explicitly rec­
ognizes the intertemporal links in consumption by 
making current consumption decisions dependent on 
past choices. The model thus incorporates the elements 
of tolerance, reinforcement, and withdrawal, which 
distinguish the consumption of addictive from non­
addictive substances (USDHHS 1988). 
Reducing Tobacco Use 
Although many of the factors described in this 
introduction have an important impact on demand, 
the studies subsequently reviewed in this section em­
phasize the effects of money prices on cigarette smok­
ing and other tobacco use. In reviewing empirical 
studies of the demand for cigarettes and other tobacco 
products, this section focuses primarily on estimates 
of the price elasticity of demand, which is defined as 
the percentage change in consumption that results 
from a 1-percent increase in price.  (An overall reduc­
tion in cigarette consumption comprises both a reduc­
tion in the number of cigarettes consumed by current, 
persisting smokers and a reduction in the prevalence 
of smoking itself—which itself comprises both an in­
crease in smoking cessation and a decrease in smok­
ing initiation.) 
Numerous studies have estimated the price elas­
ticity of demand for cigarettes.  These studies used di­
verse econometric and other statistical methods on 
different types of data from many countries.  Relatively 
few studies have examined the demand for other to­
bacco products, and none have examined the effects 
on brand choice of the price differentials between pre­
mium brands and the lower-price discount and generic 
cigarettes. 
Studies Using Aggregate Data 
Several studies of the demand for cigarettes in 
the United States have used aggregate data (Table 6.7). 
Some of these were time series studies for the nation 
as a whole or for geographic units (notably Califor­
nia).  Others employed pooled cross-sectional time se­
ries data consisting of annual observations for some or 
all states over time. Price elasticity (the percentage 
change in the quantity demanded resulting from a 
1-percent increase in price) estimates obtained from 
recent studies using aggregate data fall in the overall 
wide range of –0.14 to –1.12, but most of these estimates 
are between –0.3 and –0.5.  Differences in the estimates 
resulted from differences in theoretical and empirical 
modeling, in the data employed, and in the economet­
ric and statistical methods used to analyze these data. 
All but two of these studies were econometric 
studies that tried to control for other factors that could 
affect the demand for cigarettes, including income, 
socioeconomic and demographic factors, and exist­
ing policies for reducing tobacco use.  The other two 
studies (Baltagi and Goel 1987; Peterson et al. 1992) 
used alternative quasi-experimental methods that 
compared changes in cigarette consumption in states 
with tax increases with those in states with no tax in­
creases; both studies obtained estimates of the price 
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Table 6.7.  Recent estimates of the price elasticity of cigarette demand from aggregate data 
Estimated price 
Study elasticity Comments 
Advisory Commission –0.45 Time series of state cross-sections, 1981–1983; 
on Intergovernmental ordinary least squares methods; detailed effort to 
Relations 1985 account for short-distance smuggling of cigarettes. 
Bishop and Yoo –0.45 Time series for United States, 1954–1980; three-stage 
1985 least squares methods; simultaneous model of supply 
and demand. 
Baltagi and Levin –0.14 Time series of 46 state cross-sections, 1963–1980; 
1986 instrumental variables methods; partial adjustment 
model used to account for habitual consumption. 
Porter 1986 –0.27 Time series for United States, 1947–1982; two-stage 
least squares methods; simultaneous model of supply 
and demand. 
Baltagi and Goel –0.56 (1956–1964) Time series of state cross-sections, 1956–1983; 
1987 –0.17 (1972–1983) quasi-experimental methods. 
Seldon and Doroodian –0.40 Time series for United States, 1952–1984; three-stage 
1989 least squares methods; simultaneous model of demand 
and advertising. 
Seldon and Boyd –0.22 (short run) Times series for United States, 1953–1984; varying 
1991 –0.37 (long run) parameter methods. 
Showalter 1991 –0.56 to –0.71 Time series of annual state cross-sections, 1956–1988; 
simultaneous modeling of supply and demand with 
addiction; detailed modeling of short- and long-
distance smuggling. 
Simonich 1991 –0.37 Quarterly time series for United States, 1960–1983; 
two-stage least squares methods. 
Tegene 1991 –0.66 (1956) Time series for United States, 1956–1985; Kalman 
–0.15 (1985) filter methods; allows change in elasticity over time. 
Chaloupka and Saffer –0.28 Time series of state cross-sections, 1975–1985; two-step 
1992 endogenous law model; detailed modeling of short-
and long-distance smuggling. 
Flewelling et al. –0.25 to –0.35 Quarterly time series for California, 1980–1990; 
1992 ordinary least squares and ridge regression methods. 
Peterson et al. 1992 –0.49 Time series of state cross-sections, 1955–1988; 
epidemiologic approach. 
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Reducing Tobacco Use 
Table 6.7.  Continued 
Estimated price 
Study elasticity Comments 
Keeler et al. 1993 –0.3 to –0.5 Monthly time series for California, January 1980– 
(short run) December 1990; detailed modeling of addiction; full 
–0.5 to –0.6 information maximum likelihood with instrumental 
(long run) variables and correction for autocorrelation. 
Becker et al. 1994 –0.36 to –0.44 Time series of annual state cross-sections, 1956–1985; 
(short run) instrumental variables methods; detailed modeling of 
–0.73 to –0.79 short- and long-distance smuggling and addiction. 
(long run) 
Harris 1994 –0.47 (1993) Annual time series for United States, 1964–1993; 
separate modeling of smoking participation and 
average consumption; controls for changes in average 
nicotine delivery per cigarette. 
Hu et al. 1994 –0.39 (long run) Monthly time series for California, January 1984– 
December 1991; intervention analysis. 
Sung et al. 1994 –0.40 (short run) Time series of annual state cross-sections for 11 
–0.48 (long run) western states, 1967–1990; recursive model of supply 
and demand with addiction; generalized least squares 
methods correcting for heteroscedasticity and 
autocorrelation. 
Barnett et al. 1995 –0.76 to –1.12 Annual time series for United States, 1955–1989; 
simultaneous modeling of supply and demand. 
Goel and Morey 1995 –0.28 to –0.37 Time series of annual state cross-sections, 1959–1982; 
joint demands for cigarettes and alcohol; accounts for 
addiction. 
Hu et al. 1995b –0.30 (state tax Quarterly time series for California, 1980–1992; 
elasticity) autoregressive moving-average time-series methods. 
Moore 1995 Not applicable Time series of annual state cross-sections, 1954–1988; 
reduced form estimates of impact of cigarette taxes on 
various smoking-related mortality rates. 
Tremblay and –0.41 Annual time series for United States, 1955–1990; 
Tremblay 1995 simultaneous modeling of supply and demand. 
Yurekli and Zhang 2000 –0.48 to –0.62 Time series of annual state cross-sections, 1970–1995; 
detailed modeling of smuggling and clean indoor 
air laws. 
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elasticity of demand comparable to those obtained in 
the econometric studies. 
Several difficulties can be encountered when ana­
lysts use time series data to estimate the demand for 
cigarettes.  In a time series model, estimated price and 
income elasticities of demand are sensitive to the in­
clusion of variables controlling for the effects of other 
determinants of smoking, including advertising, 
changes in existing policies for reducing tobacco use, 
and increased awareness of the health consequences 
of smoking. A serious problem can also result from the 
high correlations that are likely to exist among many of 
the variables reflecting key determinants of smoking. 
These correlations can lead to unstable estimates for the 
parameters of interest.  However, excluding potentially 
important but highly correlated determinants of de­
mand could produce biased estimates of the impact of 
the included variables on demand. Time series esti­
mates are also more likely to estimate the short-run 
responses of demand to changes in independent vari­
ables rather than the long-run responses that are of 
greater interest to policymakers. However, recent 
studies using state-of-the-art econometric methods 
for time series data have appropriately addressed 
many of these difficulties (Seldon and Boyd 1991; 
Simonich 1991; Flewelling et al. 1992; Barnett et al. 1995; 
Hu et al. 1995b; Meier and Licari 1997). Almost all of 
the estimates obtained from time series methods based 
on alternative economic theories and applied to vari­
ous data produced estimates of the price elasticity of 
demand in a relatively narrow range, which was cen­
tered on –0.4. 
The use of state cross-sectional data over time 
can also create various estimation problems.  In gen­
eral, such studies considered in this section employed 
data on state taxes paid for cigarette sales; these data 
may not accurately reflect average cigarette smoking 
within the states, because cigarettes may have been 
smuggled from low-tax states into high-tax states. 
(This problem is discussed in detail in “Theoretically 
Optimal Cigarette Taxes,” later in this chapter.)  In 
particular, these sales data are likely to overstate con­
sumption in low-tax states and understate consump­
tion in high-tax states. If this smuggling is not 
controlled for, estimates of the price elasticity of de­
mand from these data are likely to overstate the im­
pact of price on cigarette smoking.  However, many of 
the most recent studies of cigarette demand that em­
ployed pooled time series cross-sectional data for states 
made careful efforts to control for both casual and 
organized smuggling of cigarettes (Advisory Commis­
sion on Intergovernmental Relations [ACIR] 1985; 
Baltagi and Levin 1986; Showalter 1991; Chaloupka 
and Saffer 1992; Becker et al. 1994; Yurekli and Zhang 
2000). Although imperfect, these efforts should have 
significantly reduced the biases associated with the use 
of the pooled state data. When analyses controlled 
for the possible smuggling of cigarettes from low-tax 
to high-tax states, estimated price elasticities of de­
mand that were based on state tax-paid sales data were 
generally in the range of –0.3 to –0.5. 
A further problem in the analysis of aggregate 
data arises because cigarette prices are determined by 
the interaction of supply and demand. Failing to ac­
count for simultaneity would lead to biased estimates 
of the price elasticity of demand. Several recent stud­
ies that employed both pure time series data and 
pooled state-level data have theoretically and empiri­
cally modeled the supply and demand for cigarettes 
(Bishop and Yoo 1985; Porter 1986; Showalter 1991; 
Sung et al. 1994; Barnett et al. 1995; Tremblay and 
Tremblay 1995).  Most studies that controlled for the 
potential simultaneity biases in their aggregate data 
produced estimates of the price elasticity of demand 
that were in the narrow range found in other studies. 
An alternative approach to the simultaneity problem 
is to use natural experiments, such as the large increase 
in the California cigarette excise tax, to look at the im­
pact of price on demand. Several recent studies have 
used this approach (Sung et al. 1994; Hu et al. 1995b). 
Estimates of the price elasticities of demand based on 
this natural experiment are consistent with those in 
other studies. 
Many of the most recent studies of cigarette de­
mand that used aggregate data empirically modeled 
the addictive aspects of cigarette consumption in the 
context of Becker and Murphy’s (1988) economic 
model of addictive behavior (Showalter 1991; Becker 
et al. 1994; Sung et al. 1994). One of the most interest­
ing implications of the economic models of demand 
for addictive goods, including cigarettes, concerns 
short-run versus long-run effects.  Economists gener­
ally define the short run as a period during which at 
least some factors have not fully responded to the 
change being examined. In contrast, the long run is 
when all changes have occurred; the Congressional 
Research Service (CRS) defined the long run for ciga­
rette demand as 69 years, a time period that would 
allow the current 12- to 80-year-old population (which 
includes almost all smokers) to adjust to a change in 
cigarette taxes (Gravelle and Zimmerman 1994).  For 
addictive goods, the long-run impact of price on 
demand will exceed the short-run impact because the 
latter largely entails current consumption, which rep­
resents an established addiction that tends to be slow 
to decrease even in the face of a price increase.  In the 
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studies that used such a model, the estimated long-
run impact of price elasticities of demand indeed 
exceeded—by up to twice as much—the estimates for 
the short-run impact, presumably because the long-
run impact reflected would-be newly addicted con­
sumers who were put off by price increases. (These 
short- and long-run effects are further discussed in “To­
bacco Taxation and Revenues,” later in this chapter.) 
Finally, studies employing aggregate data are 
generally limited because they estimate the effects of 
prices and other factors on aggregate or per capita es­
timates of cigarette consumption.  Such studies thus 
cannot provide information on the effects of prices and 
other policies on smoking prevalence, initiation, ces­
sation, or quantity and type of cigarette smoked.  Simi­
larly, these studies cannot explore differences that sex, 
age, and socioeconomic status may have on respon­
siveness to price and other policies. Furthermore, ag­
gregate studies are of only limited use in considering 
the health effects of changes in existing policies for 
reducing tobacco use. A few recent studies have ad­
dressed some of these limitations.  Harris (1994) used 
annual time series data on both smoking prevalence 
and average cigarette consumption among smokers 
during 1964–1993. The study estimated that the price 
elasticity of smoking prevalence in 1993 was –0.238 
and that the elasticity for average consumption among 
smokers was comparable; the 1993 total price elastic­
ity of demand of –0.47 was comparable to that obtained 
in other studies. Townsend and colleagues (1994) used 
aggregate data on smoking prevalence and average 
consumption constructed from the biennial data gath­
ered in the British General Household Surveys from 
1972 through 1990.  The study found that men and 
women in lower socioeconomic groups were most re­
sponsive to changes in cigarette prices, that women 
were more responsive to price than men, and that 
smokers in the youngest age groups (16–19 years and 
20–24 years) were least affected by price.  In another 
study, Moore (1995) used state data from 1954 through 
1988 to analyze the effects of cigarette taxes on 
smoking-related death rates.  The study estimated that 
a 10-percent increase in cigarette taxes would prevent 
an estimated 5,200 smoking-related deaths each year. 
Studies Using Individual-Level Data 
Relatively few studies of cigarette demand have 
been based on individual-level data. Table 6.8 sum­
marizes the findings of these studies for samples of 
adults, and Table 6.9 presents the results of studies 
focusing on adolescents and young adults. 
Reducing Tobacco Use
 
In general, the estimated price elasticities of de­
mand obtained from these studies were comparable 
to those found in the aggregate studies.  By using self-
reported measures of smoking prevalence and aver­
age cigarette consumption, these studies avoided some 
of the problems associated with aggregate data on state 
taxes paid for cigarette sales.  Each of these studies 
also carefully considered the effect that casual smug­
gling could have on their estimates of the price elas­
ticity of demand. Moreover, because an individual 
smoker’s purchase decisions are too small to affect the 
market price of cigarettes, the use of individual-level 
data in these studies avoided the potential simultane­
ity biases inherent in the use of aggregate data.  How­
ever, the use of individual-level data may be subject 
to a substantial ecological bias, to the extent that omit­
ted variables affecting tobacco use may be correlated 
with the included determinants of demand. Exclud­
ing these variables will, consequently, produce biased 
estimates for the included variables (see the later dis­
cussion of Wasserman et al. 1991).  Furthermore, the 
use of individual-level data is subject to potential re­
porting biases. Studies using individual-level data 
have implicitly assumed that underreporting is pro­
portional to true consumption (i.e., heavy, moderate, 
and light smokers underreport by the same propor­
tion). With this assumption, elasticity estimates will 
not be systematically biased. 
The use of individual-level data allows research­
ers to explore issues difficult to address adequately 
with aggregate data.  In particular, researchers can use 
a two-part method to distinguish between the effects 
of cigarette price on two decisions:  whether to smoke 
(smoking prevalence) and how many cigarettes to 
smoke (cigarette consumption).  Likewise, the effects 
of cigarette prices on smoking cessation can be inves­
tigated. Individual-level data also allow researchers 
to explore the differential responses of various socio­
economic and demographic groups to changes in ciga­
rette prices and existing prevention policies.  However, 
the potential underreporting of cigarette consumption 
can be problematic in interpreting these data (Warner 
1978). 
Lewit and colleagues (Lewit et al. 1981; Lewit and 
Coate 1982; Grossman et al. 1983) were the first to use 
individual-level data to examine the effects of prices 
and smoking prevention policies.  Lewit and Coate 
(1982) used data on 19,288 persons aged 20–74 years 
who had participated in the 1976 National Health In­
terview Survey.  The investigators first estimated the 
effects of cigarette price on smoking prevalence and 
then looked at the effects of price on cigarette consump­
tion. These equations were estimated not only for 
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Table 6.8.  Estimates of the price elasticity of cigarette demand for adults from individual-level data 
Study 
Estimated price 
elasticities Comments 
Lewit and Coate 
1982 
–0.42 1976 National Health Interview Survey; ordinary least 
squares methods; elasticities by age and sex. 
Mullahy 1985 –0.47 1979 National Health Interview Survey; instrumental 
variables and probit methods; detailed modeling of 
addiction; elasticities by sex. 
Chaloupka 1990 –0.60 (men) 
not statistically different 
from zero (women) 
Second National Health and Nutrition Examination 
Survey, 1976–1980; instrumental variables methods; 
detailed modeling of addiction; elasticities by sex. 
Chaloupka 
1991 and 1992 
–0.27 to –0.48 Second National Health and Nutrition Examination Survey, 
1976–1980; instrumental variables methods; detailed 
modeling of addiction; elasticities by age and educational 
attainment. 
Wasserman et al. 
1991 
0.069 (1970) 
–0.23 (1988) 
1970, 1974, 1976, 1979, 1980, 1983, and 1985 National 
Health Interview Surveys; generalized least squares and 
two-part methods; allow changes in elasticity over time. 
Hu et al. 1995a –0.46 California Behavioural Risk Factor Surveys, 1985–1991; 
two-part methods; controls for interdependence of other 
behavioral risk factors and smoking. 
Ohsfeldt et al. 1997 –0.05 (tax 
elasticity, males) 
1985 Current Population Survey, males aged 16 years and 
older; treats taxes and control policies as endogenous; 
elasticity estimates for prevalence only. 
Centers for Disease 
Control and 
Prevention 1998 
–0.25 (full sample) 
–0.14 (whites) 
–0.32 (blacks) 
–1.89 (Hispanics) 
–0.29 (at or below 
median income) 
–0.17 (above median 
income) 
–0.26 (men) 
–0.19 (women) 
1976–1980, 1982, 1985, 1987–1992 National Health 
Interview Surveys; two-part methods. 
Evans and 
Ringel 1999 
–0.25 to –0.56 Natality Detail data, 1989–1992, pregnant women; 
two-part models. 
Ohsfeldt et al. 1999 –0.15 (tax 
elasticity, males) 
1992/93 Current Population Survey, males aged 16 years 
and older; treats taxes and control policies as endogenous; 
elasticity estimates for prevalence only. 
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the full sample but also for subsamples based on age 
(20–25 years, 26–35 years, and 36–74 years) and sex. 
Price had a greater impact on whether a respondent 
smoked at all than on how many cigarettes a respon­
dent smoked. The estimated elasticity of demand for 
smoking prevalence was –0.26 for the full sample, and 
the total price elasticity of demand was –0.42. The ef­
fects of price were larger for younger persons:  the to­
tal estimated price elasticity for persons 20–25 years 
old was approximately double that for persons 26–74 
years old. The study also found that men, particu­
larly those aged 20–35 years, were quite responsive to 
changes in cigarette prices, whereas women were al­
most unaffected by price. 
These findings regarding age are substantiated 
as well by Lewit and colleagues (1981), who used data 
from Cycle III of the Health Examination Survey (1966– 
1970) to examine the impact that prices and the anti­
smoking advertisements broadcast under the Fairness 
Doctrine had on cigarette smoking among 6,768 ado­
lescents (12–17 years old). Using the same basic meth­
ods employed in the study by Lewit and Coate (1982), 
this analysis estimated that the impact of price on ado­
lescent smoking (measured at a total price elasticity of 
–1.44) was about three times that for adult smoking 
(Lewit and Coate 1982). The study by Lewit and col­
leagues (1981) also confirmed that price had a greater 
impact on the decision to smoke (elasticity of 
–1.20) than on the average quantity of cigarettes con­
sumed by smokers (elasticity of –0.25). These findings 
were generally supported by another analysis of data 
from the 1974, 1976, 1977, and 1979 National House­
hold Surveys on Drug Abuse (Grossman et al. 1983). 
Mullahy (1985) was the first to estimate cigarette 
demand on the basis of a theoretical and empirical 
model treating cigarette smoking as an addictive be­
havior.  This model implied that a person’s smoking 
decisions at any point in time are dependent on that 
person’s smoking history.  However, unlike most of the 
more recent econometric applications of addictive be­
havior, this analysis assumed that individuals behave 
myopically—that is, they ignore the future conse­
quences of their cigarette addiction when making cur­
rent smoking decisions.  Using data on 13,794 persons 
who participated in the 1979 National Health Interview 
Survey, Mullahy (1985) estimated smoking prevalence 
and average cigarette consumption separately for men 
and women (aged 17 years and older). In finding that a 
person’s past cigarette smoking had a significant 
impact on current smoking decisions, the analysis 
supports the hypothesis that cigarette smoking is an ad­
dictive behavior. The study also found that both smok­
ing prevalence and average cigarette consumption 
Reducing Tobacco Use 
were inversely related to cigarette prices.  Finally, 
Mullahy estimated that men were somewhat more re­
sponsive to price than women (total price elasticities 
of demand were –0.56 and –0.39, respectively). 
Wasserman and colleagues (1991) used data from 
several of the National Health Interview Surveys from 
the 1970s and 1980s to consider how the price sensi­
tivity of cigarette demand changed over time.  Using 
a generalized linear model, the investigators concluded 
that cigarette demand has become more responsive to 
price over time. In the earlier years of their sample, 
they found that increased cigarette prices did not re­
duce cigarette smoking.  However, they estimated that, 
beginning in 1985, when the overall price elasticity of 
cigarette demand was –0.23, increases in cigarette 
prices would reduce smoking.  As part of the same 
study, these investigators used data on 1,891 youth 
aged 12–17 years who had participated in the Second 
National Health and Nutrition Examination Survey 
(1976–1980). Unlike Lewit and colleagues (1981), 
Wasserman and colleagues (1991) found that the esti­
mated price elasticity for youth was not statistically 
different from that for adults.  Indeed, the estimated 
effects of price on youth smoking were not statistically 
different from zero in any of the models.  The investi­
gators attributed their relatively low estimates of the 
price elasticity of demand to their including in their 
demand equations an index that controlled for smok­
ing restrictions.  This index, which was highly corre­
lated with price, had a negative significant effect on 
smoking (particularly on young people’s decision to 
smoke). Wasserman and colleagues argued that be­
cause of the high correlation between the index and 
cigarette prices, excluding this index would lead to 
biased estimates of the effect of prices on demand. 
Indeed, when they excluded the index from their esti­
mated equations, their estimated price elasticities were 
comparable to those from other studies. 
Chaloupka (1990, 1991, 1992) used data from the 
Second National Health and Nutrition Examination 
Survey (1976–1980) in applying the Becker and 
Murphy (1988) model of rational addiction to cigarette 
smoking. The assumption of rational (or nonmyopic) 
addictive behavior implies that individuals consider, 
to some degree, the future consequences of their cur­
rent smoking decisions (which depend on past 
choices). Chaloupka’s estimates supported the hy­
potheses that smoking is an addictive behavior and 
that the future consequences of this addiction are an 
important determinant of current cigarette smoking. 
Moreover, the estimated long-run price elasticity of 
demand (in the range of –0.27 to –0.48) was well above 
that obtained when the addictive aspects of cigarette 
Study 
Estimated price elasticities
 

Prevalence Quantity Total	 	 Comments
 

Lewit et al. –1.20 –0.25 –1.44 Health Examination Survey, Cycle 
1981	 	 III, 1966–1970; ordinary least squares 
methods for consumption and 
smoking participation; aged 12–17 
years. 
Lewit and Coate –0.74 –0.20 –0.89 1976 National Health Interview 
1982	 	 Survey; ordinary least squares 
methods; elasticities by age and 
sex; aged 20–25 years. 
Grossman et al. 0.88 –1.55 –0.67 (1974)	 	 National Household Surveys on Drug 
1983	 	 –0.62 0.11 –0.51 (1976) Abuse, 1974, 1976, 1977, and 1979; 
–0.93 0.91 –0.02 (1977) least squares methods; aged 12–17 
–0.89 0.73 –0.16 (1979) years. 
Chaloupka Not statistically different	 	 Second National Health and Nutrition 
1991 from zero	 	 Examination Survey, 1976–1980; 
instrumental variables methods; 
detailed modeling of addiction; 
aged 17–24 years. 
Wasserman et al. Not statistically different Second National Health and Nutrition 
1991 from adults (generalized linear Examination Survey, 1976–1980; 
modeling); not statistically different generalized (iterative weighted) least 
from zero (two-part model) squares and two-part methods; aged 
12–17 years. 
Douglas and No significant effect of prices on	 	 1988 and 1989 National Health 
Hariharan 1994  smoking initiation decisions	 	 Interview Surveys; hazard models 
of smoking initiation; detailed 
modeling of addiction. 
Chaloupka and –0.675 –0.638 –1.313	 	 1992, 1993, and 1994 Monitoring the 
Grossman 1996	 	 Future surveys of 8th, 10th, and 12th 
graders; two-part methods; mostly 
aged 12–18 years. 
Chaloupka and –0.53 –0.58 –1.11	 	 1993 Harvard College Alcohol Study; 
Wechsler 1997	 	 two-part methods; college students 
mostly aged 18–22 years. 
Chaloupka et al. –0.43 –0.16 –0.59	 	 1992, 1993, and 1994 Monitoring the 
1997	 	 Future surveys of 8th, 10th, and 12th 
graders; smokeless tobacco use by 
young males; two-part methods; 
mostly aged 12–18 years. 
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Table 6.9.  	Estimates of the price elasticity of cigarette demand for youth and young adults from
 individual-level data 
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Estimated price elasticities 
Prevalence Quantity Total Study Comments 
Lewit et al. 1997 –0.87 (prevalence) 
–0.95 (intentions) 
1990 and 1992 data from COMMIT* 
sites; 9th graders. 
Centers for Disease 
Control and 
Prevention 1998 
–0.37 –0.21 –0.58 1976–1980, 1982, 1985, 1987–1992 
National Health Interview Surveys; 
two-part methods; aged 18–24 years. 
Douglas 1998 No significant effects of prices on 
smoking initiation decisions; elasticity 
of approximately –1.0 for duration 
of smoking 
1987 National Health Interview 
Survey; hazard models of smoking 
initiation and cessation; detailed 
modeling of addiction. 
DeCicca et al., 
unpublished data, 
April 1998 
–1.32 (8th grade) 
–0.95 (10th grade) 
–0.71 (12th grade) 
–0.03 (smoking onset, 8th to 12th grade) 
1988 National Education Longitudinal 
Survey; treats each wave indepen-
dently for prevalence; longitudinal 
data used to estimate effect of price 
on smoking onset. 
DeCicca et al., 
unpublished data, 
August 1998 
–1.994 to –0.746 (8th grade) 
–1.230 to –0.660 (10th grade) 
–0.982 to –0.274 (12th grade) 
–0.505 to –0.025 (smoking onset, 
8th to 12th grade) 
1998 National Education Longitudinal 
Survey; treats each wave indepen-
dently for prevalence; longitudinal 
data used to estimate effect of price 
on smoking onset. 
Dee and Evans, 
unpublished data, 
1998 
–2.19 to –2.01 (8th grade) 
–1.15 to –0.94 (12th grade) 
–0.79 to –0.63 (smoking onset, 
8th to 12th grade) 
Re-analysis of DeCicca et al. April 1998 
data with same methods; differences 
in sample construction and variable 
definitions. 
Evans and Huang, 
unpublished data, 
1998 
–0.20 (1977–1992) 
–0.50 (1985–1992) 
1977–1992 Monitoring the Future 
surveys; high school seniors; state­
aggregated prevalence rates; allow for 
state effects and state-specific time 
trends. 
Chaloupka and 
Pacula 1999 
–0.928 (men) 
–0.595 (women) 
–0.639 (whites) 
–1.108 (African Americans) 
1992, 1993, and 1994 Monitoring the 
Future surveys of 8th, 10th, and 12th 
graders; prevalence only; mostly aged 
12–18 years. 
Reducing Tobacco Use 
Table 6.9.  Continued 
*COMMIT = Community Intervention Trial for Smoking Cessation.
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Prevalence Quantity Total 
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Table 6.9.  Continued 
Study Comments 
Harris and 
Chan 1999
–0.831 –0.165 –0.996 
 (aged 15–17 years) 
–0.524 –0.255 –0.779 
 (aged 18–20 years) 
–0.370 –0.274 –0.644
 (aged 21–23 years) 
–0.202 –0.455 –0.657
 (aged 24–26 years) 
–0.095  –0.234 –0.329
 (aged 27–29 years) 
1992–1993 Current Population Survey; 
two-part methods; also considered 
differential effects of premium and
discount brand prices. 
Tauras 1999 0.269 to 0.466 price elasticity of cessation Monitoring the Future survey 
longitudinal data; young adults; 
multiple failure duration analysis; 
parametric and semi-parametric 
models. 
Tauras and 
Chaloupka 
1999b 
–0.121 –0.67 –0.791 Monitoring the Future longitudinal 
data formed from high school senior 
surveys for 1976–1993; mostly aged 
18–32 years. 
Gruber 2000 –0.666 –0.059 (older teens, 
           Monitoring the Future surveys) 
–0.210 –0.003 (younger teens, 
           Monitoring the Future surveys) 
–0.311 –0.029 (all teens, 
           Monitoring the Future surveys) 
–1.534 –1.576 (older teens, 
           Youth Risk Behavior Survey)
 0.419 –0.227 (younger teens,
           Youth Risk Behavior Survey) 
–0.126 –0.526 (all teens,
           Youth Risk Behavior Survey) 
–0.376 –0.145 (older teens,
 Natality Detail files) 
–0.240 –0.058 (younger teens,
 Natality Detail files) 
–0.353 –0.124 (all teens,
 Natality Detail files) 
1991–1997 Monitoring the Future
surveys of 8th, 10th, and 12th graders; 
1991, 1993, 1995, and 1997 Youth Risk
Behavior Surveys; 1991–1997 Vital 
Statistics Natality Detail files for teens
giving birth before age 19; two-part 
models; state and year fixed effects.
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smoking were ignored.  Furthermore, these estimates 
of the price responsiveness of demand were not sensi­
tive to the inclusion of variables reflecting smoking 
restrictions. Chaloupka (1990, 1991, 1992) found that 
young adults were not responsive to changes in ciga­
rette prices (in contrast to the findings of Lewit and 
Coate [1982]) and that men and less-educated persons 
were much more responsive to changes in cigarette 
prices than were women and more-educated persons. 
Douglas and Hariharan (1994) applied ideas from 
Becker and Murphy’s (1988) economic model of ad­
diction to look at smoking initiation decisions. Using 
data from the 1978 and 1979 smoking supplements to 
the National Health Interview Survey, Douglas and 
Hariharan estimated a parametric duration model that 
accounted for observed patterns of smoking initiation: 
the “hazard” of smoking initiation rises sharply from 
ages 12 through 20 and then declines dramatically, with 
initiation being unlikely after age 25. On the basis of 
this model, the analysis found that increases in ciga­
rette prices had no impact on teenagers’ decisions to 
begin smoking. Douglas (1998) extended this work 
by estimating a model of the hazards of smoking ini­
tiation and cessation using data from the cancer risk 
factor supplement to the 1987 National Health Inter­
view Survey.  Douglas also finds little empirical evi­
dence that higher cigarette prices would reduce 
smoking initiation. However, the investigators noted 
that their estimated price effects were likely to be bi­
ased downward because of problems with the mea­
surement of the price variables they employed. 
Douglas did find, however, that increases in cigarette 
prices significantly increase the likelihood of smoking 
cessation, concluding that a 10-percent increase in price 
would reduce the duration of smoking by approxi­
mately 10 percent. 
More recent work by Tauras confirms the findings 
that higher cigarette prices induce smoking cessation 
(Tauras 1999; Tauras and Chaloupka 1999a).  Using the 
longitudinal data on young adults from the Monitor­
ing the Future project, Tauras (1999) estimated paramet­
ric and semi-parametric duration models that allow for 
multiple cessation attempts by young adult smokers. 
His estimates indicate that the likelihood of an initial 
cessation attempt and the probabilities of subsequent 
attempts rise as cigarette prices rise, with an average 
price elasticity of cessation of 0.343. In a somewhat less 
sophisticated analysis using the same data that exam­
ined the potential for gender differences in the effects 
of price on cessation, Tauras and Chaloupka (1999b) 
concluded that the likelihood of smoking cessation 
among both young adult men and young adult women 
rises significantly as cigarette prices rise. 
Reducing Tobacco Use 
Hu and colleagues (1995a) used data from the 
1985–1991 California Behavior Risk Factor Surveys to 
estimate smoking prevalence and average cigarette 
consumption through equations that accounted for the 
interdependence of smoking and other behavioral risk 
factors. Using two-part methods, Hu and colleagues 
found that their estimates of the price elasticity of 
smoking prevalence were significantly lower when 
allowing for the interdependence of smoking and other 
behavioral risk factors (such as drinking and obesity), 
whereas their estimates of the effect of price on aver­
age cigarette consumption by smokers were unaf­
fected. The analysis estimated that the price elasticity 
of demand was –0.46 overall, –0.24 for smoking preva­
lence, and –0.22 for cigarette consumption. 
More recently, data from the 1976–1980, 1983, 
1985, and 1987–1992 National Health Interview Sur­
veys have been used to study the effects of prices on 
smoking among adults (CDC 1998). Researchers found 
that both the probability of smoking and the average 
cigarette consumption among smokers were inversely 
related to cigarette prices, with an overall estimated 
price elasticity of demand of –0.25. In addition, they 
found significant differences in price responsiveness 
for various subpopulations, including those defined 
by race/ethnicity, age, family income, and gender. 
They found that blacks are twice as responsive as 
whites to changes in cigarette prices and that Hispan­
ics are even more price sensitive.  Similarly, the re­
searchers’ estimated price elasticity of –0.58 for young 
adults (aged 18–24 years) is well above that estimated 
for the full sample, whereas individuals with family 
incomes at or below the sample median were about 70 
percent more responsive to price than those with 
higher family incomes. Finally, they found that men 
are much more price responsive than women. 
To determine whether smokers engage in any 
form of compensating behavior in response to higher 
cigarette taxes, Evans and Farrelly (1998) focused on 
the data from the 1979 Smoking and 1987 Cancer Con­
trol Supplements to the National Health Interview 
Survey. These supplements were unique in that they 
collected information on the brand of cigarettes smoked. 
This information was converted into detailed data on 
tar and nicotine content, length of cigarette, and type of 
filter. The investigators found that continuing smok­
ers engage in compensating behavior in response to 
higher cigarette taxes. That is, they found that smok­
ers in high-tax states were more likely than smokers in 
low-tax states to smoke higher-tar and higher-nicotine 
cigarettes as well as longer cigarettes. This compensat­
ing behavior by continuing smokers left their average 
daily tar and nicotine intake unchanged. Moreover, 
   
  
  
 
Surgeon General's Report
 
younger smokers were much more likely to engage in 
this compensating behavior, so much so that the higher 
taxes led to an increase in average daily tar and nico­
tine intake among continuing young adult smokers. 
Recent research by Chaloupka and colleagues fo­
cused on the price responsiveness of cigarette smoking 
among adolescents and young adults. Chaloupka and 
Wechsler (1997) used 1993 data from 16,277 students in 
140 U.S. colleges and universities to estimate the price 
elasticity of cigarette smoking among young adults. 
Using two-part methods, the investigators separately 
estimated the effects of prices on smoking prevalence 
and on average consumption among smokers after con­
trolling for restrictions on cigarette smoking and limits 
on youth access to tobacco. College students, who were 
mostly aged 18–22 years, were very responsive to 
changes in cigarette prices.  The estimated price elastic­
ity of smoking prevalence in this population was –0.53, 
and the elasticity for average cigarette consumption was 
–0.58, for an overall price elasticity of demand of –1.11. 
Chaloupka and Grossman (1996) employed simi­
lar methods to examine cigarette smoking among more 
than 110,000 young people participating in the 1992, 
1993, and 1994 Monitoring the Future surveys of 8th-, 
10th-, and 12th-grade students. Like several other re­
searchers, Chaloupka and Grossman found that smok­
ing by younger persons is very responsive to changes 
in cigarette prices. Their estimated elasticity of smok­
ing prevalence for this sample of mostly 12- through 
18-year-olds was –0.675, with an overall estimated price 
elasticity of demand centered on –1.313.  Chaloupka and 
Pacula (1999) used these data to look at the differential 
response by gender and race, concluding that young 
men and young African Americans are more respon­
sive to price than young women and young whites. 
Most recently, Tauras and Chaloupka (John A. 
Tauras and Frank J. Chaloupka. Price, clean indoor air 
laws, and cigarette smoking: evidence from longitudi­
nal data for young adults, unpublished data, July 1, 
1998) used data from the longitudinal component of 
the Monitoring the Future surveys to estimate the ef­
fects of price on young adult smoking. Using 35 pan­
els formed from the 1976 through 1993 high school 
senior surveys, they estimated models controlling for 
unobserved state and individual factors affecting ciga­
rette demand.  For their sample of young adults, mostly 
aged 18–32, Tauras and Chaloupka estimated an over­
all price elasticity of demand centered on –0.79. Taken 
together, these estimates imply that increases in ciga­
rette prices would lead to relatively large reductions 
in smoking among adolescents and young adults. 
This conclusion is supported by recent studies 
by Lewit and colleagues (1997) and Evans and Huang 
(William N. Evans and Lynn X. Huang, Cigarette taxes 
and teen smoking: new evidence from panels of re­
peated cross-sections, unpublished data, April 15, 1998; 
Harris and Chan 1999; Gruber 2000).  Lewit and col­
leagues used data for ninth-grade students in 1990 and 
1992 collected in the 22 North American communities 
from the Community Intervention Trial for Smoking 
Cessation (COMMIT). They found that both youth 
smoking prevalence and youth intentions to smoke are 
inversely related to cigarette prices, with estimated 
price elasticities of –0.87 and –0.95, respectively.  Evans 
and Huang estimated a somewhat smaller effect of 
–0.20 for high school seniors by using annual, state-
level measures of smoking prevalence aggregated from 
the 1977 through 1992 Monitoring the Future surveys. 
However, they concluded that this had increased over 
time, estimating an elasticity of –0.50 for the period 
from 1985 through 1992.  Harris and Chan (1999), us­
ing data from the 1992–1993 Tobacco Use Supplement 
to the Current Population Survey, provide consistent 
evidence that price responsiveness falls with age.  Their 
estimated elasticities range from –0.996 for 15- to 17­
year-olds to –0.329 for 27- to 29-year-olds. Gruber (2000) 
reaches a somewhat different conclusion using data 
from the 1991 through 1997 Monitoring the Future 
surveys, the 1991, 1993, 1995, and 1997 Youth Risk Be­
havior Surveys, and the 1991 through 1997 Vital Sta­
tistics Natality Detail files for teens giving birth before 
their 19th birthday.  His estimates indicate that older 
teens are relatively more responsive to price than 
younger teens (approximately 17 to 18 years of age 
compared with approximately 13 to 16 years of age). 
His estimated price elasticity of smoking prevalence 
for older teens centers on –0.67, while he finds that 
younger teens, on average, are not sensitive to price. 
In addition, he concludes that price sensitivity among 
older teens is greatest for more socioeconomically dis­
advantaged groups, such as young blacks or those with 
less educated parents. 
In contrast, DeCicca and colleagues (Philip 
DeCicca, Donald Kenkel, and Alan Mathios, Putting 
out the fires: will higher taxes reduce youth smoking?, 
unpublished data, April 1998) concluded that higher 
cigarette taxes have a very small impact on smoking 
initiation among youth. Using data from the 1988, 
1990, and 1992 waves of the National Education Longi­
tudinal Study (NELS) of 1988, and treating each wave 
separately, the investigators estimated price elasticities 
for youth smoking prevalence comparable to those dis­
cussed above.  However, when they used the longitu­
dinal data to examine the onset of daily smoking 
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between 8th and 12th grade among youth not smok­
ing in 8th grade, DeCicca and colleagues found little 
effect of price.  In a separate analysis of the same data, 
Dee and Evans (Thomas S. Dee and William N. Evans, 
A comment on DeCicca, Kenkel, and Mathios, unpub­
lished data, May 10, 1998) come to the opposite con­
clusion. Dee and Evans made two adjustments to the 
construction of the sample used by DeCicca and 
colleagues—including respondents with missing data 
on some covariates (about 20 percent of the sample) 
and redefining several variables based on the categori­
cal data. After making these changes, Dee and Evans 
estimated a price elasticity for the onset of smoking of 
–0.63, consistent with several of the other recent stud­
ies of youth smoking based on cross-sectional data. 
In response to Dee and Evans, DeCicca and col­
leagues (Philip DeCicca, Donald Kenkel, and Alan 
Mathios, Putting out the fires: will higher taxes reduce 
youth smoking?, unpublished data, August 1998) con­
ducted a reanalysis of NELS data by using an alterna­
tive approach to dealing with the problem of missing 
data. Their reanalysis produced somewhat more sig­
nificant estimates for the effect of cigarette taxes on 
the onset of daily smoking between 8th and 12th grade; 
the implied price elasticities from alternative specifi­
cations ranged from –0.025 to –0.505.  However, 
smaller, less significant effects are found for models 
that employ cigarette prices.  After obtaining separate 
estimates based on race and ethnicity, DeCicca and col­
leagues concluded that higher cigarette taxes have little 
impact on smoking onset by black and white youth 
but significantly reduce onset among Hispanic youth 
and youth of other races. The use of longitudinal data 
to research the impact of cigarette tax and price changes 
on smoking initiation is clearly an important and ap­
propriate step.  The differing conclusions from earlier 
studies of the same data suggest, however, that these 
discordant results should be weighed cautiously 
against the prevailing findings of recent studies. 
Finally, two recent studies by Ohsfeldt and col­
leagues (1997, 1999) examined the impact of cigarette 
and other tobacco taxes on the probabilities of ciga­
rette and smokeless tobacco use by males 16 years of 
age and older using data from the 1985 and 1992/1993 
Current Population Surveys.  To account for the po­
tential reverse causality between demand and tobacco 
control policies (including taxes), the researchers esti­
mate a simultaneous equations model. They find con­
sistent evidence that higher cigarette taxes reduce the 
probability of smoking. 
Reducing Tobacco Use
 
Behavioral Economics Studies of Cigarette 
Demand 
Behavioral economics is the relatively new ap­
plication of the principles of consumer demand theory 
to experimental psychology (Hursh and Bauman 1987). 
In a laboratory setting, behavioral economists study­
ing addiction-related behaviors focus on the impact 
of unit price on drug dependence, including nicotine 
dependence. Price, in this literature, is defined as the 
response required to receive one dose of the drug 
(Bickel et al. 1993; Bickel and Madden 1999). As in 
standard economic theory, a key prediction of this 
branch of behavioral economics is that drug consump­
tion is inversely related to price.  One advantage of 
this experimental approach in the analysis of cigarette 
demand is that it allows researchers to study the ef­
fects of differences in cigarette prices that are many 
times larger than the price differences observed in 
cross-sectional data, time series data, or both.  One limi­
tation, however, is that these methods are generally 
applicable only to dependent individuals. Thus, for 
example, they do not pertain to initiation. 
In a series of papers, Bickel, DeGrandpre, and 
their colleagues reported the results of research on ciga­
rette smoking in their behavioral economics labora­
tory (Bickel et al. 1991, 1992; DeGrandpre et al. 1992, 
1994; Bickel and DeGrandpre 1996).  In the experi­
ments, nicotine-dependent smokers were rewarded 
with two puffs on a cigarette after the completion of a 
specified number of responses.  The total number of 
puffs received is the measure of consumption, and the 
number of responses required is the measure of price. 
The number of responses required to receive two puffs 
varied from 100 to 3,200, thereby allowing the research­
ers to study the impact of price on demand over a large 
range of prices. As in the econometric and other stud­
ies described previously, this experimental approach 
found an inverse relationship between cigarette smok­
ing and price. More interesting, however, is the nature 
of the relationship between price and consumption.  The 
investigators found that the price elasticity of demand 
rose as price rose.  That is, the percentage reduction in 
consumption for a given percentage rise in price was 
larger at higher prices. 
Studies of Smokeless Tobacco Use 
and Price 
Although numerous studies have examined the 
impact of cigarette prices and smoking prevention 
policies on cigarette smoking, relatively few studies 
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have examined the corresponding issues for smoke­
less tobacco use, and virtually none consider such use 
in diverse culture groups.  Similarly, few analyses have 
examined the possible substitution of smokeless to­
bacco products or cigarettes in response to changes in 
their relative prices. 
Ohsfeldt and colleagues begin to address these 
gaps in the literature in two studies of smokeless to­
bacco use (Ohsfeldt and Boyle 1994; Ohsfeldt et al. 
1997, 1999). Using state-level data for males aged 16 
years and older who had participated in the Septem­
ber 1985 Current Population Survey, Ohsfeldt and 
Boyle examined the impact of various tobacco taxes 
on the prevalence of smokeless tobacco use.  Their 
analysis, which controlled for other determinants of 
demand, found that higher taxes on smokeless tobacco 
were associated with lower use of smokeless tobacco. 
The prevalence of smokeless tobacco use, however, was 
positively related to cigarette excise taxes.  The inves­
tigators suggested that these findings might partly 
explain the growth in smokeless tobacco use among 
young males during the 1980s. During this period, 
when cigarette excise taxes were rising more rapidly 
than smokeless tobacco taxes, comparatively larger 
increases occurred in cigarette prices.  As the research 
previously described indicates, increases in cigarette 
prices significantly reduce cigarette smoking.  Ohsfeldt 
and Boyle’s analysis, however, suggested that tobacco 
use overall might not be significantly reduced, because 
some smokers might turn to using the comparatively 
less expensive smokeless tobacco products.  These find­
ings were generally confirmed by the analysis by 
Ohsfeldt and colleagues (1997) of the individual-level 
data from the September 1985 Current Population Sur­
vey and their subsequent analysis of data from the 
September 1992, January 1993, and May 1993 surveys 
(Ohsfeldt et al. 1999). The authors concluded that 
higher smokeless tobacco taxes reduce the probability 
of smokeless tobacco use but that higher cigarette taxes, 
while reducing the probability of smoking, increase 
the likelihood of smokeless tobacco use. 
Similarly, using data on young males from the 
1992, 1993, and 1994 Monitoring the Future surveys of 
8th-, 10th-, and 12th-grade students, Chaloupka and 
colleagues (1997) concluded that both the prevalence 
and the frequency of smokeless tobacco use are in­
versely related to its price.  They estimated an overall 
price elasticity of smokeless tobacco demand by young 
males of –0.59, with more than two-thirds of the effect 
on the prevalence of smokeless tobacco use. 
Cigarette Prices and Other Substance Use 
Little is known about the relationships between 
cigarette prices and other substance use, whereas much 
is known about the impact of cigarette price on smok­
ing. Economists define two goods as complements if 
an increase in the price of one good reduces the con­
sumption of not only that good but also the consump­
tion of the other.  Conversely, substitutes are goods 
for which an increase in the price of one results in an 
increase in the consumption of the other.  A few very 
recent econometric studies have examined the relation­
ship between cigarette prices and other substance use 
(Pacula 1998a,b; Chaloupka et al. 1999; Farrelly et al. 
1999; Pacula et al. 2000). 
Research on patterns of substance use among 
youth generally concludes that youth begin with to­
bacco, or alcohol, or both and that some youth progress 
to marijuana and other illicit drug use (Kandel 1975; 
Kandel and Yamaguchi 1993; USDHHS 1994).  Other 
research concludes that cigarette smoking is a signifi­
cant predictor of both the probability and the frequency 
of other drug use (USDHHS 1988; Henningfield et al. 
1990). This research suggests that cigarettes and other 
substances are complements for one another and that 
higher cigarette prices, by discouraging smoking 
among youth, could significantly reduce youth and 
adult drinking and illicit drug use. 
Pacula (1998a), in the first econometric examina­
tion of this “gateway hypothesis,” used data from the 
National Longitudinal Survey of Youth to examine the 
impact of cigarette prices in earlier years on current 
marijuana use by young adults. Her estimates are con­
sistent with the gateway hypothesis; that is, higher past 
cigarette prices (which are expected to reduce past ciga­
rette smoking) reduce the likelihood that a young adult 
currently uses marijuana.  However, she finds no rela­
tionship between contemporaneous cigarette prices 
and marijuana use (Pacula 1998b). Chaloupka and 
colleagues (1999) used data from the 1992 through 1994 
Monitoring the Future surveys of 8th-, 10th-, and 12th­
grade students to examine the relationship between 
current cigarette prices and current cigarette smoking 
and marijuana use. They found that higher cigarette 
prices, in addition to reducing current cigarette smok­
ing, also reduce current marijuana use.  Farrelly and 
colleagues (1999) found similar evidence for adults 
using several of the recent National Household Sur­
veys on Drug Abuse.  In addition, they found that 
higher cigarette prices reduced alcohol use.  More re­
cently, using a longer time series of data from the Moni­
toring the Future surveys of 12th-grade students, 
Pacula and colleagues (2000) found little impact of 
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cigarette taxes on youth marijuana use.  The growing 
evidence suggests that cigarettes and marijuana are not 
substitutes for one another, implying that higher ciga­
rette prices will not lead to increased marijuana use, 
with several studies implying the opposite—that 
higher cigarette prices will reduce both cigarette and 
marijuana smoking. Much more research is needed, 
however, to firmly establish these relationships. 
Discussion 
A few general conclusions can be drawn from 
these studies of the effects of cigarette prices on smok­
ing. First, increases in cigarette prices lead to signifi­
cant reductions in cigarette smoking; most studies, using 
a wide variety of data and methods with various 
strengths and weaknesses, predict that a 10-percent 
increase in price will reduce overall cigarette consump­
tion by 3–5 percent.  Second, the effects of increases in 
Taxation of Tobacco Products 
Reducing Tobacco Use
 
cigarette prices are not limited to reductions in average 
cigarette consumption among smokers but include sig­
nificant reductions in smoking prevalence.  These ef­
fects on smoking prevalence constitute both an increase 
in smoking cessation among smokers and a reduction 
in smoking initiation among potential young smokers. 
Third, although evidence concerning the effects of 
prices on adolescent smoking is mixed, the majority 
of the evidence from recent studies indicates that ado­
lescents and young adults are significantly more re­
sponsive than adults to changes in cigarette prices. 
Most recent studies found that adolescents and young 
adults were two to three times more sensitive than 
adults to price. Ongoing research, particularly that 
based on longitudinal data, will help clarify this issue. 
Finally, the limited number of studies of smokeless 
tobacco use suggest that increases in smokeless tobacco 
prices would reduce the prevalence of smokeless to­
bacco use. 
As the preceding section indicates, numerous 
studies of the demand for cigarettes confirm a funda­
mental principle of economics: increased tobacco 
prices will reduce tobacco use. In general, several fac­
tors will determine the retail prices of cigarettes and 
other tobacco products.  For example, factors that re­
duce the supply of tobacco will raise the prices of to­
bacco products.  As described previously, these factors 
include tobacco price support programs, market power 
and collusive behavior among firms in the markets for 
tobacco products, and restrictions on trade in tobacco 
and tobacco products.  The most important policy-
related determinants of prices, however, are taxes on 
tobacco products. 
In the United States, tobacco is taxed in various 
ways by the federal, state, and local governments. The 
most important of these are the excise, or per unit, taxes 
imposed on cigarettes and the general sales tax (an ad 
valorem tax) applied to cigarettes and other tobacco 
products in most states.  Ad valorem taxes are a fixed 
percentage of the price and thereby increase or de­
crease as price changes.  Excise taxes, on the other 
hand, do not change over time with prices. 
Tobacco taxes have relatively low administrative 
costs and can generate substantial revenues.  In recent 
years, increased taxation of tobacco products has been 
used as a strategy to reduce tobacco consumption and 
thereby to improve public health.  For example, the 
health benefits of tax-induced reductions in smoking 
were often cited by supporters of the federal cigarette 
excise tax proposed as part of the Clinton admini­
stration’s proposed Health Security Act of 1993, which 
included an increase of 75 cents per pack.  (The act did 
not pass.) Similarly, anticipated large reductions in 
youth smoking were, in part, the rationale for tax in­
creases of up to $2.00 per pack proposed as part of 
most proposals for national tobacco legislation and the 
average $2.00 state and federal tax set as a goal for 
2010 by the Healthy People 2010 initiative. The health 
benefits of higher taxes were also the focus of the large 
voter-initiated tax increases in Arizona, California, 
Massachusetts, Michigan, and Oregon, as well as the 
large legislated tax increases in Alaska, Maine, and 
elsewhere. 
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Rationales for Tobacco Taxation 
Alternative approaches have been used to deter­
mine the appropriate level of cigarette and other to­
bacco taxes. One such approach is the historical or 
comparative standard, which looks at the relative value 
of these taxes over time or cross-sectionally.  A second 
approach is to use an efficiency standard based on the 
external costs of smoking; this approach implies that 
tobacco taxes can be thought of as “user fees” suffi­
cient to cover the external costs of tobacco use. This 
approach, however, raises questions concerning the 
fairness of such taxes. A further argument has been 
made for substantial increases in tobacco taxes, because 
these tax hikes would lead to substantial reductions 
in the morbidity and mortality associated with ciga­
rette smoking. Finally, because taxes on cigarettes and 
other tobacco products are a relatively simple way to 
generate revenues, it has been suggested that these 
taxes can be set at levels that maximize their returns. 
Each of these alternatives will be discussed. 
Historical or Comparative Standard 
Federal Tobacco Taxes 
Tobacco has been taxed in North America since 
the British government first imposed taxes during co­
lonial times. Beginning in 1794, the U.S. government 
imposed tobacco taxes that periodically rose with rev­
enue needs and subsequently fell because of consumer 
opposition. Since 1864, when cigarette and other to­
bacco taxes were included in a package to finance the 
Civil War, taxes on tobacco in one form or another have 
remained a part of the federal tax system. Taxes con­
tinued to rise and fall over the next 87 years, generally 
increasing with revenue needs during the Spanish-
American War, World Wars I and II, and the Korean 
War (Table 6.10).  The final war-related increase in the 
federal excise tax per pack of cigarettes was from 7.0 
cents to 8.0 cents per pack on November 1, 1951, where 
it remained for the next three decades. 
The most recent federal tax increases were moti­
vated by a need to raise revenues for a different 
purpose—to reduce the increasing federal budget defi­
cit. The first of these hikes in the federal cigarette ex­
cise tax came as part of the Tax Equity and Fiscal 
Responsibility Act of 1982 (Public Law 97-248), which 
temporarily doubled the per pack tax to 16.0 cents, 
effective January 1, 1983.  The tax was to revert to 8 
cents on October 1, 1985, but after several extensions, 
the 16-cent tax was made permanent in 1986. As the 
result of two 4-cent increases included in the Omni­
bus Budget Reconciliation Act of 1990, the tax per pack 
was increased to 20.0 cents on January 1, 1991, and 
then to 24.0 cents on January 1, 1993. Finally, as a re­
sult of the 1998 budget agreement, federal cigarette 
excise taxes are scheduled to rise by 10 cents per pack 
in 2000 and by an additional 5 cents per pack in 2002. 
Also as part of the Consolidated Omnibus Bud­
get Reconciliation Act of 1985, taxes of 8.0, 24.0, and 
45.0 cents per pound were imposed on chewing to­
bacco, snuff, and pipe tobacco, respectively.  These 
were the first new federal taxes on chewing tobacco 
and snuff since 1965, when the taxation was set at 10 
cents per pound. These taxes are currently 12.0, 36.0, 
and 67.5 cents per pound (Table 6.11).  This assessment 
amounts to approximately 2.7 cents per 1.2-ounce can 
of snuff, 2.3 cents per 3-ounce pouch of chewing to­
bacco, and 6.3 cents per 1.5-ounce pouch of pipe to­
bacco. Tobacco for roll-your-own cigarettes is not taxed 
at the federal level. 
State and Local Tobacco Taxes 
All 50 states and the District of Columbia cur­
rently impose excise taxes on cigarettes.  The first of 
these was a tax levied by Iowa in 1921. It was fol­
lowed in 1923 by taxes in Georgia, South Carolina, 
South Dakota, and Utah. On October 1, 1969, North 
Carolina became the last state to impose a tax on ciga­
rettes. As of May 1, 2000, these taxes ranged from 2.5 
cents per pack in Virginia to $1.11 per pack in New 
York (Table 6.12).  Forty-four states currently impose 
taxes on tobacco products other than cigarettes (Table 
6.13); only 17 states imposed such taxes in 1964. In 
general, these other taxes are ad valorem taxes.  The 
general sales tax in most states applies to cigarettes 
and other tobacco products, with the tax base in most 
states including the excise tax. As of November 1, 1999, 
these sales taxes added 8–25 cents per pack to the price 
of cigarettes (Table 6.12).  In eight states, 450 cities and 
counties impose additional taxes on the sale of ciga­
rettes, and 85 of these also tax other tobacco products. 
The largest of the local cigarette taxes are those im­
posed in Chicago (combined county and city taxes of 
34 cents per pack) and New York City (8 cents per 
pack). 
At least until the 1950s, state taxes on cigarettes 
were enacted and raised to generate revenues rather 
than to discourage consumption. The average year 
such taxes were initiated in the six major tobacco-
producing states (1939) slightly predates the average 
year for the other states (1940) (Warner 1981).  Before 
the widespread publicity on the health consequences 
of smoking, the average tax rate in the six tobacco states 
was only slightly lower than that in the other states 
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Effective date Tax per pack of 20 cigarettes (cents)
 

June 30, 1864* 0.8, 2.4 
April 1, 1865† 2.4, 4.0 
August 1, 1866‡ 4.0, 8.0, 8.0+20% 
March 2, 1867 10.0 
July 20, 1868 3.0 
March 3, 1875 3.5 
March 3, 1883 1.0 
August 15, 1897 2.0 
June 14, 1898 3.0 
July 1, 1901§  1.08, 2.16 
July 1, 1910 2.5 
October 4, 1917 4.1 
February 25, 1919 6.0 
July 1, 1940 6.5 
November 1, 1942 7.0 
November 1, 1951 8.0 
January 1, 1983 16.0 
January 1, 1991 20.0 
January 1, 1993 24.0 
January 1, 2000 34.0 
January 1, 2002Δ 39.0 
(2.5 vs. 2.9 cents per pack). Since the release in the 
mid-1950s of the first reports describing the adverse 
health effects of cigarette smoking, and even more so 
since the 1964 release of the initial Surgeon General’s 
report on smoking and health, state governments have 
actively used cigarette taxes as a principal tool in their 
Table 6.10.	 Federal cigarette excise taxes, selected 
dates, 1864–2002 
*Lower rate applied to cigarettes valued at $6 or less 
per 100 packs of 25 each. 
†Lower rate applied to cigarettes valued at $5 or less 
per 100 packs of 25 each. 
‡Lower rate applied to cigarettes valued at $8 or less 
per 1,000. Higher rate applied to cigarettes valued at 
more than $12 per 1,000. 
§Lower rate applied to cigarettes valued at $2 or less 
per 1,000.
ΔScheduled. 
Source:  Orzechowski and Walker 2000. 
Reducing Tobacco Use 
campaigns to reduce tobacco use.  For example, the 
number of tax increases has risen from an average of 
less than three per year in the early 1950s to an aver­
age of more than eight per year in the late 1950s, and a 
record 22 states increased their cigarette taxes in 1965 
(Table 6.14).  Similar activity occurred during 1967– 
1970, when antismoking ads were broadcast under the 
Fairness Doctrine and after cigarette advertising on 
television and radio was banned in 1971. The once-
negligible difference in cigarette excise tax rates be­
tween the tobacco-producing states and other states 
grew substantially over this period.  By May 1, 2000, 
the simple average of cigarette taxes in the six largest 
tobacco-growing states was 7.1 cents compared with 
46.5 cents in the remaining states and the District of 
Columbia. 
The use of increased cigarette and other tobacco 
taxes to discourage all tobacco use was even more ob­
vious in the late 1980s and early 1990s. In November 
1988, California voters approved the Tobacco Tax and 
Health Protection Act (Proposition 99), the then-
largest single increase (25 cents per pack) in any state 
excise tax on cigarettes.  New taxes were also imposed 
on other forms of tobacco. The novel feature of this 
tax hike was that 20 percent of the new revenues gen­
erated by the tax increase was earmarked for tobacco-
related education activities and 5 percent was allocated 
to tobacco-related research. 
The success of Proposition 99 in California led to 
a similar voter-approved measure in Massachusetts. 
In November 1992, voters passed Question 1, which 
raised the state cigarette tax from 26 cents to 51 cents 
per pack and increased the state tax on chewing 
Table 6.11.	 Federal excise tax rates (cents/pound) 
on chewing tobacco, snuff, and pipe 
tobacco, selected years, 1986–2002 
Year 
Chewing 
tobacco Snuff 
Pipe 
tobacco 
1986 8.0 24.0 45.0 
1991 10.0 30.0 56.25 
1993 12.0 36.0 67.5 
2000 17.0 51.0 95.67 
2002* 19.5 58.5 109.69 
*Scheduled.
 

Sources:  Advisory Commission on Intergovernmen­

tal Relations 1991; Bureau of Alcohol, Tobacco and
 

Firearms 2000.
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Table 6.12. State cigarette excise taxes and sales taxes (cents/pack) applied to cigarettes
 
Excise tax rate 
May 1, 
2000 
Sales tax 
November 1, 
State 1999 
Alabama 16.5 11.0 
Alaska 100.0 0 
Arizona 58.0 16.0 
Arkansas 31.5* 13.0 
California 87.0 25.0 
Colorado 20.0 0 
Connecticut 50.0 19.0 
Delaware 24.0 0 
District of Columbia 65.0 19.0 
Florida 33.9 17.0 
Georgia 12.0 8.0 
Hawaii 100.0 15.0 
Idaho 28.0 14.0 
Illinois 58.0 20.0 
Indiana 15.5 13.0 
Iowa 36.0 14.0 
Kansas 24.0 13.0 
Kentucky  3.0 15.0 
Louisiana 20.0 11.0 
Maine 74.0 18.0 
Maryland 66.0 16.0 
Massachusetts 76.0 18.0 
Michigan 75.0 20.0 
Minnesota 48.0 19.0 
Mississippi 18.0 19.0 
Missouri 17.0 11.0 
Excise tax rate 
May 1, 
2000 
Sales tax 
November 1, 
State 1999 
Montana 18.0 0 
Nebraska 34.0 13.0 
Nevada 35.0 20.0 
New Hampshire 52.0 0 
New Jersey 80.0 17.0 
New Mexico 21.0 14.0 
New York 111.0 13.0 
North Carolina 5.0 10.0 
North Dakota 44.0 18.0 
Ohio 24.0 13.0 
Oklahoma 23.0 12.0 
Oregon 68.0 0 
Pennsylvania 31.0 17.0 
Rhode Island 71.0 23.0 
South Carolina 7.0 13.0 
South Dakota 33.0 11.0 
Tennessee 13.0 21.0 
Texas 41.0 18.0 
Utah 51.5 15.0 
Vermont 44.0 15.0 
Virginia 2.5 11.0 
Washington 82.5 23.0 
West Virginia 17.0 15.0 
Wisconsin 59.0 16.0 
Wyoming 12.0 11.0 
*Arkansas tax can rise to 34 cents if the state does not appropriate adequate funds for breast cancer
  research and control. 
Sources:  Orzechowski and Walker 2000; Centers for Disease Control and Prevention, Office on Smoking and 
Health, State Tobacco Activities Tracking and Evaluation System, unpublished data. 
tobacco by 25 percent.  Although Massachusetts law 
prevents funds raised by the tax from being earmarked 
for tobacco-related education and prevention efforts, 
the funds are placed into a Health Protection Fund, 
and the wording of the approved measure strongly 
recommended that at least part of the funds be allo­
cated to activities related to reducing tobacco use. 
More recently, Michigan voters in 1994 enacted 
Proposal A, which changed the financing for Michi­
gan public schools. Part of this plan included raising 
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the general state sales tax (which is applied to ciga­
rettes and other tobacco products) from 4 to 6 percent 
and tripling the state excise tax on cigarettes to 75 cents 
per pack, representing the largest single increase in 
cigarette taxes ever implemented in the United States. 
New taxes were also imposed on various other tobacco 
products.  Six percent of the new revenues were ear­
marked for health improvement activities, including 
tobacco-related education and prevention efforts. 
In November 1994, Arizona voters approved the 
Tobacco Tax and Health Care Act, which included a 
40-cent increase in the state cigarette tax with earmark­
ing provisions similar to those in California, Massa­
chusetts, and Michigan. At the same time, however, 
voters in Colorado rejected a tax hike of 50 cents per 
pack with similar features. In November 1996, Oregon 
voters approved Measure 44, which increased cigarette 
taxes by 30 cents per pack, raised the tax on other to­
bacco products from 35 to 65 percent of wholesale 
price, and dedicated a portion of the increased rev­
enue to tobacco use prevention and education.  Simi­
lar large cigarette-tax increases, including some that 
dedicate significant funds to tobacco control activities, 
have been recently legislated in a number of states, 
including Alaska, Maine, New Jersey, and New York. 
In addition, in 1998, voters in California approved an 
additional 50-cent per pack increase in the state ciga­
rette tax. 
The relative ease with which cigarettes and other 
tobacco products can be transported and the potential 
profits from illegal activity of this kind have limited 
state and local governments’ ability to further raise 
tobacco taxes. The large disparities in price resulting 
from differences in tobacco taxation create incentives 
to (1) smuggle on a casual level (involving small quan­
tities for personal use) or on an organized level (in­
volving large quantities, generally for resale); (2) 
purchase cigarettes through tax-free outlets, including 
military stores and American Indian reservations; and 
(3) illegally divert cigarettes within the usual distri­
bution system by forging tax stamps, which results in 
underreporting.  Altogether, this “butt legging” (ACIR 
1977) can result in a net loss of revenues when tobacco 
taxes are increased. 
Although casual smuggling has always been a 
problem, states reported that organized smuggling 
activities rose significantly after the cigarette tax hikes 
of the late 1960s. In response to state pressure, the 
Trafficking in Contraband Cigarettes Act of 1978 (Pub­
lic Law 95-575) was enacted. This act, which dealt only 
with the organized smuggling of cigarettes, prohib­
ited the single-transaction transport, receipt, shipment, 
possession, distribution, or purchase of more than 
Reducing Tobacco Use 
60,000 cigarettes not bearing the tax indicia of the state 
in which the cigarettes were initially sold.  The ACIR 
(1985) suggests that the law was even more effective 
than its proponents predicted.  Casual smuggling, 
however, may become a more significant problem as 
the differences between cigarette taxes in neighboring 
states increase as the result of some of the recent large 
tax hikes in some states. 
Several econometric analyses of cigarette demand 
have carefully considered the effects of price differen­
tials on organized and casual cigarette smuggling on 
state cigarette sales (Baltagi and Levin 1986, 1992; 
Chaloupka and Saffer 1992; Becker et al. 1994; Saba et 
al. 1995; Jackson and Saba 1997; Yurekli and Zhang 
2000). In general, these studies concluded that smug­
gling has a significant, but small, impact on cigarette 
demand, implying that a state cigarette tax increase 
will lead to some smuggling. Yurekli and Zhang 
(2000), for example, estimate that, on average, 6 per­
cent of state cigarette tax revenues were lost due to 
smuggling activities in 1995. However, given the mag­
nitude of these estimates, Merriman (1994) and Baltagi 
and Levin (1992) estimated that state cigarette taxes 
are below their revenue-maximizing levels.  Thus, 
states can raise cigarette taxes and generate increased 
revenues, even as cigarette sales decline and interstate 
smuggling increases. 
Cigarette Taxes and Cigarette Prices 
Increases in cigarette and other tobacco taxes re­
sult in higher prices for these products.  Most ciga­
rette taxes, however, are excise taxes; unless they are 
increased regularly over time, the value of the tax will 
fall in real terms (after analysis accounts for the effects 
that inflation, as measured by the Consumer Price In­
dex, has on the tax). Because taxes are an important 
component of price, one of the consequences of an ex­
cise tax system with relatively infrequent increases is 
that, at least during the period between excise tax in­
creases, the real price of cigarettes will fall over time 
as the prices of other goods and services increase more 
rapidly. 
When trends are examined in real cigarette prices 
over the past four decades, three clear periods are ob­
served (Table 6.15).  The first is 1955–1971, when states 
were increasing taxes not only to raise revenues but 
also to discourage smoking. The real value of state 
taxes during this period approximately doubled from 
13.1 cents (1982–1984 dollars) to 26.4 cents per pack. 
This increase was more than sufficient to offset the re­
ductions in the real federal tax (from 29.9 cents to 19.8 
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Table 6.13.  State tax rates on tobacco products other than cigarettes as of January 1, 2000 
State Taxes on other tobacco products 
Alabama Cigars retailing for: 
a) <3.5 cents each or less, $150 per thousand; 
b) >3.5 and ≤5 cents each, $3.00 per thousand; 
c) >5 and ≤8 cents each, $4.50 per thousand; 
d) >8 and ≤10 cents each, $7.50 per thousand; 
e) >10 and ≤20 cents each, $15 per thousand; 
f) >20 cents each, $20.25 per thousand. 
Little cigars: 2 cents for each 10 or fraction thereof. 
Smoking tobacco: 
a) <1.125 ounces, 2 cents; 
b) >0.125 ounces and ≤2 ounces, 5 cents; 
c) >2 ounces and ≤3 ounces, 8 cents; 
d) >3 ounces and ≤4 ounces, 11 cents; 
e) 3 cents additional tax for each ounce or fraction part thereof over
 4 ounces. 
Chewing tobacco: 0.75 cents of each ounce or fraction thereof. 
Snuff: 
a) <0.625 ounces, 0.5 cents; 
b) >0.625 ounces, and ≤1.625 ounces, 1 cent; 
c) >1.625 ounces and ≤2.5 ounces, 2 cents; 
d) >2.5 ounces and ≤3 ounces, 2.5 cents; 
e) >3 ounces and ≤5 ounces (cans, packages, gullets), 3 cents; 
f) >3 ounces and ≤5 ounces (glasses, tumblers, bottles), 3.5 cents; 
g) >5 ounces and ≤6 ounces, 4 cents; 
h) 1 cent additional tax for each ounce or fraction thereof over 6 ounces. 
Alaska 75% of wholesale price. 
Arizona Cigars retailing for: 
a) ≤5 cents, 6.4 cents for each 3 cigars; 
b) >5 cents, 6.4 cents each. 
Little cigars: 12.9 cents for each 20 or fraction thereof. 
Smoking and chewing tobacco and snuff: 6.5 cents per ounce or 
major fraction thereof. 
Plug tobacco: 1.6 cents per ounce or fraction thereof. 
Arkansas 23% of manufacturers’ invoice price. 
California* 61.56% of wholesale price.† 
Colorado 20% of manufacturers’ price. 
Connecticut* 20% of manufacturers’ price. 
Delaware 15% of wholesale price. 
District of Columbia None. 
*Little cigars taxed at the same rate as cigarettes. 
†California rate reset at beginning of each fiscal year; New Hampshire rate reset semiannually. 
‡Maryland tax becomes effective July 1, 2000.
 

Sources:  Orzechowski and Walker 2000; Centers for Disease Control and Prevention, Office on Smoking and
 

Health, State Tobacco Activities Tracking and Evaluation System, unpublished data.
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Table 6.13.  Continued 
State Taxes on other tobacco products 
Florida Smoking tobacco, chewing tobacco, and snuff:  25% of wholesale price. 
Georgia Little cigars: weighing ≤3 pounds per 1,000, 2 mills each. 
All other cigars: 13% of wholesale price. 
Hawaii 40% of wholesale price. 
Idaho 40% of wholesale sales price. 
Illinois 18% of wholesale price. 
Indiana 15% of wholesale price. 
Iowa* 22% of wholesale price. 
Kansas 10% of original invoice price from the manufacturer to the wholesaler. 
Kentucky None. 
Louisiana Cigars: 
a) a list price of $120 per thousand or less, tax is 8% of net invoice price; 
b) a list price of over $120 per thousand, tax is 20% of net invoice price. 
Smoking tobacco: 33% of net invoice price. 
Maine* Chewing tobacco and snuff:  62% of wholesale sales price. 
Cigars and smoking tobacco: 16% of wholesale sales price. 
Maryland‡ All other products 15% of wholesale price. 
Massachusetts 75% of wholesale price for smokeless tobacco products. 15% of wholesale price 
for cigars and pipe tobacco. 
Michigan 16% of wholesale price. 
Minnesota 35% of wholesale price. 
Mississippi 15% of manufacturers’ list price. 
Missouri 10% of manufacturers’ price. 
Montana 12.5% of wholesale price. 
Nebraska 15% of wholesale price. 
Nevada 30% of wholesale price. 
New Hampshire† Chewing tobacco and snuff:  17.9% of wholesale price invoiced to retailer. 
New Jersey 48% of wholesale price. 
New Mexico 25% of product value. 
New York 20% of wholesale price. 
North Carolina 2% of wholesale price. 
North Dakota 28% of wholesale price. 
Ohio 17% of wholesale price. 
Oklahoma Cigars, cheroots, stogies, etc., weighing >3 pounds per thousand retailing for: 
a) ≤4 cents each, $10 per thousand; 
b) >4 cents each, $30 per thousand. 
Little cigars: 9 mills each. 
Smoking tobacco: 40% of factory list price. 
Chewing tobacco and snuff:  30% of factory list price. 
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Table 6.13.  Continued 
State Taxes on other tobacco products
 

Oregon* 65% of wholesale sales price.
 

Pennsylvania None.
 

Rhode Island 20% of wholesale price.
 

South Carolina Cigars, cheroots, stogies, etc., retailing for:
 

a) ≤5 cents each, $11 per thousand; 
b) >5 cents each, $20 per thousand. 
Little cigars: 2 cents for each 8 or fraction thereof. 
Smoking tobacco: 36% of manufacturers’ price. 
Chewing tobacco and snuff:  5% of manufacturers’ price. 
South Dakota 10% of wholesale price. 
Tennessee* 6% of wholesale price. 
Texas Cigars: Tax on cigars and tobacco is based on weight per 1,000 and retail selling 
price. 
a) ≥3 pounds per 1,000, 1 cent for each 10 cigars; 
b) >3 pounds per 1,000 and retailing for ≤3.3 cents each, $7.50
 per 1,000; 
c) >3 pounds per 1,000, retailing for >3.3 cents each and
    containing a substantial amount of nontobacco ingredients,
    $11 per thousand; 
d) >3 pounds per 1,000, retailing for >3.3 cents each and
    containing a substantial amount of nontobacco ingredients,
 $15 per thousand; 
e) Chewing, pipe, or smoking tobacco, and snuff:  35.213% of the
    manufacturers’ list price exclusive of any trade discount, special discount, 
or deal. 
Utah 35% of manufacturers’ selling price delivered into state. 
Vermont 41% of distributors’ price. 
Virginia None. 
Washington 74.9% of wholesale price. 
West Virginia None. 
Wisconsin 20% of wholesale price. 
Wyoming All other products 20% of wholesale price. 
cents per pack); as a result, cigarette taxes continued 
to account for about 50 percent of cigarette prices. 
during this period, taxes as a share of cigarette prices 
fell from 46.8 to 33.1 percent, because the nontax com­
ponent of real price was relatively stable. During the 1970s, however, the real price of ciga­
rettes dropped significantly because of the stability of 
cigarette excise taxes and the relatively rapid increases 
in the prices of other goods and services. During this 
period, the real value of the federal cigarette tax (which 
was unchanged in nominal terms) fell by more than 
50 percent, and the real value of state taxes dropped 
by nearly as much. The net result was a decline of 
38.5 percent in the real price of cigarettes.  Moreover, 
Since 1981, however, the real price of cigarettes 
has increased sharply, from 69.3 cents to 127.1 cents 
per pack in November 1992, and further in early 1993. 
Important factors behind this increase were the fed­
eral tax increases in 1983, 1991, and 1993, which tripled 
the nominal value of the cigarette excise tax. Also 
important was the steady rise in the real value of av­
erage state excise taxes on cigarettes, from a low of 
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Table 6.14. Number of increases and decreases in 
state excise taxes on cigarettes, 
July 1, 1950–May 1, 2000 
(from 33.1 to 24.9 percent).  The most important factor 
behind the rise in real cigarette prices, then, was the 
sharp rise in nontax (i.e., manufacturer-added) price 
components. In 1981, the real value of the nontax por­
tion of average cigarette prices was 46 cents.  By 1993, 
this amount was 79.5 cents, which is an increase of 
more than 70 percent.  As described earlier in this chap­
ter, in “High Tobacco Concentration and the Impact of 
Prevention Policies,” much of this increase was attrib­
utable to the less than perfectly competitive supply 
side of the cigarette market.  The result of the increases 
in both the tax and the nontax components of ciga­
rette prices was an increase of almost 85 percent in the 
real price of cigarettes from 1981 to 1993. 
Increases Increases 
Year (Decreases) Year (Decreases) 
1950 2 1976 1 
1951 7 (1) 1977 4 
1952 0 1978 1 (1) 
1953 2 1979 4 
1954 3 1980 2 
1955 11 1981 6 (1) 
1956 5 (1) 1982 10 
1957 8 1983 13 
1958 4 1984 4 
1959 15 1985 11 
1960 4 (2) 1986 6 
1961 17 (1) 1987 13 
1962 2 1988 3 
1963 15 1989 14 (1) 
1964 5 1990 8 
1965 22 1991 13 (1) 
1966 4 (1) 1992 7 
1967 12 1993 15 (2) 
1968 8 1994 8 
1969 20 1995 5 
1970 7 1996 2 
1971 16 1997 9 
1972 5 1998 2 
1973 2 1999 3 
1974 2 2000 1 
1975 5 
Sources:  Orzechowski and Walker 2000; Centers for 
Disease Control and Prevention, Office on Smoking 
and Health, State Tobacco Activities Tracking and 
Evaluation System, unpublished data. 
14.0 cents per pack in 1982 to 19.4 cents per pack in 
1993. However, even with the increases in the real 
values of the federal and state taxes on cigarettes, taxes 
as a share of price fell substantially from 1981 to 1993 
Real cigarette prices declined sharply as a result 
of “Marlboro Friday” in April 1993, when wholesale 
cigarette prices, first for Marlboro then soon after for 
other premium brands, were cut by 25 percent.  More 
recently, however, real cigarette prices have risen sig­
nificantly.  These increases are partly the result of in­
creases in state and federal cigarette excise taxes over 
the past few years. More important, however, are the 
significant increases in wholesale cigarette prices be­
ginning in 1997. These prices increased by more than 
12 percent between March 1997 and April 1998, return­
ing to their 1992 nominal level (USDA 1998a), in part 
the result of increased costs associated with tobacco 
industry settlements with Mississippi, Florida, Texas, 
and Minnesota. Wholesale prices increased an addi­
tional 45 cents per pack in November 1998, on the day 
the Master Settlement Agreement was announced. 
This increase, the largest in history, was followed nine 
months later by an additional 18-cent per pack increase 
(USDA 2000). 
International Tobacco Taxes 
Among industrialized countries around the world, 
the United States has one of the lowest average prices 
and taxes on cigarettes (Table 6.16).  As of December 
31, 1996, the average tax in the United States was 66.0 
cents per pack, well below the taxes imposed in almost 
every other industrialized country. At that time, taxes 
in various other countries, in U.S. dollars, ranged from 
$5.23 per pack in Norway to 47 cents per pack in 
South Africa.  Most developed countries have at least 
double the average tax in the United States. Some in­
teresting features of these taxes include earmarking 
for tobacco-related education and other health-related 
activities (in Denmark, Finland, Iceland, Peru, and else­
where), the creation of state-based Health Promotion 
Foundations in Australia and the Health Sponsorship 
Council in New Zealand to fund sporting and artistic 
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Table 6.15.  Cigarette taxes and cigarette prices, 1955–2000 (cents/pack) 
Taxes as a Real Real 
Weighted Average Average percentage of Real average average 
Year 
average 
state tax*† 
federal 
tax† 
cigarette 
price‡ 
average 
price§ 
average 
state tax†Δ
federal 
tax†Δ
cigarette 
priceΔ
1955 3.5 8.0 22.7 48.7 13.1 29.9 84.7 
1956 3.8 8.0 23.2 47.4 14.0 29.4 85.3 
1957 3.9 8.0 23.8 48.8 13.9 28.5 84.7 
1958 4.0 8.0 25.0 48.0 13.8 27.7 86.5 
1959 4.2 8.0 25.6 46.6 14.4 27.5 88.0 
1960 4.7 8.0 26.1 48.9 15.9 27.0 88.2 
1961 4.7 8.0 26.1 48.6 15.7 26.8 87.3 
1962 5.1 8.0 26.9 48.3 16.9 26.5 89.1 
1963 5.2 8.0 26.8 49.4 17.0 26.1 87.6 
1964 5.6 8.0 27.9 49.3 18.1 25.8 90.0 
1965 5.9 8.0 28.2 49.8 18.7 25.4 89.5 
1966 6.9 8.0 30.0 51.4 21.3 24.7 92.6 
1967 7.1 8.0 30.5 50.8 21.3 24.0 91.3 
1968 8.4 8.0 32.3 49.2 24.1 23.0 92.8 
1969 9.1 8.0 32.8 48.9 24.8 21.8 89.4 
1970 10.2 8.0 37.1 47.7 26.3 20.6 95.6 
1971 10.7 8.0 38.9 46.8 26.4 19.8 96.0 
1972 11.6 8.0 40.0 47.7 27.8 19.1 95.7 
1973 12.1 8.0 40.3 48.4 27.3 18.0 90.8 
1974 12.1 8.0 41.8 47.6 24.5 16.2 84.8 
*State taxes are an average of taxes in all taxing states (42 in 1955; 50 in 1970 and thereafter) and the District of 
 Columbia, weighted by tax-paid cigarette sales in those states. 
†Nominal and real average state and federal tax data are for the fiscal year ending June 30. 
‡Price reflects the median retail price for cigarettes (including generic brands) in all taxing states, generally as 
 of November 1 of the state fiscal year. 
§Percentages cannot be calculated directly from the tax and price information, because taxes are weighted 
 average taxes for the entire fiscal year, whereas prices and percentages are generally as of November 1.
ΔReal cigarette taxes and prices are obtained by dividing the nominal taxes and prices by the national 
 Consumer Price Index; the average of 1982–1984 is the benchmark. 
¶Preliminary estimate. 
Source:  Orzechowski and Walker 2000. 
events previously backed by the tobacco industry, and 
the differential taxes on cigarettes with high-tar and 
high-nicotine content used in previous years in the 
United Kingdom (Roemer 1993). 
One consequence of the differences in cigarette 
taxes and prices across countries is the potential for 
casual and organized cigarette smuggling and other 
forms of tax evasion. The cigarette industry, for ex­
ample, frequently argues that cigarette tax increases 
   Economic Approaches 347
 
   
Reducing Tobacco Use 
Table 6.15.  Continued 
Taxes as a Real Real 
Weighted Average Average percentage of Real average average 
Year 
average 
state tax*† 
federal 
tax† 
cigarette 
price‡ 
average 
price§ 
average 
state tax†Δ
federal 
tax†Δ
cigarette 
priceΔ
1975 12.2 8.0 44.5 44.5 22.7 14.9 82.7 
1976 12.4 8.0 47.9 41.4 21.8 14.1 84.2 
1977 12.5 8.0 49.2 40.5 20.6 13.2 81.2 
1978 12.9 8.0 54.3 37.1 19.8 12.3 83.3 
1979 12.9 8.0 56.8 35.5 17.8 11.0 78.2 
1980 13.1 8.0 60.0 34.5 15.9 9.7 72.8 
1981 13.2 8.0 63.0 33.1 14.5 8.8 69.3 
1982 13.5 8.0 69.7 29.9 14.0 8.3 72.2 
1983 14.7 12.0 81.9 26.8 14.8 12.0 82.2 
1984 15.3 16.0 94.7 33.2 14.7 15.4 91.1 
1985 15.9 16.0 97.8 32.3 14.8 14.9 90.9 
1986 16.2 16.0 104.5 30.8 14.8 14.6 95.3 
1987 16.9 16.0 110.0 29.9 14.9 14.1 96.8 
1988 18.2 16.0 122.2 28.1 15.4 13.5 103.3 
1989 21.8 16.0 127.5 26.5 17.6 12.9 102.8 
1990 24.7 16.0 144.1 26.4 18.9 12.2` 110.3 
1991 25.9 16.0 153.3 25.6 19.0 11.7 112.6 
1992 26.5 20.0 173.5 25.6 18.9 14.3 123.7 
1993 28.0 22.0 183.7 24.9 19.4 15.2 127.1 
1994 31.5 24.0 169.3 31.4 21.3 16.2 114.2 
1995 31.2 24.0 175.8 31.0 20.5 15.7 115.4 
1996 31.7 24.0 179.6 31.6 20.2 15.3 114.5 
1997 31.8 24.0 185.4 30.5 19.8 15.0 115.5 
1998 34.1 24.0 195.0 31.5 20.9 14.7 119.6 
1999 36.4 24.0 217.5 28.2 21.8 14.4 130.6 
2000 39.8¶ 29.0¶ 292.6 22.1 23.2¶ 16.9¶ 170.5¶ 
will actually lead to reductions in tax revenues due to 
smuggling and other tax evasion (British-American 
Tobacco Company Limited 1994).  The smuggling 
problem is exacerbated by the relative ease with which 
tobacco products can be transported, the potential prof­
its from this illegal activity, the presence of corruption 
and organized crime, the widespread street selling, the 
availability of tax-free and duty-free cigarettes, and the 
nonexistent or relatively weak policies concerning 
cigarette smuggling and their lack of enforcement 
(ACIR 1977, 1985; Joossens and Raw 1995; Joossens et 
al., in press). Joossens and Raw (1995, 1998) argued 
that many of these other factors can be as important 
as price differences in spawning cigarette smuggling. 
For example, they noted that there is little evidence of 
smuggling in some of the highest priced European 
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Table 6.16. Average retail cigarette price and total taxes per pack (U.S. dollars/pack), selected countries, 
December 31, 1996 
Average Tax as a percentage 
Country retail price Total taxes of retail price* 
Norway 7.05 5.23 74 
United Kingdom 5.27 4.30 82 
Ireland 4.94 4.16 84 
Denmark 4.75 4.02 85 
Finland 4.54 3.48 77 
Australia 4.50 2.92 65 
Sweden 4.47 3.13 70 
New Zealand 4.17 2.79 66 
Canada (highest provincial taxes) 4.09 2.97 73 
Singapore 3.72 1.87 50 
Hong Kong 3.62 1.76 49 
France 3.47 2.61 75 
Belgium 3.23 2.39 74 
Germany 3.18 2.28 72 
Canada (average provincial taxes) 3.00 1.97 66 
Austria 2.84 2.11 74 
Netherlands 2.66 1.94 73 
United States (highest state taxes) 2.65 1.24 47 
Italy 2.17 1.59 73 
Canada (lowest provincial taxes) 2.02 1.12 55 
United States (average state taxes) 1.90 0.66 35 
Greece 1.82 1.33 73 
Portugal 1.77 1.43 81 
United States (lowest state taxes) 1.60 0.34 21 
Thailand 1.58 0.89 56 
Taiwan 1.45 0.62 43 
Brazil 1.43 1.06 74 
Spain 1.08 0.81 75 
South Africa 1.04 0.47 45 
Notes:  (a) Figures given are for a package of 20 of the most popular price category; (b) exchange rates are 
from the Bank of Canada Official Exchange Rates as of December 31, 1996. 
*The tax as a percentage of retail price refers to the portion of the average retail selling price that composes all
  applicable taxes and other fees imposed on the product. 
Source:  Smoking and Health Action Foundation (Canada), unpublished data, April 30, 1997. 
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countries, including France, Norway, Sweden, and the 
United Kingdom, whereas there is extensive evidence 
of smuggling in countries with relatively low prices, 
such as Spain and Italy.  Merriman and colleagues (in 
press) provide empirical evidence that the perceived 
level of corruption explains more of the variance in 
experts’ estimates of the magnitude of cigarette smug­
gling than do cigarette prices.  Moreover, Joossens and 
colleagues (Joossens and Raw 1998; Joossens et al., in 
press) concluded that much of the smuggling that does 
occur in Europe and elsewhere is encouraged by mul­
tinational tobacco companies. Thursby and Thursby 
(1994) provided empirical support for this argument, 
based on their analysis of data from the United States 
from which they concluded that increases in federal 
cigarette excise taxes lead to increased commercial 
cigarette smuggling. 
Perhaps the most interesting international com­
parison is between cigarette tax policy in the United 
States and Canada. In 1970, average taxes (including 
sales taxes) on cigarettes were 30 cents per pack in 
Canada and 20 cents per pack in the United States. By 
1980, the average Canadian tax, 46 cents per pack, was 
double the U.S. tax. Real prices in both countries had 
fallen sharply throughout the 1970s, but after 1980, the 
gap between the two countries widened rapidly.  One 
main reason for this change was the adoption of an ad 
valorem tax by the federal and provincial governments 
in Canada. As a result, cigarette taxes in Canada 
doubled between 1980 and 1984, leading to a 25­
percent increase in real cigarette prices.  In response 
to pressure from the cigarette industry, however, the 
ad valorem tax structure was replaced with an excise 
tax system in 1984. 
The growth in Canadian taxes slowed over the 
next few years. Most taxing took place at the provin­
cial rather than the federal level. In 1988, however, 
the Canadian federal government committed to an 
aggressive campaign to reduce tobacco use; highlight­
ing the campaign was a ban enacted that year on to­
bacco advertising. In 1989, the federal tax was raised 
by 2 cents per cigarette, and another hike of 3 cents 
per cigarette occurred in 1991.  At the same time, pro­
vincial taxes were increasing rapidly.  By early 1994, 
the average tax per pack of cigarettes was $2.96 (in 
U.S. dollars), which is more than five times the aver­
age U.S. tax. 
The large disparities in Canadian and U.S. ciga­
rette prices led to substantial smuggling, which was 
enabled by the long stretches of unmonitored border 
between Canada and the United States, the relatively 
weak border controls, and the high concentration of 
the Canadian population near U.S. borders (Sweanor 
Reducing Tobacco Use 
and Martial 1994). Much of the black market trade 
that resulted was in Canadian-produced cigarettes that 
had been exported to the United States (exports were 
not subject to the Canadian taxes) and then smuggled 
back into Canada. Relatively little black market trade 
involved cigarettes produced in the United States; U.S. 
cigarettes use a blend of tobacco different from Cana­
dian cigarettes and are less desired by Canadian smok­
ers (Sweanor and Martial 1994). In a short-lived effort 
to reduce the smuggling problem, a tax of 80 cents per 
pack was applied to Canadian cigarette exports in mid-
February 1992. This tax was repealed six weeks later, 
although preliminary evidence indicated that it had 
been successful in reducing smuggling (Sweanor and 
Martial 1994). After the repeal of the export tax, Ca­
nadian cigarette exports to the United States rose dra­
matically, and smuggling increased again. 
In response to an aggressive industry-sponsored 
campaign, the federal tax on cigarettes in Canada was 
reduced by $5.00 per carton on February 9, 1994.  More­
over, the federal government agreed to match provin­
cial reductions in taxes up to an additional $10.00 per 
carton. Quebec immediately lowered its provincial tax 
by $11.00 per carton for a total tax cut of $26.00 per 
carton, leading to a 50-percent drop in price.  By Au­
gust 1994, four other provinces had reduced cigarette 
taxes substantially.  These cuts reduced the average 
Canadian tax per pack from $2.96 before the federal 
tax cut to $1.97 as of December 31, 1996 (in U.S. dol­
lars), which was an amount still well above the aver­
age U.S. cigarette tax of 66 cents per pack at that time. 
The Canadian experience was cited by the tobacco 
industry during the recent debates over the proposed 
national tobacco settlement as evidence that a black 
market in cigarettes would develop in the United States 
in response to large cigarette tax increases.  However, 
there is little evidence to support this contention. Given 
that Canadian cigarette taxes were reduced because of 
smuggling from the United States, it is likely that these 
taxes would be increased if the United States were to 
adopt large tax increases, making it unlikely that wide­
spread smuggling of cigarettes from Canada into the 
United States would occur.  Cigarette prices in Mexico, 
however, are well below those in the United States, and 
large increases in U.S. prices could make smuggling 
cigarettes from Mexico a highly profitable venture.  To 
date, however, no empirical evidence supports the con­
tention of significant smuggling of cigarettes from 
Mexico into the United States. Furthermore, unlike the 
U.S.-Canadian border, the border between the United 
States and Mexico is relatively short and heavily 
guarded, making it much more difficult to smuggle 
large quantities of a bulky product like cigarettes. 
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Finally, several relatively easy options exist for 
limiting cigarette smuggling (Joossens and van der 
Merwe 1997; Joossens et al., in press).  These include 
prominent tax-paid markings on all tobacco products 
and sizable increases in the penalties for cigarette 
smuggling. The ACIR (1985), for example, concluded 
that the Trafficking in Contraband Cigarettes Act (Pub­
lic Law 95-575), which prohibited the transportation, 
receipt, shipment, possession, distribution, or purchase 
of large quantities of cigarettes that did not bear the 
tax indicia of the state in which the cigarettes are found, 
led to a significant reduction in interstate cigarette 
smuggling resulting from interstate price differentials. 
Discussion 
If one applies Cook and Moore’s (1993) discus­
sion of alcohol taxes to cigarette taxes, a provocative 
question arises when one compares previous cigarette 
excise taxes with current ones:  why is the current tax 
rate deemed appropriate when it is just over one-half 
the level that was deemed appropriate in 1951?  Un­
less it is in the public interest to tax cigarettes at a much 
lower rate now than then (an odd notion, given that in 
1951 much less evidence was available on the health 
hazards of smoking), a case can be made for restoring 
taxes to their earlier levels. Similar arguments can be 
made at the state level, particularly in those states 
where taxes have not changed or have been increased 
modestly and infrequently over time. 
Other, comparative standards for appropriate 
taxes could be used. For example, as shown in Table 
6.12, state excise taxes on cigarettes differ substantially; 
these differences reflect several factors, including the 
importance of tobacco for the local economy.  At an­
other level of comparison, large differences between 
cigarette taxes in Canada and the United States gave 
rise to a significant black market trade, which in turn 
resulted in reductions in Canadian taxes.  At the glo­
bal level, cigarette and other tobacco taxes in the United 
States are among the lowest in industrialized coun­
tries around the world.  Such comparisons suggest that 
relatively high taxes may be appropriate in some ar­
eas and low taxes appropriate in others.  On the other 
hand, one could argue that the taxes on all tobacco 
products should be equivalent.  This last issue is dis­
cussed in greater detail in the next section, “Fairness 
Standard and Optimal Cigarette Taxes.” 
Taxes on smokeless tobacco products are much 
lower than taxes on cigarettes, particularly at the fed­
eral level. The limited research suggests that increases 
in cigarette excise taxes may have reduced cigarette 
smoking but also may have contributed to an increased 
use of smokeless tobacco products (Ohsfeldt and Boyle 
1994; Ohsfeldt et al. 1997, 1999). Some public health 
advocates and others have therefore called for the 
equalization of taxes on tobacco (CSH 1994; U.S. House 
of Representatives 1994). 
Fairness Standard and Optimal 
Cigarette Taxes 
Fair tax policy is an issue that is often debated 
but difficult to apply when “optimal” taxes of poten­
tially hazardous substances are discussed (Cook and 
Moore 1993).  For taxes on cigarettes and other tobacco 
products, part of the debate revolves around the per­
ceived health benefits and reductions in social costs 
associated with higher taxes. 
In their analysis of economic interventions to re­
duce alcohol abuse, Cook and Moore (1993) noted that 
several criteria can be included to judge fairness by 
those on both sides of the debate. These criteria in­
clude a horizontal equity criterion, which suggests that 
equals should be treated equally; a vertical equity cri­
terion, which suggests that those with the greatest abil­
ity to pay should be taxed more heavily; and a benefit 
criterion, which suggests that those who receive the 
greatest benefit from government activities should be 
taxed more heavily.  If the basic notion is accepted that 
people who are otherwise similar should be taxed dif­
ferently because one uses more tobacco products than 
the other (a notion that violates the horizontal equity 
criterion), then other questions about fairness arise. 
These include questions concerning the alleged 
regressivity of the taxes and the external costs of smok­
ing and other tobacco use (Cook and Moore 1993). 
Equity, Incidence, and Distribution of the Tobacco 
Tax Burden 
As has been discussed previously, increases in 
cigarette excise taxes are passed on to consumers 
through higher cigarette prices.  Primarily because of 
the less than perfectly competitive nature of the ciga­
rette industry, prices have increased by more than re­
cent increases in cigarette taxes.  Because consumers will 
pay at least the full amount of a tax increase in higher 
cigarette prices, some questions of fairness revolve 
around the distributional effects of the tax hike.  To un­
derstand these effects, it is useful to look at the relation­
ship between tobacco use and income (or expenditures). 
(As Cook and Moore [1993] note, income or expendi­
tures are not the only scale on which fairness can be 
judged, but they are the most commonly used.) 
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A 1990 report by the Congressional Budget 
Office (CBO), which used data from the 1984–1985 
Consumer Expenditure Survey, made several obser­
vations. For example, expenditures on tobacco prod­
ucts increased with income except for people in the 
highest income quintile. As a percentage of posttax 
income, however, spending on tobacco was highest in 
the lowest income quintile (4.0 percent of posttax in­
come) and fell almost proportionately with increased 
income. Also, if expenditures on tobacco are consid­
ered as a percentage of expenditures on all goods and 
services, however, the share of tobacco expenditures 
fell gradually over the first four income quintiles (from 
1.6 to 1.1 percent) and dropped sharply only in the 
top quintile (to 0.7 percent). Thus, the CBO notes, if 
annual family expenditures are more reflective of life­
time income than annual family income, then expen­
ditures on tobacco are only slightly regressive over 
income classes. Finally, the CBO noted that younger 
families spent a higher percentage of income on to­
bacco products and that their share of spending on 
tobacco products as a percentage of total expenditures 
was higher as well. 
To examine the distributional impact of cigarette 
excise tax increases on consumers, the CBO simulated 
what the effects on expenditures would be were the 
1990 federal excise tax on cigarettes (16 cents per pack) 
doubled. At first glance, the simulated increase ap­
peared to fall most heavily on the lowest income cate­
gories, thereby implying that cigarette taxes are 
regressive.  However, when income tax brackets and 
transfer payments (discussed in the next section, “Es­
timates of the Costs of Smoking”) were indexed to ac­
count for the price increases associated with excise tax 
hikes, lowering individual income taxes and raising 
transfer payments, the apparent regressivity of the tax 
was reduced.  When looking at the tax increase rela­
tive to expenditures rather than income, the CBO con­
cluded that cigarette taxes were approximately 
proportional rather than regressive.  Finally, the CBO 
noted that the largest share of the simulated tax increase 
was paid for by families in the third and fourth income 
quintiles and that the smallest share was paid by fami­
lies in the lowest income (first and second) quintiles. 
All of the CBO estimates were based on measures 
of current income. Lyon and Schwab (1995) used an 
alternative approach that used measures of permanent 
or lifetime income to examine the distributional effects 
of cigarette and other “sin” taxes. This approach could 
account for the intertemporal nature of cigarette con­
sumption decisions. The investigators concluded that 
cigarette excise taxes are as regressive as was implied 
by studies based on current income. 
Although cigarette taxes fall most heavily on 
lower income groups, two recent studies suggest that 
increases in cigarette taxes may reduce the perceived 
regressivity of these taxes.  A study using data from 
the British General Household Survey concluded that 
people in the lowest income groups were the most re­
sponsive to price increases (Townsend et al. 1994).  Simi­
lar findings have been obtained in the United States 
using data from 13 of the National Health Interview 
Surveys conducted from 1976 through 1993 (CDC 1998). 
The price elasticity of cigarette demand by those at or 
below the median income was estimated to be approxi­
mately 70 percent higher than that for persons above 
the median. Another study found that less educated 
persons were more responsive than more educated 
persons to cigarette price changes (Chaloupka 1991). 
Given the high correlation between income and edu­
cation, the three studies implied that increased ciga­
rette taxes would reduce observed differences in 
smoking among socioeconomic groups (i.e., that smok­
ing prevalence is higher in the lower socioeconomic 
groups) and would thereby counter the perception that 
cigarette taxes are regressive.  Recent research from 
developing countries supports the hypothesis that 
lower income populations are relatively more sensi­
tive to price (Jha and Chaloupka 1999; see Chaloupka 
et al., in press, for a thorough review).  Indeed, while 
cigarette taxes may fall more heavily on lower income 
groups, an increase in the cigarette tax, because of the 
greater price sensitivity of lower income smokers, may 
actually be progressive.  Moreover, given the estimates 
from these studies, the health benefits resulting from 
reductions in smoking stimulated by increased ciga­
rette taxes would be disproportionately larger in the 
lowest income populations. 
Finally, as the CBO report pointed out, although 
the potential regressivity of cigarette taxes is of some 
concern, the U.S. tax system is a mix of many different 
taxes. Increased progressivity of other taxes and trans­
fer programs could be used to compensate low income 
families for the tax increase.  The CBO considered three 
alternative changes—a 5-percent increase in food 
stamp payments, a 10-percent increase in the earned 
income tax credit, and a combination of the two—to 
offset the potential regressivity of an increase in the 
cigarette excise tax.  In each case, the CBO concluded 
that these changes would spend about 15 percent of 
the net revenues resulting from the tax increase.  A simi­
lar idea was implicit in the proposed Health Security 
Act of 1993, which proposed a federal tax increase of 
75 cents per pack to partially finance the provision 
of health insurance and the expansion of benefits 
to the uninsured and underinsured, most of whom are 
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in lower socioeconomic groups.  Likewise, several re­
cent proposals for national tobacco legislation contain 
provisions that would offset the potential regressivity 
of large increases in cigarette taxes. 
Estimates of the Costs of Smoking 
An alternative approach to the question of fair­
ness deals with the notion that smokers and other to­
bacco users impose costs on nonusers. One of these 
costs is the health consequences for nonsmokers of 
exposure to ETS. A second is the financial external 
effect caused by collectively financed programs (e.g., 
Medicaid and Medicare) where payments in and out 
are not tied to changes in costs and life expectancy 
caused by smoking. Thus it can be argued that it would 
be fair for smokers and other tobacco users to pay for 
the consequences of their use. Cigarette and other to­
bacco taxes are one relatively efficient approach for 
attaining this result. However, to set taxes at a level 
sufficient to cover the costs of cigarette smoking and 
other tobacco use requires an estimate of these costs. 
All studies of the economic costs of tobacco use 
have focused on the costs of cigarette smoking.  The 
Office of Technology Assessment (U.S. House of Rep­
resentatives 1994) has noted that although measuring 
these costs is an inexact science, three general compo­
nents are included: 
•	 	 The direct costs of providing health care services 
to those persons with smoking-related diseases. 
Such costs include expenditures for preventing, 
detecting, diagnosing, and treating smoking-
related diseases and medical conditions. 
•	 	 The indirect morbidity costs associated with lost 
earnings from work because of smoking-related 
illness. 
•	 	 The indirect mortality costs related to the loss of 
future earnings from premature death from 
smoking-related causes. 
Researchers have tried to estimate the economic 
costs of cigarette smoking by using data from the United 
States (Rice et al. 1986; Manning et al. 1989, 1991; 
Hodgson 1992; CDC 1994; U.S. House of Representa­
tives 1994; Miller et al. 1998, 1999) and elsewhere (see 
Lightwood et al., in press, for a comprehensive review). 
In addition, as part of the research resulting from Propo­
sition 99, several recent studies have estimated these 
costs for California (California Department of Health 
Services 1992; Rice and Max 1992; Max and Rice 1995). 
Most of the estimates of the economic costs of 
smoking have been prevalence based.  That is, they 
are based on the estimated prevalence of smoking-
related illnesses in a given year and on the costs asso­
ciated with those illnesses. Because of the long lags 
between smoking initiation and the onset of most 
smoking-related illnesses, these estimates reflect his­
torical trends in smoking and thus cannot be used to 
predict the impact of changes in smoking prevention 
policies except over long periods. However, this ap­
proach has been widely used because of its relatively 
simple methodology and the availability of reliable 
data (Rice et al. 1986). 
Several of the recent estimates of the costs of 
smoking have been incidence based (Oster et al. 1984; 
Manning et al. 1989, 1991; Hay 1991; Hodgson 1992). 
That is, these studies attempt to estimate the average 
additional costs of smoking over the smoker’s lifetime. 
Cost estimates would differ by the person’s age, sex, 
and level of smoking (i.e., a heavy smoker would have 
higher lifetime costs than a relatively light smoker with 
the same characteristics). These estimates of the costs 
of smoking can be useful for policymakers, who can 
estimate the change in the costs of smoking associated 
with a change in smoking behavior resulting from a 
change in policies to reduce smoking.  However, these 
estimates are sensitive to assumptions about future 
costs and about issues such as technological change 
and its diffusion (Hodgson 1988). 
Many of the studies of the economic costs of 
smoking have included notably different direct costs 
in their computations. For example, most include the 
costs of hospital and nursing home care, physicians’ 
fees, and medications used to treat smoking-related 
illnesses. One such study estimated that these costs in 
1993 were $50 billion and that 43.3 percent of them 
were paid through public sources (CDC 1994). How­
ever, some studies of direct costs have been limited to 
the costs associated with lung cancer only, whereas oth­
ers examined a more comprehensive list of smoking-
related illnesses, including cardiovascular disease and 
chronic obstructive pulmonary disease. 
Other more recent studies have sought a broader 
measure of the direct costs of smoking by comparing 
the differences between total health care spending by 
smokers and nonsmokers. The most sophisticated of 
these recent studies control for other risk factors likely 
to be correlated with smoking in an effort to isolate 
the impact of smoking on medical expenditures (Miller 
et al. 1998, 1999). These recent studies estimated 
smoking-attributable medical care costs of between $53 
billion and $73 billion for 1993, or between 6.5 percent 
and 11.8 percent of all U.S. health care expenditures. 
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It is likely, however, that these studies have un­
derestimated the direct costs of smoking for a variety 
of reasons (Warner et al. 1999).  For example, they 
ignore other significant economic costs, including the 
costs of transportation associated with obtaining 
medical care and the costs of nonmedical care associ­
ated with accommodating a person with a smoking-
related chronic illness.  These estimates also generally 
fail to account for other medical care costs related to 
cigarette smoking, such as burn care from injuries in 
smoking-related fires and perinatal care for low-birth­
weight infants of mothers who smoke. Few studies 
have attempted to include the direct costs for non­
smokers of diseases related to exposure to ETS, and 
none of these studies has tried to estimate the intan­
gible costs of smoking-related illnesses (i.e., the pain 
and suffering associated with the illness and the grief 
experienced by family and friends). 
A human capital approach is generally used to 
estimate the indirect morbidity and mortality costs 
associated with cigarette smoking.  This approach 
views an individual as producing a stream of output 
or earnings computed at market value or as the im­
puted value of housekeeping services. Thus, the value 
of a person is reflected by his or her earnings, and the 
lifetime value for that person is equal to the discounted 
stream of future earnings (Max and Rice 1995).  This 
approach places a relatively high value on morbidity 
and mortality among young adults, men, and the more 
educated because of the relatively higher earnings that 
would be lost by these smokers (Markandya and 
Pearce 1989); moreover, lost earnings may not be an 
accurate reflection of the value people place on their 
health or on their lives. Furthermore, the human capi­
tal approach is in contrast to the “willingness-to-pay” 
approach, which tries to estimate the value a person 
assigns to reducing his or her risk of premature death. 
A more controversial component in the compu­
tation of the lifetime costs of smoking concerns the 
treatment of transfer payments.  These transfer pay­
ments include the reduction in income taxes and in­
surance premiums paid by smokers because of reduced 
earnings associated with smoking-related illnesses, the 
value of Social Security and private pensions foregone 
because of smoking-related premature deaths, higher 
health care costs associated with smoking-related 
illnesses and paid by public and private insurance 
plans, and increased sick pay and disability benefits 
paid during smoking-related illnesses.  Particularly ob­
jectionable to many people is the idea that foregone 
Social Security and private pension benefits from smok­
ers who die prematurely from smoking-related illnesses 
should be considered “benefits” to nonsmokers. As 
Harris (U.S. House of Representatives 1994) and oth­
ers have noted, premature deaths are not considered a 
benefit when policymakers determine what levels of 
funded research are appropriate for reducing prema­
ture deaths from other risk exposures (CSH 1994; 
Warner et al. 1995, 1999).  Nevertheless, several recent 
estimates of the costs of smoking have considered these 
foregone benefits in their computations of the economic 
costs of cigarette smoking (Manning et al. 1989, 1991; 
Shoven et al. 1989). These studies aim to provide a 
complete accounting of the costs of smoking to answer 
the question of whether payments by those who have 
ever smoked into collectively financed systems such 
as Medicare and Social Security equal receipts by those 
who have ever smoked. 
Theoretically Optimal Cigarette Taxes 
As was just discussed, several estimates of the 
optimal or fair tax on cigarettes are based on the vari­
ous studies of the costs of smoking. In the context of 
the preceding discussion, an optimal tax is one that 
equates the total revenues from these taxes to the net 
external costs of cigarette smoking.  These estimates 
have ranged from those implying that current taxes 
more than cover the external costs of smoking (Man­
ning et al. 1989) to those that have suggested that cur­
rent taxes are far too low.  For example, one such study 
that included the costs of the long-term intellectual and 
physical consequences resulting from smoking-related 
low birth weight among infants born to mothers who 
smoke indicated that $4.80 was an appropriate tax on 
a pack of cigarettes (Hay 1991). 
Another study (Pigou 1962) advanced a similar 
notion in providing a theoretical justification for taxes 
on goods with market prices not fully reflecting the 
social costs associated with their production and con­
sumption. From that perspective, these taxes could 
be viewed as improving economic efficiency by rais­
ing a smoker’s marginal cost of smoking to a level 
nearer the social marginal cost.  For some goods, taxes 
could generate revenues that exceed total external costs 
because the taxes would be based on marginal rather 
than average external costs (Cook and Moore 1993). 
Estimates of optimal taxes on cigarettes imply that 
smokers are fully informed about the risks associated 
with cigarette smoking (Cordes et al. 1990).  If smokers 
underestimate these risks, then even higher taxes could 
be appropriate to discourage people from smoking. 
This issue may be particularly relevant for an addic­
tive product such as cigarettes if, when people take up 
smoking, they do not fully understand the addictive 
properties of consumption and the implications of 
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addiction for future choices. Gruber and Koszegi 
(2000), for example, concluded that if these “internali­
ties” are taken into account, they suggest sizable addi­
tional taxes of one dollar or more per pack of cigarettes. 
Among the most widely cited recent estimates 
of the optimal tax are the studies of the economic costs 
of cigarette smoking by Manning and colleagues (1989, 
1991). These incidence-based estimates used data from 
the RAND Corporation’s Health Insurance Experiment 
and the 1983 National Health Interview Survey.  To 
calculate the optimal tax on cigarettes, the analyses 
estimated both the lifetime external costs associated 
with cigarette smoking and the perceived “savings” 
that result from smokers’ dying earlier and not realiz­
ing their pension and Social Security benefits. 
Using their midrange estimates, Manning and col­
leagues (1989, 1991) concluded that for a new smoker, 
the total external cost of smoking was 43 cents per pack 
of cigarettes in 1986. This estimate comprised 1 cent in 
extra costs for sick leave, 2 cents in costs for smoking-
related fires, 5 cents in added costs for group life insur­
ance, 9 cents in lost tax revenues (to finance retirement 
and health benefits), and 26 cents in spending on addi­
tional medical care.  These costs would be offset, how­
ever, by an estimated 27 cents per pack in external 
savings resulting from smoking-related premature 
deaths. Converting these figures to 1995 dollars (based 
on the medical service price index and the gross national 
product deflator), the CRS estimated a net external cost 
of 33 cents per pack for cigarettes, which is approxi­
mately two-thirds of the average federal, state, and lo­
cal taxes on cigarettes of 50 cents per pack in late 1993 
(Gravelle and Zimmerman 1994). The CRS thus con­
cluded that smokers were more than paying their way. 
Critics of the studies of Manning and colleagues 
(1989, 1991) contend that many of the assumptions 
made in obtaining the estimates are inappropriate.  If 
the analyses had not included the effects of unrealized 
pension and Social Security benefits of smokers who 
die prematurely, the resulting external costs of smok­
ing would have amounted to approximately 89 cents 
per pack in 1995 dollars. 
Moreover, the studies of Manning and colleagues 
(1989, 1991) made a debatable distinction between in­
ternal costs (those borne by the smoker) and external 
costs (those that smokers impose on nonsmokers). For 
example, the lost productivity costs described in those 
analyses were treated as internal costs, whereas only 
the higher, collectively financed, group premiums for 
health, life, and other insurance that nonsmokers paid 
to cover smoking-related costs not reflected in the pre­
miums paid by smokers were considered external costs. 
More controversial, however, was these analy­
ses’ assumption that the cost of ETS was an internal 
cost. This assumption was based on the argument that 
the family is the economic unit involved in making 
smoking and other decisions and that the health con­
sequences of ETS are largely confined to the nonsmok­
ing spouses of smokers. As Manning and colleagues 
(1991) note, when this assumption is modified to treat 
the consequences of passive smoking as external costs, 
the estimated external costs of smoking rise signifi­
cantly.  For example, under the assumptions of 
Gravelle and Zimmerman (1994) concerning prices, the 
estimates of Manning and colleagues (1991) imply that 
including the relatively conservative estimate of 2,400 
lung cancer deaths from ETS would add approximately 
31 cents per pack (in 1995 dollars) to the external costs 
of smoking.  Similarly, updating the researchers’ esti­
mates of the costs of neonatal care for smoking-related 
low birth weight would add more than 4 cents per pack. 
Doing the same for deaths from smoking-related fires 
would add 20 cents per pack and for smoking-related 
fetal deaths would add 31 cents per pack. 
These estimates probably understate the true 
costs of ETS. After reviewing the literature on the links 
between ETS and heart disease, Glantz and Parmley 
(1995) concluded that 30,000–60,000 persons die pre­
maturely from heart disease related to ETS.  Including 
these numbers in estimates by using the same assump­
tions used in the CRS report would add at least an­
other 70 cents to the estimate of the optimal tax. 
Moreover, the CRS report ignored the 150,000–300,000 
cases of ETS-linked lower respiratory tract infections 
in children up to 18 months old and the ETS-linked 
worsening of asthma in 200,000 to 1 million children 
(Environmental Protection Agency [EPA] 1992).  In­
cluding these costs would lead to an even larger opti­
mal tax. Finally, the estimates excluded the long-term 
developmental consequences suffered by infants with 
smoking-related low birth weight (Hay 1991); were 
these costs included, the optimal cigarette tax would 
be nearly $5 per pack. 
Using the human capital approach, Manning 
and colleagues (1989, 1991) estimated that the life of a 
nonsmoker who died prematurely from ETS exposure 
was worth $1.66 million. In a recent cost-benefit 
evaluation of the proposed Smoke-Free Environment 
Act of 1993 (introduced in the 103rd Congress but not 
passed), the EPA (Mudarri 1994) used the willingness-
to-pay approach and obtained a $4.8 million baseline 
estimate of the value of a life. The EPA also used this 
approach to include the effects of ETS on heart dis­
ease and children’s health when calculating the value 
of benefits from reduced ETS exposure. 
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By using the willingness-to-pay approach and 
making some relatively conservative assumptions, the 
EPA estimated that the total benefits from the reduced 
ETS exposure that would result from a ban on smok­
ing in all worksites was $39–71 billion per year.  This 
estimate assumed that the ban would reduce the num­
ber of current smokers by 3–6 percent, the number of 
future smokers by 5–10 percent, and consumption 
among continuing smokers by 10–15 percent; the re­
sulting total long-run reduction in consumption would 
be 14–22 percent.  The combined effect of these reduc­
tions in smoking and of the creation of designated 
smoking areas was predicted to reduce out-of-home 
exposures to ETS by 90 percent and in-home exposures 
by a midrange estimate of 6 percent. Estimates from 
the 1992 EPA report on ETS and lung cancer suggested 
that 73 percent of exposures to ETS occur outside the 
home and that 27 percent occur in the home.  The total 
reduction in ETS exposure was thus predicted to be 66 
percent; if it were applied to estimated total ETS costs 
of $58.7–106.9 billion, this reduction would yield the 
EPA’s estimated cost benefits of $39–71 billion.  Given 
current cigarette sales of about 24 billion packs per year, 
this estimate implied that the per pack external costs 
of ETS were between $2.45 and $4.45.  This estimate is 
likely to be low, because the short-term and long-term 
costs of fetal and perinatal exposure to ETS were not 
included in the EPA’s computations. 
Viscusi (1995), however, reached a much different 
conclusion in analyzing the social costs of smoking. This 
investigator updated much of the analysis by Manning 
and colleagues (1989, 1991), used a willingness-to-pay 
approach, and included the same ETS risks used in the 
EPA’s analysis (Mudarri 1994).  Viscusi, however, ar­
gued that the EPA approach overestimated the risks of 
ETS by failing to account for the change in the tar con­
tent of cigarettes and the changes in cigarette consump­
tion per smoker.  Noting that the average tar content of 
cigarettes declined from 46.1 mg per cigarette in 1944 
to 12 mg per cigarette in 1994, Viscusi asserted that the 
health risks associated with cigarette smoking, as well 
as the risks from exposure to ETS, are linearly related to 
the tar content of cigarettes.  Although presenting no 
evidence for either assertion, he contended that esti­
mates of the health risks based on consumption of 
higher-tar cigarettes and exposure to ETS from higher-
tar cigarettes need to be adjusted to reflect the decline 
in tar content. When not adjusting for tar, Viscusi ob­
tained an estimate for the per pack external costs of ciga­
rette smoking well above the average tax on a pack of 
cigarettes; when adjusting for tar, he concluded that 
current cigarette taxes exceed the external costs of 
smoking. 
A clear consensus is lacking regarding the opti­
mal tax on cigarettes.  Optimal tax calculations from 
prevalence-based estimates that include the direct and 
indirect costs of smoking-related morbidity and mor­
tality are likely to be inappropriate, because the calcu­
lations include lost productivity and other costs that 
should arguably be considered internal costs. Similarly, 
optimal tax calculations from the recent incidence-
based estimates probably underestimate the optimal 
tax, because these calculations exclude many of the 
external costs of smoking. Nevertheless, because of 
the growing evidence of the substantial health conse­
quences of exposure to ETS (including fetal and peri­
natal exposure), a tax that would generate sufficient 
revenues to cover all external costs from smoking is 
likely well above the current average of federal, state, 
and local taxes on cigarettes. 
Cigarette Taxes and Health 
As the review of studies on cigarette demand 
demonstrated, increases in cigarette prices lead to sub­
stantial reductions in cigarette smoking by deterring 
smoking initiation among youth, prompting smoking 
cessation among adults, and reducing the average ciga­
rette consumption among continuing smokers. Be­
cause of the substantial health consequences of 
cigarette smoking and the health benefits of smoking 
cessation, these reductions in cigarette smoking would 
lead to significant improvements in health by reduc­
ing smoking-related morbidity and mortality.  Thus, 
increases in cigarette excise taxes, which would result 
in increases in cigarette prices, would be an effective 
policy tool in improving health. 
Several recent studies have provided some esti­
mates of the health benefits resulting from cigarette 
tax increases.  For example, Warner (1986) used pub­
lished estimates of price elasticity (Lewit et al. 1981; 
Lewit and Coate 1982) to estimate the impact of higher 
cigarette excise taxes on smoking and health.  The 
study predicted that a sustained, real 15 percent tax-
induced increase in cigarette prices in 1984 (which 
would have been equivalent to restoring the federal 
tax to its real value in 1951—a nominal tax of 32 cents 
per pack) would deter 800,000 young people from 
smoking and encourage about 2.7 million adults to 
quit. Using the conservative assumption that one of 
every four lifelong smokers dies prematurely of a 
smoking-related illness, the researchers estimated that 
this tax increase would reduce premature deaths 
among persons 12 years and older by 860,000. 
The GAO (1989) used the same estimates of price 
elasticity to predict the health benefits from a sustained, 
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real tax increase of 21 cents per pack in 1989 (which 
they estimated would raise the price by 15 percent). 
Using the one-in-four assumptions made by Warner 
(1986), the analysis estimated that this tax increase 
would reduce the number of youth who smoke by 
500,000 and would subsequently reduce premature 
deaths from cigarette smoking among youth by 
125,000. 
Harris (1987) used various estimates of the price 
elasticity of demand in an analysis of the health impli­
cations of the 1983 tax hike and corresponding price 
increase.  The analysis concluded that this tax increase 
deterred 600,000 young people from smoking.  After 
reviewing the epidemiologic literature, Harris esti­
mated that an additional 54,000 young people and a 
total of 100,000 people would survive to at least 65 
years of age as a result of the tax increase. 
Two recent studies directly examined the health 
benefits of increases in cigarette excise taxes (Moore 
1995; Evans and Ringel 1999). Using annual state-level 
death rates from smoking-related diseases (including 
heart disease, lung cancer, cardiovascular disease, 
mouth and throat cancer, and asthma), the study di­
rectly estimated, through appropriate econometric 
methods, the impact of higher taxes on health. The 
resulting estimates implied that a 10-percent increase 
in cigarette excise taxes would save approximately 
5,200 lives annually.  Similarly, Evans and Ringel 
(1999), using data from the 1989–1992 Natality Detail 
files, concluded that higher cigarette taxes would sig­
nificantly improve birth outcomes. 
The CSH (1994) analyzed the health benefits of 
higher cigarette excise taxes by using relatively con­
servative estimates of the price elasticity of demand 
and of deaths related to cigarette smoking.  The study 
estimated that, based on 1992 taxes and cigarette smok­
ing data, an increase of 75 cents per pack in the federal 
cigarette excise would reduce premature deaths by 
900,000. The study further estimated that a $2.00 
increase would save an additional 1 million lives. 
Similarly, Chaloupka (1998) provided estimates 
of the effects of alternative cigarette tax and price in­
creases contained in various national tobacco settle­
ment proposals based on Chaloupka and Grossman’s 
(1996) econometric analysis of youth smoking. For 
example, he estimated that a $1.50 increase in cigarette 
taxes and prices, phased in over a relatively short pe­
riod of time and then adjusted for inflation, would re­
duce overall cigarette consumption by approximately 
30 percent, while cutting the prevalence of youth smok­
ing nearly in half. Given the CDC’s recent estimate 
that 16,620,878 youth in the 1995 cohort of 0- through 
17-year-olds would eventually become smokers and 
that 32 percent of regular smokers eventually die from 
a smoking-related disease, Chaloupka (1998) estimated 
that this tax would prevent approximately 2.5 million 
premature deaths in this cohort. 
The substantial econometric literature clearly in­
dicates that increases in cigarette prices will reduce 
both smoking prevalence and average cigarette con­
sumption. Because of the well-documented health 
consequences of smoking, tax-induced increases in 
cigarette prices would generate substantial improve­
ments in health. Thus, higher taxes on cigarettes and 
other tobacco products appear appropriate from a pub­
lic health perspective. In addition, at a gathering 
convened by the CDC to evaluate the criteria for de­
fining an optimal cigarette tax, economists raised two 
further reasons for higher cigarette taxes (Warner et 
al. 1995). First, to the extent that adolescents and young 
adults do not fully understand the addictive nature of 
cigarette smoking, the argument could be made that 
higher cigarette taxes can reduce smoking by youth 
before it is too late for them to quit easily.  Second, to 
the extent that youth behave more myopically than 
adults (in particular, more than the adults that they 
will later be), young people are more likely to take on 
a habit with long-term health consequences. Thus, by 
discouraging smoking, the higher tax can help correct 
youth’s myopic behavior. 
Although higher cigarette taxes are likely to pro­
duce substantial improvements in health, several fac­
tors could mitigate the impact of these taxes. First, as 
the limited research on the demand for smokeless to­
bacco products suggests (Ohsfeldt and Boyle 1994; 
Ohsfeldt et al. 1997, 1999), increases in cigarette taxes 
not matched by similar increases in smokeless tobacco 
taxes may induce people to substitute other tobacco 
products with similar health consequences.  For ex­
ample, the large increases in Canada’s cigarette excise 
taxes and the consequent increases in the differential 
between cigarette taxes and taxes on roll-your-own 
tobacco led to a sharp rise in the use of the latter (De­
partment of Finance, Canada 1993). This substitution 
could easily be avoided by increasing all tobacco taxes 
simultaneously.  Canada’s experience also raises the 
issue of equalized taxes between nations, because 
relatively large tobacco tax hikes resulted in a border-
crossing black market in cigarettes and other tobacco 
products as well as in other efforts to avoid taxes.  Al­
ternatively, as Evans and Farrelly (1998) found, the 
higher taxes may lead smokers to change the kinds of 
cigarettes they smoke (i.e., they may switch to higher-
tar and higher-nicotine cigarettes), thereby reducing 
the health benefits of higher cigarette taxes.  The re­
sults of the study by Evans and Farrelly suggest that 
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taxes based on the tar, nicotine, and carbon monoxide 
content of cigarettes (first suggested by Harris 1980) 
may be the most appropriate means to address the 
public health consequences of smoking. 
Of course, cigarettes and other tobacco products 
are not the only goods that can be taxed on the basis of 
these arguments.  Heavy consumption of alcoholic 
beverages, for example, also leads to health problems, 
unintentional injuries, property damage, and other 
consequences. Cook and Moore (1993) provide a de­
tailed discussion of the rationale for higher alcoholic 
beverage excise taxes. A number of studies of the “op­
timal” tax on alcoholic beverages have concluded that 
current taxes are well below the level that would cover 
the social costs of alcohol abuse (Manning et al. 1989, 
1991; Saffer and Chaloupka 1994). 
Tobacco Taxation and Revenues 
An alternative rationale for tobacco taxes is that 
they are a relatively simple way to generate revenues. 
Even some prominent proponents of the free market 
philosophy have supported tobacco taxes to generate 
revenues. “Sugar, rum, and tobacco,” wrote Adam 
Smith in his 1776 economic treatise, An Inquiry Into the 
Nature and Causes of the Wealth of Nations, “are commodi­
ties which are no where necessaries of life, which are 
become objects of almost universal consumption, and 
which are therefore extremely proper subjects of taxa­
tion” (1976, Book V, p. 474). 
As described earlier in this chapter (in “Ration­
ales for Tobacco Taxation”), various levels of govern­
ment have long used cigarette and other tobacco taxes 
to raise revenues.  Such policy is supported by eco­
nomic theory.  An economically efficient way to raise 
revenues while minimizing the welfare losses associ­
ated with the price distortions resulting from taxes is 
to impose relatively higher taxes on goods with more 
inelastic demand (one for which the percentage reduc­
tion in demand is smaller than the percentage increase 
in price) (Ramsey 1927). As described earlier in this 
chapter (in “Effect of Price on Demand for Tobacco 
Products”), the numerous studies of cigarette demand 
and the limited studies of the demand for other to­
bacco products have implied that overall demand, at 
least in the short run, is inelastic.  Thus, large increases 
in tobacco taxes can generate substantial increases in 
revenues, particularly in the short run. 
Since 1960, the dollar amount of federal revenues 
generated by tobacco taxes has increased significantly, 
from $1.9 billion to nearly $5.9 billion in 1997.  Over 
this same period, state revenues from tobacco have also 
increased significantly in nominal terms, from slightly 
Reducing Tobacco Use
 
less than $1 billion to more than $7.5 billion.  As new 
sources of tax revenues have been identified, however, 
tobacco revenues have constituted a smaller propor­
tion of total revenues. Tobacco taxes accounted for 
3.36 percent of all federal revenues in 1950, but they 
were only 0.44 percent of revenues in 1989 (CBO 1990). 
Similarly, total federal tobacco tax revenues as a share 
of the gross national product fell from 0.55 percent in 
1950 to 0.08 percent in 1989. 
Merriman (1994) considered whether cigarette 
excise taxes are set to maximize the revenues from 
these taxes. More specifically, Merriman tested the idea 
that elected officials, in an effort to maximize their own 
utility, may increase taxes on some goods to the point 
where revenues from these taxes begin to decline 
(Buchanan and Lee 1982). Using published estimates 
of cigarette demand (Becker et al. 1994), the study 
found that cigarette excise taxes in every state were 
well below the revenue-maximizing level of these 
taxes, at least as of 1985. Furthermore, these estimates 
of the marginal revenue effects of higher taxes were 
lower-bound estimates, because they held constant 
other states’ taxes (a consideration that allowed for 
increases in the casual and organized smuggling of 
cigarettes in response to a tax hike in a given state). 
Coordinated state tax increases, as a result, would gen­
erate even higher revenues. 
Grossman (1993) considered this issue of maxi­
mizing the federal excise tax on cigarettes. Using pub­
lished estimates of cigarette demand (Chaloupka 1991; 
Becker et al. 1994), Grossman predicted that in the long 
run, a real federal tax rate of $1.26 would maximize 
federal tax revenues at $16 billion and would gener­
ate even larger immediate increases in revenues.  Like­
wise, Becker and Grossman (1994) suggested that the 
long-run revenue-maximizing value of the federal ciga­
rette excise tax is 95 cents per pack in 1994 dollars. 
This tax would generate approximately $12 billion in 
total revenues and would raise considerably more than 
in the short run.  These estimates were consistent with 
the prediction that a sustained real increase of 75 cents 
in the federal tax on cigarettes would in the long run 
lead to a net increase in cigarette tax revenues of just 
over $16 billion (Gravelle and Zimmerman 1994). 
Other studies, however, have predicted that 
higher federal taxes would generate much greater rev­
enues (Harris 1994; Womach 1994a).  For example, 
Harris has predicted that raising the federal tax to $2.00 
per pack would have generated nearly $20 billion in 
additional revenues annually, on average, from 1995 
through 1999, whereas Chaloupka (1998) estimates that 
a $1.50 increase would, in the short run, raise $22.5 
billion annually. 
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The differences among the predicted revenue ef­
fects of higher cigarette taxes may be attributed to dif­
ferent assumptions used to obtain these estimates as 
well as to differences in the period for which the pre­
dictions are made. For example, two studies (Gross­
man 1993; Becker and Grossman 1994) have assumed 
a linear demand function for cigarettes.  One of the 
implications of this function is that the price elasticity 
of demand rises as price rises. Thus, when the effects 
of a large increase in the cigarette excise tax are pre­
dicted, cigarette demand is assumed to become more 
responsive to price.  This assumption implies that there 
is an inverted U-shaped relationship between cigarette 
taxes and revenues:  increasing cigarette taxes from 
relatively low levels will initially lead to increased rev­
enues; beyond some point, further increases in taxes 
will lead to even larger reductions in demand, thereby 
causing revenues to fall. The same basic argument is 
implicit in the well-known Laffer curve, which relates 
income tax rates to income tax revenues. 
The assumption of a linear demand function for 
cigarettes is in contrast to the assumption made by 
some other analysts that the price elasticity of demand 
is constant over the range of prices under consider­
ation. Because almost all of the studies described in 
this section found that the demand for cigarettes is 
inelastic, the assumption of a constant elasticity im­
plies that even very large increases in taxes will al­
ways generate large increases in revenues. 
The differences in revenues predicted by these 
two assumptions, although only minor when analy­
ses predict the impact of relatively small cigarette tax 
increases, grow with the size of the tax increase.  Be­
cause either assumption could be questioned, the rev­
enue effects of a tax increase will likely fall somewhere 
between the predictions obtained from the two 
(Grossman et al. 1993).  The limited evidence from the 
behavioral economics literature suggests, however, 
that the effects of large increases in cigarette prices will 
lead to larger reductions in cigarette demand than pre­
dicted by the assumption of a linear demand function 
(Bickel et al. 1991). 
A second key factor leading to the differences 
discussed here is the distinction between the short-run 
and long-run effects of the tax hikes.  Economic theory 
implies that the demand for most consumer goods will 
be more responsive to price in the long run than in the 
short run.  For cigarettes and other tobacco products, 
additional factors increase the likelihood that the long-
run effects of an increase in price on cigarette demand 
will exceed the short-run effects—that is, price elastic­
ity will increase in a manner similar to the increase for 
other, nonaddictive goods and services.  Increased 
cigarette taxes will thus lead to smaller increases in 
revenues in the long run than in the short run. 
That adolescents and young adults are more re­
sponsive to prices than older adults are and the fact 
that cigarette smoking is an addictive behavior are of 
particular importance when predicting the short-run 
and long-run revenue effects of higher cigarette taxes. 
Age difference in price elasticity implies that sustained 
real tax increases will lead to greater reductions in 
smoking prevalence and consumption as the number 
of adolescents and young adults who have not yet 
decided to smoke replaces the number of older adults 
who already smoke.  The assumption of addiction 
implies that price has a cumulative effect on consump­
tion: the price increase immediately reduces current 
consumption by discouraging young people from ex­
perimenting or continuing to experiment with smok­
ing, as well as by encouraging current smokers to 
smoke less; future consumption is then reduced by the 
continuously fewer current smokers who also continue 
to smoke less in the face of a sustained real increase in 
price. The cumulative effect of price on consumption 
thus exceeds the immediate effect.  This sequence ulti­
mately leads to reduced revenues. 
In summary, federal and most state excise taxes 
on cigarettes are undoubtedly well below their revenue-
maximizing levels. Thus, relatively large increases in 
these taxes would lead to substantial gains in revenues, 
particularly in the short run.  Moreover, because of the 
relatively inelastic demand for cigarettes, increases in 
cigarette taxes are an economically efficient means of 
generating substantial revenues while imposing rela­
tively small welfare losses. But if there is little argu­
ment that large increases in cigarette taxes would 
generate substantial increases in tax revenues in the 
short run, there are some questions on the revenue-
maximizing values of these taxes and the long-run 
stability of revenues generated by large increases in 
cigarette taxes. 
Part of the difficulty in estimating the effects of 
large taxes on cigarettes is that there is little experience 
in the United States with relatively large increases.  Simi­
larly, it is unlikely that the long-run effects of the more 
recent large tax increases have been fully played out. 
The short-term experience in Canada is of limited use 
in addressing these issues.  Cigarette taxes in Canada 
increased more than 500 percent between 1982 and 1992, 
which increased real cigarette prices by 170 percent, and 
total smoking fell by 38 percent (Sweanor and Martial 
1994). Because of the effects of other, contemporane­
ous activities to reduce tobacco use, the impact of the 
large price increases on smoking were consistent with 
the estimates from the studies of U.S. cigarette demand 
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described in this chapter.  Moreover, total federal and 
provincial revenues generated by Canadian cigarette 
taxes were 240 percent higher in 1992 than in 1981 even 
with the concomitant considerable black market in 
Conclusions
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cigarettes. This experience suggests that large increases 
in cigarette taxes in the United States would generate 
sizable tax revenues for many years. 
1.	 The price of tobacco has an important influence 
on the demand for tobacco products, particularly 
among young people. 
3.	 Policies that influence the supply of tobacco, par­
ticularly those that regulate international com­
merce, can have important effects on tobacco use. 
2.	 Substantial increases in the excise taxes on ciga­
rettes would have a considerable impact on the 
prevalence of smoking and, in the long term, re­
duce the adverse health effects caused by tobacco. 
4.	 Although employment in the tobacco sector is 
substantial, the importance of tobacco to the U.S. 
economy has been overstated. Judicious policies 
can be joined to higher tobacco taxes and stron­
ger prevention policies to ease economic diver­
sification in tobacco-producing areas. 
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Reducing Tobacco Use 
Introduction 
A comprehensive approach to reducing tobacco 
use recognizes that individual behavioral choices 
occur in a larger, complex context:  a social setting of 
family, community, and culture; a complex economic 
and physical environment; formal and informal gov­
ernment policy; and the prevailing legal atmosphere 
(Green and Richard 1993).  The specific programs re­
viewed in prior chapters can be better understood as 
part of a general framework for health promotion 
(World Health Organization [WHO] 1986; Health 
Promotion International 1997). Using such a frame­
work, this chapter will review community-based 
intervention studies and the current models for com­
prehensive tobacco prevention and control that are 
funded by specific excise taxes or by settlements with 
the tobacco industry. 
The evaluation of multicomponent interventions 
and socioecological models of health promotion poses 
a special problem (Green and Kreuter 1991; Sanson-
Fisher et al. 1996; Nutbeam 1998). The most effective 
models of health promotion are social movements that 
evolve (Kickbusch 1989; Allison and Rootman 1996; 
Downie et al. 1996; Nutbeam 1998). Thus, the nature 
and complexity of health promotion interventions do 
not fit the tightly defined, controlled, and presumably 
reproducible research model that is more suitable for 
epidemiologic testing (Elder et al. 1993; Mittelmark et 
al. 1993; Baum 1995; Allison and Rootman 1996; 
Conceptual Frameworks 
Macdonald et al. 1996; Nutbeam 1996, 1998). None­
theless, surveillance data, periodic surveys, and other 
administrative data from multiple sites permit these 
interventions, as well as “natural experiments,” to be 
studied. Traditionally, per capita consumption data, 
adult prevalence surveys, and surveys of tobacco-
related behaviors among young people have been the 
core of this surveillance approach.  Recently, a broader 
array of legislative, economic, media, and program 
data has emerged to enhance surveillance of the social 
environments that influence the use of tobacco prod­
ucts. For example, the WHO’s Guidelines for Control­
ling and Monitoring the Tobacco Epidemic (WHO 1998) 
provides detailed recommendations on the types of 
data that should be monitored for both planning and 
evaluating tobacco control efforts.  For the United 
States, the Centers for Disease Control and Prevention 
(CDC) has published background information on 
sources of national surveillance data (Giovino et 
al. 1994). The Federal Trade Commission provides 
annual estimates of trends in the tobacco industry’s 
advertising and promotion expenditures.  Surveillance 
data on protobacco influences are not well monitored, 
however, particularly at the state level.  Finally, 
Wakefield and Chaloupka (1999) have provided a con­
ceptual framework for the monitoring of comprehen­
sive tobacco control programs, particularly those that 
focus on preventing teenage smoking. 
From its formation in the mid-1970s, health pro­
motion has emerged as an approach that offers greater 
potential for change in the health-related behavior 
of populations than does health education (Green 
and Richard 1993; Downie et al. 1996; Health Promo­
tion International 1997). Health promotion emphasizes 
social, economic, and other environmental influences 
as the primary determinants of health behavior change 
(WHO 1986; Downie et al. 1996; Health Promotion 
International 1997). Though such health promotion 
strategies have been characterized as a new approach 
to public health, ecological and policy-oriented 
approaches are similar to the public health methods 
of the latter part of the 19th century and the early de­
cades of the 20th century (Kickbusch 1989; Green and 
Richard 1993; Mullan 2000).  As the role of individual 
risk behaviors, such as tobacco use, was increasingly 
understood in the middle of the 20th century, individu­
ally focused educational strategies gained primacy 
(Green and Richard 1993).  These strategies produced 
some important changes in health behaviors, but their 
limits were realized in the cardiovascular disease 
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prevention programs that took place in the United 
States during the 1970s and 1980s (see “Community 
Intervention Trials,” later in this chapter) (Green and 
Richard 1993; Luepker 1994; Winkleby 1994; Fisher 
1995; Schmid et al. 1995; Susser 1995). 
The shift from a health education approach that 
targets the individual to a health promotion approach 
that uses social, policy, and environmental strategies 
has several advantages. First, by recognizing that 
many environmental determinants of health behavior 
Description of Comprehensive Programs 
are not under the direct control of the individual, the 
ecological focus avoids blaming persons who fail to 
modify their behavior.  Second, many educational 
strategies are more effective with better-educated, 
wealthier persons and may thereby increase the dis­
parities in health between population groups and fail 
to reach those in greatest need.  Third, regulatory and 
policy interventions can be more cost-effective than 
multiple efforts to modify individual behavior. 
The importance of comprehensive economic, 
policy, and regulatory interventions to reduce tobacco 
use has long been recognized by international experts 
(WHO 1979). For example, the evolving WHO guide­
lines for such interventions have increasingly empha­
sized policy and legislative measures, stressing that 
these types of health promotion and health protection 
strategies are essential elements of any national effort 
to reduce tobacco use (WHO 1998).  In an extension 
of the WHO’s efforts, the National Cancer Institute 
(NCI) released a blueprint for related public health ac­
tion in the United States (NCI 1991). This monograph 
stressed that the application of social environmental 
approaches should not compete with individual ap­
proaches but should be combined synergistically with 
them.  Similarly, the Center for Substance Abuse Pre­
vention (CSAP) of the Substance Abuse and Mental 
Health Services Administration (SAMHSA) published 
guidelines that provide the concept, structure, and 
operations of a community-based approach to reduce 
tobacco use among youth (SAMHSA 1998a,b).  To fur­
ther help states overcome common obstacles to 
enforcing youth access laws, CSAP also has provided 
a document that provides strategies to address prob­
lems such as interagency and intraagency issues, in­
sufficient or uncoordinated resources, or lack of data 
sources (U.S. Department of Health and Human Ser­
vices [USDHHS] 1999). More recently, the CDC (1999a) 
has synthesized a comprehensive framework for state­
wide programs to reduce tobacco use.  This framework 
integrates four program goals with four program com­
ponents; optimally, each of the goals would be fully 
addressed in the implementation of each of the com­
ponents. The framework, described in the next sec­
tion of this chapter, recognizes that comprehensive pro­
grams will continue to evolve, in response both to new 
information and to new circumstances.  In addition, 
the framework represents a distillation of evidence and 
judgment that have been discussed in detail in the ear­
lier chapters of this report and that have been tested 
in the community-based trials and the comprehensive 
programs discussed later in this chapter. 
Program Goals for Reducing Tobacco 
Use Statewide 
1.	 	 Prevent initiation among young people. The 
hallmarks of this goal are 
• Decreasing young people’s access to tobacco 
products. 
• Increasing prohealth messages. 
• Reducing protobacco messages. 
• Increasing the price of tobacco products. 
Some of the mechanisms for decreasing 
young people’s susceptibility to tobacco use are 
promoting youth empowerment activities, 
providing school health education, offering 
positive alternatives, deglamorizing tobacco use, 
and involving parents and families. 
2.	 	 Promote quitting among adults and young 
people. An environment that supports efforts to 
quit using tobacco can be fostered by 
• Increasing access to culturally appropriate, 
effective cessation services (e.g., by expanding 
insurance coverage). 
• Increasing the price of tobacco products. 
• Increasing restrictions on environmental 
tobacco smoke (ETS). 
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• Increasing prohealth messages. 
• Decreasing protobacco messages. 
3.	 	 Eliminate exposure to ETS. The continued ex­
pansion of policies to eliminate exposure to ETS 
can be achieved by 
• Developing support for implementation. 
• Enforcing voluntary private policies. 
• Enforcing public policy and public regulation. 
• Expanding coverage of public areas. 
4.	 	 Identify and eliminate disparities among popula­
tion groups. Intrinsically linked to achieving the 
first three goals, eliminating disparities entails 
• Increasing the price of tobacco products 
through culturally acceptable programs. 
• Decreasing exposure to ETS. 
• Increasing prohealth messages. 
• Decreasing protobacco messages, particularly 
those aimed at population subgroups. 
• Increasing the availability of culturally 
acceptable cessation services. 
• Increasing protective factors among young 
people. 
• Decreasing young people’s access to tobacco 
products. 
Development, funding, and implementation 
of the major elements—some of which appear in 
several of these goals—are critically linked to com­
munity involvement and, as noted, to a culturally 
appropriate approach. 
Program Components for Reducing 
Tobacco Use Statewide 
1.	 	 Community interventions. Working through 
social organizations, systems, and networks 
promotes an environment that facilitates indi­
vidual health choices and establishes freedom 
from tobacco use as the norm.  The term “commu­
nity” encompasses a diverse set of entities, includ­
ing medical societies; schools; school districts; 
departments of education; voluntary health agen­
cies; civic, social, and recreational organizations; 
businesses and business associations; city and 
county governments; public health organizations; 
labor groups; managed care systems; faith com­
munities; and organizations for racial and ethnic 
minority groups. 
Community-based activities can include sup­
porting legislated removal or restriction of stimuli 
to use tobacco (such as advertising and promotion, 
easy access to tobacco products via self-service 
display and vending machines, and ongoing ex­
posure to ETS) as well as providing positive alter­
natives (such as promoting cessation, encouraging 
prevention advocacy, developing role modeling 
through parents and adults, and fostering youth 
empowerment). By changing the community set­
ting and institutions with which adults and young 
people interact, community-based activities work 
to denormalize, deglamorize, and discourage to­
bacco use and to provide access to resources that 
increase users’ ability to control their addiction and 
use of tobacco. This approach has the potential to 
effect substantial, sustained, populationwide 
change in tobacco use behavior. 
2.	 	 Countermarketing. Changing a social environ­
ment that fosters a norm of tobacco use is an 
essential element of national, state, and local pro­
grams. This change requires strategies to counter 
the billions of dollars spent in advertising and pro­
motion that reach young people and adults with 
misleading images about tobacco. Countermarket­
ing efforts can include using media advocacy, paid 
media, and counteradvertising; increasing 
prohealth promotions and sponsorships; and pro­
viding information on the tobacco industry’s mar­
keting and promotional tactics.  These public 
health messages should use a strategy that targets 
all age groups and populations.  In a comprehen­
sive strategy, education messages will be mutu­
ally reinforcing:  clean indoor air messages will 
provide added motivation for adults to quit smok­
ing; cessation messages for adults will discourage 
tobacco use among young people and accentuate 
the problem of addiction; and youth prevention 
messages will increase the salience of the tobacco 
issue among parents and community leaders. 
3.	 	 Program policy and regulation. Areas in which 
policy and regulation to reduce tobacco use have 
been applied include minors’ access, tobacco pric­
ing, advertising and promotion, clean indoor air, 
product regulation, product labeling, ingredient 
disclosure, and policies on insurance coverage 
for cessation services. Policies and regulations can 
be established at the federal, state, and local lev­
els (see Chapter 5). Ideally, policies and regula­
tions need to be implemented at both the 
community level and statewide. Educating the 
public about policies and regulation is crucial 
to acceptance, but such education must be sup­
ported by adequate enforcement. 
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4.	 	 Surveillance and evaluation. Surveillance and 
evaluation efforts are necessary to make the 
ongoing refinements that lead to more effective pre­
vention strategies. In addition to traditional 
surveillance methods, nontraditional approaches— 
such as monitoring the promotional activity of the 
tobacco industry at the state and local levels, moni­
toring the economic impact of smoking laws and 
other ETS policies, and performing periodic surveys 
of public opinion on program interventions—are 
critical for reducing tobacco use. 
The conceptual framework for comprehensive 
efforts to reduce tobacco use has been used to 
develop the current generation of statewide programs. 
However, even the most comprehensive programs 
Community Intervention Trials 
currently in place have not been able to fully imple­
ment all recommended components.  Policy and regu­
lation components are especially hampered, since 
many state and local actions are limited by federal 
mandates and preemptions (see “Preemption of Local 
Action by State Policy” in Chapter 5). Moreover, only 
two states, California and Massachusetts, have imple­
mented comprehensive programs for a sufficient time 
to provide evaluation data on the overall efficacy of 
the emerging comprehensive model. 
The following sections summarize the history 
and development of community-based, statewide, and 
other large-scale efforts to reduce tobacco use and con­
clude with a review of existing data on the efficacy of 
the comprehensive model. 
Large-scale trials to prevent cardiovascular 
disease have been a major source of data on population-
based approaches to reducing tobacco use.  An empha­
sis on the importance of addressing social and cultural 
determinants of smoking behavior grew directly out 
of early work on cardiovascular disease epidemiology. 
The Seven Countries Study, which was started in the 
mid-1950s by Keys and colleagues (Aravanis et al. 1970; 
Blackburn et al. 1970; Buzina et al. 1970; Fidanza et al. 
1970; Kimura and Keys 1970; Taylor et al. 1970a,b), 
examined risk factors for cardiovascular disease in 
populations around the world and documented that 
disease rates and risk factors differed markedly across 
cultural and social environments (WHO 1982).  In that 
study, more than 12,500 men aged 40–59 years from 
Finland, Greece, Italy, Japan, the Netherlands, the 
United States, and Yugoslavia were recruited for a pro­
spective study of the relationship between personal 
behaviors (e.g., diet, physical activity, smoking) and 
risk of cardiovascular disease (Aravanis et al. 1970; 
Blackburn et al. 1970; Buzina et al. 1970; Fidanza et al. 
1970; Kimura and Keys 1970; Taylor et al. 1970a,b).  Al­
though the most striking differences in lifestyle across 
cultures were in the composition of the men’s diet, 
smoking was found to be a significant risk factor.  This 
study, and many other early studies of cardiovascular 
disease epidemiology, encouraged researchers to start 
community trials to modify the identified risk factors 
in whole population groups (WHO 1982). 
Two landmark community trials that began 
in 1972 grew directly out of the work of the Seven Coun­
tries Study investigators: the Stanford Three-Commu­
nity Study (Farquhar et al. 1977) and the Finnish North 
Karelia Study (Puska et al. 1985).  A third, less directly 
tied to this early work, was the Israeli Community Syn­
drome of Hypertension, Atherosclerosis and Diabetes 
(CHAD) program (Gofin et al. 1986) begun in 1971.  In 
addition, two worksite trials focusing on population-
level changes in cardiovascular disease risk factors 
developed out of the Seven Countries Study and from 
related early work on cardiovascular disease epidemi­
ology: the Belgian Heart Disease Prevention Project 
(Kornitzer et al. 1980) and the United Kingdom Heart 
Disease Prevention Project (Rose et al. 1980).  Though 
investigators in these initial studies recognized the im­
portance of the social and cultural environment in 
modifying risk factors for cardiovascular disease, in­
cluding smoking (Farquhar 1978; WHO 1979; Farquhar 
et al. 1981, 1985; Rose 1981; McAlister et al. 1982; Puska 
et al. 1985), the smoking cessation techniques of the 
time were primarily individually oriented (McAlister 
et al. 1976; Meyer et al. 1980). 
The Stanford and North Karelia studies shared 
some community organizing and conceptual perspec­
tives in their planning (WHO 1982). Logistical and 
cultural differences between the United States and Fin­
land dictated significantly different implementation, 
however.  In the Stanford study, an intervention that 
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primarily used mass media was compared with the 
same mass media intervention plus intensive face-to­
face counseling for high-risk individuals and was also 
compared with a control community that received no 
intervention. In the initial results, the community 
cohort receiving both the mass media and the face-to­
face counseling for high-risk smokers had a signifi­
cantly greater decrease than the control community in 
the prevalence of smoking (–50 vs. –14.9 percent) and 
in the number of cigarettes smoked (percentage reduc­
tion of 51.6 vs. 21.0 percent) (Farquhar et al. 1977, 1985; 
Maccoby et al. 1977; Meyer et al. 1980). 
In the Finnish study, the people of North Karelia 
province requested the intervention because of concerns 
raised by the results of the Seven Countries Study, in 
which residents of their province had participated 
(Puska et al. 1985, 1995). The intervention had a strong 
focus on community organizing and environmental 
modification, together with multiple educational com­
ponents using mass media and other strategies 
(McAlister et al. 1982; Puska et al. 1985). Although the 
intervention’s early efforts had a greater emphasis on 
increasing direct cessation services than on prevent­
ing smoking, the importance of nonsmoking environ­
ments and other environmental changes was clearly 
recognized and emphasized (Koskela 1981). The five-
year follow-up results of the study found no signifi­
cant difference in smoking prevalence between the 
North Karelia province and Kuopio, a comparison 
province with similar baseline smoking rates (Puska 
et al. 1979). Ten years on, a significantly greater re­
duction in smoking prevalence was observed among 
men in North Karelia than in Kuopio (Salonen et al. 
1981; Puska et al. 1983a,b; Vartiainen et al. 1986).  The 
intervention trial has been continued, and new pre­
vention and population-based cessation strategies 
have been added (Vartiainen et al. 1986; Korhonen et 
al. 1992, 1993). Analyses of 20-year trends (from 1972 
to 1992) in smoking in the two provinces found a sig­
nificantly greater decline in smoking prevalence for 
adult men in North Karelia (from 52 to 32 percent) than 
in Kuopio (50 to 37 percent) and in southwestern Fin­
land. Smoking prevalence for adult women increased 
at similar rates in both provinces (increasing from 10 
to 17 percent in North Karelia and from 11 to 19 per­
cent in Kuopio) (Vartiainen et al. 1998).  The 20-year 
difference in trends in men between the two provinces 
appeared to be primarily related to cessation during 
the first 10 years and to prevention during the last 10 
years. 
The CHAD program had a somewhat more indi­
vidually focused intervention model directed at reduc­
ing the risk factors for cardiovascular disease among 
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residents in Israeli housing projects (Abramson et al. 
1981). The health care providers serving the interven­
tion communities provided risk factor screening and 
counseling for families, couples, and individuals liv­
ing in the four adjacent housing projects.  The resi­
dents of comparison housing areas received usual care 
from their providers.  In the intervention communi­
ties, group discussions were held to provide social 
support and increase group influences on individual 
lifestyle changes. Comparisons between community 
health surveys conducted at baseline (1969–1971) and 
after five years (1975–1976) showed a significantly 
greater decline in smoking prevalence among men but 
not among women in the intervention communities 
than in control communities (Gofin et al. 1986).  At the 
10-year follow-up (1981), the prevalence of smoking 
had declined significantly between 1976 and 1981 
among both men and women in the CHAD follow-up 
cohort, whereas no change or a slight increase in smok­
ing had occurred among adults in Israel overall (Gofin 
et al. 1986). 
The Belgian Heart Disease Prevention Project was 
a controlled, multifactorial trial involving men aged 
40–59 years at baseline at Belgian worksites (Kornitzer 
et al. 1980). Thirty pairs of factories were studied, with 
one site from each pair randomly assigned to the in­
tervention group and one site to the control group.  At 
baseline screenings for risk factors for cardiovascular 
disease, individuals in the upper two deciles of risk 
were identified and received semiannual individual 
counseling from the medical staff. Medical advice to 
quit smoking was reinforced in the factories by anti­
smoking posters, written messages, and health educa­
tion conferences encouraging workers to quit smoking 
and to encourage the same to their friends who smoked. 
Changes in smoking prevalence at the intervention and 
control worksites were monitored among both the 
high-risk individuals and in random samples of the 
total worksite populations. After two years of inter­
vention, a significantly greater percentage of the high-
risk smokers quit in the intervention group than in the 
control group (18.7 vs. 12.2 percent), but no difference 
was observed in the random samples. 
The United Kingdom Heart Disease Prevention 
Project was started in 1971 with 24 pairs of English 
and Welsh factories.  Each member of the pair was ran­
domly assigned to intervention or control status (Rose 
et al. 1980; Bauer et al. 1985). At baseline and in 1977– 
1978, risk factor screening for cardiovascular disease 
was conducted among men aged 40–59 years in the 
intervention sites and in a 10-percent random sample 
of similarly aged men at the control sites.  Over a five-
to six-year period, all men in the intervention sites 
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received healthy lifestyle advice by mail and by 
worksite posters. Men in the intervention sites found 
at baseline to be at high risk for cardiovascular dis­
ease were provided medical counseling on risk factor 
change, including smoking cessation. At the end of 
the intervention in 1977–1978, a small but significant 
reduction in smoking prevalence had occurred among 
the high-risk smokers in the intervention site (Rose et 
al. 1980). Five intervention and five control worksites 
were resurveyed in 1983, approximately 12 years after 
the baseline screening and at least 5 years after the end 
of the intervention program (Bauer et al. 1985).  There 
was no significant difference in the prevalence of smok­
ing between intervention and control factories, but the 
smokers at the intervention sites reported smoking sig­
nificantly fewer cigarettes per day. 
The initial design and implementation of the 
North Karelia and Stanford Three-Community trials led 
to the design of several other cardiovascular disease 
prevention trials around the world.  These included 
the Swiss National Research Program from 1977 to 1980 
(Gutzwiller et al. 1985), the South African Coronary 
Risk Factor Study from 1979 to 1984 (Steenkamp et al. 
1991), and the Australian North Coast Healthy Lifestyle 
Programme from 1978 to 1980 (Egger et al. 1983).  The 
early trials also influenced the development of two 
communitywide mass media-based smoking cessation 
trials implemented in Australia in the 1980s, in Sydney 
from 1983 to 1986 and in Melbourne from 1984 to 1986 
(Pierce et al. 1986, 1990; Macaskill et al. 1992). 
In the Swiss trial, two towns in the French-
speaking and two towns in the German-speaking 
regions of the country were assigned to either interven­
tion or reference status (Gutzwiller et al. 1985).  Baseline 
surveys of risk factors for cardiovascular disease were 
conducted among random samples of residents aged 
16 to 69 years in all four towns in 1977–1978 and 
repeated at the final assessments in 1980–1981.  In the 
interval, communitywide health education and health 
promotion interventions were conducted in the two 
intervention towns, including media campaigns, 
counseling of high-risk individuals, and community 
organization efforts to encourage environmental and 
social changes. The prevalence of smoking in the com­
munities declined from 32.8 to 27.4 percent in the 
intervention towns and from 37.1 to 35.3 percent in the 
reference towns, a significant net effect of 3.6 percent 
decline. 
In the South African Coronary Risk Factor Study, 
three rural communities, matched in size, socioeco­
nomic status, and cultural factors, were assigned to 
low-intensity prevention, high-intensity prevention, 
and control status (Steenkamp et al. 1991). Both 
the low- and the high-intensity sites received a mass 
media educational campaign using so-called small 
media, such as posters, billboards, mailings, and 
coverage in local newspapers. In the high-intensity 
community, high-risk individuals, including smokers, 
received personal interventions from health care pro­
viders. Risk factors for cardiovascular disease were 
measured in a cohort of residents aged 15 to 64 years 
from each community in 1979 and in 1983.  The baseline 
prevalence of smoking was higher among men (49.2 
vs. 44.4 percent) and women (17.0 vs. 14.5 percent) in 
the high-intensity intervention community than in 
the control community, but the difference was not sta­
tistically significant. After the four-year intervention, 
the net change in smoking prevalence in the high-
intensity community, relative to the control commu­
nity, was not significant for men but was significant 
for women. Women in both the low- and the high-
intensity intervention communities had significantly 
higher rates of quitting than women in the control com­
munity, but no differences were observed for men. 
The Australian North Coast Healthy Lifestyle 
Programme replicated the design of the Stanford 
Three-Community Study (Egger et al. 1983). In 1978, 
three communities in northern New South Wales, Aus­
tralia, were assigned to a media intervention, media 
intervention plus community program, or control sta­
tus. A two-year study for preventing cardiovascular 
disease was conducted, including a smoking cessation 
component called “Quit for Life.” The media inter­
ventions used professional commercial media and 
advertising techniques and a social marketing and 
health promotion framework involving print, posters, 
radio, television, and other advertising techniques. 
The community programs for smoking cessation in­
cluded promotions of smoking cessation organizations, 
kits handed out by doctors, distribution of self-help 
materials, and telephone help lines. The smoking ces­
sation campaigns also incorporated other community 
activities—such as organized runs, stress management 
training, and computerized health testing—that con­
veyed the overall program’s broader theme of healthy 
lifestyles. Risk factors for cardiovascular disease, in­
cluding smoking, were measured in random samples 
of residents aged 18 years and older in each commu­
nity in 1978 (baseline), 1980, and 1981. In the multiple 
logistic regression analysis model, which controlled for 
baseline differences among the three communities in 
age and sex distributions, there was a statistically 
greater decline in smoking in the two intervention com­
munities than in the comparison community, with the 
largest differences among young smokers.  Declines 
in the prevalence of smoking in the area assigned to 
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media intervention plus community program ranged 
from 15.7 percent among men aged 18–25 years to 6.1 
percent among women aged 65 years and older. 
In the 1980s, a communitywide mass media-
based smoking cessation campaign was conducted in 
Sydney and Melbourne, Australia (Dwyer et al. 1986; 
Pierce et al. 1986). The Sydney campaign began in mid­
1983, and the Melbourne campaign began one year 
later (during the preceding year, Melbourne was used 
as a control city for the Sydney campaign). The “Quit 
for Life” campaigns involved innovative and provoca­
tive smoking cessation messages delivered through 
paid spots on the radio, on television, and in newspa­
pers. These messages were supported by a telephone 
“Quit Line,” self-help “Quit Kits,” and a hospital-based 
“Quit Centre,” all of which were promoted at the end 
of the paid advertisements used in the campaigns. The 
campaigns were evaluated through monthly random 
telephone surveys in the two communities. In addi­
tion, a cohort of residents was interviewed in April– 
June 1983 and again in May 1984. In the cohort, 23 
percent of smokers in Sydney and 9 percent in 
Melbourne quit during the initial (control) year before 
the campaign was begun in Melbourne (Pierce et al. 
1986). The monthly prevalence estimates demonstrated 
an approximately 1-percent decline in Sydney in com­
parison with the rest of Australia (Dwyer et al. 1986). 
The media campaigns were continued through 1986, 
along with additional programs in conjunction with 
physician-, school-, and community-based activities. 
Long-term evaluation of trends in smoking in the two 
cities from 1981 to 1987 suggests that the sustained 
campaigns may have contributed to a decline in smok­
ing prevalence of about 1.5 percentage points per year 
in both communities among men but had little impact 
on women (Pierce et al. 1990).  An analysis of the 
campaign’s potential differential impact across educa­
tional levels suggested that the Australian mass media 
and community campaigns did not contribute to an 
increase in the gap in smoking prevalence between 
educational groups (Pierce 1989; Macaskill et al. 1992). 
The lack of a consistently positive effect from these 
initial community trials was attributed more to an 
incomplete understanding of comprehensive interven­
tions and to the relatively weak, quasi-experimental 
designs of the studies than to concern about the effi­
cacy of the overall approach (Farquhar 1978). The con­
tinuing enthusiasm for the potential efficacy of the 
communitywide approach was reflected in both na­
tional and international reviews and guidelines 
(Blackburn 1983; WHO 1982; USDHHS 1983; National 
Cholesterol Education Program Expert Panel 1988; 
Shea and Basch 1990a,b). Similarly, the positive results 
Reducing Tobacco Use 
from the Australian communitywide antismoking 
media campaigns and smoking cessation data from 
the North Karelia trial encouraged the planning of 
smoking-specific community efforts in the United 
States in the late 1980s. 
Three major community-based trials for prevent­
ing cardiovascular disease were funded by the Na­
tional Heart, Lung, and Blood Institute (NHLBI) in the 
early 1980s: the Stanford Five-City Project, the Min­
nesota Heart Health Program, and the Pawtucket 
Heart Health Program.  Each had comparison and in­
tervention communities and stronger designs and 
evaluation methodologies than the studies initiated in 
the 1970s. Each study was developed by an indepen­
dent team of investigators, and the NHLBI maintained 
a collaborative research relationship among the stud­
ies (Winkleby et al. 1997).  All three shared common 
intervention approaches that lasted five to eight years 
and focused on the major risk factors for cardiovascu­
lar disease (hypertension, cigarette smoking, high di­
etary fat, obesity, and sedentary lifestyle).  Each project 
used mass media, community mobilization, and mul­
tiple educational channels, such as health care provid­
ers, schools, worksites, and voluntary agencies. The 
programs integrated individual and social change ap­
proaches, employing some combination of social learn­
ing theory, social network diffusion theory, and social 
marketing to guide the planning and implementation 
of the interventions (Bandura 1977; McGuire 1973; 
Rothman 1979; Rogers 1983). The three projects dif­
fered initially in their relative emphasis on specific 
modalities (Stanford emphasized media; Minnesota, 
population screening; and Pawtucket, community or­
ganizations) (Shea and Basch 1990a), but frequent col­
laborations among projects decreased these differences 
over time. Many innovative strategies were devel­
oped, and the process evaluations on specific smok­
ing prevention and cessation interventions were posi­
tive (Glasgow et al. 1985; Sallis et al. 1985; Altman et 
al. 1987; Elder et al. 1987, 1993; King et al. 1987; Lando 
et al. 1990, 1991; Perry et al. 1992; Pechacek et al. 1994). 
Nonetheless, the overall impact of the three interven­
tions on smoking prevalence was modest. 
The Stanford Five-City Project began with baseline 
surveys in 1979. Five cities in Northern California were 
selected on the basis of location, size, and media mar­
kets (Farquhar et al. 1985). Monterey and Salinas shared 
a media market and were assigned to the intervention 
group.  The three control cities (Modesto, San Luis 
Obispo, and Santa Maria) were isolated from the me­
dia market of the intervention communities. The 
communitywide educational campaigns began in 
1980 in collaboration with existing community 
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organizations. The two treatment cities received con­
tinual exposure for five years; each year, four to five 
separate risk factor education campaigns took place, 
one of which focused on smoking. Evaluations in­
cluded independent, cross-sectional population 
samples aged 25 to 74 years surveyed at baseline and 
at 25, 51, and 73 months, as well as a cohort formed 
from the baseline survey that was resurveyed at 17, 
39, and 60 months. Initially, the cohort samples in the 
intervention communities experienced a significantly 
greater decline in smoking prevalence than those in 
the control communities (–7.66 vs. –3.76 percent) 
(Farquhar et al. 1990; Fortmann et al. 1993). By the 
end of the intervention in 1986, the cross-sectional 
surveys showed no such difference in declining 
prevalence.  At the final follow-up in 1989–1990, a more 
rapid though nonsignificant decline was detected in 
the control communities than in the intervention com­
munities (Winkleby et al. 1996). 
In the Minnesota Heart Health Project, three pairs 
of communities were selected, with one of each pair 
assigned to educational intervention and the other to 
comparison status (Jacobs et al. 1986; Murray et al. 
1994). The communities were matched on size, com­
munity type, and distance from the Minneapolis-
St. Paul metropolitan area.  After a 16-month baseline 
assessment period, a 5- to 6-year intervention program 
was started in November 1981 in the first education 
site, Mankato, Minnesota (Luepker et al. 1994). The 
second and third education sites, Fargo-Moorhead on 
the North Dakota-Minnesota border and Bloomington, 
Minnesota, were started 22 and 28 months later in 1983. 
The staggered entry allowed for a gradual develop­
ment of the intervention program and a stronger evalu­
ation design (Luepker et al. 1994). Starting in 1980, 
annual cross-sectional surveys among residents aged 
25 to 74 years were conducted in all six sites.  A ran­
dom sample of residents surveyed before the start of 
the education program was resurveyed.  For long-term 
smoking cessation, the cross-sectional survey data 
provided evidence of an intervention effect for women 
but not for men; no such effect was observed for ei­
ther sex in the cohort sample (Luepker et al. 1994; 
Lando et al. 1995). Unexpectedly, large declines in 
smoking prevalence, especially among men, were ob­
served in comparison communities. 
In the Pawtucket Heart Health Program, the 
impact of a communitywide program for reducing 
risks for cardiovascular disease in Pawtucket, Rhode 
Island, was compared with trends in a nearby matched 
community in southern Massachusetts (name withheld 
to honor a confidentiality agreement with the city  gov­
ernment) (Carleton et al. 1995). Pawtucket was selected 
as the intervention site from among a pool of nine 
potential northeastern New England cities; the 
comparison site had similar sociodemographic char­
acteristics. Surveys of risk factors for cardiovascular 
disease were conducted with random samples of 
residents aged 18 to 64 years in the two communities 
at two-year intervals, beginning in 1981 and continu­
ing until 1993. Communitywide educational strategies 
emphasized public awareness campaigns, behavior 
change through existing community resources and 
volunteers, and community activation to promote in­
volvement and environmental changes (Elder et al. 
1987, 1993; Lefebvre et al. 1987).  During the seven-
year intervention program from 1984 to 1991, more 
than 500 community organizations were involved, 
including schools, religious and social organizations, 
larger worksites, and city government departments. 
Overall projected risk for cardiovascular disease 
declined significantly in Pawtucket during the educa­
tional program, but the prevalence of cigarette 
smoking declined only slightly and did so more in the 
comparison than in the intervention community 
(Carleton et al. 1995). 
Concurrent with the community-based 
cardiovascular disease prevention trials in the United 
States, an antitobacco community education program 
was initiated in India (Anantha et al. 1995). The trial 
was conducted between 1986 and 1992 in the 
Karnataka State. One intervention area (117 villages) 
and two control areas (136 and 120 villages) were se­
lected within the Kolar District. A baseline survey was 
conducted in 1986, and follow-up surveys were con­
ducted two and five years later.  Villages were ran­
domly sampled in each of the three areas, and the to­
bacco use habits of all residents of each household were 
assessed. A subsample of the villages selected at 
baseline was resurveyed two and five years later to 
provide cohort follow-up.  After the baseline survey, a 
three-year educational campaign used health worker 
staff from Primary Health Centres to visit each village 
at least once a week and deliver health education mes­
sages about the risks of cigarette smoking and other 
forms of tobacco use, particularly chewing. Handbills, 
photographs, posters, and films in multiple languages 
were used to reinforce health education counseling de­
livered to individuals and small discussion groups. 
Among tobacco users in the intervention area, preva­
lence declined 26.5 percent for men and 36.7 percent 
for women. The proportional reduction in the preva­
lence of any tobacco use was significantly greater in 
both men and women in the intervention area than in 
the two control areas (10.2 vs. 2.1 and 0.5 percent for 
men and 16.3 vs. 2.9 and 0.6 percent for women). 
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The Federal Republic of Germany began the Ger­
man Cardiovascular Prevention (GCP) Study in the 
mid-1980s (GCP Study Group 1988).  The seven-year 
prevention campaign in the GCP Study targeted more 
than 1 million people in six intervention regions whose 
demographic and socioeconomic structure reflected 
that of the West German population.  The reference 
population was sampled from the total West German 
population. The goal of the campaign was to reduce 
four risk factors for cardiovascular disease (hyperten­
sion, hypercholesterolemia, smoking, and obesity) by 
using a multifaceted prevention program.  Public health 
services, voluntary welfare federations, institutions for 
adult education, sports and consumer associations, and 
other existing community resources and facilities were 
used extensively.  The campaigns sought the involve­
ment of health care providers and emphasized consum­
ers’ access to them. Special emphasis was placed on 
improving community knowledge and awareness of 
healthy nutrition, the benefits of physical activity, and 
the importance of quitting smoking. To identify per­
sons at high risk for hypertension and hypercholester­
olemia, screenings were conducted at social events, 
in factories, and at other community settings in close 
cooperation with physicians, pharmacists, and health 
insurance companies. To discourage smoking, non­
smoking restrictions were extended in public places, 
and educational campaigns were conducted in the 
media and in community settings to promote smoking 
cessation and to help smokers quit. For the evaluation 
of risk factor trends, representative samples of residents 
aged 25–69 years from the intervention regions and of 
the national population of West Germany were sur­
veyed before the intervention (May 1984 to March 1986), 
at midstudy (February 1988 to April 1989), and at the 
end of the intervention (April 1991 to April 1992) 
(Hoffmeister et al. 1996).  In the national reference 
sample, the prevalence of smoking declined from 34.0 
percent at baseline to 33.5 percent at the end of the study. 
In the intervention region, the prevalence of smoking 
declined from 35.4 percent at baseline to 32.5 percent 
at the end of the study, for a net change of –6.7 percent 
(P < 0.001).  The decline occurred exclusively among 
men (net change of –7.9 percent, P < 0.001).  Among 
women, the prevalence of smoking increased in both 
the intervention regions and nationwide, and no inter­
vention impact was noted (net change of –1.8 percent). 
Using a somewhat different design, the Com­
munity Intervention Trial for Smoking Cessation 
(COMMIT) was started in the late 1980s (COMMIT Re­
search Group 1991).  COMMIT focused solely on smok­
ing cessation and built on the initial experience in the 
ongoing trials to prevent cardiovascular disease.  COM­
MIT was planned as a randomized community trial with 
11 pairs of communities and had adequate statistical 
power to detect relatively small intervention effects (Gail 
et al. 1992).  One community of each pair was randomly 
allocated to the intervention program, and the other 
was monitored as a control.  The 11 intervention com­
munities received a four-year educational program 
that focused on adult cessation, with special empha­
sis on “heavy” cigarette smokers (those who smoked 
25 or more cigarettes per day).  The intervention 
philosophy of the trial assumed that a comprehensive 
communitywide strategy would make it difficult for 
residents in the 11 targeted sites to avoid exposure to 
messages about the importance of nonsmoking and 
would alert smokers to the many opportunities for 
cessation. Interventions focused on four primary edu­
cational channels: media-based and communitywide 
events, health care providers (e.g., physicians and den­
tists), worksites and other organizations, and cessa­
tion resources.  Within these channels, the centrally 
developed protocol specified 58 mandated activities, 
designed to be carried out largely by community vol­
unteers and local staff or agencies with limited external 
resources (Lichtenstein et al. 1990–1991).  Intervention 
activities started after the baseline survey and random­
ization, beginning with community mobilization in 
January 1989 and continuing with protocol-defined 
intervention through December 1992.  A telephone sur­
vey was conducted in each of the 22 sites to estimate 
baseline prevalence and identify cohorts of heavy 
and light-to-moderate smokers. Cohort members were 
contacted annually by telephone, with a final assess­
ment in early 1993. A final prevalence survey was 
conducted in all 22 communities from August 1993 to 
January 1994. 
There was a high degree of community owner­
ship within the 11 intervention sites (Bracht et al. 1994; 
Lichtenstein et al. 1996), and program staff and com­
munity organizations diligently delivered the 58 man­
dated activities. Hence, the modest effects observed 
in this trial were sobering for the public health com­
munity (Fisher 1995; Susser 1995). No cessation effect 
was observed for the “heavy” smokers for whom the 
trial was specifically designed (COMMIT Research 
Group 1995a).  Among the evaluation cohort of light­
to-moderate smokers, a significantly greater propor­
tion quit in the intervention than in the control 
communities (30.6 vs. 27.5 percent) over the four-year 
intervention period, and the effect was strongest 
among the less educated residents of the communi­
ties. Overall the prevalence of smoking declined 
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slightly (but nonsignificantly) more in the interven­
tion communities (3.5 percentage points) than in the 
comparison communities (3.2 percentage points) 
(COMMIT Research Group 1995b).  The quality and 
statistical power of the overall trial design (Gail et al. 
1992) make it unlikely that any true intervention 
effects were missed.  The COMMIT intervention pro­
tocol sought to apply the most effective smoking ces­
sation strategies as defined by the published literature 
(Lichtenstein et al. 1990–1991; COMMIT Research 
Group 1991). The investigators were limited, however, 
in their ability to be involved in many of the recom­
mended ecological and policy-oriented health promo­
tion strategies (WHO 1979; Green and Richard 1993) 
because of restrictions imposed by federal funding of 
the study (Fisher 1995; Susser 1995). In addition, 
process data showed that implemented protocol did 
not have a significant impact on many important in­
termediate variables (e.g., physician and dentist coun­
seling rates, worksite smoking bans, public attitudes 
toward smoking) (Glasgow et al. 1997; Ockene et al. 
Statewide Interventions 
1997; Taylor et al. 1998).  Therefore, the failure of the 
COMMIT interventions to use certain strategies or to 
change intermediate social and policy variables suggests 
that the study was not an adequate test of the efficacy 
of the social-environmental approach to reducing to­
bacco use. 
Several reviewers have provided some perspec­
tives on the modest smoking cessation effects observed 
in these community trials (Green and Richard 1993; 
Luepker 1994; Winkleby 1994; Fisher 1995; Susser 
1995). Common themes are (1) the difficulty in ob­
serving intervention effects because of the large 
secular declines in risk factors for cardiovascular dis­
ease, including smoking, that occurred during the 
period when the trials were implemented and (2) the 
need for a more comprehensive health promotion ap­
proach.  A more complete understanding is needed of 
why such modest and mixed smoking cessation effects 
have been observed in numerous well-designed and 
well-implemented communitywide trials. 
Concurrent with the implementation of the com­
munity intervention trials, a broader national move­
ment to reduce tobacco use began to emerge in the 
1980s. Unlike the community intervention trials, this 
movement, and the large-scale interventions that 
developed from it, was not structured around research 
hypotheses and preplanned evaluation designs. 
Rather, the movement was characterized by commu­
nity mobilization at the national, state, and local 
levels and encompassed the principles of health pro­
motion as a social movement that evolves (Kickbusch 
1989; Allison and Rootman 1996; Downie et al. 1996; 
Nutbeam 1998). Funding for these efforts came from 
both federal and private sources; however, an impor­
tant manifestation of this national movement was the 
establishment of statewide interventions funded by 
increases in cigarette excise taxes or settlements with 
the tobacco industry.  Such increases were the result 
of voter initiatives, beginning with those in California 
in 1990 and Massachusetts in 1993. The next section 
of this chapter reviews the main elements of the na­
tional movement. 
Community Mobilization 
A significant step in organizing the movement to 
reduce tobacco use was the founding in 1981 of the Coa­
lition on Smoking OR Health, which consisted of repre­
sentatives from three major volunteer health  agencies: 
the American Cancer Society (ACS), the American 
Heart Association, and the American Lung Association. 
The formation of a national coalition prompted state-
and local-level leaders of these organizations to form 
similar triagency coalitions. Some of these state and lo­
cal coalitions expanded to include representatives from 
other groups, such as medical societies, other volunteer 
health organizations, and state health departments. 
These coalitions were among the first efforts to mobi­
lize communities at the state and local levels. 
The consensus of the 1985 International Summit 
of Smoking Control Leaders in Washington, DC, was 
that only unified, broadly based, strategically coher­
ent, and flexible national movements for reducing 
smoking were destined to be successful.  To help build 
such movements, the summit participants recom­
mended producing a handbook on coalition building. 
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The resulting ACS publication, Smoke Fighting: A Smok­
ing Control Movement Building Guide (Pertschuk and 
Erickson 1987), examined the strengths and weak­
nesses of networks and coalitions and gave sugges­
tions for building and strengthening these forums. 
This guide was one of the earliest produced on com­
munity organizing to reduce tobacco use. 
A survey conducted by the Association of State 
and Territorial Health Officials determined that as of 
December 31, 1989, coalitions for reducing tobacco use 
had been formed in 46 states and the District of 
Columbia (CDC 1990). Only Hawaii, Kentucky, Mis­
sissippi, and South Carolina did not have state-level 
coalitions at that time. Of the 47 coalitions, 44 concen­
trated on reducing tobacco use; the remaining 3 ad­
dressed tobacco use, as well as other chronic disease 
risk factors. Although Colorado established the first 
tobacco-related coalition in 1963, coalitions in 28 states 
were not established until after 1984. Coalition activi­
ties included lobbying, providing public education, 
educating health care professionals, conducting re­
search and evaluation, and developing and implement­
ing a state plan for reducing tobacco use (Pertschuk and 
Erickson 1987). 
Until recently, the United States remained with­
out a national program for tobacco-related risk reduc­
tion analogous to those established for hypertension 
and hypercholesterolemia.  During the 1990s, three 
nationally funded programs—two by the federal gov­
ernment and one by a private foundation—and one 
federally funded research project have helped states 
and localities mobilize for reducing tobacco use.  As 
noted, several states provided funds for state and 
local community organizing. 
National Programs 
ASSIST 
The American Stop Smoking Intervention Study 
(ASSIST) for Cancer Prevention is a partnership be­
tween the NCI and the ACS to establish coalitions that 
focus on using public policy change to reduce tobacco 
use (see also “Community Programs” in Chapter 4). 
The ASSIST project was developed after many NCI 
consultants had recommended that community-based 
coalitions for reducing tobacco use be established 
in entire states or in large metropolitan areas.  The 
ASSIST guidelines provided both the rationale for the 
coalition model and the flavor of the overall project: 
Reducing Tobacco Use 
•	 	 Smoking is a public health problem that affects ev­
eryone in a community, not only smokers.  The 
solution to the smoking problem requires the ac­
tive involvement of a broad range of groups and 
individuals. 
•	 	 Significant and enduring changes in smoking be­
havior require a change in social norms, that is, 
that smoke-free environments and lifestyles are 
preferred and encouraged among all social groups. 
Changes in social norms occur over time with the 
involvement and support of a broad representa­
tion of interest groups. 
•	 	 Tremendous resources are invested each minute of 
every day to encourage young people to begin 
smoking as a normal and acceptable behavior.  The 
resources required to counter this effort and to ef­
fect a significant change in smoking behavior far 
exceed the funds available through this [ASSIST] 
project.  A large contribution of direct and in-kind 
support in the form of time, energy, volunteers, and 
other resources will be required.  Only through the 
commitment of a variety of groups and organiza­
tions can adequate resources be made available. 
•	 	 The intent of ASSIST is not to create a new insti­
tution devoted to smoking control but rather to 
increase the capacity for existing groups and or­
ganizations to sustain and enhance their role as 
smoking control agents beyond the life of ASSIST. 
Activities by different groups will be coordinated 
and efforts thereby magnified, and strategies and 
training will be disseminated and institutional­
ized in each coalition member group (NCI 1991, 
pp. 1–2). 
ASSIST included an initial planning phase (1991– 
1993) and a subsequent implementation phase (1993– 
1998) for the 17 states chosen for participation. The 
implementation phase was then extended to Septem­
ber 1999. During the planning phase, the coalitions 
performed comprehensive site analysis and developed 
a plan for reducing tobacco use.  For planning, each 
state received approximately $400,000 per year to de­
velop its own comprehensive, five-year plan (Manley 
et al. 1997a). During the implementation phase, states 
have been receiving an average of approximately $1.2 
million per year to carry out the action steps in accor­
dance with NCI guidelines and ASSIST program ob­
jectives. Intensive training of state health department 
and voluntary agency personnel in the ASSIST states 
was a primary activity during the planning phase and 
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early years of the implementation. This training fo­
cused on the program objectives, including policy 
changes, media advocacy, and community mobiliza­
tion. An interim evaluation of impact (Manley et al. 
1997b) found that per capita cigarette consumption and 
inflation-adjusted cigarette prices were nearly identi­
cal in the 17 ASSIST states and the remaining non-
ASSIST states (excluding California) before 1993, when 
full funding for the ASSIST intervention began.  By 
1996, per capita consumption in the ASSIST states was 
about 7 percent less than in the non-ASSIST states.  This 
decrease occurred in the face of a general decline in 
cigarette prices during the period of evaluation.  These 
interim results suggest that the ASSIST program has 
been associated with a significant decrease in cigarette 
consumption and that increased price from taxation 
may not be the only program influence. 
IMPACT 
In its Initiatives to Mobilize for the Prevention 
and Control of Tobacco Use (IMPACT) program, the 
CDC has funded the District of Columbia and 32 states 
that do not receive funding from the ASSIST project. 
The exception is California, which is not funded by 
ASSIST or by the CDC but since 1989 has had a to­
bacco control program funded by the state excise tax 
on cigarettes.  (The California program is described 
later in this chapter.)  A portion of IMPACT funds sup­
ports community mobilization at the state and local 
levels, with particular focus on racial and ethnic mi­
nority groups and women.  The IMPACT program also 
provides extensive training to representatives of state 
coalitions in subjects such as media advocacy, policy 
advocacy, and coalition building. 
Recently, the IMPACT program has been ex­
panded to include key national organizations to help 
them mobilize their constituencies in efforts to reduce 
tobacco use. Funds have been especially directed to 
organizations that serve populations targeted by the 
tobacco industry’s marketing plans and that are his­
torically underrepresented in the movement to reduce 
tobacco use (Farquhar et al. 1985; USDHHS 1998). 
SmokeLess States Program 
In 1994, the Robert Wood Johnson Foundation 
initiated the SmokeLess States program to provide 
additional funds to state coalitions. In the initial round 
of funding, the program awarded more than $13 mil­
lion in either four-year implementation grants or two-
year capacity-building grants to 19 state coalitions and 
also funded a youth-specific project in Tucson, Arizona 
(Robert Wood Johnson Foundation 1994).  Two years 
later, funding for the SmokeLess States program was 
expanded to $20 million. In this second round of fund­
ing, awards were made to 13 new states; in addition, 
implementation grants were made to some of the states 
that had previously received capacity-building grants. 
In 1998, SmokeLess States funded another $6 million 
in grants to eight states that had been funded for four 
years each. Currently, the SmokeLess States program 
funds 28 states and 2 cities at a total of $39 million per 
year.  The SmokeLess States program focuses on help­
ing state coalitions develop policy options, including 
prevention programs similar to those in place in Cali­
fornia and Massachusetts (as discussed later in this 
chapter) and other efforts aimed at reducing tobacco 
consumption, especially among young people. Ad­
ministered by the American Medical Association 
(1998), this grant program differs from ASSIST and 
IMPACT in that it does not have strict requirements 
concerning the makeup of the coalition, although com­
munity mobilization is a required program activity. 
National Programs to Reduce Youth 
Access to Tobacco 
In 1996, SAMHSA issued regulations to imple­
ment the Synar Legislation. These regulations and the 
provisions of the Synar Amendment to the 1992 
ADAMHA (Alcohol, Drug Abuse, and Mental Health 
Administration) Reorganization Act established a na­
tionwide effort to reduce youth access to tobacco by 
requiring states to have and enforce laws prohibiting 
the sale of tobacco products to anyone under age 18. 
Failure to meet the requirements of the Synar legisla­
tion could result in penalties against a state’s Substance 
Abuse Prevention and Treatment Block Grant.  The full 
discussion of the state efforts to meet these require­
ments is provided in Chapter 5. By establishing a 
coordinated program in all 50 states and the District 
of Columbia to address this problem, SAMHSA has 
provided a core resource to the tobacco control effort 
across this country. 
In 1996, the Food and Drug Administration 
(FDA) issued a rule mandating that tobacco retailers 
not sell tobacco to anyone under age 18 and that they 
require a picture identification card from anyone un­
der the age of 27 who attempts to purchase tobacco 
(Federal Register 1996). In support of this rule, the FDA 
entered into contracts with state agencies to institute 
compliance checks of retailers and has implemented 
mass media and direct education campaigns to inform 
retailers of this rule.  However, the March 21, 2000, 
ruling of the United States Supreme Court held that 
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the FDA lacks jurisdiction to regulate tobacco prod­
ucts as customarily marketed. Following this decision, 
the FDA immediately began the process of terminat­
ing the contracts with state agencies and shutting down 
its enforcement program.  The full discussion of this 
program is provided in Chapter 5. 
States Currently Funded in the Nationwide 
Program to Reduce Tobacco Use 
In 1998, 49 state health departments and the Dis­
trict of Columbia received funding from the USDHHS 
for activities to reduce tobacco use. The NCI’s ASSIST 
project provided 17 states with approximately $21.5 
million, and the CDC’s IMPACT program funded 32 
states and the District of Columbia with approximately 
$12 million. In February 1998, the CDC and the NCI 
were given joint responsibility to assist states and na­
tional organizations in amalgamating the findings of 
comprehensive research projects, the CDC and NCI 
programs, and the state and local programs funded 
by tax initiatives and legal settlements with the tobacco 
industry.  This process will continue the evaluation of 
a national program that includes all states, the District 
of Columbia, territories, and tribes and aims to bring 
synchrony and coherence to the efforts of all groups 
working to reduce tobacco use. 
In May 1999, the CDC launched the National 
Tobacco Control Program (NTCP) transitioning fund­
ing through various federal initiatives into one national 
program.  The purpose of the NTCP is to build and 
maintain a coordinated national effort to reduce the 
health and economic burden of tobacco use.  Federal 
funding is intended to support core public health to­
bacco control functions or to enhance existing tobacco 
control programs within state and territorial health 
departments. The program framework is based on the 
comprehensive tobacco control framework outlined 
earlier in the chapter (see “Description of Comprehen­
sive Programs”).  The NTCP funds tobacco control 
programs in all states, the District of Columbia, and 
seven U.S. territories. The NTCP also includes initia­
tives to fund American Indian tribal organizations to 
develop or improve tobacco-related regional resource 
networks and outreach to tribes. In 2000, the NTCP 
launched a new initiative to aid in the elimination of 
disparities in health status and outcomes among popu­
lations as it relates to tobacco use.  In fiscal year 1999, 
the NTCP awarded $50 million to 50 states, the District 
of Columbia, and seven territories for a five-year 
cooperative agreement starting June 1, 1999, to May 30, 
2004. In fiscal year 2000, funding to the states,  the Dis­
trict of Columbia, and territories totaled $59 million.  The 
Reducing Tobacco Use
 
average award for states and the District of Columbia 
is $1.13 million. The average award for territories is 
$140,000. The total includes supplemental awards of 
$499,400 for asthma and ETS, funded in conjunction 
with the Environmental Protection Agency, and 
$244,000 for Smoke-Free Kids and Soccer.  The state 
awards almost close the funding gap between the 
former NCI-funded states (ASSIST) and the other 
states. States with excise tax or settlement-funded pro­
grams are required to match federal funds 4 to 1.  For 
all others, the match is 1 to 10. 
Examples of Major State Programs 
State coalitions have encouraged both legislation 
and voters’ initiatives to raise state excise tax levels on 
tobacco products and earmark some portion of the new 
revenue for tobacco prevention and control programs 
(Shultz et al. 1986; Nicholl 1998). In 1985, the Minne­
sota Coalition for a Smoke-Free Society 2000 led a 
legislative effort that was the first to pass tobacco use 
prevention legislation that centered on an increase in 
the state cigarette excise tax.  Since 1985, more than 40 
other states have increased their excise tax on ciga­
rettes; as part of the appropriations process, some of 
these states have also funded selected tobacco control 
activities with this revenue increase.  One such state— 
Maine—in May 1997 legislated an excise tax increase 
that earmarked funds for a more comprehensive to­
bacco control program. 
In some states, voters’ initiative process, rather 
than the legislative process, has been the primary 
mechanism by which new revenue from an excise tax 
increase of tobacco products has been earmarked for 
tobacco prevention.  Voters in 24 states and the Dis­
trict of Columbia are permitted to sign petitions that 
place a proposed law on the state ballot for referen­
dum (Nicholl 1996). Since 1988, in eight such states, 
coalitions have tried to use the voters’ initiative pro­
cess to fund statewide tobacco control programs.  State 
coalitions were successful in winning voter approval 
in four of these states: California in 1988, Massachu­
setts in 1992, Arizona in 1994, and Oregon in 1996. 
Initiatives were unsuccessful in Montana (1990), 
Nebraska (1992), Arkansas (1992), and Colorado (1994) 
(Moon et al. 1993; Ross 1996; Nicholl 1998). 
The four state programs funded by successful 
voters’ initiatives are described in the next sections of 
this chapter.  They follow discussions of the two state 
programs (in Minnesota and Maine) that were estab­
lished by legislated appropriations for a comprehen­
sive tobacco control plan. 
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Minnesota 
In 1975, Minnesota was one of the first states that 
passed statewide comprehensive legislation for clean 
indoor air.  In 1983, the Commissioner of Health 
formed the Center for Nonsmoking and Health, which 
oversaw the development of The Minnesota Plan for 
Nonsmoking and Health (Minnesota Department of 
Health 1984) by a multidisciplinary technical advisory 
committee in 1984. In that same year, nearly 30 public 
and private organizations within the state formed the 
Minnesota Coalition for a Smoke-Free Society 2000. 
By drawing increased attention to the hazards of 
smoking and of ETS exposure, the Minnesota Depart­
ment of Health, together with civic and community 
leaders, stimulated legislation to implement the rec­
ommendations of The Minnesota Plan for Nonsmoking 
and Health. The legislative history and debate sur­
rounding the passage of the resulting 1985 compre­
hensive legislation for preventing tobacco use have 
been summarized by Shultz and colleagues (1986). The 
legislation provided for an increase in the state ciga­
rette excise tax from $0.18 to $0.23, with one cent of 
the revenue increase earmarked for a public health 
fund, approximately one-half of which was to be set 
aside for preventing tobacco use.  Further, this legisla­
tion authorized the Commissioner of Health to launch 
a major statewide initiative—the Minnesota Tobacco-
Use Prevention Initiative—to promote nonsmoking 
and established state aid for school-based programs 
to prevent tobacco use. 
The legislation allocated funding to support the 
school-based programs at the rate of $0.52 per student 
during the 1985–1986 school year and $0.54 per student 
during future years.  School districts were authorized 
to use these new funds for staff in-service training, cur­
ricula and materials, community and parent awareness 
programs, and evaluation. 
Three principles guided the state’s tobacco con­
trol programs.  First, a broad base of public support 
was developed by the collaboration of the Minnesota 
Coalition for a Smoke-Free Society 2000, the Associa­
tion for Nonsmokers—Minnesota, voluntary health 
agencies, health professionals, and insurers.  Second, 
the program maintained a positive approach that 
stressed the consequences of tobacco use rather than 
attacked the tobacco industry or blamed smokers. 
Third, the program focused on preventing tobacco use 
among adolescents and young women who had not 
yet become addicted to cigarettes or smokeless 
tobacco. 
The mass media campaigns were the most vis­
ible component. The campaigns included paid televi­
sion, radio, and outdoor/transit advertising directed 
at two target populations: 12- to 13-year-old boys and 
girls and 18- to 24-year-old women. The goal of the 
media campaign was to change a social climate that 
encouraged the use of tobacco. Advertisements fo­
cused on increasing the awareness of the negative as­
pects of tobacco use that are most important to young 
people—unpleasant social and personal consequences, 
such as bad breath, smelly clothes, and addiction. 
To foster community tobacco control programs, 
The Minnesota Plan for Nonsmoking and Health recom­
mended that schools, health services, and other 
community organizations be involved in providing 
prevention and education programs about tobacco use. 
A granting program was established in 1986 to fund 
21 proposals from local organizations that could dem­
onstrate a coordinated approach for involving multiple 
local organizations in the prevention effort.  A second 
cycle of local projects was funded in 1988. 
Schools throughout the state were involved in an 
intensive effort to plan, implement, and evaluate effec­
tive programs for students from kindergarten (K) to 
grade 12 and in technical institutes. Since the start of 
these programs in the 1986–1987 school year, the per­
centage of school districts addressing smoking in grades 
K–4 steadily increased but remained fairly constant in 
grades 5–10. The number of school districts in the state 
with a tobacco-free policy, however, steadily increased. 
Each of the main program elements funded by 
the Minnesota Tobacco-Use Prevention Initiative has 
been evaluated (Minnesota Department of Health 1989, 
1991). Youth and adults targeted by the program were 
aware of the media campaign, and the evaluation data 
suggested that the campaign improved young people’s 
attitudes toward tobacco use (Minnesota Department 
of Health 1991). There was a steady increase in the 
number of school districts whose curricula included 
components for preventing tobacco use (Minnesota 
Department of Health 1991). Nonetheless, a prospec­
tive study indicated that schools using the prevention 
curricula were not more effective in reducing adoles­
cent tobacco use than were a randomized control group 
of schools (Murray et al. 1992). In that study, a com­
parison of trends in adolescent tobacco use in Minne­
sota and Wisconsin between 1986 and 1990 found a 
slightly larger (but nonsignificant) net decline in Min­
nesota. The investigators suggested that greater reach 
and penetration of preventive efforts may be required 
to produce statewide reductions in adolescent tobacco 
use (Murray et al. 1992). 
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California 
In November 1988, the Tobacco Tax and Health 
Promotion Act (Proposition 99) was passed by Cali­
fornia voters, thus mandating the start of California’s 
Tobacco Control Program.  The program is the largest 
and most comprehensive undertaken in the United 
States to reduce tobacco use.  Initially, the program 
defined three long-term objectives: (1) to reduce the 
initiation of cigarette smoking by children and youth 
under age 19 from the 1987 rate of 26.4 percent to no 
more than 6.5 percent by 1999, (2) to reduce cigarette 
smoking among adults aged 20 years and older from 
the 1987 rate of 26.0 percent to 6.5 percent by 1999, 
and (3) to reduce smokeless tobacco use among males 
aged 12–24 years from the 1987 rate of 8.9 percent to 
no more than 2.2 percent by 1999 (Tobacco Education 
Oversight Committee 1991). The excise tax rate on 
cigarettes in California rose from $0.10 to $0.35 on Janu­
ary 1, 1989, when Proposition 99 was implemented. 
On January 1, 1994, the tax increased to $0.37, where it 
remained in 1999. Funding for tobacco control efforts 
began during fiscal year 1989 (July 1989–June 1990). 
The fiscal year 1999 budget in California was $126.8 
million ($3.90 per capita) for tobacco control activities 
funded by the Department of Health Services and the 
Department of Education. 
The NCI’s planning framework (NCI 1991) was 
used to establish the program’s target groups, in­
tervention channels, and interventions to reach them 
(Bal et al. 1990). Community mobilization is a key part 
of California’s extensive program for reducing tobacco 
use. Community-based programs are the responsibil­
ity of the California Department of Health Services and 
61 local health departments (58 county and 3 city). 
These local agencies, advised by local coalitions, es­
tablished multiple subcontracts with community-
based organizations to conduct events, programs, and 
presentations for diverse racial and ethnic groups (To­
bacco Education Oversight Committee 1991). Local 
lead agencies have been a cornerstone of the program 
by mobilizing communities to eliminate exposure to 
ETS, by closing channels for minors’ access to tobacco, 
and by advising local policymakers. The local lead 
agencies receive approximately 20 percent of funds 
allocated for education programs to achieve these ends. 
The statewide media campaign, which receives 
about 12 percent of funds, has been the program’s most 
visible element. Launched in 1990, the media cam­
paign has focused primarily on changing public opin­
ion to denormalize tobacco use. In particular, it has 
sought to raise public awareness of the tobacco 
industry’s manipulative and deceptive marketing 
tactics and of the dangers of ETS. Although young 
people are a direct target audience for some campaign 
messages, the campaign has focused more on chang­
ing social norms and reducing adult tobacco use to 
influence youth, many of whom begin using tobacco 
to be more adultlike.  Funding for the statewide me­
dia campaign was about $24 million ($0.75 per capita) 
in 1998 but has varied considerably over the years, as 
is discussed later in this section. 
About 16 percent of education funds are spent on 
competitive grants to community-based organizations. 
More than two-thirds of these grants have targeted 
racial and ethnic minority communities. The competi­
tive grants program has had multiple funding cycles, 
and 46 separate projects were funded in 1993.  In ad­
dition, the competitive grants program funds several 
statewide projects, such as the Tobacco Education 
Clearinghouse of California, which distributes library 
and video materials, and the California Tobacco Con­
trol Resource Partnership, which provides technical 
assistance and training to local lead agencies. The com­
petitive grants program has also been used to estab­
lish regional linkages among local governments and 
local nongovernmental organizations.  Twenty-four 
percent of the education funds go to school-based 
programs to prevent tobacco use and are distributed 
through the California Department of Education.  The 
project estimated that it would reach approximately 
350,000 students through programs implemented be­
tween 1994 and 1996. 
The single largest share, by far, of the education 
funds—59 percent through 1996—goes to the medical 
care programs.  This percentage is notably higher than 
the 45 percent specified by the legislation (Novotny 
and Siegel 1996). As a result of this redistribution, the 
portions of the program that deal with reducing to­
bacco use—designated for 20 percent of the fund— 
have never been fully financed. In the first year, 16.5 
percent of funds were allocated for such program 
efforts; in the second cycle, 12 percent were allocated; 
in the third, 10 percent.  This diversion of funds was 
the result of executive decisions and was strongly sup­
ported by the tobacco industry and the California 
Medical Association.  After the third diversion, civil 
action was initiated by Americans for Nonsmokers’ 
Rights, supported by the American Lung Association 
and the ACS, to prevent the reallocation.  The Sacra­
mento Superior Court found in favor of the plaintiffs 
in early 1995. The state appealed, and the judgment 
for the plaintiffs was upheld in December 1996 (Ameri­
cans for Nonsmokers’ Rights v. State of California). 
The complicated course of these events, as de­
tailed by Novotny and Siegel (1996), has highlighted 
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the role of the tobacco industry in countering efforts 
to reduce the use of its products and the opposing strat­
egy of health advocates. Begay and colleagues (1993) 
have pointed out that since Proposition 99 passed, the 
tobacco industry’s political expenditures in California 
have risen tenfold, from $790,050 in the 1985–1986 elec­
tion to $7,615,091 in the 1991–1992 election, during 
which the tobacco industry contributed more heavily 
to candidates for the California legislature than to can­
didates for the U.S. Congress.  In a further analysis, 
this same research group (Traynor et al. 1993) detailed 
the specific industry strategies to prevent local con­
trol of tobacco use.  Using case studies, they docu­
mented the industry’s use of front groups to conceal 
its involvement, its organization of local referenda to 
defeat or suspend local ordinances, and its financing 
of local election campaigns to repeal ordinances by 
popular vote. Glantz and Begay (1994) have also 
analyzed the relationship between campaign contri­
butions and votes on individual tobacco-related bills 
in the California legislature. Using a “tobacco policy 
score” (p. 1178) that ranked legislators according to 
their stance for or against reducing tobacco use, they 
found a significant relationship between the amount 
of money received from tobacco sources and a 
protobacco position.  This ongoing documentation of 
tobacco industry influence, though not a formal part 
of the California Tobacco Control Program, has been 
one of its notable features, and it provides a model of 
health advocacy for other states and localities. 
The program, which has evolved considerably 
since 1989, remains a multifocal, multichannel ap­
proach to the broad range of issues that confront large-
scale efforts to reduce tobacco use (Tobacco Education 
and Research Oversight Committee 1995; Pierce 
et al. 1998a). In 1993, the California Tobacco Control 
Program was revised, and program priorities were 
refocused (Pierce et al. 1998a).  Four broad priority 
areas, or policy themes, were established for use in the 
program planning and funding decisions: 
•	 	 Protecting people from exposure to ETS. 
•	 	 Revealing and countering tobacco industry 
influence. 
•	 	 Reducing young people’s access to tobacco 
products. 
•	 	 Providing cessation services. 
The California Tobacco Control Program contin­
ues to place its primary emphasis on a broad statewide 
infrastructure that reaches into communities across the 
state. The program’s basic structure is composed of a 
state-level office and several statewide and regional 
programs that foster a collaborative grassroots approach 
to serve a decentralized structure of community pro­
grams across the state (Pierce et al. 1998a). 
Surveillance and evaluation activities to assess 
program performance and impact were established 
as part of the initial program structure (Bal et al. 1990; 
Tobacco Education Oversight Committee 1991).  The 
evaluation is composed of large triennial surveys 
(Pierce et al. 1994, 1998a) and smaller ongoing sur­
veys (Pierce et al. 1998b), a more targeted evaluation 
of program components (Independent Evaluation 
Consortium 1998), and a wide array of local program 
evaluation efforts.  Evaluation is complicated, how­
ever, by the multiplicity of prevalence surveys avail­
able and by potential error from using data from 
surveys with differing methods (Novotny and Siegel 
1996; Siegel et al. 2000). Establishing specific rela­
tionships between large-scale social interventions and 
a change in tobacco use is difficult, but the temporal 
relationship between the decline in California’s to­
bacco consumption and the efforts generated by 
Proposition 99 can be clearly observed. 
Per Capita Cigarette Consumption 
Before the implementation of the program in 
1989, the rate of decline in monthly per capita ciga­
rette consumption was 0.42 packs, which was signifi­
cantly greater than the rate of 0.36 in the rest of the 
country (Pierce et al. 1998a,b).  From January 1989 
through December 1993, the decline in California in­
creased significantly, to 0.65 packs, while the decline 
in the rest of the United States increased nonsignifi­
cantly, to 0.45 packs.  Until early 1992, the media pro­
gram was the only part of the tobacco control program 
that was fully implemented. An econometric analysis 
(Hu et al. 1995) has estimated that of the 1,051-million 
pack decrease in sales between 1990 and 1992, approxi­
mately 232 million (22 percent) were attributed to the 
media campaign and the remaining 819 million (78 
percent) to the excise tax increase.  Between 1993 and 
1996, the rate of decline in per capita consumption in 
California slowed significantly, to 0.17, but virtually 
halted altogether in the rest of the country (at 0.04 
packs) (Pierce et al. 1998b). Consumption decreased 
more rapidly in California than in the rest of the coun­
try, even though the California cigarette excise tax 
changed only slightly during this period (from $0.35 
in 1993 to $0.37 in 1994). Between 1993 and 1996, how­
ever, expenditures for tobacco control were reduced 
by more than 50 percent from their initial funding lev­
els in fiscal year 1990 and 1991. During 1989–1993, 
spending for advertising and promotions by the 
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tobacco industry exceeded tobacco control expendi­
tures in California by a ratio of about 5 to 1; from 1993 
to 1996, that ratio increased to nearly 10 to 1 (Pierce et 
al. 1998b). 
Adult Smoking Prevalence 
Data on adult patterns of smoking prevalence are 
not as consistent or as easy to evaluate as consump­
tion trends (Novotny and Siegel 1996). Nevertheless, 
the trends in these data are consistent with the pat­
terns noted in the per capita consumption analyses. 
From 1989 to 1993, smoking prevalence declined in 
California almost twice as rapidly as in the rest of the 
country (Pierce et al. 1998b).  However, from 1994 to 
1997, the rate of decline in California appeared to slow. 
Overall, smoking prevalence has declined from 26.7 
percent in 1988 to 16.7 percent in 1995 in California 
and from 30.2 percent in 1988 to 24.7 percent in 1995 
in the rest of the country (CDC 1996; Pierce et al. 1998b). 
A recent analysis of trends in adult prevalence of smok­
ing in California compared with the rest of the United 
States observed a significant decline in smoking preva­
lence in California from 1985 to 1990 and a slower but 
still significant decline from 1990 to 1994, a period in 
which there was no significant decline in the remain­
der of the nation (Siegel et al. 2000). 
Youth Tobacco Use Prevalence 
The lack of consistent youth smoking surveil­
lance data between California and other states has 
impeded the evaluation of program impact on tobacco 
use among young people in California. However, one 
multivariate analysis of data from the school-based 
Monitoring the Future survey of 8th-, 10th-, and 12th­
grade students showed that from 1992 to 1994, the in­
crease in youth smoking rates that was experienced 
nationwide was slowed significantly in California 
(P < 0.001, controlling for price, smoking policies, and 
other nonprogram effects) as a result of the combined 
effect of the tax increase in 1994 and the implementa­
tion of the state’s tobacco control programs (Chaloupka 
and Grossman 1996). Pierce and colleagues (1994) have 
concluded that the media campaign was successful 
in stopping the rise in teen smoking that had been oc­
curring in California before the campaign launch. 
Results from other analyses of youth tobacco use 
data are consistent with the result found by Chaloupka 
and Grossman (1996).  In data reported by the Califor­
nia Independent Evaluation Consortium, between 1991 
and 1996, rates of smoking during the past 30 days 
among California youth in the 8th and 10th grades in 
the Monitoring the Future survey increased, but the 
Reducing Tobacco Use 
increase in California was less pronounced than in 
other states (Independent Evaluation Consortium 
1998). Among 8th-grade youth, since 1993 the preva­
lence of smoking during the past month has varied 
from 12 to 14 percent in California while steadily in­
creasing from 17 to 22 percent in the rest of the coun­
try.  Similarly, among 10th-grade youth, past-month 
smoking prevalence in California has been about 18 
to 19 percent since 1992 while increasing from 22 to 32 
percent in the rest of the country.  Data from the 
telephone-based California Youth Tobacco Survey in­
dicate that the prevalence of smoking during the past 
30 days among 12- to 17-year-olds increased from ap­
proximately 9 percent in the early 1990s to 11.9 per­
cent in 1995. Prevalence declined gradually after 1995, 
to 10.9 percent in 1997, while increasing in the rest of 
the country (Pierce et al. 1998a). 
Other Findings 
Since the start of the program in 1990, numerous 
changes in intermediate outcomes have been noted 
related to changes in social norms; clean indoor air 
policies in public places, worksites, and bars; and vol­
untary policies to ban smoking in homes. 
Massachusetts 
In November 1992, Massachusetts voters ap­
proved an initiative petition known as Question 1, 
establishing the Health Protection Fund with revenue 
generated from a 25-cent increase in the state’s ciga­
rette excise tax and a 25-cent increase in the wholesale 
price of smokeless tobacco products.  Revenues have 
been used to fund the Massachusetts Tobacco Control 
Program, a comprehensive set of activities and services 
that emphasize prevention programs at the local level 
and that focus on young people. The Massachusetts 
program was modeled, in part, on California’s pro­
gram. The overall goal of the program was to reduce 
tobacco use in Massachusetts by 50 percent by the end 
of 1999 (Abt Associates Inc. 1995).  With the passage 
of Question 1, the excise tax on cigarettes in Massa­
chusetts rose from $0.26 to $0.51 on January 1, 1993. 
This tax was fully absorbed by the industry through 
wholesale price reductions (CDC 1996).  However, in 
October 1996 the cigarette tax increased to $0.76 per 
pack (with comparable increases on smokeless tobacco 
products), where it currently remains. 
Funding for tobacco control efforts began with a 
large media campaign in October 1993. In late 1993 
and early 1994, funding for local agencies was begun, 
and several statewide initiatives were undertaken to 
provide direct services, as well as technical assistance, 
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training, and materials for localities. Starting in late 
1994, with the first year of complete implementation, 
the program received $43.1 million (33.7 percent) of 
the $127.8 million placed in the Health Promotion Fund 
created by the revenues from the excise tax increase. 
Other key programs receiving appropriations from the 
Health Promotion Fund were those for comprehensive 
school health education ($28.8 million, or 22.5 percent 
of the Health Promotion Fund in fiscal year 1995), drug 
education ($5.0 million, or 3.9 percent), and other 
health-related programs ($50.7 million, or 39.7 percent) 
(Abt Associates Inc. 1995).  After the first funding year, 
the program’s budget declined to $41.8 million in 1995– 
1996 and to $36.8 million in 1996–1997. Funding was 
increased for other programs receiving appropriations 
from the Health Promotion Fund (Abt Associates Inc. 
1997). 
Community-based education activities and pre­
vention activities are two main elements of the Mas­
sachusetts program.  The state’s 10 regionally based, 
primary care Prevention Centers have added a com­
ponent for reducing tobacco use and provide ongoing 
technical assistance and training to local community 
programs. Local community initiatives have included 
programs to increase community awareness about 
the hazards of tobacco use, to promote tobacco-free 
workplaces and public facilities, and to enforce local 
regulations and ordinances for reducing tobacco use; 
needs assessments in the community; mobilization of 
youth service agencies to prevent and reduce tobacco 
use among children and adolescents; funding of 
community-based agencies to work with at-risk adult 
populations, including cultural and linguistic minority 
groups, women of childbearing age, and blue-collar 
workers; and funding of school-based health centers 
(Abt Associates Inc. 1995). 
Per Capita Cigarette Consumption 
As in California, Massachusetts has experienced 
a persistent pattern of decline in per capita cigarette 
consumption. Before the 1993 implementation of these 
tobacco control programs, per capita cigarette con­
sumption was declining in Massachusetts at a rate 
approximately equivalent to that of the rest of the coun­
try (6.4 percent in Massachusetts and 5.8 percent in 
the states other than California [CDC 1996]). Between 
1992 and 1997, per capita consumption in Massachu­
setts declined by 31 percent (from 117 to 81 packs per 
adult), while the decline in the remaining 48 states was 
only 8 percent (Abt Associates Inc. 1997).  Between 1993 
and 1996, the decline in per capita consumption has been 
more consistent in Massachusetts than in California 
(CDC 1996). Although program funding declined about 
15 percent in Massachusetts from 1995–1996 to 1996– 
1997 (Abt Associates Inc. 1997), it declined less than in 
California. 
Adult Smoking Prevalence 
Adult smoking prevalence has been monitored 
in Massachusetts both by the annual survey conducted 
through the Behavioral Risk Factor Surveillance Sys­
tem (BRFSS) and by special Massachusetts Adult To­
bacco Surveys conducted in 1993, 1996, and 1997. Data 
from the BRFSS indicate that adult smoking prevalence 
in Massachusetts declined from an average of 23.5 
percent for 1990–1992 to 20.6 percent in 1997.  In the 
rest of the country (excluding California), prevalence 
declined from 24.1 percent in 1990–1992 to 23.4 per­
cent in 1993–1995 (CDC 1996; Abt Associates Inc. 1997). 
The Massachusetts survey produced different preva­
lence estimates but corroborated a similar decline in 
the prevalence of smoking among adults in Massachu­
setts (from 22.6 percent in 1993 to 21.1 percent in 1996 
and 20.6 percent in 1997) (Abt Associates Inc. 1997). 
Youth Tobacco Use Prevalence 
As in California, the observed nationwide in­
crease in the prevalence of smoking among young 
people from 1992 to 1994 was significantly less evi­
dent in Massachusetts (Chaloupka and Grossman 
1996). Follow-up data from the Youth Risk Behavior 
Survey (YRBS) indicated that the prevalence of cur­
rent smoking among Massachusetts high school stu­
dents (grades 9 to 12) declined from 35.7 percent in 
1995 to 34.4 percent in 1997 while increasing from 34.4 
to 36.4 percent nationwide (CDC 1996, 1998).  Data 
from the YRBS and other survey sources suggest a dif­
ferential pattern by age: the prevalence of current 
smoking increased in Massachusetts among older stu­
dents in a manner similar to that of the rest of the coun­
try but declined among younger students. Between 
1993 and 1996, the prevalence of smoking during the 
past 30 days among 8th-grade students in Massachu­
setts declined from 26.5 to 26.0 percent but increased 
from 16.7 to 21.0 percent nationwide (Briton et al. 1997). 
For Massachusetts, the prevalence of current smoke­
less tobacco use among 9th–12th graders decreased 
from 8.4 percent in 1995 to 6.0 percent in 1997; for 
males, the decline was from 15.1 to 10.3 percent (Kann 
et al. 1998). In the nation as a whole between 1993 and 
1996, lifetime use of smokeless tobacco among 9th– 
12th graders decreased from 25 to 20 percent, and cur­
rent use decreased from 9 to 6 percent (Briton et al. 
1997).  The most recent data from the 1999 YRBS in 
Massachusetts indicated a continuing decline in the 
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prevalence of current smoking, down to 30.3 percent 
among 9th–12th graders (Goodenow 2000); however, 
national comparison data for 1999 are not yet available. 
A 1996 survey of 12- to 14-year-olds in Massachu­
setts and a national comparison sample (Houston 
Herstek Favat, Youth exploratory 1996, Massachusetts 
Department of Public Health, presentation of findings, 
unpublished data) found that Massachusetts youth had 
significantly higher levels of agreement with issues 
addressed in the state media campaign. For example, 
59 percent of Massachusetts youth but only 35 percent 
of youth in the national sample agreed with the state­
ment, “Smoking cigarettes decreases your stamina and 
smokers have a hard time keeping up in sports.” Re­
sults from a longitudinal survey of Massachusetts 
youth provided additional support for the efficacy of 
the Massachusetts antismoking media campaign 
(Siegel and Biener 2000). In a four-year follow-up of 
youth aged 12 to 15 years in 1993, this study found that 
among the younger adolescents (aged 12 to 13 years at 
baseline), those exposed to antismoking advertisements 
were significantly less likely to progress to established 
smoking. However, among older adolescents (aged 14 
to 15 years at baseline), exposure did not prevent pro­
gression to established smoking. 
Other Findings 
There have been multiple changes in intermedi­
ate measures of program impacts related to youth 
access, protection of nonsmokers from ETS, and avail­
ability of cessation services (Abt Associates Inc. 1999). 
For example, by 1999, nearly two-thirds of Massachu­
setts residents lived in cities and towns with some kind 
of smoking restriction in restaurants, and 26 percent 
were protected by complete bans.  Prior to the start of 
the program, less than 1 percent of Massachusetts resi­
dents lived in towns with complete bans. Additionally, 
the local restaurant smoking restrictions were found to 
be more restrictive in communities receiving funding 
from the Massachusetts Tobacco Control Program. 
Arizona 
In November 1994, Arizona voters passed Propo­
sition 200, which increased the state cigarette excise 
tax from $0.18 to $0.58.  Revenues from the tax increase 
were earmarked for the state’s Medicaid program (70 
percent of revenues), for programs for preventing and 
reducing tobacco use (23 percent), for research on pre­
vention and treatment of tobacco-related disease and 
addiction (5 percent), and for an “adjustment account” 
(Arizona Tobacco Tax and Health Care Act 1994, sec. 
2C4) to offset lost revenue to other state programs 
Reducing Tobacco Use 
currently funded by revenue from the existing $0.18 
excise tax (2 percent).  The petition drive to place the 
initiative on the November 1994 state ballot and the 
campaign to win voter approval was led by the Ari­
zona for a Healthy Future coalition. Although public 
support for the initiative was strong when it was first 
proposed in 1993 (71 percent in favor, with 56 percent 
indicating strong support), the initiative was vigor­
ously opposed in a well-funded advertising effort on 
television, in posters, and by direct mail. Proposition 
200 was narrowly approved, garnering approximately 
51 percent of the vote (Nicholl 1998). 
With the passage of Proposition 200, analysts 
estimated that the revenues earmarked for tobacco 
prevention and education programs would be ap­
proximately $25 million per year (Meister 1998). 
However, measures passed during the 1995 session 
gave the legislature control over the funds and lim­
ited expenditures to $10 million per year (Madonna 
1998). Additionally, multiple restrictions were placed 
on how the funds could be used, and an advisory com­
mittee was appointed that included legislative and 
business representatives hostile to the program 
(Meister 1998). Although the Coalition for Tobacco-
Free Arizona led an effort to keep the goals of the newly 
created Arizona Tobacco Education and Prevention 
Program (AzTEPP)  “comprehensive,” the program 
efforts were narrowed to a focus on youth prevention; 
adult cessation activities were restricted to pregnant 
women and their partners. Not until the fiscal year 
that began on July 1, 1997, with a new governor and 
health department director, were the programmatic 
restrictions lifted from the health department and the 
program allowed to proceed with the implementation 
of the “draft” comprehensive tobacco control plan 
originally proposed by the Coalition for Tobacco-Free 
Arizona. 
The expenditures of AzTEPP reflect the political 
history of the program:  $9.7 million in fiscal year 1996, 
$18.2 million in 1997, and $28.2 million in 1998. Al­
though the countermarketing campaign has expanded 
(with spending increasing from $7.4 million in 1996 to 
$13.2 million in 1998) (Riester and Linton 1988), the 
greatest expansion in the program has been in the 
scope and focus of the local programs (Meister 1998) 
(with funding increasing from $1.7 million in 1996 
to $9.4 million in 1998). Recent program efforts have 
focused on all of the elements in the coalition’s draft 
comprehensive tobacco control plan (Meister 1998), 
thereby expanding its adult cessation activities 
(discussed at the fourth annual AzTEPP meeting in 
February 1999), but one of the factors that had been 
minimized in early health department efforts was 
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evaluation. Only recently have baseline data collec­
tion surveys been initiated (Meister 1998); as a result, 
no outcome data have been reported on the program, 
and subsequent evaluation efforts will be compro­
mised by the lack of baseline data collected before the 
start of the multiple large-scale program efforts. 
Respondents to an initial statewide telephone 
survey conducted in 1998 (Arizona Cancer Center 
1998), about two and a half years after the media 
campaign’s launch, reported that the advertising cam­
paign, which stressed how damaging tobacco use is 
and how unappealing it is to the user, to peers, and to 
the opposite sex, had influenced their attitudes in the 
intended direction.  For example, 80 percent of young 
people reported that the advertisements made them 
think about the negative aspects of tobacco use, and 
58 percent of pregnant or postpartum women said the 
advertisements made them uncomfortable around 
smokers. Young people who had been exposed to the 
television advertisements in the previous 30 days were 
less likely to be susceptible to using tobacco than were 
youth who had not seen the advertisements. The 
campaign’s impact on reported behaviors is less clear, 
especially among young people. Among respondents 
who were using tobacco at the start of the campaign, 
23 percent of adults, 37 percent of pregnant or post­
partum women, and 27 percent of young people said 
the advertising campaign had convinced them to try 
quitting. However, 23 percent of young people also 
reported that the campaign had convinced them to 
increase their tobacco use. Cummings and Clarke 
(1998) noted that such an unintended effect, if it is real, 
might represent young smokers’ negative reaction to 
a narrowly focused youth campaign with no messages 
directed at changing broader social norms. 
In response to a request from the Arizona Joint 
Legislative Audit Committee, the State Auditor Gen­
eral conducted a performance audit of the AzTEPP 
(State of Arizona, Office of the Auditor General 1999). 
This audit noted that evaluations of the state and local 
levels of programs have not yet produced an adequate 
assessment of the program’s tobacco control efforts. 
Thus, the audit recommended that the program 
needed to improve its evaluations to measure its ef­
fectiveness in preventing youth from starting to use 
tobacco, encouraging and assisting tobacco users to 
quit, and reducing exposure to secondhand smoke. 
Specifically, the audit found that the program had been 
unable to establish a baseline on tobacco use among 
youth and had only preliminary assessments in place 
to assess cessation services. The program has estab­
lished adequate methodologies to measure the preva­
lence of adult smoking; however, follow-up results are 
not yet available. Thus, the audit concluded that “The 
program’s evaluation approach to date leaves it far short 
of knowing whether its programs are working” (p-ii). 
In response to this audit, the Arizona Department 
of Health Services (AzDOHS) has implemented 
changes in its surveillance and evaluation systems. 
Expanded surveillance systems for youth have been 
planned and will be implemented in 2000; however, 
no baseline data are available on youth smoking rates. 
For adults, a baseline survey of adults was conducted 
in 1996 and repeated in 1999. Using methodology simi­
lar to that used by the state BRFSS, the 1996 and 1999 
Arizona Adult Tobacco Surveys were conducted by 
telephone interviews on representative samples of 
more than 4,500 adults in Arizona aged 18 years and 
older.  Results from these surveys indicate that the 
prevalence of smoking among adults declined from 
23.8 percent to 18.8 percent overall (AzDOHS 2000). 
Among adults aged 18 to 24 years, a significant de­
cline was observed also, from 27.5 percent in 1996 to 
21.0 percent in 1999.  Both of these rates compare very 
favorably to national trends, where rates overall among 
adults have not declined in recent years and rates 
among younger adults have been increasing.  Finally, 
smoking rates among Hispanics declined from 23.5 
percent to 14.6 percent, which was the largest decline 
seen in any race/ethnic group in the state.  Multiple 
other indicator variables suggest that these changes 
may be related to increases in smoke-free policies, ad­
vice from doctors and dentists, and exposure to tele­
vision antismoking information. Finally, these declines 
in smoking prevalence are consistent with declines in 
per capita sales (Orzechowski and Walker 2000) that 
indicate that declines in Arizona since 1996 are larger 
than those observed in the rest of the country. 
Oregon 
On November 5, 1996, Oregon voters approved 
Measure 44, raising the state cigarette excise tax from 
$0.38 to $0.68 (with a proportional increase in the tax 
rate on other tobacco products) and designating 
90 percent of the increased revenue for the Oregon 
Health Plan (to expand insurance for medically 
underserved state residents) and the remaining 
10 percent for a statewide tobacco prevention and edu­
cation program managed by the Oregon Health Divi­
sion. Survey data indicated that support for the 
initiative was increased by having the new revenue 
earmarked in this way (CDC 1997; Nicholl 1998). The 
Oregon campaign to place the initiative on the Novem­
ber 1996 ballot was initially led by the Committee to 
Support the Oregon Health Plan, which represented 
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primarily the private health care sector.  Nonprofit and 
public health organizations added their support and 
worked in a loosely organized network led by the ACS. 
Later in the campaign, both groups combined efforts 
and resources.  The measure had strong support from 
state media (receiving endorsements from all major 
newspapers and a majority of the smaller ones), from 
leading business groups, and from the governor, who 
conducted a three-day supportive media tour before 
the election. 
The Oregon Health Division used its existing 
Oregon Tobacco Control Plan as the model for the new 
statewide program.  Revenue from Measure 44 dur­
ing the 1997–1999 biennium was projected to be $170 
million; of this, 10 percent (approximately $17 million) 
per biennium was appropriated to fund the Tobacco 
Use Reduction Account administered by the Oregon 
Health Division. The resulting Oregon Tobacco Pre­
vention and Education Program has eight elements: 
(1) local community-based coalitions, (2) comprehen­
sive school-based programs, (3) statewide public 
awareness and education campaigns, (4) a cessation 
help line, (5) tribal tobacco prevention programs, 
(6) multicultural outreach and education, (7) demon­
stration and innovation projects, and (8) statewide 
leadership, coordination, and evaluation. 
The 1997–1999 biennium budget for these eight 
elements is combined into five categories: (1) local 
coalitions—$6.5 million (38 percent), (2) public aware­
ness and education—$4.6 million (27 percent), (3) state­
wide and regional projects—$2.75 million (16 percent), 
(4) schools—$2 million (12 percent), and (5) statewide 
coordination and evaluation—$1.2 million (7 percent). 
Evaluation data from Oregon indicate that the 
program has successfully implemented each of the 
program elements and is achieving its performance 
objectives (Oregon Health Division 1999).  Local 
community-based coalitions were created in all 36 
Oregon counties. Twenty-four school projects were 
funded, reaching 58 of the 198 (30 percent) school dis­
tricts in the state. Surveys indicated that approxi­
mately 75 percent of adults and 84 percent of the young 
people recalled seeing the state’s public awareness 
campaign. In January 1999, more than 1,500 Orego­
nians called the cessation help line. All nine federally 
recognized Indian tribes in Oregon are now receiving 
funding to implement prevention and education pro­
grams to reduce tobacco use.  Multicultural outreach 
and education programs have been established for 
Hispanic, Asian/Pacific Islander, and African Ameri­
can populations in Oregon. Five demonstration 
projects have been funded focusing on pregnant 
women, health care delivery systems, and creative 
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ways to reach youth audiences.  The program has also 
established a comprehensive and multifaceted surveil­
lance and evaluation system and has strengthened 
program management. 
Trends in per capita consumption in Oregon were 
compared with the remainder of the country (exclud­
ing California, Massachusetts, and Arizona) for the 
period before program implementation (1993–1996) 
and after (1997–1998). From 1993 to 1996, consump­
tion increased 2.2 percent in Oregon and decreased 
0.6 percent in the rest of the country (CDC 1999b).  In 
1997 and 1998, per capita consumption declined 11.3 
percent in Oregon (from 92 to 82 packs per adult).  Be­
tween 1996 and 1997, per capita consumption in the 
rest of the country declined only 1.0 percent (from 93 
packs per adult to 92 packs per adult). 
Smoking prevalence among adults in Oregon has 
been consistent with the observed declines in per capita 
consumption. Data from the BRFSS indicate that the 
prevalence of smoking among adults aged 18 years and 
older in Oregon declined from 23.4 percent in 1996 to 
21.9 percent in 1998 (Oregon Tobacco Prevention and 
Education Program 1999).  The proportion of women 
who smoked during pregnancy, as reported on state 
birth certificates, dropped from 17.7 percent in 1996 to 
15.2 percent in 1998. Data suggest that smoking rates 
among young people are continuing to increase as in 
the rest of the country. 
Maine 
In June 1997, the Maine legislature approved H.P. 
1357, An Act to Discourage Smoking, Provide Tax Re­
lief and Improve the Health of Maine Citizens, which 
increased the state cigarette excise tax from $0.37 to 
$0.74 and earmarked the increased revenue for the 
Tobacco Tax Relief Fund.  The act established the To­
bacco Prevention and Control Program within the 
Maine Bureau of Health and provided $3.5 million in 
funding for fiscal years 1998 and 1999. The legislative 
effort to gain passage of the act was a combined effort 
of the state public health community, legislative lead­
ership, and executive branch support. 
The Bureau of Health has developed the Maine 
Tobacco Prevention and Control Program to expand 
the existing ASSIST program structure and to meet the 
legislative requirement of the 1997 state statute.  The 
legislation specified that the program include an on­
going, major media campaign; grants for funding 
community-based programs; program surveillance 
and evaluation; and law enforcement efforts regard­
ing transportation, distribution, and sale of tobacco 
products.  The program’s initial $4.35 million annual 
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budget included $1.6 million for a multimedia cam­
paign, $1.25 million for community and school grants, 
$625,000 for statewide cross-cutting activities, $400,000 
for state staffing, $400,000 for evaluation, and $75,000 
for enforcing youth access provisions. 
In April 2000, legislation was passed in Maine 
that appropriated additional funds to expand the 
Maine Tobacco Prevention and Control Program; a 
total of $18.3 million from the settlement is going to 
tobacco control.  Of this total amount, $8.35 million 
will be used for community and school-based grants, 
funding communities and schools to achieve the goal 
of reducing tobacco addiction and use and resulting 
disease, with a focus on those at highest risk such as 
youth and disadvantaged populations. About $6.75 
million will be used for cessation and statewide mul­
timedia campaigns; $1.2 million is for evaluation for 
independent program evaluation, research, and out­
comes monitoring; $200,000 funds five positions in the 
Bureau of Health for administering the programs; and 
$1.8 million for improved prevention and treatment 
of tobacco-related diseases for those with Medicaid 
Insurance. 
Programs Funded by State Settlements 
With the Tobacco Industry 
As was discussed earlier in this report (see 
“Legislative Developments” and “Master Settlement 
Agreement” in Chapter 5), all 50 states, the District of 
Columbia, and five commonwealths and territories 
have settled lawsuits with the tobacco industry to re­
claim statewide costs spent treating Medicaid patients 
for diseases related to tobacco use.  Four of those states 
settled their individual lawsuits with the industry— 
Mississippi in July 1997, Florida in September 1997, 
Texas in January 1998, and Minnesota in May 1998— 
and the remaining parties jointly settled in November 
1998 in the multistate Master Settlement Agreement. 
Because of a “most favored nation” clause (ex­
plained in “Recovery Claims by Third-Party Health 
Care Payers” in Chapter 5), the four separate settle­
ments have been closely linked, particularly in how 
the terms of their awards affect the kind of compre­
hensive programs discussed in this chapter.  Most 
notably, when the State of Florida received in its 
settlement $200 million that was earmarked for a 
two-year pilot program to reduce tobacco use among 
young people, the State of Mississippi, though it had 
settled its lawsuit earlier, received $62 million for the 
same type of pilot program specified in its lawsuit. 
Texas and Minnesota received no such additional 
award, because their lawsuits did not specifically set 
aside funds for a parallel pilot program, although Min­
nesota received funds earmarked for smoking cessa­
tion and tobacco-related research. Language in the 
Texas and Minnesota settlements, however, released 
Florida and Mississippi from existing requirements to 
use their pilot program funding within two years and 
to direct their programs exclusively to young people. 
Because program planning in Florida and Mis­
sissippi was already in place when the youth-only 
restriction was removed, an emphasis on preventing 
tobacco use among young people has been evident in 
their pilot programs’ first years of activities.  These 
activities are described in the next two sections of this 
chapter.  Brief descriptions of settlement-funded plans 
in Texas and Minnesota follow.  This report does not 
attempt to describe the various plans and legislative 
proposals that are developing (at the time of this writ­
ing) in the 46 states, the District of Columbia, and the 
five commonwealths and territories included in the 
joint settlement of January 1998. 
Mississippi 
The Partnership for a Healthy Mississippi, a 
nonprofit corporation representing a broad range of 
public and private interests, plans and manages the 
state’s pilot program.  The program’s mission is to cre­
ate a youth-centered, statewide collaboration dedicated 
to fostering a healthier Mississippi and eliminating to­
bacco use among Mississippi youth. The partnership 
will award grants in five designated areas: (1) commu­
nity/school/youth activities and partnerships, (2) law 
enforcement, (3) public awareness, (4) health care ser­
vices and research, and (5) evaluation. 
In the first year, with a budget of $23.7 million, 
approximately 25 community and youth partnership 
coalitions were funded, and more are planned for the 
second year.  Local coalitions—one-quarter of whose 
membership must be young people—are among 
the statewide and regional organizations supported 
by community assistance statewide partner grants to 
provide training, tobacco prevention activities for ra­
cial and ethnic minority groups, and other technical as­
sistance. Specific programs that have been funded by 
the partnership are 4-H Youth Programs, Frontline 
(an advocacy organization for 14- to 18-year-olds), com­
prehensive school health programs, and a comprehen­
sive school health nurses pilot project.  In the first two 
years, $4 million has been allocated to these activities. 
The law enforcement program has awarded 
grants to municipalities to enforce the Mississippi 
Juvenile Tobacco Access Prevention Act of 1997.  These 
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awards will range (according to population size) from 
a minimum of $5,000 per municipality to a maximum 
of $250,000. A total of $12.65 million has been bud­
geted over the first two years of the program for these 
awards. The grants will require municipalities to con­
duct periodic enforcement checks on the illegal sale 
of tobacco to minors, provide retailer education pro­
grams, provide education programs in schools, orga­
nize youth partnerships, and work with community 
coalitions on enforcement issues.  Other enforcement 
activities are being performed statewide by the Mis­
sissippi Attorney General’s Office. 
The partnership has budgeted $12.5 million for 
a countermarketing media campaign and other pub­
lic awareness activities to be conducted during the first 
two years. The health care services and research com­
ponent focuses on nicotine addiction and cessation 
among young people. An expenditure of $5 million is 
anticipated for the first and second years for training 
health providers in cessation counseling, for research­
ing childhood and adolescent tobacco abuse, and for 
coordinating cessation services in the state, including 
a telephone help line. The Mississippi State Depart­
ment of Health will manage the evaluation of the pi­
lot program and will focus on program effectiveness 
in preventing initial tobacco use among young people, 
helping young people quit smoking, and reducing 
young people’s exposure to ETS.  An expenditure of 
$2 million is anticipated for the first and second years’ 
evaluation activities. 
Since 1998, the Partnership for a Healthy Missis­
sippi has managed the pilot program to reduce youth 
tobacco use through a seven-member Board of Direc­
tors (www.healthy-miss.org) (McMillen et al. 1999). 
The major youth programs that have been implemented 
have included (1) the Reject All Tobacco (RAT) pro­
gram among students in grades K–3, (2) the Students 
Working Against Tobacco (SWAT) Program for students 
in grades 4–7, and (3) the Frontline youth advocacy 
movement. Community programs have involved 26 
community/youth partnership grants, targeted pro­
grams in collaboration with statewide organizations, 
and the school nurse program in 52 Mississippi school 
districts. Grants have funded 245 municipalities and 
74 counties to empower the local law enforcement agen­
cies to reduce sales to minors.  Cessation services have 
included the Adolescent and Child Tobacco Treatment 
Center and a Mississippi Tobacco Quitline.  Finally, a 
“Question It” public awareness campaign has focused 
on the 12- to 17-year-old audience. 
The Mississippi State Department of Health has 
established a consortium of evaluation contracts in­
volving multiple state universities to implement 
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program evaluation efforts.  The overall coordination 
is being managed by the Social Science Research Cen­
ter at Mississippi State University, with the evaluation 
of the media component conducted by the University 
of Mississippi, community programs conducted by 
Jackson State University, law enforcement component 
by Mississippi State University, and the school nurses 
component by Mississippi State University (McMillen 
et al. 1999). A baseline Social Climate Survey of To­
bacco Control and Tobacco Use was conducted in 1999 
among 3,040 adults aged 18 years and older that 
provided benchmark data on several social norm 
intermediate indicator variables (McMillen et al. 1999). 
Surveillance of youth tobacco use patterns is being con­
ducted by the Mississippi State Department of Health. 
The Youth Risk Behavior Survey was conducted among 
students in grades 9 to 12 in 1993, 1995, 1997, and 1999 
and among students in grades 6 to 8 and 9 to 12 in 1998 
and 1999. Results indicate that in Mississippi, smok­
ing rates among students in grades 9 to 12 had been 
increasing, as in the rest of country, between 1993 and 
1997 (Mississippi State Department of Health 2000). 
Between 1997 and 1999, smoking rates among students 
in grades 9 to 12 appear to have stopped increasing 
and leveled off.  Among students in grades 6 to 8, 
smoking rates did not decline between 1998 and 1999. 
Florida 
Program planning and implementation initially 
were managed by the Governor’s Office, with direct 
leadership provided by Governor Lawton Chiles, who 
was a party to the state’s lawsuit and a member of the 
small team who negotiated the settlement agreement. 
The Florida Tobacco Pilot Program is now managed by 
the Office of Tobacco Control within the Florida De­
partment of Health. The program has sought the input 
of Florida youth in planning the program focus and 
materials and in working toward the main goals of 
changing young people’s attitudes about tobacco use, 
increasing youth empowerment through community 
involvement, reducing young people’s access to tobacco 
products, and reducing youth exposure to ETS.  These 
four goals will be addressed through program compo­
nents similar to those of the Mississippi program: 
•	 	 Marketing and communications initiatives are 
planned to directly counter the tobacco industry’s 
marketing efforts.  A commercial advertising firm, 
working closely with teen advisors, has developed 
the “Truth” campaign, a direct attack on the image 
of smoking as cool and rebellious.  The campaign’s 
multichannel approach—based on techniques used 
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by the tobacco industry—includes television, print, 
and billboard advertising, as well as consumer 
items, such as “Truth”-imprinted T-shirts and 
stickers. 
•	 	 Youth programming and community partnership 
activities recruited young people to a Teen Tobacco 
Summit in early 1998 to advise on the overall de­
velopment of the program.  Chapters of Students 
Working Against Tobacco are currently active in 
all 67 counties. 
•	 	 Education and training programs focus on school-
aged children.  Conducted in partnership with 
communities, schools, voluntary agencies, profes­
sional organizations, and universities, these pro­
grams ensure that effective tobacco prevention 
curricula are presented in middle and high schools 
across the state and that tobacco prevention strat­
egies are being implemented in grades K–12 in 
conjunction with the Sunshine State Standards. 
•	 	 Enforcement initiatives are aimed at improving 
Florida’s efforts to reduce the accessibility of to­
bacco products to minors.  The Florida Department 
of Business and Professional Regulation, Division 
of Alcoholic Beverages and Tobacco, provides en­
forcement, educational, and marketing initiatives 
to ensure compliance with all tobacco laws. 
•	 	 The evaluation and research component monitors 
the performance of each of the program initiatives 
and the progress of the overall program in meeting 
goals and objectives. Under the leadership of the 
Florida Department of Health, and with the con­
sultation of the University of Miami, baseline data 
were collected by Florida universities in all major 
areas before the pilot program began in early 1998. 
In the first full year of operation, the program 
budget was approximately $70 million, with program 
component allocations of approximately $26 million for 
marketing and communications, $10 million for youth 
programming and community partnerships, $13 mil­
lion for education and training, $8.5 million for enforce­
ment, and $4 million for evaluation and research.  An 
additional $5 million was budgeted for programs tar­
geting minority populations and $3.5 million for ad­
ministration and management. In the second year, 
approximately $45 million more was appropriated for 
program operations; however, there were significant 
unexpended funds from the first year of operations that 
enabled major program components, such as the mar­
keting and communications activities, to continue a 
level of expenditure similar to the first year. 
Youth Tobacco Use Prevalence 
Between 1998 and 1999, the prevalence of cur­
rent cigarette use among middle school students 
(grades 6 to 8) declined from 18.5 to 15.0 percent (CDC 
1999c). Among high school students (grades 9 to 12), 
current cigarette use declined from 27.4 to 25.2 per­
cent. However, these declines were significant only 
for non-Hispanic white students; the change in cur­
rent smoking among non-Hispanic black and Hispanic 
middle and high school students was small and non­
significant. Current cigar use declined significantly 
only for middle school students (from 14.1 to 11.9 per­
cent), and this decline was almost entirely among 
males. Similarly, current smokeless tobacco use de­
clined only among middle school students (from 6.9 
to 4.9 percent) and remained unchanged among high 
school students. 
In early 2000, additional declines in youth to­
bacco use were observed (Florida Department of 
Health 2000). Current cigarette use among middle 
school students declined to 8.6 percent, or an overall 
54-percent decline since the 1998 baseline.  Among high 
school students, current cigarette use declined to 20.9 
percent, or an overall 24-percent decline since the 1998 
baseline. Although declines between 1998 and 1999 
were significant only for non-Hispanic white students, 
the declines observed in 2000 were significant among 
all racial/ethnic groups, except among the non-
Hispanic black and “other” categories of high school 
students. Declines in current tobacco use, which in­
clude the use of cigars and smokeless tobacco, also 
were significant.  Since the 1998 baseline survey, cur­
rent cigar use declined by 46 percent among middle 
school students and 21 percent among high school stu­
dents. Smokeless tobacco use declined by 54 percent 
among middle school students and by 19 percent 
among high school students. Declines in current to­
bacco use were consistent across grade, gender, and 
ethnicity as well. 
Using additional data collected as part of the 
overall program evaluation, the Florida Tobacco Con­
trol Program has connected the declines in youth 
smoking prevalence with program activities (Univer­
sity of Miami 1999). Results suggest that students who 
reported receiving elements of a comprehensive to­
bacco use prevention education in school had greater 
declines in smoking between 1998 and 1999 than those 
students who reported not receiving such education 
in school.  Similarly, the Community Partnerships in 
the 67 Florida counties were classified as “excellent,” 
“average,” or “needing improvement” based upon 
program record data, and these ratings were linked 
to data from the Florida Youth Tobacco Survey for 
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1998 and 1999 in those counties. Declines in smoking 
prevalence were related to the classification, with the 
greatest declines among middle and high school stu­
dents in counties rated as “average” or “excellent.” 
Similar ratings of counties on the level of local enforce­
ment of youth access laws were related to youth smok­
ing prevalence, with the highest levels of enforcement 
in counties with the lowest prevalence.  Finally, data 
from the Florida Anti-Tobacco Media Evaluation 
(FAME) have indicated that the “Truth” campaign is 
producing impressive awareness among youth and 
changes in attitudes and knowledge consistent with 
the campaign themes. Between 1998 and 1999, the 
prevalence of Florida youth aged 16 years and under 
with antitobacco attitudes increased from 59 to 64 per­
cent but decreased slightly nationwide. 
National data against which to compare the 
Florida data from 1998 and 1999 are not yet available, 
but some data suggest that the prevalence of tobacco 
use among young people may have peaked nation­
wide and could be starting to decline (University of 
Michigan 1998). In addition, the impact of state excise 
tax increases that have occurred since the 1998 baseline 
data collection might be assessed. 
Adult Smoking Prevalence 
In 1998, the Florida Behavioral Risk Factor 
Surveillance System (BRFSS) expanded its assessment 
of tobacco issues. The tobacco module will enable 
changes to be assessed in tobacco use prevalence, 
cessation behaviors, family rules about tobacco use, 
environmental tobacco smoke exposure at home, and 
workplace policies regarding smoking. 
Texas 
The legislative plan developed by the Texas 
Interagency Tobacco Task Force (1998) incorporated the 
CDC recommendations for community and school-
based programs to reduce tobacco use.  The plan in­
cludes a public awareness campaign, cessation and 
nicotine addiction treatment, programs for diverse or 
special populations, enforcement of laws to reduce 
minors’ access, surveillance and evaluation, and state­
wide program administration.  The plan requests 
$20.75 million for fiscal year 2000 and $61.25 million 
for fiscal year 2001 to implement, evaluate, and ad­
minister the programs proposed. 
In the fall of 1999, the Texas legislature created 
an endowment fund of $200 million and requested the 
Texas Department of Health to conduct a pilot study 
based upon recommended interventions included in 
the 1998 tobacco task force plan.  This pilot would be 
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funded by investment revenue from the endowment 
fund, approximately $9 million per year.  In response 
to this requirement, the Texas Department of Health 
has begun an Intervention Effectiveness Pilot Study 
in conjunction with universities in the state. 
To assess the impact of tobacco use prevention 
activities in the state, the Texas Department of Health 
has conducted the Texas Youth Tobacco Survey in 1998 
and 1999 among middle and high school students from 
a sample of students statewide and in eight regions of 
the state. Results from the 1998 survey indicated 31 
percent of middle school students and 43 percent of 
high school students were currently using some form 
of tobacco products (Texas Department of Health).  For 
cigarettes alone, 21 percent of middle school students 
and 33 percent of high school students were current 
smokers. 
Minnesota Settlement Program 
In Minnesota, the Minnesota Partnership for Ac­
tion Against Tobacco, the Tobacco Work Group of the 
Minnesota Health Improvement Partnership, and the 
Minnesota Blue Cross and Blue Shield (which received 
a separate $469-million settlement award [see “Recov­
ery Claims by Third-Party Health Care Payers” in Chap­
ter 5]) all have developed plans for the statewide effort 
to reduce tobacco use.  In the 1999 Omnibus Health 
and Human Services appropriation bill, the Minnesota 
legislature set aside $968 million from the state’s 
tobacco settlement to establish two health-related 
endowments: one for preventing tobacco use and 
supporting local public health efforts ($590 million) 
and the other for tobacco-related medical education 
and research ($378 million).  The interest earned from 
these endowments will support long-term programs. 
The 1999 Minnesota Omnibus Health and 
Human Services bill established an ambitious goal to 
reduce tobacco use among young people by 30 per­
cent by the year 2005. In response to this, the Minne­
sota Department of Health developed the Minnesota 
Youth Tobacco Prevention Initiative: Strategic Plan (Min­
nesota Department of Health 1999). This plan defined 
major activities that will be funded from January 1, 
2000, through June 30, 2001, in four component areas: 
Statewide Public Information and Education Cam­
paign, Statewide Programs, Community-Based 
Prevention Programs, and Youth Leadership Projects. 
The strategic plan established “initial indicators of suc­
cess” for each program component to enable program 
performance to be assessed. 
The Statewide Public Information and Educa­
tion Campaign will have a proposed budget of $7.5 
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million for the 18-month period. The campaign will 
include both a media component and grassroots 
organizing efforts focused on the target audience of 
12- to 17-year-old youth. The Statewide Programs will 
be budgeted at $3.55 million for the initial 18-month 
period. Evaluation activities, training, and technical 
assistance services will be funded along with statewide 
organizations to support the community-based efforts. 
The Community-Based Prevention Programs will be 
budgeted at $4.4 million for the initial 18-month 
period. Community-based prevention efforts will 
include tobacco-use prevention activities at the local 
level and projects that focus on populations at risk. 
Finally, the Youth Leadership Projects will be budgeted 
at $1 million for the initial 18-month period and will 
work in conjunction with the community-based 
prevention efforts.  These activities will seek to em­
power Minnesota’s youth to take leadership in the 
planning and implementation of tobacco prevention 
and control programs at the local level.  The Minne­
sota Department of Health has established an evalua­
tion plan to track progress of the initiative, with the 
first comprehensive report on program effectiveness 
to be delivered to the legislature in January 2003. 
Programs Meeting the Needs of Special 
Populations 
The recent Surgeon General’s report Tobacco Use 
Among U.S. Racial/Ethnic Minority Groups provided a 
summary of the various approaches that have been used 
to prevent and control tobacco use among racial/eth­
nic minority groups in the United States (USDHHS 
1998). This report highlighted the need for more re­
search on the effect of culturally appropriate programs 
to address this problem.  Few new findings have 
emerged since the publication of that report; hence, the 
elimination of disparities in health among population 
groups remains hampered by the lack of culturally ap­
propriate programs of proven efficacy.  Below are some 
examples of community-based interventions that have 
proven to be effective and that may serve as examples 
for the development of future program initiatives. 
Uniting and mobilizing the movement to reduce 
tobacco use among racial/ethnic groups have not been 
easy.  Tension frequently occurs between various orga­
nizations within the community regarding appropriate 
strategies to achieve particular goals, “turf” disagree­
ments, competition for fund-raising dollars, and other 
issues. Many of these problems were identified during 
the 1989–1992 COMMIT trial. Though COMMIT 
researchers did not attribute to internal dissension the 
program’s inability to reach its goals (Thompson et al. 
1993), internecine rivalry can splinter community mo­
bilization efforts and greatly impair the effectiveness of 
any program trying to reduce tobacco use. 
Diverse views and dissent are an expected part 
of organizing activity.  A more serious issue for com­
munity mobilization has been a lag in engendering 
support from all segments of society.  Historically, the 
movement to reduce tobacco use has been dominated 
by organizations composed of middle- and upper-class 
white Americans and often led by white males (see 
Chapter 2). For many years, participation in the move­
ment was further limited to organizations concerned 
with health and medical issues and nonsmokers’ rights. 
In the early 1980s, increasing dissatisfaction was 
voiced by women and underrepresented communities 
who felt that their issues and contributions were not 
adequately integrated into mainstream efforts to reduce 
tobacco use (Jacobson 1983). In recent years, a number 
of persons and organizations representing more diverse 
perspectives have assumed a greater role (see the text 
boxes “Uptown,” “X,” and “Dakota”). Particularly in 
view of the tobacco industry’s targeted marketing to 
women, African Americans, Hispanics, and young 
people (USDHHS 1994, 1998), such heightened activity 
is of critical importance to ensure a nonsmoking norm 
within diverse communities. In some instances— 
exemplified by the low and declining smoking preva­
lence among African American youth (USDHHS 
1994)—such a norm may have already taken hold. 
Programs for the African American 
Community 
Several leadership groups, such as the National 
Black Leadership Initiative on Cancer, which is funded 
by the NCI, and the National Association of African 
Americans for Positive Imagery, funded in part by the 
CDC, have begun to have a voice in activities to re­
duce tobacco use in the African American community. 
For example, in 1989, a strong coalition guided com­
munity mobilization efforts to mount a successful cam­
paign against the test-marketing of Uptown, a new 
brand of cigarettes targeting African Americans (see 
the text box “Uptown”). A similar community-
organized campaign in 1995 resulted in the withdrawal 
of X, another new brand seemingly intended for the 
African American community (see the text box “X”). 
In 1992 and 1993, the ACS provided funds for 
community demonstration projects to use Pathways to 
Freedom: Winning the Fight Against Tobacco, a self-help 
guide for African American smokers (Robinson et al. 
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Uptown 
In mid-December 1989, R.J. Reynolds Tobacco Company announced that on February 5, 1990, it 
would begin test-marketing a new cigarette in Phila­
delphia, Pennsylvania. The cigarette, to be named 
Uptown, was the first to be marketed directly to 
African American smokers.  Within 10 days of this 
announcement, the Coalition Against Uptown Ciga­
rettes (CAUC) was formed. Using existing church 
and community organizations and word of mouth, 
the coalition grew to include 26 diverse organiza­
tions representing health, religious, and community 
groups.  The group’s leaders were African Ameri­
cans with long-standing ties to the Philadelphia 
African American community.  The Philadelphia 
chapter of the National Black Leadership Initiative 
on Cancer, an organization funded in part by the 
National Cancer Institute and dedicated to reduc­
ing cancer in the African American community, and 
the Committee to Prevent Cancer Among Blacks 
facilitated the coalition’s formation. Also active in 
the CAUC were several other organizations that 
addressed local issues on cancer control.  These 
groups included chapters of the American Cancer 
Society and the American Lung Association, as well 
as the Fox Chase Cancer Center. 
The CAUC decided that its initial goal would 
be to limit R.J. Reynolds’ ability to use Philadelphia 
as a test market by convincing African American 
smokers to boycott the new cigarette. The coalition 
mobilized both smokers and nonsmokers in support 
of this goal by focusing on R.J. Reynolds’ strategy to 
promote tobacco use among African Americans.  The 
coalition initially used local media to reinforce the 
messages being sent through grassroots channels and 
did not seek out national coverage, which the coali­
tion members believed would hinder their goal of 
1992). Awardees used Pathways to Freedom to bring 
tobacco control efforts to the African American com­
munity.  Through these demonstration projects, many 
ACS divisions began or enhanced their work in the 
African American community. 
A recent study in three predominately low-
income, African American neighborhoods has demon­
strated that culturally appropriate interventions can 
produce significant declines in smoking behaviors 
(Fisher et al. 1998). The Neighbors for a Smoke Free 
building a local, grassroots constituency.  On behalf 
of the CAUC campaign, Dr. Louis Sullivan, then 
Secretary of Health and Human Services, addressed 
the University of Pennsylvania School of Medicine 
on January 18, 1990. In his remarks, Secretary 
Sullivan said that “at a time when [African Ameri­
cans] desperately need the message of health pro­
motion, Uptown’s message is more disease, more 
suffering and more death for a group of people al­
ready bearing more than its share of smoking-
related illness and mortality” (quoted in Heller 
1990, pp. 32–3). 
The national media embraced the story.  Sec­
retary Sullivan’s remarks were prominently fea­
tured in the evening news and were front-page 
headlines across the country.  R.J. Reynolds initially 
responded by defending their targeted marketing 
strategy, but the company later claimed that Up­
town was not aimed specifically at African Ameri­
cans. On January 19, 1990, R.J. Reynolds canceled 
the Philadelphia test-marketing of Uptown. On 
January 31, 1990, the company canceled production 
of the cigarette. 
The course of events suggests that the Uptown 
coalition played a decisive role in altering R.J. 
Reynolds’ targeting strategy.  A united response from 
Philadelphia’s African American community, an or­
ganized local grassroots effort, the strategic alliance 
with a national figure, and media management were 
associated with product cancellation less than two 
months after introduction.  The episode highlights 
the importance of timing in measures to reduce to­
bacco use. In this instance, a marketing campaign 
appears to have been derailed in its beginning stages 
by short-term, high-intensity media advocacy (see 
“Media Advocacy,” later in this chapter). 
North Side organized residents in wellness councils 
to encourage nonsmoking in their areas. A citywide 
advisory council, composed mostly of African Ameri­
cans, carried out central planning for the program and 
provided linkages to community resources and tech­
nical assistance to neighborhood councils.  The pro­
gram implemented a wide range of activities over a 
24-month period, including smoking cessation classes, 
billboard public education campaigns, door-to-door 
campaigns, and a “gospelfest.” A quasi-experimental 
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In early 1995, the memory of the grassroots vic­tory against Uptown cigarettes (see the previous 
text box, “Uptown”) served as a rallying cry in the 
African American community in Boston against the 
potential threat of a new brand—X cigarettes.  As 
with Uptown in Philadelphia, the first information 
about this cigarette brand came in local media— 
in X’s case, in articles in the Boston Globe and the 
Boston Herald. 
This distinctive menthol cigarette brand was 
packaged in the Afrocentric colors red, black, and 
green and featured a prominent “X,” a symbol fre­
quently associated with the well-known, deceased 
African American leader Malcolm X.  Community 
leaders in Boston and throughout the United States 
thought that the product had the potential to attract 
young African Americans—a group whose smok­
ing rates had dropped dramatically in recent years. 
The use of “X” on a cigarette brand also was seen as 
a defamation of Malcolm X, a noted nonsmoker.  Al­
though manufactured and distributed by two com­
panies without large marketing budgets, there was 
a fear that even a small success with X cigarettes 
would stimulate the creation of similar products by 
the major tobacco companies, which would have 
significant resources for advertising and promotion 
in African American communities. 
The National Association of African Americans 
for Positive Imagery (NAAAPI) and the Boston-
based organization Churches Organized to Stop 
Tobacco took the lead in opposing X cigarettes.  Two 
NAAAPI leaders, Reverend Jesse W. Brown, Jr., and 
design was used to evaluate the impact of this pro­
gram. The three intervention neighborhoods in St. 
Louis were matched by ethnicity, income, and  educa­
tion with three comparison zip code areas in Kansas 
City, Missouri.  Baseline and follow-up random-digit 
dialing telephone surveys were conducted among 
adults (aged 18 years or older) in the three interven­
tion and three comparison areas in 1990 and in 1992. 
Smoking prevalence declined significantly in the 
St. Louis neighborhoods, from 34 to 27 percent, but 
declined only slightly in the Kansas City comparison 
areas, from 34 to 33 percent.  Thus, the results of this 
trial suggest that a culturally appropriate community-
organizing approach to smoking cessation that 
Charyn D. Sutton, both of whom had been involved 
in the Coalition Against Uptown Cigarettes, spoke 
in Boston in February 1995 about the need for com­
munities to mobilize against tobacco marketing. 
Their visits were covered extensively by print and 
broadcast media.  As a result of NAAAPI’s orga­
nizing efforts, the manufacturer and distributor of 
X cigarettes received calls from around the coun­
try, most notably from the organizations involved 
in the African American Tobacco Education Net­
work of California. 
Because the brand’s marketing seemed to be 
confined to the Boston area, NAAAPI decided to 
demand in writing that X cigarettes be withdrawn 
immediately to prevent any wider distribution.  The 
manufacturer (Star Tobacco Corporation, Petersburg, 
Virginia) and distributor (Stowecroft Brook Distribu­
tors, Charlestown, Massachusetts) both responded 
within 10 days to that request, although they contin­
ued to insist that the cigarette brand had not been 
specifically targeted to the African American com­
munity. On March 16, 1995, news conferences were 
held in Boston and Los Angeles by tobacco advo­
cates to announce the withdrawal of X cigarettes 
from the market. 
The course of events suggests that the actions 
of activist groups had direct influence on the out­
come. As was the case with the Uptown protest, 
the X experience suggests the critical role of a rapid 
but organized community response in efforts to 
prevent the targeted marketing of tobacco products 
to racial and ethnic minority groups. 
emphasizes local authority and involvement in pro­
gram planning can have a significant impact on the 
smoking behavior among residents of low-income, 
African American neighborhoods. 
Programs for Women 
The Women vs. Smoking Network, a project of the 
Advocacy Institute, was the first national network of 
women’s organizations and women’s leaders to 
focus on reducing tobacco use among women.  With 
financial support from the NCI, the network provided 
technical assistance and information to women’s orga­
nizations in an effort to interest them in the movement 
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to reduce tobacco use.  The network also focused on 
obtaining media coverage for issues concerning 
women and smoking. The network’s most notable ef­
fort was the release of a plan by R.J. Reynolds to mar­
ket cigarettes to young, uneducated women (see the 
text box “Dakota”). Subsequent media attention made 
this one of the most widely covered tobacco stories of 
1990 (Pertschuk 1992). The network was short-lived 
(1989–1991), however, because of lack of funding.  The 
International Network of Women Against Tobacco 
(INWAT) was established in 1990 as an international 
organization to counter the marketing and promotion 
of tobacco products to women and to foster the devel­
opment of programs for the prevention and cessation 
of tobacco use among women. Through support from 
the American Public Health Association, INWAT has 
worked to draw attention to issues concerning women 
and tobacco and has sought to unite and inform 
women’s advocates around the world.  As a record of 
its Herstories project, INWAT assisted in preparing an 
issue of World Smoking and Health (INWAT 1994) that 
was a collection of brief essays about the role of to­
bacco in women’s lives in various countries. INWAT 
has also published and distributed an international 
directory that lists women who are advocates for 
reducing tobacco use and includes their areas of spe­
cialization (American Public Health Association 1994). 
The National Coalition for Women Against Tobacco, 
whose sponsoring organization is the American Medi­
cal Women’s Association, provides educational mate­
rials and advocacy messages to counteract tobacco 
industry marketing and combat tobacco use among 
women and girls (http://www.womenagainst.org). 
Federal and State Programs 
At the federal level, the CDC’s IMPACT program 
awarded three-year cooperative agreements in 1994 
to selected national organizations to enhance their 
work in reducing tobacco use at the national, state, and 
local levels. Organizations were chosen on the basis 
of their ability to provide services and outreach to 
young people, women, blue-collar and agricultural 
workers, African Americans, Hispanics, Asian Ameri­
cans and Pacific Islanders, and American Indians. 
Among the states, California has made a concerted 
effort to involve racial and ethnic minority groups and 
women in its efforts funded—by Proposition 99—to 
reduce tobacco use (see the section on  California, ear­
lier in this chapter). In 1990, four organizations were 
funded to form networks among Hispanics, African 
Americans, Asian Americans and Pacific Islanders, and 
American Indians. Members of the networks convene 
Reducing Tobacco Use 
meetings, share experiences, participate in the devel­
opment of culturally appropriate materials, and help 
community organizations reach their respective com­
munities. These networks currently conduct programs 
and campaigns to build a strong statewide coalition 
among their respective populations (Tobacco Educa­
tion Oversight Committee 2000). California also has 
funded a statewide organization, Women and Girls 
Against Tobacco, to focus on tobacco product market­
ing that targets females.  Created in 1992, the organi­
zation focuses on empowering women’s and girls’ 
organizations to divest themselves of tobacco indus­
try sponsorship and funding and on eliminating 
tobacco advertising in leading magazines with read­
ership among young women (Women and Girls 
Against Tobacco, n.d.). 
Religious Organizations 
Although not specifically representative of 
minority or underserved groups, some religious orga­
nizations that have an important impact in minority 
communities have had long-standing involvement in 
issues related to reducing tobacco use.  The Interfaith 
Center on Corporate Responsibility, a coalition of 250 
Roman Catholic and Protestant institutional investors, 
pioneered the corporate responsibility movement in 
the early 1970s. The value of their combined portfo­
lios is estimated at $40 billion. In 1981, the Province of 
St. Joseph of the Capuchin Order was the first mem­
ber of the coalition to file a shareholder resolution with 
a tobacco company on the issue of smoking and health. 
Since then, the coalition has filed numerous share­
holder resolutions with the major tobacco companies. 
These resolutions are a unique opportunity to engage 
in a public dialogue with executives of major tobacco 
companies; the shareholder meetings frequently re­
ceive media attention. 
A more recent effort to involve religious organiza­
tions and thereby diversify efforts to reduce tobacco use 
is the formation of the Interreligious Coalition on 
Smoking OR Health. The stated purpose of the group is 
to mobilize the faith communities in the United 
States to improve the effectiveness of public 
policy concerning tobacco. The Coalition is con­
cerned with policies affecting United States cor­
porations involved in the manufacture and sale 
of tobacco products. The primary focus of the 
Coalition is educating policy makers within both 
the legislative and executive branches of the 
United States federal government (Interreligious 
Coalition on Smoking OR Health 1993, p. 1). 
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Dakota 
The Women vs. Smoking Network, under the aegis of the Advocacy Institute, was a project 
aimed at informing and uniting women’s organi­
zations to oppose the tobacco industry’s efforts to 
market its products specifically to women.  In No­
vember 1989, the network sent a letter to the editor 
of more than 100 newspapers nationwide.  Several 
newspapers printed the letter, which responded to 
a Philip Morris advertisement that had previously 
run in these newspapers as a mock apology to 
women for alleged “shortages” of their new ciga­
rette, Virginia Slims Super.  As a result, several ma­
jor national papers and ABC News subsequently ran 
stories on tobacco advertising that targeted women. 
Soon thereafter, the controversy and media cover­
age surrounding the planned test-marketing of 
Uptown cigarettes to African Americans began (see 
the text box “Uptown”). In response, many jour­
nalists wrote stories on the related issue of targeted 
marketing to women. These stories prepared the 
public for the events that followed. 
In February 1990, an anonymous source sent 
the Women vs. Smoking Network copies of confi­
dential marketing documents for a new cigarette 
brand, Dakota. The cigarette, produced by R.J. 
Reynolds Tobacco Company, was scheduled for test-
marketing in April 1990.  The marketing documents, 
entitled “Dakota Field Marketing Concepts,” con­
sisted of more than 200 pages of test-marketing pro­
posals from two different advertising firms.  The 
marketing documents described Dakota, which was 
The coalition was formed in cooperation with 
leading organizations within the mainstream tobacco 
control community.  As of January 1994, the coalition 
had enlisted 16 main religious organizations, includ­
ing Catholic, Muslim, and Protestant denominations, 
in the effort to support a large increase in the federal 
excise tax on a pack of cigarettes (Interreligious Coali­
tion on Smoking OR Health 1994). 
Special Efforts to Reduce 
Chewing Tobacco Use 
In 1995, Oral Health America established the 
National Spit Tobacco Education Program (NSTEP), 
code-named Project Virile Female, as a cigarette ex­
plicitly for young women (18–20 years old). The 
demographic and psychological profile prepared by 
Trone Advertising Inc. of the typical Dakota smoker 
described her as a “caucasian female, 18–20 years 
old, with no education beyond high school, work­
ing at whatever job she can get” (Butler 1990, p. 1, 
citing Trone Advertising Inc.).  She aspired to have 
an ongoing relationship with a man and “to get 
married in her early twenties and have a family.” 
She spent her free time “with her boyfriend doing 
whatever he is doing.” The marketing documents 
also included specific promotional strategies to 
attract young women to the new cigarette. 
Recognizing the value of the documents, staff 
of the Advocacy Institute negotiated with the Wash­
ington Post for front-page coverage of the story in 
exchange for initial exclusive release of what the 
institute staff called “Dakota Papers.”  The Wash­
ington Post ran the story on Saturday, February 17, 
1990, with the headline, “Marketers Target ‘Virile 
Female’: R.J. Reynolds Plans to Introduce Ciga­
rette” (Specter 1990). The Advocacy Institute held 
back further details on the documents until Tues­
day, February 20, so that the director of the Women 
vs. Smoking Network could appear on CBS This 
Morning with Dr. Louis Sullivan, then Secretary of 
Health and Human Services, to “release” the story 
of the documents. Secretary Sullivan strongly con­
demned R.J. Reynolds’ plans to target women in its 
marketing strategies. 
continued on next page 
an effort aimed at reducing the use of smokeless to­
bacco among youth in sports. Oral Health America 
teamed up former major league baseball players, such 
as Joe Garagiola, Hank Aaron, and Bill Tuttle, to help 
get the message out that smokeless tobacco products 
are not a safe alternative to smoking. The components 
of NSTEP include in-stadium events, public service 
announcements that have been televised during ma­
jor league baseball games, printed materials, and edu­
cational videos. An external evaluation of NSTEP is 
being developed to address all levels of the program 
and its public health impact. 
Significant successes of the program include the 
inclusion of spit tobacco on the national tobacco policy 
agenda, with specific credit to NSTEP and national 
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continued 
selling the cigarette, which had been test-marketed, 
as planned, beginning in April 1990.  The Women 
vs. Smoking Network provided strategic counsel-
ing and technical support to the grassroots coali­
tion and was instrumental in helping arrange a press 
conference in Washington, DC, in June 1990, which 
featured then Surgeon General Antonia Novello, 
Senator Larry Pressler (R-SD), and others objecting 
to the marketing plan.
Within the next few weeks, representatives of 
the Women vs. Smoking Network appeared on NBC 
Nightly News, CBS This Morning, CBS Evening News, 
the MacNeil-Lehrer NewsHour, Nightwatch, and 
Nightline. Representatives were also interviewed by 
major national newspapers, including USA 
Today; by numerous local papers; by CBS Radio 
Network, the Black Radio Network, and National 
Public Radio; and by local talk shows. Last, repre-
sentatives were asked to testify on the topic at con­
gressional hearings.  The network followed up on 
the publicity by spotlighting several different 
projects, including a petition to the tobacco compa­
nies to adhere to their own voluntary code of cor-
porate ethics. 
Although advocacy groups were able to gen­
erate considerable community and media mobili­
zation, R.J. Reynolds continued test-marketing.
Advocates felt they had raised national concern
about the targeting of cigarette advertising, al­
though this impression was not directly verified 
through survey research.  Dakota cigarettes were 
withdrawn two years later, however, because the 
brand did not sell as well as officials had hoped 
(American Medical News 1992). In this instance, al­
though advocates might attribute the end result to 
the effective use of the media to promote the agenda 
for reducing tobacco use, the demise of the Dakota 
brand was probably more attributable to market 
forces. 
Even the cigarette’s proposed name drew criti­
cism. Groups in North Dakota and South Dakota 
objected to the name, as did Sioux tribal organiza­
tions, because “Dakota” means “friend” or “ally” 
in the Sioux language. These groups formed a coa­
lition of more than 40 organizations and collected 
25,000 signatures on a petition objecting to the use 
of the word and demanding that R.J. Reynolds cease 
chairman Joe Garagiola by lawmakers and Secretary 
of Health and Human Services Donna Shalala. More 
than $70 million in electronic media coverage has been 
generated directly from NSTEP efforts.  In addition, 
NSTEP activities appear to have substantially in­
creased the coverage of smokeless tobacco issues in 
the print media. Before NSTEP there were approxi­
mately 500 print articles annually devoted to smoke­
less tobacco; since NSTEP that number has climbed to 
Components of Community Programs 
Community Advocacy and Mobilization 
Electronic Networking 
Interactive communication technologies, such as 
computer networks, have been used extensively by 
advocacy groups for reducing tobacco use.  For ex­
ample, daily communications played an important 
more than 5,000.  One article alone appeared in more 
than 800 newspapers on a given weekend, and NSTEP 
estimated the value of this media coverage at $15 mil­
lion. A recent survey of major league baseball players 
and coaches found that more than 44 percent of smoke­
less tobacco users want to quit in the next six months, 
perhaps attributable to NSTEP’s active participation 
in educating ballplayers during spring training. 
part in the response to Philip Morris’ Bill of Rights Tour 
(see the text box later in this chapter). Many active, 
functioning networks now provide communication 
services to assist in efforts to reduce tobacco use. 
The Institute for Global Communications, based 
in San Francisco, was an early provider of issue-
specific networks to the general public. PeaceNet and 
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EcoNet, which were developed in 1986, are among the 
most widely used and well known of the institute’s 
networks. As of October 1994, the institute reported a 
combined membership of 12,000 people from 130 coun­
tries (Moore 1994).  Within these networks, and others 
like them, are smaller groups focused on a specific as­
pect of an issue or a particular policy.  For instance, 
among HandsNet’s 2,500 member organizations, 
which span the nonprofit sector, is a forum linking 200 
community coalitions on substance abuse. This forum, 
managed by the Boston-based group Join Together and 
supported by the Robert Wood Johnson Foundation, 
provides on-line technical assistance to these coalitions. 
The forum also provides news summaries and infor­
mation available on funding opportunities and 
proposed legislation. 
Several networks link people who work in health-
related areas.  In 1993, the Public Health Network pro­
vided forums, e-mail service, and databases for 
its membership, which was composed of nearly 600 
users from state and local health agencies and of 
program directors who were members of the CDC’s 
Public Health Leadership Institute. In 1998, this 
network was replaced by the Information Network for 
Public Health Officials.  Established by the CDC’s Pub­
lic Health Practice Program Office, the network links 
the public health community to the Internet and pro­
vides access to on-line information. Planned Parent­
hood Federation of America hosts PPXNet, a network 
for its affiliates in regional and national offices, pri­
marily for communication within the organization 
itself. During the 1990s, the CDC offered the electronic 
resource WONDER to public health officials, acade­
micians, and others so that they were able to commu­
nicate via e-mail with and have access to the CDC’s 
databases of health data. The advent of the Internet, 
including Web-based e-mail and list serv technology, 
has facilitated the exchange of public health informa­
tion for health professionals and the public.  CDC now 
offers its health data, materials, databases, electronic 
journals, and other resources on its Web site at 
www.cdc.gov. 
In 1990, the Advocacy Institute founded 
SCARCNet, a multiuser interactive bulletin board that 
served the tobacco control community.  (The history 
of the bulletin board’s sponsoring organization—the 
resource center known by the acronym SCARC—is 
discussed in “Impact of Direct Advocacy,” later in this 
chapter.)  When SCARCNet ceased in January 2000, it 
had more than 1,000 subscribers and was circulated to 
thousands of readers throughout the world on vari­
ous networks. SCARCNet’s most popular feature was 
the “Daily Bulletin,” which each day summarized 
major newspaper and journal stories on reducing to­
bacco use (Advocacy Institute 1994). The “Daily Bul­
letin” was accompanied by a “Morning Briefing,” 
which put these news stories in perspective for the 
tobacco control community.  The contents of the “Daily 
Bulletin” stories were retained and stored in a data­
base that is currently available for searching at 
www.tobacco.org.   Another notable feature of 
SCARCNet was the publication of “Action Alerts.” 
These two-page summaries of current issues requir­
ing immediate action included objectives for action, 
suggested actions, media bites, quotes, and talking 
points and were sent to SCARCNet as needed (on av­
erage, twice per month). The conferencing section on 
SCARCNet, called the “Strategy Exchanges,” provided 
a forum for planning, counseling, and experience 
sharing. The technology allowed for concurrent but 
separate discussions on discrete issues, such as clean 
indoor air, tobacco advertising and promotion, tobacco 
pricing policies, and minors’ access to tobacco prod­
ucts. Since its inception in 1990 to its final edition on 
January 31, 2000, SCARCNet, along with its global 
counterpart GLOBALink, became an important re­
source for the tobacco control community.  In Febru­
ary 2000, the American Legacy Foundation began its 
support of a newly designed and enhanced news ser­
vice system that harnesses advances in Web technol­
ogy to build on SCARCNet’s valued features.  This 
system provides users with the leading national news 
stories and also includes a news service that allows 
users to receive a customized selection of other stories 
based on their geographic location and specialty 
areas of greatest personal interest (e.g., advertising, en­
forcement, etc.). 
SCARCNet has served as a model for other pub­
lic health advocacy networks. Examples include Safety 
Net (an advocacy network for violence prevention) and 
the Marin Institute’s ALCNet (a network for alcohol 
control advocates), which is modeled closely after 
SCARCNet. ALCNet has been used for media advo­
cacy as well, particularly to facilitate strategy devel­
opment to counteract certain alcohol products and 
promotions. 
As with other modalities used for social change, 
the precise role of on-line networks—one element in a 
multifaceted approach—is difficult to define.  Al­
though process measures are available (e.g., frequency 
of interactions and message traffic), they do not assess 
the basic value of computer links in furthering the 
agenda for reducing tobacco use, nor is it likely (as is 
noted at the beginning of this chapter for social inter­
ventions overall) that their efficacy can be precisely 
estimated. Current enthusiasm for the mechanism, 
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however, will probably ensure its continuation, and 
accrued anecdotal experience—to date, quite positive— 
will provide the ultimate judgment. 
Direct Advocacy 
History and Activities 
National-level activities, including the work of 
the Coalition on Smoking OR Health (see “Further 
Regulatory Steps” in Chapter 5; see also “Community 
Mobilization,” earlier in this chapter) and others (see 
Chapter 2 and USDHHS 1989b), have played a promi­
nent role in the evolving policy changes concerning 
the reduction of tobacco use.  Of equal interest, from 
the point of view of the potential impact of advocacy, 
are decentralized grassroots organizations. 
The nonsmokers’ rights movement originated in 
the early 1970s (see “From Antismoking to Nonsmok­
ers’ Rights” in Chapter 2). It consisted of individuals 
acting on their own and of small grassroots organiza­
tions of people irritated by ETS or convinced that their 
health suffered from it.  During this period, the docu­
mented adverse health effects of ETS were first being 
brought to the public’s attention (Steinfeld 1972; U.S. 
Department of Health, Education, and Welfare 1972). 
As research documenting these health hazards accu­
mulated, nonsmokers’ rights organizations grew in 
number and strength. 
Many of the early grassroots organizations used 
the acronym GASP to represent similar titles, includ­
ing the Group Against Smokers’ Pollution, the Group 
Against Smoking Pollution, the Group to Alleviate 
Smoking in Public Places, and Georgians Against 
Smoking Pollution. Other acronyms were also used, 
including FANS (Fresh Air for Nonsmokers), TAPS 
(Texans Against Public Smoking), and ANSR— 
pronounced “answer”—(Association for Nonsmokers 
Rights). Organizations were small, poorly funded, and 
often run from home by volunteers. 
Initially, many nonsmokers’ rights organizations 
simply provided a forum for nonsmokers to express 
their concerns about smoking and ETS. These groups 
helped legitimize their members’ complaints and em­
power them to take protective actions.  Such actions 
required courage, assertiveness, and no small measure 
of tact, since smoking in public areas was normative 
at the time. Group members might thus learn how to 
politely ask people to refrain from smoking; or to ob­
viate direct confrontation with smokers, groups might 
provide members with signs, cards, or buttons asking 
people not to smoke in their presence. 
Early in the movement, nonsmokers’ rights 
associations adopted public policy change as an 
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important goal. Groups began to work for passage of 
measures to restrict public smoking.  Such regulations 
are often referred to as clean indoor air laws (see “Clean 
Indoor Air Regulation” in Chapter 5).  To encourage 
these measures, an early GASP organization produced 
a “Bill of Rights” that stated, in part, that 
Non-Smokers have the right to breathe clean air, 
free from harmful and irritating tobacco smoke. 
This right supersedes the right to smoke when the 
two conflict. Non-Smokers have the right to 
express—firmly but politely—their discomfort 
and adverse reactions to tobacco smoke. . . . Non-
Smokers have the right to take action through 
legislative channels, social pressures or any other 
legitimate means—as individuals or in groups— 
to prevent or discourage smokers from polluting 
the atmosphere and to seek the restriction of 
smoking in public places (Group Against Smokers’ 
Pollution, n.d.). 
Over time, many organizations moved to encom­
pass broader policy goals for reducing tobacco use— 
in particular, they sought ways to decrease tobacco use 
by minors. Largely as a consequence of those efforts, 
direct advocacy and public policy change became im­
portant parts of these organizational strategies. 
In some communities, nonsmokers’ rights orga­
nizations worked in isolation. In others, they formed 
associations with medical societies, voluntary health 
associations, and other organizations; the result was a 
more intense effort to ensure passage of desired legis­
lation. Despite initial obstacles, in many communities 
nonsmokers’ rights associations were a driving force 
in moving their allies toward a legislative approach to 
reducing tobacco use. For example, one of the earliest 
and most influential nonsmokers’ rights organizations 
was California GASP, founded in 1976, which eventu­
ally became Americans for Nonsmokers’ Rights 
(ANR). ANR is now the principal national-level 
tobacco control group devoted primarily to promot­
ing legislation for clean indoor air.  In California, ANR 
helped support the passage of such ordinances in many 
localities. Partly as a result of ANR’s work, California 
has more local ordinances for clean indoor air than any 
other state. ANR has served as a national consultant 
to other groups pursuing such legislation. 
Impact of Direct Advocacy 
In retrospect, the grassroots organizations can be 
seen as having worked to diminish the legitimacy of 
tobacco use in the eyes of the public and the credibil­
ity of the tobacco industry.  The passage of ordinances 
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against public smoking (see “Clean Indoor Air Regu­
lation” in Chapter 5) occurred over several years, dur­
ing which a shift in public opinion about smoking 
became evident. During the 1960s and 1970s, the right 
to smoke was largely unquestioned.  In more recent 
years, declining smoking prevalence and public opin­
ion polls have indicated an increasing intolerance for 
public smoking (USDHHS 1989b). The work of non­
smokers’ rights organizations is coeval with these 
legal, epidemiologic, and social changes. Sorting out 
cause and effect is difficult, but the nonsmokers’ rights 
movement seems to have contributed to the changing 
social norm (Glantz 1987). 
There were, however, some important exceptions 
to the emerging nonsmoking norms.  By the mid-1980s, 
it was apparent that both the traditional educational 
efforts and the passage of ordinances to protect non­
smokers from ETS had a limited effect on young 
people’s smoking-related attitudes and behaviors 
(USDHHS 1994). Efforts to reduce smoking appeared 
unable to reduce the prevalence of smoking among 
teenagers (Lynch and Bonnie 1994), and smoking 
prevalence among white females began increasing 
sharply during the 1970s, as did the prevalence of 
smokeless tobacco use among males. 
The failure to decrease smoking among young 
people is as difficult to assess as is the success observed 
among adults (particularly among adult men). Ana­
lyzing the effect of prevention activities on young 
people must include weighing the hampering effects 
of advertising and promotional efforts backed by the 
tobacco industry’s enormous marketing budget (see 
“Advertising and Promotion” in Chapter 5; DiFranza 
et al. 1991; Pierce et al. 1991; Lynch and Bonnie 1994; 
USDHHS 1994). Whatever the interplay of the forces 
involved, the result is that protobacco activity directed 
at those entering the market has been generally suc­
cessful. An exception is the continued decline in preva­
lence among young African Americans, particularly 
among young women (USDHHS 1998). 
Perhaps some of the shortfall in grassroots efforts 
to reduce tobacco use is associated with the early iso­
lation of these groups from the established national 
advocacy organization.  Anecdotally, there is evidence 
of a culture clash. When the nonsmokers’ rights move­
ment emerged in the 1970s, many medical and volun­
tary health organizations decried what they perceived 
as the unprofessional, indecorous, confrontational ap­
proach that these activists took to an issue that had 
previously fallen in the domain of the traditional pub­
lic health structure.  Some traditional organizations in 
the public health arena may also have felt that 
grassroots organizations were infringing on their 
“turf” and their fund-raising base. 
For their part, nonsmokers’ rights associations 
objected to what they saw as the overly cautious, mea­
sured approach of researchers, medical associations, 
and volunteer health associations, whose efforts 
seemed to have done little to solve the problems of 
day-to-day exposure to ETS. The grassroots organi­
zations urged voluntary health organizations to exam­
ine their mission statements and dedicate appropriate 
resources to cost-effective solutions to reducing to­
bacco use. 
In time, both approaches acknowledged that the 
lack of coordination and cohesion was a significant 
barrier to their efforts. The groups noted that, in con­
trast, the tobacco industry operated as a monolith 
through the coordinated efforts of the Tobacco Insti­
tute, a lobbying and public relations organization 
representing the industry.  This insight led to the emer­
gence of several groups—somewhat disparate in their 
approaches—that attempted to bridge some of the dis­
tance between the grassroots and national approaches 
to reducing tobacco use. 
Among the oldest of these groups is DOC (Doc­
tors Ought to Care), which was founded in 1977 as a 
national coalition of health professionals, students, and 
concerned individuals. DOC groups take an activist 
approach to public health problems and sponsor com­
munity projects and events on reducing tobacco use 
and other issues. From the outset, members chose con­
frontational programs, such as counteradvertising and 
picketing industry-sponsored sports events, to 
delegitimize the tobacco industry and focus attention 
on its activities by involving both physicians and 
young people in advocacy activities. DOC groups use 
satire, ridicule, and parody in their work to appeal to 
children and teenagers (Blum 1982); for example, they 
have sponsored “Emphysema Slims” tennis matches 
featuring appearances by “Martina Nosmokanova.” 
DOC also maintains a large archive of activities related 
to the tobacco industry, including past advertising 
campaigns and marketing strategies (Mintz 1995). The 
activities of DOC are similar in style, if not content, to 
those of the Australian organization Billboard Utilising 
Graffitists Against Unhealthy Promotions (BUGA-UP), 
which was founded in 1979. BUGA-UP members, 
some of whom are physicians, have used unconven­
tional tactics, such as spray-painting billboards that 
advertise tobacco products (Jacobson 1983). 
Another group is Stop Teenage Addiction to To­
bacco (STAT), which was founded in 1985 with the aim 
of reducing tobacco use among minors. From its 
inception, STAT aimed to unite the medical and 
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scientific arm and the grassroots arm of the movement 
to reduce tobacco use.  Although STAT frequently ap­
proaches tobacco issues from the activist perspective, 
the organization has long included key members 
of the medical and public health establishment in 
its leadership. DOC, STAT, and other groups have 
attempted to make the activist, confrontational ap­
proach to reducing tobacco use acceptable to the more 
conservative medical and voluntary health organiza­
tions. Partly because of these efforts, an activist 
approach is now an important component of the move­
ment (see the text box “Bill of Rights Tour”). 
Another impetus for a more unified movement 
was the establishment of the Smoking Control Advo­
cacy Resource Center (SCARC) at the Advocacy Insti­
tute in 1987. The Advocacy Institute’s mission—to 
study, analyze, and teach public interest advocacy— 
included a focus on smoking reduction as a model 
public interest movement. The institute received fund­
ing from the Henry J. Kaiser Family Foundation to 
establish SCARC. Rather than be a frontline organi­
zation, SCARC proposed to help build the movement’s 
infrastructure.  As such, SCARC would be viewed as 
a neutral player and would not vie with the 
movement’s other organizations in seeking media, 
voluntary, or funding sources.  Since its formation, 
SCARC has served three important roles as convener, 
tobacco industry monitor, and center for strategic 
development, training, and counseling (Butler 1990). 
Media Advocacy 
Media advocacy for reducing tobacco use was 
developed during the 1980s by a small number of ac­
tivists working primarily in the United States, Canada, 
Australia, and the United Kingdom. The attendees at 
the September 1985 International Summit of Smoking 
Control Leaders resolved to produce a handbook that 
would provide guidance on using the media to sup­
port tobacco control.  The resulting document, Smoke 
Signals: The Smoking Control Media Handbook (Pertschuk 
1987), describes many of the important themes and 
skills needed for using what would later be dubbed 
“media advocacy.”  In January 1988, the Advocacy In­
stitute convened a two-day consensus workshop, 
sponsored by the NCI, that produced a second hand­
book on media advocacy, Media Strategies for Smoking 
Control: Guidelines (USDHHS 1989a), which formally 
recognized the importance of media advocacy in re­
ducing tobacco use (and in which the term “media 
advocacy” was first employed). 
Media advocacy has been defined as the strate­
gic use of mass media to advance a social or public 
Reducing Tobacco Use
 
policy initiative (NCI 1991). In contrast to the goal of 
traditional health communications efforts, the goal of 
media advocacy is to change public policy and thereby 
generate a broader impact on tobacco use by creating 
an environment in which smoking is not normative. 
Smoke Signals articulates six critical tasks the media 
must perform to help accomplish this goal: (1) edu­
cate the public about the severity of the risks of smok­
ing, the susceptibility of every smoker, and the health 
benefits of quitting; (2) educate the public about the 
health risks of ETS; (3) alert citizens and policymakers 
to injurious public policies that promote smoking, in­
cluding insufficiently regulated advertising and pro­
motion of cigarettes, as well as unrestricted smoking 
in public areas and the workplace; (4) respond to and 
counteract the propaganda and disinformation cam­
paigns of the tobacco industry; (5) counter the eco­
nomic and political influence of the tobacco industry, 
which thwarts the adoption of remedial policies; and 
(6) reinforce evolving social nonsmoking norms 
(Pertschuk 1987). 
Media advocacy campaigns have been likened 
to political campaigns “in which competing forces con­
tinuously react to unexpected events, breaking news, 
and opportunities” (Pertschuk et al. 1991, p. 3). Such 
campaigns require both presenting the public health 
side of an issue and negating the opposing side. Like 
political campaigns, media advocacy campaigns re­
quire quick reactions that contrast with the carefully 
planned, fixed agendas of traditional media programs. 
Media advocacy recognizes the potential of the 
press to place on the public agenda issues concerning 
the reduction of tobacco use and to either advance or 
retard progress toward policy goals.  Successful me­
dia influence requires gaining access to the news and 
framing or shaping coverage of the resulting story. 
These strategies are interrelated, since the framing of 
a story helps determine whether a journalist will agree 
to cover it. 
The use of media advocacy has two daunting limi­
tations: it is a new technique that requires complex 
skills and an understanding of the news media, and it 
demands a large investment in time (Wallack 1990).  But 
another apparent barrier—the reliance on an outside 
party (the media) to achieve program goals—is also a 
source of considerable strength:  media advocacy is a 
means by which public health practitioners can indi­
rectly confront and compete with forces that are tradi­
tionally beyond their policy and financial reach.  These 
forces represent powerful vested interests—the tobacco 
industry, advertising industry, retail establishments that 
sell tobacco, and others. The financial and political 
influence of these entities can limit the ability of public 
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Bill of Rights Tour 
In fall 1989, Philip Morris, the largest U.S. manu­facturer of cigarettes, contracted with the U.S. 
National Archives and Records Administration to 
sponsor a commemoration of the 200th anniversary 
of the Bill of Rights. The commemoration involved 
a national advertising campaign, including com­
mercials on prime-time television and full-page 
advertisements in major newspapers, asking Ameri­
cans to “Join Philip Morris and the National Archives 
in celebrating the 200th anniversary of the Bill of 
Rights” (cited in Advocacy Institute 1989, p. 1).  Philip 
Morris soon announced plans to transport Virginia’s 
copy of the Bill of Rights to all 50 states in coopera­
tion with the Virginia State Library and Archives. 
Advocates for reducing tobacco use inter­
preted Philip Morris’ effort as an attempt to link 
smoking with the national freedoms guaranteed by 
the Bill of Rights. These groups believed that Philip 
Morris would use its association with the Bill of 
Rights Tour, which highlighted themes of liberty 
and freedom of expression, to gain public support 
for the company’s claim of a First Amendment right 
to advertise. Philip Morris’ project with the National 
Archives raised concern in the U.S. House of Rep­
resentatives, which held hearings on the issue but 
did not intervene. Advocates for reducing tobacco 
use began using the 16-month tour schedule to 
coordinate local efforts to counter what they con­
sidered to be a tobacco-marketing plan. 
The Washington state chapter of Doctors 
Ought to Care (DOC) built a countersymbol, the 
“Statue of Nicotina,” to travel with the tour.  At a 
press conference, comments from the president of 
the chapter, Dr. Robert Jaffe, captured the flavor of 
the symbol’s proposed use: 
Nicotina is modeled [on] the Statue of Liberty. 
She’s holding a cigarette in her upheld hand, 
instead of a torch, and her eyes are closed, the 
symbol of shame that she’s been . . . made a 
symbol of tobacco. The chains from her ciga­
rettes in the pack help to illustrate to all of the 
children who are going to see the Bill of Rights 
Tour that this is a dangerous, addictive drug. 
At her feet are the words, “Give me your poor, 
your tired, your women, your children yearn­
ing to breathe free . . .” (quoted in Wallack et al. 
1993, p. 185). 
The Advocacy Institute published an advance 
schedule of the national tour, including dates and 
specific locations for each of the tour’s stops.  The 
institute also tracked activities in various states and 
disseminated strategic information through Action 
Alerts posted on SCARCNet, the institute’s com­
puter network dedicated to sharing information on 
reducing tobacco use. SCARCNet (see “Electronic 
Networking,” earlier in this chapter) was a key 
mechanism for advocates to share information and 
develop strategies. In addition, the American Lung 
Association and the American Medical Association 
provided materials and strategic support to its in­
terested affiliates. 
Initially, Philip Morris responded to protests 
at tour sites by establishing a “speaker’s corner” 
that restricted protesters to a site away from the 
exhibit hall. At first, this strategy successfully 
muted attacks and deflected positive attention from 
protesters. Indeed, by appearing to encourage 
protesters, Philip Morris was portrayed by some me­
dia reports as being faithful to the spirit of the Bill 
of Rights. As the tour continued, however, groups 
opposed to the sponsorship learned from experience 
in other states. The groups refined their message, 
learned how best to respond to Philip Morris’ 
spokespersons, discussed public reaction to their 
protests, and modified their tactics appropriately. 
They developed a simple slogan, “Bill of Rights Yes/ 
Philip Morris No” (cited in Wallack et al. 1993, p. 
186), to clarify the theme of their protests. 
With the changed approach, advocates re­
ported improved media coverage of the protests. 
At almost every tour stop, advocates staged press 
conferences before the opening of the exhibit and 
displayed the Statue of Nicotina, which was trans­
ported from state to state. By February 1991, five 
months into the tour, Philip Morris scaled down 
the number of scheduled stops. The tour, accom­
panied by advocates for reducing tobacco use, 
continued through its conclusion in Richmond, 
Virginia, in December 1991. 
The ultimate effectiveness of this advocacy 
effort is difficult to judge, but the effort played an 
obvious role in muting the public relations benefits 
to the tobacco industry.  At the very least, the re­
sources invested by the industry did not appear to 
bring the expected return. 
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(as well as private) agencies to use confrontational tac­
tics. In addition, many communities prefer consensus 
building to confrontation with powerful opposition 
parties. However, because the visible products of me­
dia advocacy—the media reports themselves—emerge 
from a disinterested party (the media) rather than from 
parties for or against reducing tobacco use, this new­
est form of social intervention can be successful in pre­
viously problematic areas. 
As with other social interventions, the precise 
contribution of media advocacy to the effort to reduce 
tobacco use is difficult to judge. Events like those sur­
rounding the marketing of the cigarette brands Up­
town, X, and Dakota and the Philip Morris-sponsored 
Bill of Rights Tour demonstrate the role that media 
advocacy can play in the overall effort. 
Countermarketing 
Mass Media in Tobacco Control 
In contemporary society, the mass media are the 
most important means of educating and informing the 
public and, through public response to media, policy-
makers.  By design or not, the media plays an enor­
mous role in influencing the smoking behavior of 
individuals and the actions of policymakers in both the 
public and the private sector (Pertschuk 1987).  Public 
health programs have used various health communi­
cation programs to inform and influence the behavior 
of the general public. Traditionally, communication 
programs intended to reduce tobacco use have tried 
to influence the behavior of individuals. Most such 
media campaigns have focused on influencing the 
behavior of adult smokers—and hence have focused 
more on smoking cessation than on prevention.  Flay 
(1987) describes three prominent types of mass media 
programs and campaigns designed to influence 
smoking-related knowledge, attitudes, and behavior: 
(1) those that inform the public of the negative health 
consequences of cigarette smoking and try to motivate 
smokers to quit, (2) those that promote specific smok­
ing cessation actions to those smokers motivated to 
quit (e.g., smokers are encouraged to call a help line 
or to request specific materials, such as a tip sheet or a 
self-help manual), and (3) those that promote smok­
ing cessation self-help clinics for those smokers who 
desire to quit.  A smaller number of campaigns have 
focused on youth, either encouraging young people 
to avoid using tobacco products or convincing young 
people who smoke to try to quit (USDHHS 1994). 
A factor that has limited the success of traditional 
mass media campaigns is the small size of the cam­
paign budgets compared with the advertising and 
Reducing Tobacco Use 
marketing budgets of the tobacco industry (Flay 1987; 
USDHHS 1994). In addition, these campaigns to re­
duce tobacco use have experienced drawbacks because 
of their traditional reliance on public service announce­
ments (PSAs). Although PSAs have been an integral 
part of such efforts for many years, the number of PSAs 
on any subject provided to broadcasters has increased, 
whereas the amount of donated air time available for 
PSAs has decreased.  Also, the advent of cable tech­
nology, which has increased the number of channels 
through which people can be reached and therefore 
has diffused the audience, has further hampered 
efforts to reach targeted groups efficiently.  By the mid­
1980s, it had become apparent that the role of the 
media in the effort to reduce tobacco use required re­
evaluation. In the following sections, the uses of mass 
media approaches for tobacco control are summarized. 
Effects of Protobacco Advertising and Promotion 
The effect of tobacco advertising and promotion 
activities on both adult consumption and youth ini­
tiation has been the subject of considerable research 
over the past decade (see “Advertising and Promo­
tion” in Chapter 5). While noting that existing evi­
dence suggests that tobacco marketing increases the 
level of tobacco consumption, the 1989 Surgeon 
General’s report Reducing the Health Consequences 
of Smoking: 25 Years of Progress concluded that the 
issue is so complex that a sufficiently rigorous study 
capable of providing definitive scientific evidence is 
not available and that “none is likely to be forthcom­
ing in the foreseeable future” (USDHHS 1989b, pp. 
516–7). The 1994 Surgeon General’s report Preventing 
Tobacco Use Among Young People similarly noted the 
absence of a definitive longitudinal study of the direct 
relationship of tobacco advertising to adolescent smok­
ing. However, acknowledging the value of recent 
nonlongitudinal studies focused on young people, the 
report offered this major conclusion:  “Cigarette 
advertising appears to increase young people’s risk of 
smoking by affecting their perceptions of the perva­
siveness, image, and function of smoking” (USDHHS 
1994, p. 6). Also in 1994, the Institute of Medicine con­
cluded that the preponderance of evidence suggests 
that tobacco marketing encourages young people to 
smoke (Lynch and Bonnie 1994). 
In its rule to restrict the access and appeal of to­
bacco products to young people, the Food and Drug 
Administration (FDA) reviewed the quantitative and 
qualitative evidence and concluded that cigarette ad­
vertising is causally related to the prevalence of smok­
ing among young people (Federal Register 1996). The 
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agency also cited statements from internal documents 
of the tobacco industry to show the importance of the 
youth market segment to the industry’s continued 
success. More recently, a 1998 Report to the United 
Kingdom’s Chief Medical Officer by the Scientific 
Committee on Tobacco and Health concluded unani­
mously that tobacco advertising and promotion influ­
ence young people to begin smoking (Scientific 
Committee on Tobacco and Health 1998). 
Survey data show that among children who 
smoke, most use the most heavily advertised brands 
of cigarettes, whereas many adult smokers buy generic 
or value category brands, which have little or no im­
age advertising (CDC 1994). A major econometric 
marketing study found that young people are three 
times more affected by advertising than are adults 
(Pollay et al. 1996). Research has also pointed to the 
impact of other tobacco promotional activities, such 
as sponsorship of public entertainment events and dis­
tribution of specialty or premium items.  These activi­
ties constitute the largest (and an increasing) share of 
tobacco marketing expenditures. The CDC has esti­
mated that today’s U.S. teens already have been ex­
posed to more than $20 billion in imagery advertising 
and promotions since age 6, creating a “friendly fa­
miliarity” for tobacco products and an environment 
in which smoking is seen as glamorous, social, and 
normal (Eriksen 1997). Although the effect of this ex­
posure is difficult to quantify, especially nationwide, 
one study has estimated that 34 percent of all youth 
experimentation with smoking in California between 
1993 and 1996 can be attributed to tobacco promotional 
activities (Pierce et al. 1998).  A recent study found that 
teenagers who can readily name a cigarette brand and 
who own a tobacco-company-sponsored promotional 
item are more than twice as likely to become estab­
lished smokers than adolescents who do neither 
(Biener and Siegel 2000). 
Effects of Tobacco Countermarketing 
In light of ubiquitous and sustained protobacco 
messages, countermarketing efforts of comparable in­
tensity and duration are needed to alter the social and 
environmental context of tobacco use.  Evidence of 
effectiveness comes from three main sources:  (1) the 
natural experiment of the counteradvertising cam­
paign that occurred during the late 1960s as the result 
of a Fairness Doctrine ruling (also discussed in “Broad­
cast Advertising Ban” in Chapter 5), (2) school and 
community intervention studies incorporating mass 
media approaches (see “Supplemental Programs” in 
Chapter 3), and (3) recent experience with large paid 
media campaigns in several U.S. states and with a na­
tionwide campaign funded by the FDA. Because of 
the special sensitivity of young people to tobacco mar­
keting and the high rates of tobacco use among teen­
agers, the subsequent review in this chapter will focus 
on countermarketing media campaigns that include 
prominent youth-targeted components.  The literature 
provides strong evidence of the value of mass media 
campaigns to inform the public at large—including 
young people—about the hazards of smoking, to pro­
mote specific cessation actions and services (such as 
telephone help lines), and to provide cessation clinics 
to adult smokers (Flay 1987; Pierce 1995). 
The Fairness Doctrine campaign. In 1967, the 
Federal Communications Commission (FCC) applied 
the Fairness Doctrine (discussed in “Broadcast Adver­
tising Ban” in Chapter 5) to cigarette advertising and 
required broadcasters to provide a significant amount 
of airtime to antismoking messages—a requirement 
interpreted by the FCC at that time to be about one 
antismoking message per three tobacco advertising 
messages). This requirement resulted in the only sus­
tained nationwide tobacco control media campaign 
to date. From mid-1967 through 1970, roughly $200 
million in commercial airtime (in 1970 dollars) or $75 
million per year was donated for antismoking mes­
sages on television and radio (Warner 1986; USDHHS 
1989b). 
The campaign produced significant reductions 
in both adult and youth smoking behaviors (Hamilton 
1972). For the first time in the 20th century, adult per 
capita cigarette consumption fell for more than three 
consecutive years. Teenage smoking prevalence was 
3 percentage points smaller during the Fairness Doc­
trine period than it was in the 16 months before the 
campaign, and the campaign was associated overall 
with a 3.4-percentage point reduction in teen smoking 
prevalence.  Perhaps the ultimate indicator of the 
campaign’s impact was a change that followed the 
campaign’s end: with the 1971 enactment of congres­
sional legislation banning tobacco commercials from 
television—and with them, the Fairness Doctrine-
mandated counteradvertisements—per capita 
cigarette consumption immediately resumed its 
upward trend (see “Broadcast Advertising Ban” in 
Chapter 5). 
Hamilton (1972) suggested that during the Fair­
ness Doctrine period, the antismoking campaign mes­
sages had an effect that was nearly six times that of 
cigarette advertisements.  Warner (1979) noted that the 
government’s broadcast ban—and the consequent end 
of the countermarketing campaign—was especially 
detrimental to the ongoing effort to prevent young 
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people from smoking.  Cigarette promotion remained 
highly visible in the print media and in tobacco com­
panies’ sponsorship of sporting events at the same time 
the broadcast ban “virtually eliminated mass promo­
tion of the antismoking cause” (p. 445). 
Community intervention studies. As described 
in “Research on Multifaceted Programs” in Chapter 3, 
multicomponent youth-directed programs that include 
a prominent mass media component have shown long-
term success in postponing or preventing smoking 
onset in adolescents. In the University of Vermont 
School and Mass Media Project, the study featuring 
the most intensive paid counteradvertising campaign, 
the preventive effect actually increased during the two-
year intervention period among the adolescents at 
higher risk for smoking (Flynn et al. 1997)—a rare 
outcome for most campaigns trying to change health 
behaviors. The authors noted that counteradvertising 
can effectively reach higher-risk youth because of their 
greater exposure to the mass media, particularly ra­
dio and television. It is also likely that higher-risk 
youth make their decisions about tobacco use earlier 
in life than lower-risk youth; mass media influences 
can be especially powerful in shaping attitudes and 
normative perceptions at early ages. 
State-based media campaigns. Mass media cam­
paigns are standard components of the well-funded, 
ongoing tobacco control programs in California, Mas­
sachusetts, Arizona, Florida, and other states receiv­
ing money for counteradvertising programs from state 
excise tax increases or tobacco settlement allotments 
(as was discussed in “Example of Major State Pro­
grams,” earlier in this chapter). Although it is diffi­
cult to sort out the effectiveness of media campaigns 
from other program components, evaluations of these 
statewide public education programs, particularly in 
California and Massachusetts (see “Supplemental Pro­
grams” in Chapter 3), have shown their success in re­
ducing tobacco use among adults, slowing the uptake 
of tobacco among youth, and protecting children from 
exposure to ETS (CDC 1996). A recent study of the 
Massachusetts media campaign in 1993 and 1997 found 
that among younger adolescents (those aged 12–13 
years in 1993), those who had been exposed to the 
counteradvertising campaign on television were about 
half as likely to have become smokers as those who had 
not been able to recall campaign advertisements (Siegel 
and Biener 2000). 
Food and Drug Administration campaign. In 
1998, the FDA launched a national advertising 
campaign to help retailers comply with the age and 
photo identification provisions of the FDA’s rules to 
prevent tobacco sales to children and adolescents.  The 
Reducing Tobacco Use 
campaign began with a test in Arkansas and by year’s 
end was active in 42 states. Funded annually at about 
$9 million, the campaign featured radio spots, bill­
boards, newspaper advertisements, posters, and store 
signage. The overall approach was to use humor to 
relieve the discomfort clerks may feel when checking 
young people’s identification/proof-of-age cards and 
to increase awareness of the rule provisions among re­
tailers, underage youth, and the general population. 
One counter card, for example, reads, “Our cashier 
really stinks at guessing ages. So if you want ciga­
rettes, can we see some I.D.?” 
A campaign tracking survey (Market Facts 1998) 
in nine states with test and control sites found that 
during the first year of the campaign, knowledge of 
age 27 as the cutoff age for checking identification 
increased from 34 to 54 percent in test sites and from 
31 to 40 percent in control sites.  Most important was a 
small but significant decline in the average number of 
times minors tried to buy tobacco. According to re­
tailer self-reports, this number declined from 3.4 times 
each day before the campaign to 2.8 times daily after 
the media effort.  In control sites, the frequency of un­
derage purchase attempts did not decrease from be­
fore (2.4 times daily) to after (2.7 times daily) the time 
of the campaign. For customers from whom identifi­
cation was requested in the test sites, retailers reported 
that the proportion of those who were “often” or “al­
ways” irritated declined from 34 percent to 28 percent. 
Counteradvertising and entertainment media. 
The increase in movie depictions of tobacco use is a 
powerful media influence promoting use among teens 
(Stockwell and Glantz 1997). In focus groups, young 
people are not able to recall antismoking messages on 
television or in the movies, but they recall specific 
movies that portray smoking and can identify actors 
and actresses who smoke in their entertainment roles 
(Crawford et al. 1998).  Counteradvertising holds 
promise for helping denormalize and deglamorize 
these portrayals in the entertainment media. In an 
experimental study, Pechmann and Shih (1999) found 
that placement of a 30-second California Department 
of Health Services tobacco counteradvertisement 
before the popular movie Reality Bites served to inocu­
late teenagers against the movie’s pervasive 
prosmoking cues without detracting from their enjoy­
ment of the film. Because paid advertising in movie 
theaters is a highly efficient method of reaching 
adolescents, the authors recommend this tactic as a 
nationwide cost-effective prevention strategy. 
Research on best practices.  Although produc­
ers of counteradvertising campaigns use formative re­
search techniques to develop products, inconsistent 
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testing methods hinder comparison of the effective­
ness of different messages.  This situation has helped 
create the impression that there is little agreement 
over “what works” in tobacco counteradvertising, as 
typified by this Washington Post headline: “The Anti-
Smoking Campaign’s a Many Splendored Thing, and 
That’s the Problem” (Teinowitz 1998). 
Goldman and Glantz (1998), using available fo­
cus group data and research reports obtained from a 
number of states, concluded that two message strate­
gies, industry manipulation and the hazards of ETS, 
are the most effective for denormalizing smoking 
among young people and reducing consumption 
among adults. The researchers reported that addic­
tion and cessation messages can also be effective, but 
that four strategies are not effective:  youth access, 
short-term health effects, long-term health effects, and 
romantic rejection.  They also characterized 
California’s counteradvertising campaign as more 
“confrontational with the industry” (p. 772) than Mas­
sachusetts’ “more youth-oriented approach” (p. 772), 
citing this difference as a major reason for their find­
ing that the California media campaign was relatively 
more cost-effective.  This paper elicited some strong 
responses.  The University of Vermont School and Mass 
Media Project investigators (Worden et al. 1998) em­
phasized the limitations of focus group results and the 
importance of audience age in reactions to messages. 
They argued that for young people aged 10 to 12 years 
(the age group in which they recommended starting 
prevention efforts), presenting messages that foster 
positive social influence and social norms have proved 
most effective in reducing tobacco use among youth. 
Balch and Rudman (1998) responded that young 
people participating in 110 focus groups in five differ­
ent states considered numerous concepts and judged 
five to be more credible, relevant, and persuasive: 
addiction, short-term health effects, athletic perfor­
mance, role model for younger siblings, and effects on 
family.  From Massachusetts, Connolly and Harris 
(1998) noted that industry manipulation and ETS 
themes constituted 32 percent of all youth-targeted 
messages and 37 percent of all messages in the Massa­
chusetts tobacco control media campaign and that on 
a per capita basis, the state actually outspent Califor­
nia on these messages. Moreover, the researchers re­
ported that Massachusetts experienced a larger decline 
in per capita cigarette consumption than did Califor­
nia for the period 1990–1996. 
To obtain data in a more quantitative way, 
Pechmann and Shih (1999) created a typology based 
on 196 youth-oriented antismoking television adver­
tisements. They identified three main types—fear 
appeals, peer norms, and tobacco marketing—and 
further subdivided these into seven main messages: 
(1) smokers may face serious health problems, (2) to­
bacco company deception results in disease and death, 
(3) smokers endanger their family members, (4) smok­
ing is unattractive, (5) smokers are perceived by peers 
as misguided, (6) most young people choose not to 
smoke, and (7) advertisement shows how tobacco com­
panies market their products.  The investigators tested 
a sample of 56 of their advertisements in a group of 
ethnically diverse 7th, 9th, and 10th graders. After 
viewing a selection of test and placebo advertisements, 
study participants completed an evaluation survey to 
assess the effect of each category on their intent to 
smoke and on other pertinent measures, such as atti­
tudes toward smoking and knowledge of tobacco 
marketing tactics. Results showed that only three of 
the seven messages were highly effective in reducing 
teenagers’ intent to smoke: those that conveyed that 
smokers endanger their family members, that smok­
ers are perceived by peers as misguided, and that most 
young people choose not to smoke. 
In the Massachusetts campaign study (Siegel and 
Biener 2000), the authors tested eight smoking-related 
knowledge and attitude variables corresponding to 
campaign themes. Only one variable, perceived youth 
smoking prevalence, changed significantly with expo­
sure to the media campaign at baseline and was asso­
ciated with the reported reduction in tobacco uptake. 
Exposed youths were more than twice as likely than 
their unexposed peers to have an accurate perception 
at follow-up that fewer than half of the students at their 
high school were smokers. Variables that did not 
change were knowledge and attitudes related to low-
tar cigarettes, environmental tobacco smoke, chemi­
cals, wrinkles, tobacco company tactics, dating, and 
sports. This finding points to the power of the mass 
media, especially television, to set social norms and 
supports the effectiveness of counteradvertising mes­
sages that denormalize tobacco use. 
As part of a three-year study exploring racial/ 
ethnic and gender differences in teen tobacco use, a 
group of 11 CDC-funded university-based Prevention 
Research Centers conducted a series of focus groups 
during 1996–1997 to explore potentially effective 
counteradvertising strategies and messages. Six of the 
11 centers used television spots from CDC’s Media 
Campaign Resource Center for Tobacco Control to elicit 
reactions and stimulate discussion. For the most part, 
different centers used different advertisements, and 
they did not attempt to “test” the advertisements in 
any standardized way to determine relative effective­
ness. Nevertheless, the conclusions that emerged from 
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Teen Focus Group Response to Counteradvertising Messages 
(Findings from 11 Prevention Research Centers) 
•	 	 Without an overall context provided by ongo-
ing advertising and other program elements, the 
message that tobacco companies are manipu-
lating young people to smoke (“they’re lying 
to you”) has relatively low interest and salience 
among teens and may be miscomprehended. 
• As advertising professionals have reported in 
the research literature, humor was found to be 
a double-edged sword:  it can be very effec­
tive, but if used inappropriately can be seen 
as trivializing the issue. In some focus groups, 
humorous advertisements obtained both the 
highest and the lowest scores. •	 	 Attempts to explain the concept of nicotine ad­
diction and make it personally relevant for 
young nonsmokers is difficult because most 
have not experienced the physical cravings of 
addiction and tend to take messages literally. 
• Young people reacted emotionally and favor-
ably to true, nonpreachy stories about the im­
pact of smoking on a person’s or family 
member’s life (such as a television spot from 
California featuring a man whose wife had
died from exposure to his smoking). •	 	 The television spot shown to the most focus groups (about physical performance and fea­

turing the U.S. Women’s National Soccer Team) 
was easily understood, attention getting, and 
credible and may be generalizable (with some 
effort) to nonathletic endeavors. 
• Cartoons tend to have low “stopping power” 

because teens have seen so many, whereas the 

use of surprising characters like animals (such 

as the “Animals” and “Butts” spots from Min­

nesota) can rivet attention. These attention­
getting spots do not necessarily communicate
an effective countermessage, however. 
•	 	 Young people did not like advertisements that 
feature text. 
•	 	 Young people, particularly whites, were sharply 
critical of any advertisement they perceived as 
corny, “cute,” staged, or unhip. 
•	 	 Messages that portray the negative social effects 
of tobacco use perform well among teens; mes­
sages that focus on health effects can be effec­
tive if they are presented dramatically but 
realistically (such as a California spot featuring 
a laryngectomy patient smoking a cigarette). 
this research (Tobacco Network, unpublished data) give 
some indication of the complexity of people’s response 
and the considerable challenges to crafting effective 
messages (see the text box “Teen Focus Group Response 
to Counteradvertising Messages”). 
Audience targeting. The use of counteradver­
tising aimed only at young people rather than the use 
of a general marketing approach has been controver­
sial. Glantz (1996) criticized the public health 
community’s “preoccupation with youth” (p. 157), 
particularly youth access campaigns, as an ineffective 
strategy and one that diverts energy from reducing 
adult smoking and creating a smoke-free society. 
Cummings and Clarke (1998) warned that campaigns 
focused exclusively on young people may be counter­
productive if the messages make smoking more ap­
pealing to youth by promoting it as something that is 
not for them. Indeed, a chief criticism of the tobacco 
industry-funded booklet Tobacco: Helping Youth Say No 
was that it portrayed tobacco use as a forbidden fruit 
and a badge of maturity, thereby increasing its attrac­
tion to youth (DiFranza and McAfee 1992). The Insti­
tute of Medicine noted that “as adolescents venture 
more and more into the community, their perceptions 
that certain norms seem to apply only to them and 
not to adults may promote health-compromising 
behaviors” (Lynch and Bonnie 1994, p. 87).  Young 
people participating in focus groups conducted dur­
ing the third year (1997–1998) of the CDC-funded 
Tobacco Network project reported that they respect 
and regard policies targeted to the public at large, such 
as clean indoor air laws, but resent policies specific to 
them, such as youth access restrictions. They also 
resented the inconsistent enforcement of general 
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Tips for Success in Health Promotion Campaigns 
•	 	 Target young people in grades six and nine (ages 
11 and 15). These years define critical periods 
in most children’s social development, times 
when many young people change schools and 
peer groups. 
•	 	 Target adults with complementary, noncontra­
dictory messages. In a comprehensive strategy, 
media messages that inevitably spill over from 
one audience to another can be mutually rein­
forcing and synergistic.  Clean indoor air mes­
sages can provide added motivation for adults 
to quit smoking. Cessation messages for adults 
can affect young people’s perception of norms 
and highlight the problem of addiction. Pre­
vention messages for young people can increase 
the salience of the tobacco issue among parents 
and community leaders. 
•	 	 Highlight nonsmoking as the majority behavior. 
Most young people overestimate the number 
of their peers who use tobacco. Campaigns 
should not seek to correct this misperception 
and highlight an increasing “problem” of kids 
who smoke. 
•	 	 Present realistic tobacco-free lifestyles as prac­
ticed by diverse, appealing, and interesting per­
sons. Youth behaviors are driven by how young 
people perceive the behaviors of people like 
them. Having a repertoire of social choices is a 
fundamental need for teens, who are going 
through a period of profound social and envi­
ronmental transition. 
policies, such as allowing teachers but not students to 
smoke on school property. 
Worden (in Cummings and Clarke 1998), referring 
to the research literature on multifaceted education cam­
paigns, noted that reducing the demand for tobacco 
among young people requires a combination of direct 
(to youth) and indirect (to adults) messages and careful 
attention to audience segmentation. He stressed that 
young people and adults need separate media cam­
paigns that do not contradict each other.  For example, 
a youth-directed television spot that communicates the 
•	 	 Provide constructive alternatives to tobacco 
use and discourage destructive alternatives. 
Sports and other youth-oriented activities as­
sociated with the tobacco-free lifestyle can pro­
vide some of that positive social repertoire. 
•	 	 Communicate the relevant dangers of tobacco. 
Certain dangers of tobacco, if explained in a 
creative and memorable manner, resonate with 
young people—for example, addiction por­
trayed as a loss of control, the carcinogenicity 
of environmental tobacco smoke, the toxic 
chemicals in tobacco products and smoke, and 
the tangible suffering and visible disfigurement 
from tobacco-related diseases.  Communicate 
health messages through personal testimonies 
(tell a story) and creative executions that break 
through young people’s sense of immortality 
and their (and adults’) resistance to traditional 
health messages. 
•	 	 Encourage youth empowerment and control. 
Teens need to be offered information and anec­
dotal experience from which they can begin to 
understand the world and take control of their 
own lives. 
•	 	 Abandon the search for the “magic-bullet” 
message. There is no single best motivator for 
preventing or reducing tobacco use.  Campaign 
messages for both young people and adults 
should feature a variety of themes, appeals (fear, 
humor, satire, testimonials, etc.), and execu­
tional styles. Maximize the number, variety, 
and novelty of messages rather than communi­
cating a few messages repeatedly. 
continued on next page 
message “most kids don’t smoke” can be neutralized 
by an adult-aimed but youth-viewed spot that says 
“more and more kids are smoking every day.” 
Characteristics of Successful Campaigns 
Though debate continues over the relative effec­
tiveness of strategies employing specific messages, the 
experience reviewed in preceding sections suggests 
consensus that counteradvertising campaigns must 
have sufficient reach, frequency, and duration to be 
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continued 
• Use multiple nonpreachy voices. Not only do 
different teens require different appeals and 
creative executions, but diversity of messages 
is itself a sophisticated message. Teens 
strongly reject attempts by anyone to domi­
nate or direct them.  Messages about indus­
try manipulation, if they are to be relevant and 
acceptable to youth, should be delivered by 
nonauthoritarian sources (such as Florida’s 
“Truth” campaign teenagers), not with melo­
dramatic appeals. Avoid highlighting a single 
theme, tagline, identifier, or sponsor. 
• Maximize use of existing high-quality media 
materials produced by the government, volun­
tary agencies, and a number of individual states. 
(A new, high-quality television spot commonly 
costs more than $100,000 to produce.)  A large 
collection of advertisements is currently avail-
able through the CDC’s Media Campaign Re-
source Center for Tobacco Control.  The cost of 
placing an advertisement will vary significantly 
by state and media market. 
• Include grassroots promotions, local media ad­
vocacy, event sponsorships, and other com­
munity tie-ins to support and reinforce the 
counteradvertising campaign (see “Media Ad-
vocacy,” earlier in this chapter).  Work in con­
cert with other interventions to promote policies 
that aim to change social norms regarding to-
bacco. A local “look” for local media messages 
(e.g., featuring people of ethnic or geographic 
representation similar to the viewing audience) 
appears to be more important for adults than 
for youth, because young people tend to share 
and be shaped by a more universal, multiethnic 
youth “media world.” 
• Use a complementary, reinforcing mix of tele­
vision, radio, print, and outdoor advertising. 
The campaign should also explore the vari­
ous alternative media options available (e.g., 
movie trailers, the Internet, other computer 
resources, video games, materials for schools 
and community groups).  The media mix is 
especially important in view of today’s pro-
liferating fragmented media market. 
• Involve parents and families in activities that 
will reduce risk factors and promote protec­
tive factors for young people at risk for to-
bacco use. Parents and other family members 
have substantial influence on the perceptions 
and behaviors of young people. 
successful. The 1967–1970 media campaign, enabled 
by the Fairness Doctrine, achieved high frequency (one 
antismoking advertisement per three cigarette adver­
tisements), extended reach (virtually complete audi­
ence penetration through three [pre-cable television] 
national networks), and long duration (three and a half 
years). The youth-aimed media campaign of the Uni­
versity of Vermont School and Mass Media Project 
exposed 50 percent of the target population to each 
television and radio spot about 6 times each year over 
a four-year period (about the midpoint in the recom­
mended exposure range of 3 to 10 times per year).  This 
level of exposure is possible only through paid media 
placement. 
Another lesson from health promotion campaigns 
is the need for research at every phase of campaign 
planning and implementation. Campaigns should be 
grounded in the extensive literature on psychosocial 
risk factors for initiating, continuing, and stopping 
tobacco use and should be guided by expertise in 
communications theory and practice. Media materials 
should undergo rigorous audience pretesting to ensure 
they achieve predetermined communication objectives 
with their target audiences.  Ongoing measurement of 
the communications’ impact is needed to evaluate the 
effectiveness of the campaign and to guide midcourse 
corrections. 
Through the Columbia University Prevention 
Research Center in New York City, the CDC convened 
a panel of youth marketing and research experts in 1996 
to advise the agency on effective countermarketing 
approaches to prevent tobacco use among young 
people. Over two years, the expert panel reviewed the 
literature, interviewed experts in tobacco control and 
health promotion, and drew on their private-sector 
experience and resources to develop a set of strategic 
guidelines for such a campaign (McKenna et al. 2000). 
This work, supplemented by other reviews of 
counteradvertising campaigns (USDHHS 1994; 
Pechmann 1997; Siegel 1998; Teenage Research 
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Unlimited 1999; Pechmann and Reibling 2000), 
yielded recommendations for effective media cam­
paigns to prevent tobacco use (see the text box “Tips 
for Success in Health Promotion Campaigns”). 
These recommendations serve as general guidance 
for tobacco counteradvertising efforts, but further 
research is needed to refine our understanding of the 
role and effects of mass media.  Relevant areas for fur­
ther investigation include determining the impact of 
Summary 
counteradvertising on tobacco use behaviors, on readi­
ness to quit, on attitudes toward tobacco advertising 
and tobacco use, and on other predictors of initiation 
and cessation; identifying the most effective themes, 
techniques, and messages; tailoring messages to high-
risk groups; exploring the role of new communication 
tools, such as the Internet; attributing impact; and ex­
amining the interaction of media campaigns with pri­
vate and public tobacco control policies. 
The conceptual framework described at the start 
of this chapter defines the basic components of the health 
promotion intervention model.  The statewide tobacco 
control programs being funded either by increases in 
cigarette excise taxes or settlements with the tobacco in­
dustry are creating a new laboratory to test many of these 
conceptual models for comprehensive tobacco control. 
Recently, both the Institute of Medicine (IOM) and re­
searchers have released reviews of the emerging data 
from these statewide tobacco control efforts.  In their 
report, the IOM (2000) noted that  it is difficult to at­
tribute a reduction in tobacco use to any single factor; 
nevertheless, they conclude that “multifaceted state 
tobacco control programs are effective in reducing to­
bacco use”(p. 4). In a review focusing more specifically 
on the effectiveness of these new statewide tobacco con­
trol programs on teenage smoking, Wakefield and 
Chaloupka (1999) conclude that “There is consistent 
evidence the programs are associated with a decline in 
adult smoking prevalence”(p. 6), but they are somewhat 
more cautious about the impact of these programs on 
youth smoking. Nevertheless, they do conclude that 
“Notwithstanding these cautions, we find that the 
weight of evidence falls in favor of comprehensive 
tobacco control programs being able to reduce teenage 
tobacco use” (p. 6). 
In the consideration of the emerging data from 
these statewide tobacco control programs, it is impor­
tant to note that many programmatic elements of the 
comprehensive tobacco control program framework 
are still being refined and evaluated.  Thus, no current 
statewide program serves an ideal or model program. 
Wakefield and Chaloupka (1999) conducted a careful 
review of the various elements of the statewide 
programs in Arizona, California, Florida, Massachu­
setts, and Oregon.  They placed special attention on 
the strengths of the “inputs”—“namely, what was 
actually implemented as part of the programs.” Addi­
tionally, they assessed how “actual implementation of 
program strategies may differ substantially from in­
tended implementation” and noted that “the extent of 
disparity may vary over time and between programs.” 
Much more evaluation research is needed in order to 
sort out the efficacy of individual components of these 
evolving comprehensive programs and to refine the 
comprehensive program structure. 
Finally, although the data from these statewide 
tobacco control programs are encouraging, these results 
need to be considered in the perspective of the less fa­
vorable results from the community trials.  The concep­
tual framework for the comprehensive tobacco control 
programs shares many elements with the theoretical 
models used to develop the community trial interven­
tions. However, as Wakefield and Chaloupka (1999) 
noted, the programs actually implemented may differ 
substantially from the intended implementation.  There 
has been some effort to analyze how the program 
components within the emerging statewide tobacco 
control programs may differ from interventions tested 
within the community trials (Green and Richard 1993; 
Schmid et al. 1995), but much more work is needed in 
this area.  As the IOM (2000) and Wakefield and 
Chaloupka (1999) concluded, the results from the state­
wide tobacco control programs are favorable. However, 
both reviews emphasize the importance of continued 
surveillance and evaluation efforts to monitor program 
performance, to provide accountability for the use of 
public funds, and to improve program  efforts. 
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Conclusions 
1.	 The large-scale interventions conducted in com­
munity trials have not demonstrated a conclusive 
impact on preventing and reducing tobacco use. 
3.	 Initial results from the statewide tobacco control 
programs are favorable, especially regarding 
declines in per capita consumption of tobacco 
products. 
2.	 Statewide programs have emerged as the new 
laboratory for developing and evaluating compre­
hensive plans to reduce tobacco use. 
4.	 Results of statewide tobacco control programs sug­
gest that youth behaviors regarding tobacco use are 
more difficult to change than adult ones, but initial 
results of these programs are generally favorable. 
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Reducing Tobacco Use 
Introduction 
Tobacco use, particularly cigarette smoking, re­
mains the leading cause of preventable illness and death 
in the United States (McGinnis and Foege 1993). A ma­
jor challenge to our nation’s public health leaders in 
the new millennium is to make this disturbing obser­
vation a thing of the past. Such a goal is no millennial 
dream. This Surgeon General’s report provides evi­
dence that tobacco use in this nation can be reduced 
through existing modalities of interventions. 
The substantial body of literature reviewed in this 
report indicates that each of the modalities—educational, 
clinical, regulatory, economic, and social—provides 
evidence of effectiveness.  The six major conclusions of 
this report provide the framework for the development 
of a coherent, long-term tobacco policy for this nation. 
Thus, although our knowledge about tobacco control re­
mains imperfect, we know more than enough to act now. 
Widespread dissemination of the approaches and meth­
ods shown to be effective in each modality and especially 
in combination would substantially 
•	 	 Reduce the number of young people who will 
become addicted to tobacco. 
•	 	 Increase the success rate of young people and 
adults trying to quit using tobacco. 
•	 	 Decrease the level of exposure of nonsmokers to 
environmental tobacco smoke (ETS). 
Continuing to Build the Scientific Base 
•	 	 Reduce the disparities related to tobacco use and 
its health effects among different population 
groups. 
•	 	 Decrease the future health burden of tobacco-
related disease and death in this country. 
These achievable improvements parallel the 
health objectives set forth in Healthy People 2010, the 
national action plan for improving the health of all 
people living in the United States for the first decade 
of the 21st century (U.S. Department of Health and 
Human Services [USDHHS] 2000). Twenty-one specific 
national health objectives related to tobacco use are 
listed in Healthy People 2010, including reducing the 
rates among young people and adults to less than 
half of the current rate of use.  Attaining all of these 
tobacco-related objectives will almost certainly 
require significant national commitment to the vari­
ous successful approaches described in this report. 
The report’s major conclusions are not formal 
policy recommendations.  Rather, they offer a sum­
mary of the scientific literature about what works.  In 
short, this report is intended to offer policymakers, 
public health professionals, professional and advocacy 
organizations, researchers, and, most important, the 
American people guidance on how to ensure that ef­
forts to prevent and control tobacco use are commen­
surate with the harm it causes. 
Beginning with the 1964 Surgeon General’s re­
port, Smoking and Health (U.S. Department of Health, 
Education, and Welfare 1964), tobacco control policy 
in this nation has been built on a foundation of scien­
tific knowledge. Each of the subsequent 24 reports of 
the Surgeon General on tobacco use has documented 
a vast and growing body of scientific literature.  The 
substantial research reviewed in this report focuses on 
a key segment of the literature—what has been tried 
in the decades-old effort to reduce tobacco use.  In turn, 
this focus clarifies which efforts work best.  Certainly 
more research is needed so that these efforts can be 
more efficient and effective; the key conclusion from 
this report, however, is that we know more than 
enough to take actions now to decrease the future 
health burden of tobacco-related disease and death in 
this country. 
In the process of applying our current state of 
knowledge about preventing and controlling tobacco 
use, accountability and evaluation of the public health 
effort will be critical.  However, because of the wide 
array of educational, clinical, regulatory, economic, and 
social influences that have been and will need to be 
brought to bear on the tobacco use problem, the direct 
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impact of a specific maneuver on a specific outcome 
becomes less meaningful as the combined effects be­
come more substantial.  Investigators tend to work on 
small, manageable aspects of the tobacco use problem, 
but the synergistic influence of multiple factors over 
time will likely extend far beyond the outcomes pre­
dicted from these smaller research undertakings.  For 
example, as this report demonstrates, the most effica­
cious educational programs are those that take place 
in a larger community context, one that engenders and 
supports an environment of nonsmoking.  Similarly, 
although clinical interventions to manage tobacco ad­
diction clearly have some specific power to help smok­
ers quit, primarily through pharmacological means, the 
social environment remains a major determinant of 
whether these new former smokers maintain their ab­
stinence from nicotine addiction.  Regulatory efforts, 
on the other hand, raise a host of social and economic 
issues and can produce broad societal changes—issues 
and changes, however, that are difficult to isolate, docu­
ment, and evaluate. Economic strategies also have a 
great potential, but being fundamentally political in 
The Changing Tobacco Industry 
nature, they require public consensus and changes in 
social norms before they can be attempted.  Finally, the 
public health advocacy involved in social program 
modalities is virtually impossible to assess in a pro­
spective or controlled research design. 
The research and evaluation tools of public health 
must expand to meet these complex issues. Compre­
hensive, multifactorial approaches to tobacco control 
appear to offer the most promise.  However, the pen­
alty for comprehensive approaches is a loss of statisti­
cal power to attribute outcomes to specific activities. 
Within each of the modalities, appropriate evaluation 
methodologies are being used (see Table 1.1).  However, 
many of these methodologies involve retrospective 
case study, time trend, econometric, and surveillance ap­
proaches to evaluate the “natural experiment” as it 
evolves in the changing social environment. Thus, the 
traditional biomedical and epidemiologic research 
methods that have worked so well in defining the health 
consequences of tobacco use are not well suited to evalu­
ating the potentially most efficacious methods to reduce 
tobacco use. 
This report documents that this country’s efforts 
to prevent the onset or continuance of tobacco use 
have faced the pervasive, countervailing influences 
of tobacco promotion by the tobacco industry. De­
spite the overwhelming and continually growing body 
of evidence of adverse health consequences of tobacco 
use, the norm of social acceptance of tobacco use in this 
nation has receded more slowly than might be ex­
pected, in part because of such continued promotion. 
Litigation and legal settlements have produced 
notable changes in the tobacco industry’s public posi­
tions on health risks, nicotine addiction, and advertis­
ing and promotion limits.  Additionally, individual 
manufacturing companies have become more directly 
involved in efforts to limit the access of underage per­
sons to tobacco products and to prevent young people 
from initiating tobacco use.  In this rapidly changing 
social and legal environment, it is difficult to project the 
nature and scope of future changes by the industry or 
their impact on the national effort to reduce tobacco use. 
Nevertheless, any analysis of changes in patterns of 
tobacco use must consider the influence of these indus­
try changes. 
One of the major arenas of potential change will 
be in the tobacco product itself.  The manufactured 
cigarette that is widely marketed in the developed 
world was noted to be changing dramatically when 
this issue was first considered by the Surgeon General 
in 1981, in The Changing Cigarette (USDHHS 1981). 
Recent public statements by the tobacco industry sug­
gest that the pace of changes in the manufactured ciga­
rette could be accelerating in the future.  The public 
health implications of changes in manufactured ciga­
rettes and other tobacco-containing products will re­
quire careful and significant attention from both public 
health researchers and policymakers. 
The litigation environment has demonstrated 
the importance of tobacco industry documents in 
analyzing the industry’s influence. Legal and public 
health analyses are just beginning to sift through the 
millions of pages of documents made public as part 
of the various legal actions undertaken over the last 
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decade. As this process continues, public health contributed to the character, pace, or direction of 
researchers may develop better methods to define and changes in tobacco use patterns in this country or 
evaluate the industry’s past activities that may have around the world. 
The Need for a Comprehensive Approach 
The evidence of effectiveness summarized in this 
report emphasizes that public health success in reduc­
ing tobacco use requires activity using multiple mo­
dalities. A comprehensive approach—one that 
optimizes synergy from applying a mix of educational, 
clinical, regulatory, economic, and social strategies— 
has emerged as the guiding principle for future efforts 
to reduce tobacco use.  The public health goals of such 
comprehensive programs are to reduce disease, dis­
ability, and death related to tobacco use through pre­
vention and cessation, as well as through protection 
of the nonsmoker from ETS. 
The emerging body of data on statewide tobacco 
control efforts is coming from programs broadly fo­
cused on prevention, cessation, and protection of the 
nonsmoker from ETS (Chapter 7).  Preventing initia­
tion among young people is a primary goal of any to­
bacco control effort.  However, young people will 
perceive contradictory or inconsistent messages in our 
prevention efforts if programs do not also address the 
smoking behavior of millions of parents and other 
adult role models and the public health risks of ETS. 
The Centers for Disease Control and Prevention 
(CDC) recently released Best Practices for Compr­
ehensive Tobacco Control Programs (CDC 1999), which 
recommends that states establish tobacco control 
programs that are comprehensive, sustainable, and 
accountable. This document draws upon “best prac­
tices” determined by evidence-based conclusions from 
research and evaluation of such comprehensive pro­
grams at the state level. In the review of evidence from 
these states, it was evident that reducing the broad 
cultural acceptability of tobacco use necessitates 
changing many facets of the social environment.  Nine 
specific elements of a comprehensive program are de­
fined in the guidance document. Although the im­
portance of each of the elements is highlighted, the 
document stresses that these individual components 
must work together to produce the synergistic effects 
of a comprehensive program. 
A medical analogy might be helpful to under­
stand the practical implications of the current state of 
knowledge about these best practices of tobacco con­
trol.  If we found a combination of nine therapy ele­
ments that effectively treated an almost incurable 
disease (e.g., advanced lung cancer), we would study 
the combined therapy in many ways to learn more 
about how it worked and which aspects of this combi­
nation therapy were most effective.  However, while 
we were doing this research, we would give every 
patient with the disease the full combination of the 
nine therapy elements. 
In the same way, with the nine components of 
Best Practices, we need to continue evaluating ongo­
ing comprehensive programs to gain more knowledge 
about how the components work individually and in 
combination. But while this research continues, states 
should be applying all nine components. 
Best Practices thus provides effective guidance for 
state-level efforts; a comprehensive national tobacco 
control effort, however, requires strategies that go be­
yond this guidance to states. As documented in ear­
lier chapters of this report, a comprehensive national 
effort should involve the application of a mix of edu­
cational, clinical, regulatory, economic, and social strat­
egies. In each of these modalities, some of the program 
and policy changes that are needed can be addressed 
most effectively at the national level. 
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Identifying and Eliminating Disparities 
The elimination of health disparities related to 
tobacco use poses a great national challenge.  Although 
this issue was not a main aspect of the current report, 
two other recent USDHHS publications have taken 
this focus. The 1998 Surgeon General’s report Tobacco 
Use Among U.S. Racial/Ethnic Minority Groups was the 
first to address the diverse tobacco control needs of 
the four major U.S. racial/ethnic minority groups— 
African Americans, American Indians and Alaska 
Natives, Asian Americans and Pacific Islanders, and 
Hispanics (USDHHS 1998). Similarly, Healthy People 
2010, released in January 2000, has two overarching 
goals: increase quality and years of healthy life and 
eliminate health disparities among different segments 
of the U.S. population (USDHHS 2000). Both publica­
tions not only highlight the significant disparities in 
health that exist in the United States but also stress the 
critical need for a greater focus on this issue, both in 
research and in public health action. 
Cultural, ethnic, religious, and social differences 
are clearly important in understanding patterns of to­
bacco use, but little research has been completed on the 
relative effectiveness of interventions for prevention and 
treatment in some of the population groups or com­
munities. Reaching the national goal of eliminating 
health disparities related to tobacco use will necessi­
tate improved collection and use of standardized data 
to correctly identify disparities in both health outcomes 
and efficacy of prevention programs among various 
population groups. Broader historical, societal, and 
community characteristics can have a significant in­
fluence on the manner in which prevention and con­
trol strategies that work overall for the population as 
a whole may impact diverse groups.  Many of these 
broader variables do not lend themselves to traditional 
measurement methods, nor are they easily assessed at 
the individual level through the use of traditional epi­
demiologic methods. 
Improving the Dissemination of State-of-the-Art Interventions
 

One of the greatest challenges in tobacco control 
and public health in general continues to be overcom­
ing the difficulty in getting advances in prevention and 
treatment strategies effectively disseminated, adopted, 
and implemented in their appropriate delivery systems. 
Simply stated, our recent lack of progress in tobacco 
control is attributable more to the failure to implement 
proven strategies than it is to a lack of knowledge about 
what to do. The result is that each year in this nation, 
more than 1 million young people continue to smoke, 
and more than 400,000 adults continue to die prema­
turely from tobacco-related diseases. 
Within each of the modalities reviewed in this 
report, some specific research advances in tobacco pre­
vention and control strategies have not been fully 
implemented. Studies are urgently needed to identify 
the social, institutional, and political barriers to the 
more rapid dissemination of these research advances. 
Understanding these barriers and determining how 
they could be overcome would benefit not only tobacco 
control but also public health efforts more broadly. 
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Tobacco Use in Developing Nations 
Analyses by the World Health Organization 
(WHO) have concluded that by 2030, current smok­
ing patterns will produce about 500 million premature 
deaths from tobacco-related disease among people 
alive today (World Health Organization 1999).  WHO 
further estimates that by 2030, tobacco is expected to 
be the single greatest cause of death worldwide, ac­
counting for an estimated 10 million deaths per year. 
Although the impact of tobacco-related disease and 
death has been until recently a problem primarily for 
the developed countries of this world, WHO now es­
timates that by 2020, 7 of every 10 tobacco-related 
deaths will be in the developing world. 
This report addresses research on strategies to re­
duce tobacco use within our nation’s social, legal, and 
cultural environment.  Nevertheless, findings from 
this report may have broad utility in the planning of 
tobacco control efforts around the world.  As Chapter 2 
documents, the public health response in this country 
to the scientific findings about the health consequences 
of tobacco products has taken more than four decades 
to emerge. In many parts of the developing world, 
the problems of tobacco use are similar to those in this 
country in the 1950s and 1960s. Hence, a key public 
health question for this millennium may be the fol­
lowing: can the time interval be significantly short­
ened between when the health risks of tobacco for a 
developing country are recognized and when a com­
prehensive national response is begun? 
WHO, the World Bank, and the United Nations 
Foundation, with technical assistance from the CDC, 
have undertaken major new initiatives to address this 
problem.  The WHO Tobacco Free Initiative is develop­
ing an international tobacco control infrastructure, 
which includes a global tobacco surveillance system, 
intervention tool kits, and regional technical assistance 
workshops. The World Bank has published Curbing 
the Epidemic: Governments and the Economics of Tobacco 
Control (Jha and Chaloupka 1999). This document 
provides an economic analysis that supports a 
multipronged approach to tobacco control, involving 
raising excise taxes, promoting policy changes related 
to the sales and promotion of tobacco products as well 
as to restrictions on smoking in public places, and wid­
ening access to smoking cessation therapies. The sci­
entific findings in this report are consistent with the 
programmatic recommendations of both the WHO 
Tobacco Free Initiative and the World Bank document. 
A momentous undertaking of WHO and mem­
ber states, including the United States, is the develop­
ment and negotiation of the Framework Convention 
on Tobacco Control.  If brought to its intended ratifi­
cation in the next few years, this agreement would 
provide a framework within which countries could 
develop more specific bilateral and multilateral pro­
tocols for cooperation on containing the spread of the 
tobacco epidemic. The framework would enable coun­
tries to start from a common understanding of the is­
sues, priorities, and strategies necessary to harmonize 
tobacco control efforts between themselves so that 
some countries do not benefit at the expense of others. 
This is the spirit of the other activities of U.S. govern­
mental and nongovernmental agencies in their effort 
to collaborate with WHO and with other countries in 
their development of surveillance, cessation, preven­
tion, mass media, regulatory, economic, and social 
approaches to global tobacco control. 
In the near future, emphasis must be placed on 
the development of surveillance systems so that coun­
tries can know the extent, distribution, and trends of 
the tobacco consumption problems in their popula­
tions. These systems will also track—for international 
comparison and monitoring of progress—the emer­
gence of new forms of tobacco promotion, as well as 
new legislation, regulations, and programs for coun­
tering tobacco use. In the longer term, the gaps must 
be filled in each country’s defenses against the incur­
sions of tobacco use on their young people and other 
vulnerable populations. In particular, there will be a 
continuing need to ensure that the rapidly expanding 
knowledge about the efficacy of various tobacco con­
trol modalities be made available to the developing 
world. 
The challenge to the world is to prevent tobacco 
use, particularly smoking, from ever becoming the lead­
ing cause of preventable illness and death in the world. 
Dr. Gro Harlem Brundtland, the current director-
general of WHO, clearly defined this challenge when 
she stated, “If we do not act decisively, a hundred years 
from now our grandchildren and their children will 
look back and seriously question how people claim­
ing to be committed to public health and social justice 
allowed the tobacco epidemic to unfold unchecked” 
(Asma et al., in press). 
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Tobacco Control in the New Millennium 
Tobacco use will remain the leading cause of 
preventable illness and death in this nation and a grow­
ing number of other countries until tobacco preven­
tion and control efforts are commensurate with the 
harm caused by tobacco use. This report provides the 
composite review of the major methods—educational, 
clinical, regulatory, economic, and social—that can 
guide the development of this expanded national ef­
fort. This report is, therefore, a prologue to the devel­
opment of a coherent, long-term tobacco policy for this 
nation. 
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